Conventional	O
cultivation	O
methods	O
were	O
used	O
to	O
evaluate	O
total	O
bacterial	O
growth	O
.	O

Total	O
genomic	O
DNA	O
was	O
isolated	O
and	O
a	O
specific	O
16S	O
rRNA	O
gene	O
-	O
targeted	O
region	O
was	O
PCR	O
-	O
amplified	O
and	O
separated	O
by	O
denaturing	O
gradient	O
gel	O
electrophoresis	O
.	O

A	O
combination	O
of	O
1D	O
sodium	O
dodecyl	O
sulfate	O
polyacrylamide	O
gel	O
electrophoresis	O
and	O
LC	O
-	O
MS	O
/	O
MS	O
methods	O
was	O
used	O
to	O
determine	O
the	O
effect	O
of	O
the	O
protease	O
inhibitors	O
on	O
the	O
integrity	O
of	O
salivary	O
proteins	O
and	O
peptides	O
.	O

Interestingly	O
,	O
no	O
significant	O
differences	O
were	O
observed	O
in	O
either	O
the	O
bacterial	O
growth	O
and	O
composition	O
or	O
the	O
integrity	O
of	O
salivary	O
proteins	O
between	O
the	O
two	O
groups	O
.	O

Correlation	O
coefficients	O
between	O
the	O
paired	O
samples	O
for	O
total	O
cultivable	O
microbiota	O
(	O
r	O
(	O
2	O
)	O
=	O
0	O
.	O
847	O
)	O
,	O
total	O
mutans	B-bacteria
streptococci	I-bacteria
(	O
r	O
(	O
2	O
)	O
=	O
0	O
.	O
898	O
)	O
,	O
total	O
oral	O
lactobacilli	B-bacteria
(	O
r	O
(	O
2	O
)	O
=	O
0	O
.	O
933	O
)	O
,	O
and	O
total	O
Streptococcus	B-bacteria
mutans	I-bacteria
(	O
r	O
(	O
2	O
)	O
=	O
0	O
.	O
870	O
)	O
also	O
exceeded	O
expected	O
values	O
.	O

The	O
results	O
suggest	O
that	O
the	O
addition	O
of	O
a	O
protease	O
inhibitor	O
cocktail	O
in	O
saliva	O
samples	O
does	O
not	O
impact	O
the	O
growth	O
of	O
oral	O
microbiota	O
or	O
compromise	O
the	O
ability	O
to	O
characterize	O
its	O
composition	O
.	O

Using	O
food	O
and	O
commensal	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
(	O
LAB	B-bacteria
)	O
as	O
vehicles	O
for	O
DNA	O
delivery	O
into	O
epithelial	O
cells	O
is	O
a	O
new	O
strategy	O
for	O
vaccine	O
delivery	O
or	O
gene	O
therapy	O
.	O

However	O
,	O
present	O
methods	O
for	O
DNA	O
delivery	O
with	O
LAB	B-bacteria
have	O
suffered	O
low	O
efficiency	O
.	O

Our	O
goal	O
was	O
to	O
develop	O
a	O
new	O
system	O
to	O
deliver	O
DNA	O
into	O
epithelial	O
cells	O
with	O
high	O
efficiency	O
using	O
food	O
and	O
commensal	O
LAB	B-bacteria
.	O

An	O
Escherichia	B-bacteria
coli	I-bacteria
-	O
LAB	B-bacteria
shuttle	O
plasmid	O
,	O
pLKV1	O
,	O
for	O
DNA	O
delivery	O
into	O
eukaryotic	O
cells	O
was	O
constructed	O
.	O

Two	O
reporter	O
plasmids	O
with	O
green	O
and	O
red	O
fluorescent	O
protein	O
genes	O
were	O
also	O
constructed	O
to	O
monitor	O
the	O
uptake	O
of	O
protein	O
and	O
DNA	O
,	O
respectively	O
.	O

Bacteria	O
delivering	O
these	O
reporter	O
plasmids	O
into	O
Caco	O
-	O
2	O
cells	O
were	O
monitored	O
by	O
fluorescence	O
microscopy	O
.	O

Several	O
methods	O
that	O
weaken	O
the	O
bacterial	O
cell	O
wall	O
prior	O
to	O
co	O
-	O
culture	O
with	O
Caco	O
-	O
2	O
cells	O
were	O
evaluated	O
for	O
their	O
role	O
in	O
the	O
improvement	O
of	O
gene	O
transfer	O
efficiency	O
.	O

Treating	O
Streptococcus	B-bacteria
gordonii	I-bacteria
with	O
penicillin	O
and	O
lysozyme	O
greatly	O
increased	O
its	O
rate	O
of	O
gene	O
delivery	O
to	O
mammalian	O
cells	O
compared	O
to	O
untreated	O
control	O
bacteria	O
,	O
while	O
glycine	O
pretreatment	O
promoted	O
the	O
highest	O
gene	O
transfer	O
rate	O
for	O
Lactococcus	B-bacteria
lactis	I-bacteria
.	O

Uptake	O
of	O
green	O
fluorescent	O
bacteria	O
by	O
Caco	O
-	O
2	O
cells	O
showed	O
that	O
the	O
cell	O
wall	O
-	O
weakening	O
treatment	O
promoted	O
the	O
internalization	O
of	O
the	O
noninvasive	O
bacteria	O
into	O
Caco	O
-	O
2	O
cells	O
.	O

In	O
conclusion	O
,	O
we	O
have	O
developed	O
a	O
noninvasive	O
system	O
using	O
LAB	B-bacteria
as	O
a	O
vehicle	O
for	O
vaccine	O
delivery	O
or	O
gene	O
therapy	O
,	O
and	O
tested	O
this	O
system	O
in	O
vitro	O
with	O
Caco	O
-	O
2	O
cells	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
infection	O
is	O
associated	O
with	O
peptic	O
ulcer	O
and	O
gastric	O
carcinoma	O
.	O

The	O
oral	O
cavity	O
may	O
be	O
a	O
reservoir	O
for	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
;	O
however	O
,	O
the	O
results	O
of	O
studies	O
on	O
this	O
subject	O
are	O
controversial	O
.	O

We	O
employed	O
single	O
-	O
step	O
and	O
nested	O
polymerase	O
chain	O
reactions	O
(	O
PCR	O
)	O
to	O
detect	O
the	O
presence	O
of	O
the	O
vacA	O
,	O
ureA	O
and	O
16S	O
rDNA	O
genes	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
stomach	O
,	O
saliva	O
and	O
dental	O
plaque	O
of	O
30	O
subjects	O
.	O

The	O
results	O
were	O
confirmed	O
by	O
sequencing	O
.	O

Nested	O
16S	O
rDNA	O
and	O
ureA	O
amplification	O
was	O
achieved	O
in	O
80	O
%	O
of	O
gastric	O
,	O
30	O
%	O
of	O
saliva	O
and	O
20	O
%	O
of	O
dental	O
plaque	O
specimens	O
.	O

Sequencing	O
of	O
10	O
,	O
seven	O
and	O
four	O
16S	O
rDNA	O
products	O
from	O
stomach	O
,	O
saliva	O
and	O
dental	O
plaque	O
,	O
respectively	O
,	O
showed	O
>	O
99	O
%	O
identity	O
with	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
.	O

Sequencing	O
of	O
the	O
other	O
four	O
oral	O
cavity	O
PCR	O
products	O
showed	O
similarity	O
with	O
Campylobacter	B-bacteria
and	O
Wolinella	B-bacteria
species	I-bacteria
.	O

Additionally	O
,	O
the	O
vacA	O
genotype	O
identified	O
in	O
the	O
samples	O
of	O
different	O
sites	O
was	O
the	O
same	O
within	O
a	O
given	O
subject	O
.	O

H	B-bacteria
.	I-bacteria
pylori	I-bacteria
may	O
be	O
found	O
in	O
the	O
oral	O
cavity	O
of	O
patients	O
with	O
gastric	O
infection	O
,	O
thus	O
it	O
could	O
be	O
a	O
source	O
of	O
transmission	O
.	O

However	O
,	O
results	O
obtained	O
with	O
detection	O
methods	O
based	O
only	O
on	O
PCR	O
should	O
be	O
interpreted	O
with	O
caution	O
because	O
other	O
microorganisms	O
that	O
are	O
phylogenetically	O
very	O
close	O
to	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
are	O
also	O
present	O
in	O
the	O
mouth	O
.	O

Periodontitis	O
is	O
a	O
chronic	O
inflammatory	O
disease	O
that	O
results	O
in	O
the	O
destruction	O
of	O
the	O
supporting	O
tissues	O
of	O
the	O
teeth	O
.	O

Gingival	O
epithelial	O
cells	O
are	O
an	O
important	O
mechanical	O
barrier	O
and	O
participate	O
in	O
the	O
host	O
inflammatory	O
response	O
to	O
periodontopathogens	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
is	O
to	O
investigate	O
the	O
capacity	O
of	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
to	O
bind	O
to	O
the	O
complement	O
regulatory	O
protein	O
CD46	O
expressed	O
by	O
oral	O
epithelial	O
cells	O
and	O
to	O
determine	O
the	O
impact	O
of	O
the	O
binding	O
on	O
the	O
gene	O
expression	O
and	O
protein	O
secretion	O
of	O
interleukin	O
(	O
IL	O
)	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
and	O
matrix	O
metalloproteinase	O
(	O
MMP	O
)	O
-	O
9	O
by	O
oral	O
epithelial	O
cells	O
.	O

Binding	O
of	O
recombinant	O
human	O
CD46	O
to	O
the	O
surface	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
was	O
demonstrated	O
by	O
immunologic	O
assays	O
.	O

After	O
stimulation	O
of	O
oral	O
epithelial	O
cells	O
with	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
,	O
gene	O
expression	O
was	O
determined	O
by	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
analysis	O
while	O
protein	O
secretion	O
was	O
monitored	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assays	O
.	O

Heat	O
and	O
protease	O
treatments	O
of	O
bacterial	O
cells	O
reduced	O
CD46	O
binding	O
.	O

F	O
.	O
nucleatum	O
-	O
bound	O
CD46	O
mediated	O
the	O
cleavage	O
of	O
C3b	O
in	O
the	O
presence	O
of	O
factor	O
I	O
.	O

Stimulating	O
oral	O
epithelial	O
cells	O
with	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
at	O
a	O
multiplicity	O
of	O
infection	O
of	O
50	O
resulted	O
in	O
a	O
significant	O
upregulation	O
of	O
the	O
gene	O
expression	O
and	O
protein	O
secretion	O
of	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
and	O
MMP	O
-	O
9	O
by	O
oral	O
epithelial	O
cells	O
.	O

However	O
,	O
pretreating	O
the	O
epithelial	O
cells	O
with	O
an	O
anti	O
-	O
CD46	O
polyclonal	O
antibody	O
attenuated	O
the	O
production	O
of	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
and	O
MMP	O
-	O
9	O
in	O
response	O
to	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

Such	O
an	O
inhibitory	O
effect	O
was	O
not	O
observed	O
with	O
non	O
-	O
specific	O
antibodies	O
.	O

The	O
present	O
study	O
demonstrates	O
that	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
can	O
bind	O
the	O
complement	O
regulatory	O
protein	O
CD46	O
.	O

The	O
interaction	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
with	O
epithelial	O
cell	O
surface	O
CD46	O
may	O
contribute	O
to	O
increasing	O
the	O
levels	O
of	O
proinflammatory	O
mediators	O
and	O
MMPs	O
in	O
periodontal	O
sites	O
and	O
consequently	O
modulate	O
tissue	O
destruction	O
.	O

The	O
oral	O
microbiota	O
plays	O
an	O
important	O
role	O
in	O
buccal	O
health	O
and	O
in	O
diseases	O
such	O
as	O
periodontitis	O
and	O
meningitis	O
.	O

The	O
study	O
of	O
the	O
human	O
oral	O
bacteria	O
has	O
so	O
far	O
focused	O
on	O
subjects	O
from	O
Western	O
societies	O
,	O
while	O
little	O
is	O
known	O
about	O
subjects	O
from	O
isolated	O
communities	O
.	O

This	O
work	O
determined	O
the	O
composition	O
of	O
the	O
oral	O
mucosa	O
microbiota	O
from	O
six	O
Amazon	O
Amerindians	O
,	O
and	O
tested	O
a	O
sample	O
preservation	O
alternative	O
to	O
freezing	O
.	O

Paired	O
oral	O
swabs	O
were	O
taken	O
from	O
six	O
adults	O
of	O
Guahibo	O
ethnicity	O
living	O
in	O
the	O
community	O
of	O
Platanillal	O
,	O
Amazonas	O
State	O
,	O
Venezuela	O
.	O

Replicate	O
swabs	O
were	O
preserved	O
in	O
liquid	O
nitrogen	O
and	O
in	O
Aware	O
Messenger	O
fluid	O
(	O
Calypte	O
)	O
.	O

Buccal	O
DNA	O
was	O
extracted	O
,	O
and	O
the	O
V2	O
region	O
of	O
the	O
16S	O
rRNA	O
gene	O
was	O
amplified	O
and	O
pyrosequenced	O
.	O

A	O
total	O
of	O
17	O
214	O
oral	O
bacterial	O
sequences	O
were	O
obtained	O
from	O
the	O
six	O
subjects	O
;	O
these	O
were	O
binned	O
into	O
1034	O
OTUs	O
from	O
10	O
phyla	O
,	O
30	O
families	O
and	O
51	O
genera	O
.	O

The	O
oral	O
mucosa	O
was	O
highly	O
dominated	O
by	O
four	O
phyla	O
:	O
Firmicutes	B-bacteria
(	O
mostly	O
the	O
genera	O
Streptococcus	B-bacteria
and	O
Veillonella	B-bacteria
)	O
,	O
Proteobacteria	B-bacteria
(	O
mostly	O
Neisseria	B-bacteria
)	O
,	O
Bacterioidetes	B-bacteria
(	O
Prevotella	B-bacteria
)	O
and	O
Actinobacteria	B-bacteria
(	O
Micrococcineae	B-bacteria
)	O
.	O

Although	O
the	O
microbiota	O
were	O
similar	O
at	O
the	O
phylum	O
level	O
,	O
the	O
Amerindians	O
shared	O
only	O
62	O
%	O
of	O
the	O
families	O
and	O
23	O
%	O
of	O
the	O
genera	O
with	O
non	O
-	O
Amerindians	O
from	O
previous	O
studies	O
,	O
and	O
had	O
a	O
lower	O
richness	O
of	O
genera	O
(	O
51	O
vs	O
177	O
reported	O
in	O
non	O
-	O
Amerindians	O
)	O
.	O

The	O
Amerindians	O
carried	O
unidentified	O
members	O
of	O
the	O
phyla	O
Bacteroidetes	B-bacteria
,	O
Firmicutes	B-bacteria
and	O
Proteobacteria	B-bacteria
and	O
their	O
microbiota	O
included	O
soil	O
bacteria	O
Gp1	B-bacteria
(	O
Acidobacteriaceae	B-bacteria
)	O
and	O
Xylanibacter	B-bacteria
(	O
Prevotellaceae	B-bacteria
)	O
,	O
and	O
the	O
rare	O
genus	O
Phocoenobacter	B-bacteria
(	O
Pasteurellaceae	B-bacteria
)	O
.	O

Preserving	O
buccal	O
swabs	O
in	O
the	O
Aware	O
Messenger	O
oral	O
fluid	O
collection	O
device	O
substantially	O
altered	O
the	O
bacterial	O
composition	O
in	O
comparison	O
to	O
freezing	O
,	O
and	O
therefore	O
this	O
method	O
can	O
not	O
be	O
used	O
to	O
preserve	O
samples	O
for	O
the	O
study	O
of	O
microbial	O
communities	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
assess	O
the	O
antibacterial	O
activity	O
of	O
sodium	O
citrate	O
against	O
Streptococcus	B-bacteria
pneumoniae	I-bacteria
and	O
several	O
oral	O
bacteria	O
.	O

The	O
antibacterial	O
activity	O
was	O
determined	O
by	O
broth	O
microdilution	O
method	O
.	O

The	O
results	O
showed	O
that	O
although	O
Enterocuccus	B-bacteria
faecium	I-bacteria
OB7084	I-bacteria
and	O
Klebsiella	B-bacteria
pneumoniae	I-bacteria
OB7088	I-bacteria
had	O
high	O
tolerance	O
to	O
sodium	O
citrate	O
,	O
several	O
oral	O
bacteria	O
including	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
JCM8532	I-bacteria
(	O
T	O
)	O
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
JCM5705	I-bacteria
(	O
T	O
)	O
and	O
Strep	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
NBRC102642	I-bacteria
(	O
T	O
)	O
were	O
susceptible	O
.	O

Furthermore	O
,	O
the	O
bactericidal	O
activity	O
of	O
sodium	O
citrate	O
against	O
Strep	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
NBRC102642	I-bacteria
(	O
T	O
)	O
was	O
not	O
influenced	O
by	O
pH	O
in	O
the	O
range	O
of	O
5	O
.	O
0	O
-	O
8	O
.	O
0	O
,	O
whereas	O
that	O
of	O
sodium	O
lactate	O
was	O
weakened	O
at	O
neutral	O
or	O
weak	O
alkaline	O
pH	O
.	O

When	O
Strep	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
NBRC102642	I-bacteria
(	O
T	O
)	O
was	O
treated	O
with	O
sodium	O
citrate	O
for	O
2	O
h	O
,	O
many	O
burst	O
cells	O
were	O
observed	O
.	O

However	O
,	O
addition	O
of	O
MgCl	O
(	O
2	O
)	O
or	O
CaCl	O
(	O
2	O
)	O
to	O
an	O
assay	O
medium	O
weakened	O
the	O
antimicrobial	O
activity	O
although	O
ZnCl	O
(	O
2	O
)	O
or	O
MnCl	O
(	O
2	O
)	O
did	O
not	O
influence	O
.	O

Independent	O
of	O
pH	O
,	O
sodium	O
citrate	O
inhibited	O
the	O
growth	O
of	O
oral	O
bacteria	O
,	O
which	O
suggests	O
that	O
the	O
mechanism	O
is	O
different	O
from	O
that	O
of	O
sodium	O
lactate	O
.	O

The	O
results	O
presented	O
in	O
this	O
study	O
would	O
be	O
available	O
for	O
understanding	O
the	O
antimicrobial	O
property	O
of	O
sodium	O
citrate	O
.	O

Acid	O
etching	O
procedures	O
may	O
disrupt	O
residual	O
bacteria	O
and	O
contribute	O
to	O
the	O
success	O
of	O
incomplete	O
caries	O
removal	O
followed	O
by	O
adhesive	O
restoration	O
.	O

This	O
study	O
evaluated	O
the	O
in	O
vivo	O
effect	O
of	O
acid	O
etching	O
on	O
cariogenic	O
bacterial	O
activity	O
within	O
affected	O
dentin	O
after	O
minimally	O
invasive	O
treatment	O
of	O
caries	O
lesions	O
.	O

Twenty	O
-	O
eight	O
carious	O
permanent	O
teeth	O
received	O
standardized	O
selective	O
caries	O
removal	O
and	O
random	O
acid	O
etch	O
treatment	O
(	O
E	O
)	O
or	O
not	O
(	O
NE	O
)	O
prior	O
to	O
adhesive	O
restoration	O
.	O

Baseline	O
and	O
3	O
-	O
month	O
dentin	O
biopsies	O
were	O
collected	O
.	O

The	O
number	O
of	O
bacteria	O
and	O
activity	O
of	O
total	O
bacterial	O
cells	O
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
were	O
determined	O
by	O
quantitative	O
PCR	O
and	O
RT	O
-	O
PCR	O
.	O

No	O
statistically	O
significant	O
differences	O
were	O
observed	O
in	O
total	O
bacterial	O
number	O
and	O
activity	O
between	O
E	O
and	O
NE	O
treatments	O
(	O
p	O
>	O
0	O
.	O
3008	O
)	O
.	O

For	O
NE	O
,	O
however	O
,	O
the	O
residual	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
bacterial	O
cells	O
were	O
reduced	O
(	O
p	O
=	O
0	O
.	O
0027	O
)	O
,	O
while	O
the	O
activity	O
per	O
cell	O
was	O
significantly	O
increased	O
(	O
p	O
=	O
0	O
.	O
0010	O
)	O
after	O
reentry	O
at	O
3	O
months	O
after	O
restoration	O
.	O

This	O
effect	O
was	O
not	O
observed	O
in	O
group	O
E	O
.	O

Although	O
no	O
significant	O
differences	O
were	O
found	O
between	O
groups	O
,	O
this	O
study	O
suggests	O
that	O
acid	O
etching	O
of	O
affected	O
dentin	O
prior	O
to	O
adhesive	O
restoration	O
may	O
directly	O
or	O
indirectly	O
have	O
an	O
inhibitive	O
effect	O
on	O
the	O
activity	O
of	O
residual	O
cariogenic	O
bacteria	O
.	O

Further	O
research	O
is	O
required	O
to	O
investigate	O
this	O
potential	O
effect	O
.	O

Severe	O
early	O
childhood	O
caries	O
is	O
a	O
microbial	O
infection	O
that	O
severely	O
compromises	O
the	O
dentition	O
of	O
young	O
children	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
characterize	O
the	O
microbiota	O
of	O
severe	O
early	O
childhood	O
caries	O
.	O

Dental	O
plaque	O
samples	O
from	O
2	O
-	O
to	O
6	O
-	O
year	O
-	O
old	O
children	O
were	O
analyzed	O
using	O
16S	O
rRNA	O
gene	O
cloning	O
and	O
sequencing	O
,	O
and	O
by	O
specific	O
PCR	O
amplification	O
for	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Bifidobacteriaceae	B-bacteria
species	I-bacteria
.	O

Children	O
with	O
severe	O
caries	O
(	O
n	O
=	O
39	O
)	O
had	O
more	O
dental	O
plaque	O
and	O
gingival	O
inflammation	O
than	O
caries	O
-	O
free	O
children	O
(	O
n	O
=	O
41	O
)	O
.	O

Analysis	O
of	O
phylotypes	O
from	O
operational	O
taxonomic	O
unit	O
analysis	O
of	O
16S	O
rRNA	O
clonal	O
metalibraries	O
from	O
severe	O
caries	O
and	O
caries	O
-	O
free	O
children	O
indicated	O
that	O
while	O
libraries	O
differed	O
significantly	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
,	O
there	O
was	O
increased	O
diversity	O
than	O
detected	O
in	O
this	O
clonal	O
analysis	O
.	O

Using	O
the	O
Human	O
Oral	O
Microbiome	O
Database	O
,	O
139	O
different	O
taxa	O
were	O
identified	O
.	O

Within	O
the	O
limits	O
of	O
this	O
study	O
,	O
caries	O
-	O
associated	O
taxa	O
included	O
Granulicatella	B-bacteria
elegans	I-bacteria
(	O
p	O
<	O
0	O
.	O
01	O
)	O
and	O
Veillonella	B-bacteria
sp	I-bacteria
.	I-bacteria
HOT	I-bacteria
-	I-bacteria
780	I-bacteria
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

The	O
species	O
associated	O
with	O
caries	O
-	O
free	O
children	O
included	O
Capnocytophaga	B-bacteria
gingivalis	I-bacteria
(	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
Abiotrophia	B-bacteria
defectiva	I-bacteria
(	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
Lachnospiraceae	B-bacteria
sp	I-bacteria
.	I-bacteria
HOT	I-bacteria
-	I-bacteria
100	I-bacteria
(	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
(	O
p	O
<	O
0	O
.	O
05	O
)	O
and	O
Streptococcus	B-bacteria
cristatus	I-bacteria
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

By	O
specific	O
PCR	O
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
(	O
p	O
<	O
0	O
.	O
005	O
)	O
and	O
Bifidobacteriaceae	B-bacteria
spp	I-bacteria
.	I-bacteria
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
were	O
significantly	O
associated	O
with	O
severe	O
caries	O
.	O

Clonal	O
analysis	O
of	O
80	O
children	O
identified	O
a	O
diverse	O
microbiota	O
that	O
differed	O
between	O
severe	O
caries	O
and	O
caries	O
-	O
free	O
children	O
,	O
but	O
the	O
association	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
with	O
caries	O
was	O
from	O
specific	O
PCR	O
analysis	O
,	O
not	O
from	O
clonal	O
analysis	O
,	O
of	O
samples	O
.	O

To	O
investigate	O
whether	O
short	O
-	O
term	O
daily	O
consumption	O
of	O
yoghurt	O
leads	O
to	O
colonization	O
by	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
in	O
a	O
group	O
of	O
human	O
subjects	O
who	O
were	O
initially	O
totally	O
devoid	O
of	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
in	O
their	O
oral	O
cavities	O
.	O

Twenty	O
-	O
three	O
volunteers	O
consumed	O
yogurt	O
containing	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
during	O
a	O
14	O
-	O
day	O
trial	O
stage	O
.	O

Oral	O
and	O
fecal	O
samples	O
were	O
collected	O
at	O
the	O
clearance	O
stage	O
and	O
at	O
the	O
post	O
-	O
yoghurt	O
intake	O
stage	O
until	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
was	O
found	O
.	O

Standard	O
polymerase	O
chain	O
reaction	O
methods	O
using	O
specific	O
primers	O
were	O
adopted	O
for	O
the	O
detection	O
and	O
identification	O
of	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
.	O

The	O
isolation	O
frequency	O
decreased	O
rapidly	O
72	O
h	O
after	O
stopping	O
intake	O
of	O
yoghurt	O
.	O

After	O
1	O
week	O
,	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
was	O
absent	O
in	O
all	O
oral	O
samples	O
.	O

Non	O
-	O
significant	O
differences	O
were	O
found	O
between	O
the	O
survival	O
rates	O
of	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
in	O
samples	O
of	O
saliva	O
,	O
plaque	O
,	O
tongue	O
surface	O
,	O
and	O
buccal	O
mucosa	O
.	O

L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
was	O
also	O
found	O
to	O
remain	O
in	O
the	O
gastrointestinal	O
tract	O
for	O
longer	O
than	O
in	O
the	O
oral	O
cavity	O
.	O

Allochthonous	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
is	O
not	O
likely	O
to	O
permanently	O
colonize	O
the	O
oral	O
cavity	O
and	O
intestine	O
.	O

Quorum	O
sensing	O
is	O
defined	O
as	O
the	O
ability	O
of	O
microorganisms	O
to	O
sense	O
their	O
population	O
density	O
via	O
the	O
release	O
of	O
signaling	O
molecules	O
composed	O
of	O
acyl	O
-	O
homoserine	O
lactone	O
(	O
AHL	O
)	O
,	O
which	O
is	O
a	O
type	O
of	O
autoinducer	O
(	O
AI	O
)	O
.	O

Previous	O
structure	O
-	O
activity	O
relationship	O
(	O
SAR	O
)	O
studies	O
demonstrated	O
that	O
the	O
3	O
-	O
oxo	O
group	O
,	O
homoserine	O
lactone	O
of	O
L	O
-	O
form	O
,	O
and	O
long	O
acyl	O
side	O
chain	O
have	O
crucial	O
roles	O
in	O
apoptosis	O
induction	O
.	O

Various	O
types	O
of	O
synthetic	O
AI	O
analogs	O
of	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
were	O
prepared	O
,	O
and	O
SAR	O
study	O
was	O
conducted	O
to	O
determine	O
their	O
effects	O
against	O
human	O
oral	O
squamous	O
carcinoma	O
cells	O
derived	O
from	O
gingival	O
carcinoma	O
Ca9	O
-	O
22	O
cells	O
and	O
tongue	O
cancer	O
SAS	O
cells	O
.	O

Not	O
only	O
the	O
antiproliferative	O
potential	O
but	O
also	O
the	O
radiation	O
-	O
sensitizing	O
effects	O
against	O
these	O
cells	O
were	O
examined	O
.	O

It	O
was	O
found	O
that	O
antiproliferative	O
activity	O
partly	O
depended	O
on	O
HSL	O
structure	O
and	O
acyl	O
side	O
chain	O
length	O
.	O

Moreover	O
,	O
a	O
few	O
compounds	O
,	O
compound	O
5	O
and	O
87	O
,	O
showed	O
antiproliferative	O
effects	O
against	O
both	O
Ca9	O
-	O
22	O
and	O
SAS	O
cells	O
,	O
and	O
also	O
induced	O
radiation	O
-	O
sensitizing	O
effects	O
against	O
Ca9	O
-	O
22	O
cells	O
.	O

Compound	O
5	O
alone	O
induced	O
apoptotic	O
cell	O
death	O
accompanied	O
by	O
sub	O
-	O
G1	O
phase	O
accumulation	O
in	O
cell	O
cycle	O
and	O
caspase	O
-	O
3	O
activation	O
,	O
and	O
radiation	O
-	O
sensitizing	O
effects	O
of	O
compound	O
5	O
could	O
be	O
attributed	O
to	O
enhanced	O
apoptosis	O
induction	O
.	O

In	O
contrast	O
,	O
there	O
were	O
no	O
remarkable	O
alterations	O
in	O
cell	O
cycle	O
distribution	O
in	O
Ca9	O
-	O
22	O
treated	O
with	O
compound	O
87	O
alone	O
or	O
in	O
combination	O
.	O

However	O
,	O
both	O
compounds	O
lack	O
3	O
-	O
oxo	O
and	O
their	O
acyl	O
side	O
chain	O
lengths	O
are	O
not	O
necessarily	O
long	O
.	O

This	O
SAR	O
study	O
demonstrated	O
that	O
HSL	O
analogs	O
,	O
which	O
lacked	O
the	O
recommended	O
characteristics	O
for	O
apoptosis	O
induction	O
clearly	O
showed	O
antiproliferative	O
and	O
radiation	O
-	O
sensitizing	O
activity	O
in	O
Ca9	O
-	O
22	O
cells	O
.	O

This	O
study	O
examined	O
in	O
vivo	O
and	O
in	O
vitro	O
colonization	O
by	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
an	O
organism	O
highly	O
associated	O
with	O
aggressive	O
periodontitis	O
.	O

Thirteen	O
volunteers	O
(	O
5	O
were	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
positive	O
for	O
buccal	O
epithelial	O
cells	O
[	O
BECs	O
]	O
and	O
teeth	O
,	O
5	O
were	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
positive	O
for	O
teeth	O
only	O
,	O
and	O
3	O
were	O
A	O
.	O
actinomycetemcomitans	O
-	O
negative	O
controls	O
)	O
had	O
two	O
mandibular	O
stents	O
fabricated	O
.	O

Each	O
stent	O
contained	O
3	O
removable	O
hydroxyapatite	O
(	O
HA	O
)	O
tooth	O
surrogates	O
.	O

One	O
HA	O
square	O
was	O
removed	O
from	O
a	O
stent	O
at	O
5	O
time	O
points	O
over	O
7	O
h	O
to	O
assess	O
the	O
transfer	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
from	O
teeth	O
or	O
BECs	O
to	O
HA	O
.	O

Streptococcus	B-bacteria
,	O
Actinomyces	B-bacteria
,	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
and	O
total	O
anaerobic	O
counts	O
were	O
evaluated	O
on	O
each	O
square	O
over	O
time	O
.	O

In	O
vitro	O
experiments	O
evaluated	O
binding	O
,	O
desorption	O
,	O
transfer	O
,	O
and	O
reattachment	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
wild	O
-	O
type	O
and	O
mutant	O
strains	O
to	O
BECs	O
and	O
saliva	O
-	O
coated	O
HA	O
(	O
SHA	O
)	O
.	O

Streptococcus	B-bacteria
and	O
Actinomyces	B-bacteria
formed	O
80	O
%	O
of	O
the	O
cultivable	O
flora	O
on	O
HA	O
in	O
all	O
subjects	O
.	O

Transfer	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
to	O
HA	O
was	O
not	O
seen	O
in	O
subjects	O
with	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
on	O
teeth	O
only	O
.	O

All	O
5	O
subjects	O
with	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
on	O
BECs	O
showed	O
transfer	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
to	O
HA	O
.	O

In	O
vitro	O
,	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
desorbed	O
from	O
BECs	O
and	O
transferred	O
to	O
SHA	O
.	O

A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
binding	O
to	O
SHA	O
was	O
irreversible	O
and	O
did	O
not	O
transfer	O
to	O
BECs	O
.	O

The	O
adhesin	O
Aae	O
showed	O
specificity	O
for	O
BECs	O
.	O

Fimbrial	O
mutants	O
showed	O
the	O
greatest	O
reduction	O
in	O
binding	O
to	O
SHA	O
.	O

A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
migrated	O
from	O
BECs	O
to	O
HA	O
in	O
vivo	O
and	O
to	O
SHA	O
in	O
vitro	O
;	O
however	O
,	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
movement	O
from	O
teeth	O
and	O
SHA	O
to	O
BECs	O
did	O
not	O
occur	O
.	O

In	O
vivo	O
,	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
colonized	O
HA	O
within	O
6	O
h	O
and	O
thus	O
can	O
be	O
considered	O
an	O
early	O
colonizer	O
.	O

BECs	O
are	O
a	O
likely	O
reservoir	O
for	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
tooth	O
colonization	O
.	O

Dental	O
caries	O
is	O
initiated	O
by	O
demineralization	O
of	O
the	O
tooth	O
surface	O
through	O
acid	O
production	O
by	O
sugar	O
metabolism	O
of	O
supragingival	O
plaque	O
microflora	O
.	O

To	O
elucidate	O
the	O
sugar	O
metabolic	O
system	O
,	O
we	O
used	O
CE	O
-	O
MS	O
to	O
perform	O
metabolomics	O
of	O
the	O
central	O
carbon	O
metabolism	O
,	O
the	O
EMP	O
pathway	O
,	O
the	O
pentose	O
-	O
phosphate	O
pathway	O
,	O
and	O
the	O
TCA	O
cycle	O
in	O
supra	O
-	O
gingival	O
plaque	O
and	O
representative	O
oral	O
bacteria	O
,	O
Streptococcus	B-bacteria
and	O
Actinomyces	B-bacteria
.	O

Supragingival	O
plaque	O
contained	O
all	O
the	O
targeted	O
metabolites	O
in	O
the	O
central	O
carbon	O
metabolism	O
,	O
except	O
erythrose	O
4	O
-	O
phosphate	O
in	O
the	O
pentose	O
-	O
phosphate	O
pathway	O
.	O

After	O
glucose	O
rinse	O
,	O
glucose	O
6	O
-	O
phosphate	O
,	O
fructose	O
6	O
-	O
phosphate	O
,	O
fructose	O
1	O
,	O
6	O
-	O
bisphosphate	O
,	O
dihydroxyacetone	O
phosphate	O
,	O
and	O
pyruvate	O
in	O
the	O
EMP	O
pathway	O
and	O
6	O
-	O
phosphogluconate	O
,	O
ribulose	O
5	O
-	O
phosphate	O
,	O
and	O
sedoheptulose	O
7	O
-	O
phosphate	O
in	O
the	O
pentose	O
-	O
phosphate	O
pathway	O
,	O
and	O
acetyl	O
CoA	O
were	O
increased	O
.	O

Meanwhile	O
,	O
3	O
-	O
phosphoglycerate	O
and	O
phosphoenolpyruvate	O
in	O
the	O
EMP	O
pathway	O
and	O
succinate	O
,	O
fumarate	O
,	O
and	O
malate	O
in	O
the	O
TCA	O
cycle	O
were	O
decreased	O
.	O

These	O
pathways	O
and	O
changes	O
in	O
metabolites	O
observed	O
in	O
supragingival	O
plaque	O
were	O
similar	O
to	O
the	O
integration	O
of	O
metabolite	O
profiles	O
in	O
Streptococcus	B-bacteria
and	O
Actinomyces	B-bacteria
.	O

Supra	O
-	O
and	O
subgingival	O
biofilm	O
formation	O
is	O
considered	O
to	O
be	O
mainly	O
responsible	O
for	O
early	O
implant	O
failure	O
caused	O
by	O
inflammations	O
of	O
periimplant	O
tissues	O
.	O

Nevertheless	O
,	O
little	O
is	O
known	O
about	O
the	O
complex	O
microbial	O
diversity	O
and	O
interindividual	O
similarities	O
around	O
dental	O
implants	O
.	O

An	O
atraumatic	O
assessment	O
was	O
made	O
of	O
the	O
diversity	O
of	O
microbial	O
communities	O
around	O
titanium	O
implants	O
by	O
single	O
strand	O
conformation	O
polymorphism	O
(	O
SSCP	O
)	O
analysis	O
of	O
the	O
16S	O
rRNA	O
gene	O
amplicons	O
as	O
well	O
as	O
subsequent	O
sequence	O
analysis	O
.	O

Samples	O
of	O
adherent	O
supra	O
-	O
and	O
subgingival	O
periimplant	O
biofilms	O
were	O
collected	O
from	O
ten	O
patients	O
.	O

Additionally	O
,	O
samples	O
of	O
sulcusfluid	O
were	O
taken	O
at	O
titanium	O
implant	O
abutments	O
and	O
remaining	O
teeth	O
.	O

The	O
bacteria	O
in	O
the	O
samples	O
were	O
characterized	O
by	O
SSCP	O
and	O
sequence	O
analysis	O
.	O

A	O
high	O
diversity	O
of	O
bacteria	O
varying	O
between	O
patients	O
and	O
within	O
one	O
patient	O
at	O
different	O
locations	O
was	O
found	O
.	O

Bacteria	O
characteristic	O
for	O
sulcusfluid	O
and	O
supra	O
-	O
and	O
subgingival	O
biofilm	O
communities	O
were	O
identified	O
.	O

Sulcusfluid	O
of	O
the	O
abutments	O
showed	O
higher	O
abundance	O
of	O
Streptococcus	B-bacteria
species	I-bacteria
than	O
from	O
residual	O
teeth	O
.	O

Prevotella	B-bacteria
and	O
Rothia	B-bacteria
species	I-bacteria
frequently	O
reported	O
from	O
the	O
oral	O
cavity	O
were	O
not	O
detected	O
at	O
the	O
abutments	O
suggesting	O
a	O
role	O
as	O
late	O
colonizers	O
.	O

Different	O
niches	O
in	O
the	O
human	O
mouth	O
are	O
characterized	O
by	O
specific	O
groups	O
of	O
bacteria	O
.	O

Implant	O
abutments	O
are	O
a	O
very	O
valuable	O
approach	O
to	O
study	O
dental	O
biofilm	O
development	O
in	O
vivo	O
.	O

Interferon	O
gamma	O
(	O
IFN	O
-	O
gamma	O
)	O
is	O
one	O
of	O
the	O
key	O
regulatory	O
cytokines	O
that	O
has	O
a	O
significant	O
effect	O
on	O
immune	O
responses	O
.	O

It	O
may	O
be	O
important	O
in	O
the	O
chronic	O
inflammatory	O
diseases	O
such	O
as	O
periodontitis	O
in	O
which	O
increased	O
IFN	O
-	O
gamma	O
levels	O
were	O
found	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
analyze	O
+	O
874A	O
/	O
T	O
polymorphism	O
in	O
the	O
IFN	O
-	O
gamma	O
gene	O
and	O
its	O
associations	O
with	O
the	O
presence	O
of	O
periodontopathic	O
bacteria	O
and	O
susceptibility	O
to	O
generalized	O
chronic	O
periodontitis	O
(	O
CP	O
)	O
.	O

A	O
total	O
of	O
498	O
unrelated	O
Czech	O
white	O
subjects	O
were	O
included	O
in	O
the	O
present	O
study	O
.	O

Genomic	O
DNA	O
was	O
obtained	O
from	O
the	O
peripheral	O
blood	O
of	O
244	O
patients	O
with	O
CP	O
and	O
254	O
healthy	O
subjects	O
.	O

The	O
IFN	O
-	O
gamma	O
+	O
874A	O
/	O
T	O
polymorphism	O
was	O
determined	O
by	O
amplification	O
refractory	O
mutation	O
system	O
-	O
polymerase	O
chain	O
reaction	O
(	O
ARMS	O
-	O
PCR	O
)	O
.	O

Subgingival	O
bacterial	O
colonization	O
(	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
,	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
,	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
micros	I-bacteria
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
in	O
subgingival	O
pockets	O
)	O
was	O
investigated	O
by	O
the	O
DNA	O
-	O
microarray	O
based	O
periodontal	O
pathogen	O
detection	O
kit	O
in	O
a	O
subgroup	O
of	O
subjects	O
(	O
N	O
=	O
110	O
)	O
.	O

Our	O
results	O
showed	O
no	O
differences	O
in	O
the	O
allele	O
and	O
genotype	O
frequencies	O
of	O
the	O
IFN	O
-	O
gamma	O
+	O
874A	O
/	O
T	O
polymorphism	O
between	O
patients	O
with	O
CP	O
and	O
controls	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
.	O

Although	O
we	O
found	O
significant	O
differences	O
in	O
the	O
occurrence	O
of	O
periodontal	O
bacteria	O
between	O
patients	O
with	O
CP	O
and	O
healthy	O
controls	O
(	O
from	O
P	O
<	O
0	O
.	O
00001	O
to	O
P	O
<	O
0	O
.	O
05	O
)	O
,	O
no	O
significant	O
association	O
between	O
IFN	O
-	O
gamma	O
+	O
874A	O
/	O
T	O
polymorphism	O
and	O
periodontal	O
pathogens	O
was	O
observed	O
in	O
any	O
group	O
.	O

In	O
conclusion	O
,	O
these	O
findings	O
indicate	O
that	O
putative	O
functional	O
variant	O
in	O
the	O
IFN	O
-	O
gamma	O
is	O
not	O
associated	O
with	O
susceptibility	O
to	O
chronic	O
periodontitis	O
or	O
microbial	O
composition	O
in	O
the	O
Czech	O
population	O
.	O

Propolis	O
is	O
a	O
multifunctional	O
substance	O
used	O
by	O
bees	O
to	O
maintain	O
the	O
safety	O
of	O
their	O
hives	O
.	O

It	O
is	O
worldwide	O
used	O
for	O
its	O
potential	O
therapeutic	O
effects	O
.	O

In	O
this	O
study	O
,	O
Tunisian	O
propolis	O
ethanol	O
extract	O
(	O
EEP	O
)	O
was	O
tested	O
for	O
their	O
anti	O
-	O
cariogenic	O
,	O
anti	O
-	O
biofilms	O
and	O
antiproliferative	O
effects	O
of	O
many	O
cell	O
lines	O
.	O

The	O
Tunisian	O
EEP	O
was	O
evaluated	O
in	O
vitro	O
against	O
33	O
oral	O
pathogens	O
including	O
streptococci	B-bacteria
and	O
enterococci	B-bacteria
using	O
broth	O
microdilution	O
method	O
.	O

The	O
anti	O
-	O
biofilms	O
activity	O
of	O
EEP	O
was	O
assessed	O
via	O
Crystal	O
Violet	O
staining	O
and	O
MTT	O
assays	O
.	O

The	O
Tunisian	O
EEP	O
antiproliferative	O
effect	O
was	O
evaluated	O
on	O
normal	O
(	O
MRC	O
-	O
5	O
)	O
and	O
cancer	O
cell	O
lines	O
(	O
HT	O
-	O
29	O
,	O
A549	O
,	O
Hep	O
-	O
2	O
,	O
raw	O
264	O
.	O
7	O
,	O
Vero	O
)	O
by	O
the	O
ability	O
of	O
the	O
cells	O
to	O
metabolically	O
reduce	O
MTT	O
to	O
a	O
formazan	O
dye	O
.	O

Our	O
results	O
revealed	O
that	O
Tunisian	O
EEP	O
possessed	O
excellent	O
protective	O
effects	O
against	O
cariogenic	O
and	O
biofilms	O
activity	O
of	O
oral	O
streptococci	B-bacteria
.	O

Furthermore	O
,	O
EEP	O
showed	O
a	O
strong	O
antiproliferative	O
potencies	O
against	O
all	O
studied	O
cancer	O
cell	O
lines	O
as	O
judged	O
by	O
IC50	O
and	O
its	O
value	O
ranges	O
from	O
15	O
.	O
7	O
+	O
/	O
-	O
3	O
.	O
4	O
to	O
200	O
+	O
/	O
-	O
22	O
.	O
2	O
mug	O
mL	O
(	O
-	O
)	O
(	O
1	O
)	O
.	O

These	O
results	O
suggest	O
that	O
EEP	O
is	O
able	O
to	O
inhibit	O
cancer	O
cell	O
proliferation	O
,	O
cariogenic	O
bacteria	O
and	O
oral	O
biofilms	O
formation	O
.	O

It	O
could	O
have	O
a	O
promising	O
role	O
in	O
the	O
future	O
medicine	O
and	O
nutrition	O
when	O
used	O
as	O
antibiotic	O
or	O
food	O
additive	O
.	O

Periodontal	O
disease	O
has	O
been	O
associated	O
with	O
atherosclerosis	O
,	O
suggesting	O
that	O
bacteria	O
from	O
the	O
oral	O
cavity	O
may	O
contribute	O
to	O
the	O
development	O
of	O
atherosclerosis	O
and	O
cardiovascular	O
disease	O
.	O

Furthermore	O
,	O
the	O
gut	O
microbiota	O
may	O
affect	O
obesity	O
,	O
which	O
is	O
associated	O
with	O
atherosclerosis	O
.	O

Using	O
qPCR	O
,	O
we	O
show	O
that	O
bacterial	O
DNA	O
was	O
present	O
in	O
the	O
atherosclerotic	O
plaque	O
and	O
that	O
the	O
amount	O
of	O
DNA	O
correlated	O
with	O
the	O
amount	O
of	O
leukocytes	O
in	O
the	O
atherosclerotic	O
plaque	O
.	O

To	O
investigate	O
the	O
microbial	O
composition	O
of	O
atherosclerotic	O
plaques	O
and	O
test	O
the	O
hypothesis	O
that	O
the	O
oral	O
or	O
gut	O
microbiota	O
may	O
contribute	O
to	O
atherosclerosis	O
in	O
humans	O
,	O
we	O
used	O
454	O
pyrosequencing	O
of	O
16S	O
rRNA	O
genes	O
to	O
survey	O
the	O
bacterial	O
diversity	O
of	O
atherosclerotic	O
plaque	O
,	O
oral	O
,	O
and	O
gut	O
samples	O
of	O
15	O
patients	O
with	O
atherosclerosis	O
,	O
and	O
oral	O
and	O
gut	O
samples	O
of	O
healthy	O
controls	O
.	O

We	O
identified	O
Chryseomonas	B-bacteria
in	O
all	O
atherosclerotic	O
plaque	O
samples	O
,	O
and	O
Veillonella	B-bacteria
and	O
Streptococcus	B-bacteria
in	O
the	O
majority	O
.	O

Interestingly	O
,	O
the	O
combined	O
abundances	O
of	O
Veillonella	B-bacteria
and	O
Streptococcus	B-bacteria
in	O
atherosclerotic	O
plaques	O
correlated	O
with	O
their	O
abundance	O
in	O
the	O
oral	O
cavity	O
.	O

Moreover	O
,	O
several	O
additional	O
bacterial	O
phylotypes	O
were	O
common	O
to	O
the	O
atherosclerotic	O
plaque	O
and	O
oral	O
or	O
gut	O
samples	O
within	O
the	O
same	O
individual	O
.	O

Interestingly	O
,	O
several	O
bacterial	O
taxa	O
in	O
the	O
oral	O
cavity	O
and	O
the	O
gut	O
correlated	O
with	O
plasma	O
cholesterol	O
levels	O
.	O

Taken	O
together	O
,	O
our	O
findings	O
suggest	O
that	O
bacteria	O
from	O
the	O
oral	O
cavity	O
,	O
and	O
perhaps	O
even	O
the	O
gut	O
,	O
may	O
correlate	O
with	O
disease	O
markers	O
of	O
atherosclerosis	O
.	O

Mother	O
'	O
s	O
milk	O
is	O
a	O
source	O
of	O
bacteria	O
that	O
influences	O
the	O
development	O
of	O
the	O
infant	O
commensal	O
gut	O
microbiota	O
.	O

To	O
date	O
,	O
the	O
species	O
diversity	O
and	O
relative	O
abundance	O
of	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
in	O
the	O
milk	O
of	O
non	O
-	O
human	O
primates	O
have	O
not	O
been	O
described	O
.	O

Milk	O
samples	O
were	O
aseptically	O
obtained	O
from	O
54	O
female	O
rhesus	O
monkeys	O
(	O
Macaca	O
mulatta	O
)	O
at	O
peak	O
lactation	O
.	O

Following	O
GM17	O
and	O
MRS	O
agar	O
plating	O
,	O
single	O
bacterial	O
colonies	O
were	O
isolated	O
based	O
on	O
difference	O
in	O
morphotypes	O
,	O
then	O
grouped	O
based	O
on	O
whole	O
-	O
cell	O
protein	O
profiles	O
on	O
SDS	O
-	O
PAGE	O
.	O

Bacterial	O
DNA	O
was	O
isolated	O
and	O
the	O
sequence	O
the	O
16S	O
rRNA	O
gene	O
was	O
analyzed	O
.	O

A	O
total	O
of	O
106	O
strains	O
of	O
19	O
distinct	O
bacterial	O
species	O
,	O
belonging	O
to	O
five	O
genera	O
,	O
Bacillus	B-bacteria
,	O
Enterococcus	B-bacteria
,	O
Lactobacillus	B-bacteria
,	O
Pediococcus	B-bacteria
,	O
and	O
Streptococcus	B-bacteria
,	O
were	O
identified	O
.	O

Maternal	O
gut	O
and	O
oral	O
commensal	O
bacteria	O
may	O
be	O
translocated	O
to	O
the	O
mammary	O
gland	O
during	O
lactation	O
and	O
present	O
in	O
milk	O
.	O

This	O
pathway	O
can	O
be	O
an	O
important	O
source	O
of	O
commensal	O
bacteria	O
to	O
the	O
infant	O
gut	O
and	O
oral	O
cavity	O
.	O

To	O
study	O
the	O
plasma	O
treatment	O
effects	O
on	O
deactivation	O
effectiveness	O
of	O
oral	O
bacteria	O
.	O

A	O
low	O
temperature	O
atmospheric	O
argon	O
plasma	O
brush	O
were	O
used	O
to	O
study	O
the	O
oral	O
bacterial	O
deactivation	O
effects	O
in	O
terms	O
of	O
plasma	O
conditions	O
,	O
plasma	O
exposure	O
time	O
,	O
and	O
bacterial	O
supporting	O
media	O
.	O

Oral	O
bacteria	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
with	O
an	O
initial	O
bacterial	O
population	O
density	O
between	O
1	O
.	O
0x10	O
(	O
8	O
)	O
and	O
5	O
.	O
0x10	O
(	O
8	O
)	O
cfu	O
/	O
ml	O
were	O
seeded	O
on	O
various	O
media	O
and	O
their	O
survivability	O
with	O
plasma	O
exposure	O
was	O
examined	O
.	O

Scanning	O
electron	O
microscopy	O
was	O
used	O
to	O
examine	O
the	O
morphological	O
changes	O
of	O
the	O
plasma	O
treated	O
bacteria	O
.	O

Optical	O
absorption	O
was	O
used	O
to	O
determine	O
the	O
leakage	O
of	O
intracellular	O
proteins	O
and	O
DNAs	O
of	O
the	O
plasma	O
treated	O
bacteria	O
.	O

The	O
experimental	O
data	O
indicated	O
that	O
the	O
argon	O
atmospheric	O
plasma	O
brush	O
was	O
very	O
effective	O
in	O
deactivating	O
oral	O
bacteria	O
.	O

The	O
plasma	O
exposure	O
time	O
for	O
a	O
99	O
.	O
9999	O
%	O
cell	O
reduction	O
was	O
less	O
than	O
15s	O
for	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
within	O
5	O
min	O
for	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
.	O

It	O
was	O
found	O
that	O
the	O
plasma	O
deactivation	O
efficiency	O
was	O
also	O
dependent	O
on	O
the	O
bacterial	O
supporting	O
media	O
.	O

With	O
plasma	O
exposure	O
,	O
significant	O
damages	O
to	O
bacterial	O
cell	O
structures	O
were	O
observed	O
with	O
both	O
bacterium	O
species	O
.	O

Leakage	O
of	O
intracellular	O
proteins	O
and	O
DNAs	O
after	O
plasma	O
exposure	O
was	O
observed	O
through	O
monitoring	O
the	O
absorbance	O
peaks	O
at	O
wavelengths	O
of	O
280	O
nm	O
and	O
260	O
nm	O
,	O
respectively	O
.	O

The	O
experimental	O
results	O
from	O
this	O
study	O
indicated	O
that	O
low	O
temperature	O
atmospheric	O
plasma	O
treatment	O
was	O
very	O
effective	O
in	O
deactivation	O
of	O
oral	O
bacteria	O
and	O
could	O
be	O
a	O
promising	O
technique	O
in	O
various	O
dental	O
clinical	O
applications	O
such	O
as	O
bacterial	O
disinfection	O
and	O
caries	O
early	O
prevention	O
.	O

Enterococci	B-bacteria
,	O
particularly	O
Enterococcus	B-bacteria
faecalis	I-bacteria
,	O
are	O
still	O
a	O
primary	O
concern	O
in	O
endodontic	O
infections	O
.	O

To	O
date	O
,	O
enterococci	B-bacteria
have	O
been	O
considered	O
to	O
be	O
only	O
transiently	O
present	O
in	O
the	O
oral	O
cavity	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	O
whether	O
different	O
enterococci	B-bacteria
from	O
food	O
are	O
able	O
to	O
reside	O
in	O
oral	O
biofilm	O
.	O

Six	O
healthy	O
volunteers	O
wore	O
dental	O
splints	O
loaded	O
with	O
enamel	O
slabs	O
.	O

After	O
3	O
days	O
,	O
the	O
volunteers	O
consumed	O
cheese	O
containing	O
enterococci	B-bacteria
.	O

The	O
fate	O
of	O
the	O
enterococci	B-bacteria
was	O
analyzed	O
by	O
culture	O
technique	O
and	O
16S	O
rRNA	O
gene	O
sequencing	O
.	O

All	O
isolates	O
were	O
characterized	O
genotypically	O
by	O
macrorestriction	O
analysis	O
(	O
SmaI	O
)	O
and	O
pulsed	O
-	O
field	O
gel	O
electrophoresis	O
.	O

E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
was	O
also	O
analyzed	O
by	O
using	O
fluorescent	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
.	O

E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
,	O
E	B-bacteria
.	I-bacteria
faecium	I-bacteria
,	O
E	B-bacteria
.	I-bacteria
avium	I-bacteria
,	O
and	O
E	B-bacteria
.	I-bacteria
durans	I-bacteria
were	O
detected	O
in	O
the	O
initial	O
biofilm	O
after	O
2	O
hours	O
,	O
as	O
well	O
as	O
in	O
the	O
5	O
-	O
day	O
-	O
old	O
oral	O
biofilm	O
.	O

E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
,	O
E	B-bacteria
.	I-bacteria
faecium	I-bacteria
,	O
and	O
E	B-bacteria
.	I-bacteria
avium	I-bacteria
isolated	O
from	O
the	O
initial	O
biofilm	O
and	O
from	O
the	O
5	O
-	O
day	O
-	O
old	O
biofilm	O
,	O
as	O
well	O
as	O
those	O
isolated	O
from	O
cheese	O
,	O
showed	O
genetic	O
homogeneity	O
.	O

E	B-bacteria
.	I-bacteria
faecium	I-bacteria
and	O
E	B-bacteria
.	I-bacteria
avium	I-bacteria
had	O
integrated	O
into	O
a	O
pre	O
-	O
existing	O
3	O
-	O
day	O
-	O
old	O
biofilm	O
.	O

No	O
genetic	O
similarity	O
between	O
E	B-bacteria
.	I-bacteria
durans	I-bacteria
strains	I-bacteria
isolated	O
from	O
cheese	O
and	O
those	O
from	O
the	O
initial	O
and	O
5	O
-	O
day	O
-	O
old	O
oral	O
biofilm	O
was	O
detected	O
.	O

E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
was	O
also	O
detected	O
in	O
the	O
oral	O
biofilm	O
by	O
using	O
FISH	O
.	O

Food	O
-	O
borne	O
enterococci	B-bacteria
,	O
particularly	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
,	O
might	O
not	O
only	O
be	O
transient	O
but	O
could	O
also	O
survive	O
in	O
the	O
oral	O
biofilm	O
and	O
become	O
a	O
source	O
for	O
endodontic	O
infections	O
.	O

Moreover	O
,	O
genotypic	O
analysis	O
is	O
required	O
to	O
study	O
the	O
source	O
of	O
oral	O
enterococci	B-bacteria
.	O

Dental	O
caries	O
and	O
periodontitis	O
are	O
common	O
oral	O
bacterial	O
infectious	O
diseases	O
.	O

Their	O
prevention	O
and	O
treatment	O
requires	O
control	O
of	O
the	O
causative	O
pathogens	O
,	O
such	O
as	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
that	O
exist	O
within	O
dental	O
plaque	O
.	O

As	O
one	O
of	O
the	O
attractive	O
future	O
substitutes	O
for	O
conventional	O
antibiotics	O
,	O
antimicrobial	O
peptides	O
(	O
AMPs	O
)	O
,	O
both	O
natural	O
and	O
synthetic	O
,	O
have	O
been	O
widely	O
tested	O
and	O
used	O
for	O
controlling	O
bacterial	O
infections	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
antimicrobial	O
activity	O
of	O
KSL	O
(	O
KKVVFKVKFK	O
-	O
NH	O
(	O
2	O
)	O
)	O
,	O
a	O
novel	O
AMP	O
,	O
against	O
several	O
major	O
cariogenic	O
and	O
periodontopathogenic	O
bacteria	O
as	O
well	O
as	O
Candida	O
albicans	O
in	O
vitro	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
,	O
the	O
causative	O
agent	O
of	O
dental	O
caries	O
,	O
was	O
chosen	O
for	O
in	O
-	O
depth	O
testing	O
.	O

Bacterial	O
susceptibility	O
and	O
time	O
-	O
kill	O
assays	O
were	O
performed	O
to	O
investigate	O
the	O
sensitivity	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
to	O
KSL	O
.	O

The	O
effect	O
of	O
KSL	O
on	O
biofilm	O
formation	O
and	O
on	O
pre	O
-	O
formed	O
biofilm	O
was	O
also	O
examined	O
.	O

For	O
biofilm	O
studies	O
,	O
confocal	O
laser	O
scanning	O
microscopy	O
(	O
CLSM	O
)	O
was	O
used	O
to	O
observe	O
and	O
analyse	O
bacterial	O
biofilm	O
.	O

The	O
results	O
showed	O
that	O
KSL	O
had	O
antimicrobial	O
activity	O
against	O
a	O
variety	O
of	O
oral	O
bacteria	O
and	O
fungi	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
were	O
the	O
most	O
susceptible	O
strains	O
to	O
KSL	O
peptide	O
[	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
of	O
0	O
.	O
0625	O
mg	O
/	O
mL	O
]	O
compared	O
with	O
other	O
species	O
tested	O
(	O
MICs	O
of	O
0	O
.	O
125	O
-	O
1mg	O
/	O
mL	O
)	O
.	O

KSL	O
also	O
inhibited	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilm	O
formation	O
,	O
with	O
a	O
minimum	O
biofilm	O
inhibition	O
concentration	O
of	O
0	O
.	O
0625	O
-	O
0	O
.	O
125	O
mg	O
/	O
mL	O
,	O
and	O
reduced	O
1	O
-	O
day	O
-	O
old	O
developed	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilm	O
,	O
with	O
a	O
minimum	O
biofilm	O
reduction	O
concentration	O
of	O
0	O
.	O
25	O
-	O
0	O
.	O
5mg	O
/	O
mL	O
.	O

CLSM	O
images	O
showed	O
that	O
KSL	O
significantly	O
reduced	O
the	O
viability	O
of	O
biofilm	O
cells	O
.	O

This	O
study	O
suggests	O
that	O
KSL	O
may	O
have	O
a	O
potential	O
clinical	O
application	O
in	O
treating	O
dental	O
caries	O
by	O
killing	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
within	O
dental	O
plaque	O
.	O

Caries	O
and	O
periodontitis	O
are	O
important	O
human	O
diseases	O
associated	O
with	O
formation	O
of	O
multi	O
-	O
species	O
biofilms	O
.	O

The	O
involved	O
bacteria	O
are	O
intensively	O
studied	O
to	O
understand	O
the	O
molecular	O
basis	O
of	O
the	O
interactions	O
in	O
such	O
biofilms	O
.	O

This	O
study	O
established	O
a	O
basic	O
in	O
vitro	O
single	O
and	O
mixed	O
-	O
species	O
culture	O
model	O
for	O
oral	O
bacteria	O
combining	O
three	O
complimentary	O
methods	O
.	O

The	O
setup	O
allows	O
a	O
rapid	O
screening	O
for	O
effects	O
in	O
the	O
mutual	O
species	O
interaction	O
.	O

Furthermore	O
,	O
it	O
is	O
easy	O
to	O
handle	O
,	O
inexpensive	O
,	O
and	O
reproducible	O
.	O

Streptococcus	B-bacteria
mitis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
,	O
typical	O
inhabitants	O
of	O
the	O
healthy	O
oral	O
cavity	O
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
as	O
main	O
carriogenic	O
species	O
,	O
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Parvimonas	B-bacteria
micra	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
intermedius	I-bacteria
and	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
as	O
periodontitis	O
-	O
associated	O
bacteria	O
,	O
were	O
investigated	O
for	O
their	O
biofilm	O
forming	O
ability	O
.	O

Different	O
liquid	O
growth	O
media	O
were	O
evaluated	O
.	O

Safranin	O
-	O
staining	O
allowed	O
monitoring	O
of	O
biofilm	O
formation	O
under	O
the	O
chosen	O
conditions	O
.	O

Viable	O
counts	O
and	O
microscopy	O
permitted	O
investigation	O
of	O
biofilm	O
behavior	O
in	O
mixed	O
-	O
species	O
and	O
transwell	O
setups	O
.	O

S	B-bacteria
.	I-bacteria
mitis	I-bacteria
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
micra	I-bacteria
failed	O
to	O
form	O
biofilm	O
structures	O
.	O

S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
intermedius	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
established	O
abundant	O
biofilm	O
masses	O
in	O
CDM	O
/	O
sucrose	O
.	O

A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
formed	O
patchy	O
monolayers	O
.	O

For	O
in	O
depth	O
analysis	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
were	O
chosen	O
,	O
because	O
i	O
)	O
they	O
are	O
representatives	O
of	O
the	O
physiological	O
-	O
,	O
cariogenic	O
and	O
periodontitis	O
-	O
associated	O
bacterial	O
flora	O
,	O
respectively	O
and	O
ii	O
)	O
their	O
difference	O
in	O
their	O
biofilm	O
forming	O
ability	O
.	O

Microscopic	O
analysis	O
confirmed	O
the	O
results	O
of	O
safranin	O
staining	O
.	O

Investigation	O
of	O
two	O
species	O
combinations	O
of	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
with	O
either	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
or	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
revealed	O
bacterial	O
interactions	O
influencing	O
biofilm	O
mass	O
,	O
biofilm	O
structure	O
and	O
cell	O
viability	O
.	O

This	O
setup	O
shows	O
safranin	O
staining	O
,	O
microscopic	O
analysis	O
and	O
viable	O
counts	O
together	O
are	O
crucial	O
for	O
basic	O
examination	O
and	O
evaluation	O
of	O
biofilms	O
.	O

Our	O
experiment	O
generated	O
meaningful	O
results	O
,	O
exemplified	O
by	O
the	O
noted	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
influence	O
,	O
and	O
allows	O
a	O
fast	O
decision	O
about	O
the	O
most	O
important	O
bacterial	O
interactions	O
which	O
should	O
be	O
investigated	O
in	O
depth	O
.	O

Whereas	O
periodontal	O
disease	O
is	O
ultimately	O
of	O
bacterial	O
etiology	O
,	O
from	O
multispecies	O
biofilms	O
of	O
gram	O
-	O
negative	O
anaerobic	O
microorganisms	O
,	O
much	O
of	O
the	O
deleterious	O
effects	O
are	O
caused	O
by	O
the	O
resultant	O
epithelial	O
inflammatory	O
response	O
.	O

Hence	O
,	O
development	O
of	O
a	O
treatment	O
that	O
combines	O
anti	O
-	O
biofilm	O
antibiotic	O
activity	O
with	O
anti	O
-	O
inflammatory	O
activity	O
would	O
be	O
of	O
great	O
utility	O
.	O

Antimicrobial	O
peptides	O
(	O
AMPs	O
)	O
such	O
as	O
defensins	O
are	O
naturally	O
occurring	O
peptides	O
that	O
exhibit	O
broad	O
-	O
spectrum	O
activity	O
as	O
well	O
as	O
a	O
variety	O
of	O
immunomodulatory	O
activities	O
.	O

Furthermore	O
,	O
bacteria	O
do	O
not	O
readily	O
develop	O
resistance	O
to	O
these	O
agents	O
.	O

However	O
,	O
clinical	O
studies	O
have	O
suggested	O
that	O
they	O
do	O
not	O
represent	O
optimal	O
candidates	O
for	O
exogenous	O
therapeutic	O
agents	O
.	O

Small	O
-	O
molecule	O
mimetics	O
of	O
these	O
AMPs	O
exhibit	O
similar	O
activities	O
to	O
the	O
parent	O
peptides	O
,	O
in	O
addition	O
to	O
having	O
low	O
toxicity	O
,	O
high	O
stability	O
and	O
low	O
cost	O
.	O

To	O
determine	O
whether	O
AMP	O
mimetics	O
have	O
the	O
potential	O
for	O
treatment	O
of	O
periodontal	O
disease	O
,	O
we	O
examined	O
the	O
activity	O
of	O
one	O
mimetic	O
,	O
mPE	O
,	O
against	O
biofilm	O
cultures	O
of	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
.	O

Metabolic	O
assays	O
as	O
well	O
as	O
culture	O
and	O
biomass	O
measurement	O
assays	O
demonstrated	O
that	O
mPE	O
exhibits	O
potent	O
activity	O
against	O
biofilm	O
cultures	O
of	O
both	O
species	O
.	O

Furthermore	O
,	O
as	O
little	O
as	O
2	O
mug	O
ml	O
(	O
-	O
1	O
)	O
mPE	O
was	O
sufficient	O
to	O
inhibit	O
interleukin	O
-	O
1beta	O
-	O
induced	O
secretion	O
of	O
interleukin	O
-	O
8	O
in	O
both	O
gingival	O
epithelial	O
cells	O
and	O
THP	O
-	O
1	O
cells	O
.	O

This	O
anti	O
-	O
inflammatory	O
activity	O
is	O
associated	O
with	O
a	O
reduction	O
in	O
activation	O
of	O
nuclear	O
factor	O
-	O
kappaB	O
,	O
suggesting	O
that	O
mPE	O
can	O
act	O
both	O
as	O
an	O
anti	O
-	O
biofilm	O
agent	O
in	O
an	O
anaerobic	O
environment	O
and	O
as	O
an	O
anti	O
-	O
inflammatory	O
agent	O
in	O
infected	O
tissues	O
.	O

Oral	O
lesions	O
of	O
tuberculosis	O
though	O
uncommon	O
,	O
are	O
seen	O
both	O
in	O
the	O
primary	O
as	O
well	O
as	O
the	O
secondary	O
stages	O
of	O
the	O
disease	O
.	O

In	O
secondary	O
tuberculosis	O
,	O
the	O
oral	O
manifestations	O
are	O
accompanied	O
by	O
lesions	O
in	O
the	O
lung	O
,	O
lymph	O
nodes	O
,	O
or	O
any	O
other	O
organ	O
system	O
of	O
the	O
body	O
.	O

This	O
can	O
be	O
detected	O
by	O
the	O
usual	O
clinical	O
history	O
and	O
systemic	O
examination	O
.	O

Primary	O
oral	O
tuberculosis	O
may	O
thus	O
present	O
as	O
a	O
diagnostic	O
challenge	O
to	O
the	O
clinician	O
.	O

Amongst	O
the	O
oral	O
lesions	O
also	O
,	O
tongue	O
is	O
the	O
usual	O
site	O
for	O
tubercular	O
infection	O
,	O
with	O
the	O
upper	O
lip	O
and	O
soft	O
palate	O
being	O
the	O
least	O
affected	O
.	O

The	O
authors	O
report	O
two	O
rare	O
cases	O
of	O
children	O
with	O
isolated	O
primary	O
tuberculosis	O
of	O
the	O
lip	O
and	O
uvula	O
.	O

Interestingly	O
,	O
the	O
first	O
case	O
presenting	O
just	O
as	O
a	O
diffuse	O
swelling	O
of	O
the	O
upper	O
lip	O
,	O
and	O
the	O
second	O
as	O
pain	O
in	O
throat	O
with	O
congestion	O
and	O
granulations	O
on	O
the	O
uvula	O
.	O

We	O
suggest	O
a	O
distinct	O
Indian	O
social	O
habit	O
which	O
predisposes	O
to	O
primary	O
lip	O
and	O
uvular	O
tuberculosis	O
,	O
sites	O
not	O
common	O
in	O
the	O
rest	O
of	O
the	O
world	O
.	O

The	O
habit	O
of	O
doing	O
`	O
`	O
datoon	O
'	O
'	O
i	O
.	O
e	O
.	O
brushing	O
of	O
the	O
teeth	O
with	O
neem	O
twigs	O
in	O
rural	O
India	O
,	O
which	O
at	O
times	O
causes	O
trauma	O
on	O
the	O
palate	O
and	O
thus	O
predisposing	O
to	O
seedling	O
of	O
the	O
wound	O
with	O
mycobacterium	B-bacteria
tuberculosis	I-bacteria
.	O

Oral	O
streptococci	B-bacteria
are	O
a	O
heterogeneous	O
group	O
of	O
human	O
commensals	O
,	O
with	O
a	O
potential	O
to	O
cause	O
serious	O
infections	O
.	O

Activation	O
of	O
plasminogen	O
has	O
been	O
shown	O
to	O
increase	O
the	O
virulence	O
of	O
typical	O
human	O
pathogenic	O
streptococci	B-bacteria
such	O
as	O
S	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
.	O

One	O
important	O
factor	O
for	O
plasminogen	O
activation	O
is	O
the	O
streptococcal	B-bacteria
alpha	O
-	O
enolase	O
.	O

Here	O
we	O
report	O
that	O
plasminogen	O
activation	O
is	O
also	O
common	O
in	O
oral	O
streptococci	B-bacteria
species	I-bacteria
involved	O
in	O
clinical	O
infection	O
and	O
that	O
it	O
depends	O
on	O
the	O
action	O
of	O
human	O
plasminogen	O
activators	O
.	O

The	O
ability	O
to	O
activate	O
plasminogen	O
did	O
not	O
require	O
full	O
conservation	O
of	O
the	O
internal	O
plasminogen	O
binding	O
sequence	O
motif	O
FYDKERKVY	O
of	O
alpha	O
-	O
enolase	O
that	O
was	O
previously	O
described	O
as	O
crucial	O
for	O
increased	O
plasminogen	O
binding	O
,	O
activation	O
and	O
virulence	O
.	O

Instead	O
,	O
experiments	O
with	O
recombinant	O
alpha	O
-	O
enolase	O
variants	O
indicate	O
that	O
the	O
naturally	O
occurring	O
variations	O
do	O
not	O
impair	O
plasminogen	O
binding	O
.	O

In	O
spite	O
of	O
these	O
variations	O
in	O
the	O
internal	O
plasminogen	O
binding	O
motif	O
oral	O
streptococci	B-bacteria
showed	O
similar	O
activation	O
of	O
plasminogen	O
.	O

We	O
conclude	O
that	O
the	O
pathomechanism	O
of	O
plasminogen	O
activation	O
is	O
conserved	O
in	O
oral	O
streptococci	B-bacteria
that	O
cause	O
infections	O
in	O
human	O
.	O

This	O
may	O
contribute	O
to	O
their	O
opportunistic	O
pathogenic	O
character	O
that	O
is	O
unfurled	O
in	O
certain	O
niches	O
.	O

The	O
antibacterial	O
activity	O
and	O
cytotoxicity	O
of	O
two	O
novel	O
cross	O
-	O
linking	O
antibacterial	O
monomers	O
,	O
2	O
-	O
methacryloxylethyl	O
dodecyl	O
methyl	O
ammonium	O
bromide	O
(	O
MAE	O
-	O
DB	O
)	O
and	O
2	O
-	O
methacryloxylethyl	O
hexadecyl	O
methyl	O
ammonium	O
bromide	O
(	O
MAE	O
-	O
HB	O
)	O
were	O
tested	O
in	O
this	O
study	O
.	O

The	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
and	O
the	O
minimum	O
bactericidal	O
concentration	O
(	O
MBC	O
)	O
of	O
unpolymerized	O
MAE	O
-	O
DB	O
and	O
MAE	O
-	O
HB	O
against	O
eight	O
strains	O
of	O
oral	O
bacteria	O
were	O
tested	O
using	O
a	O
broth	O
dilution	O
test	O
.	O

Time	O
-	O
kill	O
determinations	O
were	O
performed	O
to	O
examine	O
the	O
kinetics	O
of	O
unpolymerized	O
MAE	O
-	O
DB	O
and	O
MAE	O
-	O
HB	O
against	O
Streptococcus	B-bacteria
mutans	I-bacteria
UA159	I-bacteria
and	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
ATCC6715	I-bacteria
.	O

Bacterial	O
morphology	O
was	O
observed	O
using	O
a	O
field	O
emission	O
scanning	O
electron	O
microscope	O
(	O
Fe	O
-	O
SEM	O
)	O
.	O

The	O
cytotoxicity	O
of	O
unpolymerized	O
two	O
new	O
monomers	O
and	O
Bis	O
-	O
GMA	O
on	O
the	O
human	O
gingival	O
fibroblast	O
cell	O
line	O
H2620	O
was	O
assessed	O
using	O
a	O
methyl	O
thiazolyl	O
tetrazolium	O
assay	O
.	O

Unpolymerized	O
MAE	O
-	O
DB	O
and	O
MAE	O
-	O
HB	O
showed	O
strong	O
bactericidal	O
activity	O
against	O
oral	O
bacteria	O
.	O

The	O
MBC	O
value	O
of	O
MAE	O
-	O
DB	O
ranged	O
from	O
12	O
.	O
2	O
to	O
24	O
.	O
4mug	O
/	O
ml	O
and	O
the	O
MBC	O
value	O
of	O
MAE	O
-	O
HB	O
ranged	O
from	O
6	O
.	O
2	O
to	O
48	O
.	O
8mug	O
/	O
ml	O
.	O

Time	O
-	O
kill	O
determinations	O
indicated	O
that	O
unpolymerized	O
MAE	O
-	O
DB	O
and	O
MAE	O
-	O
HB	O
had	O
rapid	O
killing	O
effects	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
UA159	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
ATCC6715	I-bacteria
at	O
the	O
concentration	O
of	O
4x	O
MBC	O
.	O

The	O
Fe	O
-	O
SEM	O
observation	O
showed	O
that	O
MAE	O
-	O
DB	O
and	O
MAE	O
-	O
HB	O
could	O
disturb	O
the	O
integrity	O
of	O
bacteria	O
and	O
cause	O
lysis	O
of	O
bacterial	O
cells	O
.	O

The	O
median	O
lethal	O
concentration	O
values	O
on	O
human	O
gingival	O
fibroblast	O
for	O
both	O
monomers	O
were	O
between	O
10	O
and	O
20mug	O
/	O
ml	O
,	O
and	O
greater	O
than	O
that	O
of	O
Bis	O
-	O
GMA	O
.	O

Unpolymerized	O
MAE	O
-	O
DB	O
and	O
MAE	O
-	O
HB	O
monomers	O
had	O
strong	O
bactericidal	O
activity	O
against	O
eight	O
strains	O
of	O
oral	O
bacteria	O
.	O

Their	O
cytotoxicities	O
were	O
less	O
than	O
that	O
of	O
Bis	O
-	O
GMA	O
.	O

The	O
gingival	O
epithelium	O
plays	O
an	O
important	O
role	O
in	O
the	O
protection	O
of	O
oral	O
tissues	O
from	O
microbial	O
challenge	O
.	O

Oral	O
keratinocytes	O
form	O
various	O
cellular	O
contacts	O
,	O
including	O
tight	O
junctions	O
,	O
and	O
thus	O
are	O
able	O
to	O
create	O
an	O
epithelial	O
barrier	O
.	O

A	O
measurable	O
indicator	O
of	O
barrier	O
function	O
in	O
vitro	O
is	O
the	O
transepithelial	O
electrical	O
resistance	O
(	O
TER	O
)	O
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
is	O
recognized	O
as	O
a	O
major	O
aetiologic	O
agent	O
of	O
periodontal	O
disease	O
and	O
exhibits	O
a	O
variety	O
of	O
virulence	O
factors	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
investigate	O
the	O
effect	O
,	O
in	O
vitro	O
,	O
of	O
infection	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
on	O
gingival	O
barriers	O
composed	O
of	O
primary	O
and	O
immortalized	O
human	O
keratinocytes	O
.	O

Primary	O
and	O
immortalized	O
human	O
gingival	O
keratinocytes	O
were	O
infected	O
with	O
different	O
strains	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

The	O
impact	O
of	O
the	O
bacterial	O
challenge	O
on	O
the	O
barrier	O
was	O
analysed	O
by	O
measuring	O
the	O
TER	O
.	O

The	O
destructive	O
effects	O
of	O
gingipains	O
were	O
blocked	O
by	O
specific	O
enzyme	O
inhibitors	O
.	O

After	O
an	O
initial	O
increase	O
of	O
about	O
20	O
-	O
30	O
%	O
in	O
infected	O
wells	O
,	O
the	O
TER	O
decreased	O
to	O
zero	O
.	O

Gingipain	O
inhibitors	O
delayed	O
the	O
destruction	O
of	O
the	O
barrier	O
by	O
12	O
+	O
/	O
-	O
4	O
h	O
.	O
In	O
all	O
cases	O
,	O
the	O
loss	O
of	O
TER	O
was	O
accelerated	O
if	O
the	O
system	O
was	O
infected	O
from	O
the	O
basolateral	O
side	O
.	O

A	O
distinct	O
effect	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
on	O
the	O
epithelial	O
barrier	O
function	O
of	O
three	O
-	O
dimensional	O
cultured	O
epithelial	O
cell	O
models	O
was	O
demonstrated	O
,	O
which	O
can	O
partly	O
be	O
attributed	O
to	O
the	O
activity	O
of	O
gingipains	O
.	O

Pneumonia	O
is	O
reported	O
to	O
be	O
associated	O
with	O
high	O
morbidity	O
in	O
elderly	O
and	O
compromised	O
individuals	O
,	O
with	O
poor	O
oral	O
health	O
demonstrated	O
to	O
be	O
a	O
significant	O
risk	O
factor	O
for	O
pneumonia	O
.	O

Several	O
opportunistic	O
pathogens	O
,	O
such	O
as	O
Streptococcus	B-bacteria
pneumoniae	I-bacteria
,	O
Klebsiella	B-bacteria
pneumoniae	I-bacteria
,	O
Escherichia	B-bacteria
coli	I-bacteria
and	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
have	O
been	O
detected	O
in	O
patients	O
with	O
pneumonia	O
.	O

We	O
investigated	O
the	O
prevalence	O
of	O
opportunistic	O
pathogens	O
in	O
the	O
oral	O
cavity	O
of	O
healthy	O
independent	O
living	O
Japanese	O
elderly	O
subjects	O
and	O
analysed	O
factors	O
related	O
to	O
harbouring	O
those	O
pathogens	O
.	O

We	O
studied	O
265	O
subjects	O
,	O
each	O
of	O
whom	O
received	O
a	O
dental	O
examination	O
,	O
during	O
which	O
specimens	O
were	O
collected	O
with	O
a	O
tongue	O
swab	O
and	O
examined	O
for	O
the	O
presence	O
of	O
10	O
oral	O
opportunistic	O
pathogens	O
using	O
single	O
or	O
multiple	O
selective	O
media	O
.	O

Furthermore	O
,	O
the	O
presence	O
of	O
occult	O
blood	O
in	O
saliva	O
was	O
examined	O
using	O
test	O
paper	O
strips	O
.	O

Oral	O
opportunistic	O
pathogens	O
were	O
detected	O
in	O
13	O
.	O
6	O
%	O
of	O
the	O
subjects	O
.	O

Those	O
positive	O
for	O
occult	O
blood	O
in	O
saliva	O
had	O
a	O
significantly	O
higher	O
rate	O
of	O
harbouring	O
the	O
pathogens	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

In	O
addition	O
,	O
age	O
was	O
a	O
significant	O
factor	O
for	O
the	O
presence	O
of	O
pathogenic	O
microbes	O
in	O
the	O
oral	O
cavity	O
(	O
p	O
=	O
0	O
.	O
033	O
)	O
.	O

Positive	O
findings	O
of	O
occult	O
blood	O
in	O
saliva	O
and	O
older	O
age	O
are	O
suggested	O
to	O
be	O
significant	O
factors	O
for	O
harbouring	O
opportunistic	O
pathogens	O
in	O
the	O
oral	O
cavity	O
.	O

Data	O
concerning	O
treatment	O
outcomes	O
in	O
patients	O
with	O
generalized	O
aggressive	O
periodontitis	O
(	O
GAgP	O
)	O
are	O
limited	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
investigate	O
6	O
-	O
month	O
clinical	O
and	O
microbiologic	O
outcomes	O
of	O
the	O
one	O
-	O
stage	O
full	O
-	O
mouth	O
disinfection	O
(	O
OSFMD	O
)	O
in	O
the	O
management	O
of	O
patients	O
with	O
GAgP	O
.	O

Twenty	O
-	O
seven	O
patients	O
with	O
advanced	O
GAgP	O
were	O
included	O
in	O
this	O
prospective	O
follow	O
-	O
up	O
intervention	O
study	O
.	O

Clinical	O
and	O
microbiologic	O
parameters	O
were	O
collected	O
at	O
baseline	O
and	O
3	O
and	O
6	O
months	O
after	O
the	O
OSFMD	O
.	O

Patient	O
-	O
,	O
tooth	O
-	O
,	O
and	O
site	O
-	O
level	O
analyses	O
were	O
carried	O
out	O
.	O

Subgingival	O
samples	O
from	O
moderate	O
(	O
4	O
to	O
5	O
mm	O
)	O
and	O
deep	O
(	O
>	O
/	O
=	O
6	O
mm	O
)	O
pocket	O
sites	O
were	O
analyzed	O
using	O
a	O
polymerase	O
chain	O
reaction	O
for	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
(	O
previously	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
)	O
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
(	O
previously	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
)	O
,	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
.	O

The	O
OSFMD	O
resulted	O
in	O
significant	O
improvements	O
in	O
all	O
parameters	O
.	O

After	O
6	O
months	O
,	O
the	O
whole	O
-	O
mouth	O
probing	O
depth	O
(	O
PD	O
)	O
decreased	O
from	O
4	O
.	O
2	O
+	O
/	O
-	O
1	O
.	O
1	O
mm	O
to	O
2	O
.	O
8	O
+	O
/	O
-	O
0	O
.	O
6	O
mm	O
,	O
and	O
the	O
clinical	O
attachment	O
level	O
was	O
reduced	O
from	O
4	O
.	O
5	O
+	O
/	O
-	O
1	O
.	O
2	O
mm	O
to	O
3	O
.	O
4	O
+	O
/	O
-	O
1	O
.	O
1	O
mm	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

When	O
data	O
were	O
analyzed	O
based	O
on	O
the	O
frequency	O
distribution	O
of	O
PD	O
,	O
the	O
number	O
of	O
sites	O
with	O
PD	O
>	O
/	O
=	O
5	O
mm	O
decreased	O
by	O
61	O
%	O
from	O
baseline	O
values	O
,	O
and	O
mean	O
PD	O
reductions	O
of	O
1	O
.	O
5	O
and	O
2	O
.	O
5	O
mm	O
were	O
noted	O
in	O
moderate	O
and	O
deep	O
pockets	O
,	O
respectively	O
.	O

At	O
6	O
months	O
,	O
percentages	O
of	O
moderate	O
and	O
deep	O
sites	O
free	O
of	O
pathogens	O
were	O
40	O
%	O
and	O
27	O
%	O
,	O
respectively	O
.	O

The	O
OSFMD	O
may	O
be	O
a	O
viable	O
approach	O
to	O
deal	O
with	O
severe	O
GAgP	O
.	O

After	O
incubation	O
of	O
saliva	O
from	O
58	O
semi	O
-	O
bedridden	O
elderly	O
persons	O
,	O
the	O
cultures	O
were	O
identified	O
based	O
on	O
the	O
16S	O
rRNA	O
gene	O
base	O
sequence	O
to	O
compare	O
the	O
identification	O
by	O
the	O
conventional	O
culture	O
method	O
.	O

As	O
a	O
result	O
,	O
the	O
16S	O
rRNA	O
gene	O
base	O
sequence	O
of	O
198	O
strains	O
identified	O
by	O
the	O
culture	O
method	O
showed	O
98	O
.	O
5	O
%	O
or	O
more	O
homology	O
in	O
some	O
of	O
the	O
Human	O
Oral	O
Microbiome	O
database	O
,	O
and	O
the	O
identification	O
of	O
bacterial	O
species	O
and	O
genus	O
was	O
possible	O
.	O

When	O
an	O
organism	O
identified	O
by	O
the	O
16S	O
rRNA	O
gene	O
sequencing	O
method	O
was	O
compared	O
with	O
that	O
by	O
the	O
culture	O
method	O
,	O
the	O
concordance	O
rates	O
were	O
54	O
.	O
5	O
%	O
at	O
the	O
genus	O
level	O
and	O
35	O
.	O
9	O
%	O
at	O
the	O
species	O
level	O
.	O

Streptococcus	B-bacteria
mitis	I-bacteria
strains	I-bacteria
most	O
frequently	O
isolated	O
from	O
saliva	O
that	O
were	O
identified	O
by	O
the	O
culture	O
method	O
were	O
identified	O
as	O
the	O
same	O
species	O
by	O
the	O
16S	O
rRNA	O
gene	O
sequencing	O
method	O
(	O
32	O
/	O
35	O
)	O
,	O
and	O
all	O
the	O
11	O
Streptococcus	B-bacteria
salivarius	I-bacteria
strains	I-bacteria
identified	O
by	O
the	O
culture	O
method	O
were	O
identified	O
as	O
the	O
same	O
species	O
by	O
the	O
16S	O
rRNA	O
gene	O
sequencing	O
method	O
.	O

All	O
the	O
strains	O
identified	O
as	O
Streptococcus	B-bacteria
anginosus	I-bacteria
group	O
by	O
the	O
culture	O
method	O
and	O
8	O
of	O
the	O
9	O
strains	O
identified	O
as	O
Prevotella	B-bacteria
species	I-bacteria
by	O
the	O
culture	O
method	O
were	O
identified	O
as	O
the	O
same	O
group	O
and	O
genus	O
by	O
the	O
16S	O
rRNA	O
gene	O
sequencing	O
method	O
.	O

When	O
an	O
oral	O
microbial	O
flora	O
test	O
with	O
saliva	O
samples	O
from	O
elderly	O
persons	O
is	O
performed	O
,	O
the	O
16S	O
rRNA	O
gene	O
sequence	O
identification	O
enables	O
us	O
to	O
identify	O
major	O
indigenous	O
bacteria	O
and	O
pathogenic	O
bacteria	O
and	O
is	O
considered	O
useful	O
as	O
a	O
means	O
of	O
supplementing	O
the	O
conventional	O
culture	O
method	O
.	O

The	O
focus	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
potential	O
use	O
of	O
the	O
predatoryO	O
bacteriaO	O
Bdellovibrio	B-bacteria
bacteriovorus	I-bacteria
and	O
Micavibrio	B-bacteria
aeruginosavorus	I-bacteria
to	O
control	O
the	O
pathogens	O
associated	O
with	O
human	O
infection	O
.	O

By	O
coculturing	O
B	B-bacteria
.	I-bacteria
bacteriovorus	I-bacteria
109J	I-bacteria
and	O
M	B-bacteria
.	I-bacteria
aeruginosavorus	I-bacteria
ARL	I-bacteria
-	I-bacteria
13	I-bacteria
with	O
selected	O
pathogens	O
,	O
we	O
have	O
demonstrated	O
that	O
predatory	O
bacteria	O
are	O
able	O
to	O
attack	O
bacteria	O
from	O
the	O
genus	O
Acinetobacter	B-bacteria
,	O
Aeromonas	B-bacteria
,	O
Bordetella	B-bacteria
,	O
Burkholderia	B-bacteria
,	O
Citrobacter	B-bacteria
,	O
Enterobacter	B-bacteria
,	O
Escherichia	B-bacteria
,	O
Klebsiella	B-bacteria
,	O
Listonella	B-bacteria
,	O
Morganella	B-bacteria
,	O
Proteus	B-bacteria
,	O
Pseudomonas	B-bacteria
,	O
Salmonella	B-bacteria
,	O
Serratia	B-bacteria
,	O
Shigella	B-bacteria
,	O
Vibrio	B-bacteria
and	O
Yersinia	B-bacteria
.	O

Predation	O
was	O
measured	O
in	O
single	O
and	O
multispecies	O
microbial	O
cultures	O
as	O
well	O
as	O
on	O
monolayer	O
and	O
multilayer	O
preformed	O
biofilms	O
.	O

Additional	O
experiments	O
aimed	O
at	O
assessing	O
the	O
optimal	O
predation	O
characteristics	O
of	O
M	B-bacteria
.	I-bacteria
aeruginosavorus	I-bacteria
demonstrated	O
that	O
the	O
predator	O
is	O
able	O
to	O
prey	O
at	O
temperatures	O
of	O
25	O
-	O
37	O
degrees	O
C	O
but	O
is	O
unable	O
to	O
prey	O
under	O
oxygen	O
-	O
limiting	O
conditions	O
.	O

In	O
addition	O
,	O
an	O
increase	O
in	O
M	B-bacteria
.	I-bacteria
aeruginosavorus	I-bacteria
ARL	I-bacteria
-	I-bacteria
13	I-bacteria
prey	O
range	O
was	O
also	O
observed	O
.	O

Bdellovibrio	B-bacteria
bacteriovorus	I-bacteria
and	O
M	B-bacteria
.	I-bacteria
aeruginosavorus	I-bacteria
have	O
an	O
ability	O
to	O
prey	O
and	O
reduce	O
many	O
of	O
the	O
multidrug	O
-	O
resistant	O
pathogens	O
associated	O
with	O
human	O
infection	O
.	O

Infectious	O
complications	O
caused	O
by	O
micro	O
-	O
organisms	O
that	O
have	O
become	O
resistant	O
to	O
drug	O
therapy	O
are	O
an	O
increasing	O
problem	O
in	O
medicine	O
,	O
with	O
more	O
infections	O
becoming	O
difficult	O
to	O
treat	O
using	O
traditional	O
antimicrobial	O
agents	O
.	O

The	O
work	O
presented	O
here	O
highlights	O
the	O
potential	O
use	O
of	O
predatory	O
bacteria	O
as	O
a	O
biological	O
-	O
based	O
agent	O
for	O
eradicating	O
multidrug	O
-	O
resistant	O
bacteria	O
,	O
with	O
the	O
hope	O
of	O
paving	O
the	O
way	O
for	O
future	O
studies	O
in	O
animal	O
models	O
.	O

During	O
the	O
past	O
few	O
years	O
there	O
has	O
been	O
a	O
global	O
spread	O
of	O
resistant	O
gram	O
-	O
negative	O
bacteria	O
that	O
are	O
insensitive	O
to	O
cephalosporins	O
and	O
carbapenems	O
.	O

Extended	O
spectrum	O
beta	O
-	O
lactamase	O
(	O
ESBL	O
)	O
-	O
producing	O
bacteria	O
are	O
capable	O
of	O
inactivating	O
the	O
newest	O
generation	O
of	O
cephalosporins	O
.	O

It	O
is	O
notable	O
that	O
ESBL	O
-	O
producing	O
bacteria	O
are	O
found	O
predominantly	O
outside	O
the	O
hospital	O
situation	O
in	O
the	O
environment	O
,	O
in	O
food	O
and	O
in	O
meat	O
products	O
,	O
which	O
leads	O
to	O
the	O
presumption	O
that	O
the	O
food	O
chain	O
is	O
contributing	O
to	O
the	O
rapid	O
spread	O
of	O
these	O
bacteria	O
.	O

Several	O
types	O
of	O
carbapenemase	O
-	O
producing	O
bacteria	O
have	O
been	O
distinguished	O
,	O
of	O
which	O
the	O
'	O
New	O
Delhi	O
metallo	O
beta	O
-	O
lactamase	O
1	O
(	O
NDM	O
-	O
1	O
)	O
'	O
type	O
seems	O
to	O
be	O
prevalent	O
in	O
Asia	O
outside	O
the	O
hospital	O
situation	O
in	O
the	O
community	O
,	O
and	O
is	O
now	O
being	O
transmitted	O
to	O
other	O
continents	O
as	O
a	O
result	O
of	O
migration	O
and	O
tourism	O
.	O

With	O
the	O
rise	O
of	O
ESBL	O
-	O
and	O
carbapenemase	O
-	O
producing	O
gram	O
-	O
negative	O
bacteria	O
(	O
which	O
are	O
also	O
often	O
resistant	O
to	O
most	O
other	O
antibiotics	O
)	O
comes	O
the	O
very	O
real	O
concern	O
that	O
treatment	O
of	O
infections	O
such	O
as	O
urinary	O
tract	O
infections	O
that	O
are	O
currently	O
simple	O
to	O
treat	O
with	O
common	O
oral	O
antibiotics	O
will	O
be	O
problematic	O
in	O
the	O
future	O
.	O

The	O
widespread	O
use	O
of	O
antibiotics	O
in	O
animal	O
husbandry	O
is	O
an	O
important	O
factor	O
in	O
the	O
problem	O
of	O
antibiotic	O
resistance	O
.	O

Since	O
economic	O
motives	O
are	O
of	O
importance	O
,	O
a	O
coordinated	O
approach	O
from	O
many	O
parties	O
concerned	O
will	O
be	O
necessary	O
,	O
not	O
just	O
from	O
the	O
medical	O
sector	O
but	O
also	O
from	O
the	O
veterinary	O
and	O
agricultural	O
world	O
,	O
and	O
from	O
food	O
producers	O
and	O
pharmaceutical	O
companies	O
to	O
combat	O
the	O
spread	O
of	O
multiresistant	O
gram	O
-	O
negative	O
bacteria	O
effectively	O
.	O

The	O
placement	O
of	O
cadavers	O
in	O
shallow	O
,	O
clandestine	O
graves	O
may	O
alter	O
the	O
microbial	O
and	O
geochemical	O
composition	O
of	O
the	O
underlying	O
and	O
adjacent	O
soils	O
.	O

Using	O
amplicon	O
length	O
heterogeneity	O
-	O
PCR	O
(	O
LH	O
-	O
PCR	O
)	O
the	O
microbial	O
community	O
changes	O
in	O
these	O
soils	O
can	O
be	O
assessed	O
.	O

In	O
this	O
investigation	O
,	O
nine	O
different	O
grave	O
sites	O
were	O
examined	O
over	O
a	O
period	O
of	O
16weeks	O
.	O

The	O
results	O
indicated	O
that	O
measurable	O
changes	O
occurred	O
in	O
the	O
soil	O
bacterial	O
community	O
during	O
the	O
decomposition	O
process	O
.	O

In	O
this	O
study	O
,	O
amplicons	O
corresponding	O
to	O
anaerobic	O
bacteria	O
,	O
not	O
indigenous	O
to	O
the	O
soil	O
,	O
were	O
shown	O
to	O
produce	O
differences	O
between	O
grave	O
sites	O
and	O
control	O
soils	O
.	O

Among	O
the	O
bacteria	O
linked	O
to	O
these	O
amplicons	O
are	O
those	O
that	O
are	O
most	O
often	O
part	O
of	O
the	O
commensal	O
flora	O
of	O
the	O
intestines	O
,	O
mouth	O
and	O
skin	O
.	O

In	O
addition	O
,	O
over	O
the	O
16week	O
sampling	O
interval	O
,	O
the	O
level	O
of	O
indicator	O
organisms	O
(	O
i	O
.	O
e	O
.	O
,	O
nitrogen	O
fixing	O
bacteria	O
)	O
dropped	O
as	O
the	O
body	O
decomposed	O
and	O
after	O
four	O
weeks	O
of	O
environmental	O
exposure	O
they	O
began	O
to	O
increase	O
again	O
;	O
thus	O
differences	O
in	O
the	O
abundance	O
of	O
nitrogen	O
fixing	O
bacteria	O
were	O
also	O
found	O
to	O
contribute	O
to	O
the	O
variation	O
between	O
controls	O
and	O
grave	O
soils	O
.	O

These	O
results	O
were	O
verified	O
using	O
primers	O
that	O
specifically	O
targeted	O
the	O
nifH	O
gene	O
coding	O
for	O
nitrogenase	O
reductase	O
.	O

LH	O
-	O
PCR	O
provides	O
a	O
fast	O
,	O
robust	O
and	O
reproducible	O
method	O
to	O
measure	O
microbial	O
changes	O
in	O
soil	O
and	O
could	O
be	O
used	O
to	O
determine	O
potential	O
cadaveric	O
contact	O
in	O
a	O
given	O
area	O
.	O

The	O
results	O
obtained	O
with	O
this	O
method	O
could	O
ultimately	O
provide	O
leads	O
to	O
investigators	O
in	O
criminal	O
or	O
missing	O
person	O
scenarios	O
and	O
allow	O
for	O
further	O
analysis	O
using	O
human	O
specific	O
DNA	O
assays	O
to	O
establish	O
the	O
identity	O
of	O
the	O
buried	O
body	O
.	O

Internalin	O
A	O
(	O
InlA	O
)	O
is	O
a	O
critical	O
virulence	O
factor	O
which	O
mediates	O
the	O
initiation	O
of	O
Listeria	B-bacteria
monocytogenes	I-bacteria
infection	O
by	O
the	O
oral	O
route	O
in	O
permissive	O
hosts	O
.	O

The	O
interaction	O
of	O
InlA	O
with	O
the	O
host	O
cell	O
ligand	O
E	O
-	O
cadherin	O
efficiently	O
stimulates	O
L	B-bacteria
.	I-bacteria
monocytogenes	I-bacteria
entry	O
into	O
human	O
enterocytes	O
,	O
but	O
has	O
only	O
a	O
limited	O
interaction	O
with	O
murine	O
cells	O
.	O

We	O
have	O
created	O
a	O
surface	O
display	O
library	O
of	O
randomly	O
mutated	O
InlA	O
in	O
a	O
non	O
-	O
invasive	O
heterologous	O
host	O
Lactococcus	B-bacteria
lactis	I-bacteria
in	O
order	O
to	O
create	O
and	O
screen	O
novel	O
variants	O
of	O
this	O
invasion	O
factor	O
.	O

After	O
sequential	O
passage	O
through	O
a	O
murine	O
cell	O
line	O
(	O
CT	O
-	O
26	O
)	O
,	O
multiple	O
clones	O
with	O
enhanced	O
invasion	O
characteristics	O
were	O
identified	O
.	O

Competitive	O
index	O
experiments	O
were	O
conducted	O
in	O
mice	O
using	O
selected	O
mutations	O
introduced	O
into	O
L	B-bacteria
.	I-bacteria
monocytogenes	I-bacteria
EGD	O
-	O
e	O
background	O
.	O

A	O
novel	O
single	O
amino	O
acid	O
change	O
was	O
identified	O
which	O
enhanced	O
virulence	O
by	O
the	O
oral	O
route	O
in	O
the	O
murine	O
model	O
and	O
will	O
form	O
the	O
basis	O
of	O
further	O
engineering	O
approaches	O
.	O

As	O
a	O
control	O
a	O
previously	O
described	O
EGD	O
-	O
InlA	O
(	O
m	O
)	O
murinized	O
strain	O
was	O
also	O
re	O
-	O
created	O
as	O
part	O
of	O
this	O
study	O
with	O
minor	O
modifications	O
and	O
designated	O
EGD	O
-	O
e	O
InlA	O
(	O
m	O
)	O
*	O
.	O

The	O
strain	O
was	O
created	O
using	O
a	O
procedure	O
that	O
minimizes	O
the	O
likelihood	O
of	O
secondary	O
mutations	O
and	O
incorporates	O
Listeria	O
-	O
optimized	O
codons	O
encoding	O
the	O
altered	O
amino	O
acids	O
.	O

L	B-bacteria
.	I-bacteria
monocytogenes	I-bacteria
EGD	O
-	O
e	O
InlA	O
(	O
m	O
)	O
*	O
yielded	O
consistently	O
higher	O
level	O
murine	O
infections	O
by	O
the	O
oral	O
route	O
when	O
compared	O
to	O
EGD	O
-	O
e	O
,	O
but	O
did	O
not	O
display	O
the	O
two	O
-	O
fold	O
increased	O
invasion	O
into	O
a	O
human	O
cell	O
line	O
that	O
was	O
previously	O
described	O
for	O
the	O
EGD	O
-	O
InlA	O
(	O
m	O
)	O
strain	O
.	O

We	O
have	O
used	O
both	O
site	O
-	O
directed	O
mutagenesis	O
and	O
directed	O
evolution	O
to	O
create	O
variants	O
of	O
InlA	O
which	O
may	O
inform	O
future	O
structure	O
-	O
function	O
analyses	O
of	O
this	O
protein	O
.	O

During	O
the	O
course	O
of	O
the	O
study	O
we	O
engineered	O
a	O
murinized	O
strain	O
of	O
L	B-bacteria
.	I-bacteria
monocytogenes	I-bacteria
EGD	O
-	O
e	O
which	O
shows	O
reproducibly	O
higher	O
infectivity	O
in	O
the	O
intragastric	O
murine	O
infection	O
model	O
than	O
the	O
wild	O
type	O
,	O
but	O
does	O
not	O
display	O
enhanced	O
entry	O
into	O
human	O
cells	O
as	O
previously	O
observed	O
.	O

This	O
murinized	O
L	B-bacteria
.	I-bacteria
monocytogenes	I-bacteria
strain	I-bacteria
will	O
provide	O
a	O
useful	O
tool	O
for	O
the	O
analysis	O
of	O
the	O
gastrointestinal	O
phase	O
of	O
listeriosis	O
.	O

Is	O
low	O
-	O
concentration	O
chlorhexidine	O
effective	O
against	O
reducing	O
the	O
mutans	B-bacteria
streptococci	I-bacteria
(	O
MS	B-bacteria
)	O
in	O
saliva	O
?	O

To	O
compare	O
the	O
efficacy	O
of	O
different	O
concentrations	O
of	O
chlorhexidine	O
mouth	O
rinses	O
,	O
i	O
.	O
e	O
.	O

0	O
.	O
02	O
%	O
,	O
0	O
.	O
06	O
%	O
and	O
0	O
.	O
12	O
%	O
,	O
in	O
reducing	O
the	O
mutants	B-bacteria
streptococci	I-bacteria
count	O
in	O
saliva	O
.	O

Forty	O
subjects	O
in	O
the	O
age	O
group	O
of	O
12	O
-	O
14	O
years	O
were	O
selected	O
from	O
the	O
schools	O
of	O
Chennai	O
and	O
were	O
equally	O
divided	O
into	O
four	O
groups	O
.	O

The	O
first	O
three	O
were	O
study	O
groups	O
and	O
the	O
fourth	O
group	O
was	O
the	O
control	O
group	O
.	O

The	O
subjects	O
were	O
instructed	O
to	O
rinse	O
with	O
a	O
measured	O
amount	O
of	O
mouth	O
rinse	O
for	O
1	O
min	O
,	O
twice	O
-	O
daily	O
,	O
for	O
1	O
week	O
.	O

Salivary	O
samples	O
were	O
collected	O
at	O
baseline	O
and	O
1	O
week	O
after	O
mouth	O
rinsing	O
with	O
various	O
concentrations	O
and	O
were	O
cultured	O
on	O
MSB	B-bacteria
agar	O
.	O

The	O
number	O
of	O
MS	B-bacteria
colonies	O
was	O
counted	O
on	O
agar	O
medium	O
under	O
anaerobic	O
conditions	O
.	O

The	O
results	O
of	O
the	O
study	O
confirmed	O
that	O
children	O
using	O
chlorhexidine	O
of	O
concentration	O
0	O
.	O
12	O
%	O
showed	O
the	O
maximum	O
reduction	O
in	O
MS	B-bacteria
when	O
compared	O
with	O
subjects	O
using	O
0	O
.	O
02	O
%	O
and	O
0	O
.	O
06	O
%	O
concentrations	O
.	O

But	O
,	O
children	O
using	O
chlorhexidine	O
of	O
concentration	O
0	O
.	O
06	O
%	O
also	O
showed	O
significant	O
reduction	O
in	O
MS	B-bacteria
when	O
compared	O
with	O
the	O
control	O
group	O
.	O

From	O
the	O
above	O
study	O
,	O
we	O
conclude	O
that	O
chlorhexidine	O
used	O
in	O
different	O
concentrations	O
(	O
0	O
.	O
02	O
%	O
,	O
0	O
.	O
06	O
%	O
,	O
0	O
.	O
12	O
%	O
)	O
efficiently	O
reduced	O
the	O
mutans	O
count	O
.	O

Probiotic	O
technology	O
represents	O
a	O
breakthrough	O
approach	O
to	O
maintaining	O
oral	O
health	O
by	O
utilizing	O
natural	O
beneficial	O
bacteria	O
commonly	O
found	O
in	O
healthy	O
mouths	O
to	O
provide	O
a	O
natural	O
defense	O
against	O
those	O
bacteria	O
thought	O
to	O
be	O
harmful	O
to	O
teeth	O
and	O
gums	O
.	O

However	O
,	O
data	O
are	O
still	O
sparse	O
on	O
the	O
probiotic	O
action	O
in	O
the	O
oral	O
cavity	O
.	O

The	O
review	O
article	O
on	O
probiotics	O
in	O
children	O
published	O
by	O
Twetman	O
and	O
Stecksen	O
-	O
Blicks	O
in	O
2008	O
showed	O
only	O
one	O
study	O
of	O
dental	O
interest	O
on	O
probiotics	O
in	O
children	O
.	O

The	O
present	O
study	O
evaluated	O
clinically	O
the	O
efficacy	O
of	O
a	O
probiotic	O
and	O
chlorhexidine	O
mouth	O
rinses	O
on	O
plaque	O
and	O
gingival	O
accumulation	O
in	O
children	O
.	O

The	O
trial	O
design	O
is	O
a	O
double	O
-	O
blind	O
parallel	O
group	O
,	O
14	O
days	O
comparative	O
study	O
between	O
a	O
probiotic	O
mouth	O
rinse	O
and	O
a	O
chlorhexidine	O
mouth	O
rinse	O
,	O
which	O
included	O
45	O
healthy	O
children	O
in	O
the	O
age	O
group	O
of	O
6	O
-	O
8	O
years	O
.	O

The	O
Probiotic	O
and	O
Chlorhexidine	O
groups	O
had	O
less	O
plaque	O
accumulations	O
compared	O
with	O
the	O
Control	O
group	O
at	O
the	O
end	O
of	O
14	O
years	O
(	O
P	O
<	O
0	O
.	O
001	O
and	O
P	O
<	O
0	O
.	O
001	O
,	O
respectively	O
)	O
.	O

But	O
,	O
unlike	O
the	O
plaque	O
score	O
,	O
there	O
was	O
a	O
significant	O
difference	O
in	O
the	O
Gingival	O
Index	O
between	O
the	O
Probiotic	O
and	O
the	O
Chlorhexidine	O
groups	O
(	O
P	O
=	O
0	O
.	O
009	O
)	O
,	O
Probiotic	O
group	O
being	O
better	O
than	O
the	O
Chlorhexidine	O
group	O
(	O
mean	O
=	O
0	O
.	O
2300	O
and	O
0	O
.	O
6805	O
,	O
respectively	O
)	O
.	O

The	O
Probiotic	O
mouth	O
rinse	O
was	O
found	O
effective	O
in	O
reducing	O
plaque	O
accumulation	O
and	O
gingival	O
inflammation	O
.	O

Therefore	O
,	O
probiotic	O
mouth	O
rinse	O
obviously	O
has	O
a	O
potential	O
therapeutic	O
value	O
and	O
further	O
long	O
-	O
term	O
study	O
is	O
recommended	O
to	O
determine	O
its	O
efficacy	O
.	O

To	O
compare	O
the	O
use	O
of	O
the	O
Halimeter	O
and	O
the	O
Oral	O
Chroma	O
to	O
assess	O
the	O
ability	O
of	O
common	O
oral	O
anaerobic	O
bacteria	O
isolated	O
from	O
the	O
Kuwaiti	O
population	O
to	O
produce	O
volatile	O
sulfur	O
compounds	O
(	O
VSCs	O
)	O
.	O

Broth	O
cultures	O
of	O
common	O
anaerobes	O
isolated	O
from	O
supragingival	O
plaque	O
were	O
centrifuged	O
and	O
pellets	O
resuspended	O
in	O
phosphate	O
buffer	O
(	O
pH	O
7	O
.	O
7	O
)	O
with	O
an	O
optical	O
density	O
OD	O
(	O
550	O
)	O
of	O
0	O
.	O
3	O
.	O

100	O
mul	O
of	O
this	O
suspension	O
and	O
870	O
mul	O
of	O
buffer	O
were	O
added	O
in	O
2	O
sterile	O
15	O
-	O
ml	O
head	O
space	O
vials	O
.	O

Reaction	O
was	O
initiated	O
by	O
addition	O
of	O
30	O
mul	O
of	O
33	O
mML	O
-	O
methionine	O
and	O
L	O
-	O
cysteine	O
,	O
respectively	O
,	O
in	O
each	O
vial	O
and	O
incubation	O
at	O
37	O
degrees	O
C	O
for	O
90	O
min	O
.	O

500	O
mul	O
of	O
3	O
M	O
phosphoric	O
acid	O
was	O
added	O
to	O
tubes	O
and	O
was	O
kept	O
aside	O
for	O
10	O
min	O
.	O

Production	O
of	O
VSCs	O
was	O
measured	O
using	O
the	O
Halimeter	O
and	O
the	O
Oral	O
Chroma	O
.	O

The	O
major	O
VSC	O
producers	O
identified	O
by	O
both	O
Halimeter	O
and	O
Oral	O
Chroma	O
with	O
L	O
-	O
cystenine	O
as	O
substrate	O
were	O
Campylobacter	B-bacteria
ureolyticus	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
and	O
Gemella	B-bacteria
morbillorum	I-bacteria
.	O

The	O
concentrations	O
of	O
hydrogen	O
sulfide	O
recorded	O
by	O
both	O
Halimeter	O
and	O
Oral	O
Chroma	O
were	O
essentially	O
identical	O
.	O

With	O
L	O
-	O
methionine	O
as	O
substrate	O
,	O
both	O
Halimeter	O
and	O
Oral	O
Chroma	O
identified	O
different	O
complements	O
of	O
anaerobes	O
with	O
C	B-bacteria
.	I-bacteria
ureolyticus	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
as	O
major	O
VSC	O
producers	O
.	O

The	O
concentrations	O
of	O
methyl	O
mercaptan	O
recorded	O
by	O
the	O
Halimeter	O
were	O
lower	O
compared	O
to	O
those	O
assessed	O
by	O
the	O
Oral	O
Chroma	O
.	O

The	O
results	O
suggest	O
that	O
the	O
Oral	O
Chroma	O
may	O
produce	O
a	O
more	O
comprehensive	O
assessment	O
of	O
VSC	O
production	O
by	O
oral	O
microflora	O
than	O
the	O
Halimeter	O
.	O

The	O
aim	O
of	O
the	O
present	O
pilot	O
study	O
was	O
to	O
investigate	O
the	O
microbial	O
profile	O
in	O
saliva	O
and	O
supragingival	O
plaque	O
samples	O
collected	O
from	O
caries	O
-	O
active	O
adolescents	O
before	O
and	O
after	O
a	O
daily	O
short	O
-	O
term	O
intake	O
of	O
milk	O
supplemented	O
with	O
the	O
probiotic	O
bacteria	O
.	O

The	O
present	O
study	O
group	O
consisted	O
of	O
18	O
caries	O
-	O
active	O
adolescents	O
of	O
both	O
sexes	O
who	O
volunteered	O
for	O
participation	O
giving	O
an	O
informed	O
consent	O
.	O

The	O
study	O
has	O
a	O
randomised	O
placebo	O
-	O
controlled	O
double	O
-	O
blind	O
pilot	O
design	O
with	O
two	O
parallel	O
arms	O
.	O

After	O
a	O
2	O
-	O
week	O
run	O
-	O
in	O
period	O
,	O
the	O
subjects	O
were	O
instructed	O
to	O
drink	O
2	O
.	O
5	O
dl	O
of	O
milk	O
supplemented	O
with	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
LB21	I-bacteria
(	O
107	O
CFU	O
/	O
ml	O
)	O
(	O
test	O
)	O
or	O
standard	O
control	O
milk	O
(	O
placebo	O
)	O
once	O
daily	O
for	O
a	O
period	O
of	O
2	O
weeks	O
(	O
intervention	O
period	O
)	O
.	O

Samples	O
of	O
stimulated	O
whole	O
saliva	O
and	O
supragingival	O
plaque	O
were	O
collected	O
at	O
baseline	O
(	O
after	O
run	O
-	O
in	O
)	O
and	O
immediately	O
after	O
the	O
end	O
of	O
the	O
intervention	O
period	O
(	O
follow	O
-	O
up	O
)	O
.	O

The	O
salivary	O
levels	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
and	O
lactobacilli	B-bacteria
were	O
estimated	O
by	O
conventional	O
culturing	O
on	O
selective	O
agar	O
plates	O
.	O

The	O
presence	O
and	O
level	O
of	O
19	O
oral	O
species	O
associated	O
with	O
the	O
caries	O
process	O
were	O
determined	O
using	O
the	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridisation	O
technique	O
.	O

Differences	O
between	O
the	O
groups	O
were	O
assessed	O
using	O
the	O
non	O
-	O
parametric	O
Wilcoxon	O
-	O
Mann	O
-	O
Whitney	O
and	O
chi	O
-	O
square	O
tests	O
.	O

The	O
mean	O
caries	O
experience	O
was	O
high	O
with	O
an	O
average	O
of	O
7	O
.	O
0	O
+	O
/	O
-	O
3	O
.	O
8	O
proximal	O
enamel	O
lesions	O
.	O

The	O
most	O
prevalent	O
dominating	O
species	O
in	O
the	O
plaque	O
samples	O
were	O
Streptococcus	B-bacteria
mitis	I-bacteria
,	O
Veillonella	B-bacteria
parvula	I-bacteria
and	O
Streptococcus	B-bacteria
gordonii	I-bacteria
.	O

The	O
saliva	O
samples	O
displayed	O
a	O
more	O
mixed	O
profile	O
,	O
with	O
Streptococcus	B-bacteria
mitis	I-bacteria
,	O
Rothia	B-bacteria
dentocariosa	I-bacteria
,	O
Lactobacillus	B-bacteria
casei	I-bacteria
and	O
Lactobacillus	B-bacteria
curvata	I-bacteria
being	O
frequently	O
identified	O
species	O
.	O

All	O
of	O
the	O
subjects	O
harboured	O
mutans	B-bacteria
streptococci	I-bacteria
in	O
their	O
saliva	O
,	O
with	O
61	O
%	O
of	O
them	O
colonised	O
with	O
salivary	O
lactobacilli	B-bacteria
.	O

No	O
statistically	O
significant	O
differences	O
in	O
the	O
microbial	O
profiles	O
or	O
the	O
estimated	O
counts	O
between	O
the	O
baseline	O
and	O
follow	O
-	O
up	O
samples	O
,	O
or	O
between	O
the	O
two	O
study	O
groups	O
,	O
were	O
observed	O
.	O

The	O
present	O
study	O
showed	O
that	O
a	O
short	O
-	O
term	O
daily	O
intake	O
of	O
milk	O
supplemented	O
with	O
the	O
probiotic	O
bacterium	O
L	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
LB21	I-bacteria
did	O
not	O
significantly	O
affect	O
the	O
microbial	O
profiles	O
or	O
the	O
levels	O
of	O
caries	O
-	O
associated	O
bacteria	O
in	O
saliva	O
and	O
supragingival	O
plaque	O
samples	O
collected	O
from	O
caries	O
-	O
active	O
adolescents	O
.	O

The	O
antibacterial	O
activity	O
of	O
Coffea	O
canephora	O
extract	O
was	O
evaluated	O
in	O
vitro	O
against	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
.	O

The	O
viability	O
of	O
planktonic	O
cells	O
was	O
analysed	O
by	O
susceptibility	O
tests	O
(	O
MIC	O
and	O
MBC	O
)	O
and	O
time	O
-	O
kill	O
assays	O
.	O

The	O
effect	O
of	O
the	O
extract	O
on	O
dental	O
demineralisation	O
was	O
also	O
investigated	O
.	O

Primary	O
1st	O
molar	O
fragments	O
(	O
n	O
=	O
24	O
)	O
were	O
inoculated	O
with	O
a	O
saliva	O
pool	O
and	O
sustained	O
in	O
a	O
multiple	O
plaque	O
growth	O
system	O
for	O
10	O
days	O
to	O
form	O
biofilm	O
.	O

The	O
biofilm	O
was	O
treated	O
with	O
light	O
roasted	O
C	O
.	O
canephora	O
extract	O
at	O
20	O
%	O
,	O
Milli	O
-	O
Q	O
water	O
(	O
negative	O
control	O
)	O
and	O
chlorhexidine	O
(	O
positive	O
control	O
)	O
once	O
a	O
day	O
,	O
during	O
a	O
week	O
.	O

Blank	O
controls	O
comprised	O
fragments	O
without	O
treatment	O
.	O

biofilm	O
pH	O
was	O
monitored	O
in	O
the	O
last	O
day	O
of	O
treatment	O
.	O

Changes	O
in	O
tooth	O
mineralisation	O
were	O
assessed	O
by	O
cross	O
-	O
sectional	O
microhardness	O
(	O
CSMH	O
)	O
test	O
.	O

MIC	O
and	O
MBC	O
for	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
were	O
7	O
+	O
/	O
-	O
2	O
mg	O
/	O
mL	O
and	O
160	O
+	O
/	O
-	O
0	O
mg	O
/	O
mL	O
,	O
respectively	O
,	O
showing	O
no	O
activity	O
for	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
.	O

The	O
extract	O
produced	O
a	O
4	O
-	O
log	O
reduction	O
in	O
the	O
number	O
of	O
colonies	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
after	O
3	O
-	O
h	O
treatment	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
with	O
undiluted	O
extract	O
(	O
20	O
%	O
)	O
and	O
MBC	O
concentration	O
(	O
16	O
%	O
)	O
.	O

There	O
was	O
no	O
difference	O
among	O
negative	O
/	O
blank	O
controls	O
and	O
coffee	O
plaque	O
pH	O
.	O

Differences	O
between	O
CSMH	O
values	O
of	O
dental	O
fragments	O
subjected	O
to	O
the	O
coffee	O
extract	O
and	O
to	O
chlorhexidine	O
were	O
not	O
significant	O
.	O

At	O
depths	O
up	O
to	O
30	O
mum	O
from	O
the	O
enamel	O
surface	O
,	O
coffee	O
extract	O
and	O
chlorhexidine	O
promoted	O
higher	O
CSMH	O
values	O
when	O
compared	O
to	O
blank	O
/	O
negative	O
controls	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Our	O
data	O
suggest	O
that	O
light	O
roasted	O
C	O
.	O
canephora	O
extract	O
is	O
beneficial	O
as	O
an	O
anticariogenic	O
substance	O
.	O

To	O
evaluate	O
the	O
antimicrobial	O
efficacies	O
of	O
two	O
toothpaste	O
formulations	O
containing	O
natural	O
antimicrobials	O
(	O
herbal	O
extracts	O
and	O
chitosan	O
)	O
against	O
oral	O
biofilms	O
of	O
different	O
composition	O
and	O
maturational	O
status	O
.	O

Bacteria	O
from	O
a	O
buffer	O
suspension	O
or	O
fresh	O
saliva	O
were	O
adhered	O
for	O
2h	O
to	O
a	O
salivary	O
conditioning	O
film	O
and	O
subsequently	O
grown	O
for	O
16h	O
.	O

Dual	O
-	O
species	O
biofilms	O
were	O
prepared	O
from	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
T14V	I-bacteria
-	I-bacteria
J1	I-bacteria
and	O
Streptococcus	B-bacteria
oralis	I-bacteria
J22	I-bacteria
,	O
whilst	O
multi	O
-	O
species	O
biofilms	O
were	O
grown	O
from	O
freshly	O
collected	O
human	O
saliva	O
.	O

Biofilms	O
were	O
exposed	O
to	O
25wt	O
%	O
toothpaste	O
supernatants	O
.	O

A	O
chlorhexidine	O
-	O
containing	O
mouthrinse	O
and	O
a	O
buffer	O
were	O
used	O
as	O
positive	O
-	O
and	O
negative	O
-	O
controls	O
,	O
respectively	O
.	O

Antibacterial	O
efficacy	O
was	O
concluded	O
from	O
acute	O
killing	O
,	O
bacterial	O
removal	O
,	O
prevention	O
of	O
bacterial	O
re	O
-	O
deposition	O
and	O
continued	O
killing	O
during	O
re	O
-	O
deposition	O
.	O

The	O
herbal	O
-	O
and	O
chitosan	O
-	O
based	O
supernatants	O
showed	O
immediate	O
killing	O
of	O
oral	O
biofilm	O
bacteria	O
,	O
comparable	O
with	O
chlorhexidine	O
.	O

Moreover	O
,	O
exposure	O
of	O
a	O
biofilm	O
to	O
these	O
supernatants	O
or	O
chlorhexidine	O
,	O
yielded	O
ongoing	O
killing	O
of	O
biofilm	O
bacteria	O
after	O
exposure	O
during	O
re	O
-	O
deposition	O
of	O
bacteria	O
to	O
a	O
matured	O
16h	O
biofilm	O
,	O
but	O
not	O
to	O
a	O
much	O
thinner	O
initial	O
biofilm	O
formed	O
by	O
2h	O
adhesion	O
only	O
.	O

This	O
suggests	O
that	O
thicker	O
,	O
more	O
matured	O
biofilms	O
can	O
absorb	O
and	O
release	O
oral	O
antimicrobials	O
.	O

Supernatants	O
based	O
on	O
herbal	O
-	O
and	O
chitosan	O
-	O
based	O
toothpastes	O
have	O
comparable	O
immediate	O
and	O
ongoing	O
antibacterial	O
efficacies	O
as	O
chlorhexidine	O
.	O

Natural	O
antimicrobials	O
and	O
chlorhexidine	O
absorb	O
in	O
oral	O
biofilms	O
which	O
contributes	O
to	O
their	O
substantive	O
action	O
.	O

The	O
composition	O
of	O
oral	O
microbiota	O
in	O
comatose	O
patients	O
remains	O
uncertain	O
.	O

Some	O
pulmonary	O
pathogens	O
may	O
be	O
found	O
in	O
dental	O
biofilms	O
or	O
as	O
part	O
of	O
the	O
saliva	O
microbiota	O
.	O

It	O
is	O
supposed	O
that	O
some	O
pneumopathogenic	O
microorganisms	O
may	O
overgrow	O
in	O
the	O
mouths	O
of	O
comatose	O
patients	O
and	O
spread	O
to	O
their	O
lungs	O
.	O

The	O
oral	O
colonization	O
dynamics	O
of	O
staphylococci	B-bacteria
,	O
Enterobacteriaceae	B-bacteria
and	O
yeasts	O
in	O
nine	O
comatose	O
patients	O
(	O
group	O
1	O
)	O
,	O
and	O
in	O
12	O
conscious	O
patients	O
that	O
brushed	O
their	O
teeth	O
at	O
least	O
twice	O
a	O
day	O
(	O
group	O
2	O
)	O
was	O
evaluated	O
.	O

Both	O
groups	O
were	O
followed	O
up	O
for	O
7	O
days	O
after	O
hospitalization	O
.	O

Daily	O
samples	O
of	O
saliva	O
were	O
obtained	O
,	O
dispersed	O
and	O
plated	O
on	O
selective	O
culture	O
media	O
and	O
colony	O
forming	O
units	O
of	O
each	O
microbial	O
group	O
were	O
obtained	O
.	O

For	O
patients	O
in	O
group	O
1	O
,	O
the	O
counts	O
of	O
total	O
viable	O
bacteria	O
,	O
staphylococci	B-bacteria
,	O
Enterobacteriaceae	B-bacteria
and	O
yeasts	O
progressively	O
increased	O
in	O
a	O
time	O
-	O
dependant	O
manner	O
.	O

For	O
the	O
conscious	O
patients	O
of	O
group	O
2	O
,	O
there	O
was	O
no	O
increase	O
.	O

It	O
would	O
appear	O
that	O
concomitant	O
consciousness	O
and	O
brushing	O
teeth	O
are	O
determinants	O
in	O
controlling	O
the	O
selected	O
pneumopathogen	O
counts	O
in	O
resting	O
saliva	O
.	O

The	O
increase	O
in	O
microbial	O
counts	O
in	O
comatose	O
patients	O
is	O
understandable	O
because	O
these	O
microorganisms	O
could	O
spread	O
to	O
the	O
lungs	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
infection	O
is	O
associated	O
with	O
numerous	O
gastroduodenal	O
diseases	O
.	O

The	O
oral	O
cavity	O
could	O
be	O
a	O
potential	O
extragastric	O
reservoir	O
for	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
,	O
and	O
oral	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
might	O
cause	O
gastric	O
reinfection	O
after	O
the	O
eradication	O
therapy	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
evaluate	O
the	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
oral	O
cavity	O
of	O
patients	O
with	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
and	O
to	O
examine	O
the	O
effectiveness	O
of	O
the	O
eradication	O
therapy	O
against	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
stomach	O
and	O
in	O
the	O
oral	O
cavity	O
.	O

Fifty	O
-	O
six	O
patients	O
with	O
chronic	O
periodontitis	O
and	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
were	O
enrolled	O
in	O
the	O
study	O
.	O

Gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
was	O
determined	O
using	O
(	O
13	O
)	O
C	O
-	O
urea	O
breath	O
test	O
before	O
and	O
3	O
months	O
after	O
eradication	O
therapy	O
.	O

The	O
presence	O
of	O
the	O
oral	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
was	O
assessed	O
using	O
polymerase	O
chain	O
reaction	O
before	O
and	O
3	O
months	O
after	O
eradication	O
therapy	O
.	O

The	O
1	O
-	O
week	O
eradication	O
therapy	O
consisted	O
of	O
amoxycilin	O
1	O
g	O
,	O
clarithromycin	O
500	O
mg	O
,	O
and	O
proton	O
pump	O
inhibitor	O
20	O
mg	O
twice	O
a	O
day	O
.	O

Of	O
56	O
subjects	O
with	O
gastric	O
infection	O
,	O
23	O
(	O
41	O
.	O
1	O
%	O
)	O
harbored	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
cavity	O
.	O

Eradication	O
rate	O
in	O
stomach	O
was	O
78	O
.	O
3	O
%	O
,	O
whereas	O
in	O
the	O
oral	O
cavity	O
,	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
was	O
not	O
detected	O
from	O
any	O
sample	O
after	O
the	O
eradication	O
therapy	O
.	O

Almost	O
half	O
of	O
the	O
patients	O
with	O
gastric	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
harbored	O
the	O
bacterium	O
in	O
the	O
oral	O
cavity	O
.	O

After	O
the	O
eradication	O
therapy	O
,	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
was	O
not	O
detected	O
in	O
the	O
oral	O
cavity	O
,	O
what	O
suggests	O
high	O
effectiveness	O
of	O
the	O
therapy	O
protocol	O
in	O
the	O
oral	O
cavity	O
,	O
or	O
it	O
is	O
possible	O
that	O
oral	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
is	O
of	O
a	O
transient	O
character	O
.	O

Leprosy	O
is	O
an	O
important	O
health	O
problem	O
in	O
Brazil	O
despite	O
extensive	O
use	O
of	O
multidrug	O
therapy	O
.	O

The	O
nasal	O
mucosa	O
is	O
the	O
preferential	O
site	O
of	O
entry	O
and	O
exit	O
of	O
Mycobacterium	B-bacteria
leprae	I-bacteria
,	O
and	O
although	O
lesions	O
have	O
been	O
found	O
in	O
the	O
oral	O
mucosa	O
,	O
its	O
potential	O
involvement	O
in	O
the	O
transmission	O
of	O
leprosy	O
bacilli	O
has	O
never	O
been	O
investigated	O
.	O

We	O
investigated	O
the	O
presence	O
of	O
the	O
M	B-bacteria
.	I-bacteria
leprae	I-bacteria
DNA	O
in	O
buccal	O
swabs	O
of	O
leprosy	O
patients	O
(	O
334	O
)	O
and	O
household	O
contacts	O
(	O
1288	O
)	O
through	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
,	O
and	O
correlated	O
this	O
with	O
clinical	O
and	O
laboratorial	O
evaluations	O
.	O

The	O
overall	O
positivity	O
for	O
patients	O
and	O
contacts	O
was	O
18	O
.	O
26	O
%	O
and	O
6	O
.	O
83	O
%	O
,	O
respectively	O
.	O

Subclinical	O
infection	O
among	O
contacts	O
was	O
considered	O
when	O
PCR	O
and	O
anti	O
-	O
PGL	O
-	O
1	O
ELISA	O
presented	O
positive	O
results	O
.	O

This	O
study	O
provides	O
evidence	O
that	O
the	O
oral	O
mucosa	O
may	O
be	O
a	O
secondary	O
site	O
of	O
M	B-bacteria
.	I-bacteria
leprae	I-bacteria
transmission	O
and	O
infection	O
,	O
and	O
contacts	O
with	O
bacillary	O
DNA	O
may	O
be	O
actively	O
involved	O
in	O
transmission	O
.	O

We	O
have	O
also	O
shown	O
that	O
bacilli	O
DNA	O
is	O
more	O
frequently	O
found	O
in	O
the	O
oral	O
mucosa	O
of	O
PB	O
patients	O
.	O

Our	O
findings	O
have	O
great	O
epidemiological	O
relevance	O
and	O
indicate	O
an	O
additional	O
strategy	O
for	O
leprosy	O
control	O
programmes	O
and	O
dental	O
clinics	O
.	O

In	O
the	O
oral	O
cavity	O
,	O
chronic	O
inflammation	O
has	O
been	O
observed	O
at	O
various	O
stages	O
of	O
oral	O
squamous	O
cell	O
carcinomas	O
(	O
OSCC	O
)	O
.	O

Such	O
inflammation	O
could	O
result	O
from	O
persistent	O
mucosal	O
or	O
epithelial	O
cell	O
colonization	O
by	O
microorganisms	O
.	O

There	O
is	O
increasing	O
evidence	O
of	O
the	O
involvement	O
of	O
oral	O
bacteria	O
in	O
inflammation	O
,	O
warranting	O
further	O
studies	O
on	O
the	O
association	O
of	O
bacteria	O
with	O
the	O
progression	O
of	O
OSCC	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
diversity	O
and	O
relative	O
abundance	O
of	O
bacteria	O
in	O
the	O
saliva	O
of	O
subjects	O
with	O
OSCC	O
.	O

Using	O
454	O
parallel	O
DNA	O
sequencing	O
,	O
approximately	O
58	O
,	O
000	O
PCR	O
amplicons	O
that	O
span	O
the	O
V4	O
-	O
V5	O
hypervariable	O
region	O
of	O
rRNAs	O
from	O
five	O
subjects	O
were	O
sequenced	O
.	O

Members	O
of	O
eight	O
phyla	O
(	O
divisions	O
)	O
of	O
bacteria	O
were	O
detected	O
.	O

The	O
majority	O
of	O
classified	O
sequences	O
belonged	O
to	O
the	O
phyla	O
Firmicutes	B-bacteria
(	O
45	O
%	O
)	O
and	O
Bacteroidetes	B-bacteria
(	O
25	O
%	O
)	O
.	O

Further	O
,	O
52	O
different	O
genera	O
containing	O
approximately	O
860	O
(	O
16	O
.	O
51	O
%	O
)	O
known	O
species	O
were	O
identified	O
and	O
1077	O
(	O
67	O
%	O
)	O
sequences	O
belonging	O
to	O
various	O
uncultured	O
bacteria	O
or	O
unclassified	O
groups	O
.	O

The	O
species	O
diversity	O
estimates	O
obtained	O
with	O
abundance	O
-	O
based	O
coverage	O
estimators	O
and	O
Chao1	O
were	O
greater	O
than	O
published	O
analyses	O
of	O
other	O
microbial	O
profiles	O
from	O
the	O
oral	O
cavity	O
.	O

Fifteen	O
unique	O
phylotypes	O
were	O
present	O
in	O
all	O
three	O
OSCC	O
subjects	O
.	O

Periodontal	O
disease	O
is	O
associated	O
with	O
specific	O
periodontal	O
pathogens	O
and	O
may	O
persist	O
as	O
gingivitis	O
or	O
progress	O
to	O
more	O
severe	O
disease	O
.	O

The	O
bacteria	O
involved	O
in	O
disease	O
initiation	O
and	O
progression	O
have	O
not	O
been	O
identified	O
.	O

We	O
used	O
quantitative	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
to	O
compare	O
the	O
levels	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
and	O
total	O
bacteria	O
detected	O
by	O
different	O
sampling	O
methods	O
.	O

On	O
the	O
basis	O
of	O
the	O
results	O
of	O
clinical	O
examinations	O
,	O
57	O
patients	O
were	O
divided	O
into	O
3	O
groups	O
:	O
healthy	O
group	O
(	O
group	O
A	O
)	O
,	O
gingivitis	O
group	O
(	O
group	O
B	O
)	O
,	O
and	O
periodontitis	O
group	O
(	O
group	O
C	O
)	O
.	O

Bacterial	O
samples	O
were	O
collected	O
from	O
saliva	O
,	O
mouthwash	O
,	O
and	O
by	O
paper	O
-	O
point	O
sampling	O
of	O
gingival	O
crevicular	O
fluid	O
(	O
GCF	O
)	O
,	O
and	O
the	O
samples	O
were	O
analyzed	O
with	O
quantitative	O
PCR	O
targeting	O
16S	O
rRNA	O
.	O

The	O
numbers	O
of	O
total	O
bacteria	O
in	O
samples	O
of	O
GCF	O
,	O
saliva	O
,	O
and	O
mouthwash	O
were	O
10	O
(	O
5	O
)	O
to	O
10	O
(	O
6	O
)	O
,	O
10	O
(	O
8	O
)	O
,	O
and	O
10	O
(	O
7	O
)	O
,	O
respectively	O
,	O
per	O
milliliter	O
.	O

The	O
number	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
in	O
GCF	O
samples	O
was	O
lower	O
than	O
10	O
in	O
group	O
A	O
;	O
however	O
,	O
in	O
groups	O
B	O
and	O
C	O
,	O
the	O
values	O
were	O
10	O
(	O
3	O
)	O
and	O
10	O
(	O
4	O
)	O
,	O
respectively	O
,	O
indicating	O
that	O
the	O
number	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
increased	O
with	O
worsening	O
clinical	O
status	O
.	O

Findings	O
were	O
similar	O
in	O
the	O
samples	O
of	O
saliva	O
and	O
mouthwash	O
.	O

The	O
numbers	O
of	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
showed	O
a	O
pattern	O
similar	O
to	O
that	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
in	O
all	O
3	O
samples	O
.	O

These	O
results	O
suggest	O
that	O
saliva	O
and	O
mouthwash	O
samples	O
are	O
clinically	O
useful	O
for	O
bacterial	O
testing	O
of	O
periodontal	O
diseases	O
by	O
quantitative	O
PCR	O
.	O

In	O
addition	O
,	O
mouthwash	O
sampling	O
is	O
more	O
feasible	O
and	O
straightforward	O
than	O
saliva	O
sampling	O
.	O

The	O
epithelial	O
cell	O
barrier	O
is	O
the	O
first	O
line	O
of	O
host	O
defense	O
against	O
bacterial	O
aggression	O
in	O
periodontal	O
sites	O
.	O

In	O
view	O
of	O
the	O
fact	O
that	O
oral	O
epithelial	O
cells	O
do	O
not	O
express	O
membrane	O
CD14	O
and	O
that	O
high	O
levels	O
of	O
the	O
soluble	O
form	O
of	O
the	O
CD14	O
receptor	O
have	O
been	O
detected	O
in	O
the	O
gingival	O
crevicular	O
fluid	O
of	O
patients	O
with	O
periodontitis	O
,	O
we	O
investigated	O
the	O
effects	O
of	O
recombinant	O
soluble	O
CD14	O
(	O
rsCD14	O
)	O
,	O
alone	O
and	O
in	O
combination	O
with	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
lipopolysaccharide	O
(	O
LPS	O
)	O
on	O
the	O
inflammatory	O
response	O
of	O
human	O
oral	O
epithelial	O
cells	O
.	O

The	O
oral	O
epithelial	O
cell	O
line	O
GMSM	O
-	O
K	O
was	O
stimulated	O
with	O
rsCD14	O
,	O
alone	O
or	O
in	O
combination	O
with	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
LPS	O
,	O
and	O
the	O
levels	O
of	O
the	O
inflammatory	O
mediators	O
interleukin	O
(	O
IL	O
)	O
-	O
6	O
,	O
IL	O
-	O
8	O
and	O
chemokine	O
(	O
C	O
-	O
C	O
motif	O
)	O
ligand	O
5	O
(	O
CCL5	O
)	O
were	O
determined	O
using	O
ELISAs	O
.	O

Activation	O
of	O
the	O
transcription	O
factors	O
nuclear	O
factor	O
-	O
kappaB	O
(	O
NF	O
-	O
kappaB	O
)	O
and	O
activator	O
protein	O
-	O
1	O
was	O
also	O
monitored	O
using	O
ELISAs	O
.	O

rsCD14	O
significantly	O
induced	O
the	O
secretion	O
of	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
and	O
CCL5	O
by	O
oral	O
epithelial	O
cells	O
.	O

The	O
combination	O
of	O
rsCD14	O
and	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
LPS	O
augmented	O
this	O
effect	O
.	O

Activation	O
of	O
the	O
NF	O
-	O
kappaB	O
pathway	O
was	O
significantly	O
increased	O
in	O
epithelial	O
cells	O
treated	O
with	O
rsCD14	O
compared	O
with	O
a	O
nonstimulated	O
control	O
,	O
whereas	O
there	O
was	O
no	O
effect	O
on	O
the	O
activation	O
of	O
activator	O
protein	O
-	O
1	O
.	O

rsCD14	O
stimulated	O
the	O
inflammation	O
cascade	O
in	O
oral	O
epithelial	O
cells	O
,	O
both	O
alone	O
or	O
when	O
associated	O
with	O
bacterial	O
LPS	O
,	O
through	O
an	O
NF	O
-	O
kappaB	O
-	O
dependent	O
pathway	O
.	O

This	O
suggests	O
that	O
the	O
presence	O
of	O
soluble	O
CD14	O
in	O
periodontitis	O
lesions	O
may	O
contribute	O
to	O
the	O
inflammatory	O
process	O
of	O
periodontal	O
disease	O
.	O

Periodontal	O
diseases	O
are	O
multifactorial	O
infections	O
elicited	O
by	O
a	O
complex	O
of	O
primarily	O
gram	O
-	O
negative	O
bacteria	O
that	O
interact	O
with	O
host	O
tissues	O
and	O
lead	O
to	O
the	O
destruction	O
of	O
the	O
periodontal	O
structures	O
.	O

Bdellovibrio	B-bacteria
bacteriovorus	I-bacteria
is	O
a	O
gram	O
-	O
negative	O
bacterium	O
that	O
preys	O
upon	O
other	O
gram	O
-	O
negative	O
bacteria	O
.	O

It	O
was	O
previously	O
shown	O
that	O
B	B-bacteria
.	I-bacteria
bacteriovorus	I-bacteria
has	O
an	O
ability	O
to	O
attack	O
and	O
remove	O
surface	O
-	O
attached	O
bacteria	O
or	O
biofilms	O
.	O

In	O
this	O
study	O
,	O
we	O
examined	O
the	O
host	O
specificity	O
of	O
B	B-bacteria
.	I-bacteria
bacteriovorus	I-bacteria
strain	I-bacteria
109J	I-bacteria
and	O
its	O
ability	O
to	O
prey	O
on	O
oral	O
pathogens	O
associated	O
with	O
periodontitis	O
,	O
including	O
;	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Eikenella	B-bacteria
corrodens	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
.	O

We	O
further	O
demonstrated	O
that	O
B	B-bacteria
.	I-bacteria
bacteriovorus	I-bacteria
109J	I-bacteria
has	O
an	O
ability	O
to	O
remove	O
biofilms	O
of	O
Ei	B-bacteria
.	I-bacteria
corrodens	I-bacteria
as	O
well	O
as	O
biofilms	O
composed	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
.	O

Bdellovibrio	B-bacteria
bacteriovorus	I-bacteria
was	O
able	O
to	O
remove	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
biofilms	O
developed	O
on	O
hydroxyapatite	O
surfaces	O
and	O
in	O
the	O
presence	O
of	O
saliva	O
,	O
as	O
well	O
as	O
to	O
detach	O
metabolically	O
inactive	O
biofilms	O
.	O

Experiments	O
aimed	O
at	O
enhancing	O
the	O
biofilm	O
removal	O
aptitude	O
of	O
B	B-bacteria
.	I-bacteria
bacteriovorus	I-bacteria
with	O
the	O
aid	O
of	O
extracellular	O
-	O
polymeric	O
-	O
substance	O
-	O
degrading	O
enzymes	O
demonstrated	O
that	O
proteinase	O
-	O
K	O
inhibits	O
predation	O
.	O

However	O
,	O
treating	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
biofilms	O
with	O
DspB	O
,	O
a	O
poly	O
-	O
N	O
-	O
acetylglucosamine	O
(	O
PGA	O
)	O
-	O
hydrolysing	O
enzyme	O
,	O
increased	O
biofilm	O
removal	O
.	O

Increased	O
biofilm	O
removal	O
was	O
also	O
recorded	O
when	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
PGA	O
-	O
defective	O
mutants	O
were	O
used	O
as	O
host	O
cells	O
,	O
suggesting	O
that	O
PGA	O
degradation	O
could	O
enhance	O
the	O
removal	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
biofilm	O
by	O
B	B-bacteria
.	I-bacteria
bacteriovorus	I-bacteria
.	O

Recently	O
,	O
the	O
predation	O
of	O
Bdellovibrio	B-bacteria
bacteriovorus	I-bacteria
on	O
a	O
periodontal	O
pathogen	O
has	O
been	O
described	O
.	O

The	O
current	O
study	O
explores	O
the	O
potential	O
antimicrobial	O
activity	O
of	O
a	O
range	O
of	O
predatory	O
bacteria	O
against	O
key	O
periodontal	O
pathogens	O
.	O

A	O
number	O
of	O
representatives	O
from	O
the	O
Bdellovibrio	B-bacteria
,	O
Bacteriovorax	B-bacteria
and	O
Peredibacter	B-bacteria
lineages	O
(	O
called	O
'	O
BALOs	O
'	O
)	O
were	O
tested	O
for	O
their	O
activity	O
towards	O
a	O
group	O
of	O
key	O
periodontal	O
pathogens	O
and	O
an	O
optimal	O
multiplicity	O
of	O
infection	O
was	O
established	O
.	O

As	O
the	O
oral	O
cavity	O
contains	O
a	O
wide	O
variety	O
of	O
bacteria	O
that	O
are	O
not	O
preyed	O
upon	O
,	O
it	O
was	O
investigated	O
if	O
they	O
can	O
have	O
an	O
effect	O
on	O
the	O
predation	O
efficiency	O
of	O
BALOs	O
.	O

It	O
was	O
concluded	O
that	O
a	O
number	O
of	O
important	O
variables	O
involved	O
in	O
bacterial	O
predation	O
are	O
found	O
to	O
be	O
compatible	O
with	O
the	O
composition	O
of	O
the	O
oral	O
microbiota	O
.	O

This	O
finding	O
makes	O
the	O
case	O
for	O
continued	O
study	O
of	O
the	O
potential	O
for	O
BALOs	O
to	O
combat	O
periodontal	O
pathogens	O
.	O

Oral	O
viridans	B-bacteria
group	I-bacteria
streptococci	I-bacteria
are	O
the	O
major	O
commensal	O
bacteria	O
of	O
the	O
supragingival	O
oral	O
biofilm	O
and	O
have	O
been	O
detected	O
in	O
human	O
atheromatous	O
plaque	O
.	O

Atherosclerosis	O
involves	O
an	O
ongoing	O
inflammatory	O
response	O
,	O
reportedly	O
involving	O
chronic	O
infection	O
caused	O
by	O
multiple	O
pathogens	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
invasion	O
of	O
human	O
aortic	O
endothelial	O
cells	O
(	O
HAECs	O
)	O
by	O
oral	O
viridans	B-bacteria
group	I-bacteria
streptococci	I-bacteria
and	O
the	O
subsequent	O
cytokine	O
production	O
by	O
viable	O
invaded	O
HAECs	O
.	O

The	O
invasion	O
of	O
HAECs	O
by	O
bacteria	O
was	O
examined	O
using	O
antibiotic	O
protection	O
assays	O
and	O
was	O
visualized	O
by	O
confocal	O
scanning	O
laser	O
microscopy	O
.	O

The	O
inhibitory	O
effects	O
of	O
catalase	O
and	O
cytochalasin	O
D	O
on	O
the	O
invasion	O
of	O
HAECs	O
were	O
also	O
examined	O
.	O

The	O
production	O
of	O
cytokines	O
by	O
invaded	O
or	O
infected	O
HAECs	O
was	O
determined	O
using	O
enzyme	O
-	O
linked	O
immunosorbent	O
assays	O
,	O
and	O
a	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
method	O
was	O
used	O
to	O
evaluate	O
the	O
expression	O
of	O
cytokine	O
messenger	O
RNA	O
.	O

The	O
oral	O
streptococci	B-bacteria
tested	O
were	O
capable	O
of	O
invading	O
HAECs	O
.	O

The	O
number	O
of	O
invasive	O
bacteria	O
increased	O
with	O
the	O
length	O
of	O
the	O
co	O
-	O
culture	O
period	O
.	O

After	O
a	O
certain	O
co	O
-	O
culture	O
period	O
,	O
some	O
organisms	O
were	O
cytotoxic	O
to	O
the	O
HAECs	O
.	O

Catalase	O
and	O
cytochalasin	O
D	O
inhibited	O
the	O
invasion	O
of	O
HAECs	O
by	O
the	O
organism	O
.	O

HAECs	O
invaded	O
by	O
Streptococcus	B-bacteria
mutans	I-bacteria
Xc	I-bacteria
,	O
Streptococcus	B-bacteria
gordonii	I-bacteria
DL1	I-bacteria
(	O
Challis	B-bacteria
)	O
,	O
Streptococcus	B-bacteria
gordonii	I-bacteria
ATCC	I-bacteria
10558	I-bacteria
and	O
Streptococcus	B-bacteria
salivarius	I-bacteria
ATCC	I-bacteria
13419	I-bacteria
produced	O
more	O
cytokine	O
(	O
s	O
)	O
(	O
interleukin	O
-	O
6	O
,	O
interleukin	O
-	O
8	O
,	O
monocyte	O
chemoattractant	O
protein	O
-	O
1	O
)	O
than	O
non	O
-	O
invaded	O
HAECs	O
.	O

The	O
HAECs	O
invaded	O
by	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
Xc	I-bacteria
produced	O
the	O
largest	O
amounts	O
of	O
cytokines	O
,	O
and	O
the	O
messenger	O
RNA	O
expression	O
of	O
cytokines	O
by	O
invaded	O
HAECs	O
increased	O
markedly	O
compared	O
with	O
that	O
by	O
non	O
-	O
invaded	O
HAECs	O
.	O

These	O
results	O
suggest	O
that	O
oral	O
streptococci	B-bacteria
may	O
participate	O
in	O
the	O
pathogenesis	O
of	O
atherosclerosis	O
.	O

The	O
human	O
oral	O
microbial	O
biota	O
represents	O
a	O
highly	O
diverse	O
biofilm	O
.	O

Twenty	O
-	O
five	O
species	O
of	O
oral	O
streptococci	B-bacteria
inhabit	O
the	O
human	O
oral	O
cavity	O
and	O
represent	O
about	O
20	O
%	O
of	O
the	O
total	O
oral	O
bacteria	O
.	O

Taxonomy	O
of	O
these	O
bacteria	O
is	O
complex	O
and	O
remains	O
provisional	O
.	O

Oral	O
streptococci	B-bacteria
encompass	O
friends	O
and	O
foes	O
bacteria	O
.	O

Each	O
species	O
has	O
developed	O
specific	O
properties	O
for	O
colonizing	O
the	O
different	O
oral	O
sites	O
subjected	O
to	O
constantly	O
changing	O
conditions	O
,	O
for	O
competing	O
against	O
competitors	O
,	O
and	O
for	O
resisting	O
external	O
agressions	O
(	O
host	O
immune	O
system	O
,	O
physico	O
-	O
chemical	O
shocks	O
,	O
and	O
mechanical	O
frictions	O
)	O
.	O

Imbalance	O
in	O
the	O
indigenous	O
microbial	O
biota	O
generates	O
oral	O
diseases	O
,	O
and	O
under	O
proper	O
conditions	O
,	O
commensal	O
streptococci	B-bacteria
can	O
switch	O
to	O
opportunistic	O
pathogens	O
that	O
initiate	O
disease	O
in	O
and	O
damage	O
to	O
the	O
host	O
.	O

The	O
group	O
of	O
`	O
`	O
mutans	B-bacteria
streptococci	I-bacteria
'	O
'	O
was	O
described	O
as	O
the	O
most	O
important	O
bacteria	O
related	O
to	O
the	O
formation	O
of	O
dental	O
caries	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
,	O
although	O
naturally	O
present	O
among	O
the	O
human	O
oral	O
microbiota	O
,	O
is	O
the	O
microbial	O
species	O
most	O
strongly	O
associated	O
with	O
carious	O
lesions	O
.	O

This	O
minireview	O
describes	O
the	O
oral	O
streptococci	B-bacteria
ecology	O
and	O
their	O
biofilm	O
life	O
style	O
by	O
focusing	O
on	O
the	O
mutans	O
group	O
,	O
mainly	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

Virulence	O
traits	O
,	O
interactions	O
in	O
the	O
biofilm	O
,	O
and	O
influence	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
dental	O
caries	O
etiology	O
are	O
discussed	O
.	O

Some	O
gastrointestinal	O
bacteria	O
synthesize	O
hydrogen	O
(	O
H	O
(	O
2	O
)	O
)	O
by	O
fermentation	O
.	O

Despite	O
the	O
presence	O
of	O
bactericidal	O
factors	O
in	O
human	O
saliva	O
,	O
a	O
large	O
number	O
of	O
bacteria	O
also	O
live	O
in	O
the	O
oral	O
cavity	O
.	O

It	O
has	O
never	O
been	O
shown	O
that	O
oral	O
bacteria	O
also	O
produce	O
H	O
(	O
2	O
)	O
or	O
what	O
role	O
H	O
(	O
2	O
)	O
might	O
play	O
in	O
the	O
oral	O
cavity	O
.	O

It	O
was	O
found	O
that	O
a	O
significant	O
amount	O
of	O
H	O
(	O
2	O
)	O
is	O
synthesized	O
in	O
the	O
oral	O
cavity	O
of	O
healthy	O
human	O
subjects	O
,	O
and	O
that	O
its	O
generation	O
is	O
enhanced	O
by	O
the	O
presence	O
of	O
glucose	O
but	O
inhibited	O
by	O
either	O
teeth	O
brushing	O
or	O
sterilization	O
with	O
povidone	O
iodine	O
.	O

These	O
observations	O
suggest	O
the	O
presence	O
of	O
H	O
(	O
2	O
)	O
-	O
generating	O
bacteria	O
in	O
the	O
oral	O
cavity	O
.	O

The	O
screening	O
of	O
commensal	O
bacteria	O
in	O
the	O
oral	O
cavity	O
revealed	O
that	O
a	O
variety	O
of	O
anaerobic	O
bacteria	O
generate	O
H	O
(	O
2	O
)	O
.	O

Among	O
them	O
,	O
Klebsiella	B-bacteria
pneumoniae	I-bacteria
(	O
K	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
)	O
generated	O
significantly	O
large	O
amounts	O
of	O
H	O
(	O
2	O
)	O
in	O
the	O
presence	O
of	O
glucose	O
.	O

Biochemical	O
analysis	O
revealed	O
that	O
various	O
proteins	O
in	O
K	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
are	O
carbonylated	O
under	O
standard	O
culture	O
conditions	O
,	O
and	O
that	O
oxidative	O
stress	O
induced	O
by	O
the	O
presence	O
of	O
Fe	O
(	O
+	O
+	O
)	O
and	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
increases	O
the	O
number	O
of	O
carbonylated	O
proteins	O
,	O
particularly	O
when	O
their	O
hydrogenase	O
activity	O
is	O
inhibited	O
by	O
KCN	O
.	O

Inhibition	O
of	O
H	O
(	O
2	O
)	O
generation	O
markedly	O
suppresses	O
the	O
growth	O
of	O
K	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
.	O

These	O
observations	O
suggest	O
that	O
H	O
(	O
2	O
)	O
generation	O
and	O
/	O
or	O
the	O
reduction	O
of	O
oxidative	O
stress	O
is	O
important	O
for	O
the	O
survival	O
and	O
growth	O
of	O
K	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
in	O
the	O
oral	O
cavity	O
.	O

The	O
oral	O
cavity	O
is	O
a	O
specialized	O
ecosystem	O
composed	O
of	O
dentition	O
and	O
mucosa	O
exposed	O
to	O
the	O
effects	O
of	O
saliva	O
and	O
gingival	O
liquid	O
.	O

Its	O
structure	O
provides	O
advantageous	O
conditions	O
for	O
various	O
microorganisms	O
,	O
both	O
aerobic	O
streptococci	B-bacteria
and	O
anaerobic	O
bacilli	O
.	O

The	O
dynamic	O
balance	O
of	O
the	O
oral	O
cavity	O
ecosystem	O
can	O
be	O
threatened	O
by	O
various	O
factors	O
.	O

Lip	O
and	O
palatal	O
clefts	O
are	O
the	O
most	O
frequent	O
disorders	O
in	O
embryonic	O
facial	O
development	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
evaluate	O
whether	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
and	O
oral	O
cavity	O
hygiene	O
in	O
patients	O
with	O
cleft	O
palate	O
treated	O
orthodontically	O
are	O
significantly	O
different	O
compared	O
with	O
patients	O
without	O
these	O
congenital	O
malformations	O
.	O

The	O
study	O
group	O
consisted	O
of	O
200	O
patients	O
aged	O
6	O
-	O
21	O
who	O
were	O
divided	O
into	O
two	O
groups	O
depending	O
on	O
the	O
presence	O
of	O
cleft	O
palate	O
and	O
treatment	O
method	O
.	O

Group	O
C	O
(	O
control	O
)	O
consisted	O
of	O
50	O
orthodontically	O
untreated	O
patients	O
with	O
occlusal	O
dental	O
defects	O
.	O

The	O
performed	O
studies	O
consisted	O
of	O
2	O
parts	O
:	O
the	O
clinical	O
-	O
laboratory	O
part	O
and	O
statistical	O
analysis	O
.	O

Clinical	O
-	O
laboratory	O
part	O
High	O
bacteria	O
levels	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
in	O
saliva	O
of	O
patients	O
were	O
comparably	O
frequent	O
between	O
groups	O
,	O
but	O
there	O
were	O
statistically	O
significant	O
differences	O
in	O
inter	O
-	O
group	O
comparisons	O
.	O

As	O
the	O
orthodontic	O
treatment	O
changes	O
the	O
oral	O
environment	O
,	O
control	O
of	O
proper	O
hygienic	O
behavior	O
is	O
an	O
essential	O
element	O
of	O
health	O
education	O
.	O

Introduction	O
of	O
preventive	O
programs	O
is	O
also	O
very	O
important	O
.	O

The	O
oral	O
cavity	O
contains	O
the	O
greatest	O
biodiversity	O
,	O
over	O
70	O
species	O
being	O
isolated	O
from	O
mouth	O
mucosa	O
,	O
saliva	O
,	O
denture	O
surfaces	O
and	O
/	O
or	O
dental	O
-	O
plaque	O
.	O

The	O
oral	O
streptococci	B-bacteria
,	O
representing	O
over	O
80	O
%	O
of	O
the	O
mouth	O
micro	O
flora	O
,	O
are	O
able	O
to	O
synthesize	O
glucosyl	O
-	O
transferases	O
,	O
enzymes	O
involved	O
in	O
glucans	O
production	O
.	O

Glucans	O
are	O
involved	O
in	O
production	O
of	O
an	O
extracellular	O
slime	O
layer	O
promoting	O
adhesion	O
and	O
formation	O
of	O
a	O
dental	O
plaque	O
biofilm	O
.	O

The	O
43	O
isolates	O
studied	O
obtained	O
from	O
partially	O
and	O
/	O
or	O
totally	O
edentulous	O
,	O
were	O
identified	O
by	O
VITEK	O
system	O
using	O
gram	O
-	O
positive	O
identification	O
cards	O
.	O

Species	O
-	O
specific	O
regions	O
within	O
the	O
genes	O
coding	O
for	O
glucosyl	O
-	O
transferases	O
(	O
gtf	O
genes	O
)	O
were	O
targeted	O
for	O
PCR	O
identification	O
of	O
isolates	O
.	O

Sequencing	O
of	O
16S	O
rRNA	O
was	O
used	O
as	O
gold	O
standard	O
for	O
strain	O
confirmation	O
.	O

system	O
identified	O
a	O
number	O
of	O
11	O
strains	O
as	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
/	I-bacteria
oralis	I-bacteria
,	O
12	O
strains	O
as	O
S	B-bacteria
.	I-bacteria
anginosus	I-bacteria
/	I-bacteria
gordonii	I-bacteria
,	O
12	O
strains	O
as	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
/	I-bacteria
parasanguinis	I-bacteria
,	O
3	O
strains	O
as	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
,	O
3	O
strains	O
as	O
S	B-bacteria
.	I-bacteria
plurianimalium	I-bacteria
,	O
1	O
strain	O
as	O
S	B-bacteria
.	I-bacteria
cristatus	I-bacteria
and	O
1	O
strain	O
as	O
S	B-bacteria
.	I-bacteria
alactolyticus	I-bacteria
,	O
respectively	O
.	O

The	O
PCR	O
system	O
targeting	O
gtf	O
genes	O
was	O
able	O
to	O
identify	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
strains	I-bacteria
.	O

Sequence	O
of	O
16S	O
rRNA	O
discriminated	O
among	O
streptococci	B-bacteria
species	I-bacteria
and	O
revealed	O
16	O
strains	O
of	O
Leuconostoc	B-bacteria
mesenteroides	I-bacteria
.	O

Many	O
studies	O
are	O
needed	O
in	O
order	O
to	O
select	O
the	O
most	O
reliable	O
phenotypic	O
and	O
genotypic	O
methods	O
in	O
order	O
to	O
improve	O
the	O
identification	O
algorithm	O
for	O
oral	O
streptococci	B-bacteria
used	O
by	O
clinical	O
laboratories	O
.	O

Their	O
accurate	O
identification	O
is	O
mandatory	O
for	O
better	O
understanding	O
their	O
role	O
in	O
human	O
infections	O
.	O

Streptococcus	B-bacteria
sanguinis	I-bacteria
is	O
a	O
member	O
of	O
oral	O
streptococci	B-bacteria
and	O
one	O
of	O
the	O
most	O
abundant	O
species	O
found	O
in	O
oral	O
biofilm	O
called	O
dental	O
plaque	O
.	O

Colonization	O
of	O
the	O
oral	O
streptococci	B-bacteria
on	O
the	O
tooth	O
surface	O
depends	O
on	O
the	O
adhesion	O
of	O
bacteria	O
to	O
salivary	O
components	O
adsorbed	O
to	O
the	O
tooth	O
surface	O
.	O

Recently	O
,	O
we	O
identified	O
unique	O
cell	O
surface	O
long	O
filamentous	O
structures	O
named	O
pili	O
in	O
this	O
species	O
.	O

Herein	O
,	O
we	O
investigated	O
the	O
role	O
of	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
pili	O
in	O
biofilm	O
formation	O
.	O

We	O
found	O
that	O
pili	O
-	O
deficient	O
mutant	O
,	O
in	O
which	O
the	O
genes	O
encoding	O
the	O
three	O
pilus	O
proteins	O
PilA	O
,	O
PilB	O
and	O
PilC	O
have	O
been	O
deleted	O
,	O
showed	O
an	O
impaired	O
bacterial	O
accumulation	O
on	O
saliva	O
-	O
coated	O
surfaces	O
.	O

Confocal	O
microscopic	O
observations	O
suggested	O
that	O
the	O
mutant	O
was	O
incapable	O
of	O
producing	O
typical	O
three	O
-	O
dimensional	O
layer	O
of	O
biofilm	O
.	O

Ligand	O
blot	O
analysis	O
showed	O
that	O
the	O
ancillary	O
pilus	O
proteins	O
PilB	O
and	O
PilC	O
bound	O
to	O
human	O
whole	O
saliva	O
.	O

Additional	O
analysis	O
demonstrated	O
that	O
PilC	O
bound	O
to	O
multiple	O
salivary	O
components	O
,	O
and	O
one	O
of	O
which	O
was	O
found	O
to	O
be	O
salivary	O
alpha	O
-	O
amylase	O
.	O

These	O
results	O
indicate	O
that	O
pilus	O
proteins	O
are	O
members	O
of	O
saliva	O
-	O
binding	O
proteins	O
of	O
oral	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
,	O
and	O
suggest	O
the	O
involvement	O
of	O
pili	O
in	O
its	O
colonization	O
on	O
saliva	O
-	O
coated	O
tooth	O
surfaces	O
and	O
in	O
the	O
human	O
oral	O
cavity	O
.	O

Capnocytophaga	B-bacteria
canimorsus	I-bacteria
is	O
a	O
potentially	O
pathogenic	O
microorganism	O
when	O
transmitted	O
to	O
humans	O
from	O
the	O
oral	O
cavity	O
of	O
canines	O
.	O

Although	O
there	O
is	O
some	O
knowledge	O
about	O
the	O
frequency	O
of	O
occurrence	O
in	O
canines	O
,	O
it	O
is	O
uncertain	O
whether	O
there	O
is	O
a	O
correlation	O
between	O
its	O
occurrence	O
and	O
lifestyle	O
,	O
health	O
,	O
or	O
breed	O
of	O
dog	O
.	O

Samples	O
of	O
tooth	O
plaque	O
from	O
a	O
total	O
of	O
131	O
canines	O
were	O
collected	O
,	O
cultured	O
on	O
selective	O
media	O
,	O
and	O
tested	O
using	O
physiological	O
and	O
molecular	O
analyses	O
to	O
help	O
discern	O
the	O
presence	O
of	O
C	B-bacteria
.	I-bacteria
canimorsus	I-bacteria
.	O

Phylogenetic	O
analyses	O
determined	O
that	O
49	O
.	O
2	O
%	O
of	O
canines	O
sampled	O
carried	O
a	O
species	O
of	O
Capnocytophaga	B-bacteria
and	O
21	O
.	O
7	O
%	O
of	O
the	O
canines	O
sampled	O
in	O
this	O
study	O
carried	O
C	B-bacteria
.	I-bacteria
canimorsus	I-bacteria
.	O

Statistical	O
analyses	O
found	O
that	O
male	O
dogs	O
and	O
those	O
that	O
are	O
neutered	O
and	O
spayed	O
are	O
more	O
likely	O
to	O
host	O
Capnocytophaga	B-bacteria
species	I-bacteria
.	O

The	O
data	O
also	O
suggested	O
that	O
breed	O
was	O
a	O
statistically	O
significant	O
predictor	O
of	O
C	B-bacteria
.	I-bacteria
canimorsus	I-bacteria
,	O
with	O
the	O
smaller	O
breeds	O
more	O
likely	O
to	O
carry	O
the	O
potential	O
pathogen	O
.	O

In	O
addition	O
,	O
three	O
`	O
`	O
human	O
'	O
'	O
species	O
of	O
Capnocytophaga	B-bacteria
;	O
C	B-bacteria
.	I-bacteria
ochracea	I-bacteria
,	O
C	B-bacteria
.	I-bacteria
haemolytica	I-bacteria
,	O
and	O
one	O
isolate	O
of	O
either	O
C	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
or	O
C	B-bacteria
.	I-bacteria
granulosa	I-bacteria
were	O
cultured	O
from	O
five	O
canines	O
.	O

Sixteen	O
canines	O
sampled	O
carried	O
an	O
unidentified	O
Capnocytophaga	B-bacteria
species	I-bacteria
,	O
with	O
the	O
sequences	O
from	O
all	O
isolates	O
forming	O
a	O
well	O
-	O
defined	O
phylogenetic	O
clade	O
with	O
100	O
%	O
bootstrap	O
support	O
that	O
may	O
well	O
represent	O
a	O
new	O
species	O
of	O
Capnocytophaga	B-bacteria
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
,	O
the	O
principal	O
etiologic	O
agents	O
of	O
caries	O
decay	O
of	O
teeth	O
,	O
are	O
generally	O
acquired	O
in	O
oral	O
cavity	O
at	O
the	O
moment	O
of	O
tooth	O
eruption	O
.	O

However	O
,	O
as	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
has	O
been	O
detected	O
in	O
oral	O
cavity	O
of	O
predentate	O
children	O
,	O
the	O
eruption	O
of	O
teeth	O
seems	O
not	O
to	O
be	O
a	O
necessary	O
prerequisite	O
,	O
suggesting	O
that	O
this	O
species	O
may	O
be	O
not	O
confined	O
to	O
dental	O
plaque	O
.	O

Here	O
,	O
we	O
evaluate	O
the	O
ability	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
in	O
planktonic	O
and	O
biofilm	O
lifestyle	O
to	O
adhere	O
,	O
invade	O
and	O
survive	O
within	O
human	O
gingival	O
fibroblast	O
(	O
HGF	O
-	O
1	O
)	O
cells	O
.	O

Planktonic	O
and	O
biofilm	O
streptococci	B-bacteria
adhered	O
and	O
invaded	O
host	O
cells	O
to	O
different	O
extents	O
,	O
showing	O
higher	O
efficiencies	O
of	O
biofilm	O
than	O
planktonic	O
counterparts	O
.	O

Moreover	O
,	O
planktonic	O
and	O
biofilm	O
streptococci	B-bacteria
showed	O
the	O
same	O
percentage	O
of	O
survival	O
within	O
host	O
cells	O
.	O

Transmission	O
electron	O
and	O
confocal	O
microscopy	O
observations	O
confirmed	O
intracellular	O
localization	O
of	O
planktonic	O
and	O
biofilm	O
bacteria	O
.	O

The	O
adhesion	O
,	O
invasion	O
and	O
survival	O
abilities	O
within	O
human	O
oral	O
cells	O
may	O
be	O
considered	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
virulence	O
mechanisms	O
to	O
colonize	O
and	O
persist	O
in	O
the	O
oral	O
cavity	O
in	O
the	O
absence	O
of	O
tooth	O
surface	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
design	O
and	O
evaluate	O
fluorescent	O
in	O
situ	O
hybridization	O
(	O
FISH	O
)	O
probes	O
for	O
the	O
single	O
-	O
cell	O
detection	O
and	O
enumeration	O
of	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
,	O
in	O
particular	O
organisms	O
belonging	O
to	O
the	O
major	O
phylogenetic	O
groups	O
and	O
species	O
of	O
oral	O
lactobacilli	B-bacteria
and	O
to	O
Abiotrophia	B-bacteria
/	O
Granulicatella	I-bacteria
.	O

As	O
lactobacilli	B-bacteria
are	O
known	O
for	O
notorious	O
resistance	O
to	O
probe	O
penetration	O
,	O
probe	O
-	O
specific	O
assay	O
protocols	O
were	O
experimentally	O
developed	O
to	O
provide	O
maximum	O
cell	O
wall	O
permeability	O
,	O
probe	O
accessibility	O
,	O
hybridization	O
stringency	O
,	O
and	O
fluorescence	O
intensity	O
.	O

The	O
new	O
assays	O
were	O
then	O
applied	O
in	O
a	O
pilot	O
study	O
to	O
three	O
biofilm	O
samples	O
harvested	O
from	O
variably	O
demineralized	O
bovine	O
enamel	O
discs	O
that	O
had	O
been	O
carried	O
in	O
situ	O
for	O
10	O
days	O
by	O
different	O
volunteers	O
.	O

Best	O
probe	O
penetration	O
and	O
fluorescent	O
labeling	O
of	O
reference	O
strains	O
were	O
obtained	O
after	O
combined	O
lysozyme	O
and	O
achromopeptidase	O
treatment	O
followed	O
by	O
exposure	O
to	O
lipase	O
.	O

Hybridization	O
stringency	O
had	O
to	O
be	O
established	O
strictly	O
for	O
each	O
probe	O
.	O

Thereafter	O
all	O
probes	O
showed	O
the	O
expected	O
specificity	O
with	O
reference	O
strains	O
and	O
labeled	O
the	O
anticipated	O
morphotypes	O
in	O
dental	O
plaques	O
.	O

Applied	O
to	O
in	O
situ	O
grown	O
biofilms	O
the	O
set	O
of	O
probes	O
detected	O
only	O
Lactobacillus	B-bacteria
fermentum	I-bacteria
and	O
bacteria	O
of	O
the	O
Lactobacillus	B-bacteria
casei	I-bacteria
group	O
.	O

The	O
most	O
cariogenic	O
biofilm	O
contained	O
two	O
orders	O
of	O
magnitude	O
higher	O
L	B-bacteria
.	I-bacteria
fermentum	I-bacteria
cell	O
numbers	O
than	O
the	O
other	O
biofilms	O
.	O

Abiotrophia	B-bacteria
/	O
Granulicatella	B-bacteria
and	O
streptococci	B-bacteria
from	O
the	O
mitis	O
group	O
were	O
found	O
in	O
all	O
samples	O
at	O
high	O
levels	O
,	O
whereas	O
Streptococcus	B-bacteria
mutans	I-bacteria
was	O
detected	O
in	O
only	O
one	O
sample	O
in	O
very	O
low	O
numbers	O
.	O

Application	O
of	O
these	O
new	O
group	O
-	O
and	O
species	O
-	O
specific	O
FISH	O
probes	O
to	O
oral	O
biofilm	O
-	O
forming	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
will	O
allow	O
a	O
clearer	O
understanding	O
of	O
the	O
supragingival	O
biome	O
,	O
its	O
spatial	O
architecture	O
and	O
of	O
structure	O
-	O
function	O
relationships	O
implicated	O
during	O
plaque	O
homeostasis	O
and	O
caries	O
development	O
.	O

The	O
probes	O
should	O
prove	O
of	O
value	O
far	O
beyond	O
the	O
field	O
of	O
oral	O
microbiology	O
,	O
as	O
many	O
of	O
them	O
detect	O
non	O
-	O
oral	O
species	O
and	O
phylogenetic	O
groups	O
of	O
importance	O
in	O
a	O
variety	O
of	O
medical	O
conditions	O
and	O
the	O
food	O
industry	O
.	O

Gingival	O
epithelia	O
utilize	O
multiple	O
signaling	O
pathways	O
to	O
regulate	O
innate	O
immune	O
responses	O
to	O
various	O
oral	O
bacteria	O
,	O
but	O
little	O
is	O
understood	O
about	O
how	O
these	O
bacteria	O
alter	O
epithelial	O
epigenetic	O
status	O
.	O

In	O
this	O
study	O
we	O
report	O
that	O
DNA	O
methyltransferase	O
(	O
DNMT1	O
)	O
and	O
histone	O
deacetylase	O
expression	O
were	O
decreased	O
in	O
gingival	O
epithelial	O
cells	O
treated	O
with	O
oral	O
pathogen	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
nonpathogen	B-bacteria
Fusobacterium	I-bacteria
nucleatum	I-bacteria
.	O

Pretreatment	O
with	O
trichostatin	O
A	O
and	O
sodium	O
butyrate	O
,	O
which	O
increase	O
acetylation	O
of	O
chromatin	O
histones	O
,	O
significantly	O
enhanced	O
the	O
gene	O
expression	O
of	O
antimicrobial	O
proteins	O
human	O
beta	O
-	O
defensin	O
2	O
(	O
hBD2	O
)	O
and	O
CC	O
chemokine	O
ligand	O
20	O
(	O
CCL20	O
)	O
in	O
response	O
to	O
both	O
bacterial	O
challenges	O
.	O

Pretreatment	O
with	O
DNMT	O
inhibitor	O
5	O
'	O
-	O
azacytidine	O
increased	O
hBD2	O
and	O
CCL20	O
expression	O
in	O
response	O
to	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
,	O
but	O
not	O
to	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

Furthermore	O
,	O
we	O
observed	O
a	O
differential	O
pattern	O
of	O
protein	O
levels	O
of	O
H3K4me3	O
,	O
which	O
has	O
been	O
associated	O
with	O
chromatin	O
remodeling	O
and	O
activation	O
of	O
gene	O
transcription	O
,	O
in	O
response	O
to	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
vs	O
.	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

This	O
study	O
provides	O
a	O
new	O
insight	O
into	O
the	O
bacteria	O
-	O
specific	O
innate	O
immune	O
responses	O
via	O
epigenetic	O
regulation	O
.	O

Early	O
childhood	O
caries	O
(	O
ECC	O
)	O
is	O
a	O
virulent	O
form	O
of	O
dental	O
caries	O
that	O
can	O
destroy	O
the	O
primary	O
dentition	O
of	O
toddlers	O
and	O
preschool	O
children	O
.	O

It	O
occurs	O
worldwide	O
,	O
afflicting	O
predominantly	O
disadvantaged	O
children	O
.	O

Although	O
Streptococcus	B-bacteria
mutans	I-bacteria
is	O
the	O
most	O
likely	O
causative	O
agent	O
,	O
diet	O
also	O
plays	O
a	O
critical	O
role	O
in	O
the	O
acquisition	O
and	O
clinical	O
expression	O
of	O
this	O
infection	O
.	O

Early	O
acquisition	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
via	O
vertical	O
or	O
horizontal	O
transmission	O
is	O
a	O
key	O
event	O
in	O
the	O
natural	O
history	O
of	O
the	O
disease	O
that	O
coupled	O
with	O
caries	O
promoting	O
feeding	O
behaviours	O
results	O
in	O
accumulation	O
of	O
these	O
organisms	O
to	O
levels	O
exceeding	O
30	O
%	O
of	O
the	O
total	O
cultivable	O
plaque	O
flora	O
,	O
which	O
in	O
turn	O
leads	O
to	O
rapid	O
demineralization	O
of	O
the	O
tooth	O
structure	O
.	O

Inflicted	O
children	O
may	O
also	O
have	O
other	O
associated	O
health	O
problems	O
,	O
ranging	O
from	O
local	O
infections	O
to	O
oral	O
pain	O
that	O
manifest	O
as	O
difficulty	O
in	O
eating	O
and	O
sleeping	O
,	O
reduced	O
growth	O
and	O
altered	O
behaviour	O
.	O

Oral	O
rehabilitation	O
usually	O
consists	O
of	O
restoration	O
or	O
surgical	O
removal	O
of	O
carious	O
teeth	O
along	O
with	O
recommendations	O
regarding	O
feeding	O
habits	O
.	O

Although	O
treatment	O
can	O
be	O
instituted	O
in	O
the	O
dental	O
clinic	O
,	O
it	O
becomes	O
costly	O
sometimes	O
when	O
cooperative	O
capacity	O
of	O
babies	O
and	O
preschool	O
children	O
necessitates	O
the	O
use	O
of	O
general	O
anaesthesia	O
.	O

Primary	O
prevention	O
of	O
ECC	O
has	O
largely	O
been	O
restricted	O
to	O
counselling	O
parents	O
regarding	O
proper	O
feeding	O
behaviour	O
,	O
oral	O
hygiene	O
measures	O
and	O
new	O
strategies	O
that	O
address	O
the	O
infectious	O
component	O
through	O
use	O
of	O
topical	O
antimicrobial	O
therapy	O
in	O
order	O
to	O
defeat	O
this	O
common	O
oral	O
affliction	O
.	O

Chronic	O
periodontitis	O
is	O
associated	O
with	O
systemic	O
diseases	O
such	O
as	O
atherosclerosis	O
.	O

In	O
this	O
study	O
,	O
we	O
evaluated	O
the	O
efficacy	O
of	O
serum	O
IgG	O
antibody	O
titer	O
to	O
periodontal	O
bacteria	O
for	O
prognosis	O
of	O
periodontitis	O
recurrence	O
during	O
supportive	O
periodontal	O
therapy	O
(	O
SPT	O
)	O
phase	O
.	O

The	O
139	O
patients	O
during	O
SPT	O
phase	O
were	O
selected	O
and	O
divided	O
to	O
two	O
groups	O
as	O
follows	O
:	O
`	O
`	O
Stable	O
'	O
'	O
and	O
`	O
`	O
Recurrence	O
'	O
'	O
group	O
at	O
SPT	O
phase	O
for	O
case	O
-	O
control	O
study	O
:	O
`	O
`	O
High	O
IgG	O
titer	O
'	O
'	O
and	O
`	O
`	O
Normal	O
IgG	O
titer	O
'	O
'	O
group	O
before	O
transition	O
to	O
SPT	O
phase	O
for	O
cohort	O
study	O
.	O

We	O
examined	O
whether	O
clinical	O
findings	O
or	O
serum	O
IgG	O
antibody	O
titers	O
to	O
periodontal	O
bacteria	O
are	O
risk	O
factors	O
for	O
the	O
development	O
of	O
periodontitis	O
recurrence	O
.	O

Case	O
-	O
control	O
study	O
showed	O
that	O
there	O
were	O
significant	O
differences	O
between	O
the	O
stable	O
and	O
recurrence	O
groups	O
in	O
age	O
and	O
number	O
of	O
teeth	O
.	O

The	O
serum	O
IgG	O
antibody	O
titer	O
to	O
Eikenella	B-bacteria
corrodens	I-bacteria
FDC1073	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
SU63	I-bacteria
,	O
and	O
Campylobacter	B-bacteria
rectus	I-bacteria
ATCC33238	I-bacteria
was	O
significantly	O
higher	O
in	O
the	O
recurrence	O
group	O
.	O

Next	O
,	O
we	O
found	O
,	O
that	O
the	O
recurrence	O
ratio	O
in	O
the	O
high	O
IgG	O
titer	O
group	O
to	O
Gram	O
-	O
negative	O
obligate	O
anaerobe	O
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
and	O
C	B-bacteria
.	I-bacteria
rectus	I-bacteria
was	O
significantly	O
higher	O
than	O
that	O
of	O
the	O
normal	O
IgG	O
titer	O
group	O
.	O

Taken	O
together	O
,	O
serum	O
IgG	O
antibody	O
titer	O
test	O
is	O
useful	O
in	O
the	O
prognosis	O
of	O
periodontitis	O
recurrence	O
during	O
the	O
SPT	O
phase	O
.	O

There	O
are	O
few	O
in	O
vitro	O
models	O
available	O
in	O
the	O
scientific	O
literature	O
for	O
study	O
of	O
the	O
structure	O
,	O
formation	O
and	O
development	O
of	O
the	O
subgingival	O
biofilm	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
develop	O
and	O
validate	O
an	O
in	O
vitro	O
biofilm	O
model	O
,	O
using	O
representative	O
selected	O
bacteria	O
from	O
the	O
subgingival	O
microbiota	O
.	O

Six	O
standard	O
reference	O
strains	O
were	O
used	O
to	O
develop	O
biofilms	O
over	O
sterile	O
ceramic	O
calcium	O
hydroxyapatite	O
discs	O
coated	O
with	O
saliva	O
within	O
the	O
wells	O
of	O
presterilized	O
polystyrene	O
tissue	O
culture	O
plates	O
.	O

The	O
selected	O
species	O
represent	O
initial	O
(	O
Streptococcus	B-bacteria
oralis	I-bacteria
and	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
)	O
,	O
early	O
(	O
Veillonella	B-bacteria
parvula	I-bacteria
)	O
,	O
secondary	O
(	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
)	O
and	O
late	O
colonizers	O
(	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
)	O
.	O

The	O
structure	O
of	O
the	O
biofilm	O
obtained	O
was	O
studied	O
using	O
a	O
vital	O
fluorescence	O
technique	O
in	O
conjunction	O
with	O
confocal	O
laser	O
scanning	O
microscopy	O
.	O

The	O
biofilm	O
bacterial	O
kinetics	O
were	O
studied	O
by	O
terminal	O
restriction	O
fragment	O
length	O
polymorphism	O
analysis	O
.	O

After	O
12	O
h	O
,	O
initial	O
and	O
early	O
colonizers	O
were	O
the	O
first	O
microorganisms	O
detected	O
adhering	O
to	O
the	O
calcium	O
hydroxyapatite	O
discs	O
.	O

The	O
intermediate	O
colonizer	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
was	O
not	O
detected	O
in	O
the	O
model	O
until	O
24	O
h	O
of	O
incubation	O
.	O

Late	O
colonizers	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
could	O
be	O
measured	O
inside	O
the	O
biofilm	O
after	O
48	O
h	O
.	O

The	O
biofilm	O
reached	O
its	O
steady	O
state	O
between	O
72	O
and	O
96	O
h	O
after	O
inoculation	O
,	O
with	O
bacterial	O
vitality	O
increasing	O
from	O
the	O
hydroxyapatite	O
surface	O
to	O
the	O
central	O
part	O
of	O
the	O
biofilm	O
.	O

An	O
in	O
vitro	O
biofilm	O
model	O
was	O
developed	O
and	O
validated	O
,	O
demonstrating	O
a	O
pattern	O
of	O
bacterial	O
colonization	O
and	O
maturation	O
similar	O
to	O
the	O
in	O
vivo	O
development	O
of	O
the	O
subgingival	O
biofilm	O
.	O

In	O
vitro	O
testing	O
of	O
antimicrobial	O
agents	O
is	O
an	O
important	O
tool	O
in	O
the	O
testing	O
hierarchy	O
,	O
and	O
may	O
provide	O
interesting	O
insights	O
into	O
their	O
potential	O
clinical	O
efficacy	O
.	O

Agents	O
with	O
demonstrable	O
in	O
vitro	O
antimicrobial	O
activity	O
may	O
be	O
effective	O
against	O
the	O
same	O
microorganisms	O
in	O
vivo	O
,	O
whereas	O
agents	O
without	O
demonstrable	O
in	O
vitro	O
antimicrobial	O
activity	O
are	O
unlikely	O
to	O
exhibit	O
in	O
vivo	O
antimicrobial	O
activity	O
.	O

In	O
addition	O
,	O
these	O
methods	O
may	O
also	O
be	O
useful	O
in	O
screening	O
antimicrobial	O
agents	O
in	O
product	O
formulations	O
because	O
such	O
agents	O
with	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
activity	O
may	O
have	O
reduced	O
antimicrobial	O
effects	O
when	O
formulated	O
into	O
a	O
dentifrice	O
.	O

Accordingly	O
,	O
this	O
study	O
examined	O
the	O
in	O
vitro	O
and	O
ex	O
vivo	O
antimicrobial	O
activity	O
of	O
three	O
commercial	O
dentifrices	O
:	O
one	O
formulated	O
with	O
0	O
.	O
243	O
%	O
sodium	O
fluoride	O
(	O
Crest	O
Cavity	O
Protection	O
Toothpaste	O
-	O
Regular	O
)	O
;	O
one	O
with	O
0	O
.	O
454	O
%	O
stannous	O
fluoride	O
,	O
sodium	O
hexametaphosphate	O
,	O
and	O
zinc	O
lactate	O
(	O
Crest	O
Pro	O
-	O
Health	O
)	O
,	O
and	O
one	O
with	O
0	O
.	O
3	O
%	O
triclosan	O
,	O
2	O
.	O
0	O
%	O
PVM	O
/	O
MA	O
copolymer	O
,	O
and	O
0	O
.	O
243	O
%	O
sodium	O
fluoride	O
(	O
Colgate	O
Total	O
)	O
.	O

The	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
of	O
each	O
dentifrice	O
was	O
determined	O
for	O
resident	O
oral	O
bacterial	O
species	O
,	O
including	O
bacteria	O
that	O
are	O
associated	O
with	O
dental	O
caries	O
;	O
periodontitis	O
,	O
and	O
oral	O
halitosis	O
.	O

Evaluations	O
were	O
performed	O
on	O
individual	O
laboratory	O
strains	O
,	O
and	O
on	O
oral	O
bacteria	O
from	O
supragingival	O
plaque	O
samples	O
obtained	O
from	O
10	O
adults	O
and	O
from	O
oral	O
rinse	O
samples	O
obtained	O
from	O
18	O
adults	O
.	O

The	O
lowest	O
MICs	O
against	O
the	O
oral	O
strains	O
and	O
human	O
samples	O
,	O
i	O
.	O
e	O
.	O
,	O
greatest	O
antimicrobial	O
activity	O
,	O
were	O
seen	O
for	O
the	O
triclosan	O
/	O
copolymer	O
dentifrice	O
.	O

There	O
was	O
,	O
in	O
general	O
,	O
a	O
four	O
-	O
fold	O
difference	O
in	O
MICs	O
between	O
the	O
triclosan	O
/	O
copolymer	O
dentifrice	O
and	O
the	O
stannous	O
fluoride	O
/	O
sodium	O
hexametaphosphate	O
/	O
zinc	O
lactate	O
dentifrice	O
.	O

The	O
triclosan	O
/	O
copolymer	O
dentifrice	O
significantly	O
inhibited	O
periodontal	O
pathogens	O
,	O
such	O
as	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Eikenella	B-bacteria
corrodens	I-bacteria
,	O
and	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
.	O

In	O
ex	O
vivo	O
tests	O
measuring	O
antimicrobial	O
effects	O
,	O
the	O
triclosan	O
/	O
copolymer	O
dentifrice	O
substantially	O
inhibited	O
bacterial	O
growth	O
after	O
30	O
-	O
,	O
60	O
-	O
,	O
and	O
120	O
-	O
second	O
exposures	O
compared	O
to	O
the	O
sodium	O
fluoride	O
or	O
stannous	O
fluoride	O
/	O
sodium	O
hexametaphosphate	O
/	O
zinc	O
lactate	O
dentifrices	O
.	O

Similarly	O
,	O
in	O
ex	O
vivo	O
tests	O
measuring	O
antimicrobial	O
effects	O
on	O
supragingival	O
plaque	O
biofilms	O
,	O
the	O
triclosan	O
/	O
copolymer	O
dentifrice	O
substantially	O
inhibited	O
bacterial	O
growth	O
compared	O
to	O
the	O
other	O
test	O
dentifrices	O
.	O

Different	O
in	O
vitro	O
and	O
ex	O
vivo	O
analyses	O
show	O
that	O
the	O
triclosan	O
/	O
copolymer	O
dentifrice	O
has	O
significant	O
antimicrobial	O
activity	O
on	O
oral	O
bacteria	O
,	O
including	O
species	O
causing	O
dental	O
caries	O
,	O
periodontitis	O
,	O
and	O
oral	O
halitosis	O
,	O
and	O
it	O
provides	O
superior	O
efficacy	O
compared	O
to	O
the	O
stannous	O
fluoride	O
/	O
sodium	O
hexametaphosphate	O
/	O
zinc	O
lactate	O
dentifrice	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
have	O
been	O
found	O
in	O
the	O
oral	O
cavity	O
and	O
stomach	O
.	O

This	O
study	O
is	O
to	O
establish	O
whether	O
there	O
might	O
be	O
any	O
associations	O
between	O
isolates	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
cavity	O
and	O
those	O
in	O
the	O
stomach	O
by	O
meta	O
-	O
analysis	O
.	O

Studies	O
reporting	O
raw	O
data	O
on	O
the	O
prevalence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
in	O
the	O
oral	O
cavity	O
in	O
gastric	O
H	O
.	O
pylori	O
-	O
positive	O
and	O
H	O
.	O
pylori	O
-	O
negative	O
patients	O
,	O
in	O
patients	O
with	O
gastroesophageal	O
diseases	O
,	O
and	O
in	O
healthy	O
individuals	O
and	O
studies	O
reporting	O
data	O
on	O
the	O
eradication	O
rate	O
in	O
the	O
oral	O
cavity	O
or	O
stomach	O
,	O
published	O
in	O
the	O
English	O
language	O
,	O
were	O
identified	O
through	O
MEDLINE	O
and	O
EMBASE	O
up	O
to	O
May	O
2010	O
.	O

The	O
prevalence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
in	O
the	O
oral	O
cavity	O
in	O
gastric	O
H	O
.	O
pylori	O
-	O
positive	O
patients	O
was	O
significantly	O
higher	O
(	O
45	O
.	O
0	O
%	O
)	O
than	O
that	O
in	O
gastric	O
H	O
.	O
pylori	O
-	O
negative	O
patients	O
(	O
23	O
.	O
9	O
%	O
)	O
.	O

The	O
pooled	O
odds	O
ration	O
(	O
OR	O
)	O
was	O
3	O
.	O
61	O
and	O
the	O
95	O
%	O
CI	O
was	O
1	O
.	O
91	O
-	O
6	O
.	O
82	O
(	O
P	O
<	O
0	O
.	O
0001	O
)	O
.	O

Different	O
diagnostic	O
methods	O
produced	O
different	O
pooled	O
ORs	O
with	O
PCR	O
the	O
highest	O
(	O
OR	O
=	O
5	O
.	O
11	O
,	O
95	O
%	O
CI	O
:	O
2	O
.	O
08	O
-	O
12	O
.	O
54	O
,	O
P	O
=	O
0	O
.	O
0004	O
)	O
and	O
rapid	O
urease	O
test	O
(	O
RUT	O
)	O
the	O
lowest	O
(	O
OR	O
=	O
2	O
.	O
00	O
,	O
95	O
%	O
CI	O
:	O
0	O
.	O
80	O
-	O
5	O
.	O
00	O
,	O
P	O
=	O
0	O
.	O
14	O
)	O
.	O

The	O
44	O
.	O
8	O
%	O
(	O
91	O
/	O
203	O
)	O
prevalence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
infection	O
in	O
the	O
oral	O
cavity	O
in	O
patients	O
with	O
clinical	O
and	O
/	O
or	O
histological	O
gastroesophageal	O
diseases	O
was	O
significantly	O
higher	O
than	O
the	O
13	O
.	O
2	O
%	O
(	O
21	O
/	O
159	O
)	O
in	O
patients	O
with	O
non	O
-	O
ulcerous	O
dyspepsia	O
or	O
healthy	O
controls	O
(	O
OR	O
=	O
5	O
.	O
15	O
,	O
95	O
%	O
CI	O
:	O
2	O
.	O
97	O
-	O
8	O
.	O
92	O
,	O
P	O
<	O
0	O
.	O
00001	O
)	O
.	O

The	O
eradication	O
efficiency	O
in	O
stomach	O
is	O
85	O
.	O
8	O
%	O
(	O
187	O
/	O
218	O
)	O
,	O
while	O
in	O
oral	O
cavity	O
it	O
is	O
only	O
5	O
.	O
7	O
%	O
(	O
9	O
/	O
158	O
)	O
.	O

The	O
OR	O
is	O
55	O
.	O
59	O
,	O
P	O
<	O
0	O
.	O
00001	O
.	O

There	O
is	O
a	O
close	O
relation	O
between	O
the	O
infection	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
cavity	O
and	O
stomach	O
.	O

H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
the	O
oral	O
cavity	O
are	O
more	O
difficult	O
to	O
be	O
eradicated	O
than	O
in	O
the	O
stomach	O
.	O

It	O
may	O
be	O
a	O
source	O
of	O
reinfection	O
.	O

Candida	O
albicans	O
is	O
a	O
commensal	O
organism	O
that	O
can	O
be	O
isolated	O
from	O
the	O
majority	O
of	O
healthy	O
individuals	O
.	O

However	O
,	O
in	O
certain	O
susceptible	O
individuals	O
C	O
.	O
albicans	O
can	O
become	O
pathogenic	O
leading	O
to	O
the	O
mucocutaneous	O
infection	O
;	O
oral	O
candidiasis	O
.	O

Murine	O
models	O
and	O
in	O
vitro	O
monolayer	O
cultures	O
have	O
generated	O
some	O
data	O
on	O
the	O
likely	O
virulence	O
and	O
host	O
factors	O
that	O
contribute	O
to	O
oral	O
candidiasis	O
but	O
these	O
models	O
have	O
limitations	O
.	O

Recently	O
,	O
tissue	O
engineered	O
oral	O
mucosal	O
models	O
have	O
been	O
developed	O
to	O
mimic	O
the	O
normal	O
oral	O
mucosa	O
but	O
little	O
information	O
is	O
available	O
on	O
their	O
true	O
representation	O
.	O

In	O
this	O
study	O
,	O
we	O
assessed	O
the	O
histological	O
features	O
of	O
three	O
different	O
tissue	O
engineered	O
oral	O
mucosal	O
models	O
compared	O
to	O
the	O
normal	O
oral	O
mucosa	O
and	O
analysed	O
both	O
cell	O
damage	O
and	O
cytokine	O
release	O
following	O
infection	O
with	O
C	O
.	O
albicans	O
.	O

Models	O
comprised	O
of	O
normal	O
oral	O
keratinocytes	O
and	O
a	O
fibroblast	O
-	O
containing	O
matrix	O
displayed	O
more	O
similar	O
immunohistological	O
and	O
proliferation	O
characteristics	O
to	O
normal	O
mucosa	O
,	O
compared	O
to	O
models	O
composed	O
of	O
an	O
oral	O
carcinoma	O
cell	O
line	O
.	O

Although	O
all	O
models	O
were	O
invaded	O
and	O
damaged	O
by	O
C	O
.	O
albicans	O
in	O
a	O
similar	O
manner	O
,	O
the	O
cytokine	O
response	O
was	O
much	O
more	O
pronounced	O
in	O
models	O
containing	O
normal	O
keratinocytes	O
.	O

These	O
data	O
suggest	O
that	O
models	O
based	O
on	O
normal	O
keratinocytes	O
atop	O
a	O
fibroblast	O
-	O
containing	O
connective	O
tissue	O
will	O
significantly	O
aid	O
in	O
dissecting	O
the	O
molecular	O
pathogenesis	O
of	O
oral	O
candidiasis	O
.	O

Metagenomic	O
techniques	O
are	O
used	O
to	O
analyse	O
bacterial	O
communities	O
allowing	O
both	O
culturable	O
and	O
unculturable	O
species	O
to	O
be	O
represented	O
.	O

However	O
,	O
the	O
screening	O
of	O
oral	O
metagenomic	O
samples	O
can	O
be	O
hindered	O
by	O
high	O
animal	O
host	O
DNA	O
content	O
.	O

This	O
study	O
evaluated	O
methods	O
for	O
the	O
reduction	O
of	O
human	O
DNA	O
concentrations	O
within	O
oral	O
metagenomic	O
samples	O
.	O

Plaque	O
samples	O
were	O
collected	O
from	O
27	O
patients	O
presenting	O
with	O
periodontal	O
disease	O
and	O
treated	O
to	O
remove	O
human	O
DNA	O
using	O
either	O
selective	O
lysis	O
of	O
eukaryotic	O
cells	O
at	O
several	O
buffer	O
concentrations	O
or	O
differential	O
centrifugation	O
after	O
treatment	O
with	O
trypsin	O
and	O
/	O
or	O
detergents	O
.	O

Human	O
and	O
bacterial	O
DNA	O
levels	O
were	O
determined	O
by	O
quantitative	O
polymerase	O
chain	O
reaction	O
(	O
qPCR	O
)	O
.	O

The	O
human	O
DNA	O
content	O
of	O
plaque	O
extracts	O
was	O
significantly	O
reduced	O
by	O
all	O
treatments	O
compared	O
with	O
an	O
untreated	O
control	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

However	O
,	O
differential	O
centrifugation	O
simultaneously	O
reduced	O
the	O
bacterial	O
DNA	O
content	O
unless	O
samples	O
were	O
pretreated	O
with	O
a	O
detergent	O
.	O

Observations	O
of	O
Gram	O
stained	O
samples	O
that	O
were	O
processed	O
using	O
differential	O
centrifugation	O
without	O
detergent	O
suggest	O
that	O
many	O
bacteria	O
remain	O
adhered	O
to	O
human	O
cells	O
.	O

An	O
approach	O
that	O
uses	O
differential	O
centrifugation	O
in	O
parallel	O
with	O
selective	O
lysis	O
is	O
recommended	O
to	O
fully	O
represent	O
the	O
oral	O
microbiota	O
in	O
metagenomic	O
samples	O
,	O
including	O
those	O
tightly	O
adhered	O
to	O
human	O
cells	O
and	O
more	O
delicate	O
bacteria	O
such	O
as	O
Mycoplasma	B-bacteria
.	O

Smoking	O
is	O
an	O
independent	O
risk	O
factor	O
for	O
the	O
initiation	O
,	O
extent	O
and	O
severity	O
of	O
periodontal	O
disease	O
.	O

This	O
study	O
examined	O
the	O
ability	O
of	O
the	O
host	O
immune	O
system	O
to	O
discriminate	O
commensal	O
oral	O
bacteria	O
from	O
pathogens	O
at	O
mucosal	O
surfaces	O
,	O
i	O
.	O
e	O
.	O

oral	O
cavity	O
.	O

Serum	O
immunoglobulin	O
(	O
Ig	O
)	O
G	O
antibody	O
reactive	O
with	O
three	O
pathogenic	O
and	O
five	O
commensal	O
oral	O
bacteria	O
in	O
301	O
current	O
smokers	O
(	O
age	O
range	O
21	O
-	O
66	O
years	O
)	O
were	O
examined	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

Clinical	O
features	O
of	O
periodontal	O
health	O
were	O
used	O
as	O
measures	O
of	O
periodontitis	O
.	O

Antibody	O
to	O
the	O
pathogens	O
and	O
salivary	O
cotinine	O
levels	O
were	O
related	O
positively	O
to	O
disease	O
severity	O
;	O
however	O
,	O
the	O
antibody	O
levels	O
were	O
best	O
described	O
by	O
the	O
clinical	O
disease	O
unrelated	O
to	O
the	O
amount	O
of	O
smoking	O
.	O

The	O
data	O
showed	O
a	O
greater	O
immune	O
response	O
to	O
pathogens	O
than	O
commensals	O
that	O
was	O
related	O
specifically	O
to	O
disease	O
extent	O
,	O
and	O
most	O
noted	O
in	O
black	O
males	O
.	O

Significant	O
correlations	O
in	O
individual	O
patient	O
responses	O
to	O
the	O
pathogens	O
and	O
commensals	O
were	O
lost	O
with	O
an	O
increasing	O
extent	O
of	O
periodontitis	O
and	O
serum	O
antibody	O
to	O
the	O
pathogens	O
.	O

Antibody	O
to	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
was	O
particularly	O
distinct	O
with	O
respect	O
to	O
the	O
discriminatory	O
nature	O
of	O
the	O
immune	O
responses	O
in	O
recognizing	O
the	O
pathogens	O
.	O

Antibody	O
responses	O
to	O
selected	O
pathogenic	O
and	O
commensal	O
oral	O
microorganisms	O
differed	O
among	O
racial	O
groups	O
and	O
genders	O
.	O

The	O
antibody	O
response	O
to	O
the	O
pathogens	O
was	O
related	O
to	O
disease	O
severity	O
.	O

The	O
level	O
of	O
antibody	O
to	O
the	O
pathogens	O
,	O
and	O
in	O
particular	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
was	O
correlated	O
with	O
disease	O
severity	O
in	O
black	O
and	O
male	O
subsets	O
of	O
patients	O
.	O

The	O
amount	O
of	O
smoking	O
did	O
not	O
appear	O
to	O
impact	O
directly	O
serum	O
antibody	O
levels	O
to	O
these	O
oral	O
bacteria	O
.	O

Investigate	O
the	O
presence	O
of	O
Lactobacillus	B-bacteria
reuteri	I-bacteria
in	O
saliva	O
after	O
supplementation	O
with	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
and	O
the	O
probiotic	O
effect	O
of	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
on	O
plaque	O
index	O
and	O
supra	O
-	O
and	O
subgingival	O
microbiota	O
.	O

The	O
study	O
included	O
23	O
healthy	O
individuals	O
,	O
randomised	O
into	O
test	O
or	O
control	O
subjects	O
.	O

At	O
baseline	O
and	O
after	O
12	O
weeks	O
saliva	O
samples	O
,	O
plaque	O
index	O
and	O
supra	O
-	O
and	O
subgingival	O
plaque	O
samples	O
were	O
obtained	O
.	O

The	O
test	O
subjects	O
were	O
given	O
the	O
study	O
product	O
(	O
containing	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
,	O
ATCC	B-bacteria
55730	I-bacteria
and	O
ATCC	B-bacteria
PTA	I-bacteria
5289	I-bacteria
)	O
and	O
the	O
control	O
subjects	O
placebo	O
for	O
12	O
weeks	O
.	O

Microbiological	O
analyses	O
were	O
done	O
by	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
technique	O
and	O
selective	O
culturing	O
for	O
lactobacilli	B-bacteria
determination	O
.	O

A	O
significant	O
increase	O
in	O
total	O
Lactobacillus	B-bacteria
counts	O
in	O
saliva	O
occurred	O
in	O
both	O
groups	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
with	O
a	O
significant	O
increase	O
of	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
(	O
p	O
=	O
0	O
.	O
008	O
)	O
in	O
the	O
test	O
group	O
.	O

Termination	O
of	O
intervention	O
resulted	O
in	O
a	O
wash	O
out	O
of	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
.	O

The	O
control	O
group	O
demonstrated	O
a	O
statistically	O
significant	O
increase	O
in	O
PII	O
after	O
12	O
weeks	O
(	O
p	O
=	O
0	O
.	O
023	O
)	O
whilst	O
there	O
was	O
no	O
significant	O
change	O
in	O
the	O
test	O
group	O
.	O

A	O
significant	O
increase	O
was	O
found	O
for	O
most	O
bacterial	O
species	O
in	O
both	O
groups	O
in	O
supra	O
-	O
and	O
subgingival	O
plaque	O
with	O
no	O
significant	O
difference	O
for	O
any	O
of	O
the	O
species	O
between	O
the	O
groups	O
.	O

The	O
ratio	O
between	O
`	O
`	O
bad	O
/	O
good	O
'	O
'	O
supragingival	O
bacteria	O
decreased	O
for	O
the	O
test	O
group	O
but	O
this	O
decrease	O
did	O
not	O
reach	O
significance	O
.	O

The	O
corresponding	O
ratio	O
for	O
subgingival	O
bacteria	O
decreased	O
significantly	O
in	O
both	O
groups	O
.	O

Supplementation	O
of	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
resulted	O
in	O
presence	O
of	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
in	O
saliva	O
but	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
was	O
washed	O
out	O
after	O
termination	O
of	O
intervention	O
.	O

No	O
significant	O
effect	O
on	O
supra	O
-	O
or	O
subgingival	O
microbiota	O
was	O
observed	O
.	O

The	O
significant	O
increase	O
in	O
PII	O
in	O
the	O
control	O
group	O
with	O
no	O
significant	O
change	O
in	O
the	O
test	O
group	O
may	O
,	O
however	O
,	O
indicate	O
a	O
probiotic	O
effect	O
of	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
in	O
this	O
study	O
population	O
.	O

This	O
study	O
evaluated	O
the	O
resistance	O
to	O
antimicrobials	O
of	O
aerobes	O
and	O
facultative	O
anaerobes	O
isolated	O
from	O
patients	O
wearing	O
complete	O
dentures	O
,	O
patients	O
with	O
gingivitis	O
and	O
periodontitis	O
,	O
and	O
periodontally	O
health	O
subjects	O
.	O

Three	O
hundred	O
and	O
four	O
isolates	O
were	O
tested	O
.	O

The	O
minimal	O
inhibitory	O
concentrations	O
of	O
the	O
drugs	O
were	O
evaluated	O
through	O
the	O
agar	O
dilution	O
method	O
using	O
Mueller	O
-	O
Hinton	O
agar	O
.	O

The	O
most	O
active	O
antimicrobial	O
drugs	O
were	O
the	O
carbapenems	O
(	O
meropenem	O
and	O
imipenem	O
)	O
,	O
and	O
resistance	O
to	O
these	O
drugs	O
was	O
restrict	O
to	O
1	O
.	O
6	O
-	O
2	O
.	O
3	O
%	O
of	O
the	O
isolates	O
,	O
as	O
well	O
as	O
ciprofloxacin	O
and	O
rifampin	O
.	O

Microbial	O
resistance	O
to	O
ampicillin	O
,	O
amoxicillin	O
/	O
clavulanic	O
acid	O
,	O
cefoxitin	O
,	O
cephalothin	O
,	O
amikacin	O
,	O
chloramphenicol	O
and	O
nalidixic	O
acid	O
was	O
particularly	O
high	O
.	O

In	O
most	O
cases	O
,	O
the	O
resistance	O
to	O
beta	O
-	O
lactams	O
was	O
mediated	O
by	O
the	O
production	O
of	O
hydrolytic	O
enzymes	O
,	O
especially	O
in	O
gram	O
-	O
negative	O
enteric	O
rods	O
,	O
while	O
enterococci	B-bacteria
did	O
not	O
evidence	O
production	O
of	O
these	O
enzymes	O
.	O

The	O
association	O
amoxicillin	O
/	O
clavulanic	O
acid	O
was	O
not	O
effective	O
in	O
28	O
.	O
3	O
%	O
of	O
the	O
tested	O
isolates	O
.	O

The	O
results	O
of	O
this	O
investigation	O
confirmed	O
that	O
the	O
oral	O
cavity	O
of	O
patients	O
with	O
periodontitis	O
and	O
gingivitis	O
,	O
and	O
particularly	O
edentulous	O
patients	O
wearing	O
complete	O
dentures	O
could	O
harbor	O
microorganisms	O
with	O
several	O
antimicrobial	O
resistance	O
markers	O
,	O
and	O
these	O
microorganisms	O
are	O
frequently	O
implicated	O
in	O
multiresistant	O
,	O
systemic	O
,	O
oral	O
or	O
nosocomial	O
infections	O
.	O

Examination	O
of	O
dental	O
deposits	O
from	O
45	O
healthy	O
individuals	O
detected	O
3	O
lactobacillus	B-bacteria
strains	I-bacteria
showing	O
a	O
high	O
antagonism	O
toward	O
test	O
cultures	O
.	O

The	O
api	O
50	O
CH	O
`	O
`	O
bio	O
Merieux	O
'	O
'	O
test	O
systems	O
were	O
employed	O
to	O
identify	O
strains	O
as	O
Lactobacillus	B-bacteria
fermentum	I-bacteria
39	I-bacteria
,	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
24	I-bacteria
and	O
Lactobacillus	B-bacteria
paracasei	I-bacteria
50	I-bacteria
.	O

The	O
results	O
of	O
analyzing	O
the	O
sequences	O
of	O
the	O
16S	O
rRNA	O
genes	O
of	O
the	O
test	O
strains	O
confirmed	O
this	O
identification	O
,	O
except	O
for	O
the	O
latter	O
strain	O
.	O

The	O
taxonomic	O
status	O
of	O
the	O
third	O
strain	O
L	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
50	I-bacteria
was	O
determined	O
by	O
the	O
bioinformative	O
analysis	O
of	O
the	O
nucleotide	O
sequence	O
of	O
the	O
16S	O
rRNA	O
genes	O
.	O

A	O
newly	O
acquired	O
rhesus	O
macaque	O
was	O
suffering	O
from	O
rapid	O
destruction	O
of	O
the	O
left	O
cheek	O
caused	O
by	O
necrotizing	O
stomatitis	O
.	O

To	O
restore	O
reconstructive	O
surgery	O
and	O
intensive	O
care	O
with	O
antibiotics	O
,	O
wound	O
protection	O
,	O
wound	O
healing	O
agents	O
,	O
and	O
debridement	O
were	O
applied	O
.	O

Staphylococcus	B-bacteria
aureus	I-bacteria
and	O
Enterococcus	B-bacteria
faecalis	I-bacteria
were	O
isolated	O
from	O
the	O
culture	O
of	O
the	O
lesion	O
,	O
and	O
the	O
antibiotic	O
susceptibility	O
test	O
revealed	O
methicillin	B-bacteria
-	I-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
infection	O
.	O

Vancomycin	O
and	O
ampicillin	O
-	O
sulbactam	O
effectively	O
treated	O
the	O
bacterial	O
infections	O
,	O
and	O
reconstructive	O
surgery	O
was	O
performed	O
once	O
the	O
infection	O
was	O
cleared	O
.	O

Topical	O
application	O
of	O
recombinant	O
human	O
epidermal	O
growth	O
factor	O
(	O
rhEGF	O
)	O
was	O
useful	O
to	O
treat	O
exposed	O
wound	O
of	O
the	O
noma	O
lesion	O
.	O

Simian	O
noma	O
associated	O
with	O
methicillin	B-bacteria
-	I-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
(	O
MRSA	B-bacteria
)	O
had	O
not	O
previously	O
been	O
reported	O
in	O
non	O
-	O
human	O
primates	O
.	O

Although	O
noma	O
associated	O
with	O
MRSA	B-bacteria
is	O
hard	O
to	O
cure	O
because	O
of	O
its	O
rapid	O
and	O
destructive	O
progress	O
,	O
the	O
aggressive	O
therapy	O
used	O
in	O
this	O
study	O
led	O
to	O
the	O
successful	O
resolution	O
of	O
an	O
acute	O
necrotic	O
stomatitis	O
lesion	O
in	O
a	O
rhesus	O
macaque	O
.	O

This	O
study	O
assessed	O
the	O
antibacterial	O
activity	O
of	O
short	O
-	O
,	O
medium	O
-	O
,	O
and	O
long	O
-	O
chain	O
fatty	O
acids	O
against	O
various	O
oral	O
microorganisms	O
.	O

The	O
short	O
-	O
chain	O
fatty	O
acids	O
[	O
formic	O
acid	O
(	O
C1	O
)	O
,	O
acetic	O
acid	O
(	O
C2	O
)	O
,	O
propionic	O
acid	O
(	O
C3	O
)	O
,	O
butyric	O
acid	O
(	O
C4	O
)	O
,	O
isobutyric	O
acid	O
(	O
C4	O
)	O
,	O
isovaleric	O
acid	O
(	O
C5	O
)	O
,	O
hexanoic	O
acid	O
(	O
C6	O
)	O
]	O
,	O
medium	O
-	O
chain	O
fatty	O
acids	O
[	O
octanoic	O
acid	O
(	O
C8	O
)	O
,	O
capric	O
acid	O
(	O
C10	O
)	O
,	O
lauric	O
acid	O
(	O
12	O
)	O
]	O
,	O
and	O
long	O
-	O
chain	O
fatty	O
acids	O
[	O
myristic	O
acid	O
(	O
C14	O
)	O
,	O
palmitic	O
acid	O
(	O
C16	O
)	O
]	O
,	O
were	O
investigated	O
for	O
antimicrobial	O
activity	O
against	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
Streptococcus	B-bacteria
sanguis	I-bacteria
,	O
Candida	O
albicans	O
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
.	O

The	O
data	O
demonstrated	O
that	O
the	O
fatty	O
acids	O
exhibited	O
patterns	O
of	O
inhibition	O
against	O
oral	O
bacteria	O
with	O
some	O
specificity	O
that	O
appeared	O
related	O
more	O
to	O
the	O
bacterial	O
species	O
that	O
the	O
general	O
structural	O
characteristics	O
of	O
the	O
microorganism	O
.	O

As	O
a	O
group	O
the	O
fatty	O
acids	O
were	O
much	O
less	O
effective	O
against	O
C	O
.	O
albicans	O
than	O
the	O
oral	O
bacteria	O
,	O
with	O
effectiveness	O
limited	O
to	O
hexanoic	O
,	O
octanoic	O
,	O
and	O
lauric	O
acids	O
.	O

Formic	O
acid	O
,	O
capric	O
,	O
and	O
lauric	O
acids	O
were	O
broadly	O
inhibitory	O
for	O
the	O
bacteria	O
.	O

Interestingly	O
,	O
fatty	O
acids	O
that	O
are	O
produced	O
at	O
metabolic	O
end	O
-	O
products	O
by	O
a	O
number	O
of	O
these	O
bacteria	O
,	O
were	O
specifically	O
inactive	O
against	O
the	O
producing	O
species	O
,	O
whilst	O
substantially	O
inhibiting	O
the	O
growth	O
of	O
other	O
oral	O
microorganisms	O
.	O

The	O
results	O
indicate	O
that	O
the	O
antimicrobial	O
activity	O
of	O
short	O
-	O
chain	O
fatty	O
acids	O
(	O
SCFAs	O
)	O
,	O
medium	O
-	O
chain	O
fatty	O
acids	O
(	O
MCFAs	O
)	O
,	O
long	O
-	O
chain	O
fatty	O
acids	O
(	O
LCFAs	O
)	O
could	O
influence	O
the	O
microbial	O
ecology	O
in	O
the	O
oral	O
cavity	O
via	O
at	O
least	O
2	O
potential	O
pathways	O
.	O

First	O
,	O
the	O
agents	O
delivered	O
exogenously	O
as	O
therapeutic	O
adjuncts	O
could	O
be	O
packaged	O
to	O
enhance	O
a	O
microbial	O
-	O
regulatory	O
environment	O
in	O
the	O
subgingival	O
sulcus	O
.	O

Second	O
,	O
it	O
would	O
be	O
the	O
intrinsic	O
nature	O
of	O
these	O
fatty	O
acid	O
inhibitors	O
in	O
contributing	O
to	O
the	O
characteristics	O
of	O
the	O
microbial	O
biofilms	O
,	O
their	O
evolution	O
,	O
and	O
emergence	O
of	O
species	O
within	O
the	O
biofilms	O
.	O

Further	O
studies	O
on	O
these	O
functions	O
are	O
required	O
to	O
better	O
understand	O
the	O
nature	O
of	O
these	O
potential	O
microbial	O
interactions	O
in	O
the	O
biofilms	O
.	O

Studies	O
on	O
the	O
adherence	O
properties	O
of	O
oral	O
bacteria	O
have	O
been	O
a	O
major	O
focus	O
in	O
microbiology	O
research	O
for	O
several	O
decades	O
.	O

The	O
ability	O
of	O
bacteria	O
to	O
adhere	O
to	O
the	O
variety	O
of	O
surfaces	O
present	O
in	O
the	O
oral	O
cavity	O
,	O
and	O
to	O
become	O
integrated	O
within	O
the	O
resident	O
microbial	O
communities	O
,	O
confers	O
growth	O
and	O
survival	O
properties	O
.	O

Molecular	O
analyses	O
have	O
revealed	O
several	O
families	O
of	O
Gram	O
-	O
positive	O
bacterial	O
surface	O
proteins	O
,	O
including	O
serine	O
-	O
rich	O
repeat	O
,	O
antigen	O
I	O
/	O
II	O
,	O
and	O
pilus	O
families	O
,	O
that	O
mediate	O
adherence	O
to	O
a	O
variety	O
of	O
salivary	O
and	O
oral	O
bacterial	O
receptors	O
.	O

In	O
Gram	O
-	O
negative	O
bacteria	O
,	O
pili	O
,	O
auto	O
-	O
transporters	O
,	O
and	O
extracellular	O
matrix	O
-	O
binding	O
proteins	O
provide	O
components	O
for	O
host	O
tissue	O
recognition	O
and	O
building	O
of	O
complex	O
microbial	O
communities	O
.	O

Future	O
studies	O
will	O
reveal	O
in	O
greater	O
detail	O
the	O
binding	O
pockets	O
for	O
these	O
adhesin	O
families	O
and	O
their	O
receptors	O
.	O

This	O
information	O
will	O
be	O
crucial	O
for	O
the	O
development	O
of	O
new	O
inhibitors	O
or	O
vaccines	O
that	O
target	O
the	O
functional	O
regions	O
of	O
bacterial	O
proteins	O
that	O
are	O
involved	O
in	O
colonization	O
and	O
pathogenesis	O
.	O

The	O
aim	O
of	O
our	O
study	O
was	O
to	O
investigate	O
how	O
teenage	O
smoking	O
affects	O
the	O
prevalence	O
of	O
periodontal	O
bacteria	O
and	O
periodontal	O
health	O
with	O
the	O
hypothesis	O
that	O
smoking	O
increases	O
the	O
prevalence	O
of	O
the	O
bacteria	O
.	O

Oral	O
health	O
of	O
264	O
adolescents	O
(	O
15	O
-	O
to	O
16	O
-	O
year	O
-	O
olds	O
)	O
was	O
clinically	O
examined	O
,	O
and	O
their	O
smoking	O
history	O
was	O
recorded	O
.	O

The	O
participants	O
also	O
filled	O
in	O
a	O
structured	O
questionnaire	O
recording	O
their	O
general	O
health	O
and	O
health	O
habits	O
.	O

Pooled	O
subgingival	O
plaque	O
samples	O
were	O
taken	O
for	O
polymerase	O
chain	O
reaction	O
analysis	O
of	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Prevotella	B-bacteria
nigrescens	I-bacteria
,	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
.	O

The	O
prevalence	O
of	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
(	O
21	O
%	O
vs	O
.	O
4	O
%	O
,	O
p	O
=	O
0	O
.	O
01	O
)	O
and	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
(	O
23	O
%	O
vs	O
.	O
8	O
%	O
,	O
p	O
<	O
0	O
.	O
05	O
,	O
for	O
both	O
)	O
was	O
higher	O
among	O
female	O
smokers	O
than	O
among	O
non	O
-	O
smokers	O
.	O

T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
were	O
more	O
often	O
associated	O
with	O
bleeding	O
on	O
probing	O
(	O
29	O
%	O
vs	O
.	O
12	O
%	O
;	O
25	O
%	O
vs	O
.	O
10	O
%	O
,	O
respectively	O
)	O
and	O
deep	O
pockets	O
(	O
25	O
%	O
vs	O
.	O
15	O
%	O
;	O
23	O
%	O
vs	O
.	O
10	O
%	O
,	O
respectively	O
)	O
with	O
smokers	O
than	O
non	O
-	O
smokers	O
.	O

Among	O
the	O
girls	O
,	O
a	O
significant	O
association	O
was	O
found	O
between	O
pack	O
-	O
years	O
and	O
the	O
prevalence	O
of	O
P	B-bacteria
.	I-bacteria
nigrescens	I-bacteria
(	O
p	O
<	O
0	O
.	O
007	O
)	O
.	O

In	O
both	O
genders	O
,	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
were	O
rare	O
in	O
this	O
study	O
.	O

To	O
conclude	O
,	O
periodontal	O
bacteria	O
were	O
associated	O
with	O
higher	O
periodontal	O
index	O
scores	O
among	O
all	O
teenage	O
smokers	O
.	O

Smoking	O
girls	O
harbored	O
more	O
frequently	O
certain	O
periodontal	O
bacteria	O
than	O
non	O
-	O
smokers	O
,	O
but	O
this	O
was	O
not	O
seen	O
in	O
boys	O
.	O

Hence	O
,	O
our	O
study	O
hypothesis	O
was	O
only	O
partly	O
confirmed	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
ability	O
of	O
biofilm	O
formation	O
among	O
mutans	O
and	O
non	O
mutans	O
oral	O
streptococci	B-bacteria
and	O
to	O
determine	O
the	O
effect	O
of	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
DSM	I-bacteria
20079	I-bacteria
as	O
a	O
probiot	O
on	O
the	O
adhesion	O
of	O
selected	O
streptococcal	B-bacteria
strains	I-bacteria
on	O
the	O
surfaces	O
.	O

The	O
sample	O
comprised	O
40	O
isolates	O
of	O
oral	O
streptococci	B-bacteria
from	O
dental	O
plaque	O
and	O
caries	O
of	O
volunteer	O
persons	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
ATCC35668	I-bacteria
(	O
no24	O
)	O
was	O
as	O
an	O
standard	O
strain	O
.	O

The	O
probiotic	O
strain	O
was	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
DSM	I-bacteria
20079	I-bacteria
.	O

The	O
ability	O
of	O
biofilm	O
formation	O
was	O
investigated	O
with	O
colorimetric	O
method	O
and	O
the	O
strongest	O
isolates	O
were	O
selected	O
.	O

Then	O
the	O
effect	O
of	O
probiotic	O
strain	O
on	O
the	O
adhesion	O
of	O
streptococci	B-bacteria
isolates	I-bacteria
was	O
determined	O
in	O
polystyrene	O
microtiter	O
plate	O
simultaneously	O
and	O
30	O
minutes	O
before	O
streptococci	B-bacteria
entrance	O
to	O
the	O
system	O
.	O

The	O
results	O
showed	O
that	O
42	O
%	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
were	O
strongly	O
adherent	O
(	O
SA	O
)	O
and	O
in	O
non	B-bacteria
mutans	I-bacteria
streptococci	I-bacteria
,	O
only	O
23	O
.	O
5	O
%	O
of	O
isolates	O
were	O
found	O
strongly	O
adherent	O
.	O

The	O
strong	O
biofilm	O
forming	O
bacterium	O
isolated	O
was	O
Streptococcus	B-bacteria
mutans	I-bacteria
strain22	I-bacteria
.	O

In	O
the	O
next	O
step	O
,	O
in	O
the	O
presence	O
of	O
probiotic	O
strain	O
the	O
streptococcal	B-bacteria
adhesion	O
were	O
reduced	O
,	O
and	O
this	O
reduction	O
was	O
non	O
significantly	O
stronger	O
if	O
the	O
probiotic	O
strain	O
was	O
inoculated	O
to	O
the	O
system	O
before	O
the	O
oral	O
bacteria	O
.	O

The	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
had	O
more	O
effect	O
on	O
adherence	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
than	O
non	B-bacteria
mutans	I-bacteria
streptococci	I-bacteria
with	O
significant	O
difference	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Adhesion	O
reduction	O
is	O
likely	O
due	O
to	O
bacterial	O
interactions	O
and	O
colonization	O
of	O
adhesion	O
sites	O
with	O
probiotic	O
strain	O
before	O
the	O
presence	O
of	O
streptococci	B-bacteria
.	O

Adhesion	O
reduction	O
can	O
be	O
an	O
effective	O
way	O
on	O
decreasing	O
cariogenic	O
potential	O
of	O
oral	O
streptococci	B-bacteria
.	O

Novel	O
phosphorylated	O
dihydroceramide	O
(	O
PDHC	O
)	O
lipids	O
produced	O
by	O
the	O
periodontal	O
pathogen	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
include	O
phosphoethanolamine	O
(	O
PE	O
DHC	O
)	O
and	O
phosphoglycerol	O
dihydroceramides	O
(	O
PG	O
DHC	O
)	O
lipids	O
.	O

These	O
PDHC	O
lipids	O
mediate	O
cellular	O
effects	O
through	O
Toll	O
-	O
like	O
receptor	O
2	O
(	O
TLR2	O
)	O
including	O
promotion	O
of	O
IL	O
-	O
6	O
secretion	O
from	O
dendritic	O
cells	O
and	O
inhibition	O
of	O
osteoblast	O
differentiation	O
and	O
function	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

The	O
PE	O
DHC	O
lipids	O
also	O
enhance	O
(	O
TLR2	O
)	O
-	O
dependent	O
murine	O
experimental	O
autoimmune	O
encephalomyelitis	O
(	O
EAE	O
)	O
,	O
a	O
model	O
for	O
multiple	O
sclerosis	O
.	O

The	O
unique	O
non	O
-	O
mammalian	O
structures	O
of	O
these	O
lipids	O
allows	O
for	O
their	O
specific	O
quantification	O
in	O
bacteria	O
and	O
human	O
tissues	O
using	O
multiple	O
reaction	O
monitoring	O
(	O
MRM	O
)	O
-	O
mass	O
spectrometry	O
(	O
MS	O
)	O
.	O

Synthesis	O
of	O
these	O
lipids	O
by	O
other	O
common	O
human	O
bacteria	O
and	O
the	O
presence	O
of	O
these	O
lipids	O
in	O
human	O
tissues	O
have	O
not	O
yet	O
been	O
determined	O
.	O

We	O
now	O
report	O
that	O
synthesis	O
of	O
these	O
lipids	O
can	O
be	O
attributed	O
to	O
a	O
small	O
number	O
of	O
intestinal	O
and	O
oral	O
organisms	O
within	O
the	O
Bacteroides	B-bacteria
,	O
Parabacteroides	B-bacteria
,	O
Prevotella	B-bacteria
,	O
Tannerella	B-bacteria
and	O
Porphyromonas	B-bacteria
genera	I-bacteria
.	O

Additionally	O
,	O
the	O
PDHCs	O
are	O
not	O
only	O
present	O
in	O
gingival	O
tissues	O
,	O
but	O
are	O
also	O
present	O
in	O
human	O
blood	O
,	O
vasculature	O
tissues	O
and	O
brain	O
.	O

Finally	O
,	O
the	O
distribution	O
of	O
these	O
TLR2	O
-	O
activating	O
lipids	O
in	O
human	O
tissues	O
varies	O
with	O
both	O
the	O
tissue	O
site	O
and	O
disease	O
status	O
of	O
the	O
tissue	O
suggesting	O
a	O
role	O
for	O
PDHCs	O
in	O
human	O
disease	O
.	O

To	O
develop	O
a	O
convenient	O
method	O
for	O
the	O
localization	O
and	O
quantification	O
of	O
live	O
and	O
dead	O
bacteria	O
in	O
human	O
ex	O
vivo	O
mineralized	O
dentinal	O
tubules	O
.	O

The	O
roots	O
from	O
human	O
single	O
-	O
rooted	O
teeth	O
(	O
n	O
=	O
12	O
)	O
were	O
infected	O
with	O
Enterococcus	B-bacteria
faecalis	I-bacteria
V583	I-bacteria
and	O
either	O
treated	O
with	O
calcium	O
hydroxide	O
paste	O
or	O
left	O
untreated	O
;	O
six	O
control	O
roots	O
were	O
uninoculated	O
and	O
untreated	O
.	O

Following	O
further	O
incubation	O
,	O
roots	O
were	O
stained	O
with	O
fluorescent	O
DNA	O
-	O
binding	O
reagents	O
,	O
washed	O
thoroughly	O
,	O
sectioned	O
and	O
examined	O
by	O
confocal	O
laser	O
scanning	O
microscopy	O
.	O

Computer	O
-	O
assisted	O
determinations	O
of	O
fluorescence	O
(	O
bacterial	O
viability	O
)	O
were	O
compared	O
statistically	O
.	O

Bacteria	O
were	O
distributed	O
in	O
the	O
tubules	O
throughout	O
the	O
length	O
of	O
the	O
roots	O
but	O
tubule	O
penetration	O
distance	O
was	O
slightly	O
reduced	O
in	O
the	O
apical	O
sections	O
.	O

There	O
was	O
no	O
significant	O
difference	O
in	O
bacterial	O
tubule	O
penetration	O
between	O
roots	O
from	O
different	O
teeth	O
and	O
small	O
standard	O
deviations	O
indicated	O
reproducibility	O
appropriate	O
for	O
experimental	O
application	O
.	O

Following	O
treatment	O
with	O
calcium	O
hydroxide	O
paste	O
,	O
live	O
and	O
dead	O
bacteria	O
were	O
readily	O
distinguishable	O
by	O
contrasting	O
green	O
and	O
red	O
fluorescence	O
.	O

Bacterial	O
viability	O
determinations	O
amongst	O
roots	O
treated	O
in	O
the	O
same	O
way	O
were	O
not	O
significantly	O
different	O
,	O
and	O
the	O
small	O
standard	O
deviation	O
is	O
commensurate	O
with	O
experimental	O
application	O
.	O

Fluorescent	O
viability	O
staining	O
is	O
a	O
convenient	O
,	O
accurate	O
and	O
reproducible	O
method	O
for	O
localizing	O
and	O
quantifying	O
live	O
and	O
dead	O
bacteria	O
in	O
human	O
ex	O
vivo	O
mineralized	O
dentinal	O
tubules	O
.	O

Staphylococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
are	O
opportunistic	O
microorganisms	O
known	O
for	O
their	O
capacity	O
to	O
develop	O
resistance	O
against	O
antimicrobial	O
agents	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
effect	O
of	O
photodynamic	O
therapy	O
(	O
PDT	O
)	O
on	O
20	O
Staphylococcus	B-bacteria
strains	I-bacteria
isolated	O
from	O
the	O
human	O
oral	O
cavity	O
,	O
including	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
schleiferi	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
epidermidis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
capitis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
haemolyticus	I-bacteria
,	O
and	O
S	B-bacteria
.	I-bacteria
lentus	I-bacteria
.	O

A	O
suspension	O
of	O
each	O
Staphylococcus	B-bacteria
strain	I-bacteria
(	O
10	O
(	O
6	O
)	O
cells	O
/	O
mL	O
)	O
was	O
submitted	O
to	O
PDT	O
using	O
methylene	O
blue	O
and	O
a	O
low	O
power	O
laser	O
.	O

The	O
isolated	O
effects	O
of	O
methylene	O
blue	O
,	O
laser	O
treatment	O
and	O
ciprofloxacin	O
were	O
also	O
evaluated	O
.	O

After	O
the	O
experimental	O
treatments	O
,	O
0	O
.	O
1	O
mL	O
aliquots	O
of	O
the	O
suspensions	O
were	O
seeded	O
onto	O
BHI	O
agar	O
for	O
determination	O
of	O
the	O
number	O
of	O
colony	O
-	O
forming	O
units	O
(	O
CFU	O
/	O
mL	O
)	O
.	O

The	O
results	O
were	O
analyzed	O
by	O
analysis	O
of	O
variance	O
and	O
Tukey	O
'	O
s	O
test	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
mean	O
reduction	O
in	O
bacterial	O
counts	O
of	O
the	O
strains	O
submitted	O
to	O
PDT	O
ranged	O
from	O
4	O
.	O
89	O
to	O
6	O
.	O
83	O
CFU	O
(	O
log10	O
)	O
/	O
mL	O
,	O
with	O
the	O
observation	O
of	O
a	O
decreasing	O
susceptibility	O
to	O
treatment	O
of	O
S	B-bacteria
.	I-bacteria
schleiferi	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
haemolyticus	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
epidermidis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
capitis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
,	O
and	O
S	B-bacteria
.	I-bacteria
lentus	I-bacteria
.	O

The	O
results	O
showed	O
that	O
PDT	O
was	O
effective	O
in	O
reducing	O
the	O
number	O
of	O
viable	O
cells	O
of	O
all	O
clinical	O
Staphylococcus	B-bacteria
isolates	I-bacteria
studied	O
.	O

We	O
investigated	O
in	O
a	O
nationally	O
representative	O
sample	O
,	O
how	O
periodontitis	O
modifies	O
the	O
association	O
between	O
the	O
carriage	O
of	O
periodontal	O
pathogens	O
and	O
serology	O
.	O

The	O
population	O
comprised	O
1586	O
dentate	O
subjects	O
who	O
participated	O
in	O
an	O
interview	O
,	O
clinical	O
and	O
radiological	O
oral	O
health	O
examination	O
,	O
and	O
saliva	O
collection	O
.	O

Serum	O
immunoglobulin	O
A	O
(	O
IgA	O
)	O
-	O
and	O
IgG	O
-	O
class	O
antibody	O
levels	O
against	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
their	O
salivary	O
occurrence	O
were	O
determined	O
in	O
the	O
whole	O
population	O
.	O

The	O
quantity	O
of	O
the	O
pathogens	O
was	O
measured	O
in	O
a	O
subpopulation	O
.	O

In	O
the	O
univariate	O
analyses	O
,	O
the	O
corresponding	O
antibody	O
levels	O
were	O
higher	O
in	O
the	O
pathogen	O
carriers	O
compared	O
with	O
the	O
non	O
-	O
carriers	O
,	O
and	O
clearly	O
higher	O
in	O
the	O
carriers	O
with	O
periodontal	O
pockets	O
compared	O
with	O
the	O
carriers	O
without	O
.	O

In	O
the	O
multi	O
-	O
variate	O
analyses	O
,	O
however	O
,	O
all	O
antibody	O
levels	O
associated	O
strongly	O
with	O
age	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
the	O
carriage	O
of	O
the	O
corresponding	O
pathogen	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
but	O
only	O
weakly	O
with	O
the	O
presence	O
or	O
number	O
of	O
teeth	O
with	O
periodontal	O
pockets	O
.	O

In	O
the	O
subpopulation	O
,	O
the	O
antibody	O
levels	O
and	O
the	O
numbers	O
of	O
corresponding	O
bacteria	O
in	O
saliva	O
had	O
a	O
positive	O
association	O
,	O
which	O
was	O
not	O
affected	O
by	O
the	O
disease	O
.	O

The	O
carriage	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
is	O
the	O
strongest	O
determinant	O
of	O
the	O
systemic	O
antibody	O
response	O
to	O
these	O
pathogens	O
,	O
and	O
the	O
extent	O
of	O
periodontitis	O
has	O
at	O
most	O
a	O
modest	O
modifying	O
effect	O
.	O

West	O
Virginia	O
has	O
the	O
worst	O
oral	O
health	O
in	O
the	O
United	O
States	O
,	O
but	O
the	O
reasons	O
for	O
this	O
are	O
unclear	O
.	O

This	O
pilot	O
study	O
explored	O
the	O
etiology	O
of	O
this	O
disparity	O
using	O
culture	O
-	O
independent	O
analyses	O
to	O
identify	O
bacterial	O
species	O
associated	O
with	O
oral	O
disease	O
.	O

Bacteria	O
in	O
subgingival	O
plaque	O
samples	O
from	O
twelve	O
participants	O
in	O
two	O
independent	O
West	O
Virginia	O
dental	O
-	O
related	O
studies	O
were	O
characterized	O
using	O
16S	O
rRNA	O
gene	O
sequencing	O
and	O
Human	O
Oral	O
Microbe	O
Identification	O
Microarray	O
(	O
HOMIM	O
)	O
analysis	O
.	O

Unifrac	O
analysis	O
was	O
used	O
to	O
characterize	O
phylogenetic	O
differences	O
between	O
bacterial	O
communities	O
obtained	O
from	O
plaque	O
of	O
participants	O
with	O
low	O
or	O
high	O
oral	O
disease	O
,	O
which	O
was	O
further	O
evaluated	O
using	O
clustering	O
and	O
Principal	O
Coordinate	O
Analysis	O
.	O

Statistically	O
different	O
bacterial	O
signatures	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
were	O
identified	O
in	O
subgingival	O
plaque	O
of	O
individuals	O
with	O
low	O
or	O
high	O
oral	O
disease	O
in	O
West	O
Virginia	O
based	O
on	O
16S	O
rRNA	O
gene	O
sequencing	O
.	O

Low	O
disease	O
contained	O
a	O
high	O
frequency	O
of	O
Veillonella	B-bacteria
and	O
Streptococcus	B-bacteria
,	O
with	O
a	O
moderate	O
number	O
of	O
Capnocytophaga	B-bacteria
.	O

High	O
disease	O
exhibited	O
substantially	O
increased	O
bacterial	O
diversity	O
and	O
included	O
a	O
large	O
proportion	O
of	O
Clostridiales	B-bacteria
cluster	I-bacteria
bacteria	I-bacteria
(	O
Selenomonas	B-bacteria
,	O
Eubacterium	B-bacteria
,	O
Dialister	B-bacteria
)	O
.	O

Phylogenetic	O
trees	O
constructed	O
using	O
16S	O
rRNA	O
gene	O
sequencing	O
revealed	O
that	O
Clostridiales	B-bacteria
were	O
repeated	O
colonizers	O
in	O
plaque	O
associated	O
with	O
high	O
oral	O
disease	O
,	O
providing	O
evidence	O
that	O
the	O
oral	O
environment	O
is	O
somehow	O
influencing	O
the	O
bacterial	O
signature	O
linked	O
to	O
disease	O
.	O

Culture	O
-	O
independent	O
analyses	O
identified	O
an	O
atypical	O
bacterial	O
signature	O
associated	O
with	O
high	O
oral	O
disease	O
in	O
West	O
Virginians	O
and	O
provided	O
evidence	O
that	O
the	O
oral	O
environment	O
influenced	O
this	O
signature	O
.	O

Both	O
findings	O
provide	O
insight	O
into	O
the	O
etiology	O
of	O
the	O
oral	O
disparity	O
in	O
West	O
Virginia	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
compare	O
zirconium	O
oxide	O
and	O
titanium	O
alloys	O
with	O
respect	O
to	O
their	O
tendency	O
to	O
adhesion	O
and	O
colonization	O
of	O
two	O
periodontal	O
pathogens	O
on	O
both	O
hard	O
surfaces	O
and	O
on	O
soft	O
tissues	O
in	O
vivo	O
.	O

The	O
present	O
study	O
was	O
designed	O
as	O
a	O
prospective	O
stratified	O
randomized	O
controlled	O
clinical	O
trial	O
.	O

Patients	O
were	O
scheduled	O
to	O
receive	O
two	O
implants	O
with	O
different	O
types	O
of	O
abutments	O
in	O
the	O
posterior	O
mandible	O
.	O

Three	O
months	O
after	O
implant	O
placement	O
,	O
titanium	O
and	O
zirconium	O
abutments	O
were	O
connected	O
.	O

Five	O
weeks	O
after	O
abutment	O
connections	O
,	O
the	O
abutments	O
were	O
removed	O
,	O
probing	O
depth	O
measurements	O
were	O
recorded	O
,	O
and	O
gingival	O
biopsy	O
samples	O
were	O
obtained	O
.	O

Abutments	O
and	O
biopsy	O
specimens	O
were	O
analyzed	O
by	O
reverse	O
-	O
transcriptase	O
polymerase	O
chain	O
reaction	O
to	O
compare	O
the	O
DNA	O
copy	O
numbers	O
of	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
and	O
total	O
bacteria	O
.	O

The	O
surface	O
free	O
energy	O
of	O
the	O
abutments	O
was	O
calculated	O
by	O
sesile	O
water	O
drop	O
before	O
replacement	O
.	O

No	O
statistically	O
significant	O
differences	O
were	O
found	O
between	O
probing	O
depths	O
or	O
DNA	O
copy	O
numbers	O
of	O
A	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
P	B-bacteria
gingivalis	I-bacteria
,	O
and	O
total	O
bacteria	O
both	O
for	O
both	O
titanium	O
alloys	O
and	O
zirconium	O
oxide	O
surfaces	O
and	O
the	O
biops	O
specimens	O
obtained	O
from	O
their	O
buccal	O
gingival	O
.	O

With	O
respect	O
to	O
the	O
surface	O
free	O
energy	O
of	O
zirconium	O
and	O
titanium	O
abutments	O
,	O
zirconium	O
abutments	O
showed	O
lower	O
surface	O
free	O
energy	O
than	O
titanium	O
abutments	O
.	O

The	O
results	O
of	O
this	O
study	O
showed	O
that	O
zirconium	O
oxide	O
surfaces	O
have	O
comparable	O
properties	O
to	O
titanium	O
alloy	O
surfaces	O
in	O
their	O
tendency	O
to	O
adhesion	O
and	O
colonization	O
of	O
two	O
periodontal	O
pathogens	O
on	O
both	O
hard	O
surfaces	O
and	O
in	O
soft	O
tissues	O
.	O

Epidemiological	O
evidence	O
suggests	O
that	O
infections	O
may	O
contribute	O
to	O
atherogenesis	O
.	O

However	O
,	O
with	O
the	O
exception	O
of	O
Chlamydophila	B-bacteria
pneumoniae	I-bacteria
,	O
cultivable	O
bacteria	O
have	O
not	O
been	O
recovered	O
from	O
atherosclerotic	O
lesions	O
.	O

Therefore	O
,	O
we	O
aimed	O
at	O
developing	O
an	O
approach	O
to	O
recover	O
uncultivable	O
bacteria	O
from	O
atherectomy	O
tissues	O
.	O

We	O
cultured	O
homogenates	O
from	O
atherectomy	O
specimens	O
from	O
seven	O
nonseptic	O
patients	O
undergoing	O
surgery	O
for	O
arterial	O
obstruction	O
either	O
alone	O
or	O
together	O
with	O
THP	O
-	O
1	O
monocyte	O
-	O
like	O
cells	O
.	O

We	O
performed	O
16S	O
rDNA	O
analysis	O
,	O
biochemical	O
tests	O
,	O
random	O
amplification	O
of	O
polymorphic	O
DNA	O
PCR	O
analysis	O
,	O
quantitative	O
polymerase	O
chain	O
reaction	O
(	O
qPCR	O
)	O
and	O
immunohistofluorescence	O
to	O
identify	O
the	O
cultivated	O
bacteria	O
.	O

Wilcoxon	O
signed	O
-	O
rank	O
tests	O
were	O
used	O
to	O
determine	O
whether	O
THP	O
-	O
1	O
treatment	O
yielded	O
a	O
higher	O
number	O
of	O
isolates	O
than	O
did	O
the	O
untreated	O
controls	O
.	O

We	O
recovered	O
more	O
bacteria	O
from	O
cocultures	O
of	O
atherectomy	O
specimens	O
with	O
THP	O
-	O
1	O
cells	O
than	O
atherectomy	O
specimens	O
cultured	O
alone	O
.	O

On	O
average	O
,	O
tissue	O
homogenates	O
incubated	O
with	O
THP	O
-	O
1	O
cells	O
versus	O
control	O
yielded	O
124	O
vs	O
.	O
22	O
colony	O
-	O
forming	O
units	O
,	O
a	O
median	O
of	O
140	O
vs	O
.	O
7	O
,	O
respectively	O
(	O
P	O
=	O
0	O
.	O
02	O
)	O
.	O

We	O
recovered	O
872	O
isolates	O
of	O
limited	O
number	O
of	O
species	O
,	O
including	O
Propionibacterium	B-bacteria
acnes	I-bacteria
,	O
Staphylococcus	B-bacteria
epidermidis	I-bacteria
and	O
Streptococcus	B-bacteria
infantis	I-bacteria
and	O
the	O
fastidious	O
anaerobe	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
and	O
confirmed	O
its	O
presence	O
in	O
tissue	O
using	O
double	O
immunofluorescence	O
imaging	O
.	O

qPCR	O
demonstrated	O
the	O
presence	O
of	O
>	O
/	O
=	O
3	O
.	O
5	O
x	O
10	O
(	O
3	O
)	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
genomes	O
per	O
gram	O
of	O
atheromatous	O
tissue	O
.	O

These	O
results	O
indicate	O
that	O
viable	O
previously	O
uncultivable	O
bacterial	O
species	O
are	O
present	O
within	O
atheromas	O
.	O

Our	O
results	O
suggest	O
revisiting	O
the	O
hypothesis	O
that	O
infections	O
may	O
have	O
a	O
causative	O
role	O
in	O
atherosclerotic	O
inflammation	O
and	O
have	O
implications	O
for	O
research	O
regarding	O
novel	O
diagnostics	O
and	O
treatments	O
for	O
cardiovascular	O
disease	O
.	O

An	O
understanding	O
of	O
the	O
relation	O
of	O
commensal	O
microbiota	O
to	O
health	O
is	O
essential	O
in	O
preventing	O
disease	O
.	O

Here	O
we	O
studied	O
the	O
oral	O
microbial	O
composition	O
of	O
children	O
(	O
N	O
=	O
74	O
,	O
aged	O
3	O
-	O
18	O
years	O
)	O
in	O
natural	O
transition	O
from	O
their	O
deciduous	O
to	O
a	O
permanent	O
dentition	O
and	O
related	O
the	O
microbial	O
profiles	O
to	O
their	O
oral	O
health	O
status	O
.	O

The	O
microbial	O
composition	O
of	O
saliva	O
was	O
assessed	O
by	O
barcoded	O
pyrosequencing	O
of	O
the	O
V5	O
-	O
V6	O
hypervariable	O
regions	O
of	O
the	O
16	O
S	O
rRNA	O
,	O
as	O
well	O
as	O
by	O
using	O
phylogenetic	O
microarrays	O
.	O

Pyrosequencing	O
reads	O
(	O
126174	O
reads	O
,	O
1045	O
unique	O
sequences	O
)	O
represented	O
8	O
phyla	O
and	O
113	O
higher	O
taxa	O
in	O
saliva	O
samples	O
.	O

Four	O
phyla	O
-	O
-	O
Firmicutes	B-bacteria
,	O
Bacteriodetes	B-bacteria
,	O
Proteobacteria	B-bacteria
and	O
Actinobacteria	B-bacteria
-	O
-	O
predominated	O
in	O
all	O
groups	O
.	O

The	O
deciduous	O
dentition	O
harboured	O
a	O
higher	O
proportion	O
of	O
Proteobacteria	B-bacteria
(	O
Gammaproteobacteria	B-bacteria
,	O
Moraxellaceae	B-bacteria
)	O
than	O
Bacteroidetes	B-bacteria
,	O
while	O
in	O
all	O
other	O
groups	O
Bacteroidetes	B-bacteria
were	O
at	O
least	O
as	O
abundant	O
as	O
Proteobacteria	B-bacteria
.	O

Bacteroidetes	B-bacteria
(	O
mainly	O
genus	B-bacteria
Prevotella	I-bacteria
)	O
,	O
Veillonellaceae	B-bacteria
family	I-bacteria
,	O
Spirochaetes	B-bacteria
and	O
candidate	O
division	O
TM7	B-bacteria
increased	O
with	O
increasing	O
age	O
,	O
reflecting	O
maturation	O
of	O
the	O
microbiome	O
driven	O
by	O
biological	O
changes	O
with	O
age	O
.	O

Microarray	O
analysis	O
enabled	O
further	O
analysis	O
of	O
the	O
individual	O
salivary	O
microbiota	O
.	O

Of	O
350	O
microarray	O
probes	O
,	O
156	O
gave	O
a	O
positive	O
signal	O
with	O
,	O
on	O
average	O
,	O
77	O
(	O
range	O
48	O
-	O
93	O
)	O
probes	O
per	O
individual	O
sample	O
.	O

A	O
caries	O
-	O
free	O
oral	O
status	O
significantly	O
associated	O
with	O
the	O
higher	O
signal	O
of	O
the	O
probes	O
targeting	O
Porphyromonas	B-bacteria
catoniae	I-bacteria
and	O
Neisseria	B-bacteria
flavescens	I-bacteria
.	O

The	O
potential	O
role	O
of	O
P	B-bacteria
.	I-bacteria
catoniae	I-bacteria
and	O
N	B-bacteria
.	I-bacteria
flavescens	I-bacteria
as	O
oral	O
health	O
markers	O
should	O
be	O
assessed	O
in	O
large	O
-	O
scale	O
clinical	O
studies	O
.	O

The	O
combination	O
of	O
both	O
open	O
-	O
ended	O
and	O
targeted	O
molecular	O
approaches	O
provides	O
us	O
with	O
information	O
that	O
will	O
increase	O
our	O
understanding	O
of	O
the	O
interplay	O
between	O
the	O
human	O
host	O
and	O
its	O
microbiome	O
.	O

We	O
show	O
that	O
bacteria	O
with	O
methylotrophic	O
potential	O
are	O
ubiquitous	O
in	O
the	O
human	O
mouth	O
microbiota	O
.	O

Numerous	O
strains	O
of	O
Actinobacteria	B-bacteria
(	O
Brevibacterium	B-bacteria
,	O
Gordonia	B-bacteria
,	O
Leifsonia	B-bacteria
,	O
Microbacterium	B-bacteria
,	O
Micrococcus	B-bacteria
,	O
Rhodococcus	B-bacteria
)	O
and	O
Proteobacteria	B-bacteria
(	O
Achromobacter	B-bacteria
,	O
Klebsiella	B-bacteria
,	O
Methylobacterium	B-bacteria
,	O
Pseudomonas	B-bacteria
,	O
Ralstonia	B-bacteria
)	O
were	O
isolated	O
,	O
and	O
one	O
strain	O
of	O
each	O
of	O
the	O
eleven	O
genera	O
was	O
studied	O
in	O
detail	O
.	O

These	O
strains	O
expressed	O
enzymes	O
associated	O
with	O
methylotrophic	O
metabolism	O
(	O
methanol	O
,	O
methylamine	O
,	O
and	O
formate	O
dehydrogenases	O
)	O
,	O
and	O
the	O
assimilation	O
of	O
one	O
-	O
carbon	O
compounds	O
by	O
the	O
serine	O
pathway	O
(	O
hydroxypyruvate	O
reductase	O
)	O
.	O

Methylotrophic	O
growth	O
of	O
the	O
strains	O
was	O
enhanced	O
by	O
the	O
addition	O
of	O
glass	O
beads	O
to	O
cultures	O
,	O
suggesting	O
that	O
they	O
may	O
naturally	O
occur	O
in	O
biofilms	O
in	O
the	O
mouth	O
.	O

This	O
is	O
the	O
first	O
report	O
of	O
Gordonia	B-bacteria
,	O
Leifsonia	B-bacteria
,	O
and	O
Rhodococcus	B-bacteria
being	O
present	O
in	O
the	O
mouth	O
and	O
of	O
the	O
unequivocal	O
demonstration	O
for	O
the	O
first	O
time	O
of	O
the	O
methylotrophic	O
potential	O
of	O
strains	O
of	O
Gordonia	B-bacteria
,	O
Leifsonia	B-bacteria
,	O
and	O
Microbacterium	B-bacteria
.	O

To	O
determine	O
ability	O
of	O
lactobacilli	B-bacteria
strains	I-bacteria
indigenous	O
for	O
oral	O
cavity	O
of	O
healthy	O
persons	O
to	O
adhesion	O
,	O
autoaggregation	O
,	O
surface	O
hydrophobicity	O
,	O
coaggregation	O
and	O
formation	O
of	O
biofilms	O
.	O

Twenty	O
-	O
three	O
anatagonistically	O
active	O
isolates	O
of	O
lactobacilli	B-bacteria
,	O
including	O
5	O
strains	O
of	O
Lactobacillus	B-bacteria
plantarum	I-bacteria
,	O
6	O
-	O
-	O
L	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
,	O
4	O
-	O
-	O
L	B-bacteria
.	I-bacteria
paracasei	I-bacteria
,	O
and	O
8	O
-	O
-	O
L	B-bacteria
.	I-bacteria
fermentum	I-bacteria
,	O
were	O
studied	O
.	O

Characteristics	O
of	O
lactobacilli	B-bacteria
associated	O
with	O
adhesion	O
,	O
autoaggregation	O
,	O
surface	O
hydrophobicity	O
,	O
coaggregation	O
,	O
and	O
formation	O
of	O
biofilms	O
were	O
determined	O
.	O

Bacteria	O
were	O
characterized	O
by	O
high	O
and	O
intermediate	O
level	O
of	O
adhesion	O
,	O
autoaggregation	O
,	O
surface	O
hydrophobicity	O
,	O
expressed	O
ability	O
to	O
form	O
biofilms	O
and	O
different	O
coaggregation	O
activity	O
relative	O
to	O
test	O
-	O
strains	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
Escherichia	B-bacteria
coli	I-bacteria
,	O
Candida	O
albicans	O
,	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
,	O
and	O
Bacillus	B-bacteria
subtilis	I-bacteria
.	O

Studied	O
characteristics	O
of	O
lactobacilli	B-bacteria
could	O
be	O
used	O
for	O
development	O
of	O
new	O
probiotics	O
aimed	O
at	O
stabilization	O
of	O
oral	O
cavity	O
normoflora	O
.	O

The	O
loads	O
and	O
locations	O
of	O
bacterial	O
types	O
associated	O
with	O
oral	O
malodour	O
on	O
the	O
tongue	O
surface	O
and	O
gingival	O
crevice	O
were	O
investigated	O
in	O
man	O
and	O
the	O
dog	O
respectively	O
.	O

In	O
the	O
human	O
study	O
,	O
samples	O
were	O
taken	O
from	O
50	O
subjects	O
with	O
brushes	O
at	O
the	O
dorsal	O
anterior	O
,	O
dorsal	O
middle	O
,	O
dorsal	O
posterior	O
,	O
dorsal	O
posterior	O
to	O
the	O
circumvallate	O
papillae	O
(	O
DPCP	O
)	O
,	O
lateral	O
posterior	O
and	O
ventral	O
posterior	O
(	O
VP	O
)	O
surfaces	O
,	O
and	O
cultured	O
appropriately	O
.	O

Malodour	O
was	O
assessed	O
by	O
trained	O
judges	O
.	O

Mean	O
volatile	O
sulfur	O
compound	O
(	O
VSC	O
)	O
producing	O
bacterial	O
counts	O
(	O
colony	O
forming	O
units	O
/	O
brush	O
x	O
10	O
(	O
5	O
)	O
)	O
were	O
found	O
to	O
be	O
highest	O
(	O
88	O
.	O
94	O
)	O
and	O
lowest	O
(	O
0	O
.	O
33	O
)	O
at	O
the	O
DPCP	O
and	O
VP	O
sites	O
respectively	O
.	O

Anaerobic	O
,	O
gram	O
-	O
negative	O
and	O
VSC	O
counts	O
at	O
DPCP	O
surfaces	O
increased	O
with	O
malodour	O
intensity	O
,	O
whereas	O
aerobic	O
and	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
counts	O
decreased	O
.	O

The	O
prevalence	O
and	O
populations	O
of	O
the	O
VSC	O
producing	O
Porphyromonas	B-bacteria
and	O
Prevotella	B-bacteria
species	I-bacteria
were	O
determined	O
in	O
the	O
dental	O
plaque	O
from	O
34	O
dogs	O
.	O

Porphyromonas	B-bacteria
gulae	I-bacteria
and	O
Prevotella	B-bacteria
intermedia	I-bacteria
were	O
present	O
in	O
68	O
%	O
and	O
44	O
%	O
of	O
dogs	O
,	O
and	O
47	O
%	O
and	O
23	O
%	O
of	O
plaque	O
samples	O
respectively	O
.	O

P	B-bacteria
.	I-bacteria
gulae	I-bacteria
and	O
Prev	B-bacteria
.	I-bacteria
intermedia	I-bacteria
counts	O
increased	O
with	O
plaque	O
quantity	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
and	O
gingivitis	O
(	O
P	O
<	O
0	O
.	O
1	O
)	O
.	O

The	O
close	O
association	O
observed	O
between	O
canine	O
periodontal	O
disease	O
and	O
measurements	O
of	O
oral	O
malodour	O
is	O
supported	O
.	O

Pathogens	O
related	O
to	O
systemic	O
infections	O
have	O
been	O
detected	O
in	O
the	O
periodontal	O
microbiota	O
.	O

The	O
relationship	O
amongst	O
these	O
pathogens	O
,	O
periodontal	O
bacteria	O
and	O
periodontal	O
clinical	O
status	O
is	O
poorly	O
understood	O
.	O

This	O
study	O
evaluated	O
the	O
association	O
amongst	O
red	O
complex	O
,	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
(	O
A	B-bacteria
.	I-bacteria
a	I-bacteria
)	O
and	O
non	O
-	O
oral	O
pathogenic	O
bacteria	O
in	O
subjects	O
with	O
good	O
periodontal	O
health	O
(	O
PH	O
)	O
,	O
gingivitis	O
(	O
G	O
)	O
,	O
chronic	O
(	O
CP	O
)	O
and	O
aggressive	O
(	O
AP	O
)	O
periodontitis	O
.	O

Subgingival	O
biofilm	O
samples	O
were	O
obtained	O
from	O
51	O
PH	O
,	O
42	O
G	O
,	O
219	O
CP	O
and	O
90	O
AP	O
subjects	O
.	O

The	O
presence	O
and	O
levels	O
of	O
A	B-bacteria
.	I-bacteria
a	I-bacteria
,	O
red	O
complex	O
(	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
)	O
,	O
Acinetobacter	B-bacteria
baumannii	I-bacteria
,	O
Escherichia	B-bacteria
coli	I-bacteria
,	O
Enterococcus	B-bacteria
faecalis	I-bacteria
,	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
,	O
and	O
Staphylococcus	B-bacteria
aureus	I-bacteria
were	O
determined	O
by	O
DNA	O
probes	O
and	O
DNA	O
-	O
DNA	O
hybridization	O
technique	O
.	O

CP	O
and	O
AP	O
subjects	O
presented	O
significantly	O
higher	O
prevalence	O
and	O
levels	O
of	O
A	B-bacteria
.	I-bacteria
a	I-bacteria
,	O
red	O
complex	O
and	O
A	B-bacteria
.	I-bacteria
baumannii	I-bacteria
than	O
G	O
and	O
PH	O
individuals	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
whereas	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
was	O
detected	O
in	O
lower	O
frequency	O
and	O
counts	O
in	O
AP	O
as	O
compared	O
to	O
the	O
other	O
groups	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

The	O
predictor	O
variables	O
age	O
,	O
prevalence	O
of	O
red	O
complex	O
,	O
and	O
the	O
presence	O
of	O
A	B-bacteria
.	I-bacteria
baumannii	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
were	O
strongly	O
associated	O
with	O
the	O
frequency	O
of	O
sites	O
with	O
PD	O
and	O
CAL	O
>	O
/	O
=	O
5	O
mm	O
.	O

Increasing	O
age	O
(	O
OR	O
1	O
.	O
08	O
)	O
,	O
high	O
frequency	O
of	O
red	O
complex	O
(	O
OR	O
6	O
.	O
10	O
)	O
,	O
and	O
the	O
presence	O
of	O
A	O
.	O
a	O
with	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
(	O
OR	O
1	O
.	O
90	O
)	O
were	O
associated	O
with	O
periodontal	O
disease	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Subjects	O
harbouring	O
a	O
high	O
prevalence	O
of	O
A	B-bacteria
.	I-bacteria
a	I-bacteria
,	O
A	B-bacteria
.	I-bacteria
baumannii	I-bacteria
,	O
and	O
red	O
complex	O
with	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
were	O
more	O
likely	O
to	O
have	O
AP	O
than	O
CP	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Putative	O
periodontal	O
pathogens	O
and	O
non	O
-	O
oral	O
bacteria	O
alone	O
or	O
in	O
association	O
were	O
strongly	O
associated	O
with	O
periodontitis	O
.	O

Prunus	O
mume	O
is	O
a	O
common	O
fruit	O
in	O
Asia	O
,	O
which	O
has	O
been	O
used	O
in	O
traditional	O
Chinese	O
medicine	O
.	O

In	O
this	O
study	O
,	O
we	O
focused	O
on	O
the	O
antimicrobial	O
properties	O
of	O
Prunus	O
mume	O
extract	O
against	O
oral	O
pathogens	O
related	O
to	O
dental	O
caries	O
and	O
periodontal	O
diseases	O
.	O

A	O
total	O
of	O
15	O
oral	O
pathogens	O
including	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
,	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
and	O
Candida	O
species	O
were	O
included	O
in	O
the	O
study	O
.	O

Initially	O
,	O
agar	O
diffusion	O
assay	O
was	O
performed	O
to	O
screen	O
the	O
antimicrobial	O
activities	O
of	O
Prunus	O
mume	O
extract	O
.	O

Minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
and	O
minimum	O
bactericidal	O
concentration	O
(	O
MBC	O
)	O
were	O
then	O
determined	O
for	O
sensitive	O
species	O
.	O

Effect	O
of	O
Prunus	O
mume	O
extract	O
on	O
human	O
oral	O
keratinocytes	O
(	O
HOK	O
)	O
viability	O
was	O
also	O
tested	O
.	O

In	O
the	O
agar	O
diffusion	O
assay	O
,	O
drug	O
suspension	O
of	O
2	O
g	O
/	O
mL	O
was	O
able	O
to	O
inhibit	O
all	O
the	O
bacterial	O
species	O
tested	O
,	O
but	O
not	O
the	O
fungal	O
species	O
.	O

MIC	O
and	O
MBC	O
range	O
of	O
Prunus	O
mume	O
extract	O
against	O
the	O
oral	O
bacteria	O
was	O
0	O
.	O
15625	O
-	O
0	O
.	O
0003	O
g	O
/	O
mL	O
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
being	O
the	O
most	O
susceptible	O
species	O
.	O

Prune	O
extract	O
did	O
not	O
cause	O
any	O
detrimental	O
effect	O
on	O
HOK	O
.	O

Prunus	O
mume	O
extract	O
may	O
be	O
a	O
potential	O
candidate	O
for	O
developing	O
an	O
oral	O
antimicrobial	O
agent	O
to	O
control	O
or	O
prevent	O
dental	O
diseases	O
associated	O
with	O
oral	O
pathogenic	O
bacteria	O
.	O

This	O
study	O
assessed	O
the	O
prevalence	O
of	O
colonization	O
by	O
Staphylococcus	B-bacteria
aureus	I-bacteria
in	O
hospital	O
housekeepers	O
,	O
and	O
their	O
knowledge	O
and	O
beliefs	O
regarding	O
this	O
problem	O
.	O

Three	O
saliva	O
samples	O
were	O
collected	O
and	O
a	O
questionnaire	O
regarding	O
knowledge	O
and	O
beliefs	O
was	O
applied	O
.	O

Of	O
the	O
92	O
workers	O
,	O
63	O
(	O
68	O
.	O
5	O
%	O
)	O
participated	O
in	O
the	O
study	O
;	O
20	O
were	O
not	O
and	O
43	O
were	O
colonized	O
;	O
13	O
by	O
methicillin	B-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
and	O
30	O
by	O
methicillin	B-bacteria
sensitive	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
.	O

Persistent	O
carrier	O
status	O
of	O
methicillin	B-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
was	O
detected	O
in	O
15	O
.	O
4	O
%	O
of	O
cases	O
.	O

Low	O
knowledge	O
and	O
perception	O
of	O
occupational	O
risk	O
were	O
observed	O
.	O

The	O
mouth	O
was	O
identified	O
as	O
an	O
important	O
reservoir	O
of	O
methicillin	B-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
.	O

Analyzing	O
knowledge	O
and	O
beliefs	O
,	O
as	O
well	O
as	O
the	O
state	O
of	O
carrier	O
,	O
is	O
an	O
important	O
strategy	O
to	O
be	O
added	O
to	O
educational	O
actions	O
for	O
the	O
prevention	O
of	O
workers	O
'	O
colonization	O
.	O

In	O
this	O
work	O
,	O
we	O
review	O
the	O
state	O
of	O
knowledge	O
of	O
Archaea	O
associated	O
with	O
the	O
human	O
microbiome	O
.	O

These	O
prokaryotes	O
,	O
initially	O
discovered	O
in	O
extreme	O
environments	O
,	O
were	O
named	O
Archaea	O
because	O
these	O
environments	O
were	O
thought	O
to	O
be	O
the	O
most	O
primitive	O
on	O
Earth	O
.	O

Further	O
research	O
revealed	O
that	O
this	O
terminology	O
is	O
misleading	O
because	O
these	O
organisms	O
were	O
later	O
found	O
in	O
various	O
non	O
-	O
extreme	O
environments	O
,	O
including	O
the	O
human	O
host	O
.	O

Further	O
examination	O
of	O
the	O
human	O
microbiome	O
has	O
enabled	O
the	O
isolation	O
of	O
three	O
archaeal	O
species	O
,	O
Methanobrevibacter	B-bacteria
smithii	I-bacteria
,	O
Methanosphaera	B-bacteria
stadtmanae	I-bacteria
and	O
Methanobrevibacter	B-bacteria
oralis	I-bacteria
,	O
which	O
are	O
associated	O
with	O
oral	O
,	O
intestinal	O
and	O
vaginal	O
mucosae	O
in	O
humans	O
.	O

Moreover	O
,	O
molecular	O
studies	O
including	O
metagenomic	O
analyses	O
detected	O
DNA	O
sequences	O
indicative	O
of	O
the	O
presence	O
of	O
additional	O
methanogenic	O
and	O
non	O
-	O
methanogenic	O
Archaea	O
in	O
the	O
human	O
intestinal	O
tract	O
.	O

All	O
three	O
culturable	O
Archaea	O
are	O
strict	O
anaerobes	O
,	O
although	O
their	O
potential	O
role	O
in	O
human	O
diseases	O
remains	O
to	O
be	O
established	O
.	O

Future	O
research	O
aims	O
to	O
detect	O
and	O
culture	O
additional	O
human	O
mucosa	O
-	O
associated	O
Archaea	O
and	O
to	O
look	O
for	O
their	O
presence	O
in	O
additional	O
human	O
tissues	O
,	O
to	O
establish	O
their	O
role	O
in	O
human	O
infections	O
involving	O
complex	O
flora	O
.	O

The	O
aim	O
was	O
to	O
evaluate	O
the	O
presence	O
of	O
Staphylococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Enterobacteriaceae	B-bacteria
and	O
Pseudomonadaceae	B-bacteria
in	O
the	O
oral	O
cavities	O
of	O
HIV	O
-	O
positive	O
patients	O
.	O

Forty	O
-	O
five	O
individuals	O
diagnosed	O
as	O
HIV	O
-	O
positive	O
by	O
ELISA	O
and	O
Western	O
-	O
blot	O
,	O
and	O
under	O
anti	O
-	O
retroviral	O
therapy	O
for	O
at	O
least	O
1	O
year	O
,	O
were	O
included	O
in	O
the	O
study	O
.	O

The	O
control	O
group	O
constituted	O
45	O
systemically	O
healthy	O
individuals	O
matched	O
to	O
the	O
HIV	O
patients	O
to	O
gender	O
,	O
age	O
and	O
oral	O
conditions	O
.	O

Oral	O
rinses	O
were	O
collected	O
and	O
isolates	O
were	O
identified	O
by	O
API	O
system	O
.	O

Counts	O
of	O
microorganisms	O
from	O
HIV	O
and	O
control	O
groups	O
were	O
compared	O
statistically	O
by	O
a	O
Mann	O
-	O
Whitney	O
test	O
(	O
alpha	O
=	O
5	O
%	O
)	O
.	O

The	O
percentages	O
of	O
individuals	O
positive	O
for	O
staphylococci	B-bacteria
were	O
similar	O
between	O
the	O
groups	O
(	O
p	O
=	O
0	O
.	O
764	O
)	O
,	O
whereas	O
for	O
Gram	O
-	O
negative	O
rods	O
,	O
a	O
higher	O
percentage	O
was	O
observed	O
amongst	O
HIV	O
-	O
positive	O
(	O
p	O
=	O
0	O
.	O
001	O
)	O
.	O

There	O
was	O
no	O
difference	O
in	O
Staphylococcus	B-bacteria
counts	O
between	O
HIV	O
and	O
control	O
groups	O
(	O
p	O
=	O
0	O
.	O
1008	O
)	O
.	O

Counts	O
were	O
lower	O
in	O
the	O
oral	O
cavities	O
of	O
patients	O
with	O
low	O
viral	O
load	O
(	O
p	O
=	O
0	O
.	O
021	O
)	O
,	O
and	O
no	O
difference	O
was	O
observed	O
in	O
relation	O
to	O
CD4	O
counts	O
(	O
p	O
=	O
0	O
.	O
929	O
)	O
.	O

Staphylococcus	B-bacteria
aureus	I-bacteria
was	O
the	O
most	O
frequently	O
isolated	O
species	O
in	O
HIV	O
group	O
,	O
and	O
Staphylococcus	B-bacteria
epidermidis	I-bacteria
was	O
the	O
prevalent	O
species	O
in	O
the	O
control	O
group	O
.	O

Significantly	O
higher	O
numbers	O
of	O
enteric	O
bacteria	O
and	O
pseudomonas	B-bacteria
were	O
detected	O
in	O
the	O
oral	O
cavities	O
of	O
the	O
HIV	O
group	O
than	O
in	O
the	O
control	O
(	O
p	O
=	O
0	O
.	O
0001	O
)	O
.	O

Enterobacter	B-bacteria
cloacae	I-bacteria
was	O
the	O
most	O
frequently	O
isolated	O
species	O
in	O
both	O
groups	O
.	O

Counts	O
of	O
enteric	O
bacteria	O
and	O
pseudomonas	B-bacteria
were	O
significantly	O
lower	O
in	O
patients	O
with	O
low	O
CD4	O
counts	O
(	O
p	O
=	O
0	O
.	O
011	O
)	O
;	O
however	O
,	O
there	O
was	O
no	O
difference	O
relating	O
to	O
viral	O
load	O
.	O

It	O
may	O
be	O
concluded	O
that	O
HIV	O
group	O
showed	O
greater	O
species	O
diversity	O
and	O
a	O
higher	O
prevalence	O
of	O
Enterobacteriaceae	B-bacteria
/	O
Pseudomonadaceae	B-bacteria
.	O

The	O
AIDS	O
pandemic	O
continues	O
.	O

Little	O
is	O
understood	O
about	O
how	O
HIV	O
gains	O
access	O
to	O
permissive	O
cells	O
across	O
mucosal	O
surfaces	O
,	O
yet	O
such	O
knowledge	O
is	O
crucial	O
to	O
the	O
development	O
of	O
successful	O
topical	O
anti	O
-	O
HIV	O
-	O
1	O
agents	O
and	O
mucosal	O
vaccines	O
.	O

HIV	O
-	O
1	O
rapidly	O
internalizes	O
and	O
integrates	O
into	O
the	O
mucosal	O
keratinocyte	O
genome	O
,	O
and	O
integrated	O
copies	O
of	O
HIV	O
-	O
1	O
persist	O
upon	O
cell	O
passage	O
.	O

The	O
virus	O
does	O
not	O
appear	O
to	O
replicate	O
,	O
and	O
the	O
infection	O
may	O
become	O
latent	O
.	O

Interactions	O
between	O
HIV	O
-	O
1	O
and	O
oral	O
keratinocytes	O
have	O
been	O
modeled	O
in	O
the	O
context	O
of	O
key	O
environmental	O
factors	O
,	O
including	O
putative	O
copathogens	O
and	O
saliva	O
.	O

In	O
keratinocytes	O
,	O
HIV	O
-	O
1	O
internalizes	O
within	O
minutes	O
;	O
in	O
saliva	O
,	O
an	O
infectious	O
fraction	O
escapes	O
inactivation	O
and	O
is	O
harbored	O
and	O
transferable	O
to	O
permissive	O
target	O
cells	O
for	O
up	O
to	O
48	O
hours	O
.	O

When	O
incubated	O
with	O
the	O
common	O
oral	O
pathogen	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
CCR5	O
-	O
oral	O
keratinocytes	O
signal	O
through	O
protease	O
-	O
activated	O
receptors	O
and	O
Toll	O
-	O
like	O
receptors	O
to	O
induce	O
expression	O
of	O
CCR5	O
,	O
which	O
increases	O
selective	O
uptake	O
of	O
infectious	O
R5	O
-	O
tropic	O
HIV	O
-	O
1	O
into	O
oral	O
keratinocytes	O
and	O
transfer	O
to	O
permissive	O
cells	O
.	O

Hence	O
,	O
oral	O
keratinocytes	O
-	O
like	O
squamous	O
keratinocytes	O
of	O
other	O
tissues	O
-	O
may	O
be	O
targets	O
for	O
low	O
-	O
level	O
HIV	O
-	O
1	O
internalization	O
and	O
subsequent	O
dissemination	O
by	O
transfer	O
to	O
permissive	O
cells	O
.	O

Oral	O
biofilms	O
such	O
as	O
dental	O
plaque	O
cause	O
dental	O
caries	O
and	O
periodontitis	O
,	O
as	O
well	O
as	O
aspiration	O
pneumonia	O
and	O
infectious	O
endocarditis	O
by	O
translocation	O
.	O

Hence	O
,	O
the	O
suppression	O
of	O
oral	O
biofilm	O
formation	O
is	O
an	O
issue	O
of	O
considerable	O
importance	O
.	O

Mechanical	O
removal	O
,	O
disinfectants	O
,	O
inhibition	O
of	O
polysaccharide	O
formation	O
,	O
and	O
artificial	O
sugar	O
have	O
been	O
used	O
for	O
the	O
reduction	O
of	O
oral	O
biofilm	O
.	O

From	O
the	O
viewpoint	O
of	O
the	O
inhibition	O
of	O
bacterial	O
adherence	O
,	O
we	O
investigated	O
whether	O
aqueous	O
biocompatible	O
2	O
-	O
methacryloyloxyethyl	O
phosphorylcholine	O
(	O
MPC	O
)	O
-	O
polymer	O
can	O
reduce	O
streptococcal	B-bacteria
colonization	O
and	O
biofilm	O
formation	O
.	O

We	O
examined	O
the	O
effects	O
of	O
MPC	O
-	O
polymer	O
on	O
streptococcal	B-bacteria
adherence	O
to	O
saliva	O
-	O
coated	O
hydroxyapatite	O
and	O
oral	O
epithelial	O
cells	O
,	O
and	O
the	O
adherence	O
of	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
to	O
streptococcal	B-bacteria
biofilm	O
.	O

MPC	O
-	O
polymer	O
application	O
markedly	O
inhibited	O
both	O
the	O
adherence	O
and	O
biofilm	O
formation	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
on	O
saliva	O
-	O
coated	O
hydroxyapatite	O
and	O
streptococcal	B-bacteria
adherence	O
to	O
oral	O
epithelial	O
cells	O
,	O
and	O
reduced	O
the	O
adherence	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
to	O
streptococcal	B-bacteria
biofilms	O
.	O

A	O
small	O
-	O
scale	O
clinical	O
trial	O
revealed	O
that	O
mouthrinsing	O
with	O
MPC	O
-	O
polymer	O
inhibited	O
the	O
increase	O
of	O
oral	O
bacterial	O
numbers	O
,	O
especially	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

These	O
findings	O
suggest	O
that	O
MPC	O
-	O
polymer	O
is	O
a	O
potent	O
inhibitor	O
of	O
bacterial	O
adherence	O
and	O
biofilm	O
development	O
,	O
and	O
may	O
be	O
useful	O
to	O
prevent	O
dental	O
-	O
plaque	O
-	O
related	O
diseases	O
.	O

Dental	O
caries	O
(	O
tooth	O
decay	O
)	O
is	O
caused	O
by	O
a	O
specific	O
group	O
of	O
cariogenic	O
bacteria	O
,	O
like	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
which	O
convert	O
dietary	O
sugars	O
into	O
acids	O
that	O
dissolve	O
the	O
mineral	O
in	O
tooth	O
structure	O
.	O

Killing	O
cariogenic	O
bacteria	O
is	O
an	O
effective	O
way	O
to	O
control	O
or	O
prevent	O
tooth	O
decay	O
.	O

In	O
a	O
previous	O
study	O
,	O
we	O
discovered	O
a	O
novel	O
compound	O
(	O
Glycyrrhizol	O
A	O
)	O
,	O
from	O
the	O
extraction	O
of	O
licorice	O
roots	O
,	O
with	O
strong	O
antimicrobial	O
activity	O
against	O
cariogenic	O
bacteria	O
.	O

In	O
the	O
current	O
study	O
,	O
we	O
developed	O
a	O
method	O
to	O
produce	O
these	O
specific	O
herbal	O
extracts	O
in	O
large	O
quantities	O
,	O
and	O
then	O
used	O
these	O
extracts	O
to	O
develop	O
a	O
sugar	O
-	O
free	O
lollipop	O
that	O
effectively	O
kills	O
cariogenic	O
bacteria	O
like	O
Streptococcus	B-bacteria
mutans	I-bacteria
.	O

Further	O
studies	O
showed	O
that	O
these	O
sugar	O
-	O
free	O
lollipops	O
are	O
safe	O
and	O
their	O
antimicrobial	O
activity	O
is	O
stable	O
.	O

Two	O
pilot	O
human	O
studies	O
indicate	O
that	O
a	O
brief	O
application	O
of	O
these	O
lollipops	O
(	O
twice	O
a	O
day	O
for	O
ten	O
days	O
)	O
led	O
to	O
a	O
marked	O
reduction	O
of	O
cariogenic	O
bacteria	O
in	O
oral	O
cavity	O
among	O
most	O
human	O
subjects	O
tested	O
.	O

This	O
herbal	O
lollipop	O
could	O
be	O
a	O
novel	O
tool	O
to	O
promote	O
oral	O
health	O
through	O
functional	O
foods	O
.	O

The	O
cytolethal	O
distending	O
toxin	O
(	O
Cdt	O
)	O
,	O
expressed	O
by	O
the	O
periodontal	O
pathogen	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
inhibits	O
the	O
proliferation	O
of	O
cultured	O
epithelial	O
cells	O
by	O
arresting	O
the	O
cell	O
cycle	O
.	O

The	O
gingival	O
epithelium	O
is	O
an	O
early	O
line	O
of	O
defense	O
against	O
microbial	O
assault	O
.	O

When	O
damaged	O
,	O
bacteria	O
collectively	O
gain	O
entry	O
into	O
underlying	O
connective	O
biofilm	O
where	O
microbial	O
products	O
can	O
affect	O
infiltrating	O
inflammatory	O
cells	O
,	O
leading	O
to	O
the	O
destruction	O
of	O
the	O
attachment	O
apparatus	O
.	O

Histological	O
evaluation	O
of	O
rat	O
and	O
healthy	O
human	O
gingival	O
biofilm	O
exposed	O
ex	O
vivo	O
to	O
the	O
Cdt	O
for	O
36	O
and	O
18	O
hours	O
,	O
respectively	O
,	O
revealed	O
extensive	O
detachment	O
of	O
the	O
keratinized	O
outer	O
layer	O
and	O
distention	O
of	O
spinous	O
and	O
basal	O
cells	O
in	O
the	O
oral	O
epithelium	O
.	O

Treated	O
human	O
biofilm	O
also	O
exhibited	O
disruption	O
of	O
rete	O
pegs	O
and	O
dissolution	O
of	O
cell	O
junctions	O
.	O

Cells	O
in	O
the	O
connective	O
biofilm	O
appeared	O
unaffected	O
.	O

Primary	O
gingival	O
epithelial	O
cells	O
,	O
but	O
not	O
gingival	O
fibroblasts	O
,	O
isolated	O
from	O
the	O
same	O
healthy	O
human	O
biofilm	O
were	O
cell	O
-	O
cycle	O
-	O
arrested	O
when	O
treated	O
with	O
the	O
toxin	O
.	O

These	O
findings	O
provide	O
new	O
evidence	O
that	O
the	O
Cdt	O
severely	O
damages	O
the	O
oral	O
epithelium	O
,	O
ex	O
vivo	O
,	O
by	O
specifically	O
targeting	O
epithelial	O
cells	O
,	O
in	O
situ	O
.	O

The	O
Cdt	O
shows	O
preferential	O
targeting	O
of	O
the	O
epithelium	O
as	O
opposed	O
to	O
connective	O
biofilm	O
in	O
animal	O
and	O
human	O
gingival	O
explant	O
models	O
.	O

cytolethal	O
distending	O
toxin	O
(	O
Cdt	O
)	O
,	O
connective	O
biofilm	O
(	O
CT	O
)	O
,	O
4	O
'	O
,	O
6	O
-	O
diamidino	O
-	O
2	O
-	O
phenylindole	O
(	O
DAPI	O
)	O
,	O
human	O
gingival	O
epithelial	O
cells	O
(	O
HGEC	O
)	O
,	O
human	O
gingival	O
explants	O
(	O
HGX	O
)	O
,	O
human	O
gingival	O
fibroblasts	O
(	O
HGF	O
)	O
,	O
junctional	O
epithelium	O
(	O
JE	O
)	O
,	O
oral	O
epithelium	O
(	O
OE	O
)	O
,	O
rete	O
pegs	O
(	O
RP	O
)	O
,	O
sulcular	O
epithelium	O
(	O
SE	O
)	O
.	O

Cranberry	O
juice	O
cocktail	O
(	O
CJC	O
)	O
has	O
been	O
shown	O
to	O
inhibit	O
the	O
formation	O
of	O
biofilm	O
by	O
uropathogenic	B-bacteria
Escherichia	I-bacteria
coli	I-bacteria
.	O

In	O
order	O
to	O
investigate	O
whether	O
the	O
anti	O
-	O
adhesive	O
components	O
could	O
reach	O
the	O
urinary	O
tract	O
after	O
oral	O
consumption	O
of	O
CJC	O
,	O
a	O
volunteer	O
was	O
given	O
16	O
oz	O
of	O
either	O
water	O
or	O
CJC	O
.	O

Urine	O
samples	O
were	O
collected	O
at	O
0	O
,	O
2	O
,	O
4	O
,	O
6	O
,	O
and	O
8	O
hours	O
after	O
consumption	O
of	O
a	O
single	O
dose	O
.	O

The	O
ability	O
of	O
compounds	O
in	O
the	O
urine	O
to	O
influence	O
bacterial	O
adhesion	O
was	O
tested	O
for	O
six	O
clinical	O
uropathogenic	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
strains	I-bacteria
,	O
including	O
four	O
P	O
-	O
fimbriated	O
strains	O
(	O
B37	B-bacteria
,	O
CFT073	B-bacteria
,	O
BF1023	B-bacteria
,	O
and	O
J96	B-bacteria
)	O
and	O
two	O
strains	O
not	O
expressing	O
P	O
-	O
fimbriae	O
but	O
exhibiting	O
mannose	O
-	O
resistant	O
hemagglutination	O
(	O
B73	B-bacteria
and	O
B78	B-bacteria
)	O
.	O

A	O
non	O
-	O
fimbriated	O
strain	O
,	O
HB101	B-bacteria
,	O
was	O
used	O
as	O
a	O
control	O
.	O

Atomic	O
force	O
microscopy	O
(	O
AFM	O
)	O
was	O
used	O
to	O
measure	O
the	O
adhesion	O
force	O
between	O
a	O
silicon	O
nitride	O
probe	O
and	O
bacteria	O
treated	O
with	O
urine	O
samples	O
.	O

Within	O
2	O
hours	O
after	O
CJC	O
consumption	O
,	O
bacteria	O
of	O
the	O
clinical	O
strains	O
treated	O
with	O
the	O
corresponding	O
urine	O
sample	O
demonstrated	O
lower	O
adhesion	O
forces	O
than	O
those	O
treated	O
with	O
urine	O
collected	O
before	O
CJC	O
consumption	O
.	O

The	O
adhesion	O
forces	O
continued	O
decreasing	O
with	O
time	O
after	O
CJC	O
consumption	O
over	O
the	O
8	O
-	O
hour	O
measurement	O
period	O
.	O

The	O
adhesion	O
forces	O
of	O
bacteria	O
after	O
exposure	O
to	O
urine	O
collected	O
following	O
water	O
consumption	O
did	O
not	O
change	O
.	O

HB101	B-bacteria
showed	O
low	O
adhesion	O
forces	O
following	O
both	O
water	O
and	O
CJC	O
consumption	O
,	O
and	O
these	O
did	O
not	O
change	O
over	O
time	O
.	O

The	O
AFM	O
adhesion	O
force	O
measurements	O
were	O
consistent	O
with	O
the	O
results	O
of	O
a	O
hemagglutination	O
assay	O
,	O
confirming	O
that	O
oral	O
consumption	O
of	O
CJC	O
could	O
act	O
against	O
adhesion	O
of	O
uropathogenic	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
.	O

To	O
investigate	O
the	O
root	O
canal	O
microbiota	O
of	O
primary	O
teeth	O
with	O
apical	O
periodontitis	O
and	O
the	O
in	O
vivo	O
antimicrobial	O
effects	O
of	O
a	O
calcium	O
hydroxide	O
/	O
chlorhexidine	O
paste	O
used	O
as	O
root	O
canal	O
dressing	O
.	O

Baseline	O
samples	O
were	O
collected	O
from	O
30	O
root	O
canals	O
of	O
primary	O
teeth	O
with	O
apical	O
periodontitis	O
.	O

Then	O
,	O
the	O
root	O
canals	O
were	O
filled	O
with	O
a	O
calcium	O
hydroxide	O
paste	O
containing	O
1	O
%	O
chlorhexidine	O
for	O
14	O
days	O
and	O
the	O
second	O
bacteriologic	O
samples	O
were	O
taken	O
prior	O
to	O
root	O
canal	O
filling	O
.	O

Samples	O
were	O
submitted	O
to	O
microbiologic	O
culture	O
procedure	O
to	O
detect	O
root	O
canal	O
bacteria	O
and	O
processed	O
for	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
.	O

Baseline	O
microbial	O
culture	O
revealed	O
high	O
prevalence	O
and	O
cfu	O
number	O
of	O
anaerobic	O
,	O
black	O
-	O
pigmented	O
bacteroides	O
,	O
Streptococcus	B-bacteria
,	O
and	O
aerobic	O
microorganisms	O
.	O

Following	O
root	O
canal	O
dressing	O
,	O
the	O
overall	O
number	O
of	O
cfu	O
was	O
dramatically	O
diminished	O
compared	O
to	O
initial	O
contamination	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
,	O
although	O
prevalence	O
did	O
not	O
change	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
.	O

Of	O
35	O
probes	O
used	O
for	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
,	O
31	O
(	O
88	O
.	O
57	O
%	O
)	O
were	O
present	O
at	O
baseline	O
,	O
and	O
following	O
root	O
canal	O
dressing	O
,	O
the	O
number	O
of	O
positive	O
probes	O
reduced	O
to	O
13	O
(	O
37	O
.	O
14	O
%	O
)	O
.	O

Similarly	O
,	O
the	O
number	O
of	O
bacterial	O
cells	O
diminished	O
folowing	O
application	O
of	O
calcium	O
hydroxide	O
/	O
chlorhexidine	O
root	O
canal	O
dressing	O
(	O
P	O
=	O
0	O
.	O
006	O
)	O
.	O

Apical	O
periodontitis	O
is	O
caused	O
by	O
a	O
polymicrobial	O
infection	O
,	O
and	O
a	O
calcium	O
hydroxide	O
/	O
chlorhexidine	O
paste	O
is	O
effective	O
in	O
reducing	O
the	O
number	O
of	O
bacteria	O
inside	O
root	O
canals	O
when	O
applied	O
as	O
a	O
root	O
canal	O
dressing	O
.	O

Information	O
on	O
co	O
-	O
adherence	O
of	O
different	O
oral	O
bacterial	O
species	O
is	O
important	O
for	O
understanding	O
interspecies	O
interactions	O
within	O
oral	O
microbial	O
community	O
.	O

Current	O
knowledge	O
on	O
this	O
topic	O
is	O
heavily	O
based	O
on	O
pariwise	O
coaggregation	O
of	O
known	O
,	O
cultivable	O
species	O
.	O

In	O
this	O
study	O
,	O
we	O
employed	O
a	O
membrane	O
binding	O
assay	O
coupled	O
with	O
polymerase	O
chain	O
reaction	O
-	O
denaturing	O
gradient	O
gel	O
electrophoresis	O
(	O
PCR	O
-	O
DGGE	O
)	O
to	O
systematically	O
analyze	O
the	O
co	O
-	O
adherence	O
profiles	O
of	O
oral	O
bacterial	O
species	O
,	O
and	O
achieved	O
a	O
more	O
profound	O
knowledge	O
beyond	O
pairwise	O
coaggregation	O
.	O

Two	O
oral	O
bacterial	O
species	O
were	O
selected	O
to	O
serve	O
as	O
`	O
`	O
bait	O
'	O
'	O
:	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
(	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
)	O
whose	O
ability	O
to	O
adhere	O
to	O
a	O
multitude	O
of	O
oral	O
bacterial	O
species	O
has	O
been	O
extensively	O
studied	O
for	O
pairwise	O
interactions	O
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
(	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
)	O
whose	O
interacting	O
partners	O
are	O
largely	O
unknown	O
.	O

To	O
enable	O
screening	O
of	O
interacting	O
partner	O
species	O
within	O
bacterial	O
mixtures	O
,	O
cells	O
of	O
the	O
`	O
`	O
bait	O
'	O
'	O
oral	O
bacterium	O
were	O
immobilized	O
on	O
nitrocellulose	O
membranes	O
which	O
were	O
washed	O
and	O
blocked	O
to	O
prevent	O
unspecific	O
binding	O
.	O

The	O
`	O
`	O
prey	O
'	O
'	O
bacterial	O
mixtures	O
(	O
including	O
known	O
species	O
or	O
natural	O
saliva	O
samples	O
)	O
were	O
added	O
,	O
unbound	O
cells	O
were	O
washed	O
off	O
after	O
the	O
incubation	O
period	O
and	O
the	O
remaining	O
cells	O
were	O
eluted	O
using	O
0	O
.	O
2	O
mol	O
x	O
L	O
(	O
-	O
1	O
)	O
glycine	O
.	O

Genomic	O
DNA	O
was	O
extracted	O
,	O
subjected	O
to	O
16S	O
rRNA	O
PCR	O
amplification	O
and	O
separation	O
of	O
the	O
resulting	O
PCR	O
products	O
by	O
DGGE	O
.	O

Selected	O
bands	O
were	O
recovered	O
from	O
the	O
gel	O
,	O
sequenced	O
and	O
identified	O
via	O
Nucleotide	O
searches	O
against	O
different	O
databases	O
.	O

While	O
few	O
bacterial	O
species	O
bound	O
to	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
consistent	O
with	O
previous	O
findings	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
adhered	O
to	O
a	O
variety	O
of	O
bacterial	O
species	O
including	O
uncultivable	O
and	O
uncharacterized	O
ones	O
.	O

This	O
new	O
approach	O
can	O
more	O
effectively	O
analyze	O
the	O
co	O
-	O
adherence	O
profiles	O
of	O
oral	O
bacteria	O
,	O
and	O
could	O
facilitate	O
the	O
systematic	O
study	O
of	O
interbacterial	O
binding	O
of	O
oral	O
microbial	O
species	O
.	O

The	O
aim	O
of	O
this	O
study	O
is	O
to	O
confirm	O
the	O
association	O
among	O
oral	O
health	O
behaviors	O
,	O
periodontitis	O
,	O
and	O
preeclampsia	O
in	O
Korean	O
women	O
.	O

This	O
study	O
is	O
designed	O
as	O
a	O
case	O
-	O
control	O
study	O
.	O

Sixteen	O
women	O
with	O
preeclampsia	O
and	O
48	O
without	O
preeclampsia	O
post	O
-	O
delivery	O
were	O
included	O
in	O
this	O
study	O
from	O
November	O
2007	O
to	O
January	O
2010	O
.	O

Information	O
was	O
collected	O
on	O
demographics	O
,	O
health	O
behaviors	O
,	O
and	O
obstetric	O
and	O
systemic	O
diseases	O
that	O
may	O
influence	O
the	O
periodontal	O
condition	O
and	O
preeclampsia	O
.	O

Full	O
-	O
mouth	O
periodontal	O
probing	O
was	O
conducted	O
by	O
one	O
trained	O
examiner	O
(	O
KHB	O
)	O
.	O

Localized	O
periodontitis	O
was	O
defined	O
as	O
periodontal	O
clinical	O
attachment	O
loss	O
(	O
AL	O
)	O
>	O
/	O
=	O
3	O
.	O
5	O
mm	O
on	O
two	O
or	O
three	O
sites	O
not	O
on	O
the	O
same	O
tooth	O
.	O

In	O
addition	O
,	O
generalized	O
periodontitis	O
was	O
defined	O
as	O
clinical	O
AL	O
>	O
/	O
=	O
3	O
.	O
5	O
mm	O
on	O
>	O
/	O
=	O
4	O
sites	O
not	O
on	O
the	O
same	O
tooth	O
.	O

Gingival	O
crevicular	O
fluid	O
was	O
collected	O
using	O
a	O
sterilized	O
paper	O
point	O
for	O
quantitative	O
analysis	O
of	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
(	O
Pi	B-bacteria
)	O
,	O
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
(	O
previously	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
)	O
.	O

After	O
adjusting	O
for	O
confounders	O
,	O
the	O
adjusted	O
odds	O
ratio	O
(	O
OR	O
)	O
was	O
4	O
.	O
79	O
(	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]	O
:	O
1	O
.	O
02	O
to	O
29	O
.	O
72	O
)	O
for	O
localized	O
periodontitis	O
and	O
6	O
.	O
60	O
(	O
95	O
%	O
CI	O
:	O
1	O
.	O
25	O
to	O
41	O
.	O
61	O
)	O
for	O
generalized	O
periodontitis	O
.	O

In	O
addition	O
,	O
the	O
proportion	O
of	O
floss	O
or	O
interdental	O
brush	O
users	O
in	O
women	O
with	O
preeclampsia	O
was	O
lower	O
than	O
that	O
in	O
women	O
without	O
(	O
adjusted	O
OR	O
:	O
0	O
.	O
21	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
02	O
to	O
0	O
.	O
93	O
)	O
.	O

Pi	B-bacteria
was	O
significantly	O
more	O
prevalent	O
in	O
women	O
with	O
preeclampsia	O
(	O
P	O
=	O
0	O
.	O
028	O
)	O
.	O

These	O
results	O
indicate	O
that	O
preeclampsia	O
could	O
be	O
associated	O
with	O
the	O
maternal	O
periodontal	O
condition	O
and	O
interdental	O
cleaning	O
.	O

Recent	O
studies	O
showed	O
that	O
qPCR	O
could	O
detect	O
bacteria	O
related	O
to	O
periodontitis	O
and	O
peri	O
-	O
implantitis	O
in	O
a	O
low	O
concentration	O
after	O
full	O
-	O
mouth	O
tooth	O
extraction	O
.	O

This	O
study	O
monitored	O
the	O
microbiota	O
from	O
tooth	O
extraction	O
,	O
over	O
9	O
months	O
of	O
full	O
edentulism	O
,	O
up	O
to	O
1	O
year	O
after	O
abutment	O
connection	O
.	O

Ten	O
patients	O
with	O
severe	O
periodontitis	O
were	O
recruited	O
.	O

Six	O
months	O
after	O
tooth	O
extraction	O
,	O
implants	O
were	O
inserted	O
.	O

Three	O
to	O
6	O
months	O
later	O
,	O
they	O
were	O
connected	O
to	O
abutments	O
.	O

Plaque	O
samples	O
were	O
collected	O
from	O
the	O
tongue	O
dorsum	O
,	O
saliva	O
,	O
and	O
subgingival	O
area	O
(	O
teeth	O
/	O
implants	O
)	O
before	O
extraction	O
up	O
to	O
1	O
year	O
after	O
abutment	O
connection	O
,	O
and	O
analysed	O
via	O
culture	O
,	O
qPCR	O
,	O
and	O
checkerboard	O
technology	O
.	O

A	O
reduction	O
in	O
the	O
total	O
amount	O
of	O
aerobic	O
and	O
anaerobic	O
CFU	O
/	O
ml	O
was	O
observed	O
.	O

The	O
concentration	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
(	O
qPCR	O
and	O
checkerboard	O
)	O
in	O
the	O
saliva	O
and	O
,	O
to	O
a	O
lower	O
extent	O
,	O
on	O
the	O
tongue	O
dorsum	O
reduced	O
.	O

For	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
changes	O
were	O
negligible	O
and	O
no	O
changes	O
could	O
be	O
detected	O
for	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
.	O

The	O
pristine	O
subgingival	O
niches	O
were	O
quickly	O
colonized	O
by	O
key	O
pathogens	O
.	O

Their	O
final	O
concentration	O
remained	O
low	O
,	O
while	O
the	O
detection	O
frequencies	O
remained	O
very	O
high	O
over	O
time	O
.	O

Complete	O
edentulation	O
results	O
in	O
a	O
significant	O
reduction	O
of	O
bacteria	O
related	O
to	O
periodontitis	O
and	O
peri	O
-	O
implantitis	O
,	O
with	O
the	O
exception	O
of	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
,	O
which	O
might	O
indicate	O
that	O
key	O
pathogens	O
can	O
survive	O
without	O
pockets	O
.	O

To	O
monitor	O
microbial	O
shifts	O
during	O
dental	O
biofilm	O
re	O
-	O
development	O
.	O

Supra	O
-	O
and	O
subgingival	O
plaque	O
samples	O
were	O
taken	O
separately	O
from	O
28	O
teeth	O
in	O
38	O
healthy	O
and	O
17	O
periodontitis	O
subjects	O
at	O
baseline	O
and	O
immediately	O
after	O
tooth	O
cleaning	O
.	O

Samples	O
were	O
taken	O
again	O
from	O
seven	O
teeth	O
in	O
randomly	O
selected	O
quadrants	O
during	O
1	O
,	O
2	O
,	O
4	O
and	O
7	O
days	O
of	O
no	O
oral	O
hygiene	O
.	O

Samples	O
were	O
analysed	O
using	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
.	O

Species	O
counts	O
were	O
averaged	O
within	O
subjects	O
at	O
each	O
time	O
point	O
.	O

Significant	O
differences	O
in	O
the	O
counts	O
between	O
healthy	O
and	O
periodontitis	O
subjects	O
were	O
determined	O
using	O
the	O
Mann	O
-	O
Whitney	O
test	O
.	O

The	O
total	O
supra	O
-	O
and	O
subgingival	O
counts	O
were	O
significantly	O
higher	O
in	O
periodontitis	O
on	O
entry	O
and	O
reached	O
or	O
exceeded	O
the	O
baseline	O
values	O
after	O
day	O
2	O
.	O

Supragingival	O
counts	O
of	O
Veillonella	B-bacteria
parvula	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
ss	I-bacteria
vincentii	I-bacteria
and	O
Neisseria	B-bacteria
mucosa	I-bacteria
increased	O
from	O
2	O
to	O
7	O
days	O
.	O

Subgingival	O
counts	O
were	O
greater	O
for	O
Actinomyces	B-bacteria
,	O
green	O
and	O
orange	O
complex	O
species	O
.	O

Significant	O
differences	O
between	O
groups	O
in	O
supragingival	O
counts	O
occurred	O
for	O
17	O
of	O
41	O
species	O
at	O
entry	O
,	O
0	O
at	O
day	O
7	O
;	O
for	O
subgingival	O
plaque	O
,	O
these	O
values	O
were	O
39	O
/	O
41	O
taxa	O
at	O
entry	O
,	O
17	O
/	O
41	O
at	O
day	O
7	O
.	O

Supragingival	O
plaque	O
re	O
-	O
development	O
was	O
similar	O
in	O
periodontitis	O
and	O
health	O
,	O
but	O
subgingival	O
species	O
recolonization	O
was	O
more	O
marked	O
in	O
periodontitis	O
.	O

This	O
study	O
evaluated	O
the	O
occurrence	O
of	O
enteric	O
bacteria	O
and	O
pseudomonads	O
resistant	O
to	O
tetracycline	O
and	O
beta	O
-	O
lactams	O
in	O
the	O
oral	O
cavity	O
of	O
patients	O
exhibiting	O
gingivitis	O
(	O
n	O
=	O
89	O
)	O
,	O
periodontitis	O
(	O
n	O
=	O
79	O
)	O
,	O
periodontally	O
healthy	O
(	O
n	O
=	O
50	O
)	O
and	O
wearing	O
complete	O
dentures	O
(	O
n	O
=	O
41	O
)	O
.	O

Microbial	O
identification	O
and	O
presence	O
of	O
resistance	O
markers	O
associated	O
with	O
the	O
production	O
of	O
beta	O
-	O
lactamases	O
and	O
tetracycline	O
resistance	O
were	O
performed	O
by	O
using	O
biochemical	O
tests	O
and	O
PCR	O
.	O

Susceptibility	O
tests	O
were	O
carried	O
out	O
in	O
201	O
isolates	O
of	O
enteric	O
cocci	O
and	O
rods	O
.	O

Resistance	O
to	O
ampicillin	O
,	O
amoxicillin	O
/	O
clavulanic	O
acid	O
,	O
imipenem	O
,	O
meropenem	O
and	O
tetracycline	O
was	O
detected	O
in	O
57	O
.	O
4	O
%	O
,	O
34	O
.	O
6	O
%	O
,	O
2	O
.	O
4	O
%	O
,	O
1	O
.	O
9	O
%	O
and	O
36	O
.	O
5	O
%	O
of	O
the	O
isolates	O
,	O
respectively	O
.	O

beta	O
-	O
lactamase	O
production	O
was	O
observed	O
in	O
41	O
.	O
2	O
%	O
of	O
tested	O
microorganisms	O
,	O
while	O
the	O
most	O
commonly	O
found	O
beta	O
-	O
lactamase	O
genetic	O
determinant	O
was	O
gene	O
blaTEM	O
.	O

Tetracycline	O
resistance	O
was	O
disseminated	O
and	O
a	O
wide	O
scope	O
of	O
tet	O
genes	O
were	O
detected	O
in	O
all	O
studied	O
microbial	O
genus	O
.	O

Disseminated	O
histoplasmosis	O
caused	O
by	O
Histoplasma	O
capsulatum	O
,	O
a	O
zoonotic	O
fungal	O
organism	O
,	O
is	O
an	O
important	O
disease	O
in	O
animals	O
and	O
humans	O
,	O
particularly	O
those	O
with	O
compromised	O
immune	O
systems	O
.	O

Reports	O
of	O
disseminated	O
histoplasmosis	O
in	O
an	O
avian	O
species	O
are	O
not	O
available	O
within	O
the	O
current	O
literature	O
.	O

Candida	O
albicans	O
,	O
another	O
fungal	O
agent	O
with	O
zoonotic	O
importance	O
,	O
is	O
a	O
commensal	O
of	O
the	O
avian	O
digestive	O
tract	O
that	O
is	O
often	O
associated	O
with	O
opportunistic	O
infections	O
particularly	O
in	O
young	O
or	O
immunocompromised	O
birds	O
.	O

This	O
report	O
describes	O
a	O
case	O
of	O
concomitant	O
histoplasmosis	O
and	O
candidiasis	O
in	O
an	O
Eclectus	O
parrot	O
(	O
Eclectus	O
roratus	O
)	O
characterized	O
by	O
severe	O
granulomatous	O
glossitis	O
,	O
blepharitis	O
and	O
osteomyelitis	O
with	O
numerous	O
intrahistiocytic	O
and	O
extracellular	O
yeasts	O
(	O
H	O
.	O
capsulatum	O
)	O
as	O
well	O
as	O
intralesional	O
hyphae	O
,	O
pseudohyphae	O
and	O
conidia	O
(	O
C	O
.	O
albicans	O
)	O
.	O

To	O
our	O
knowledge	O
,	O
co	O
-	O
infection	O
with	O
H	O
.	O
capsulatum	O
and	O
C	O
.	O
albicans	O
has	O
not	O
been	O
reported	O
in	O
an	O
avian	O
species	O
.	O

The	O
highly	O
antagonistic	O
lactobacillus	B-bacteria
strains	I-bacteria
isolated	O
from	O
the	O
oral	O
cavity	O
of	O
human	O
individuals	O
were	O
genetically	O
passported	O
as	O
L	B-bacteria
.	I-bacteria
fermentum	I-bacteria
39	I-bacteria
,	O
L	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
50	I-bacteria
,	O
and	O
L	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
24	I-bacteria
,	O
by	O
applying	O
the	O
RAPD	O
-	O
PCR	O
technique	O
with	O
two	O
types	O
of	O
primers	O
(	O
M13	O
,	O
MSP	O
)	O
.	O

These	O
lactobacillus	B-bacteria
strains	I-bacteria
showed	O
high	O
degrees	O
of	O
autoaggregation	O
,	O
surface	O
hydrophobicity	O
,	O
coaggregation	O
,	O
and	O
adhesion	O
.	O

These	O
characteristics	O
determine	O
the	O
obvious	O
capacity	O
of	O
lactobacilli	B-bacteria
to	O
form	O
biofilms	O
,	O
which	O
may	O
be	O
used	O
to	O
design	O
new	O
probiotic	O
agents	O
.	O

Samples	O
were	O
taken	O
under	O
strictly	O
anaerobic	O
conditions	O
from	O
the	O
root	O
canals	O
of	O
22	O
patients	O
having	O
a	O
tooth	O
in	O
which	O
necrotic	O
pulp	O
was	O
associated	O
with	O
an	O
inflammatory	O
peri	O
-	O
apical	O
lesion	O
an	O
optical	O
periodontitis	O
.	O

In	O
the	O
majority	O
of	O
cases	O
(	O
85	O
%	O
)	O
,	O
these	O
lesions	O
were	O
chronic	O
and	O
the	O
pulp	O
chamber	O
was	O
closed	O
.	O

One	O
hundred	O
and	O
two	O
strains	O
were	O
isolated	O
,	O
71	O
.	O
7	O
%	O
of	O
the	O
bacteria	O
being	O
obligate	O
anaerobes	O
and	O
49	O
.	O
8	O
%	O
being	O
Gram	O
-	O
negative	O
bacilli	O
.	O

Their	O
ability	O
to	O
produce	O
beta	O
-	O
lactamases	O
was	O
tested	O
and	O
8	O
.	O
8	O
%	O
gave	O
a	O
positive	O
reaction	O
in	O
a	O
cefinase	O
test	O
.	O

These	O
cefinase	O
positive	O
strains	O
were	O
nevertheless	O
susceptible	O
to	O
3rd	O
-	O
generation	O
cephalosporins	O
(	O
cefoxitin	O
)	O
and	O
to	O
amoxicillin	O
-	O
clavulanate	O
,	O
with	O
the	O
exception	O
of	O
M	B-bacteria
.	I-bacteria
Morganii	I-bacteria
.	O

Microbial	O
agents	O
in	O
root	O
canal	O
systems	O
can	O
induce	O
periodontal	O
inflammation	O
.	O

The	O
aims	O
of	O
this	O
study	O
are	O
to	O
detect	O
anaerobic	O
microorganisms	O
in	O
endodontic	O
-	O
periodontal	O
lesions	O
,	O
determine	O
the	O
genetic	O
diversity	O
among	O
them	O
,	O
and	O
assess	O
the	O
simultaneous	O
colonization	O
of	O
the	O
pulp	O
and	O
periodontal	O
microenvironments	O
by	O
a	O
single	O
clone	O
.	O

Twenty	O
-	O
seven	O
teeth	O
of	O
patients	O
with	O
endodontic	O
-	O
periodontal	O
lesions	O
were	O
selected	O
.	O

Samples	O
were	O
spread	O
on	O
an	O
agar	O
-	O
blood	O
medium	O
,	O
the	O
detection	O
of	O
each	O
species	O
was	O
performed	O
using	O
a	O
polymerase	O
chain	O
reaction	O
,	O
and	O
the	O
determination	O
of	O
the	O
simultaneous	O
presence	O
of	O
the	O
same	O
species	O
in	O
the	O
microenvironments	O
by	O
one	O
or	O
more	O
clones	O
was	O
determined	O
using	O
arbitrarily	O
primed	O
PCR	O
.	O

Prevotella	B-bacteria
intermedia	I-bacteria
(	O
Pi	B-bacteria
)	O
was	O
the	O
most	O
prevalent	O
species	O
of	O
the	O
colonies	O
in	O
periodontal	O
pockets	O
,	O
whereas	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
Pg	B-bacteria
)	O
and	O
Pi	B-bacteria
were	O
the	O
more	O
prevalent	O
in	O
root	O
canals	O
.	O

Isolates	O
of	O
Pi	B-bacteria
and	O
Pg	B-bacteria
were	O
simultaneously	O
identified	O
in	O
root	O
canals	O
and	O
periodontal	O
pockets	O
.	O

Eighteen	O
percent	O
of	O
teeth	O
exhibited	O
the	O
simultaneous	O
colonization	O
by	O
Pg	B-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
(	O
previously	O
T	B-bacteria
.	I-bacteria
forsythensis	I-bacteria
)	O
,	O
and	O
Porphyromonas	B-bacteria
endodontalis	I-bacteria
in	O
the	O
pulp	O
and	O
periodontal	O
microenvironments	O
.	O

The	O
presence	O
of	O
these	O
species	O
was	O
noted	O
even	O
in	O
niches	O
from	O
which	O
no	O
colonies	O
were	O
isolated	O
.	O

Seventeen	O
different	O
genotypes	O
were	O
found	O
in	O
periodontal	O
and	O
pulp	O
sites	O
,	O
with	O
the	O
majority	O
of	O
sites	O
colonized	O
by	O
one	O
or	O
two	O
different	O
genotypes	O
.	O

A	O
high	O
degree	O
of	O
genotype	O
similarity	O
was	O
found	O
for	O
samples	O
of	O
Pg	B-bacteria
isolated	O
from	O
only	O
one	O
site	O
as	O
well	O
as	O
for	O
those	O
isolated	O
from	O
both	O
microenvironments	O
.	O

Different	O
clones	O
of	O
Pi	B-bacteria
and	O
Pg	B-bacteria
with	O
a	O
high	O
intraspecific	O
genotype	O
similarity	O
were	O
found	O
to	O
colonize	O
the	O
same	O
anatomic	O
sites	O
in	O
endodontic	O
-	O
periodontal	O
infections	O
.	O

A	O
variety	O
of	O
oral	O
topical	O
agents	O
have	O
been	O
used	O
for	O
prevention	O
and	O
management	O
of	O
radiotherapy	O
-	O
induced	O
adverse	O
effects	O
.	O

The	O
antimicrobial	O
nature	O
of	O
some	O
of	O
the	O
commonly	O
used	O
agents	O
is	O
unknown	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
antimicrobial	O
efficacies	O
of	O
various	O
oral	O
topical	O
agents	O
on	O
common	O
microorganisms	O
associated	O
with	O
radiated	O
head	O
and	O
neck	O
cancer	O
patients	O
.	O

Seven	O
commonly	O
used	O
topical	O
oral	O
agents	O
-	O
0	O
.	O
12	O
%	O
chlorhexidine	O
with	O
alcohol	O
,	O
0	O
.	O
12	O
%	O
chlorhexidine	O
without	O
alcohol	O
,	O
baking	O
soda	O
-	O
salt	O
rinse	O
,	O
0	O
.	O
4	O
%	O
stannous	O
fluoride	O
gel	O
,	O
0	O
.	O
63	O
%	O
stannous	O
fluoride	O
rinse	O
,	O
calcium	O
phosphate	O
mouthrinse	O
,	O
and	O
acemannan	O
hydrogel	O
(	O
aloe	O
vera	O
)	O
rinse	O
-	O
were	O
evaluated	O
in	O
vitro	O
for	O
their	O
antimicrobial	O
efficacies	O
against	O
four	O
common	O
microorganisms	O
.	O

A	O
combination	O
of	O
baking	O
soda	O
-	O
salt	O
rinse	O
and	O
0	O
.	O
4	O
%	O
stannous	O
fluoride	O
gel	O
was	O
evaluated	O
as	O
the	O
eighth	O
agent	O
.	O

The	O
microorganisms	O
used	O
were	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
group	B-bacteria
B	I-bacteria
Streptococcus	I-bacteria
,	O
Escherichia	B-bacteria
coli	I-bacteria
,	O
and	O
Candida	O
albicans	O
.	O

An	O
ELISA	O
reader	O
was	O
used	O
to	O
measure	O
the	O
turbidity	O
of	O
microbial	O
culture	O
wells	O
and	O
optical	O
density	O
(	O
OD	O
)	O
values	O
for	O
each	O
of	O
the	O
960	O
wells	O
recorded	O
.	O

Mean	O
OD	O
values	O
were	O
rank	O
ordered	O
based	O
on	O
their	O
turbidity	O
.	O

One	O
-	O
way	O
ANOVA	O
with	O
Tukey	O
HSD	O
post	O
hoc	O
analysis	O
was	O
used	O
to	O
study	O
differences	O
in	O
OD	O
values	O
(	O
P	O
<	O
.	O
05	O
)	O
.	O

Mean	O
OD	O
values	O
classified	O
for	O
topical	O
agents	O
from	O
lowest	O
to	O
highest	O
were	O
chlorhexidine	O
with	O
alcohol	O
,	O
chlorhexidine	O
without	O
alcohol	O
,	O
baking	O
soda	O
-	O
salt	O
,	O
calcium	O
phosphate	O
rinse	O
,	O
and	O
the	O
combination	O
of	O
baking	O
soda	O
-	O
salt	O
and	O
stannous	O
fluoride	O
gel	O
.	O

Mean	O
OD	O
values	O
classified	O
for	O
microorganisms	O
from	O
lowest	O
to	O
highest	O
were	O
Escherichia	B-bacteria
coli	I-bacteria
,	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
group	B-bacteria
B	I-bacteria
Streptococcus	I-bacteria
,	O
and	O
Candida	O
albicans	O
.	O

A	O
significant	O
difference	O
among	O
the	O
antimicrobial	O
efficacies	O
of	O
topical	O
agents	O
was	O
evident	O
for	O
each	O
of	O
four	O
microorganisms	O
(	O
P	O
<	O
.	O
05	O
)	O
.	O

There	O
was	O
also	O
a	O
significant	O
difference	O
among	O
the	O
antimicrobial	O
efficacies	O
of	O
the	O
same	O
topical	O
agent	O
on	O
the	O
four	O
microorganisms	O
tested	O
(	O
P	O
<	O
.	O
05	O
)	O
.	O

Dental	O
implants	O
and	O
peri	O
-	O
implant	O
tissue	O
are	O
susceptible	O
to	O
disease	O
conditions	O
that	O
may	O
lead	O
to	O
implant	O
loss	O
.	O

The	O
objective	O
of	O
the	O
present	O
study	O
was	O
to	O
describe	O
teeth	O
and	O
implant	O
surroundings	O
as	O
well	O
as	O
clinical	O
health	O
indices	O
and	O
oral	O
microbiologic	O
parameters	O
.	O

A	O
group	O
of	O
83	O
adults	O
(	O
42	O
men	O
and	O
41	O
women	O
)	O
were	O
enrolled	O
in	O
the	O
study	O
.	O

Clinical	O
assessments	O
of	O
dental	O
implants	O
and	O
contralateral	O
natural	O
teeth	O
included	O
dental	O
plaque	O
,	O
gingival	O
inflammation	O
,	O
and	O
bleeding	O
on	O
probing	O
.	O

Microbiologic	O
assessments	O
included	O
bacterial	O
culture	O
,	O
light	O
and	O
phase	O
contrast	O
microscopy	O
,	O
and	O
DNA	O
probe	O
hybridization	O
for	O
a	O
panel	O
of	O
14	O
target	O
microorganisms	O
.	O

Clinical	O
and	O
microbiologic	O
data	O
were	O
compared	O
by	O
paired	O
t	O
test	O
and	O
ANOVA	O
.	O

P	O
<	O
.	O
05	O
was	O
considered	O
statistically	O
significant	O
.	O

The	O
Plaque	O
Index	O
for	O
the	O
implants	O
was	O
1	O
.	O
85	O
+	O
/	O
-	O
0	O
.	O
47	O
,	O
whereas	O
the	O
score	O
for	O
natural	O
teeth	O
was	O
significantly	O
higher	O
,	O
2	O
.	O
15	O
+	O
/	O
-	O
0	O
.	O
52	O
.	O

Compared	O
to	O
the	O
samples	O
obtained	O
from	O
the	O
dental	O
implants	O
,	O
the	O
samples	O
from	O
natural	O
teeth	O
demonstrated	O
significantly	O
higher	O
total	O
bacterial	O
cell	O
numbers	O
(	O
P	O
<	O
.	O
05	O
)	O
.	O

Consistent	O
with	O
the	O
clinical	O
measures	O
of	O
dental	O
plaque	O
,	O
significantly	O
higher	O
numbers	O
of	O
oral	O
bacteria	O
,	O
including	O
aerobic	O
and	O
anaerobic	O
bacteria	O
,	O
were	O
found	O
in	O
dental	O
plaque	O
samples	O
from	O
teeth	O
(	O
aerobic	O
5	O
.	O
648	O
+	O
/	O
-	O
0	O
.	O
512	O
,	O
anaerobic	O
6	O
.	O
243	O
+	O
/	O
-	O
0	O
.	O
535	O
,	O
P	O
<	O
.	O
0001	O
)	O
compared	O
to	O
implants	O
(	O
aerobic	O
5	O
.	O
430	O
+	O
/	O
-	O
0	O
.	O
541	O
,	O
anaerobic	O
5	O
.	O
917	O
+	O
/	O
-	O
0	O
.	O
523	O
,	O
P	O
<	O
.	O
0001	O
)	O
.	O

In	O
addition	O
,	O
there	O
were	O
significantly	O
higher	O
numbers	O
of	O
anaerobic	O
(	O
6	O
.	O
243	O
+	O
/	O
-	O
0	O
.	O
535	O
and	O
5	O
.	O
917	O
+	O
/	O
-	O
0	O
.	O
523	O
,	O
P	O
<	O
.	O
0001	O
)	O
than	O
aerobic	O
(	O
5	O
.	O
648	O
+	O
/	O
-	O
0	O
.	O
512	O
and	O
5	O
.	O
430	O
+	O
/	O
-	O
0	O
.	O
541	O
,	O
P	O
<	O
.	O
008	O
)	O
bacteria	O
for	O
samples	O
from	O
teeth	O
and	O
implants	O
,	O
respectively	O
.	O

Clinical	O
and	O
microbiologic	O
analyses	O
provide	O
consistent	O
findings	O
that	O
suggest	O
differences	O
in	O
quantity	O
of	O
plaque	O
and	O
bacterial	O
species	O
between	O
teeth	O
and	O
dental	O
implants	O
.	O

For	O
long	O
-	O
term	O
treatment	O
success	O
,	O
the	O
importance	O
of	O
plaque	O
control	O
and	O
oral	O
hygiene	O
of	O
both	O
periodontal	O
and	O
dental	O
implant	O
therapy	O
is	O
emphasized	O
.	O

Topical	O
tetracyclines	O
,	O
such	O
as	O
minocycline	O
ointment	O
,	O
are	O
frequently	O
used	O
for	O
the	O
treatment	O
of	O
periodontal	O
infection	O
.	O

We	O
investigated	O
the	O
influence	O
of	O
minocycline	O
ointment	O
use	O
on	O
oral	O
bacteria	O
,	O
using	O
supragingival	O
plaque	O
samples	O
from	O
adults	O
who	O
had	O
not	O
taken	O
any	O
antibiotics	O
for	O
6	O
months	O
.	O

Initially	O
we	O
investigated	O
the	O
effect	O
of	O
topical	O
minocycline	O
administration	O
on	O
the	O
emergence	O
of	O
tetracycline	O
-	O
resistant	O
oral	O
bacteria	O
in	O
four	O
healthy	O
adults	O
.	O

The	O
isolation	O
frequency	O
of	O
tetracycline	O
-	O
resistant	O
oral	O
bacteria	O
to	O
total	O
viable	O
bacteria	O
increased	O
substantially	O
on	O
day	O
6	O
after	O
treatment	O
,	O
although	O
it	O
returned	O
to	O
baseline	O
on	O
day	O
25	O
.	O

Subsequently	O
we	O
investigated	O
the	O
isolation	O
frequency	O
of	O
tetracycline	B-bacteria
-	I-bacteria
resistant	I-bacteria
oral	I-bacteria
streptococci	I-bacteria
(	O
TOS	B-bacteria
)	O
as	O
a	O
representative	O
oral	O
bacterium	O
,	O
using	O
samples	O
from	O
41	O
subjects	O
with	O
periodontal	O
diseases	O
.	O

The	O
percentage	O
of	O
TOS	B-bacteria
(	O
of	O
the	O
total	O
oral	O
streptococci	B-bacteria
)	O
increased	O
significantly	O
(	O
from	O
11	O
.	O
9	O
+	O
/	O
-	O
15	O
.	O
6	O
%	O
to	O
34	O
.	O
2	O
+	O
/	O
-	O
24	O
.	O
0	O
%	O
)	O
after	O
minocycline	O
treatment	O
.	O

Various	O
TOS	B-bacteria
species	I-bacteria
were	O
identified	O
;	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
,	O
and	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
were	O
frequently	O
isolated	O
.	O

PCR	O
and	O
Southern	O
blotting	O
allowed	O
us	O
to	O
identify	O
tetM	O
on	O
the	O
Tn916	O
-	O
like	O
elements	O
as	O
the	O
gene	O
responsible	O
for	O
tetracycline	O
-	O
resistance	O
.	O

These	O
findings	O
suggest	O
that	O
the	O
potential	O
risk	O
of	O
the	O
spread	O
of	O
similar	O
genetic	O
elements	O
through	O
bacteria	O
in	O
the	O
oral	O
cavity	O
should	O
be	O
considered	O
.	O

Autism	O
of	O
the	O
regressive	O
variety	O
is	O
selected	O
as	O
an	O
example	O
of	O
the	O
importance	O
of	O
intestinal	O
bacterial	O
microflora	O
in	O
disease	O
other	O
than	O
classical	O
infection	O
.	O

Our	O
studies	O
have	O
indicated	O
that	O
intestinal	O
bacteria	O
play	O
a	O
role	O
in	O
this	O
disease	O
since	O
it	O
responds	O
to	O
oral	O
vancomycin	O
,	O
a	O
drug	O
that	O
is	O
not	O
absorbed	O
from	O
the	O
GI	O
tract	O
.	O

Pyrosequencing	O
studies	O
document	O
an	O
abnormal	O
gut	O
microflora	O
in	O
regressive	O
autism	O
subjects	O
as	O
compared	O
to	O
controls	O
.	O

Finally	O
,	O
we	O
present	O
preliminary	O
evidence	O
suggesting	O
that	O
Desulfovibrio	B-bacteria
may	O
play	O
a	O
key	O
role	O
in	O
this	O
disease	O
.	O

The	O
hygiene	O
hypothesis	O
contends	O
that	O
fewer	O
opportunities	O
for	O
infections	O
and	O
microbial	O
exposures	O
have	O
resulted	O
in	O
more	O
widespread	O
asthma	O
and	O
atopic	O
disease	O
.	O

Consistent	O
with	O
that	O
hypothesis	O
,	O
decreases	O
in	O
infectious	O
oral	O
diseases	O
over	O
the	O
past	O
half	O
century	O
have	O
coincided	O
with	O
increases	O
in	O
the	O
prevalence	O
of	O
asthma	O
and	O
other	O
allergic	O
diseases	O
.	O

This	O
observation	O
has	O
led	O
some	O
researchers	O
to	O
speculate	O
that	O
exposures	O
to	O
oral	O
bacteria	O
,	O
including	O
pathogens	O
associated	O
with	O
periodontal	O
diseases	O
,	O
such	O
as	O
gingivitis	O
and	O
periodontitis	O
,	O
might	O
play	O
a	O
protective	O
role	O
in	O
the	O
development	O
of	O
asthma	O
and	O
allergy	O
.	O

Colonization	O
of	O
the	O
oral	O
cavity	O
with	O
bacteria	O
,	O
including	O
some	O
species	O
of	O
periodontal	O
pathogens	O
,	O
begins	O
shortly	O
after	O
birth	O
,	O
and	O
the	O
detection	O
of	O
serum	O
antibodies	O
to	O
oral	O
pathogens	O
in	O
early	O
childhood	O
provides	O
evidence	O
of	O
an	O
early	O
immune	O
response	O
to	O
these	O
bacteria	O
.	O

Current	O
knowledge	O
of	O
the	O
immune	O
response	O
to	O
oral	O
bacteria	O
and	O
the	O
immunologic	O
pathogenesis	O
of	O
periodontal	O
diseases	O
suggests	O
biologically	O
plausible	O
mechanisms	O
by	O
which	O
oral	O
pathogens	O
could	O
influence	O
the	O
risk	O
of	O
allergic	O
disease	O
.	O

However	O
,	O
studies	O
investigating	O
the	O
association	O
between	O
oral	O
pathogen	O
exposures	O
and	O
allergic	O
disease	O
are	O
few	O
in	O
number	O
and	O
limited	O
by	O
cross	O
-	O
sectional	O
or	O
case	O
-	O
control	O
design	O
,	O
exclusion	O
of	O
young	O
children	O
,	O
and	O
use	O
of	O
surrogate	O
measures	O
of	O
oral	O
bacterial	O
colonization	O
.	O

Additional	O
studies	O
,	O
particularly	O
well	O
-	O
designed	O
case	O
-	O
control	O
studies	O
among	O
very	O
young	O
children	O
and	O
prospective	O
birth	O
cohort	O
studies	O
,	O
are	O
needed	O
.	O

The	O
oral	O
cavity	O
contains	O
almost	O
half	O
of	O
the	O
commensal	O
bacterial	O
population	O
present	O
in	O
the	O
human	O
body	O
.	O

An	O
increase	O
in	O
the	O
number	O
of	O
these	O
microorganisms	O
may	O
result	O
in	O
systemic	O
diseases	O
such	O
as	O
infective	O
endocarditis	O
and	O
aspiration	O
pneumonia	O
as	O
well	O
as	O
oral	O
infections	O
.	O

It	O
is	O
essential	O
to	O
control	O
the	O
total	O
numbers	O
of	O
these	O
microorganisms	O
in	O
order	O
to	O
suppress	O
disease	O
onset	O
.	O

Thus	O
,	O
we	O
examined	O
the	O
antimicrobial	O
activity	O
of	O
a	O
newly	O
developed	O
gel	O
-	O
entrapped	O
catechin	O
(	O
GEC	O
)	O
preparation	O
against	O
oral	O
microorganisms	O
.	O

The	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
of	O
GEC	O
was	O
determined	O
based	O
on	O
the	O
relationship	O
between	O
a	O
modified	O
agar	O
diffusion	O
method	O
and	O
a	O
broth	O
microdilution	O
method	O
.	O

GEC	O
inhibited	O
the	O
growth	O
of	O
the	O
Actinomyces	B-bacteria
,	O
periodontopathic	O
bacteria	O
and	O
Candida	O
strains	O
tested	O
,	O
but	O
did	O
not	O
inhibit	O
the	O
growth	O
of	O
the	O
oral	O
streptococci	B-bacteria
that	O
are	O
important	O
in	O
the	O
normal	O
oral	O
flora	O
.	O

Commercially	O
available	O
moisture	O
gels	O
containing	O
antimicrobial	O
components	O
showed	O
antimicrobial	O
activity	O
against	O
all	O
of	O
the	O
tested	O
strains	O
.	O

After	O
a	O
series	O
of	O
washes	O
and	O
after	O
a	O
24	O
-	O
h	O
incubation	O
,	O
GEC	O
retained	O
the	O
antimicrobial	O
activity	O
of	O
the	O
catechins	O
.	O

Catalase	O
prevented	O
GEC	O
-	O
induced	O
growth	O
inhibition	O
of	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
suggesting	O
that	O
hydrogen	O
peroxide	O
may	O
be	O
involved	O
in	O
the	O
antimicrobial	O
activity	O
of	O
catechins	O
.	O

These	O
results	O
suggest	O
that	O
GEC	O
may	O
be	O
useful	O
for	O
controlling	O
oral	O
microorganism	O
populations	O
and	O
reducing	O
the	O
accumulation	O
of	O
dental	O
plaque	O
,	O
thereby	O
helping	O
to	O
prevent	O
periodontal	O
disease	O
and	O
oral	O
candidiasis	O
.	O

To	O
determine	O
the	O
genetic	O
diversity	O
and	O
possible	O
origin	O
of	O
Lactobacillus	B-bacteria
paracasei	I-bacteria
found	O
in	O
the	O
oral	O
biofilm	O
.	O

Lactobacilli	B-bacteria
were	O
isolated	O
from	O
a	O
biofilm	O
model	O
,	O
formed	O
in	O
situ	O
prior	O
to	O
and	O
during	O
a	O
period	O
of	O
exposure	O
to	O
20	O
%	O
sucrose	O
solution	O
(	O
28	O
days	O
)	O
,	O
using	O
Rogosa	O
Agar	O
.	O

The	O
lactobacillus	B-bacteria
colonies	O
were	O
randomly	O
selected	O
(	O
n	O
=	O
222	O
)	O
and	O
subcultured	O
.	O

The	O
isolates	O
were	O
identified	O
using	O
pheS	O
or	O
rpoA	O
gene	O
sequence	O
analysis	O
.	O

Lactobacilli	B-bacteria
identified	O
as	O
Lact	B-bacteria
.	I-bacteria
paracasei	I-bacteria
(	O
n	O
=	O
75	O
)	O
were	O
subjected	O
to	O
multilocus	O
sequencing	O
typing	O
(	O
MLST	O
)	O
analysis	O
by	O
determining	O
partial	O
sequences	O
of	O
seven	O
housekeeping	O
genes	O
fusA	O
,	O
ileS	O
,	O
lepA	O
,	O
leuS	O
,	O
pyrG	O
,	O
recA	O
and	O
recG	O
.	O

An	O
increase	O
recovery	O
of	O
lactobacilli	B-bacteria
after	O
sucrose	O
phase	O
compared	O
with	O
nonsucrose	O
period	O
was	O
observed	O
(	O
31	O
prior	O
to	O
and	O
191	O
following	O
a	O
sucrose	O
exposure	O
period	O
)	O
.	O

Seven	O
subjects	O
harboured	O
Lact	B-bacteria
.	I-bacteria
paracasei	I-bacteria
and	O
these	O
represented	O
14	O
sequence	O
types	O
(	O
ST	O
)	O
.	O

Comparison	O
of	O
the	O
STs	O
showed	O
that	O
unrelated	O
subjects	O
may	O
harbour	O
the	O
same	O
ST	O
and	O
that	O
individuals	O
harbour	O
multiple	O
STs	O
.	O

Three	O
subjects	O
harboured	O
STs	O
previously	O
isolated	O
from	O
dairy	O
products	O
.	O

The	O
present	O
data	O
supports	O
the	O
hypothesis	O
that	O
oral	O
lactobacilli	B-bacteria
may	O
be	O
of	O
exogenous	O
origin	O
.	O

The	O
study	O
allow	O
us	O
to	O
gain	O
insight	O
into	O
the	O
genetic	O
diversity	O
of	O
lactobacilli	B-bacteria
paracasei	I-bacteria
in	O
oral	O
biofilm	O
.	O

The	O
interaction	O
between	O
Lactobacillus	B-bacteria
reuteri	I-bacteria
,	O
a	O
probiotic	O
bacterium	O
,	O
and	O
oral	O
pathogenic	O
bacteria	O
have	O
not	O
been	O
studied	O
adequately	O
.	O

This	O
study	O
examined	O
the	O
effects	O
of	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
on	O
the	O
proliferation	O
of	O
periodontopathic	O
bacteria	O
including	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
and	O
on	O
the	O
formation	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
biofilms	O
.	O

Human	O
-	O
derived	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
strains	I-bacteria
(	O
KCTC	B-bacteria
3594	I-bacteria
and	O
KCTC	B-bacteria
3678	I-bacteria
)	O
and	O
rat	O
-	O
derived	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
KCTC	I-bacteria
3679	I-bacteria
were	O
used	O
.	O

All	O
strains	O
exhibited	O
significant	O
inhibitory	O
effects	O
on	O
the	O
growth	O
of	O
periodontopathic	O
bacteria	O
and	O
the	O
formation	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilms	O
.	O

These	O
antibacterial	O
activities	O
of	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
were	O
attributed	O
to	O
the	O
production	O
of	O
organic	O
acids	O
,	O
hydrogen	O
peroxide	O
,	O
and	O
a	O
bacteriocin	O
-	O
like	O
compound	O
.	O

Reuterin	O
,	O
an	O
antimicrobial	O
factor	O
,	O
was	O
produced	O
only	O
by	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
KCTC	I-bacteria
3594	I-bacteria
.	O

In	O
addition	O
,	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
inhibited	O
the	O
production	O
of	O
methyl	O
mercaptan	O
by	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
.	O

Overall	O
,	O
these	O
results	O
suggest	O
that	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
may	O
be	O
useful	O
as	O
a	O
probiotic	O
agent	O
for	O
improving	O
oral	O
health	O
.	O

As	O
peri	O
-	O
implantitis	O
is	O
an	O
emerging	O
problem	O
,	O
the	O
development	O
of	O
validated	O
animal	O
models	O
is	O
mandatory	O
.	O

The	O
aim	O
of	O
this	O
pilot	O
study	O
was	O
to	O
provide	O
a	O
first	O
step	O
in	O
describing	O
the	O
normal	O
oral	O
flora	O
of	O
minipigs	O
.	O

In	O
five	O
minipigs	O
,	O
samples	O
of	O
the	O
oral	O
flora	O
were	O
collected	O
with	O
sterile	O
cotton	O
swabs	O
from	O
the	O
buccal	O
gingiva	O
of	O
the	O
lower	O
jaw	O
.	O

Two	O
swabs	O
per	O
animal	O
were	O
collected	O
,	O
followed	O
by	O
bacterial	O
isolation	O
under	O
both	O
aerobe	O
and	O
anaerobe	O
conditions	O
.	O

Microbiological	O
analyses	O
included	O
biochemical	O
tests	O
,	O
matrix	O
-	O
assisted	O
laser	O
desorption	O
/	O
ionization	O
time	O
-	O
of	O
-	O
flight	O
mass	O
spectrometry	O
and	O
16S	O
rDNA	O
gene	O
sequence	O
analysis	O
.	O

A	O
total	O
of	O
61	O
taxa	O
were	O
detected	O
,	O
14	O
-	O
21	O
different	O
bacterial	O
taxa	O
from	O
each	O
minipig	O
.	O

Among	O
the	O
Gram	O
-	O
positive	O
cocci	O
,	O
mainly	O
staphylococcal	B-bacteria
and	O
streptococcal	B-bacteria
species	I-bacteria
were	O
identified	O
.	O

Different	O
Actinomyces	B-bacteria
species	I-bacteria
were	O
the	O
most	O
abundant	O
taxa	O
in	O
the	O
group	O
of	O
Gram	O
-	O
positive	O
rods	O
.	O

Among	O
the	O
anaerobic	O
bacteria	O
,	O
the	O
Gram	O
-	O
negative	O
genera	O
Fusobacterium	B-bacteria
,	O
Bacteroides	B-bacteria
and	O
Prevotella	B-bacteria
were	O
the	O
most	O
often	O
observed	O
taxa	O
.	O

This	O
is	O
the	O
first	O
study	O
which	O
begins	O
to	O
describe	O
the	O
normal	O
oral	O
flora	O
in	O
minipigs	O
in	O
cultures	O
to	O
allow	O
for	O
the	O
detection	O
of	O
a	O
broad	O
spectrum	O
.	O

Several	O
bacterial	O
species	O
identified	O
are	O
different	O
from	O
human	O
ones	O
.	O

No	O
specific	O
species	O
for	O
peri	O
-	O
implantitis	O
could	O
be	O
detected	O
in	O
that	O
healthy	O
sample	O
.	O

Membrane	O
-	O
anchored	O
complement	O
regulatory	O
proteins	O
(	O
CRPs	O
)	O
,	O
including	O
CD46	O
,	O
CD55	O
,	O
and	O
CD59	O
,	O
protect	O
host	O
cells	O
from	O
complement	O
attack	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
investigated	O
whether	O
periodontopathogen	O
lipopolysaccharide	O
and	O
proinflammatory	O
cytokines	O
modulate	O
CRP	O
gene	O
/	O
protein	O
expression	O
in	O
human	O
oral	O
epithelial	O
cells	O
.	O

The	O
lipopolysaccharide	O
of	O
Treponema	B-bacteria
denticola	I-bacteria
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
were	O
the	O
most	O
potent	O
for	O
increasing	O
the	O
gene	O
expression	O
of	O
CD55	O
and	O
CD59	O
,	O
and	O
to	O
a	O
lesser	O
extent	O
CD46	O
,	O
after	O
a	O
48	O
-	O
h	O
stimulation	O
.	O

An	O
lipopolysaccharide	O
-	O
induced	O
upregulation	O
of	O
epithelial	O
cell	O
-	O
surface	O
CRP	O
was	O
also	O
demonstrated	O
.	O

The	O
stimulation	O
of	O
epithelial	O
cells	O
with	O
lipopolysaccharide	O
was	O
associated	O
with	O
interleukin	O
-	O
6	O
(	O
IL	O
-	O
6	O
)	O
and	O
IL	O
-	O
8	O
secretion	O
.	O

Although	O
these	O
two	O
cytokines	O
had	O
no	O
effect	O
on	O
CD46	O
and	O
CD55	O
gene	O
expression	O
in	O
epithelial	O
cells	O
,	O
IL	O
-	O
1beta	O
and	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
induced	O
a	O
significant	O
upregulation	O
.	O

The	O
cell	O
-	O
surface	O
expression	O
of	O
CRP	O
was	O
also	O
increased	O
by	O
the	O
stimulation	O
of	O
epithelial	O
cells	O
with	O
cytokines	O
.	O

The	O
CD46	O
,	O
CD55	O
,	O
and	O
CD59	O
gene	O
/	O
protein	O
expression	O
was	O
upregulated	O
by	O
periodontopathogen	O
lipopolysaccharide	O
and	O
proinflammatory	O
cytokines	O
.	O

It	O
can	O
be	O
hypothesized	O
that	O
,	O
when	O
faced	O
with	O
bacterial	O
challenges	O
and	O
inflammatory	O
conditions	O
associated	O
with	O
active	O
periodontal	O
sites	O
,	O
oral	O
epithelial	O
cells	O
may	O
respond	O
by	O
increasing	O
CRP	O
gene	O
/	O
protein	O
expression	O
to	O
avoid	O
cell	O
lysis	O
by	O
the	O
complement	O
system	O
,	O
which	O
is	O
activated	O
during	O
periodontitis	O
.	O

Primary	O
gingival	O
epithelial	O
cells	O
were	O
cultured	O
in	O
multilayers	O
as	O
a	O
model	O
for	O
the	O
study	O
of	O
interactions	O
with	O
oral	O
bacteria	O
associated	O
with	O
health	O
and	O
periodontal	O
disease	O
.	O

Multilayers	O
maintained	O
at	O
an	O
air	O
-	O
liquid	O
interface	O
in	O
low	O
-	O
calcium	O
medium	O
displayed	O
differentiation	O
and	O
cytokeratin	O
properties	O
characteristic	O
of	O
junctional	O
epithelium	O
.	O

Multilayers	O
were	O
infected	O
with	O
fluorescently	O
labeled	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
or	O
Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
and	O
bacterial	O
association	O
was	O
determined	O
by	O
confocal	O
microscopy	O
and	O
quantitative	O
image	O
analysis	O
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
invaded	O
intracellularly	O
and	O
spread	O
from	O
cell	O
to	O
cell	O
;	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
remained	O
extracellular	O
and	O
showed	O
intercellular	O
movement	O
through	O
the	O
multilayer	O
;	O
whereas	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
remained	O
extracellular	O
and	O
predominantly	O
associated	O
with	O
the	O
superficial	O
cell	O
layer	O
.	O

None	O
of	O
the	O
bacterial	O
species	O
disrupted	O
barrier	O
function	O
as	O
measured	O
by	O
transepithelial	O
electrical	O
resistance	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
did	O
not	O
elicit	O
secretion	O
of	O
proinflammatory	O
cytokines	O
.	O

However	O
,	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
induced	O
interleukin	O
-	O
1beta	O
(	O
IL	O
-	O
1beta	O
)	O
,	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
(	O
TNF	O
-	O
alpha	O
)	O
,	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
secretion	O
;	O
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
stimulated	O
production	O
of	O
IL	O
-	O
1beta	O
and	O
TNF	O
-	O
alpha	O
.	O

Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
,	O
but	O
not	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
increased	O
levels	O
of	O
apoptosis	O
after	O
24	O
h	O
infection	O
.	O

The	O
results	O
indicate	O
that	O
the	O
organisms	O
with	O
pathogenic	O
potential	O
were	O
able	O
to	O
traverse	O
the	O
epithelium	O
,	O
whereas	O
the	O
commensal	O
bacteria	O
did	O
not	O
.	O

In	O
addition	O
,	O
distinct	O
host	O
responses	O
characterized	O
the	O
interaction	O
between	O
the	O
junctional	O
epithelium	O
and	O
oral	O
bacteria	O
.	O

In	O
the	O
oral	O
biofilm	O
,	O
the	O
'	B-bacteria
mitis	I-bacteria
'	I-bacteria
streptococci	I-bacteria
are	O
among	O
the	O
first	O
group	O
of	O
organisms	O
to	O
colonize	O
the	O
tooth	O
surface	O
.	O

Their	O
proliferation	O
is	O
thought	O
to	O
be	O
an	O
important	O
factor	O
required	O
for	O
antagonizing	O
the	O
growth	O
of	O
cariogenic	O
species	O
such	O
as	O
Streptococcus	B-bacteria
mutans	I-bacteria
.	O

In	O
this	O
study	O
,	O
we	O
used	O
a	O
three	O
-	O
species	O
mixed	O
culture	O
to	O
demonstrate	O
that	O
another	O
ubiquitous	O
early	O
colonizing	O
species	O
,	O
Veillonella	B-bacteria
parvula	I-bacteria
,	O
can	O
greatly	O
affect	O
the	O
outcome	O
of	O
the	O
competition	O
between	O
a	O
pair	O
of	O
antagonists	O
such	O
as	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
Streptococcus	B-bacteria
gordonii	I-bacteria
.	O

Transcriptome	O
analysis	O
further	O
revealed	O
that	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
responds	O
differentially	O
to	O
its	O
friend	O
(	O
V	B-bacteria
.	I-bacteria
parvula	I-bacteria
)	O
and	O
foe	O
(	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
)	O
.	O

In	O
the	O
mixed	O
culture	O
with	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
,	O
all	O
but	O
one	O
of	O
the	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
sugar	O
uptake	O
and	O
metabolic	O
genes	O
were	O
downregulated	O
,	O
while	O
genes	O
for	O
alternative	O
energy	O
source	O
utilization	O
and	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
tolerance	O
were	O
upregulated	O
,	O
resulting	O
in	O
a	O
slower	O
but	O
persistent	O
growth	O
.	O

In	O
contrast	O
,	O
when	O
cultured	O
with	O
V	B-bacteria
.	I-bacteria
parvula	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
grew	O
equally	O
well	O
or	O
better	O
than	O
in	O
monoculture	O
and	O
exhibited	O
relatively	O
few	O
changes	O
within	O
its	O
transcriptome	O
.	O

When	O
V	B-bacteria
.	I-bacteria
parvula	I-bacteria
was	O
introduced	O
into	O
the	O
mixed	O
culture	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
,	O
it	O
rescued	O
the	O
growth	O
inhibition	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

In	O
this	O
three	O
-	O
species	O
environment	O
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
increased	O
the	O
expression	O
of	O
genes	O
required	O
for	O
the	O
uptake	O
and	O
metabolism	O
of	O
minor	O
sugars	O
,	O
while	O
genes	O
required	O
for	O
oxidative	O
stress	O
tolerance	O
were	O
downregulated	O
.	O

We	O
conclude	O
that	O
the	O
major	O
factors	O
that	O
affect	O
the	O
competition	O
between	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
are	O
carbohydrate	O
utilization	O
and	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
resistance	O
.	O

The	O
presence	O
of	O
V	B-bacteria
.	I-bacteria
parvula	I-bacteria
in	O
the	O
tri	O
-	O
species	O
culture	O
mitigates	O
these	O
two	O
major	O
factors	O
and	O
allows	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
to	O
proliferate	O
,	O
despite	O
the	O
presence	O
of	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
.	O

Despite	O
the	O
targeted	O
and	O
incidental	O
exposure	O
of	O
the	O
oral	O
cavity	O
to	O
probiotic	O
bacteria	O
,	O
relatively	O
little	O
information	O
is	O
available	O
concerning	O
their	O
bacteriological	O
effects	O
or	O
ecological	O
fate	O
in	O
this	O
environment	O
.	O

We	O
have	O
investigated	O
the	O
effects	O
of	O
an	O
oral	O
probiotic	O
bacterium	O
,	O
Lactobacillus	B-bacteria
reuteri	I-bacteria
on	O
salivary	O
biofilm	O
microcosms	O
.	O

Nascent	O
in	O
vitro	O
plaques	O
in	O
hydroxyapatite	O
disc	O
model	O
and	O
mature	O
continuous	O
culture	O
plaques	O
within	O
constant	O
depth	O
film	O
fermenters	O
(	O
CDFFs	O
)	O
were	O
exposed	O
to	O
probiotic	O
strains	O
of	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
.	O

Microbial	O
composition	O
was	O
assessed	O
using	O
differential	O
viable	O
counting	O
and	O
CDFF	O
plaques	O
were	O
additionally	O
characterised	O
using	O
qPCR	O
and	O
PCR	O
-	O
DGGE	O
.	O

Probiotic	O
dosing	O
of	O
nascent	O
plaques	O
was	O
associated	O
with	O
significant	O
increases	O
in	O
lactobacilli	B-bacteria
and	O
Gram	O
-	O
negative	O
anaerobes	O
in	O
both	O
biofilm	O
and	O
planktonic	O
phases	O
,	O
and	O
with	O
elevated	O
counts	O
of	O
streptococci	B-bacteria
in	O
the	O
planktonic	O
phase	O
that	O
were	O
not	O
accompanied	O
by	O
decreases	O
in	O
pH	O
.	O

In	O
mature	O
CDFF	O
plaques	O
,	O
differential	O
culture	O
indicated	O
that	O
whilst	O
significant	O
increases	O
in	O
lactobacillus	B-bacteria
counts	O
occurred	O
during	O
dosing	O
,	O
numbers	O
of	O
other	O
bacterial	O
groups	O
and	O
pH	O
did	O
not	O
significantly	O
change	O
.	O

Monitoring	O
the	O
probiotic	O
strain	O
in	O
CDFFs	O
using	O
selective	O
culture	O
and	O
qPCR	O
indicated	O
that	O
the	O
exogenous	O
bacterium	O
reached	O
and	O
maintained	O
c	O
.	O
5	O
log	O
(	O
10	O
)	O
CFU	O
/	O
mm	O
(	O
2	O
)	O
during	O
dosing	O
and	O
20	O
days	O
after	O
cessation	O
.	O

The	O
apparent	O
lack	O
of	O
marked	O
bacterial	O
inhibition	O
by	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
in	O
both	O
model	O
systems	O
was	O
supported	O
by	O
the	O
absence	O
of	O
antagonism	O
in	O
binary	O
antagonism	O
assays	O
.	O

The	O
largest	O
compositional	O
changes	O
occurred	O
in	O
nascent	O
plaques	O
where	O
the	O
addition	O
of	O
lactobacilli	B-bacteria
caused	O
significant	O
increases	O
in	O
streptococci	B-bacteria
and	O
Gram	O
-	O
negative	O
anaerobes	O
,	O
the	O
latter	O
possibly	O
via	O
lactate	O
syntrophy	O
.	O

Exogenous	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
persisted	O
in	O
mature	O
plaque	O
microcosms	O
after	O
dosing	O
ceased	O
.	O

The	O
present	O
study	O
aimed	O
to	O
develop	O
an	O
innovative	O
,	O
strain	O
-	O
specific	O
means	O
of	O
identifying	O
the	O
probiotic	O
Lactobacillus	B-bacteria
gasseri	I-bacteria
TMC0356	I-bacteria
and	O
to	O
determine	O
whether	O
orally	O
administered	O
TMC0356	B-bacteria
could	O
be	O
recovered	O
from	O
the	O
human	O
intestine	O
.	O

High	O
molecular	O
weight	O
genomic	O
DNA	O
was	O
isolated	O
from	O
TMC0356	B-bacteria
and	O
14	O
reference	O
strains	O
of	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
,	O
including	O
the	O
type	O
strain	O
.	O

The	O
DNA	O
samples	O
were	O
digested	O
with	O
the	O
selected	O
rare	O
-	O
cutting	O
restriction	O
endonucleases	O
SmaI	O
,	O
SacII	O
and	O
ApaI	O
and	O
the	O
resulting	O
fragments	O
separated	O
by	O
pulsed	O
-	O
field	O
gel	O
electrophoresis	O
(	O
PFGE	O
)	O
in	O
a	O
size	O
range	O
between	O
20	O
to	O
290	O
kb	O
.	O

TMC0356	B-bacteria
could	O
be	O
distinguished	O
from	O
the	O
other	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
strains	I-bacteria
on	O
the	O
basis	O
of	O
the	O
SmaI	O
and	O
SacII	O
macrorestriction	O
patterns	O
.	O

Furthermore	O
,	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
strains	I-bacteria
isolated	O
from	O
the	O
feces	O
of	O
subjects	O
who	O
had	O
ingested	O
TMC0356	B-bacteria
were	O
identical	O
to	O
TMC0356	B-bacteria
in	O
the	O
SmaI	O
,	O
SacII	O
and	O
ApaI	O
macrorestriction	O
fragments	O
of	O
digested	O
DNA	O
.	O

These	O
results	O
suggest	O
that	O
PFGE	O
of	O
genomic	O
DNA	O
digested	O
with	O
SmaI	O
,	O
SacII	O
,	O
could	O
be	O
a	O
practical	O
means	O
of	O
identification	O
of	O
TMC0356	B-bacteria
.	O

Furthermore	O
,	O
these	O
results	O
indicate	O
that	O
ingested	O
TMC0356	B-bacteria
can	O
survive	O
in	O
,	O
and	O
colonize	O
,	O
the	O
human	O
intestine	O
.	O

The	O
present	O
study	O
focused	O
on	O
the	O
antibacterial	O
and	O
biofilm	O
inhibitory	O
potential	O
of	O
4	O
-	O
epi	O
-	O
pimaric	O
acid	O
isolated	O
from	O
aerial	O
parts	O
(	O
stem	O
and	O
leaves	O
)	O
of	O
Aralia	O
cachemirica	O
L	O
.	O
(	O
Araliaceae	O
)	O
against	O
oral	O
cavity	O
pathogens	O
.	O

4	O
-	O
epi	O
-	O
Pimaric	O
acid	O
exhibited	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
in	O
the	O
range	O
of	O
4	O
-	O
16	O
mug	O
/	O
ml	O
and	O
minimum	O
bactericidal	O
concentration	O
(	O
MBC	O
)	O
two	O
-	O
to	O
four	O
-	O
folds	O
higher	O
than	O
MIC	O
.	O

There	O
was	O
significant	O
inhibition	O
in	O
the	O
biofilm	O
formation	O
by	O
Streptococcus	B-bacteria
mutans	I-bacteria
on	O
the	O
saliva	O
coated	O
surface	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
,	O
and	O
confocal	O
microscopy	O
revealed	O
that	O
4	O
-	O
epi	O
-	O
pimaric	O
acid	O
inhibited	O
the	O
clumping	O
and	O
attachment	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

At	O
8	O
x	O
MIC	O
concentration	O
,	O
it	O
significantly	O
prevented	O
the	O
pH	O
drop	O
and	O
reduced	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilms	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Increased	O
propidium	O
iodide	O
staining	O
and	O
leakage	O
of	O
260	O
-	O
and	O
280	O
-	O
nm	O
absorbing	O
material	O
by	O
4	O
-	O
epi	O
-	O
pimaric	O
acid	O
treated	O
cells	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
suggested	O
that	O
it	O
probably	O
causes	O
disruption	O
of	O
the	O
cytoplasmic	O
membrane	O
structure	O
.	O

It	O
also	O
exhibited	O
significant	O
suppression	O
of	O
TNF	O
-	O
alpha	O
expression	O
in	O
human	O
neutrophils	O
,	O
suggestive	O
of	O
its	O
anti	O
-	O
inflammatory	O
activity	O
.	O

Furthermore	O
,	O
the	O
compound	O
was	O
found	O
to	O
be	O
significantly	O
safe	O
(	O
IC	O
(	O
50	O
)	O
>	O
100	O
mug	O
/	O
ml	O
)	O
in	O
the	O
MTT	O
assay	O
on	O
AML	O
-	O
12	O
cell	O
lines	O
.	O

In	O
conclusion	O
,	O
4	O
-	O
epi	O
-	O
pimaric	O
acid	O
showed	O
promising	O
antibacterial	O
,	O
anti	O
-	O
biofilm	O
and	O
anti	O
-	O
inflammatory	O
potency	O
and	O
this	O
compound	O
can	O
be	O
exploited	O
for	O
therapeutic	O
application	O
in	O
oral	O
microbial	O
infections	O
.	O

Research	O
using	O
low	O
frequency	O
atmospheric	O
pressure	O
plasma	O
jets	O
(	O
LF	O
jet	O
)	O
is	O
becoming	O
increasingly	O
more	O
common	O
.	O

We	O
carried	O
out	O
experiments	O
to	O
evaluate	O
the	O
sterilizing	O
effects	O
of	O
this	O
technology	O
on	O
oral	O
pathogenic	O
microorganisms	O
(	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
C	O
.	O
albicans	O
and	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
)	O
and	O
to	O
determine	O
its	O
potential	O
for	O
clinical	O
application	O
.	O

We	O
performed	O
the	O
direct	O
exposure	O
test	O
on	O
a	O
solid	O
surface	O
,	O
indirect	O
exposure	O
test	O
on	O
a	O
liquid	O
phase	O
,	O
and	O
ROS	O
(	O
reactive	O
oxygen	O
species	O
)	O
inhibitory	O
test	O
.	O

The	O
results	O
showed	O
the	O
LF	O
jet	O
had	O
microbicidal	O
effects	O
on	O
oral	O
pathogens	O
,	O
and	O
that	O
the	O
ROS	O
influenced	O
this	O
sterilization	O
effect	O
.	O

The	O
experiments	O
of	O
this	O
study	O
revealed	O
that	O
LF	O
jet	O
had	O
a	O
sterilizing	O
effect	O
on	O
oral	O
pathogenic	O
microorganisms	O
present	O
in	O
both	O
the	O
solid	O
and	O
liquid	O
phases	O
.	O

The	O
sterilizing	O
mechanism	O
was	O
considered	O
to	O
be	O
related	O
to	O
the	O
effect	O
of	O
superoxide	O
anion	O
radicals	O
.	O

These	O
results	O
indicate	O
that	O
LF	O
jets	O
may	O
represent	O
a	O
novel	O
technology	O
that	O
can	O
be	O
applied	O
to	O
the	O
field	O
of	O
clinical	O
dentistry	O
.	O

Suppression	O
of	O
immune	O
system	O
in	O
treated	O
cancer	O
patients	O
may	O
lead	O
to	O
secondary	O
infections	O
that	O
obviate	O
the	O
need	O
of	O
antibiotics	O
.	O

In	O
the	O
present	O
study	O
,	O
an	O
attempt	O
was	O
made	O
to	O
understand	O
the	O
occurrence	O
of	O
secondary	O
infections	O
in	O
immuno	O
-	O
suppressed	O
patients	O
along	O
with	O
herbal	O
control	O
of	O
these	O
infections	O
with	O
the	O
following	O
objectives	O
to	O
:	O
(	O
a	O
)	O
isolate	O
the	O
microbial	O
species	O
from	O
the	O
treated	O
oral	O
cancer	O
patients	O
along	O
with	O
the	O
estimation	O
of	O
absolute	O
neutrophile	O
counts	O
of	O
patients	O
(	O
b	O
)	O
assess	O
the	O
in	O
vitro	O
antimicrobial	O
activity	O
medicinal	O
plants	O
against	O
the	O
above	O
clinical	O
isolates	O
.	O

Blood	O
and	O
oral	O
swab	O
cultures	O
were	O
taken	O
from	O
40	O
oral	O
cancer	O
patients	O
undergoing	O
treatment	O
in	O
the	O
radiotherapy	O
unit	O
of	O
Regional	O
Cancer	O
Institute	O
,	O
Pt	O
.	O
B	O
.	O
D	O
.	O
S	O
.	O

Health	O
University	O
,	O
Rohtak	O
,	O
Haryana	O
.	O

Clinical	O
isolates	O
were	O
identified	O
by	O
following	O
general	O
microbiological	O
,	O
staining	O
and	O
biochemical	O
methods	O
.	O

The	O
absolute	O
neutrophile	O
counts	O
were	O
done	O
by	O
following	O
the	O
standard	O
methods	O
.	O

The	O
medicinal	O
plants	O
selected	O
for	O
antimicrobial	O
activity	O
analysis	O
were	O
Asphodelus	O
tenuifolius	O
Cav	O
.	O
,	O
Asparagus	O
racemosus	O
Willd	O
.	O
,	O
Balanites	O
aegyptiaca	O
L	O
.	O
,	O
Cestrum	O
diurnum	O
L	O
.	O
,	O
Cordia	O
dichotoma	O
G	O
.	O
Forst	O
,	O
Eclipta	O
alba	O
L	O
.	O
,	O
Murraya	O
koenigii	O
(	O
L	O
.	O
)	O
Spreng	O
.	O

,	O
Pedalium	O
murex	O
L	O
.	O
,	O
Ricinus	O
communis	O
L	O
.	O
and	O
Trigonella	O
foenum	O
graecum	O
L	O
.	O
The	O
antimicrobial	O
efficacy	O
of	O
medicinal	O
plants	O
was	O
evaluated	O
by	O
modified	O
Kirby	O
-	O
Bauer	O
disc	O
diffusion	O
method	O
.	O

MIC	O
and	O
MFC	O
were	O
investigated	O
by	O
serial	O
two	O
fold	O
microbroth	O
dilution	O
method	O
.	O

Prevalent	O
bacterial	O
pathogens	O
isolated	O
were	O
Staphylococcus	B-bacteria
aureus	I-bacteria
(	O
23	O
.	O
2	O
%	O
)	O
,	O
Escherichia	B-bacteria
coli	I-bacteria
(	O
15	O
.	O
62	O
%	O
)	O
,	O
Staphylococcus	B-bacteria
epidermidis	I-bacteria
(	O
12	O
.	O
5	O
%	O
)	O
,	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
(	O
9	O
.	O
37	O
%	O
)	O
,	O
Klebsiella	B-bacteria
pneumonia	I-bacteria
(	O
7	O
.	O
81	O
%	O
)	O
,	O
Proteus	B-bacteria
mirabilis	I-bacteria
(	O
3	O
.	O
6	O
%	O
)	O
,	O
Proteus	B-bacteria
vulgaris	I-bacteria
(	O
4	O
.	O
2	O
%	O
)	O
and	O
the	O
fungal	O
pathogens	O
were	O
Candida	O
albicans	O
(	O
14	O
.	O
6	O
%	O
)	O
,	O
Aspergillus	O
fumigatus	O
(	O
9	O
.	O
37	O
%	O
)	O
.	O

Out	O
of	O
40	O
cases	O
,	O
35	O
(	O
87	O
.	O
5	O
%	O
)	O
were	O
observed	O
as	O
neutropenic	O
.	O

Eight	O
medicinal	O
plants	O
(	O
A	O
.	O
tenuifolius	O
,	O
A	O
.	O
racemosus	O
,	O
B	O
.	O
aegyptiaca	O
,	O
E	O
.	O
alba	O
,	O
M	O
.	O
koenigii	O
,	O
P	O
.	O
murex	O
R	O
.	O
communis	O
and	O
T	O
.	O
foenum	O
graecum	O
)	O
showed	O
significant	O
antimicrobial	O
activity	O
(	O
P	O
<	O
.	O
05	O
)	O
against	O
most	O
of	O
the	O
isolates	O
.	O

The	O
MIC	O
and	O
MFC	O
values	O
were	O
ranged	O
from	O
31	O
to	O
500	O
mug	O
/	O
ml	O
.	O

P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
was	O
observed	O
highest	O
susceptible	O
bacteria	O
(	O
46	O
.	O
6	O
%	O
)	O
on	O
the	O
basis	O
of	O
susceptible	O
index	O
.	O

It	O
can	O
be	O
concluded	O
that	O
treated	O
oral	O
cancer	O
patients	O
were	O
neutropenic	O
and	O
prone	O
to	O
secondary	O
infection	O
of	O
microbes	O
.	O

The	O
medicinal	O
plant	O
can	O
prove	O
as	O
effective	O
antimicrobial	O
agent	O
to	O
check	O
the	O
secondary	O
infections	O
in	O
treated	O
cancer	O
patients	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
quantify	O
nine	O
selected	O
cariogenic	O
bacteria	O
in	O
plaque	O
from	O
sound	O
root	O
surfaces	O
and	O
initial	O
carious	O
root	O
lesions	O
using	O
TaqMan	O
PCR	O
and	O
to	O
analyse	O
a	O
putative	O
dependence	O
on	O
the	O
kind	O
of	O
initial	O
periodontal	O
treatment	O
.	O

Fifty	O
-	O
four	O
subjects	O
with	O
generalized	O
chronic	O
periodontitis	O
were	O
randomly	O
allocated	O
to	O
one	O
of	O
the	O
following	O
initial	O
periodontal	O
therapies	O
:	O
full	O
-	O
mouth	O
disinfection	O
,	O
full	O
-	O
mouth	O
scaling	O
and	O
root	O
planing	O
or	O
scaling	O
and	O
root	O
planing	O
within	O
7	O
days	O
.	O

Plaque	O
samples	O
were	O
taken	O
before	O
and	O
after	O
periodontal	O
treatment	O
and	O
analysed	O
by	O
TaqMan	O
PCR	O
.	O

The	O
quantity	O
of	O
the	O
cariogenic	O
bacteria	O
Actinomyces	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
,	O
Lactobacilllus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Rothia	B-bacteria
dentocariosa	I-bacteria
,	O
Parvimonas	B-bacteria
micra	I-bacteria
,	O
Propionibacterium	B-bacteria
acnes	I-bacteria
and	O
Neisseria	B-bacteria
mucosa	I-bacteria
were	O
significantly	O
higher	O
,	O
while	O
the	O
quantity	O
of	O
Veillonella	B-bacteria
parvula	I-bacteria
was	O
significantly	O
lower	O
on	O
initial	O
carious	O
lesions	O
than	O
on	O
the	O
sound	O
surfaces	O
both	O
before	O
and	O
after	O
periodontal	O
therapy	O
.	O

No	O
significant	O
differences	O
could	O
be	O
found	O
in	O
any	O
of	O
the	O
tested	O
bacteria	O
except	O
P	B-bacteria
.	I-bacteria
micra	I-bacteria
on	O
initial	O
carious	O
lesions	O
and	O
sound	O
surfaces	O
for	O
both	O
examinations	O
between	O
the	O
groups	O
.	O

All	O
the	O
nine	O
species	O
analysed	O
were	O
found	O
to	O
be	O
present	O
in	O
initial	O
carious	O
root	O
lesions	O
as	O
well	O
as	O
sound	O
root	O
surfaces	O
but	O
in	O
different	O
quantities	O
,	O
independent	O
of	O
the	O
different	O
periodontal	O
therapies	O
.	O

To	O
investigate	O
the	O
effect	O
of	O
PG0839	O
gene	O
form	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
Pg	B-bacteria
)	O
on	O
inflammatory	O
cytokine	O
expression	O
in	O
human	O
oral	O
epidermoid	O
carcinoma	O
KB	O
cell	O
.	O

A	O
mutant	O
in	O
the	O
PG0839	O
gene	O
of	O
Pg	B-bacteria
was	O
created	O
by	O
insertional	O
inactivation	O
.	O

Group	O
1	O
was	O
chanllenged	O
with	O
PgW83	B-bacteria
strain	I-bacteria
,	O
group	O
2	O
with	O
PG0839	O
-	O
defective	O
mutant	O
,	O
and	O
the	O
control	O
group	O
with	O
Dulbecco	O
'	O
s	O
modified	O
Eagle	O
'	O
s	O
medium	O
only	O
.	O

KB	O
cells	O
were	O
co	O
-	O
cultured	O
with	O
presence	O
of	O
bacteria	O
for	O
24	O
h	O
.	O
At	O
the	O
time	O
point	O
of	O
0	O
.	O
5	O
,	O
2	O
,	O
6	O
,	O
12	O
and	O
24	O
h	O
,	O
cells	O
were	O
stored	O
in	O
Trizol	O
.	O

The	O
mRNA	O
expression	O
of	O
interleukin	O
-	O
1beta	O
(	O
IL	O
-	O
1beta	O
)	O
and	O
Toll	O
like	O
recepector	O
-	O
4	O
(	O
TLR	O
-	O
4	O
)	O
was	O
examined	O
by	O
reverse	O
transcription	O
polymerase	O
chain	O
reaction	O
.	O

At	O
2	O
h	O
and	O
6	O
h	O
,	O
IL	O
-	O
1beta	O
mRNA	O
expression	O
was	O
lower	O
in	O
group	O
2	O
than	O
in	O
group	O
1	O
(	O
2	O
h	O
:	O
0	O
.	O
31	O
+	O
/	O
-	O
0	O
.	O
11	O
versus	O
0	O
.	O
95	O
+	O
/	O
-	O
0	O
.	O
48	O
,	O
P	O
<	O
0	O
.	O
05	O
;	O
6	O
h	O
:	O
0	O
.	O
57	O
+	O
/	O
-	O
0	O
.	O
20	O
versus	O
1	O
.	O
29	O
+	O
/	O
-	O
0	O
.	O
55	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

At	O
0	O
.	O
5	O
h	O
and	O
6	O
h	O
,	O
TLR	O
-	O
4	O
mRNA	O
expression	O
was	O
lower	O
in	O
group	O
2	O
than	O
in	O
group	O
1	O
(	O
0	O
.	O
5	O
h	O
:	O
0	O
.	O
20	O
+	O
/	O
-	O
0	O
.	O
09	O
versus	O
0	O
.	O
58	O
+	O
/	O
-	O
0	O
.	O
09	O
,	O
P	O
<	O
0	O
.	O
05	O
;	O
6	O
h	O
:	O
0	O
.	O
34	O
+	O
/	O
-	O
0	O
.	O
04	O
versus	O
0	O
.	O
71	O
+	O
/	O
-	O
0	O
.	O
18	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

PG0839	O
gene	O
may	O
play	O
an	O
important	O
role	O
in	O
Pg	O
-	O
induced	O
inflammatory	O
effects	O
of	O
KB	O
cell	O
.	O

Tannerella	B-bacteria
forsythia	I-bacteria
,	O
a	O
Gram	O
-	O
negative	O
anaerobe	O
implicated	O
in	O
periodontitis	O
,	O
has	O
been	O
detected	O
within	O
human	O
buccal	O
epithelial	O
cells	O
and	O
shown	O
to	O
invade	O
oral	O
epithelial	O
cells	O
in	O
vitro	O
.	O

We	O
have	O
previously	O
shown	O
that	O
this	O
bacterium	O
triggers	O
host	O
tyrosine	O
kinase	O
-	O
dependent	O
phosphorylation	O
and	O
actin	O
-	O
dependent	O
cytoskeleton	O
reorganization	O
for	O
invasion	O
.	O

On	O
the	O
bacterial	O
side	O
,	O
the	O
leucine	O
-	O
rich	O
repeat	O
cell	O
-	O
surface	O
BspA	O
protein	O
is	O
important	O
for	O
entry	O
.	O

The	O
present	O
study	O
was	O
undertaken	O
to	O
identify	O
host	O
signalling	O
molecules	O
during	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
entry	O
into	O
human	O
oral	O
and	O
cervical	O
epithelial	O
cells	O
.	O

Specifically	O
,	O
the	O
roles	O
of	O
phosphatidylinositol	O
3	O
-	O
kinase	O
(	O
PI3K	O
)	O
,	O
Rho	O
-	O
family	O
GTPases	O
,	O
cholesterol	O
-	O
rich	O
membrane	O
microdomains	O
and	O
the	O
endocytic	O
protein	O
clathrin	O
were	O
investigated	O
.	O

For	O
this	O
purpose	O
,	O
cell	O
lines	O
were	O
pretreated	O
with	O
chemical	O
inhibitors	O
or	O
small	O
interfering	O
RNAs	O
(	O
siRNAs	O
)	O
that	O
target	O
PI3Ks	O
,	O
Rho	O
GTPases	O
,	O
clathrin	O
and	O
cholesterol	O
(	O
a	O
critical	O
component	O
of	O
'	O
lipid	O
rafts	O
'	O
)	O
,	O
and	O
the	O
resulting	O
effects	O
on	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
uptake	O
were	O
determined	O
.	O

Our	O
studies	O
revealed	O
that	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
entry	O
is	O
dependent	O
on	O
host	O
PI3K	O
signalling	O
,	O
and	O
that	O
purified	O
BspA	O
protein	O
causes	O
activation	O
of	O
this	O
lipid	O
kinase	O
.	O

Bacterial	O
entry	O
also	O
requires	O
the	O
cooperation	O
of	O
host	O
Rac1	O
GTPase	O
.	O

Finally	O
,	O
our	O
findings	O
indicate	O
an	O
important	O
role	O
for	O
clathrin	O
and	O
cholesterol	O
-	O
rich	O
lipid	O
microdomains	O
in	O
the	O
internalization	O
process	O
.	O

Cumulative	O
interceptive	O
supportive	O
therapy	O
(	O
CIST	O
)	O
is	O
currently	O
used	O
as	O
a	O
guideline	O
for	O
treating	O
peri	O
-	O
implant	O
diseases	O
.	O

The	O
objectives	O
of	O
this	O
study	O
were	O
to	O
determine	O
the	O
detection	O
rate	O
and	O
measure	O
the	O
number	O
of	O
periodontopathic	O
bacteria	O
in	O
lesions	O
of	O
different	O
CIST	O
levels	O
and	O
thereby	O
characterize	O
peri	O
-	O
implant	O
disease	O
from	O
a	O
bacteriological	O
viewpoint	O
.	O

This	O
study	O
included	O
105	O
patients	O
who	O
had	O
both	O
residual	O
natural	O
teeth	O
and	O
implants	O
with	O
peri	O
-	O
implant	O
disease	O
.	O

A	O
total	O
of	O
105	O
implants	O
were	O
divided	O
into	O
levels	O
A	O
,	O
B	O
,	O
C	O
and	O
D	O
according	O
to	O
the	O
CIST	O
classification	O
.	O

Bacterial	O
samples	O
were	O
collected	O
from	O
peri	O
-	O
implant	O
pockets	O
and	O
four	O
periodontopathic	O
bacteria	O
were	O
measured	O
by	O
PCR	O
and	O
PCR	O
-	O
Invader	O
assay	O
.	O

The	O
number	O
of	O
periodontopathic	O
bacteria	O
increased	O
in	O
line	O
with	O
CIST	O
level	O
,	O
and	O
the	O
detection	O
rate	O
was	O
also	O
associated	O
with	O
CIST	O
level	O
.	O

However	O
,	O
no	O
difference	O
was	O
found	O
in	O
the	O
bacterial	O
detection	O
rate	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
between	O
CIST	O
-	O
B	O
and	O
CIST	O
-	O
C	O
.	O

There	O
was	O
a	O
higher	O
detection	O
rate	O
of	O
all	O
periodontopathic	O
bacteria	O
for	O
CIST	O
-	O
D	O
.	O

The	O
number	O
of	O
periodontopathic	O
bacteria	O
and	O
detection	O
rate	O
increased	O
as	O
peri	O
-	O
implant	O
disease	O
advanced	O
.	O

However	O
,	O
there	O
were	O
no	O
major	O
differences	O
in	O
the	O
detection	O
rate	O
between	O
CIST	O
-	O
B	O
and	O
CIST	O
-	O
C	O
.	O
On	O
the	O
other	O
hand	O
,	O
a	O
higher	O
detection	O
rate	O
of	O
periodontopathic	O
bacteria	O
was	O
seen	O
for	O
CIST	O
-	O
D	O
.	O

The	O
mitis	B-bacteria
group	I-bacteria
streptococci	I-bacteria
(	O
MGS	B-bacteria
)	O
are	O
widespread	O
in	O
the	O
oral	O
cavity	O
and	O
are	O
traditionally	O
associated	O
with	O
oral	O
health	O
.	O

However	O
,	O
these	O
organisms	O
have	O
many	O
attributes	O
that	O
contribute	O
to	O
the	O
development	O
of	O
pathogenic	O
oral	O
communities	O
.	O

MGS	B-bacteria
adhere	O
rapidly	O
to	O
saliva	O
-	O
coated	O
tooth	O
surfaces	O
,	O
thereby	O
providing	O
an	O
attachment	O
substratum	O
for	O
more	O
overtly	O
pathogenic	O
organisms	O
such	O
as	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
and	O
the	O
two	O
species	O
assemble	O
into	O
heterotypic	O
communities	O
.	O

Close	O
physical	O
association	O
facilitates	O
physiologic	O
support	O
,	O
and	O
pathogens	O
such	O
as	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
display	O
resource	O
partitioning	O
to	O
favour	O
carbon	O
sources	O
generated	O
by	O
streptococcal	B-bacteria
metabolism	O
.	O

MGS	B-bacteria
exchange	O
information	O
with	O
community	O
members	O
through	O
a	O
number	O
of	O
interspecies	O
signalling	O
systems	O
including	O
AI	O
-	O
2	O
and	O
contact	O
dependent	O
mechanisms	O
.	O

Signal	O
transduction	O
systems	O
induced	O
in	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
are	O
based	O
on	O
protein	O
dephosphorylation	O
mediated	O
by	O
the	O
tyrosine	O
phosphatase	O
Ltp1	O
,	O
and	O
converge	O
on	O
a	O
LuxR	O
-	O
family	O
transcriptional	O
regulator	O
,	O
CdhR	O
.	O

Phenotypic	O
responses	O
in	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
include	O
regulation	O
of	O
hemin	O
uptake	O
systems	O
and	O
gingipain	O
activity	O
,	O
processes	O
that	O
are	O
intimately	O
linked	O
to	O
the	O
virulence	O
of	O
the	O
organism	O
.	O

Furthermore	O
,	O
communities	O
of	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
or	O
with	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
are	O
more	O
pathogenic	O
in	O
animal	O
models	O
than	O
the	O
constituent	O
species	O
alone	O
.	O

We	O
propose	O
that	O
MGS	B-bacteria
should	O
be	O
considered	O
accessory	O
pathogens	O
,	O
organisms	O
whose	O
pathogenic	O
potential	O
only	O
becomes	O
evident	O
in	O
the	O
context	O
of	O
a	O
heterotypic	O
microbial	O
community	O
.	O

Early	O
in	O
life	O
,	O
vaginally	O
delivered	O
infants	O
exhibit	O
a	O
different	O
composition	O
of	O
the	O
gut	O
flora	O
compared	O
with	O
infants	O
delivered	O
by	O
caesarean	O
section	O
(	O
C	O
-	O
section	O
)	O
;	O
however	O
,	O
it	O
is	O
unclear	O
whether	O
this	O
also	O
applies	O
to	O
the	O
oral	O
cavity	O
.	O

AIM	O
.	O

To	O
investigate	O
and	O
compare	O
the	O
oral	O
microbial	O
profile	O
between	O
infants	O
delivered	O
vaginally	O
and	O
by	O
C	O
-	O
section	O
.	O

This	O
is	O
a	O
cross	O
-	O
sectional	O
case	O
-	O
control	O
study	O
.	O

Eighty	O
-	O
four	O
infants	O
delivered	O
either	O
vaginally	O
(	O
n	O
=	O
42	O
)	O
or	O
by	O
C	O
-	O
section	O
(	O
n	O
=	O
42	O
)	O
were	O
randomly	O
selected	O
from	O
the	O
2009	O
birth	O
cohort	O
at	O
the	O
County	O
Hospital	O
in	O
Halmstad	O
,	O
Sweden	O
.	O

Medically	O
compromised	O
and	O
premature	O
children	O
(	O
<	O
32	O
weeks	O
)	O
were	O
excluded	O
.	O

The	O
mean	O
age	O
was	O
8	O
.	O
25	O
months	O
(	O
range	O
6	O
-	O
10	O
months	O
)	O
,	O
and	O
parents	O
were	O
asked	O
to	O
complete	O
a	O
questionnaire	O
on	O
socioeconomic	O
factors	O
,	O
lifestyle	O
,	O
and	O
hygiene	O
habits	O
.	O

Saliva	O
was	O
collected	O
and	O
analysed	O
using	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
.	O

RESULTS	O
.	O

A	O
higher	O
prevalence	O
of	O
salivary	O
Streptococcus	B-bacteria
salivarius	I-bacteria
,	O
Lactobacillus	B-bacteria
curvata	I-bacteria
,	O
Lactobacillus	B-bacteria
salivarius	I-bacteria
,	O
and	O
Lactobacuillus	B-bacteria
casei	I-bacteria
was	O
detected	O
in	O
infants	O
delivered	O
vaginally	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
caries	O
-	O
associated	O
bacteria	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
were	O
detected	O
in	O
63	O
%	O
and	O
59	O
%	O
of	O
all	O
children	O
,	O
respectively	O
.	O

A	O
significantly	O
higher	O
prevalence	O
of	O
certain	O
strains	O
of	O
health	O
-	O
related	O
streptococci	B-bacteria
and	O
lactobacilli	B-bacteria
was	O
found	O
in	O
vaginally	O
delivered	O
infants	O
compared	O
with	O
infants	O
delivered	O
by	O
C	O
-	O
section	O
.	O

The	O
possible	O
long	O
-	O
term	O
effects	O
on	O
oral	O
health	O
need	O
to	O
be	O
further	O
investigated	O
.	O

The	O
objective	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
inhibitory	O
effect	O
of	O
a	O
commercially	O
available	O
essential	O
oil	O
-	O
containing	O
mouth	O
rinse	O
12	O
hours	O
after	O
a	O
single	O
rinse	O
and	O
two	O
weeks	O
of	O
twice	O
daily	O
rinsing	O
,	O
on	O
volatile	O
sulphur	O
compounds	O
(	O
VSC	O
)	O
producing	O
bacteria	O
on	O
the	O
tongue	O
.	O

The	O
study	O
was	O
a	O
randomized	O
,	O
double	O
-	O
blind	O
,	O
controlled	O
crossover	O
design	O
.	O

Thirty	O
-	O
six	O
healthy	O
subjects	O
,	O
aged	O
20	O
-	O
48	O
years	O
,	O
volunteered	O
to	O
participate	O
in	O
the	O
study	O
.	O

Subjects	O
were	O
randomly	O
assigned	O
to	O
rinse	O
twice	O
daily	O
with	O
either	O
an	O
essential	O
oil	O
-	O
containing	O
mouth	O
rinse	O
(	O
Cool	O
Mint	O
Listerine	O
Antiseptic	O
)	O
or	O
a	O
negative	O
control	O
rinse	O
.	O

Bacteria	O
samples	O
were	O
taken	O
from	O
the	O
dorsum	O
of	O
the	O
tongue	O
at	O
baseline	O
,	O
after	O
the	O
first	O
rinse	O
and	O
two	O
weeks	O
later	O
.	O

They	O
were	O
plated	O
on	O
OOPS	O
medium	O
to	O
enumerate	O
the	O
VSC	O
-	O
producing	O
bacteria	O
.	O

Intergroup	O
comparisons	O
of	O
log10	O
transformed	O
colony	O
-	O
forming	O
units	O
of	O
the	O
samples	O
were	O
made	O
using	O
analysis	O
of	O
covariance	O
.	O

Each	O
comparison	O
was	O
performed	O
at	O
a	O
5	O
%	O
significance	O
level	O
.	O

The	O
mean	O
VSC	O
-	O
producing	O
bacteria	O
in	O
subjects	O
using	O
the	O
essential	O
oil	O
mouth	O
rinse	O
were	O
significantly	O
lower	O
than	O
those	O
using	O
the	O
control	O
rinse	O
twice	O
daily	O
.	O

In	O
healthy	O
subjects	O
,	O
rinsing	O
with	O
an	O
essential	O
oil	O
-	O
containing	O
mouth	O
rinse	O
can	O
have	O
a	O
significant	O
effect	O
on	O
VSC	O
-	O
producing	O
bacteria	O
on	O
the	O
tongue	O
and	O
may	O
be	O
useful	O
for	O
controlling	O
intrinsic	O
oral	O
malodor	O
over	O
prolonged	O
periods	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
effect	O
of	O
lead	O
(	O
Pb	O
)	O
on	O
growth	O
of	O
bacterial	O
species	O
related	O
to	O
dental	O
diseases	O
in	O
vitro	O
.	O

The	O
effects	O
of	O
lead	O
acetate	O
on	O
representative	O
species	O
of	O
the	O
oral	O
flora	O
were	O
examined	O
at	O
0	O
.	O
1	O
-	O
10	O
mmol	O
l	O
(	O
-	O
1	O
)	O
and	O
compared	O
with	O
the	O
effect	O
of	O
silver	O
nitrate	O
and	O
ferrous	O
sulfate	O
.	O

The	O
minimal	O
inhibitory	O
concentration	O
of	O
lead	O
acetate	O
was	O
between	O
0	O
.	O
15	O
and	O
5	O
mmol	O
l	O
(	O
-	O
1	O
)	O
for	O
the	O
bacterial	O
strains	O
tested	O
.	O

The	O
minimal	O
bactericidal	O
concentration	O
of	O
lead	O
acetate	O
for	O
most	O
oral	O
species	O
was	O
detected	O
in	O
the	O
range	O
of	O
5	O
-	O
10	O
mmol	O
l	O
(	O
-	O
1	O
)	O
.	O

Silver	O
nitrate	O
at	O
a	O
concentration	O
of	O
1	O
.	O
25	O
mmol	O
l	O
(	O
-	O
1	O
)	O
was	O
sufficient	O
to	O
exhibit	O
antibacterial	O
activity	O
against	O
almost	O
all	O
bacteria	O
tested	O
.	O

Ferrous	O
sulfate	O
had	O
the	O
lowest	O
effect	O
.	O

The	O
study	O
indicated	O
a	O
general	O
antimicrobial	O
effect	O
of	O
lead	O
on	O
oral	O
bacterial	O
species	O
in	O
the	O
range	O
of	O
0	O
.	O
15	O
-	O
10	O
mmol	O
l	O
(	O
-	O
1	O
)	O
.	O

The	O
toxicity	O
of	O
silver	O
nitrate	O
was	O
the	O
highest	O
,	O
whereas	O
that	O
of	O
ferrous	O
sulfate	O
was	O
the	O
lowest	O
.	O

Gram	O
-	O
positive	O
species	O
had	O
a	O
tendency	O
to	O
be	O
less	O
susceptible	O
for	O
metals	O
than	O
Gram	O
-	O
negatives	O
.	O

The	O
study	O
shows	O
that	O
it	O
is	O
possible	O
that	O
microbiological	O
changes	O
may	O
occur	O
in	O
the	O
dental	O
plaque	O
in	O
children	O
because	O
of	O
toxic	O
exposure	O
of	O
environmental	O
lead	O
.	O

The	O
oral	O
cavity	O
of	O
humans	O
is	O
inhabited	O
by	O
hundreds	O
of	O
bacterial	O
species	O
and	O
some	O
of	O
them	O
have	O
a	O
key	O
role	O
in	O
the	O
development	O
of	O
oral	O
diseases	O
,	O
mainly	O
dental	O
caries	O
and	O
periodontitis	O
.	O

We	O
describe	O
for	O
the	O
first	O
time	O
the	O
metagenome	O
of	O
the	O
human	O
oral	O
cavity	O
under	O
health	O
and	O
diseased	O
conditions	O
,	O
with	O
a	O
focus	O
on	O
supragingival	O
dental	O
plaque	O
and	O
cavities	O
.	O

Direct	O
pyrosequencing	O
of	O
eight	O
samples	O
with	O
different	O
oral	O
-	O
health	O
status	O
produced	O
1	O
Gbp	O
of	O
sequence	O
without	O
the	O
biases	O
imposed	O
by	O
PCR	O
or	O
cloning	O
.	O

These	O
data	O
show	O
that	O
cavities	O
are	O
not	O
dominated	O
by	O
Streptococcus	B-bacteria
mutans	I-bacteria
(	O
the	O
species	O
originally	O
identified	O
as	O
the	O
ethiological	O
agent	O
of	O
dental	O
caries	O
)	O
but	O
are	O
in	O
fact	O
a	O
complex	O
community	O
formed	O
by	O
tens	O
of	O
bacterial	O
species	O
,	O
in	O
agreement	O
with	O
the	O
view	O
that	O
caries	O
is	O
a	O
polymicrobial	O
disease	O
.	O

The	O
analysis	O
of	O
the	O
reads	O
indicated	O
that	O
the	O
oral	O
cavity	O
is	O
functionally	O
a	O
different	O
environment	O
from	O
the	O
gut	O
,	O
with	O
many	O
functional	O
categories	O
enriched	O
in	O
one	O
of	O
the	O
two	O
environments	O
and	O
depleted	O
in	O
the	O
other	O
.	O

Individuals	O
who	O
had	O
never	O
suffered	O
from	O
dental	O
caries	O
showed	O
an	O
over	O
-	O
representation	O
of	O
several	O
functional	O
categories	O
,	O
like	O
genes	O
for	O
antimicrobial	O
peptides	O
and	O
quorum	O
sensing	O
.	O

In	O
addition	O
,	O
they	O
did	O
not	O
have	O
mutans	B-bacteria
streptococci	I-bacteria
but	O
displayed	O
high	O
recruitment	O
of	O
other	O
species	O
.	O

Several	O
isolates	O
belonging	O
to	O
these	O
dominant	O
bacteria	O
in	O
healthy	O
individuals	O
were	O
cultured	O
and	O
shown	O
to	O
inhibit	O
the	O
growth	O
of	O
cariogenic	O
bacteria	O
,	O
suggesting	O
the	O
use	O
of	O
these	O
commensal	O
bacterial	O
strains	O
as	O
probiotics	O
to	O
promote	O
oral	O
health	O
and	O
prevent	O
dental	O
caries	O
.	O

The	O
etiology	O
of	O
dental	O
caries	O
remains	O
elusive	O
because	O
of	O
our	O
limited	O
understanding	O
of	O
the	O
complex	O
oral	O
microbiomes	O
.	O

The	O
current	O
methodologies	O
have	O
been	O
limited	O
by	O
insufficient	O
depth	O
and	O
breadth	O
of	O
microbial	O
sampling	O
,	O
paucity	O
of	O
data	O
for	O
diseased	O
hosts	O
particularly	O
at	O
the	O
population	O
level	O
,	O
inconsistency	O
of	O
sampled	O
sites	O
and	O
the	O
inability	O
to	O
distinguish	O
the	O
underlying	O
microbial	O
factors	O
.	O

By	O
cross	O
-	O
validating	O
16S	O
rRNA	O
gene	O
amplicon	O
-	O
based	O
and	O
whole	O
-	O
genome	O
-	O
based	O
deep	O
-	O
sequencing	O
technologies	O
,	O
we	O
report	O
the	O
most	O
in	O
-	O
depth	O
,	O
comprehensive	O
and	O
collaborated	O
view	O
to	O
date	O
of	O
the	O
adult	O
saliva	O
microbiomes	O
in	O
pilot	O
populations	O
of	O
19	O
caries	O
-	O
active	O
and	O
26	O
healthy	O
human	O
hosts	O
.	O

We	O
found	O
that	O
:	O
first	O
,	O
saliva	O
microbiomes	O
in	O
human	O
population	O
were	O
featured	O
by	O
a	O
vast	O
phylogenetic	O
diversity	O
yet	O
a	O
minimal	O
organismal	O
core	O
;	O
second	O
,	O
caries	O
microbiomes	O
were	O
significantly	O
more	O
variable	O
in	O
community	O
structure	O
whereas	O
the	O
healthy	O
ones	O
were	O
relatively	O
conserved	O
;	O
third	O
,	O
abundance	O
changes	O
of	O
certain	O
taxa	O
such	O
as	O
overabundance	O
of	O
Prevotella	B-bacteria
Genus	I-bacteria
distinguished	O
caries	O
microbiota	O
from	O
healthy	O
ones	O
,	O
and	O
furthermore	O
,	O
caries	O
-	O
active	O
and	O
normal	O
individuals	O
carried	O
different	O
arrays	O
of	O
Prevotella	B-bacteria
species	I-bacteria
;	O
and	O
finally	O
,	O
no	O
'	O
caries	O
-	O
specific	O
'	O
operational	O
taxonomic	O
units	O
(	O
OTUs	O
)	O
were	O
detected	O
,	O
yet	O
147	O
OTUs	O
were	O
'	O
caries	O
associated	O
'	O
,	O
that	O
is	O
,	O
differentially	O
distributed	O
yet	O
present	O
in	O
both	O
healthy	O
and	O
caries	O
-	O
active	O
populations	O
.	O

These	O
findings	O
underscored	O
the	O
necessity	O
of	O
species	O
-	O
and	O
strain	O
-	O
level	O
resolution	O
for	O
caries	O
prognosis	O
,	O
and	O
were	O
consistent	O
with	O
the	O
ecological	O
hypothesis	O
where	O
the	O
shifts	O
in	O
community	O
structure	O
,	O
instead	O
of	O
the	O
presence	O
or	O
absence	O
of	O
particular	O
groups	O
of	O
microbes	O
,	O
underlie	O
the	O
cariogenesis	O
.	O

Aerobic	O
and	O
facultatively	O
anaerobic	O
gram	O
-	O
negative	O
bacilli	O
(	O
AGNB	O
)	O
are	O
opportunistic	O
pathogens	O
and	O
continue	O
to	O
cause	O
a	O
large	O
number	O
of	O
hospital	O
-	O
acquired	O
infections	O
.	O

AGNB	O
residing	O
in	O
the	O
oral	O
cavity	O
and	O
oropharynx	O
have	O
been	O
linked	O
to	O
nosocomial	O
pneumonia	O
and	O
septicemia	O
.	O

Although	O
AGNB	O
are	O
not	O
considered	O
members	O
of	O
the	O
normal	O
oral	O
and	O
oropharyngeal	O
flora	O
,	O
medically	O
compromised	O
patients	O
have	O
been	O
demonstrated	O
to	O
be	O
susceptible	O
to	O
AGNB	O
colonization	O
.	O

A	O
literature	O
search	O
was	O
conducted	O
to	O
retrieve	O
articles	O
that	O
evaluated	O
the	O
effectiveness	O
of	O
oral	O
hygiene	O
interventions	O
in	O
reducing	O
the	O
oral	O
and	O
oropharyngeal	O
carriage	O
of	O
AGNB	O
in	O
medically	O
compromised	O
patients	O
.	O

Few	O
studies	O
have	O
documented	O
the	O
use	O
of	O
mechanical	O
oral	O
hygiene	O
interventions	O
alone	O
against	O
AGNB	O
.	O

Although	O
a	O
number	O
of	O
studies	O
have	O
employed	O
oral	O
hygiene	O
interventions	O
complemented	O
by	O
antiseptic	O
agents	O
such	O
as	O
chlorhexidine	O
and	O
povidone	O
iodine	O
,	O
there	O
appears	O
to	O
be	O
a	O
discrepancy	O
between	O
their	O
in	O
vitro	O
and	O
in	O
vivo	O
effectiveness	O
.	O

With	O
the	O
recognition	O
of	O
the	O
oral	O
cavity	O
and	O
oropharynx	O
as	O
a	O
reservoir	O
of	O
AGNB	O
and	O
the	O
recent	O
emergence	O
of	O
multidrug	O
and	O
pandrug	O
resistance	O
in	O
hospital	O
settings	O
,	O
there	O
is	O
a	O
pressing	O
need	O
for	O
additional	O
high	O
-	O
quality	O
randomized	O
controlled	O
trials	O
to	O
determine	O
which	O
oral	O
hygiene	O
interventions	O
or	O
combination	O
of	O
interventions	O
are	O
most	O
effective	O
in	O
eliminating	O
or	O
reducing	O
AGNB	O
carriage	O
.	O

Streptococcus	B-bacteria
salivarius	I-bacteria
is	O
naturally	O
a	O
predominant	O
member	O
of	O
the	O
human	O
oropharynx	O
and	O
the	O
commercial	O
probiotic	O
strain	O
K12	B-bacteria
has	O
been	O
consumed	O
for	O
more	O
than	O
a	O
decade	O
.	O

The	O
present	O
study	O
examines	O
the	O
health	O
responses	O
of	O
human	O
volunteers	O
to	O
oral	O
ingestion	O
of	O
high	O
doses	O
of	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
.	O

A	O
randomized	O
group	O
of	O
53	O
subjects	O
received	O
a	O
dose	O
of	O
1	O
x	O
10	O
(	O
10	O
)	O
cfu	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
(	O
N	O
=	O
25	O
)	O
or	O
placebo	O
(	O
N	O
=	O
28	O
)	O
for	O
28	O
days	O
,	O
followed	O
by	O
a	O
28	O
-	O
day	O
wash	O
out	O
period	O
.	O

Blood	O
,	O
urine	O
and	O
saliva	O
samples	O
were	O
collected	O
at	O
baseline	O
and	O
following	O
treatment	O
and	O
analyzed	O
,	O
while	O
the	O
oral	O
and	O
gastrointestinal	O
tolerance	O
of	O
the	O
subjects	O
to	O
the	O
dosing	O
regimen	O
was	O
determined	O
by	O
use	O
of	O
questionnaires	O
.	O

Adverse	O
events	O
(	O
AE	O
)	O
s	O
were	O
recorded	O
for	O
both	O
groups	O
.	O

No	O
statistically	O
significant	O
differences	O
between	O
the	O
probiotic	O
and	O
placebo	O
treated	O
groups	O
were	O
detected	O
in	O
either	O
the	O
blood	O
clinical	O
chemistry	O
or	O
hematology	O
results	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
.	O

The	O
questionnaire	O
responses	O
of	O
the	O
subjects	O
indicated	O
that	O
both	O
treatments	O
were	O
well	O
tolerated	O
.	O

The	O
frequency	O
and	O
intensity	O
of	O
AEs	O
was	O
similar	O
in	O
the	O
two	O
groups	O
.	O

This	O
data	O
demonstrates	O
that	O
the	O
daily	O
ingestion	O
of	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
over	O
a	O
28	O
-	O
day	O
period	O
does	O
not	O
adversely	O
affect	O
the	O
human	O
host	O
and	O
supports	O
the	O
safety	O
of	O
its	O
oral	O
delivery	O
in	O
a	O
food	O
-	O
based	O
carrier	O
.	O

The	O
up	O
-	O
regulation	O
of	O
the	O
B7	O
-	O
H1	O
receptors	O
in	O
host	O
cells	O
might	O
influence	O
the	O
chronicity	O
of	O
inflammatory	O
disorders	O
that	O
frequently	O
precede	O
the	O
development	O
of	O
human	O
cancers	O
.	O

B7	O
-	O
H1	O
expression	O
has	O
been	O
detected	O
in	O
the	O
majority	O
of	O
human	O
cancers	O
,	O
leading	O
to	O
anergy	O
and	O
apoptosis	O
of	O
activated	O
T	O
cells	O
,	O
and	O
enabling	O
tumor	O
cells	O
to	O
overcome	O
host	O
response	O
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
)	O
,	O
a	O
putative	O
periodontal	O
pathogen	O
,	O
is	O
an	O
etiologic	O
agent	O
of	O
periodontitis	O
and	O
expresses	O
a	O
variety	O
of	O
virulence	O
factors	O
.	O

In	O
this	O
study	O
,	O
the	O
expression	O
of	O
B7	O
-	O
H1	O
and	O
B7	O
-	O
DC	O
receptors	O
on	O
squamous	O
cell	O
carcinoma	O
cells	O
SCC	O
-	O
25	O
and	O
BHY	O
and	O
primary	O
human	O
gingival	O
keratinocytes	O
(	O
PHGK	O
)	O
was	O
analyzed	O
after	O
infection	O
with	O
two	O
virulent	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
strains	I-bacteria
in	O
vitro	O
.	O

After	O
48h	O
,	O
the	O
cells	O
were	O
stained	O
with	O
antibodies	O
for	O
human	O
B7	O
-	O
H1	O
and	O
B7	O
-	O
DC	O
and	O
further	O
analyzed	O
by	O
flow	O
cytometry	O
.	O

RNA	O
was	O
extracted	O
and	O
gene	O
expression	O
of	O
B7	O
-	O
H1	O
or	O
B7	O
-	O
DC	O
was	O
quantified	O
by	O
real	O
time	O
PCR	O
.	O

After	O
infection	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
both	O
B7	O
-	O
H1	O
and	O
B7	O
-	O
DC	O
receptors	O
were	O
up	O
-	O
regulated	O
.	O

The	O
mean	O
fluorescence	O
intensity	O
(	O
MFI	O
)	O
increased	O
from	O
4	O
.	O
5	O
to	O
9	O
.	O
9	O
(	O
B7	O
-	O
H1	O
)	O
and	O
from	O
6	O
.	O
9	O
to	O
15	O
.	O
0	O
(	O
B7	O
-	O
DC	O
)	O
(	O
p	O
<	O
0	O
.	O
05	O
,	O
respectively	O
)	O
in	O
SCC	O
-	O
25	O
cells	O
.	O

PHGK	O
showed	O
an	O
increase	O
from	O
4	O
.	O
8	O
to	O
12	O
.	O
4	O
(	O
B7	O
-	O
H1	O
)	O
and	O
from	O
5	O
.	O
5	O
to	O
15	O
.	O
6	O
(	O
B7	O
-	O
DC	O
)	O
(	O
p	O
<	O
0	O
.	O
05	O
,	O
respectively	O
)	O
.	O

Streptococcus	B-bacteria
salivarius	I-bacteria
K12	I-bacteria
,	O
a	O
commensal	O
bacterium	O
,	O
caused	O
no	O
up	O
-	O
regulation	O
.	O

After	O
24h	O
,	O
the	O
expression	O
of	O
B7H1	O
and	O
B7	O
-	O
DC	O
mRNA	O
in	O
infected	O
cells	O
,	O
normalized	O
to	O
GAPDH	O
and	O
in	O
relation	O
to	O
non	O
-	O
infected	O
cells	O
,	O
was	O
6	O
.	O
4	O
fold	O
(	O
B7	O
-	O
H1	O
)	O
and	O
8	O
.	O
6	O
fold	O
(	O
B7	O
-	O
DC	O
)	O
higher	O
.	O

In	O
PHGK	O
B7	O
-	O
H1	O
/	O
DC	O
mRNA	O
expression	O
increased	O
8	O
.	O
2	O
fold	O
(	O
B7	O
-	O
H1	O
)	O
and	O
5	O
.	O
9	O
fold	O
(	O
B7DC	O
)	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
respectively	O
.	O

The	O
results	O
of	O
the	O
study	O
demonstrate	O
that	O
in	O
contrast	O
to	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
virulent	O
P	I-bacteria
.	I-bacteria
gingivalis	I-bacteria
strains	I-bacteria
are	O
able	O
to	O
induce	O
the	O
expression	O
of	O
the	O
B7	O
-	O
H1	O
and	O
B7	O
-	O
DC	O
receptors	O
in	O
squamous	O
carcinoma	O
cells	O
and	O
human	O
gingival	O
keratinocytes	O
,	O
which	O
might	O
facilitate	O
immune	O
evasion	O
by	O
oral	O
cancers	O
.	O

Products	O
have	O
been	O
developed	O
to	O
provide	O
palliation	O
for	O
persons	O
with	O
dry	O
mouth	O
.	O

In	O
addition	O
to	O
mouth	O
-	O
wetting	O
agents	O
,	O
some	O
products	O
incorporate	O
antimicrobial	O
constituents	O
with	O
the	O
goal	O
of	O
improving	O
oral	O
microbial	O
defenses	O
.	O

The	O
aim	O
of	O
this	O
in	O
vitro	O
study	O
was	O
to	O
investigate	O
the	O
potential	O
antimicrobial	O
and	O
antifungal	O
effects	O
of	O
two	O
commercially	O
available	O
saliva	O
substitutes	O
on	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Lactobacillus	B-bacteria
acidophilus	I-bacteria
,	O
and	O
Candida	O
albicans	O
by	O
using	O
the	O
agar	O
-	O
well	O
diffusion	O
method	O
.	O

Antimicrobial	O
activity	O
as	O
measured	O
by	O
the	O
size	O
of	O
the	O
inhibition	O
zone	O
growth	O
for	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
was	O
observed	O
only	O
with	O
Biotene	O
Dry	O
Mouth	O
Oral	O
Rinse	O
(	O
R	O
)	O
and	O
BioXtra	O
(	O
R	O
)	O
gel	O
.	O

The	O
zone	O
of	O
inhibition	O
of	O
Biotene	O
Dry	O
Mouth	O
Oral	O
Rinse	O
was	O
larger	O
than	O
that	O
of	O
BioXtra	O
gel	O
(	O
p	O
=	O
0	O
.	O
00	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

No	O
anticandidal	O
effect	O
was	O
seen	O
with	O
any	O
of	O
the	O
test	O
products	O
.	O

The	O
pH	O
of	O
the	O
preparations	O
,	O
the	O
variations	O
between	O
the	O
amount	O
of	O
active	O
ingredients	O
within	O
the	O
products	O
,	O
and	O
the	O
potential	O
antimicrobial	O
effects	O
of	O
inactive	O
ingredients	O
should	O
be	O
investigated	O
to	O
determine	O
the	O
factors	O
that	O
impacted	O
microbial	O
inhibition	O
.	O

The	O
mechanisms	O
by	O
which	O
intestinal	O
bacteria	O
achieve	O
their	O
associated	O
health	O
benefits	O
can	O
be	O
complex	O
and	O
multifaceted	O
.	O

In	O
this	O
respect	O
,	O
the	O
diverse	O
microbial	O
composition	O
of	O
the	O
human	O
gastrointestinal	O
tract	O
(	O
GIT	O
)	O
provides	O
an	O
almost	O
unlimited	O
potential	O
source	O
of	O
bioactive	O
substances	O
(	O
pharmabiotics	O
)	O
which	O
can	O
directly	O
or	O
indirectly	O
affect	O
human	O
health	O
.	O

Bacteriocins	O
and	O
fatty	O
acids	O
are	O
just	O
two	O
examples	O
of	O
pharmabiotic	O
substances	O
which	O
may	O
contribute	O
to	O
probiotic	O
functionality	O
within	O
the	O
mammalian	O
GIT	O
.	O

Bacteriocin	O
production	O
is	O
believed	O
to	O
confer	O
producing	O
strains	O
with	O
a	O
competitive	O
advantage	O
within	O
complex	O
microbial	O
environments	O
as	O
a	O
consequence	O
of	O
their	O
associated	O
antimicrobial	O
activity	O
.	O

This	O
has	O
the	O
potential	O
to	O
enable	O
the	O
establishment	O
and	O
prevalence	O
of	O
producing	O
strains	O
as	O
well	O
as	O
directly	O
inhibiting	O
pathogens	O
within	O
the	O
GIT	O
.	O

Consequently	O
,	O
these	O
antimicrobial	O
peptides	O
and	O
the	O
associated	O
intestinal	O
producing	O
strains	O
may	O
be	O
exploited	O
to	O
beneficially	O
influence	O
microbial	O
populations	O
.	O

Intestinal	O
bacteria	O
are	O
also	O
known	O
to	O
produce	O
a	O
diverse	O
array	O
of	O
health	O
-	O
promoting	O
fatty	O
acids	O
.	O

Indeed	O
,	O
certain	O
strains	O
of	O
intestinal	O
bifidobacteria	B-bacteria
have	O
been	O
shown	O
to	O
produce	O
conjugated	O
linoleic	O
acid	O
(	O
CLA	O
)	O
,	O
a	O
fatty	O
acid	O
which	O
has	O
been	O
associated	O
with	O
a	O
variety	O
of	O
systemic	O
health	O
-	O
promoting	O
effects	O
.	O

Recently	O
,	O
the	O
ability	O
to	O
modulate	O
the	O
fatty	O
acid	O
composition	O
of	O
the	O
liver	O
and	O
adipose	O
tissue	O
of	O
the	O
host	O
upon	O
oral	O
administration	O
of	O
CLA	O
-	O
producing	O
bifidobacteria	B-bacteria
and	O
lactobacilli	B-bacteria
was	O
demonstrated	O
in	O
a	O
murine	O
model	O
.	O

Importantly	O
,	O
this	O
implies	O
a	O
potential	O
therapeutic	O
role	O
for	O
probiotics	O
in	O
the	O
treatment	O
of	O
certain	O
metabolic	O
and	O
immunoinflammatory	O
disorders	O
.	O

Such	O
examples	O
serve	O
to	O
highlight	O
the	O
potential	O
contribution	O
of	O
pharmabiotic	O
production	O
to	O
probiotic	O
functionality	O
in	O
relation	O
to	O
human	O
health	O
maintenance	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
(	O
HP	B-bacteria
)	O
infection	O
usually	O
occurs	O
in	O
childhood	O
.	O

While	O
there	O
are	O
various	O
studies	O
on	O
the	O
prevalence	O
of	O
HP	B-bacteria
in	O
dental	O
plaque	O
,	O
ours	O
is	O
the	O
first	O
to	O
analyze	O
its	O
prevalence	O
during	O
orthodontic	O
therapy	O
and	O
its	O
interaction	O
with	O
competitive	O
bacteria	O
in	O
adolescents	O
.	O

The	O
prevalence	O
of	O
HP	B-bacteria
was	O
examined	O
before	O
and	O
during	O
the	O
first	O
12	O
weeks	O
of	O
orthodontic	O
therapy	O
with	O
fixed	O
appliances	O
in	O
11	O
patients	O
with	O
a	O
mean	O
age	O
of	O
12	O
.	O
7	O
years	O
.	O

A	O
total	O
of	O
93	O
plaque	O
samples	O
were	O
analyzed	O
using	O
PCR	O
.	O

The	O
data	O
acquired	O
at	O
every	O
consultation	O
were	O
the	O
following	O
:	O
PCR	O
analysis	O
of	O
dental	O
plaque	O
and	O
(	O
13	O
)	O
C	O
urea	O
breath	O
tests	O
for	O
HP	B-bacteria
,	O
quantitative	O
analyses	O
of	O
saliva	O
for	O
Lactobacilli	B-bacteria
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
the	O
interproximal	O
plaque	O
index	O
(	O
API	O
)	O
,	O
and	O
sulcus	O
bleeding	O
index	O
(	O
SBI	O
)	O
.	O

The	O
prevalence	O
of	O
HP	B-bacteria
in	O
plaque	O
was	O
82	O
%	O
before	O
orthodontic	O
therapy	O
,	O
dropping	O
to	O
54	O
%	O
during	O
therapy	O
(	O
t	O
test	O
,	O
p	O
<	O
/	O
=	O
0	O
.	O
05	O
)	O
.	O

In	O
contrast	O
to	O
HP	B-bacteria
'	O
s	O
prevalence	O
,	O
the	O
Lactobacilli	B-bacteria
count	O
rose	O
(	O
p	O
<	O
/	O
=	O
0	O
.	O
05	O
)	O
.	O

The	O
number	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
bacteria	I-bacteria
in	O
saliva	O
decreased	O
during	O
orthodontic	O
therapy	O
(	O
p	O
<	O
/	O
=	O
0	O
.	O
05	O
)	O
.	O

The	O
prevalence	O
of	O
HP	B-bacteria
in	O
dental	O
plaque	O
amounted	O
to	O
82	O
%	O
.	O

Orthodontic	O
treatment	O
did	O
not	O
reduce	O
its	O
prevalence	O
.	O

The	O
prevalence	O
of	O
Lactobacilli	B-bacteria
was	O
inversely	O
proportional	O
to	O
that	O
of	O
HP	B-bacteria
.	O

To	O
assess	O
and	O
compare	O
the	O
effect	O
of	O
0	O
.	O
2	O
%	O
Chlorhexidine	O
mouth	O
rinse	O
,	O
Listerine	O
mouth	O
rinse	O
and	O
4	O
%	O
Tulsi	O
extract	O
mouth	O
rinse	O
on	O
salivary	O
Streptococcus	B-bacteria
mutans	I-bacteria
level	O
.	O

The	O
present	O
study	O
is	O
an	O
experimental	O
study	O
of	O
cross	O
over	O
type	O
,	O
employing	O
Latin	O
square	O
design	O
.	O

45	O
school	O
children	O
aged	O
14	O
-	O
15	O
years	O
were	O
divided	O
into	O
three	O
groups	O
/	O
blocks	O
.	O

The	O
baseline	O
unstimulated	O
saliva	O
samples	O
were	O
obtained	O
from	O
each	O
group	O
and	O
assessed	O
for	O
Streptococcus	B-bacteria
mutans	I-bacteria
counts	O
.	O

The	O
study	O
was	O
divided	O
in	O
to	O
three	O
phases	O
,	O
each	O
phase	O
lasted	O
for	O
8	O
days	O
separated	O
by	O
a	O
washout	O
period	O
of	O
15	O
days	O
in	O
between	O
them	O
.	O

Groups	O
A	O
,	O
B	O
and	O
C	O
were	O
treated	O
with	O
0	O
.	O
2	O
%	O
Chlorhexidine	O
,	O
Listerine	O
and	O
4	O
%	O
Tulsi	O
extract	O
mouth	O
rinses	O
respectively	O
in	O
the	O
phase	O
I	O
.	O

The	O
study	O
subjects	O
were	O
instructed	O
to	O
use	O
the	O
assigned	O
mouth	O
rinse	O
twice	O
daily	O
for	O
1	O
min	O
for	O
7	O
days	O
.	O

On	O
day	O
8th	O
the	O
subjects	O
were	O
instructed	O
to	O
use	O
the	O
mouth	O
rinse	O
only	O
once	O
in	O
the	O
morning	O
.	O

The	O
follow	O
up	O
unstimulated	O
saliva	O
samples	O
were	O
collected	O
1h	O
after	O
the	O
use	O
of	O
the	O
assigned	O
mouth	O
rinse	O
and	O
assessed	O
for	O
salivary	O
Streptococcus	B-bacteria
mutans	I-bacteria
counts	O
.	O

After	O
phase	O
I	O
,	O
mouth	O
rinses	O
were	O
crossed	O
over	O
as	O
dictated	O
by	O
the	O
Latin	O
square	O
design	O
in	O
phase	O
II	O
and	O
III	O
.	O

All	O
the	O
three	O
mouth	O
rinses	O
have	O
individually	O
shown	O
a	O
statistically	O
significant	O
reduction	O
in	O
the	O
salivary	O
Streptococcus	B-bacteria
mutans	I-bacteria
counts	O
.	O

When	O
the	O
three	O
mouth	O
rinses	O
were	O
compared	O
the	O
difference	O
did	O
not	O
reach	O
statistical	O
significance	O
.	O

Tulsi	O
has	O
stood	O
the	O
test	O
and	O
is	O
as	O
effective	O
as	O
Chlorhexidine	O
and	O
Listerine	O
in	O
reducing	O
the	O
salivary	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
levels	O
.	O

Oral	O
streptococci	B-bacteria
are	O
major	O
pathogens	O
of	O
infective	O
endocarditis	O
.	O

Prophylactic	O
antibiotics	O
are	O
commonly	O
given	O
to	O
subjects	O
with	O
certain	O
kinds	O
of	O
heart	O
disorders	O
when	O
invasive	O
dental	O
treatments	O
are	O
performed	O
,	O
with	O
amoxicillin	O
(	O
AMPC	O
)	O
being	O
widely	O
used	O
for	O
this	O
purpose	O
.	O

However	O
,	O
there	O
is	O
little	O
information	O
regarding	O
AMPC	B-bacteria
-	I-bacteria
resistant	I-bacteria
oral	I-bacteria
streptococci	I-bacteria
.	O

Here	O
,	O
a	O
total	O
of	O
344	O
dental	O
plaque	O
specimens	O
collected	O
from	O
253	O
healthy	O
Japanese	O
children	O
,	O
adolescents	O
and	O
young	O
adults	O
(	O
aged	O
2	O
-	O
22	O
years	O
)	O
were	O
diluted	O
and	O
streaked	O
onto	O
culture	O
medium	O
containing	O
high	O
-	O
dose	O
AMPC	O
.	O

The	O
MICs	O
for	O
the	O
isolated	O
strains	O
were	O
evaluated	O
using	O
a	O
macrodilution	O
broth	O
method	O
described	O
by	O
the	O
Clinical	O
and	O
Laboratory	O
Standards	O
Institute	O
.	O

Bacterial	O
DNA	O
was	O
extracted	O
from	O
each	O
strain	O
and	O
the	O
entire	O
sequences	O
of	O
the	O
16S	O
rRNA	O
gene	O
were	O
compared	O
with	O
those	O
in	O
GenBank	O
to	O
identify	O
the	O
species	O
.	O

The	O
results	O
showed	O
that	O
strains	O
with	O
AMPC	O
MICs	O
>	O
16	O
microg	O
ml	O
(	O
-	O
1	O
)	O
were	O
isolated	O
from	O
18	O
specimens	O
from	O
14	O
patients	O
.	O

Analyses	O
of	O
the	O
16S	O
rRNA	O
gene	O
sequences	O
of	O
these	O
strains	O
identified	O
them	O
as	O
major	O
oral	O
streptococcal	B-bacteria
species	I-bacteria
,	O
including	O
Streptococcus	B-bacteria
oralis	I-bacteria
and	O
Streptococcus	B-bacteria
mitis	I-bacteria
.	O

These	O
findings	O
indicate	O
that	O
oral	O
streptococci	B-bacteria
with	O
elevated	O
MICs	O
for	O
AMPC	O
exist	O
in	O
certain	O
small	O
populations	O
of	O
healthy	O
children	O
,	O
and	O
highlight	O
the	O
need	O
for	O
further	O
studies	O
to	O
determine	O
risk	O
factors	O
that	O
lead	O
to	O
the	O
appearance	O
of	O
such	O
strains	O
.	O

To	O
determine	O
the	O
inhibitory	O
effect	O
of	O
oral	O
Lactobacillus	B-bacteria
against	O
putative	O
oral	O
pathogens	O
.	O

Total	O
357	O
strains	O
comprising	O
10	O
species	O
of	O
oral	O
Lactobacillus	B-bacteria
,	O
Lactobacillus	B-bacteria
fermentum	I-bacteria
(	O
195	O
)	O
,	O
Lactobacillus	B-bacteria
salivarius	I-bacteria
(	O
53	O
)	O
,	O
Lactobacillus	B-bacteria
casei	I-bacteria
(	O
20	O
)	O
,	O
Lactobacillus	B-bacteria
gasseri	I-bacteria
(	O
18	O
)	O
,	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
(	O
14	O
)	O
,	O
Lactobacillus	B-bacteria
paracasei	I-bacteria
(	O
12	O
)	O
,	O
Lactobacillus	B-bacteria
mucosae	I-bacteria
(	O
12	O
)	O
,	O
Lactobacillus	B-bacteria
oris	I-bacteria
(	O
12	O
)	O
,	O
Lactobacillus	B-bacteria
plantarum	I-bacteria
(	O
11	O
)	O
and	O
Lactobacillus	B-bacteria
vaginalis	I-bacteria
(	O
10	O
)	O
were	O
used	O
as	O
producer	O
strains	O
.	O

Inhibitory	O
effect	O
against	O
a	O
panel	O
of	O
indicators	O
,	O
periodontitis	O
-	O
and	O
caries	O
-	O
related	O
pathogens	O
,	O
was	O
assessed	O
.	O

Most	O
oral	O
Lactobacillus	B-bacteria
was	O
able	O
to	O
inhibit	O
the	O
growth	O
of	O
both	O
periodontitis	O
-	O
and	O
caries	O
-	O
related	O
pathogens	O
.	O

The	O
strongest	O
inhibitory	O
activity	O
was	O
associated	O
with	O
Lact	B-bacteria
.	I-bacteria
paracasei	I-bacteria
,	O
Lact	B-bacteria
.	I-bacteria
plantarum	I-bacteria
,	O
Lact	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
,	O
Lact	B-bacteria
.	I-bacteria
casei	I-bacteria
and	O
Lact	B-bacteria
.	I-bacteria
salivarius	I-bacteria
.	O

Lactobacillus	B-bacteria
SD1	I-bacteria
-	I-bacteria
SD6	I-bacteria
,	O
representing	O
the	O
six	O
species	O
with	O
the	O
strong	O
inhibitory	O
effect	O
,	O
inhibited	O
growth	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
ATCC	I-bacteria
25175	I-bacteria
in	O
the	O
biofilm	O
model	O
.	O

Also	O
,	O
it	O
was	O
demonstrated	O
that	O
growth	O
of	O
Strep	B-bacteria
.	I-bacteria
mutans	I-bacteria
was	O
inhibited	O
in	O
a	O
mixture	O
with	O
Lact	B-bacteria
.	I-bacteria
paracasei	I-bacteria
SD1	I-bacteria
.	O

The	O
inhibition	O
was	O
enhanced	O
in	O
acidic	O
condition	O
and	O
5	O
%	O
glucose	O
.	O

The	O
results	O
have	O
shown	O
that	O
oral	O
Lactobacillus	B-bacteria
SD1	I-bacteria
-	I-bacteria
SD6	I-bacteria
showed	O
a	O
strong	O
inhibitory	O
effect	O
against	O
Strep	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
,	O
as	O
well	O
as	O
,	O
Gram	O
-	O
negative	O
periodontal	O
pathogens	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
and	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
.	O

The	O
results	O
indicated	O
that	O
Lactobacillus	B-bacteria
may	O
be	O
of	O
benefit	O
as	O
probiotics	O
for	O
the	O
prevention	O
of	O
oral	O
diseases	O
.	O

Complex	O
and	O
highly	O
variable	O
site	O
-	O
dependent	O
bacterial	O
ecosystems	O
exist	O
throughout	O
the	O
length	O
of	O
the	O
human	O
gastrointestinal	O
tract	O
.	O

Until	O
relatively	O
recently	O
,	O
the	O
majority	O
of	O
our	O
information	O
on	O
intestinal	O
microbiotas	O
has	O
come	O
from	O
studies	O
on	O
feces	O
,	O
or	O
from	O
aspirates	O
taken	O
from	O
the	O
upper	O
gut	O
.	O

However	O
,	O
there	O
is	O
evidence	O
showing	O
that	O
mucosal	O
bacteria	O
growing	O
in	O
biofilms	O
on	O
surfaces	O
lining	O
the	O
gut	O
differ	O
from	O
luminal	O
populations	O
,	O
and	O
that	O
due	O
to	O
their	O
proximity	O
to	O
the	O
epithelial	O
surface	O
,	O
these	O
organisms	O
may	O
be	O
important	O
in	O
modulating	O
the	O
host	O
'	O
s	O
immune	O
system	O
and	O
contributing	O
to	O
some	O
chronic	O
inflammatory	O
diseases	O
.	O

Over	O
the	O
past	O
decade	O
,	O
increasing	O
interest	O
in	O
mucosal	O
bacteria	O
,	O
coupled	O
with	O
advances	O
in	O
molecular	O
approaches	O
for	O
assessing	O
microbial	O
diversity	O
,	O
has	O
begun	O
to	O
provide	O
some	O
insight	O
into	O
the	O
complexity	O
of	O
these	O
mucosa	O
-	O
associated	O
communities	O
.	O

In	O
gastrointestinal	O
conditions	O
such	O
as	O
inflammatory	O
bowel	O
diseases	O
(	O
ulcerative	O
colitis	O
,	O
Crohn	O
'	O
s	O
disease	O
)	O
,	O
it	O
has	O
been	O
shown	O
that	O
a	O
dysbiosis	O
exists	O
in	O
microbial	O
community	O
structure	O
,	O
and	O
that	O
there	O
is	O
a	O
reduction	O
in	O
putatively	O
protective	O
mucosal	O
organisms	O
such	O
as	O
bifidobacteria	B-bacteria
.	O

Therefore	O
,	O
manipulation	O
of	O
mucosal	O
communities	O
may	O
be	O
beneficial	O
in	O
restoring	O
normal	O
functionality	O
in	O
the	O
gut	O
,	O
thereby	O
improving	O
the	O
immune	O
status	O
and	O
general	O
health	O
of	O
the	O
host	O
.	O

Biofilm	O
structure	O
and	O
function	O
has	O
been	O
studied	O
intensively	O
in	O
the	O
oral	O
cavity	O
,	O
and	O
as	O
a	O
consequence	O
,	O
mucosal	O
communities	O
in	O
the	O
mouth	O
will	O
not	O
be	O
covered	O
in	O
this	O
chapter	O
.	O

This	O
review	O
addresses	O
our	O
current	O
knowledge	O
of	O
mucosal	O
populations	O
in	O
the	O
gastrointestinal	O
tract	O
,	O
changes	O
that	O
can	O
occur	O
in	O
community	O
structure	O
in	O
disease	O
,	O
and	O
therapeutic	O
modulation	O
of	O
biofilm	O
composition	O
by	O
antibiotics	O
,	O
prebiotics	O
,	O
and	O
probiotics	O
.	O

Enteral	O
tube	O
feeding	O
is	O
widely	O
used	O
to	O
maintain	O
nutrition	O
for	O
elderly	O
adults	O
with	O
eating	O
difficulties	O
,	O
but	O
its	O
long	O
-	O
term	O
use	O
alters	O
the	O
environment	O
of	O
the	O
oral	O
ecosystem	O
.	O

This	O
study	O
characterized	O
the	O
tongue	O
microbiota	O
of	O
tube	O
-	O
fed	O
elderly	O
adults	O
by	O
analyzing	O
the	O
16S	O
rRNA	O
gene	O
.	O

The	O
terminal	O
restriction	O
fragment	O
length	O
polymorphism	O
(	O
T	O
-	O
RFLP	O
)	O
profiles	O
of	O
44	O
tube	O
-	O
fed	O
subjects	O
were	O
compared	O
with	O
those	O
of	O
54	O
subjects	O
fed	O
orally	O
(	O
average	O
age	O
,	O
86	O
.	O
4	O
+	O
/	O
-	O
6	O
.	O
9	O
years	O
)	O
.	O

Bar	O
-	O
coded	O
pyrosequencing	O
data	O
were	O
also	O
obtained	O
for	O
a	O
subset	O
of	O
the	O
subjects	O
from	O
each	O
group	O
(	O
15	O
tube	O
-	O
fed	O
subjects	O
and	O
16	O
subjects	O
fed	O
orally	O
)	O
.	O

The	O
T	O
-	O
RFLP	O
profiles	O
demonstrated	O
that	O
the	O
microbiota	O
of	O
the	O
tube	O
-	O
fed	O
subjects	O
was	O
distinct	O
from	O
that	O
of	O
the	O
subjects	O
fed	O
orally	O
(	O
permutational	O
multivariate	O
analysis	O
of	O
variance	O
[	O
perMANOVA	O
]	O
,	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

The	O
pyrosequencing	O
data	O
revealed	O
that	O
22	O
bacterial	O
genera	O
,	O
including	O
Corynebacterium	B-bacteria
,	O
Peptostreptococcus	B-bacteria
,	O
and	O
Fusobacterium	B-bacteria
,	O
were	O
significantly	O
more	O
predominant	O
in	O
tube	O
-	O
fed	O
subjects	O
,	O
whereas	O
the	O
dominant	O
genera	O
in	O
the	O
subjects	O
fed	O
orally	O
,	O
such	O
as	O
Streptococcus	B-bacteria
and	O
Veillonella	B-bacteria
,	O
were	O
present	O
in	O
much	O
lower	O
proportions	O
.	O

Opportunistic	O
pathogens	O
rarely	O
detected	O
in	O
the	O
normal	O
oral	O
microbiota	O
,	O
such	O
as	O
Corynebacterium	B-bacteria
striatum	I-bacteria
and	O
Streptococcus	B-bacteria
agalactiae	I-bacteria
,	O
were	O
often	O
found	O
in	O
high	O
proportions	O
in	O
tube	O
-	O
fed	O
subjects	O
.	O

The	O
oral	O
indigenous	O
microbiota	O
is	O
disrupted	O
by	O
the	O
use	O
of	O
enteral	O
feeding	O
,	O
allowing	O
health	O
-	O
threatening	O
bacteria	O
to	O
thrive	O
.	O

The	O
human	O
oral	O
microbiome	O
is	O
potentially	O
related	O
to	O
diverse	O
health	O
conditions	O
and	O
high	O
-	O
throughput	O
technology	O
provides	O
the	O
possibility	O
of	O
surveying	O
microbial	O
community	O
structure	O
at	O
high	O
resolution	O
.	O

We	O
compared	O
two	O
oral	O
microbiome	O
survey	O
methods	O
:	O
broad	O
-	O
based	O
microbiome	O
identification	O
by	O
16S	O
rRNA	O
gene	O
sequencing	O
and	O
targeted	O
characterization	O
of	O
microbes	O
by	O
custom	O
DNA	O
microarray	O
.	O

Oral	O
wash	O
samples	O
were	O
collected	O
from	O
20	O
individuals	O
at	O
Memorial	O
Sloan	O
-	O
Kettering	O
Cancer	O
Center	O
.	O

16S	O
rRNA	O
gene	O
survey	O
was	O
performed	O
by	O
454	O
pyrosequencing	O
of	O
the	O
V3	O
-	O
V5	O
region	O
(	O
450	O
bp	O
)	O
.	O

Targeted	O
identification	O
by	O
DNA	O
microarray	O
was	O
carried	O
out	O
with	O
the	O
Human	O
Oral	O
Microbe	O
Identification	O
Microarray	O
(	O
HOMIM	O
)	O
.	O

Correlations	O
and	O
relative	O
abundance	O
were	O
compared	O
at	O
phylum	O
and	O
genus	O
level	O
,	O
between	O
16S	O
rRNA	O
sequence	O
read	O
ratio	O
and	O
HOMIM	O
hybridization	O
intensity	O
.	O

The	O
major	O
phyla	O
,	O
Firmicutes	B-bacteria
,	O
Proteobacteria	B-bacteria
,	O
Bacteroidetes	B-bacteria
,	O
Actinobacteria	B-bacteria
,	O
and	O
Fusobacteria	B-bacteria
were	O
identified	O
with	O
high	O
correlation	O
by	O
the	O
two	O
methods	O
(	O
r	O
=	O
0	O
.	O
70	O
approximately	O
0	O
.	O
86	O
)	O
.	O

16S	O
rRNA	O
gene	O
pyrosequencing	O
identified	O
77	O
genera	O
and	O
HOMIM	O
identified	O
49	O
,	O
with	O
37	O
genera	O
detected	O
by	O
both	O
methods	O
;	O
more	O
than	O
98	O
%	O
of	O
classified	O
bacteria	O
were	O
assigned	O
in	O
these	O
37	O
genera	O
.	O

Concordance	O
by	O
the	O
two	O
assays	O
(	O
presence	O
/	O
absence	O
)	O
and	O
correlations	O
were	O
high	O
for	O
common	O
genera	O
(	O
Streptococcus	B-bacteria
,	O
Veillonella	B-bacteria
,	O
Leptotrichia	B-bacteria
,	O
Prevotella	B-bacteria
,	O
and	O
Haemophilus	B-bacteria
;	O
Correlation	O
=	O
0	O
.	O
70	O
-	O
0	O
.	O
84	O
)	O
.	O

Microbiome	O
community	O
profiles	O
assessed	O
by	O
16S	O
rRNA	O
pyrosequencing	O
and	O
HOMIM	O
were	O
highly	O
correlated	O
at	O
the	O
phylum	O
level	O
and	O
,	O
when	O
comparing	O
the	O
more	O
commonly	O
detected	O
taxa	O
,	O
also	O
at	O
the	O
genus	O
level	O
.	O

Both	O
methods	O
are	O
currently	O
suitable	O
for	O
high	O
-	O
throughput	O
epidemiologic	O
investigations	O
relating	O
identified	O
and	O
more	O
common	O
oral	O
microbial	O
taxa	O
to	O
disease	O
risk	O
;	O
yet	O
,	O
pyrosequencing	O
may	O
provide	O
a	O
broader	O
spectrum	O
of	O
taxa	O
identification	O
,	O
a	O
distinct	O
sequence	O
-	O
read	O
record	O
,	O
and	O
greater	O
detection	O
sensitivity	O
.	O

Extracellular	O
matrix	O
metalloproteinase	O
inducer	O
(	O
EMMPRIN	O
)	O
or	O
CD147	O
is	O
a	O
transmembrane	O
glycoprotein	O
expressed	O
by	O
various	O
cell	O
types	O
,	O
including	O
oral	O
epithelial	O
cells	O
.	O

Recent	O
studies	O
have	O
brought	O
evidence	O
that	O
EMMPRIN	O
plays	O
a	O
role	O
in	O
periodontitis	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
investigated	O
the	O
effect	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
a	O
major	O
pathogen	O
in	O
chronic	O
periodontitis	O
,	O
on	O
the	O
shedding	O
of	O
membrane	O
-	O
anchored	O
EMMPRIN	O
and	O
on	O
the	O
expression	O
of	O
the	O
EMMPRIN	O
gene	O
by	O
oral	O
epithelial	O
cells	O
.	O

A	O
potential	O
contribution	O
of	O
shed	O
EMMPRIN	O
to	O
the	O
inflammatory	O
process	O
of	O
periodontitis	O
was	O
analyzed	O
by	O
evaluating	O
the	O
effect	O
of	O
recombinant	O
EMMPRIN	O
on	O
cytokine	O
and	O
matrix	O
metalloproteinase	O
(	O
MMP	O
)	O
secretion	O
by	O
human	O
gingival	O
fibroblasts	O
.	O

ELISA	O
and	O
immunofluorescence	O
analyses	O
revealed	O
that	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
mediated	O
the	O
shedding	O
of	O
epithelial	O
cell	O
-	O
surface	O
EMMPRIN	O
in	O
a	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manner	O
.	O

Cysteine	O
proteinase	O
(	O
gingipain	O
)	O
-	O
deficient	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
mutants	O
were	O
used	O
to	O
demonstrate	O
that	O
both	O
Arg	O
-	O
and	O
Lys	O
-	O
gingipain	O
activities	O
are	O
involved	O
in	O
EMMPRIN	O
shedding	O
.	O

Real	O
-	O
time	O
PCR	O
showed	O
that	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
had	O
no	O
significant	O
effect	O
on	O
the	O
expression	O
of	O
the	O
EMMPRIN	O
gene	O
in	O
epithelial	O
cells	O
.	O

Recombinant	O
EMMPRIN	O
induced	O
the	O
secretion	O
of	O
IL	O
-	O
6	O
and	O
MMP	O
-	O
3	O
by	O
gingival	O
fibroblasts	O
,	O
a	O
phenomenon	O
that	O
appears	O
to	O
involve	O
mitogen	O
activated	O
protein	O
kinases	O
.	O

The	O
present	O
study	O
brought	O
to	O
light	O
a	O
new	O
mechanism	O
by	O
which	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
can	O
promote	O
the	O
inflammatory	O
response	O
during	O
periodontitis	O
.	O

Indigenous	O
microbes	O
are	O
known	O
to	O
influence	O
human	O
health	O
outcomes	O
and	O
various	O
approaches	O
are	O
now	O
being	O
made	O
to	O
positively	O
modulate	O
these	O
microbe	O
-	O
induced	O
outcomes	O
via	O
the	O
administration	O
of	O
probiotics	O
.	O

The	O
application	O
of	O
probiotics	O
that	O
are	O
specific	O
to	O
the	O
oral	O
cavity	O
is	O
a	O
relatively	O
undeveloped	O
field	O
,	O
and	O
their	O
emergence	O
has	O
largely	O
occurred	O
as	O
a	O
reasoned	O
follow	O
-	O
up	O
to	O
initial	O
studies	O
in	O
which	O
probiotics	O
that	O
had	O
already	O
been	O
developed	O
and	O
obtained	O
regulatory	O
approval	O
for	O
intestinal	O
applications	O
were	O
then	O
also	O
evaluated	O
for	O
their	O
putative	O
influence	O
on	O
oral	O
microbiota	O
functionality	O
.	O

These	O
attempts	O
to	O
extend	O
the	O
application	O
of	O
existing	O
probiotics	O
were	O
probably	O
at	O
least	O
in	O
part	O
motivated	O
by	O
recognition	O
of	O
the	O
substantial	O
safety	O
and	O
regulatory	O
hurdles	O
that	O
must	O
be	O
overcome	O
prior	O
to	O
the	O
introduction	O
of	O
a	O
novel	O
probiotic	O
agent	O
.	O

Nevertheless	O
,	O
from	O
an	O
efficacy	O
perspective	O
it	O
appears	O
more	O
logical	O
to	O
develop	O
microbes	O
of	O
oral	O
origin	O
as	O
the	O
specific	O
providers	O
of	O
probiotic	O
solutions	O
for	O
oral	O
diseases	O
,	O
rather	O
than	O
attempting	O
to	O
adapt	O
intestinally	O
-	O
derived	O
strains	O
for	O
this	O
role	O
.	O

Oral	O
bacteria	O
and	O
their	O
bioactive	O
molecules	O
have	O
evolved	O
to	O
operate	O
optimally	O
in	O
this	O
environment	O
and	O
in	O
some	O
cases	O
are	O
known	O
to	O
persist	O
only	O
in	O
oral	O
sites	O
.	O

Amongst	O
the	O
bacteria	O
of	O
more	O
than	O
700	O
species	O
now	O
identified	O
within	O
the	O
human	O
oral	O
microbiota	O
,	O
it	O
is	O
the	O
streptococci	B-bacteria
that	O
are	O
numerically	O
predominant	O
.	O

Although	O
this	O
review	O
highlights	O
the	O
development	O
of	O
the	O
oral	O
cavity	O
bacterium	O
Streptococcus	B-bacteria
salivarius	I-bacteria
as	O
an	O
oral	O
probiotic	O
,	O
a	O
number	O
of	O
other	O
streptococcal	B-bacteria
species	I-bacteria
have	O
also	O
been	O
shown	O
to	O
have	O
considerable	O
potential	O
as	O
probiotic	O
candidates	O
.	O

Posttympanostomy	O
tube	O
otorrhea	O
(	O
PTTO	O
)	O
results	O
in	O
significant	O
health	O
care	O
cost	O
and	O
decreased	O
satisfaction	O
with	O
care	O
.	O

The	O
authors	O
reviewed	O
PTTO	O
failing	O
initial	O
ototopical	O
and	O
/	O
or	O
oral	O
antibiotic	O
therapy	O
and	O
microbiology	O
/	O
susceptibility	O
data	O
from	O
cultures	O
.	O

Case	O
series	O
with	O
chart	O
review	O
.	O

A	O
community	O
university	O
satellite	O
ambulatory	O
clinic	O
and	O
the	O
outpatient	O
clinic	O
of	O
a	O
children	O
'	O
s	O
hospital	O
.	O

Review	O
of	O
202	O
patients	O
with	O
228	O
discrete	O
episodes	O
of	O
culture	O
-	O
positive	O
otorrhea	O
from	O
January	O
2004	O
to	O
January	O
2009	O
.	O

PTTO	O
occurred	O
an	O
average	O
of	O
13	O
months	O
after	O
tube	O
placement	O
.	O

Median	O
otorrhea	O
duration	O
was	O
21	O
days	O
(	O
mean	O
,	O
42	O
days	O
)	O
.	O

A	O
mean	O
of	O
1	O
.	O
6	O
visits	O
(	O
range	O
,	O
1	O
-	O
6	O
)	O
to	O
the	O
pediatric	O
otolaryngology	O
office	O
was	O
required	O
for	O
PTTO	O
resolution	O
.	O

Ototopical	O
therapy	O
was	O
reported	O
used	O
in	O
198	O
of	O
228	O
(	O
87	O
%	O
)	O
episodes	O
of	O
otorrhea	O
prior	O
to	O
pediatric	O
otolaryngology	O
visit	O
.	O

Nearly	O
50	O
%	O
of	O
patients	O
were	O
prescribed	O
at	O
least	O
1	O
or	O
more	O
courses	O
of	O
systemic	O
antibiotics	O
.	O

Staphylococcus	B-bacteria
aureus	I-bacteria
accounted	O
for	O
52	O
%	O
of	O
the	O
organisms	O
cultured	O
,	O
with	O
57	O
%	O
methicillin	B-bacteria
-	I-bacteria
resistant	I-bacteria
S	I-bacteria
aureus	I-bacteria
(	O
MRSA	B-bacteria
)	O
.	O

S	B-bacteria
aureus	I-bacteria
resistance	O
to	O
clindamycin	O
was	O
high	O
(	O
49	O
%	O
)	O
and	O
resistance	O
to	O
levofloxacin	O
was	O
low	O
(	O
1	O
.	O
8	O
%	O
)	O
.	O

MRSA	B-bacteria
was	O
68	O
%	O
clindamycin	O
resistant	O
,	O
much	O
higher	O
than	O
both	O
ours	O
and	O
the	O
children	O
'	O
s	O
hospital	O
'	O
s	O
clindamycin	O
resistance	O
rate	O
of	O
MRSA	B-bacteria
cultured	O
from	O
all	O
other	O
body	O
sites	O
.	O

PTTO	O
that	O
presents	O
as	O
having	O
failed	O
ototopical	O
and	O
/	O
or	O
oral	O
antibiotics	O
most	O
commonly	O
consists	O
of	O
S	B-bacteria
aureus	I-bacteria
,	O
Streptococcus	B-bacteria
pneumoniae	I-bacteria
,	O
and	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
.	O

MRSA	B-bacteria
is	O
highly	O
prevalent	O
in	O
this	O
population	O
.	O

It	O
is	O
not	O
necessary	O
to	O
culture	O
PTTO	O
that	O
presents	O
to	O
an	O
otolaryngology	O
office	O
,	O
as	O
resistance	O
to	O
levofloxacin	O
was	O
only	O
1	O
.	O
8	O
%	O
.	O

It	O
is	O
unclear	O
why	O
the	O
same	O
fluoroquinolone	O
ototopical	O
therapy	O
that	O
failed	O
initially	O
is	O
often	O
successful	O
in	O
treating	O
PTTO	O
after	O
otolaryngologist	O
visit	O
.	O

Five	O
species	O
of	O
oral	O
Veillonella	B-bacteria
,	O
V	B-bacteria
.	I-bacteria
atypica	I-bacteria
,	O
V	B-bacteria
.	I-bacteria
denticariosi	I-bacteria
,	O
V	B-bacteria
.	I-bacteria
dispar	I-bacteria
,	O
V	B-bacteria
.	I-bacteria
parvula	I-bacteria
,	O
and	O
V	B-bacteria
.	I-bacteria
rogosae	I-bacteria
,	O
have	O
been	O
suggested	O
to	O
be	O
early	O
colonizers	O
of	O
dental	O
biofilm	O
and	O
causes	O
of	O
opportunistic	O
infections	O
and	O
oral	O
mucosa	O
.	O

However	O
,	O
the	O
pathogenicity	O
and	O
the	O
distribution	O
of	O
oral	O
Veillonella	B-bacteria
spp	I-bacteria
.	I-bacteria
have	O
not	O
been	O
clarified	O
.	O

Previously	O
,	O
oral	O
Veillonella	B-bacteria
spp	I-bacteria
.	I-bacteria
were	O
identified	O
by	O
using	O
16S	O
rDNA	O
sequence	O
analysis	O
.	O

In	O
addition	O
,	O
recently	O
,	O
Veillonella	B-bacteria
isolates	I-bacteria
from	O
human	O
tongue	O
biofilm	O
were	O
identified	O
by	O
rpoB	O
gene	O
sequences	O
,	O
but	O
these	O
procedures	O
are	O
time	O
-	O
consuming	O
and	O
complex	O
.	O

To	O
overcome	O
this	O
problem	O
,	O
Igarashi	O
et	O
al	O
.	O
have	O
designed	O
species	O
-	O
specific	O
primer	O
sets	O
for	O
oral	O
Veillonella	B-bacteria
spp	I-bacteria
.	I-bacteria
by	O
using	O
a	O
highly	O
variable	O
region	O
in	O
the	O
rpoB	O
gene	O
.	O

In	O
the	O
present	O
study	O
,	O
the	O
distribution	O
and	O
frequency	O
of	O
oral	O
Veillonella	B-bacteria
spp	I-bacteria
.	I-bacteria
in	O
the	O
tongue	O
biofilm	O
of	O
healthy	O
adults	O
in	O
their	O
20s	O
were	O
examined	O
by	O
using	O
these	O
species	O
-	O
specific	O
primer	O
sets	O
.	O

Tongue	O
biofilm	O
of	O
these	O
subjects	O
were	O
found	O
to	O
be	O
divided	O
into	O
two	O
groups	O
based	O
on	O
the	O
distribution	O
and	O
frequency	O
of	O
oral	O
Veillonella	B-bacteria
spp	I-bacteria
.	O

In	O
one	O
group	O
,	O
V	B-bacteria
.	I-bacteria
rogosae	I-bacteria
was	O
the	O
predominant	O
species	O
;	O
the	O
other	O
group	O
consisted	O
of	O
mainly	O
V	B-bacteria
.	I-bacteria
dispar	I-bacteria
and	O
V	B-bacteria
.	I-bacteria
atypica	I-bacteria
.	O

Multiple	O
factors	O
may	O
influence	O
these	O
differences	O
in	O
distribution	O
and	O
frequency	O
of	O
oral	O
Veillonella	B-bacteria
spp	I-bacteria
.	I-bacteria
in	O
tongue	O
biofilm	O
.	O

This	O
is	O
the	O
first	O
report	O
also	O
demonstrating	O
the	O
availability	O
of	O
the	O
species	O
-	O
specific	O
primer	O
sets	O
for	O
PCR	O
to	O
determine	O
the	O
distribution	O
and	O
frequency	O
of	O
oral	O
Veillonella	B-bacteria
spp	I-bacteria
.	I-bacteria
in	O
the	O
tongue	O
biofilm	O
of	O
healthy	O
adults	O
in	O
their	O
20s	O
.	O

Bacterial	O
contribution	O
to	O
oral	O
disease	O
has	O
been	O
studied	O
in	O
young	O
children	O
,	O
but	O
there	O
is	O
a	O
lack	O
of	O
data	O
addressing	O
the	O
developmental	O
perspective	O
in	O
edentulous	O
infants	O
.	O

Our	O
primary	O
objectives	O
were	O
to	O
use	O
pyrosequencing	O
to	O
phylogenetically	O
characterize	O
the	O
salivary	O
bacterial	O
microbiome	O
of	O
edentulous	O
infants	O
and	O
to	O
make	O
comparisons	O
against	O
their	O
mothers	O
.	O

Saliva	O
samples	O
were	O
collected	O
from	O
5	O
edentulous	O
infants	O
(	O
mean	O
age	O
=	O
4	O
.	O
6	O
+	O
/	O
-	O
1	O
.	O
2	O
mo	O
old	O
)	O
and	O
their	O
mothers	O
or	O
primary	O
care	O
givers	O
(	O
mean	O
age	O
=	O
30	O
.	O
8	O
+	O
/	O
-	O
9	O
.	O
5	O
y	O
old	O
)	O
.	O

Salivary	O
DNA	O
was	O
extracted	O
,	O
used	O
to	O
generate	O
DNA	O
amplicons	O
of	O
the	O
V4	O
-	O
V6	O
hypervariable	O
region	O
of	O
the	O
bacterial	O
16S	O
rDNA	O
gene	O
,	O
and	O
subjected	O
to	O
454	O
-	O
pyrosequencing	O
.	O

On	O
average	O
,	O
over	O
80	O
,	O
000	O
sequences	O
per	O
sample	O
were	O
generated	O
.	O

High	O
bacterial	O
diversity	O
was	O
noted	O
in	O
the	O
saliva	O
of	O
adults	O
[	O
1012	O
operational	O
taxonomical	O
units	O
(	O
OTU	O
)	O
at	O
3	O
%	O
divergence	O
]	O
and	O
infants	O
(	O
578	O
OTU	O
at	O
3	O
%	O
divergence	O
)	O
.	O

Firmicutes	B-bacteria
,	O
Proteobacteria	B-bacteria
,	O
Actinobacteria	B-bacteria
,	O
and	O
Fusobacteria	B-bacteria
were	O
predominant	O
bacterial	O
phyla	O
present	O
in	O
all	O
samples	O
.	O

A	O
total	O
of	O
397	O
bacterial	O
genera	O
were	O
present	O
in	O
our	O
dataset	O
.	O

Of	O
the	O
28	O
genera	O
different	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
between	O
infants	O
and	O
adults	O
,	O
27	O
had	O
a	O
greater	O
prevalence	O
in	O
adults	O
.	O

The	O
exception	O
was	O
Streptococcus	B-bacteria
,	O
which	O
was	O
the	O
predominant	O
genera	O
in	O
infant	O
saliva	O
(	O
62	O
.	O
2	O
%	O
in	O
infants	O
vs	O
.	O
20	O
.	O
4	O
%	O
in	O
adults	O
;	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Veillonella	B-bacteria
,	O
Neisseria	B-bacteria
,	O
Rothia	B-bacteria
,	O
Haemophilus	B-bacteria
,	O
Gemella	B-bacteria
,	O
Granulicatella	B-bacteria
,	O
Leptotrichia	B-bacteria
,	O
and	O
Fusobacterium	B-bacteria
were	O
also	O
predominant	O
genera	O
in	O
infant	O
samples	O
,	O
while	O
Haemophilus	B-bacteria
,	O
Neisseria	B-bacteria
,	O
Veillonella	B-bacteria
,	O
Fusobacterium	B-bacteria
,	O
Oribacterium	B-bacteria
,	O
Rothia	B-bacteria
,	O
Treponema	B-bacteria
,	O
and	O
Actinomyces	B-bacteria
were	O
predominant	O
in	O
adults	O
.	O

Our	O
data	O
demonstrate	O
that	O
although	O
the	O
adult	O
saliva	O
bacterial	O
microbiome	O
had	O
a	O
greater	O
OTU	O
count	O
than	O
infants	O
,	O
a	O
rich	O
bacterial	O
community	O
exists	O
in	O
the	O
infant	O
oral	O
cavity	O
prior	O
to	O
tooth	O
eruption	O
.	O

Streptococcus	B-bacteria
,	O
Veillonella	B-bacteria
,	O
and	O
Neisseria	B-bacteria
are	O
the	O
predominant	O
bacterial	O
genera	O
present	O
in	O
infants	O
.	O

Further	O
research	O
is	O
required	O
to	O
characterize	O
the	O
development	O
of	O
oral	O
microbiota	O
early	O
in	O
life	O
and	O
identify	O
environmental	O
factors	O
that	O
impact	O
colonization	O
and	O
oral	O
and	O
gastrointestinal	O
disease	O
risk	O
.	O

Recent	O
evidence	O
suggests	O
that	O
smoking	O
affects	O
the	O
composition	O
of	O
the	O
disease	O
-	O
associated	O
subgingival	O
biofilm	O
,	O
yet	O
little	O
is	O
known	O
about	O
its	O
effects	O
during	O
the	O
formation	O
of	O
this	O
biofilm	O
.	O

The	O
present	O
investigation	O
was	O
undertaken	O
to	O
examine	O
the	O
contributions	O
of	O
smoking	O
to	O
the	O
composition	O
and	O
proinflammatory	O
characteristics	O
of	O
the	O
biofilm	O
during	O
de	O
novo	O
plaque	O
formation	O
.	O

Marginal	O
and	O
subgingival	O
plaque	O
and	O
gingival	O
crevicular	O
fluid	O
samples	O
were	O
collected	O
from	O
15	O
current	O
smokers	O
and	O
from	O
15	O
individuals	O
who	O
had	O
never	O
smoked	O
(	O
nonsmokers	O
)	O
following	O
1	O
,	O
2	O
,	O
4	O
,	O
and	O
7	O
days	O
of	O
undisturbed	O
plaque	O
formation	O
.	O

16S	O
rRNA	O
gene	O
cloning	O
and	O
sequencing	O
were	O
used	O
for	O
bacterial	O
identification	O
,	O
and	O
multiplex	O
bead	O
-	O
based	O
flow	O
cytometry	O
was	O
used	O
to	O
quantify	O
the	O
levels	O
of	O
27	O
immune	O
mediators	O
.	O

Smokers	O
demonstrated	O
a	O
highly	O
diverse	O
,	O
relatively	O
unstable	O
initial	O
colonization	O
of	O
both	O
marginal	O
and	O
subgingival	O
biofilms	O
,	O
with	O
lower	O
niche	O
saturation	O
than	O
that	O
seen	O
in	O
nonsmokers	O
.	O

Periodontal	O
pathogens	O
belonging	O
to	O
the	O
genera	O
Fusobacterium	B-bacteria
,	O
Cardiobacterium	B-bacteria
,	O
Synergistes	B-bacteria
,	O
and	O
Selenomonas	B-bacteria
,	O
as	O
well	O
as	O
respiratory	O
pathogens	O
belonging	O
to	O
the	O
genera	O
Haemophilus	B-bacteria
and	O
Pseudomonas	B-bacteria
,	O
colonized	O
the	O
early	O
biofilms	O
of	O
smokers	O
and	O
continued	O
to	O
persist	O
over	O
the	O
observation	O
period	O
,	O
suggesting	O
that	O
smoking	O
favors	O
early	O
acquisition	O
and	O
colonization	O
of	O
pathogens	O
in	O
oral	O
biofilms	O
.	O

Smokers	O
also	O
demonstrated	O
an	O
early	O
proinflammatory	O
response	O
to	O
this	O
colonization	O
,	O
which	O
persisted	O
over	O
7	O
days	O
.	O

Further	O
,	O
a	O
positive	O
correlation	O
between	O
proinflammatory	O
cytokine	O
levels	O
and	O
commensal	O
bacteria	O
was	O
observed	O
in	O
smokers	O
but	O
not	O
in	O
nonsmokers	O
.	O

Taken	O
together	O
,	O
the	O
data	O
suggest	O
that	O
smoking	O
influences	O
both	O
the	O
composition	O
of	O
the	O
nascent	O
biofilm	O
and	O
the	O
host	O
response	O
to	O
this	O
colonization	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
,	O
the	O
major	O
etiological	O
agent	O
of	O
dental	O
caries	O
,	O
has	O
a	O
measurable	O
impact	O
on	O
domestic	O
and	O
global	O
health	O
care	O
costs	O
.	O

Though	O
persistent	O
in	O
the	O
oral	O
cavity	O
despite	O
conventional	O
oral	O
hygiene	O
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
can	O
be	O
excluded	O
from	O
intact	O
oral	O
biofilms	O
through	O
competitive	O
exclusion	O
by	O
other	O
microorganisms	O
.	O

This	O
suggests	O
that	O
therapies	O
capable	O
of	O
selectively	O
eliminating	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
while	O
limiting	O
the	O
damage	O
to	O
the	O
normal	O
oral	O
flora	O
might	O
be	O
effective	O
long	O
-	O
term	O
interventions	O
to	O
fight	O
cariogenesis	O
.	O

To	O
meet	O
this	O
challenge	O
,	O
we	O
designed	O
C16G2	O
,	O
a	O
novel	O
synthetic	O
specifically	O
targeted	O
antimicrobial	O
peptide	O
with	O
specificity	O
for	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

C16G2	O
consists	O
of	O
a	O
S	O
.	O
mutans	O
-	O
selective	O
'	O
targeting	O
region	O
'	O
comprised	O
of	O
a	O
fragment	O
from	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
competence	O
stimulation	O
peptide	O
(	O
CSP	O
)	O
conjoined	O
to	O
a	O
'	O
killing	O
region	O
'	O
consisting	O
of	O
a	O
broad	O
-	O
spectrum	O
antimicrobial	O
peptide	O
(	O
G2	O
)	O
.	O

In	O
vitro	O
studies	O
have	O
indicated	O
that	O
C16G2	O
has	O
robust	O
efficacy	O
and	O
selectivity	O
for	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
and	O
not	O
other	O
oral	O
bacteria	O
,	O
and	O
affects	O
targeted	O
bacteria	O
within	O
seconds	O
of	O
contact	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
evaluated	O
C16G2	O
for	O
clinical	O
utility	O
in	O
vitro	O
,	O
followed	O
by	O
a	O
pilot	O
efficacy	O
study	O
to	O
examine	O
the	O
impact	O
of	O
a	O
0	O
.	O
04	O
%	O
(	O
w	O
/	O
v	O
)	O
C16G2	O
rinse	O
in	O
an	O
intra	O
-	O
oral	O
remineralization	O
/	O
demineralization	O
model	O
.	O

C16G2	O
rinse	O
usage	O
was	O
associated	O
with	O
reductions	O
in	O
plaque	O
and	O
salivary	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
lactic	O
acid	O
production	O
,	O
and	O
enamel	O
demineralization	O
.	O

The	O
impact	O
on	O
total	O
plaque	O
bacteria	O
was	O
minimal	O
.	O

These	O
results	O
suggest	O
that	O
C16G2	O
is	O
effective	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
vivo	O
and	O
should	O
be	O
evaluated	O
further	O
in	O
the	O
clinic	O
.	O

In	O
view	O
of	O
the	O
morbidity	O
potential	O
of	O
oral	O
complications	O
in	O
patients	O
with	O
leukemia	O
,	O
this	O
study	O
evaluated	O
the	O
clinical	O
and	O
microbiological	O
alterations	O
that	O
occur	O
in	O
the	O
oral	O
mucosa	O
of	O
children	O
with	O
acute	O
lymphoblastic	O
leukemia	O
(	O
ALL	O
)	O
undergoing	O
antineoplastic	O
chemotherapy	O
and	O
prophylactic	O
administration	O
of	O
0	O
.	O
12	O
%	O
chlorhexidine	O
gluconate	O
.	O

The	O
sample	O
consisted	O
of	O
17	O
children	O
aged	O
2	O
to	O
12	O
years	O
that	O
underwent	O
clinical	O
examination	O
of	O
the	O
oral	O
mucosa	O
for	O
the	O
detection	O
of	O
oral	O
lesions	O
.	O

In	O
addition	O
,	O
biological	O
material	O
was	O
collected	O
from	O
labial	O
and	O
buccal	O
mucosa	O
for	O
microbiological	O
analysis	O
.	O

Oral	O
mucositis	O
was	O
observed	O
in	O
only	O
5	O
(	O
29	O
.	O
4	O
%	O
)	O
patients	O
.	O

Microbiological	O
analysis	O
revealed	O
a	O
reduced	O
number	O
of	O
potentially	O
pathogenic	O
microorganisms	O
,	O
such	O
as	O
coagulase	B-bacteria
-	I-bacteria
negative	I-bacteria
staphylococci	I-bacteria
(	O
47	O
%	O
)	O
,	O
Candida	O
albicans	O
(	O
35	O
.	O
3	O
%	O
)	O
,	O
Klebsiella	B-bacteria
pneumoniae	I-bacteria
(	O
5	O
.	O
9	O
%	O
)	O
,	O
enteropathogenic	B-bacteria
Escherichia	I-bacteria
coli	I-bacteria
(	O
5	O
.	O
9	O
%	O
)	O
,	O
and	O
Stenotrophomonas	B-bacteria
maltophilia	I-bacteria
(	O
5	O
.	O
9	O
%	O
)	O
.	O

Patients	O
with	O
oral	O
mucositis	O
showed	O
a	O
higher	O
frequency	O
of	O
coagulase	B-bacteria
-	I-bacteria
negative	I-bacteria
staphylococci	I-bacteria
(	O
80	O
%	O
)	O
when	O
compared	O
with	O
patients	O
with	O
normal	O
oral	O
mucosa	O
(	O
33	O
.	O
3	O
%	O
)	O
.	O

In	O
conclusion	O
,	O
the	O
results	O
of	O
the	O
present	O
study	O
suggest	O
that	O
the	O
prophylactic	O
use	O
of	O
0	O
.	O
12	O
%	O
chlorhexidine	O
gluconate	O
reduces	O
the	O
frequency	O
of	O
oral	O
mucositis	O
and	O
oral	O
pathogens	O
in	O
children	O
with	O
ALL	O
.	O

In	O
addition	O
,	O
the	O
present	O
findings	O
suggest	O
a	O
possible	O
relationship	O
between	O
coagulase	B-bacteria
-	I-bacteria
negative	I-bacteria
staphylococci	I-bacteria
and	O
the	O
development	O
of	O
oral	O
mucositis	O
.	O

We	O
compared	O
the	O
clinical	O
efficacy	O
,	O
the	O
bactericidal	O
effects	O
,	O
effect	O
on	O
the	O
oral	O
microbial	O
flora	O
,	O
and	O
adverse	O
reactions	O
between	O
cefditoren	O
pivoxil	O
(	O
CDTR	O
-	O
PI	O
)	O
for	O
5	O
days	O
and	O
amoxicillin	O
(	O
AMPC	O
)	O
for	O
10	O
days	O
in	O
children	O
with	O
acute	O
group	B-bacteria
A	I-bacteria
beta	I-bacteria
-	I-bacteria
hemolytic	I-bacteria
streptococci	I-bacteria
(	O
GAS	B-bacteria
)	O
tonsillopharyngitis	O
,	O
and	O
simultaneously	O
examined	O
the	O
emm	O
genotype	O
and	O
drug	O
susceptibility	O
of	O
the	O
isolated	O
GAS	B-bacteria
.	O

The	O
results	O
showed	O
that	O
the	O
clinical	O
efficacy	O
was	O
100	O
%	O
for	O
CDTR	O
-	O
PI	O
and	O
97	O
.	O
9	O
%	O
for	O
AMPC	O
,	O
with	O
no	O
difference	O
between	O
the	O
two	O
groups	O
,	O
and	O
the	O
bacterial	O
elimination	O
rate	O
was	O
100	O
%	O
in	O
both	O
groups	O
.	O

No	O
serious	O
adverse	O
event	O
was	O
noted	O
in	O
either	O
group	O
.	O

On	O
the	O
other	O
hand	O
,	O
concerning	O
changes	O
in	O
the	O
oral	O
microbial	O
flora	O
between	O
before	O
and	O
after	O
treatment	O
,	O
the	O
amount	O
of	O
bacteria	O
showed	O
no	O
change	O
in	O
the	O
CDTR	O
-	O
PI	O
group	O
(	O
p	O
=	O
0	O
.	O
5761	O
)	O
but	O
clearly	O
decreased	O
in	O
the	O
AMPC	O
group	O
(	O
p	O
=	O
0	O
.	O
0049	O
)	O
.	O

This	O
indicates	O
that	O
CDTR	O
-	O
PI	O
does	O
not	O
disturb	O
the	O
oral	O
microbial	O
flora	O
compared	O
with	O
AMPC	O
.	O

Also	O
,	O
the	O
emm	O
types	O
determined	O
in	O
the	O
112	O
GAS	B-bacteria
strains	I-bacteria
isolated	O
in	O
this	O
study	O
were	O
similar	O
to	O
those	O
that	O
have	O
recently	O
been	O
isolated	O
frequently	O
in	O
Japan	O
.	O

Concerning	O
the	O
drug	O
resistance	O
,	O
none	O
of	O
the	O
isolates	O
showed	O
resistance	O
to	O
beta	O
-	O
lactam	O
antibiotics	O
,	O
but	O
45	O
%	O
of	O
them	O
were	O
resistant	O
to	O
macrolides	O
.	O

The	O
advantages	O
of	O
short	O
-	O
term	O
treatment	O
are	O
considered	O
to	O
include	O
a	O
lower	O
cost	O
,	O
improvement	O
in	O
drug	O
compliance	O
,	O
decrease	O
in	O
the	O
frequency	O
of	O
the	O
occurrence	O
of	O
adverse	O
reactions	O
,	O
decrease	O
in	O
the	O
frequency	O
of	O
the	O
appearance	O
of	O
drug	O
-	O
resistant	O
strains	O
,	O
and	O
alleviation	O
of	O
the	O
psychological	O
burden	O
of	O
patients	O
and	O
their	O
parents	O
.	O

For	O
these	O
reasons	O
,	O
we	O
conclude	O
that	O
CDTR	O
-	O
PI	O
for	O
5	O
days	O
is	O
a	O
useful	O
option	O
for	O
the	O
treatment	O
of	O
acute	O
GAS	B-bacteria
tonsillopharyngitis	O
in	O
children	O
.	O

Oral	O
cancer	O
is	O
the	O
most	O
common	O
cancer	O
diagnosed	O
in	O
Indian	O
men	O
and	O
is	O
the	O
leading	O
cause	O
of	O
cancer	O
deaths	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
have	O
been	O
reported	O
to	O
be	O
present	O
in	O
0	O
-	O
40	O
%	O
of	O
the	O
cases	O
with	O
head	O
neck	O
cancer	O
.	O

A	O
higher	O
percentage	O
has	O
been	O
identified	O
in	O
laryngeal	O
and	O
pharangeal	O
cancer	O
.	O

We	O
here	O
carried	O
out	O
a	O
hospital	O
-	O
based	O
,	O
case	O
-	O
control	O
study	O
of	O
20	O
patients	O
with	O
newly	O
diagnosed	O
oral	O
cancer	O
and	O
20	O
healthy	O
controls	O
without	O
any	O
cancer	O
to	O
evaluate	O
associations	O
between	O
H	B-bacteria
pylori	I-bacteria
infection	O
and	O
oral	O
cancer	O
using	O
culture	O
and	O
16sRNA	O
PCR	O
technique	O
for	O
bacterial	O
identification	O
.	O

H	B-bacteria
pylori	I-bacteria
was	O
isolated	O
from	O
the	O
culture	O
of	O
three	O
cases	O
and	O
one	O
control	O
,	O
while	O
three	O
cases	O
and	O
two	O
control	O
showed	O
PCR	O
positivity	O
for	O
H	B-bacteria
Pylori	I-bacteria
16sRNA	O
.	O

The	O
odds	O
ratio	O
by	O
culture	O
was	O
3	O
.	O
0	O
,	O
95	O
%	O
CI	O
0	O
.	O
34	O
-	O
26	O
.	O
4	O
and	O
1	O
.	O
5	O
,	O
95	O
%	O
CI	O
0	O
.	O
28	O
-	O
8	O
.	O
03	O
by	O
PCR	O
.	O

None	O
of	O
the	O
observed	O
odds	O
ratio	O
was	O
statistically	O
significant	O
.	O

However	O
,	O
the	O
results	O
of	O
this	O
pilot	O
study	O
suggest	O
a	O
possible	O
association	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
with	O
an	O
increased	O
risk	O
of	O
oral	O
cancer	O
.	O

Additional	O
studies	O
in	O
larger	O
populations	O
are	O
necessary	O
to	O
confirm	O
and	O
to	O
quantify	O
this	O
possible	O
association	O
more	O
accurately	O
.	O

Oral	O
lesions	O
are	O
rarely	O
reported	O
in	O
paucibacillary	O
forms	O
of	O
leprosy	O
.	O

We	O
report	O
here	O
a	O
case	O
with	O
an	O
erythematous	O
hyposensitive	O
lesion	O
in	O
the	O
palate	O
and	O
no	O
skin	O
lesions	O
.	O

In	O
addition	O
to	O
routine	O
tests	O
,	O
biopsies	O
of	O
the	O
lesion	O
in	O
the	O
palate	O
and	O
of	O
clinically	O
normal	O
surrounding	O
areas	O
were	O
performed	O
and	O
subjected	O
to	O
real	O
-	O
time	O
PCR	O
for	O
detection	O
of	O
Mycobacterium	B-bacteria
leprae	I-bacteria
DNA	O
.	O

The	O
biopsy	O
of	O
the	O
oral	O
lesion	O
was	O
positive	O
for	O
bacilli	O
DNA	O
,	O
followed	O
by	O
positive	O
serum	O
anti	O
-	O
PGL	O
-	O
1	O
and	O
Mitsuda	O
test	O
,	O
but	O
with	O
negative	O
histopathology	O
.	O

The	O
patient	O
was	O
diagnosed	O
with	O
a	O
borderline	O
tuberculoid	O
form	O
.	O

After	O
multidrug	O
therapy	O
the	O
lesion	O
had	O
significantly	O
regressed	O
and	O
the	O
bacilli	O
DNA	O
detection	O
in	O
the	O
former	O
lesion	O
was	O
negative	O
.	O

The	O
bacilli	O
DNA	O
detection	O
in	O
an	O
oral	O
lesion	O
by	O
real	O
-	O
time	O
PCR	O
not	O
only	O
improved	O
leprosy	O
diagnosis	O
,	O
but	O
also	O
helped	O
in	O
the	O
classification	O
of	O
clinical	O
form	O
,	O
and	O
in	O
the	O
establishment	O
of	O
the	O
appropriate	O
therapeutic	O
regime	O
.	O

It	O
is	O
a	O
well	O
-	O
established	O
fact	O
that	O
colonization	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
occurs	O
early	O
in	O
life	O
.	O

The	O
purpose	O
of	O
this	O
study	O
is	O
to	O
determine	O
the	O
correlation	O
between	O
mode	O
of	O
delivery	O
and	O
other	O
associating	O
factors	O
with	O
colonization	O
of	O
oral	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
the	O
infants	O
.	O

The	O
newborns	O
were	O
divided	O
into	O
two	O
groups	O
according	O
to	O
the	O
mode	O
of	O
delivery	O
:	O
Infants	O
who	O
were	O
delivered	O
by	O
either	O
caesarean	O
section	O
(	O
Group	O
-	O
C	O
)	O
or	O
vaginally	O
(	O
Group	O
-	O
V	O
)	O
.	O

A	O
total	O
number	O
of	O
60	O
mother	O
-	O
infant	O
pairs	O
were	O
included	O
and	O
followed	O
for	O
1	O
year	O
.	O

The	O
swab	O
samples	O
were	O
collected	O
for	O
the	O
detection	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

Analysis	O
of	O
data	O
demonstrated	O
the	O
possible	O
influence	O
of	O
prolonged	O
bottle	O
feeding	O
(	O
P	O
=	O
0	O
.	O
007	O
)	O
,	O
socioeconomic	O
status	O
(	O
P	O
=	O
0	O
.	O
00030	O
)	O
and	O
tasting	O
of	O
food	O
by	O
the	O
mothers	O
(	O
P	O
=	O
0	O
.	O
0065	O
)	O
on	O
the	O
initial	O
acquisition	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
the	O
oral	O
cavity	O
of	O
infants	O
.	O

The	O
causes	O
for	O
initial	O
acquisition	O
of	O
oral	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
infants	O
were	O
postnatal	O
factors	O
like	O
feeding	O
and	O
oral	O
hygiene	O
practices	O
.	O

Previous	O
reports	O
have	O
associated	O
salivary	O
beta	O
-	O
galactosidase	O
activity	O
with	O
non	O
-	O
periodontopathic	O
oral	O
malodour	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
localization	O
of	O
beta	O
-	O
galactosidase	O
and	O
elucidated	O
the	O
relationship	O
between	O
its	O
enzymatic	O
activity	O
and	O
physiological	O
oral	O
malodour	O
.	O

Fifty	O
-	O
six	O
patients	O
complaining	O
of	O
halitosis	O
were	O
separated	O
into	O
two	O
groups	O
:	O
periodontally	O
healthy	O
and	O
periodontitis	O
.	O

Saliva	O
samples	O
from	O
the	O
subjects	O
were	O
separated	O
by	O
centrifugation	O
,	O
and	O
the	O
level	O
of	O
beta	O
-	O
galactosidase	O
activity	O
was	O
measured	O
in	O
the	O
supernatant	O
,	O
pellet	O
lysate	O
,	O
and	O
whole	O
saliva	O
using	O
the	O
chromogenic	O
substrate	O
o	O
-	O
nitrophenyl	O
-	O
beta	O
-	O
d	O
-	O
galactopyranoside	O
.	O

The	O
correlation	O
of	O
salivary	O
beta	O
-	O
galactosidase	O
activity	O
with	O
breath	O
odour	O
and	O
associated	O
parameters	O
was	O
examined	O
.	O

Similar	O
levels	O
of	O
beta	O
-	O
galactosidase	O
activity	O
were	O
detected	O
in	O
the	O
pellet	O
lysate	O
and	O
whole	O
saliva	O
,	O
but	O
not	O
in	O
the	O
saliva	O
supernatant	O
.	O

Positive	O
correlations	O
were	O
observed	O
between	O
the	O
beta	O
-	O
galactosidase	O
activity	O
in	O
whole	O
saliva	O
and	O
oral	O
malodour	O
levels	O
in	O
the	O
periodontally	O
healthy	O
group	O
,	O
but	O
not	O
in	O
the	O
periodontitis	O
group	O
.	O

In	O
addition	O
,	O
the	O
plaque	O
index	O
and	O
tongue	O
coating	O
score	O
were	O
positively	O
correlated	O
with	O
beta	O
-	O
galactosidase	O
activity	O
in	O
the	O
periodontally	O
healthy	O
group	O
.	O

Overall	O
,	O
stimulated	O
salivary	O
flow	O
and	O
salivary	O
pH	O
were	O
negatively	O
correlated	O
with	O
enzyme	O
activity	O
.	O

The	O
amounts	O
of	O
total	O
bacteria	O
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
and	O
Streptococcus	B-bacteria
salivarius	I-bacteria
were	O
positively	O
associated	O
with	O
beta	O
-	O
galactosidase	O
activity	O
in	O
the	O
periodontally	O
healthy	O
group	O
.	O

Furthermore	O
,	O
the	O
amounts	O
of	O
total	O
bacteria	O
and	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
were	O
positively	O
associated	O
with	O
the	O
amount	O
of	O
volatile	O
sulphur	O
compounds	O
.	O

Our	O
results	O
indicate	O
that	O
beta	O
-	O
galactosidase	O
is	O
located	O
on	O
the	O
cell	O
surface	O
of	O
oral	O
bacteria	O
derived	O
from	O
dental	O
plaque	O
and	O
tongue	O
coating	O
,	O
and	O
it	O
plays	O
an	O
important	O
role	O
in	O
producing	O
the	O
malodour	O
underlying	O
physiological	O
oral	O
malodour	O
.	O

Campylobacter	B-bacteria
concisus	I-bacteria
infections	O
of	O
the	O
gastrointestinal	O
tract	O
can	O
be	O
accompanied	O
by	O
diarrhea	O
and	O
inflammation	O
,	O
whereas	O
colonization	O
of	O
the	O
human	O
oral	O
cavity	O
might	O
have	O
a	O
commensal	O
nature	O
.	O

We	O
focus	O
on	O
the	O
pathophysiology	O
of	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
and	O
the	O
effects	O
of	O
different	O
clinical	O
oral	O
and	O
fecal	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
strains	I-bacteria
on	O
human	O
HT	O
-	O
29	O
/	O
B6	O
colon	O
cells	O
.	O

Six	O
oral	O
and	O
eight	O
fecal	O
strains	O
of	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
were	O
isolated	O
.	O

Mucus	O
-	O
producing	O
HT	O
-	O
29	O
/	O
B6	O
epithelial	O
monolayers	O
were	O
infected	O
with	O
the	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
strains	I-bacteria
.	O

Transepithelial	O
electrical	O
resistance	O
(	O
R	O
(	O
t	O
)	O
)	O
and	O
tracer	O
fluxes	O
of	O
different	O
molecule	O
size	O
were	O
measured	O
in	O
Ussing	O
chambers	O
.	O

Tight	O
junction	O
(	O
TJ	O
)	O
protein	O
expression	O
was	O
determined	O
by	O
Western	O
blotting	O
,	O
and	O
subcellular	O
TJ	O
distribution	O
was	O
analyzed	O
by	O
confocal	O
laser	O
-	O
scanning	O
microscopy	O
.	O

Apoptosis	O
induction	O
was	O
examined	O
by	O
TUNEL	O
-	O
staining	O
and	O
Western	O
blot	O
of	O
caspase	O
-	O
3	O
activation	O
.	O

All	O
strains	O
invaded	O
confluent	O
HT	O
-	O
29	O
/	O
B6	O
cells	O
and	O
impaired	O
epithelial	O
barrier	O
function	O
,	O
characterized	O
by	O
a	O
time	O
-	O
and	O
dose	O
-	O
dependent	O
decrease	O
in	O
R	O
(	O
t	O
)	O
either	O
after	O
infection	O
from	O
the	O
apical	O
side	O
but	O
even	O
more	O
from	O
the	O
basolateral	O
compartment	O
.	O

TJ	O
protein	O
expression	O
changes	O
were	O
sparse	O
,	O
only	O
in	O
apoptotic	O
areas	O
of	O
infected	O
monolayers	O
TJ	O
proteins	O
were	O
redistributed	O
.	O

Solely	O
the	O
barrier	O
-	O
forming	O
TJ	O
protein	O
claudin	O
-	O
5	O
showed	O
a	O
reduced	O
expression	O
level	O
to	O
66	O
+	O
/	O
-	O
8	O
%	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
,	O
by	O
expression	O
regulation	O
from	O
the	O
gene	O
.	O

Concomitantly	O
,	O
Lactate	O
dehydrogenase	O
release	O
was	O
elevated	O
to	O
3	O
.	O
1	O
+	O
/	O
-	O
0	O
.	O
3	O
%	O
versus	O
0	O
.	O
7	O
+	O
/	O
-	O
0	O
.	O
1	O
%	O
in	O
control	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
,	O
suggesting	O
cytotoxic	O
effects	O
.	O

Furthermore	O
,	O
oral	O
and	O
fecal	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
strains	I-bacteria
elevated	O
apoptotic	O
events	O
to	O
5	O
-	O
fold	O
.	O

C	O
.	O
concisus	O
-	O
infected	O
monolayers	O
revealed	O
an	O
increased	O
permeability	O
for	O
332	O
Da	O
fluorescein	O
(	O
1	O
.	O
74	O
+	O
/	O
-	O
0	O
.	O
13	O
vs	O
.	O
0	O
.	O
56	O
+	O
/	O
-	O
0	O
.	O
17	O
10	O
(	O
-	O
6	O
)	O
cm	O
/	O
s	O
in	O
control	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
but	O
showed	O
no	O
difference	O
in	O
permeability	O
for	O
4	O
kDa	O
FITC	O
-	O
dextran	O
(	O
FD	O
-	O
4	O
)	O
.	O

The	O
same	O
was	O
true	O
in	O
camptothecin	O
-	O
exposed	O
monolayers	O
,	O
where	O
camptothecin	O
was	O
used	O
for	O
apoptosis	O
induction	O
.	O
In	O
conclusion	O
,	O
epithelial	O
barrier	O
dysfunction	O
by	O
oral	O
and	O
fecal	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
strains	I-bacteria
could	O
mainly	O
be	O
assigned	O
to	O
apoptotic	O
leaks	O
together	O
with	O
moderate	O
TJ	O
changes	O
,	O
demonstrating	O
a	O
leak	O
-	O
flux	O
mechanism	O
that	O
parallels	O
the	O
clinical	O
manifestation	O
of	O
diarrhea	O
.	O

Halitosis	O
has	O
been	O
correlated	O
with	O
the	O
concentration	O
of	O
volatile	O
sulfur	O
compounds	O
(	O
VSCs	O
)	O
produced	O
in	O
the	O
oral	O
cavity	O
by	O
metabolic	O
activity	O
of	O
bacteria	O
colonizing	O
the	O
periodontal	O
pockets	O
and	O
the	O
dorsum	O
of	O
the	O
tongue	O
.	O

It	O
has	O
been	O
assumed	O
that	O
there	O
is	O
a	O
relationship	O
between	O
periodontal	O
disease	O
and	O
diabetes	O
mellitus	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
assess	O
the	O
malodor	O
using	O
the	O
organoleptic	O
method	O
and	O
tanita	O
device	O
;	O
to	O
quantify	O
odoriferous	O
microorganisms	O
of	O
subgingival	O
plaque	O
and	O
tongue	O
coating	O
,	O
such	O
as	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
(	O
Pg	B-bacteria
)	O
,	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
(	O
Tf	B-bacteria
)	O
,	O
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
(	O
Fn	B-bacteria
)	O
using	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
in	O
nondiabetic	O
and	O
diabetic	O
chronic	O
periodontitis	O
patients	O
.	O

Thirty	O
chronic	O
periodontitis	O
patients	O
(	O
with	O
and	O
without	O
diabetes	O
)	O
with	O
5	O
-	O
7	O
mm	O
pocket	O
depth	O
,	O
radiographic	O
evidence	O
of	O
bone	O
loss	O
,	O
and	O
presence	O
of	O
oral	O
malodor	O
participated	O
in	O
this	O
study	O
.	O

Subjective	O
assessment	O
of	O
mouth	O
air	O
was	O
done	O
organoleptically	O
and	O
by	O
using	O
a	O
portable	O
sulfide	O
monitor	O
.	O

Tongue	O
coating	O
was	O
also	O
assessed	O
.	O

The	O
scores	O
of	O
plaque	O
index	O
,	O
gingival	O
index	O
,	O
gingival	O
bleeding	O
index	O
,	O
VSC	O
levels	O
,	O
and	O
tongue	O
coating	O
between	O
the	O
nondiabetic	O
and	O
diabetic	O
patients	O
were	O
not	O
significant	O
(	O
P	O
>	O
0	O
.	O
5	O
)	O
.	O

In	O
nondiabetic	O
patients	O
,	O
Fn	B-bacteria
was	O
found	O
to	O
be	O
significantly	O
(	O
P	O
<	O
0	O
.	O
5	O
)	O
more	O
in	O
tongue	O
samples	O
,	O
whereas	O
Pg	B-bacteria
and	O
Tf	B-bacteria
have	O
not	O
shown	O
significant	O
values	O
(	O
P	O
>	O
0	O
.	O
5	O
)	O
.	O

In	O
diabetic	O
patients	O
,	O
Fn	B-bacteria
and	O
Tf	B-bacteria
have	O
shown	O
significant	O
(	O
P	O
<	O
0	O
.	O
5	O
)	O
an	O
increase	O
in	O
subgingival	O
and	O
tongue	O
samples	O
,	O
respectively	O
,	O
whereas	O
Pg	B-bacteria
has	O
not	O
shown	O
significant	O
difference	O
between	O
subgingival	O
and	O
tongue	O
samples	O
.	O

The	O
results	O
confirm	O
that	O
there	O
is	O
no	O
difference	O
in	O
clinical	O
parameters	O
between	O
nondiabetic	O
and	O
diabetic	O
periodontitis	O
patients	O
,	O
but	O
the	O
odoriferous	O
microbial	O
profiles	O
in	O
tongue	O
samples	O
of	O
diabetic	O
patients	O
were	O
found	O
to	O
be	O
high	O
.	O

However	O
,	O
there	O
is	O
a	O
weak	O
positive	O
correlation	O
between	O
VSC	O
levels	O
,	O
clinical	O
parameters	O
,	O
and	O
odoriferous	O
microbial	O
profiles	O
.	O

There	O
has	O
been	O
a	O
paradigm	O
shift	O
toward	O
ecological	O
and	O
microbial	O
community	O
-	O
based	O
approach	O
in	O
understanding	O
oral	O
diseases	O
.	O

A	O
marked	O
improvement	O
in	O
gastrointestinal	O
health	O
has	O
been	O
reported	O
after	O
using	O
probiotic	O
bacteria	O
and	O
/	O
or	O
prebiotic	O
supplements	O
,	O
which	O
has	O
prompted	O
much	O
interest	O
in	O
the	O
use	O
of	O
this	O
approach	O
for	O
oral	O
applications	O
.	O

Treatment	O
of	O
periodontal	O
disease	O
in	O
recent	O
years	O
has	O
moved	O
toward	O
an	O
antibiotic	O
/	O
antimicrobial	O
model	O
of	O
disease	O
management	O
.	O

With	O
increase	O
in	O
the	O
incidence	O
of	O
resistance	O
to	O
antibiotics	O
,	O
probiotics	O
may	O
be	O
a	O
promising	O
area	O
of	O
research	O
in	O
periodontal	O
therapy	O
.	O

This	O
paper	O
reviews	O
the	O
evidences	O
for	O
the	O
use	O
of	O
probiotics	O
or	O
prebiotics	O
for	O
the	O
prevention	O
of	O
dental	O
caries	O
or	O
periodontal	O
diseases	O
,	O
and	O
also	O
adresses	O
the	O
risk	O
associated	O
with	O
their	O
prolonged	O
use	O
.	O

Many	O
questions	O
have	O
been	O
raised	O
pertaining	O
to	O
the	O
benefits	O
of	O
probiotic	O
administration	O
,	O
as	O
the	O
role	O
of	O
probiotics	O
in	O
periodontics	O
is	O
still	O
in	O
infancy	O
,	O
and	O
a	O
complete	O
understanding	O
of	O
the	O
broad	O
ecological	O
changes	O
induced	O
in	O
the	O
mouth	O
by	O
probiotics	O
or	O
prebiotics	O
is	O
essential	O
to	O
assess	O
their	O
long	O
-	O
term	O
consequences	O
for	O
oral	O
health	O
and	O
disease	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
if	O
three	O
strains	O
of	O
bacteria	O
could	O
impact	O
the	O
mechanical	O
or	O
surface	O
properties	O
of	O
a	O
dental	O
resin	O
material	O
.	O

Resin	O
material	O
specimens	O
were	O
incubated	O
at	O
37	O
degrees	O
C	O
in	O
sterile	O
saline	O
,	O
tryptic	O
soy	O
broth	O
supplemented	O
with	O
sucrose	O
(	O
TSBS	O
)	O
,	O
or	O
TSBS	O
inoculated	O
with	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
or	O
Streptococcus	B-bacteria
sanguis	I-bacteria
.	O

The	O
specimens	O
were	O
subjected	O
to	O
Fourier	O
transform	O
infrared	O
spectroscopy	O
before	O
and	O
after	O
incubation	O
.	O

The	O
flexural	O
strength	O
test	O
was	O
performed	O
once	O
a	O
week	O
for	O
6	O
weeks	O
.	O

Microhardness	O
and	O
scanning	O
electron	O
microscopy	O
(	O
SEM	O
)	O
was	O
performed	O
on	O
specimens	O
at	O
1	O
and	O
6	O
weeks	O
.	O

Differences	O
in	O
the	O
area	O
under	O
the	O
carbonyl	O
peak	O
were	O
statistically	O
significant	O
for	O
the	O
specimens	O
incubated	O
in	O
the	O
media	O
inoculated	O
with	O
either	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
or	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
.	O

To	O
determine	O
why	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
did	O
not	O
produce	O
changes	O
as	O
the	O
other	O
bacteria	O
did	O
,	O
triethylene	O
glycol	O
dimethacrylate	O
,	O
methacrylic	O
acid	O
,	O
and	O
triethylene	O
glycol	O
were	O
added	O
to	O
bacterial	O
cultures	O
at	O
increasing	O
concentrations	O
.	O

Both	O
methacrylic	O
acid	O
and	O
triethylene	O
glycol	O
reduced	O
the	O
number	O
of	O
colony	O
-	O
forming	O
units	O
of	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
.	O

Specimens	O
incubated	O
in	O
TSBS	O
,	O
saline	O
or	O
in	O
culture	O
with	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
demonstrated	O
a	O
decrease	O
in	O
peak	O
stress	O
in	O
week	O
1	O
of	O
the	O
flexure	O
strength	O
test	O
.	O

SEM	O
demonstrated	O
that	O
surface	O
topology	O
changed	O
for	O
those	O
specimens	O
incubated	O
in	O
culture	O
with	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
or	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
.	O

The	O
changes	O
in	O
surface	O
topology	O
demonstrated	O
here	O
could	O
contribute	O
to	O
the	O
secondary	O
caries	O
and	O
changes	O
in	O
esthetic	O
properties	O
seen	O
clinically	O
with	O
the	O
use	O
of	O
resin	O
materials	O
in	O
dental	O
restorations	O
.	O

Lactobacillus	B-bacteria
species	I-bacteria
are	O
commensal	O
bacteria	O
that	O
have	O
long	O
been	O
recognized	O
as	O
probiotic	O
microbes	O
and	O
are	O
generally	O
regarded	O
as	O
safe	O
(	O
GRAS	O
)	O
for	O
human	O
consumption	O
.	O

We	O
have	O
investigated	O
the	O
use	O
of	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
as	O
a	O
vaccine	O
vector	O
for	O
oral	O
immunization	O
against	O
mucosal	O
pathogens	O
.	O

Recent	O
research	O
has	O
shown	O
that	O
the	O
immune	O
response	O
to	O
different	O
lactobacilli	B-bacteria
can	O
vary	O
widely	O
depending	O
on	O
the	O
species	O
or	O
subspecies	O
of	O
Lactobacillus	B-bacteria
being	O
studied	O
.	O

While	O
some	O
lactobacilli	B-bacteria
seem	O
to	O
induce	O
oral	O
tolerance	O
,	O
others	O
induce	O
an	O
adaptive	O
immune	O
response	O
.	O

This	O
study	O
characterized	O
the	O
systemic	O
and	O
mucosal	O
immune	O
response	O
to	O
wild	O
-	O
type	O
and	O
genetically	O
modified	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
.	O

L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
primarily	O
activates	O
TLR2	O
/	O
6	O
,	O
with	O
additional	O
activation	O
through	O
the	O
TLR2	O
homodimer	O
.	O

To	O
expand	O
the	O
Toll	O
-	O
like	O
receptor	O
(	O
TLR	O
)	O
activation	O
profile	O
of	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
and	O
the	O
immunogenicity	O
of	O
the	O
vector	O
,	O
a	O
plasmid	O
containing	O
fliC	O
,	O
the	O
gene	O
encoding	O
bacterial	O
flagellin	O
,	O
was	O
introduced	O
which	O
resulted	O
in	O
the	O
strong	O
activation	O
of	O
TLR5	O
.	O

The	O
treatment	O
of	O
human	O
myeloid	O
dendritic	O
cells	O
with	O
recombinant	O
lactobacilli	B-bacteria
expressing	O
flagellin	O
triggered	O
phenotypic	O
maturation	O
and	O
the	O
release	O
of	O
proinflammatory	O
cytokines	O
.	O

In	O
contrast	O
,	O
bacterial	O
treatment	O
also	O
resulted	O
in	O
a	O
statistically	O
significant	O
increase	O
in	O
IL	O
-	O
10	O
production	O
.	O

In	O
vivo	O
studies	O
established	O
that	O
treatment	O
with	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
led	O
to	O
a	O
diversification	O
of	O
B	O
-	O
cell	O
populations	O
in	O
the	O
lamina	O
propria	O
of	O
the	O
murine	O
colon	O
.	O

Furthermore	O
,	O
treatment	O
with	O
genetically	O
modified	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
led	O
to	O
a	O
significant	O
decrease	O
in	O
the	O
percentage	O
of	O
FoxP3	O
(	O
+	O
)	O
colonic	O
lymphocytes	O
.	O

Taken	O
together	O
,	O
these	O
data	O
clarify	O
the	O
interaction	O
of	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
with	O
the	O
host	O
immune	O
system	O
and	O
support	O
further	O
investigation	O
of	O
the	O
in	O
vivo	O
immunogenicity	O
of	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
expressing	O
both	O
flagellin	O
and	O
candidate	O
vaccine	O
antigens	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
bactericidal	O
effects	O
and	O
bactericidal	O
time	O
of	O
an	O
acidified	O
sodium	O
chlorite	O
compound	O
gel	O
(	O
ASC	O
-	O
Gel	O
)	O
on	O
bacteria	O
isolated	O
from	O
the	O
peri	O
-	O
implant	O
sulci	O
of	O
10	O
patients	O
who	O
received	O
implants	O
3	O
-	O
27	O
years	O
previously	O
,	O
and	O
the	O
depth	O
of	O
each	O
peri	O
-	O
implant	O
sulcus	O
was	O
5	O
mm	O
or	O
less	O
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
ATCC33277	B-bacteria
)	O
was	O
used	O
as	O
the	O
control	O
bacterium	O
.	O

Five	O
ASC	O
-	O
Gel	O
preparations	O
were	O
created	O
by	O
adding	O
3	O
.	O
3	O
%	O
,	O
5	O
.	O
0	O
%	O
,	O
7	O
.	O
0	O
%	O
,	O
9	O
.	O
0	O
%	O
,	O
and	O
11	O
.	O
0	O
%	O
citric	O
acid	O
(	O
CA	O
)	O
(	O
condition	O
a	O
,	O
b	O
,	O
c	O
,	O
d	O
,	O
and	O
e	O
,	O
respectively	O
)	O
into	O
an	O
oral	O
moisturizing	O
gel	O
containing	O
sodium	O
chlorite	O
.	O

The	O
concentrations	O
of	O
chlorine	O
dioxide	O
(	O
ClO2	O
)	O
generated	O
in	O
ASC	O
-	O
Gel	O
under	O
conditions	O
(	O
a	O
)	O
to	O
(	O
e	O
)	O
were	O
12	O
.	O
1	O
,	O
14	O
.	O
1	O
,	O
17	O
.	O
2	O
,	O
21	O
.	O
2	O
,	O
and	O
39	O
.	O
3	O
ppm	O
,	O
respectively	O
.	O

We	O
examined	O
the	O
bactericidal	O
effects	O
of	O
the	O
5	O
ASC	O
-	O
Gel	O
preparations	O
at	O
volumes	O
of	O
0	O
.	O
5	O
,	O
1	O
.	O
0	O
,	O
and	O
2	O
.	O
0	O
mL	O
,	O
and	O
measured	O
the	O
bactericidal	O
time	O
when	O
2	O
.	O
0	O
mL	O
of	O
ASC	O
-	O
Gel	O
was	O
used	O
under	O
condition	O
(	O
e	O
)	O
.	O

The	O
bactericidal	O
effects	O
of	O
ASC	O
-	O
Gel	O
became	O
significantly	O
greater	O
with	O
increased	O
concentrations	O
of	O
CA	O
and	O
ClO2	O
and	O
with	O
increased	O
usage	O
(	O
0	O
.	O
5	O
-	O
2	O
.	O
0	O
mL	O
)	O
of	O
the	O
gel	O
.	O

All	O
bacteria	O
were	O
killed	O
by	O
using	O
2	O
.	O
0	O
mL	O
of	O
ASC	O
-	O
Gel	O
under	O
condition	O
(	O
e	O
)	O
.	O

ASC	O
-	O
Gel	O
also	O
needed	O
between	O
45	O
and	O
90	O
minutes	O
to	O
kill	O
all	O
microbes	O
under	O
condition	O
(	O
e	O
)	O
.	O

Within	O
the	O
limits	O
of	O
the	O
present	O
investigation	O
,	O
these	O
results	O
suggest	O
that	O
ASC	O
-	O
Gel	O
is	O
useful	O
as	O
a	O
chemical	O
disinfectant	O
against	O
bacteria	O
in	O
the	O
peri	O
-	O
implant	O
sulcus	O
.	O

Further	O
studies	O
are	O
also	O
required	O
to	O
protect	O
teeth	O
,	O
the	O
surface	O
of	O
hydroxyapatite	O
-	O
coated	O
implants	O
,	O
and	O
the	O
surrounding	O
soft	O
tissues	O
from	O
effects	O
of	O
chemical	O
dissolution	O
such	O
as	O
acid	O
erosion	O
due	O
to	O
the	O
low	O
pH	O
of	O
ASC	O
-	O
Gel	O
.	O

To	O
investigate	O
the	O
impact	O
on	O
microbiologic	O
variables	O
of	O
full	O
-	O
mouth	O
scaling	O
(	O
FMS	O
)	O
and	O
conventional	O
scaling	O
and	O
root	O
planing	O
(	O
cSRP	O
)	O
after	O
12	O
months	O
.	O

In	O
a	O
prospective	O
randomized	O
controlled	O
clinical	O
study	O
,	O
37	O
volunteers	O
with	O
moderate	O
chronic	O
periodontitis	O
were	O
treated	O
by	O
FMS	O
or	O
by	O
cSRP	O
in	O
two	O
sessions	O
at	O
4	O
-	O
week	O
intervals	O
.	O

Clinical	O
attachment	O
level	O
,	O
probing	O
depth	O
,	O
and	O
bleeding	O
on	O
probing	O
were	O
recorded	O
at	O
baseline	O
as	O
well	O
as	O
at	O
6	O
and	O
12	O
months	O
.	O

Four	O
subgingival	O
plaque	O
samples	O
were	O
taken	O
from	O
the	O
deepest	O
sites	O
in	O
premolars	O
and	O
molars	O
at	O
baseline	O
and	O
after	O
12	O
months	O
.	O

Pooled	O
sample	O
analysis	O
was	O
performed	O
using	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
for	O
the	O
identification	O
of	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
.	O

At	O
baseline	O
,	O
the	O
bacterial	O
load	O
of	O
A	B-bacteria
actinomycetemcomitans	I-bacteria
was	O
significantly	O
higher	O
in	O
the	O
cSRP	O
group	O
compared	O
to	O
the	O
FMS	O
group	O
(	O
P	O
=	O
.	O
042	O
)	O
.	O

In	O
the	O
cSRP	O
group	O
,	O
this	O
load	O
decreased	O
significantly	O
(	O
P	O
=	O
.	O
011	O
)	O
,	O
leading	O
to	O
similar	O
quantities	O
of	O
A	B-bacteria
actinomycetemcomitans	I-bacteria
in	O
both	O
groups	O
.	O

Further	O
,	O
significant	O
reductions	O
in	O
frequency	O
were	O
found	O
in	O
the	O
FMS	O
group	O
for	O
T	B-bacteria
forsythia	I-bacteria
and	O
P	B-bacteria
gingivalis	I-bacteria
and	O
in	O
the	O
cSRP	O
group	O
for	O
A	B-bacteria
actinomycetemcomitans	I-bacteria
and	O
T	B-bacteria
denticola	I-bacteria
.	O

The	O
data	O
suggest	O
that	O
both	O
therapy	O
modalities	O
lead	O
to	O
similar	O
effects	O
on	O
target	O
periodontal	O
pathogen	O
species	O
.	O

FMS	O
compared	O
to	O
cSRP	O
was	O
not	O
favorable	O
in	O
reduction	O
of	O
periodontopathogens	O
.	O

Changes	O
in	O
the	O
microbial	O
flora	O
on	O
the	O
oral	O
mucosa	O
after	O
cancerous	O
alteration	O
may	O
lead	O
to	O
both	O
local	O
and	O
systemic	O
infections	O
.	O

In	O
this	O
study	O
,	O
we	O
assessed	O
the	O
microbial	O
flora	O
associated	O
with	O
the	O
surfaces	O
of	O
oral	O
squamous	O
cell	O
carcinoma	O
.	O

A	O
comparative	O
evaluation	O
of	O
these	O
microbial	O
contents	O
was	O
made	O
with	O
that	O
of	O
the	O
contralateral	O
healthy	O
mucosa	O
and	O
control	O
(	O
healthy	O
)	O
mucosa	O
.	O

We	O
also	O
assessed	O
the	O
microbial	O
flora	O
from	O
the	O
saliva	O
culture	O
in	O
subjects	O
with	O
oral	O
squamous	O
cell	O
carcinoma	O
and	O
healthy	O
controls	O
.	O

The	O
case	O
control	O
study	O
was	O
made	O
up	O
of	O
30	O
subjects	O
with	O
oral	O
squamous	O
cell	O
carcinoma	O
as	O
the	O
study	O
group	O
;	O
30	O
healthy	O
age	O
-	O
,	O
sex	O
-	O
,	O
habit	O
-	O
,	O
and	O
dentition	O
-	O
matched	O
subjects	O
served	O
as	O
the	O
control	O
group	O
.	O

In	O
the	O
study	O
group	O
,	O
microbial	O
samples	O
were	O
collected	O
from	O
the	O
carcinoma	O
site	O
,	O
contralateral	O
healthy	O
mucosa	O
,	O
and	O
saliva	O
,	O
whereas	O
in	O
the	O
control	O
group	O
,	O
samples	O
were	O
collected	O
from	O
the	O
healthy	O
mucosa	O
and	O
saliva	O
.	O

These	O
samples	O
were	O
stored	O
on	O
ice	O
and	O
subsequently	O
transported	O
to	O
the	O
laboratory	O
in	O
2	O
mL	O
of	O
thioglycollate	O
transport	O
media	O
,	O
where	O
the	O
microbial	O
cultures	O
were	O
carried	O
out	O
.	O

Oral	O
squamous	O
cell	O
carcinoma	O
sites	O
harbor	O
significantly	O
more	O
microbial	O
flora	O
(	O
bacteria	O
and	O
yeasts	O
)	O
compared	O
to	O
those	O
of	O
healthy	O
mucosa	O
(	O
control	O
group	O
)	O
.	O

The	O
microbial	O
flora	O
predominantly	O
isolated	O
from	O
the	O
carcinoma	O
site	O
were	O
Streptococcus	B-bacteria
species	I-bacteria
,	O
Staphylococcus	B-bacteria
species	I-bacteria
,	O
Moraxella	B-bacteria
species	I-bacteria
,	O
Enterococcus	B-bacteria
feacalis	I-bacteria
,	O
Aerobic	B-bacteria
spore	I-bacteria
bearers	I-bacteria
,	O
Klebsiella	B-bacteria
species	I-bacteria
,	O
Citrobacter	B-bacteria
species	I-bacteria
,	O
Proteus	B-bacteria
species	I-bacteria
,	O
Pseudomonas	B-bacteria
species	I-bacteria
,	O
and	O
Candida	O
albicans	O
.	O

The	O
median	O
number	O
of	O
colony	O
forming	O
units	O
(	O
CFU	O
)	O
/	O
mL	O
at	O
carcinoma	O
sites	O
(	O
3	O
.	O
85	O
x	O
105	O
CFU	O
/	O
mL	O
)	O
was	O
significantly	O
higher	O
than	O
that	O
of	O
the	O
healthy	O
mucosa	O
(	O
0	O
.	O
571	O
x	O
105	O
CFU	O
/	O
mL	O
;	O
P	O
=	O
.	O
0000	O
,	O
Wilcoxon	O
nonparametric	O
test	O
)	O
.	O

Similarly	O
,	O
in	O
saliva	O
of	O
carcinoma	O
subjects	O
,	O
the	O
median	O
number	O
of	O
CFU	O
/	O
mL	O
(	O
2	O
.	O
408	O
x	O
105	O
CFU	O
/	O
mL	O
)	O
was	O
significantly	O
higher	O
than	O
that	O
of	O
saliva	O
in	O
control	O
subjects	O
(	O
0	O
.	O
78	O
x	O
105	O
CFU	O
/	O
mL	O
;	O
P	O
=	O
.	O
0000	O
,	O
Wilcoxon	O
nonparametric	O
test	O
)	O
.	O

The	O
present	O
study	O
clearly	O
indicates	O
that	O
the	O
subjects	O
with	O
oral	O
squamous	O
cell	O
carcinoma	O
harbor	O
significantly	O
more	O
microbial	O
flora	O
.	O

Emphasis	O
has	O
to	O
be	O
given	O
to	O
preventing	O
microbial	O
flora	O
in	O
the	O
oral	O
cavity	O
and	O
treating	O
these	O
patients	O
with	O
appropriate	O
antimicrobial	O
agents	O
,	O
thus	O
reducing	O
their	O
morbidity	O
.	O

There	O
are	O
many	O
studies	O
on	O
the	O
effect	O
of	O
preprocedural	O
mouth	O
rinses	O
in	O
adults	O
,	O
but	O
there	O
is	O
a	O
dearth	O
of	O
the	O
literature	O
on	O
the	O
effects	O
of	O
these	O
mouth	O
rinses	O
in	O
children	O
.	O

This	O
study	O
aims	O
to	O
evaluate	O
the	O
efficacy	O
of	O
two	O
commercially	O
available	O
brands	O
,	O
one	O
containing	O
chlorhexidine	O
0	O
.	O
12	O
%	O
(	O
Colgate	O
Periogard	O
)	O
and	O
the	O
other	O
containing	O
cetylpyridinium	O
chloride	O
0	O
.	O
05	O
%	O
(	O
Johnson	O
and	O
Johnson	O
'	O
s	O
Reach	O
)	O
used	O
as	O
preprocedural	O
mouth	O
rinses	O
in	O
children	O
.	O

The	O
study	O
was	O
conducted	O
on	O
18	O
patients	O
in	O
the	O
age	O
group	O
of	O
10	O
-	O
15	O
years	O
.	O

A	O
crossover	O
design	O
was	O
used	O
with	O
the	O
random	O
assignment	O
of	O
the	O
first	O
rinse	O
tested	O
and	O
a	O
wash	O
out	O
period	O
of	O
at	O
least	O
1	O
week	O
before	O
the	O
second	O
rinse	O
was	O
used	O
.	O

The	O
saliva	O
samples	O
were	O
collected	O
prerinse	O
,	O
2	O
min	O
,	O
30	O
min	O
,	O
and	O
60	O
min	O
after	O
rinsing	O
with	O
the	O
solution	O
.	O

The	O
samples	O
were	O
inoculated	O
and	O
cultured	O
for	O
aerobic	O
and	O
anaerobic	O
microorganisms	O
.	O

After	O
48	O
h	O
,	O
the	O
resultant	O
bacterial	O
colonies	O
were	O
counted	O
.	O

Statistical	O
analysis	O
was	O
done	O
using	O
Wilcoxon	O
'	O
s	O
signed	O
rank	O
test	O
,	O
ANOVA	O
,	O
and	O
Newman	O
-	O
Keul	O
'	O
s	O
studentized	O
range	O
test	O
.	O

Periogard	O
had	O
the	O
highest	O
percentage	O
reduction	O
in	O
both	O
aerobic	O
and	O
anaerobic	O
microorganisms	O
followed	O
by	O
Reach	O
and	O
the	O
least	O
effective	O
was	O
normal	O
saline	O
which	O
was	O
used	O
as	O
a	O
control	O
.	O

Periogard	O
is	O
comparatively	O
better	O
as	O
a	O
preprocedural	O
mouth	O
rinse	O
than	O
Reach	O
.	O

Commercially	O
available	O
photodynamic	O
therapy	O
for	O
periodontal	O
diseases	O
utilizes	O
methylene	O
blue	O
as	O
a	O
photosensitizer	O
.	O

Here	O
we	O
propose	O
a	O
novel	O
photosensitizer	O
dye	O
,	O
indocyanine	O
green	O
(	O
ICG	O
)	O
,	O
because	O
it	O
can	O
be	O
readily	O
activated	O
by	O
commercially	O
available	O
dental	O
810	O
nm	O
diode	O
lasers	O
and	O
has	O
an	O
established	O
safety	O
record	O
as	O
an	O
intravascular	O
agent	O
in	O
cardiac	O
imaging	O
and	O
ophthalmologic	O
photodynamic	O
therapy	O
.	O

Therefore	O
,	O
we	O
aim	O
to	O
characterize	O
ICG	O
uptake	O
and	O
killing	O
of	O
key	O
periodontal	O
pathogens	O
to	O
explore	O
its	O
potential	O
as	O
a	O
periodontal	O
photodynamic	O
therapy	O
agent	O
.	O

We	O
tested	O
ICG	O
uptake	O
by	O
spectroscopy	O
in	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
381	I-bacteria
and	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
in	O
addition	O
to	O
Escherichia	B-bacteria
coli	I-bacteria
DH5alpha	I-bacteria
and	O
a	O
human	O
gingival	O
epithelial	O
cell	O
line	O
,	O
HepG	O
,	O
in	O
relation	O
to	O
ICG	O
dose	O
and	O
exposure	O
time	O
.	O

We	O
then	O
measured	O
killing	O
of	O
bacteria	O
by	O
determining	O
viable	O
bacteria	O
counts	O
before	O
and	O
after	O
exposure	O
to	O
ICG	O
and	O
810	O
nm	O
diode	O
laser	O
light	O
(	O
0	O
-	O
0	O
.	O
5	O
W	O
output	O
settings	O
,	O
0	O
-	O
5	O
seconds	O
)	O
.	O

ICG	O
was	O
also	O
applied	O
to	O
extracted	O
,	O
restored	O
teeth	O
,	O
and	O
the	O
teeth	O
inspected	O
visually	O
for	O
staining	O
after	O
rinsing	O
with	O
saline	O
.	O

We	O
found	O
rapid	O
and	O
significant	O
uptake	O
of	O
indocyanine	O
green	O
into	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
381	I-bacteria
and	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
67	I-bacteria
,	O
compared	O
to	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
DH5alpha	I-bacteria
and	O
HepG	O
gingival	O
cell	O
line	O
.	O

This	O
correlated	O
with	O
significant	O
killing	O
of	O
strains	O
381	O
and	O
67	O
compared	O
to	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
,	O
with	O
less	O
than	O
10	O
%	O
survival	O
.	O

ICG	O
does	O
not	O
appear	O
to	O
stain	O
tooth	O
surfaces	O
and	O
materials	O
except	O
calculus	O
.	O

ICG	O
combined	O
with	O
an	O
810	O
nm	O
diode	O
laser	O
may	O
be	O
useful	O
as	O
a	O
photodynamic	O
adjunct	O
for	O
reduction	O
of	O
bacterial	O
load	O
in	O
periodontal	O
pockets	O
.	O

Periodontal	O
diseases	O
are	O
known	O
to	O
be	O
major	O
diseases	O
in	O
humans	O
,	O
and	O
are	O
also	O
common	O
in	O
dogs	O
.	O

The	O
purpose	O
of	O
the	O
present	O
study	O
was	O
to	O
analyze	O
the	O
distribution	O
of	O
periodontitis	O
-	O
related	O
bacterial	O
species	O
using	O
oral	O
swab	O
specimens	O
collected	O
from	O
26	O
pet	O
dogs	O
.	O

The	O
distribution	O
of	O
an	O
animal	O
gingival	O
organism	O
Porphyromonas	B-bacteria
gulae	I-bacteria
,	O
in	O
addition	O
to	O
10	O
human	O
periodontitis	O
-	O
related	O
bacterial	O
species	O
,	O
including	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
Capnocytophaga	B-bacteria
ochracea	I-bacteria
,	O
Capnocytophaga	B-bacteria
sputigena	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Prevotella	B-bacteria
nigrescens	I-bacteria
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Campylobacter	B-bacteria
rectus	I-bacteria
,	O
and	O
Eikenella	B-bacteria
corrodens	I-bacteria
,	O
were	O
evaluated	O
by	O
polymerase	O
chain	O
reaction	O
with	O
species	O
-	O
specific	O
sets	O
of	O
primers	O
.	O

Porphyromonas	B-bacteria
gulae	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
and	O
Campylobacter	B-bacteria
rectus	I-bacteria
were	O
detected	O
in	O
almost	O
all	O
dogs	O
analyzed	O
,	O
all	O
of	O
which	O
should	O
be	O
regarded	O
as	O
common	O
members	O
of	O
oral	O
flora	O
in	O
dogs	O
.	O

Then	O
,	O
isolation	O
and	O
identification	O
of	O
the	O
Porphyromonas	B-bacteria
species	I-bacteria
in	O
swab	O
specimens	O
were	O
performed	O
.	O

There	O
were	O
35	O
strains	O
isolated	O
from	O
22	O
dogs	O
,	O
and	O
broad	O
-	O
range	O
polymerase	O
chain	O
reaction	O
and	O
sequencing	O
methods	O
revealed	O
that	O
approximately	O
70	O
%	O
of	O
them	O
were	O
Porphyromonas	B-bacteria
gulae	I-bacteria
.	O

In	O
contrast	O
,	O
the	O
frequency	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
was	O
extremely	O
low	O
.	O

These	O
findings	O
indicate	O
the	O
presence	O
of	O
specific	O
periodontitis	O
-	O
related	O
pathogens	O
in	O
pet	O
dogs	O
,	O
especially	O
Porphyromonas	B-bacteria
gulae	I-bacteria
.	O

For	O
paediatric	O
dentists	O
,	O
an	O
indicator	O
to	O
assess	O
caries	O
risk	O
of	O
infants	O
is	O
very	O
important	O
.	O

Conventionally	O
,	O
the	O
number	O
and	O
/	O
or	O
proportions	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
have	O
been	O
employed	O
as	O
risk	O
indicator	O
;	O
however	O
,	O
because	O
such	O
figures	O
reflect	O
the	O
existing	O
situation	O
,	O
they	O
are	O
not	O
suitable	O
for	O
assessing	O
caries	O
risk	O
of	O
infants	O
that	O
have	O
not	O
yet	O
been	O
infected	O
with	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

Thus	O
,	O
we	O
searched	O
for	O
an	O
indicator	O
for	O
the	O
establishment	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

To	O
evaluate	O
the	O
changes	O
caused	O
by	O
the	O
establishment	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
the	O
microbiota	O
of	O
the	O
infant	O
oral	O
cavity	O
,	O
we	O
monitored	O
changes	O
in	O
the	O
oral	O
microbiota	O
of	O
two	O
pre	O
-	O
dentate	O
infants	O
over	O
a	O
3	O
-	O
year	O
period	O
and	O
in	O
a	O
cross	O
-	O
sectional	O
study	O
of	O
40	O
nursery	O
school	O
-	O
aged	O
children	O
by	O
cultivation	O
of	O
saliva	O
on	O
nonselective	O
blood	O
agar	O
,	O
Mitis	O
-	O
Salivarius	O
agar	O
,	O
and	O
Mitis	O
-	O
Salivarius	O
agar	O
supplemented	O
with	O
bacitracin	O
combined	O
with	O
identification	O
of	O
selected	O
isolates	O
.	O

Two	O
longitudinal	O
observations	O
suggested	O
that	O
the	O
establishment	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
would	O
induce	O
a	O
decrease	O
in	O
alpha	O
-	O
haemolytic	O
bacteria	O
in	O
the	O
microbial	O
population	O
of	O
the	O
oral	O
cavity	O
.	O

This	O
suggestion	O
was	O
compensated	O
with	O
the	O
results	O
of	O
cross	O
-	O
sectional	O
study	O
,	O
and	O
it	O
was	O
revealed	O
that	O
the	O
establishment	O
of	O
10	O
(	O
3	O
)	O
CFU	O
/	O
mL	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
in	O
saliva	O
might	O
be	O
predicted	O
by	O
a	O
microbiota	O
comprising	O
less	O
than	O
approximately	O
55	O
%	O
of	O
alpha	O
-	O
haemolytic	O
.	O

Decrease	O
in	O
the	O
proportion	O
of	O
alpha	O
-	O
haemolytic	O
bacteria	O
in	O
saliva	O
of	O
infant	O
was	O
found	O
to	O
be	O
applicable	O
as	O
an	O
indicator	O
to	O
predict	O
the	O
establishment	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
to	O
assess	O
dental	O
caries	O
risk	O
as	O
a	O
background	O
for	O
planning	O
of	O
dental	O
care	O
and	O
treatment	O
in	O
the	O
infants	O
before	O
infection	O
with	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

We	O
report	O
the	O
age	O
-	O
related	O
prevalence	O
of	O
red	O
complex	O
periodontal	O
pathogens	O
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
along	O
with	O
four	O
strains	O
of	O
orange	O
complex	O
pathogens	O
.	O

The	O
bacteria	O
present	O
in	O
samples	O
isolated	O
from	O
tongue	O
,	O
cheek	O
,	O
and	O
subgingival	O
sulcus	O
in	O
edentulous	O
newborns	O
and	O
children	O
with	O
mixed	O
dentition	O
were	O
monitored	O
by	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
was	O
not	O
detected	O
in	O
any	O
site	O
of	O
any	O
subject	O
in	O
the	O
two	O
groups	O
tested	O
.	O

However	O
,	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
was	O
not	O
only	O
found	O
in	O
the	O
6	O
-	O
13	O
years	O
age	O
group	O
,	O
but	O
also	O
in	O
edentulous	O
newborns	O
at	O
a	O
relatively	O
high	O
prevalence	O
,	O
indicating	O
non	O
-	O
dentition	O
-	O
related	O
colonization	O
by	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
.	O

Campylobacter	B-bacteria
rectus	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
,	O
Eikenella	B-bacteria
corrodens	I-bacteria
,	O
and	O
Parvimonas	B-bacteria
micra	I-bacteria
were	O
found	O
in	O
the	O
oral	O
cavity	O
of	O
most	O
subjects	O
belonging	O
to	O
the	O
6	O
-	O
13	O
years	O
age	O
group	O
compared	O
to	O
newborns	O
.	O

This	O
suggested	O
a	O
pronounced	O
association	O
between	O
these	O
colonizing	O
bacteria	O
and	O
the	O
presence	O
of	O
teeth	O
.	O

There	O
was	O
also	O
a	O
strong	O
relation	O
between	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
for	O
their	O
prevalence	O
in	O
the	O
subgingival	O
sulcus	O
of	O
the	O
6	O
-	O
13	O
years	O
age	O
group	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
,	O
but	O
not	O
in	O
the	O
other	O
sites	O
tested	O
,	O
suggesting	O
that	O
the	O
colonization	O
of	O
dentition	O
-	O
related	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
may	O
be	O
associated	O
with	O
the	O
increased	O
prevalence	O
of	O
non	O
-	O
dentition	O
-	O
related	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
in	O
the	O
subgingival	O
sulcus	O
.	O

Overall	O
,	O
these	O
results	O
suggest	O
that	O
dentition	O
is	O
a	O
key	O
determinant	O
of	O
bacterial	O
colonization	O
,	O
especially	O
orange	O
complex	O
bacteria	O
and	O
the	O
red	O
complex	O
bacterium	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
colonisation	O
by	O
periodontopathic	O
bacteria	O
and	O
the	O
sites	O
of	O
colonisation	O
in	O
elderly	O
upper	O
and	O
lower	O
complete	O
denture	O
wearers	O
.	O

We	O
also	O
investigated	O
the	O
relationship	O
between	O
level	O
of	O
oral	O
hygiene	O
and	O
colonisation	O
by	O
periodontopathic	O
bacteria	O
.	O

Forty	O
edentulous	O
and	O
37	O
dentate	O
volunteers	O
participated	O
in	O
this	O
study	O
.	O

Samples	O
were	O
collected	O
from	O
whole	O
saliva	O
,	O
and	O
levels	O
of	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
and	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
were	O
determined	O
by	O
PCR	O
Invader	O
technology	O
.	O

Detection	O
of	O
these	O
species	O
on	O
oral	O
mucosal	O
and	O
denture	O
surfaces	O
was	O
performed	O
by	O
PCR	O
.	O

Fisher	O
'	O
s	O
exact	O
test	O
was	O
used	O
for	O
the	O
statistical	O
analysis	O
.	O

Cluster	O
analysis	O
was	O
employed	O
to	O
investigate	O
trends	O
in	O
the	O
periodontopathic	O
bacteria	O
flora	O
in	O
each	O
sampling	O
area	O
.	O

Detection	O
rates	O
of	O
periodontopathic	O
bacteria	O
in	O
whole	O
saliva	O
were	O
lower	O
under	O
edentulous	O
conditions	O
than	O
under	O
dentulous	O
conditions	O
,	O
except	O
for	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O

Detection	O
rate	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
was	O
the	O
highest	O
in	O
all	O
areas	O
.	O

A	O
positive	O
correlation	O
was	O
observed	O
between	O
DNA	O
quantification	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
number	O
of	O
Candida	O
species	O
in	O
saliva	O
.	O

Cluster	O
analysis	O
of	O
the	O
test	O
species	O
identified	O
two	O
clusters	O
.	O

Tongue	O
-	O
coating	O
status	O
was	O
associated	O
with	O
the	O
detection	O
rate	O
of	O
all	O
periodontopathic	O
bacteria	O
investigated	O
,	O
and	O
denture	O
plaque	O
status	O
was	O
associated	O
with	O
the	O
detection	O
rate	O
of	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

Results	O
indicate	O
the	O
presence	O
of	O
periodontopathic	O
bacteria	O
under	O
edentulous	O
conditions	O
and	O
that	O
the	O
status	O
of	O
oral	O
hygiene	O
of	O
the	O
mucosal	O
or	O
denture	O
surfaces	O
affects	O
colonisation	O
by	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

Carbonic	O
anhydrase	O
VI	O
(	O
CA	O
VI	O
)	O
,	O
encoded	O
by	O
type	O
A	O
transcripts	O
of	O
the	O
gene	O
Car6	O
,	O
is	O
a	O
secretory	O
product	O
of	O
salivary	O
glands	O
and	O
is	O
found	O
in	O
the	O
enamel	O
pellicle	O
.	O

Because	O
higher	O
caries	O
prevalence	O
is	O
associated	O
with	O
lower	O
salivary	O
concentrations	O
of	O
CA	O
VI	O
in	O
humans	O
,	O
we	O
tested	O
whether	O
CA	O
VI	O
protects	O
enamel	O
surfaces	O
from	O
caries	O
induced	O
by	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
using	O
Car6	O
(	O
-	O
/	O
-	O
)	O
mice	O
,	O
in	O
which	O
salivary	O
CA	O
VI	O
expression	O
is	O
absent	O
.	O

We	O
detected	O
aberrant	O
Car6	O
type	O
A	O
transcripts	O
in	O
Car6	O
(	O
-	O
/	O
-	O
)	O
mice	O
,	O
likely	O
targets	O
for	O
nonsense	O
-	O
mediated	O
mRNA	O
decay	O
.	O

Expression	O
of	O
the	O
intracellular	O
stress	O
-	O
induced	O
isoform	O
of	O
CA	O
VI	O
encoded	O
by	O
type	O
B	O
transcripts	O
was	O
restricted	O
to	O
parotid	O
and	O
submandibular	O
glands	O
of	O
wild	O
type	O
mice	O
.	O

The	O
salivary	O
function	O
of	O
Car6	O
(	O
-	O
/	O
-	O
)	O
mice	O
was	O
normal	O
as	O
assessed	O
by	O
the	O
histology	O
and	O
protein	O
/	O
glycoprotein	O
profiles	O
of	O
glands	O
,	O
salivary	O
flow	O
rates	O
and	O
protein	O
/	O
glycoprotein	O
compositions	O
of	O
saliva	O
.	O

Surprisingly	O
,	O
total	O
smooth	O
surface	O
caries	O
and	O
sulcal	O
caries	O
in	O
Car6	O
(	O
-	O
/	O
-	O
)	O
mice	O
were	O
more	O
than	O
6	O
-	O
fold	O
and	O
2	O
-	O
fold	O
lower	O
than	O
in	O
wild	O
type	O
mice	O
after	O
infection	O
with	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
strain	I-bacteria
UA159	I-bacteria
.	O

Recoveries	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
total	O
microbiota	O
from	O
molars	O
were	O
also	O
lower	O
in	O
Car6	O
(	O
-	O
/	O
-	O
)	O
mice	O
.	O

To	O
explore	O
possible	O
mechanisms	O
for	O
increased	O
caries	O
susceptibility	O
,	O
we	O
found	O
no	O
differences	O
in	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
adherence	O
to	O
salivary	O
pellicles	O
,	O
in	O
vitro	O
.	O

Interestingly	O
,	O
higher	O
levels	O
of	O
Lactobacillus	B-bacteria
murinus	I-bacteria
and	O
an	O
unidentified	O
Streptococcus	B-bacteria
species	I-bacteria
were	O
cultivated	O
from	O
the	O
oral	O
microbiota	O
of	O
Car6	O
(	O
-	O
/	O
-	O
)	O
mice	O
.	O

Collective	O
results	O
suggest	O
salivary	O
CA	O
VI	O
may	O
promote	O
caries	O
by	O
modulating	O
the	O
oral	O
microbiota	O
to	O
favor	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
colonization	O
and	O
/	O
or	O
by	O
the	O
enzymatic	O
production	O
of	O
acid	O
within	O
plaque	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
the	O
inhibitory	O
effects	O
of	O
herbal	O
extracts	O
on	O
caries	O
-	O
related	O
bacteria	O
,	O
glucan	O
and	O
biofilm	O
in	O
vitro	O
.	O

Sensitive	O
tests	O
of	O
bacteria	O
were	O
carried	O
out	O
by	O
broth	O
dilution	O
method	O
on	O
a	O
96	O
-	O
microwell	O
plate	O
.	O

Glucan	O
inhibition	O
tests	O
were	O
carried	O
out	O
using	O
the	O
phenol	O
sulphate	O
method	O
.	O

A	O
minimum	O
biofilm	O
inhibitory	O
concentration	O
(	O
MBIC	O
)	O
test	O
was	O
performed	O
in	O
an	O
artificial	O
mouth	O
model	O
.	O

The	O
results	O
of	O
the	O
MBIC	O
of	O
agents	O
were	O
8	O
,	O
16	O
and	O
32	O
mg	O
mL	O
(	O
-	O
1	O
)	O
for	O
eugenol	O
,	O
tannic	O
acid	O
and	O
magnolol	O
,	O
respectively	O
.	O

For	O
the	O
results	O
of	O
glucan	O
inhibition	O
tests	O
,	O
over	O
63	O
%	O
,	O
28	O
%	O
and	O
27	O
%	O
inhibition	O
occurred	O
on	O
insoluble	O
glucan	O
syntheses	O
of	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
for	O
eugenol	O
,	O
magnolol	O
and	O
tannic	O
acid	O
,	O
respectively	O
.	O

Over	O
46	O
%	O
,	O
16	O
%	O
and	O
13	O
%	O
inhibition	O
on	O
soluble	O
glucan	O
syntheses	O
for	O
eugenol	O
,	O
magnolol	O
and	O
tannic	O
acid	O
,	O
respectively	O
,	O
were	O
also	O
observed	O
.	O

In	O
conclusion	O
,	O
the	O
inhibition	O
of	O
eugenol	O
on	O
glucan	O
is	O
essential	O
for	O
the	O
biofilm	O
inhibition	O
effect	O
on	O
caries	O
-	O
related	O
biofilm	O
in	O
an	O
artificial	O
mouth	O
model	O
in	O
vitro	O
.	O

Gluten	O
proteins	O
,	O
prominent	O
constituents	O
of	O
barley	O
,	O
wheat	O
and	O
rye	O
,	O
cause	O
celiac	O
disease	O
in	O
genetically	O
predisposed	O
subjects	O
.	O

Gluten	O
is	O
notoriously	O
difficult	O
to	O
digest	O
by	O
mammalian	O
proteolytic	O
enzymes	O
and	O
the	O
protease	O
-	O
resistant	O
domains	O
contain	O
multiple	O
immunogenic	O
epitopes	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
identify	O
novel	O
sources	O
of	O
gluten	O
-	O
digesting	O
microbial	O
enzymes	O
from	O
the	O
upper	O
gastro	O
-	O
intestinal	O
tract	O
with	O
the	O
potential	O
to	O
neutralize	O
gluten	O
epitopes	O
.	O

Oral	O
microorganisms	O
with	O
gluten	O
-	O
degrading	O
capacity	O
were	O
obtained	O
by	O
a	O
selective	O
plating	O
strategy	O
using	O
gluten	O
agar	O
.	O

Microbial	O
speciations	O
were	O
carried	O
out	O
by	O
16S	O
rDNA	O
gene	O
sequencing	O
.	O

Enzyme	O
activities	O
were	O
assessed	O
using	O
gliadin	O
-	O
derived	O
enzymatic	O
substrates	O
,	O
gliadins	O
in	O
solution	O
,	O
gliadin	O
zymography	O
,	O
and	O
33	O
-	O
mer	O
alpha	O
-	O
gliadin	O
and	O
26	O
-	O
mer	O
gamma	O
-	O
gliadin	O
immunogenic	O
peptides	O
.	O

Fragments	O
of	O
the	O
gliadin	O
peptides	O
were	O
separated	O
by	O
RP	O
-	O
HPLC	O
and	O
structurally	O
characterized	O
by	O
mass	O
spectrometry	O
.	O

Strains	O
with	O
high	O
activity	O
towards	O
gluten	O
were	O
typed	O
as	O
Rothia	B-bacteria
mucilaginosa	I-bacteria
and	O
Rothia	B-bacteria
aeria	I-bacteria
.	O

Gliadins	O
(	O
250	O
microg	O
/	O
ml	O
)	O
added	O
to	O
Rothia	B-bacteria
cell	O
suspensions	O
(	O
OD	O
(	O
620	O
)	O
1	O
.	O
2	O
)	O
were	O
degraded	O
by	O
50	O
%	O
after	O
approximately	O
30	O
min	O
of	O
incubation	O
.	O

Importantly	O
,	O
the	O
33	O
-	O
mer	O
and	O
26	O
-	O
mer	O
immunogenic	O
peptides	O
were	O
also	O
cleaved	O
,	O
primarily	O
C	O
-	O
terminal	O
to	O
Xaa	O
-	O
Pro	O
-	O
Gln	O
(	O
XPQ	O
)	O
and	O
Xaa	O
-	O
Pro	O
-	O
Tyr	O
(	O
XPY	O
)	O
.	O

The	O
major	O
gliadin	O
-	O
degrading	O
enzymes	O
produced	O
by	O
the	O
Rothia	B-bacteria
strains	I-bacteria
were	O
approximately	O
70	O
-	O
75	O
kDa	O
in	O
size	O
,	O
and	O
the	O
enzyme	O
expressed	O
by	O
Rothia	B-bacteria
aeria	I-bacteria
was	O
active	O
over	O
a	O
wide	O
pH	O
range	O
(	O
pH	O
3	O
-	O
10	O
)	O
.	O

While	O
the	O
human	O
digestive	O
enzyme	O
system	O
lacks	O
the	O
capacity	O
to	O
cleave	O
immunogenic	O
gluten	O
,	O
such	O
activities	O
are	O
naturally	O
present	O
in	O
the	O
oral	O
microbial	O
enzyme	O
repertoire	O
.	O

The	O
identified	O
bacteria	O
may	O
be	O
exploited	O
for	O
physiologic	O
degradation	O
of	O
harmful	O
gluten	O
peptides	O
.	O

Gelclair	O
is	O
an	O
oral	O
lubricating	O
gel	O
used	O
in	O
the	O
management	O
of	O
oral	O
mucositis	O
(	O
OM	O
)	O
.	O

We	O
evaluated	O
its	O
efficacy	O
,	O
tolerance	O
and	O
impact	O
on	O
oral	O
cavity	O
microbial	O
colonization	O
in	O
patients	O
with	O
OM	O
after	O
allogeneic	O
hematopoietic	O
stem	O
cells	O
transplantation	O
.	O

Gelclair	O
was	O
administered	O
in	O
a	O
group	O
of	O
22	O
patients	O
with	O
active	O
OM	O
.	O

A	O
control	O
group	O
of	O
15	O
patients	O
used	O
other	O
rinsing	O
solutions	O
(	O
chlorhexidine	O
,	O
benzydamine	O
,	O
salvia	O
)	O
.	O

Tests	O
with	O
oral	O
cavity	O
swabs	O
for	O
microbiology	O
analysis	O
were	O
performed	O
once	O
a	O
week	O
.	O

The	O
characteristics	O
of	O
OM	O
in	O
both	O
groups	O
were	O
comparable	O
,	O
and	O
rinsing	O
solutions	O
had	O
satisfactory	O
tolerability	O
.	O

There	O
was	O
no	O
difference	O
in	O
the	O
median	O
improvement	O
of	O
oral	O
intake	O
and	O
OM	O
-	O
related	O
pain	O
relief	O
,	O
which	O
was	O
assessed	O
mostly	O
as	O
`	O
`	O
slight	O
effect	O
'	O
'	O
.	O

In	O
the	O
Gelclair	O
group	O
,	O
the	O
effect	O
duration	O
was	O
longer	O
(	O
median	O
3	O
[	O
0	O
-	O
5	O
]	O
vs	O
.	O
1	O
[	O
0	O
-	O
3	O
]	O
hours	O
,	O
p	O
=	O
0	O
.	O
001	O
)	O
.	O

There	O
was	O
significant	O
increase	O
of	O
Enterococcus	B-bacteria
faecalis	I-bacteria
and	O
Candida	O
sp	O
.	O
colonization	O
of	O
the	O
oral	O
cavity	O
over	O
the	O
course	O
of	O
the	O
hospitalization	O
and	O
significantly	O
reduced	O
incidence	O
of	O
such	O
colonization	O
in	O
patients	O
with	O
OM	O
in	O
the	O
Gelclair	O
group	O
:	O
1	O
/	O
22	O
(	O
5	O
%	O
)	O
vs	O
.	O
6	O
/	O
15	O
(	O
40	O
%	O
)	O
,	O
p	O
=	O
0	O
.	O
01	O
.	O

In	O
vitro	O
tests	O
showed	O
inhibited	O
growth	O
of	O
Enterococcus	B-bacteria
faecalis	I-bacteria
and	O
Candida	O
sp	O
.	O
colonies	O
within	O
the	O
area	O
of	O
the	O
Gelclair	O
application	O
.	O

Gelclair	O
may	O
be	O
individually	O
helpful	O
in	O
the	O
management	O
of	O
OM	O
and	O
pain	O
in	O
patients	O
after	O
allogeneic	O
stem	O
cells	O
transplantation	O
.	O

Its	O
use	O
did	O
not	O
lead	O
to	O
worsened	O
oral	O
bacterial	O
and	O
yeast	O
colonization	O
and	O
probably	O
even	O
helped	O
to	O
protect	O
mucosa	O
from	O
Enterococcus	B-bacteria
and	O
Candida	O
sp	O
.	O

Further	O
studies	O
based	O
on	O
larger	O
cohorts	O
are	O
needed	O
.	O

Lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
(	O
LAB	B-bacteria
)	O
might	O
offer	O
opportunities	O
as	O
oral	O
probiotics	O
provided	O
candidate	O
strains	O
persist	O
in	O
the	O
mouth	O
.	O

After	O
intake	O
of	O
a	O
mixture	O
of	O
69	O
LAB	B-bacteria
,	O
strains	O
of	O
Lactobacillus	B-bacteria
fermentum	I-bacteria
and	O
Lactobacillus	B-bacteria
salivarius	I-bacteria
were	O
especially	O
recovered	O
.	O

Coaggregation	O
with	O
other	O
microbes	O
is	O
likely	O
not	O
a	O
prerequisite	O
for	O
persistence	O
since	O
L	B-bacteria
.	I-bacteria
salivarius	I-bacteria
strongly	O
coaggregated	O
with	O
typical	O
oral	O
cavity	O
isolates	O
,	O
whereas	O
L	B-bacteria
.	I-bacteria
fermentum	I-bacteria
failed	O
to	O
display	O
this	O
phenotype	O
.	O

The	O
aims	O
of	O
this	O
study	O
were	O
to	O
evaluate	O
the	O
effect	O
of	O
a	O
self	O
-	O
etching	O
adhesive	O
system	O
containing	O
an	O
antibacterial	O
monomer	O
on	O
periodontal	O
health	O
and	O
subgingival	O
microbiologic	O
composition	O
in	O
orthodontic	O
patients	O
and	O
to	O
compare	O
it	O
with	O
a	O
conventional	O
adhesive	O
system	O
.	O

A	O
split	O
-	O
mouth	O
design	O
was	O
chosen	O
,	O
and	O
15	O
patients	O
were	O
included	O
in	O
the	O
study	O
.	O

Brackets	O
in	O
contralateral	O
quadrants	O
were	O
bonded	O
with	O
either	O
a	O
conventional	O
adhesive	O
system	O
(	O
control	O
)	O
or	O
a	O
self	O
-	O
etching	O
adhesive	O
system	O
that	O
contained	O
an	O
antibacterial	O
monomer	O
.	O

Clinical	O
periodontal	O
parameters	O
including	O
plaque	O
index	O
,	O
gingival	O
index	O
,	O
probing	O
depths	O
,	O
and	O
bleeding	O
on	O
probing	O
were	O
determined	O
.	O

Subgingival	O
plaque	O
samples	O
were	O
collected	O
before	O
bracket	O
placement	O
(	O
T0	O
)	O
and	O
at	O
the	O
6	O
-	O
month	O
follow	O
-	O
up	O
(	O
T1	O
)	O
.	O

The	O
real	O
-	O
time	O
TaqMan	O
polymerase	O
chain	O
reaction	O
assay	O
was	O
used	O
to	O
determine	O
the	O
subgingival	O
counts	O
of	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythensis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
and	O
Campylobacter	B-bacteria
rectus	I-bacteria
.	O

For	O
clinical	O
periodontal	O
parameters	O
,	O
analysis	O
of	O
covariance	O
(	O
ANCOVA	O
)	O
and	O
,	O
for	O
bacterial	O
counts	O
,	O
Wilcoxon	O
tests	O
were	O
used	O
for	O
statistical	O
comparisons	O
at	O
the	O
P	O
<	O
0	O
.	O
05	O
level	O
.	O

Clinical	O
periodontal	O
parameters	O
were	O
not	O
changed	O
,	O
and	O
they	O
were	O
not	O
different	O
between	O
the	O
groups	O
from	O
T0	O
to	O
T1	O
.	O

T	B-bacteria
forsythensis	I-bacteria
and	O
F	B-bacteria
nucleatum	I-bacteria
increased	O
during	O
the	O
treatment	O
period	O
in	O
both	O
groups	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
majority	O
of	O
the	O
bacteria	O
were	O
T	B-bacteria
nucleatum	I-bacteria
at	O
T0	O
and	O
T1	O
in	O
both	O
groups	O
.	O

Changes	O
in	O
bacterial	O
load	O
from	O
T0	O
to	O
T1	O
were	O
not	O
different	O
between	O
groups	O
except	O
for	O
T	B-bacteria
forsythensis	I-bacteria
and	O
F	B-bacteria
nucleatum	I-bacteria
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
use	O
of	O
an	O
antibacterial	O
monomer	O
did	O
not	O
have	O
an	O
additional	O
positive	O
effect	O
on	O
clinical	O
periodontal	O
parameters	O
.	O

When	O
used	O
in	O
bonding	O
orthodontic	O
brackets	O
,	O
the	O
antibacterial	O
monomer	O
failed	O
to	O
reduce	O
periodontopathogenic	O
bacteria	O
when	O
compared	O
with	O
the	O
conventional	O
adhesive	O
system	O
during	O
a	O
6	O
-	O
month	O
treatment	O
period	O
.	O

Preterm	O
birth	O
significantly	O
impacts	O
on	O
neonatal	O
morbidity	O
and	O
mortality	O
and	O
is	O
apparently	O
increasing	O
world	O
-	O
wide	O
.	O

Several	O
studies	O
have	O
attempted	O
to	O
define	O
a	O
causative	O
role	O
for	O
periodontal	O
disease	O
in	O
adverse	O
pregnancy	O
outcomes	O
but	O
few	O
have	O
focused	O
on	O
the	O
microbiology	O
of	O
periodontal	O
disease	O
in	O
relation	O
to	O
these	O
outcomes	O
.	O

The	O
evidence	O
for	O
a	O
positive	O
correlation	O
is	O
strong	O
,	O
supported	O
by	O
microbiological	O
and	O
immunological	O
findings	O
.	O

Conflicting	O
results	O
are	O
often	O
associated	O
with	O
uncontrolled	O
confounding	O
factors	O
.	O

A	O
literature	O
search	O
was	O
conducted	O
in	O
order	O
to	O
establish	O
whether	O
or	O
not	O
a	O
role	O
exists	O
for	O
oral	O
Gram	O
-	O
negative	O
bacteria	O
in	O
adverse	O
pregnancy	O
outcomes	O
.	O

Association	O
and	O
intervention	O
studies	O
are	O
summarized	O
along	O
with	O
pathogenic	O
potential	O
of	O
the	O
Gram	O
-	O
negative	O
bacteria	O
most	O
frequently	O
implicated	O
in	O
periodontal	O
disease	O
.	O

Fusobacterium	B-bacteria
nucleatum	I-bacteria
is	O
one	O
of	O
the	O
most	O
common	O
anaerobic	O
bacteria	O
present	O
in	O
the	O
oral	O
cavity	O
and	O
is	O
often	O
isolated	O
from	O
infections	O
involving	O
other	O
body	O
sites	O
.	O

To	O
characterise	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
strains	I-bacteria
from	O
patients	O
attending	O
a	O
teaching	O
hospital	O
in	O
Nigeria	O
in	O
order	O
to	O
provide	O
information	O
on	O
the	O
methods	O
for	O
accurate	O
identification	O
of	O
anaerobes	O
in	O
clinical	O
specimen	O
.	O

Fusobacterium	B-bacteria
nucleatum	I-bacteria
specie	I-bacteria
from	O
50	O
patients	O
presenting	O
with	O
oro	O
-	O
facial	O
infections	O
were	O
studied	O
by	O
culture	O
on	O
Fusobacterium	B-bacteria
selective	O
agar	O
and	O
fastidious	O
anaerobe	O
agar	O
.	O

The	O
isolates	O
were	O
characterised	O
based	O
on	O
colonial	O
morphology	O
,	O
microscopy	O
,	O
lipase	O
production	O
,	O
susceptibility	O
to	O
kanamycin	O
and	O
colistin	O
and	O
resistance	O
to	O
vancomycin	O
.	O

Biochemical	O
tests	O
were	O
performed	O
using	O
a	O
commercial	O
test	O
kit	O
.	O

The	O
identity	O
of	O
the	O
isolates	O
was	O
confirmed	O
based	O
on	O
molecular	O
characterization	O
performed	O
using	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
analysis	O
.	O

Forty	O
-	O
eight	O
(	O
96	O
%	O
)	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
isolates	I-bacteria
were	O
obtained	O
from	O
the	O
50	O
patients	O
by	O
culture	O
and	O
all	O
the	O
isolates	O
were	O
identified	O
by	O
colonial	O
appearance	O
and	O
microscopy	O
based	O
on	O
their	O
unique	O
spindle	O
shape	O
with	O
tapered	O
ends	O
.	O

Only	O
26	O
(	O
54	O
.	O
2	O
%	O
)	O
of	O
the	O
48	O
isolates	O
were	O
identified	O
by	O
commercial	O
API	O
20A	O
test	O
kit	O
while	O
PCR	O
confirmed	O
the	O
identity	O
of	O
all	O
the	O
isolates	O
.	O

Anaerobes	O
are	O
involved	O
in	O
human	O
infections	O
and	O
their	O
study	O
is	O
quite	O
cumbersome	O
due	O
to	O
tedious	O
nature	O
and	O
high	O
cost	O
of	O
the	O
techniques	O
involved	O
.	O

Cultural	O
method	O
is	O
reliable	O
in	O
the	O
isolation	O
and	O
identification	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
species	I-bacteria
.	O

PCR	O
is	O
a	O
rapid	O
and	O
simple	O
method	O
that	O
can	O
complement	O
the	O
phenotypic	O
identification	O
of	O
anaerobes	O
and	O
would	O
assist	O
in	O
their	O
full	O
identification	O
.	O

Oral	O
pathology	O
is	O
a	O
commonly	O
reported	O
extraintestinal	O
manifestation	O
of	O
Crohn	O
'	O
s	O
disease	O
(	O
CD	O
)	O
.	O

The	O
host	O
-	O
microbe	O
interaction	O
has	O
been	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
inflammatory	O
bowel	O
disease	O
(	O
IBD	O
)	O
in	O
genetically	O
susceptible	O
hosts	O
,	O
yet	O
limited	O
information	O
exists	O
about	O
oral	O
microbes	O
in	O
IBD	O
.	O

We	O
hypothesize	O
that	O
the	O
microbiology	O
of	O
the	O
oral	O
cavity	O
may	O
differ	O
in	O
patients	O
with	O
IBD	O
.	O

Our	O
laboratory	O
has	O
developed	O
a	O
16S	O
rRNA	O
-	O
based	O
technique	O
known	O
as	O
the	O
Human	O
Oral	O
Microbe	O
Identification	O
Microarray	O
(	O
HOMIM	O
)	O
to	O
study	O
the	O
oral	O
microbiome	O
of	O
children	O
and	O
young	O
adults	O
with	O
IBD	O
.	O

Tongue	O
and	O
buccal	O
mucosal	O
brushings	O
from	O
healthy	O
controls	O
,	O
CD	O
,	O
and	O
ulcerative	O
colitis	O
(	O
UC	O
)	O
patients	O
were	O
analyzed	O
using	O
HOMIM	O
.	O

Shannon	O
Diversity	O
Index	O
(	O
SDI	O
)	O
and	O
Principal	O
Component	O
Analysis	O
(	O
PCA	O
)	O
were	O
employed	O
to	O
compare	O
population	O
and	O
phylum	O
-	O
level	O
changes	O
among	O
our	O
study	O
groups	O
.	O

In	O
all	O
,	O
114	O
unique	O
subjects	O
from	O
the	O
Children	O
'	O
s	O
Hospital	O
Boston	O
were	O
enrolled	O
.	O

Tongue	O
samples	O
from	O
patients	O
with	O
CD	O
showed	O
a	O
significant	O
decrease	O
in	O
overall	O
microbial	O
diversity	O
as	O
compared	O
with	O
the	O
same	O
location	O
in	O
healthy	O
controls	O
(	O
P	O
=	O
0	O
.	O
015	O
)	O
with	O
significant	O
changes	O
seen	O
in	O
Fusobacteria	B-bacteria
(	O
P	O
<	O
0	O
.	O
0002	O
)	O
and	O
Firmicutes	B-bacteria
(	O
P	O
=	O
0	O
.	O
022	O
)	O
.	O

Tongue	O
samples	O
from	O
patients	O
with	O
UC	O
did	O
not	O
show	O
a	O
significant	O
change	O
in	O
overall	O
microbial	O
diversity	O
as	O
compared	O
with	O
healthy	O
controls	O
(	O
P	O
=	O
0	O
.	O
418	O
)	O
.	O

As	O
detected	O
by	O
HOMIM	O
,	O
we	O
found	O
a	O
significant	O
decrease	O
in	O
overall	O
diversity	O
in	O
the	O
oral	O
microbiome	O
of	O
pediatric	O
CD	O
.	O

Considering	O
the	O
proposed	O
microbe	O
-	O
host	O
interaction	O
in	O
IBD	O
,	O
the	O
ease	O
of	O
visualization	O
and	O
direct	O
oral	O
mucosal	O
sampling	O
of	O
the	O
oral	O
cavity	O
,	O
further	O
study	O
of	O
the	O
oral	O
microbiome	O
in	O
IBD	O
is	O
of	O
potential	O
diagnostic	O
and	O
prognostic	O
value	O
.	O

To	O
test	O
the	O
hypothesis	O
whether	O
microbiota	O
in	O
oral	O
biofilm	O
is	O
linked	O
with	O
obesity	O
in	O
adolescents	O
we	O
designed	O
this	O
cross	O
-	O
sectional	O
study	O
.	O

Obese	O
adolescents	O
(	O
n	O
=	O
29	O
)	O
with	O
a	O
mean	O
age	O
of	O
14	O
.	O
7	O
years	O
and	O
normal	O
weight	O
subjects	O
(	O
n	O
=	O
58	O
)	O
matched	O
by	O
age	O
and	O
gender	O
were	O
examined	O
with	O
respect	O
to	O
visible	O
plaque	O
index	O
(	O
VPI	O
%	O
)	O
and	O
gingival	O
inflammation	O
(	O
bleeding	O
on	O
probing	O
(	O
BOP	O
%	O
)	O
)	O
.	O

Stimulated	O
saliva	O
was	O
collected	O
.	O

They	O
answered	O
a	O
questionnaire	O
concerning	O
medical	O
history	O
,	O
medication	O
,	O
oral	O
hygiene	O
habits	O
,	O
smoking	O
habits	O
,	O
and	O
sociodemographic	O
background	O
.	O

Microbiological	O
samples	O
taken	O
from	O
the	O
gingival	O
crevice	O
was	O
analyzed	O
by	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
technique	O
.	O

The	O
sum	O
of	O
bacterial	O
cells	O
in	O
subgingival	O
biofilm	O
was	O
significantly	O
associated	O
with	O
obesity	O
(	O
P	O
<	O
0	O
.	O
001	O
)	O
.	O

The	O
link	O
between	O
sum	O
of	O
bacterial	O
cells	O
and	O
obesity	O
was	O
not	O
confounded	O
by	O
any	O
of	O
the	O
studied	O
variables	O
(	O
chronic	O
disease	O
,	O
medication	O
,	O
VPI	O
%	O
,	O
BOP	O
%	O
,	O
flow	O
rate	O
of	O
whole	O
saliva	O
,	O
or	O
meal	O
frequency	O
)	O
.	O

Totally	O
23	O
bacterial	O
species	O
were	O
present	O
in	O
approximately	O
threefold	O
higher	O
amounts	O
,	O
on	O
average	O
,	O
in	O
obese	O
subjects	O
compared	O
with	O
normal	O
weight	O
controls	O
.	O

Of	O
the	O
Proteobacteria	B-bacteria
phylum	I-bacteria
,	O
Campylobacter	B-bacteria
rectus	I-bacteria
and	O
Neisseria	B-bacteria
mucosa	I-bacteria
were	O
present	O
in	O
sixfold	O
higher	O
amounts	O
among	O
obese	O
subjects	O
.	O

The	O
association	O
between	O
obesity	O
and	O
sum	O
of	O
bacterial	O
cells	O
in	O
oral	O
subgingival	O
biofilm	O
indicates	O
a	O
possible	O
link	O
between	O
oral	O
microbiota	O
and	O
obesity	O
in	O
adolescents	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
is	O
the	O
key	O
causative	O
agent	O
of	O
caries	O
and	O
infective	O
endocarditis	O
.	O

The	O
first	O
step	O
in	O
biofilm	O
development	O
and	O
the	O
consequent	O
initiation	O
of	O
further	O
disease	O
is	O
bacterial	O
adherence	O
to	O
host	O
cell	O
surfaces	O
.	O

Therefore	O
,	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
inhibitory	O
effect	O
of	O
curcumin	O
on	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
adherence	O
to	O
extracellular	O
matrices	O
and	O
tooth	O
surfaces	O
.	O

The	O
effect	O
of	O
curcumin	O
on	O
the	O
ability	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
to	O
adhere	O
to	O
glass	O
surfaces	O
coated	O
with	O
collagen	O
and	O
fibronectin	O
was	O
tested	O
in	O
order	O
to	O
determine	O
whether	O
the	O
decrease	O
of	O
the	O
bacterial	O
adhesion	O
by	O
curcumin	O
is	O
achieved	O
by	O
hindering	O
the	O
bacteria	O
in	O
adhering	O
to	O
collagen	O
and	O
/	O
or	O
fibronectin	O
.	O

Also	O
,	O
human	O
teeth	O
inoculated	O
with	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
were	O
treated	O
with	O
curcumin	O
in	O
vitro	O
in	O
order	O
to	O
assess	O
the	O
relevance	O
of	O
the	O
anti	O
-	O
adhesive	O
effect	O
to	O
oral	O
conditions	O
in	O
vivo	O
.	O

The	O
minimum	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
at	O
which	O
curcumin	O
completely	O
inhibited	O
bacterial	O
growth	O
was	O
128	O
mug	O
/	O
mL	O
.	O

The	O
addition	O
of	O
curcumin	O
below	O
the	O
MIC	O
diminished	O
bacterial	O
adherence	O
onto	O
both	O
collagen	O
-	O
and	O
fibronectin	O
-	O
coated	O
glass	O
surfaces	O
and	O
human	O
tooth	O
surfaces	O
.	O

It	O
appears	O
that	O
the	O
anti	O
-	O
adhesive	O
effect	O
of	O
curcumin	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
is	O
mediated	O
through	O
collagen	O
and	O
fibronectin	O
.	O

These	O
results	O
support	O
the	O
widespread	O
use	O
of	O
curcumin	O
as	O
a	O
food	O
-	O
based	O
antimicrobial	O
agent	O
.	O

Both	O
oral	O
cavity	O
and	O
subgingival	O
pocket	O
are	O
ecological	O
niches	O
conducive	O
to	O
hosting	O
microorganisms	O
that	O
may	O
act	O
as	O
opportunistic	O
pathogens	O
,	O
such	O
as	O
Staphylococcus	B-bacteria
aureus	I-bacteria
and	O
especially	O
methicillin	B-bacteria
-	I-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
(	O
MRSA	B-bacteria
)	O
.	O

Early	O
detection	O
of	O
MRSA	B-bacteria
is	O
a	O
matter	O
of	O
concern	O
to	O
Public	O
Health	O
.	O

The	O
aim	O
of	O
our	O
study	O
was	O
to	O
determine	O
phenotypic	O
and	O
genotypic	O
detection	O
of	O
methicillin	O
resistance	O
of	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
in	O
oral	O
mucosa	O
and	O
subgingival	O
pocket	O
in	O
102	O
patients	O
with	O
gingivitis	O
-	O
periodontitis	O
.	O

The	O
prevalence	O
of	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
was	O
10	O
.	O
8	O
%	O
(	O
n	O
=	O
11	O
)	O
in	O
subgingival	O
pocket	O
and	O
19	O
.	O
6	O
%	O
(	O
n	O
=	O
20	O
)	O
in	O
oral	O
mucosa	O
.	O

We	O
obtained	O
31	O
isolates	O
of	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
of	O
which	O
13	O
were	O
mecA	O
positive	O
and	O
18	O
were	O
mecA	O
negative	O
.	O

Detection	O
of	O
mecA	O
gene	O
by	O
PCR	O
was	O
used	O
as	O
the	O
reference	O
method	O
to	O
compare	O
the	O
results	O
of	O
phenotypic	O
methods	O
to	O
determine	O
methicillin	O
resistance	O
.	O

Early	O
,	O
accurate	O
detection	O
of	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
through	O
phenotyping	O
and	O
genotyping	O
methods	O
is	O
crucial	O
for	O
assessing	O
the	O
colonization	O
and	O
preventing	O
the	O
spread	O
of	O
MRSA	B-bacteria
.	O

To	O
determine	O
the	O
relation	O
between	O
presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
supra	O
-	O
gingival	O
dental	O
plaque	O
with	O
oral	O
hygiene	O
habits	O
and	O
oral	O
health	O
status	O
of	O
patients	O
suffering	O
from	O
symptomatic	O
dyspepsia	O
.	O

Descriptive	O
study	O
.	O

The	O
Department	O
of	O
Oral	O
Health	O
Sciences	O
,	O
Shaikh	O
Zayed	O
FPGMI	O
,	O
Lahore	O
,	O
from	O
September	O
2008	O
to	O
August	O
2009	O
.	O

One	O
hundred	O
and	O
fifty	O
dyspeptic	O
subjects	O
with	O
dental	O
plaque	O
were	O
enrolled	O
.	O

After	O
recording	O
brushing	O
frequency	O
,	O
oral	O
health	O
status	O
and	O
plaque	O
load	O
,	O
the	O
supra	O
-	O
gingival	O
dental	O
plaque	O
samples	O
were	O
collected	O
by	O
sterile	O
curettes	O
.	O

Helicobacter	B-bacteria
pylori	I-bacteria
were	O
detected	O
in	O
dental	O
plaque	O
samples	O
through	O
PCR	O
assay	O
.	O

Presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
dental	O
plaque	O
was	O
found	O
to	O
be	O
37	O
.	O
5	O
%	O
in	O
the	O
sample	O
.	O

Most	O
of	O
the	O
subjects	O
brushed	O
once	O
daily	O
,	O
had	O
plaque	O
index	O
score	O
of	O
1	O
and	O
had	O
fair	O
to	O
poor	O
oral	O
hygiene	O
status	O
.	O

Approximately	O
35	O
%	O
of	O
the	O
individuals	O
who	O
brushed	O
once	O
or	O
twice	O
a	O
day	O
harbored	O
the	O
bacterium	O
in	O
their	O
dental	O
plaque	O
.	O

There	O
was	O
no	O
difference	O
between	O
bacterial	O
detection	O
rates	O
among	O
different	O
categories	O
of	O
plaque	O
index	O
and	O
oral	O
health	O
status	O
of	O
the	O
study	O
subjects	O
.	O

Presence	O
of	O
H	B-bacteria
.	I-bacteria
pylori	I-bacteria
in	O
dental	O
plaque	O
was	O
found	O
to	O
be	O
associated	O
with	O
neither	O
brushing	O
frequency	O
nor	O
with	O
the	O
plaque	O
load	O
nor	O
with	O
the	O
oral	O
health	O
status	O
of	O
individuals	O
suffering	O
from	O
symptomatic	O
dyspepsia	O
.	O

Lactobacilli	B-bacteria
are	O
present	O
in	O
the	O
intestine	O
and	O
oral	O
cavity	O
of	O
most	O
adults	O
.	O

Secretory	O
IgA	O
in	O
mucosal	O
secretions	O
may	O
provide	O
carbohydrate	O
receptors	O
for	O
bacterial	O
adhesins	O
.	O

Here	O
,	O
oral	O
and	O
faecal	O
samples	O
from	O
33	O
IgA	O
-	O
deficient	O
individuals	O
and	O
34	O
controls	O
were	O
cultured	O
for	O
lactobacilli	B-bacteria
,	O
which	O
were	O
identified	O
using	O
species	O
-	O
specific	O
PCR	O
or	O
partial	O
16S	O
rDNA	O
sequencing	O
and	O
tested	O
for	O
expression	O
of	O
mannose	O
-	O
specific	O
adhesins	O
.	O

Lactobacilli	B-bacteria
were	O
found	O
in	O
the	O
oral	O
cavity	O
of	O
76	O
%	O
of	O
IgA	O
-	O
deficient	O
and	O
85	O
%	O
of	O
control	O
individuals	O
.	O

Lactobacillus	B-bacteria
paracasei	I-bacteria
and	O
Lactobacillus	B-bacteria
gasseri	I-bacteria
dominated	O
in	O
both	O
groups	O
.	O

Lactobacillus	B-bacteria
fermentum	I-bacteria
was	O
less	O
common	O
in	O
IgA	O
-	O
deficient	O
individuals	O
than	O
in	O
controls	O
(	O
p	O
=	O
0	O
.	O
0055	O
)	O
and	O
Lactobacillus	B-bacteria
salivarius	I-bacteria
was	O
less	O
common	O
in	O
symptomatic	O
than	O
in	O
healthy	O
IgA	O
-	O
deficient	O
individuals	O
(	O
p	O
=	O
0	O
.	O
0051	O
)	O
.	O

Faecal	O
samples	O
yielded	O
lactobacilli	B-bacteria
in	O
most	O
individuals	O
.	O

L	B-bacteria
.	I-bacteria
paracasei	I-bacteria
was	O
most	O
frequent	O
,	O
followed	O
by	O
L	B-bacteria
.	I-bacteria
gasseri	I-bacteria
and	O
Lactobacillus	B-bacteria
plantarum	I-bacteria
.	O

Mannose	O
-	O
specific	O
adhesins	O
were	O
expressed	O
more	O
frequently	O
by	O
oral	O
than	O
by	O
faecal	O
isolates	O
(	O
p	O
=	O
0	O
.	O
032	O
)	O
and	O
oral	O
isolates	O
adhered	O
in	O
higher	O
numbers	O
than	O
faecal	O
isolates	O
(	O
46	O
vs	O
.	O
14	O
bacteria	O
/	O
cell	O
,	O
p	O
=	O
0	O
.	O
0038	O
)	O
.	O

Faecal	O
isolates	O
from	O
IgA	O
-	O
deficient	O
individuals	O
more	O
frequently	O
expressed	O
mannose	O
-	O
specific	O
adhesins	O
than	O
faecal	O
isolates	O
from	O
controls	O
(	O
p	O
=	O
0	O
.	O
039	O
)	O
.	O

Mannose	O
-	O
specific	O
adhesins	O
may	O
be	O
a	O
colonisation	O
factor	O
in	O
the	O
oral	O
cavity	O
,	O
and	O
the	O
presence	O
of	O
secretory	O
IgA	O
may	O
modify	O
adhesin	O
expression	O
.	O

However	O
,	O
secretory	O
IgA	O
seems	O
to	O
have	O
little	O
influence	O
on	O
Lactobacillus	B-bacteria
species	I-bacteria
distribution	O
.	O

To	O
determine	O
the	O
Helicobacter	B-bacteria
spp	I-bacteria
present	O
in	O
the	O
oral	O
cavity	O
of	O
dogs	O
and	O
the	O
relationship	O
of	O
those	O
organisms	O
with	O
gastric	O
Helicobacter	B-bacteria
spp	I-bacteria
to	O
better	O
define	O
the	O
potential	O
for	O
dog	O
-	O
human	O
and	O
dog	O
-	O
dog	O
transmission	O
.	O

:	O
Saliva	O
and	O
dental	O
plaque	O
from	O
28	O
dogs	O
and	O
gastric	O
biopsy	O
specimens	O
from	O
a	O
subset	O
of	O
8	O
dogs	O
.	O

PCR	O
-	O
based	O
screening	O
for	O
Helicobacter	B-bacteria
spp	I-bacteria
was	O
conducted	O
on	O
samples	O
obtained	O
from	O
the	O
oral	O
cavity	O
of	O
28	O
dogs	O
.	O

Comparative	O
analysis	O
was	O
conducted	O
on	O
Helicobacteraceae	B-bacteria
16S	O
rDNA	O
clone	O
libraries	O
from	O
the	O
oral	O
cavity	O
and	O
stomach	O
of	O
a	O
subset	O
of	O
8	O
dogs	O
(	O
5	O
vomiting	O
and	O
3	O
healthy	O
)	O
that	O
had	O
positive	O
PCR	O
results	O
for	O
Helicobacter	B-bacteria
spp	I-bacteria
.	O

Helicobacteraceae	B-bacteria
DNA	O
was	O
identified	O
in	O
the	O
oral	O
cavity	O
of	O
24	O
of	O
28	O
dogs	O
.	O

Analysis	O
of	O
cloned	O
16S	O
rDNA	O
amplicons	O
from	O
8	O
dogs	O
revealed	O
that	O
Wolinella	B-bacteria
spp	I-bacteria
was	O
the	O
most	O
common	O
(	O
8	O
/	O
8	O
dogs	O
)	O
and	O
abundant	O
(	O
52	O
/	O
57	O
[	O
91	O
%	O
]	O
clones	O
)	O
member	O
of	O
the	O
Helicobacteraceae	B-bacteria
family	I-bacteria
in	O
the	O
oral	O
cavity	O
.	O

Only	O
2	O
of	O
8	O
dogs	O
harbored	O
Helicobacter	B-bacteria
spp	I-bacteria
in	O
the	O
oral	O
cavity	O
,	O
and	O
1	O
of	O
those	O
was	O
coinfected	O
with	O
Helicobacter	B-bacteria
heilmannii	I-bacteria
and	O
Helicobacter	B-bacteria
felis	I-bacteria
in	O
samples	O
obtained	O
from	O
the	O
stomach	O
and	O
saliva	O
.	O

Evaluation	O
of	O
oral	O
cavity	O
DNA	O
with	O
Wolinella	O
-	O
specific	O
PCR	O
primers	O
yielded	O
positive	O
results	O
for	O
16	O
of	O
20	O
other	O
dogs	O
(	O
24	O
/	O
28	O
samples	O
were	O
positive	O
for	O
Wolinella	B-bacteria
spp	I-bacteria
)	O
.	O

Wolinella	B-bacteria
spp	I-bacteria
rather	O
than	O
Helicobacter	B-bacteria
spp	I-bacteria
were	O
the	O
predominant	O
Helicobacteraceae	B-bacteria
in	O
the	O
oral	O
cavity	O
of	O
dogs	O
.	O

The	O
oral	O
cavity	O
of	O
dogs	O
was	O
apparently	O
not	O
a	O
zoonotically	O
important	O
reservoir	O
of	O
Helicobacter	B-bacteria
spp	I-bacteria
that	O
were	O
non	B-bacteria
-	I-bacteria
Helicobacter	I-bacteria
pylori	I-bacteria
organisms	O
.	O

The	O
mechanism	O
of	O
Cronobacter	B-bacteria
pathogenesis	O
in	O
neonatal	O
meningitis	O
and	O
potential	O
virulence	O
factors	O
(	O
aside	O
from	O
host	O
cell	O
invasion	O
ability	O
)	O
remain	O
largely	O
unknown	O
.	O

To	O
ascertain	O
whether	O
Cronobacter	B-bacteria
can	O
invade	O
and	O
transcytose	O
across	O
intestinal	O
epithelial	O
cells	O
,	O
enter	O
into	O
the	O
blood	O
stream	O
and	O
then	O
transcytose	O
across	O
the	O
blood	O
-	O
brain	O
-	O
barrier	O
,	O
we	O
have	O
utilized	O
human	O
intestinal	O
INT407	O
and	O
Caco	O
-	O
2	O
cells	O
and	O
brain	O
microvascular	O
endothelial	O
cell	O
(	O
HBMEC	O
)	O
monolayers	O
on	O
Transwell	O
filters	O
as	O
experimental	O
model	O
systems	O
.	O

Our	O
data	O
indicate	O
a	O
wide	O
range	O
of	O
heterogeneity	O
with	O
respect	O
to	O
invasion	O
efficiency	O
among	O
twenty	O
-	O
three	O
Cronobacter	B-bacteria
isolates	I-bacteria
screened	O
.	O

For	O
selected	O
isolates	O
,	O
we	O
observed	O
significant	O
levels	O
of	O
transcytosis	O
for	O
Cronobacter	B-bacteria
sakazakii	I-bacteria
across	O
tight	O
monolayers	O
of	O
both	O
Caco	O
-	O
2	O
and	O
HBMEC	O
,	O
mimicking	O
in	O
vivo	O
ability	O
to	O
cross	O
the	O
intestine	O
as	O
well	O
as	O
the	O
blood	O
brain	O
barrier	O
,	O
and	O
at	O
a	O
frequency	O
equivalent	O
to	O
that	O
of	O
a	O
control	O
meningitis	O
-	O
causing	O
Escherichia	B-bacteria
coli	I-bacteria
K1	I-bacteria
strain	I-bacteria
.	O

Finally	O
,	O
EM	O
analysis	O
demonstrated	O
intracellular	O
Cronobacter	B-bacteria
bacteria	I-bacteria
within	O
host	O
vacuoles	O
in	O
HBMEC	O
,	O
as	O
well	O
as	O
transcytosed	O
bacteria	O
at	O
the	O
basolateral	O
surface	O
.	O

These	O
data	O
reveal	O
that	O
certain	O
Cronobacter	B-bacteria
isolates	I-bacteria
can	O
invade	O
and	O
translocate	O
across	O
both	O
cultured	O
human	O
intestinal	O
epithelial	O
cells	O
and	O
HBMEC	O
,	O
thus	O
demonstrating	O
a	O
potential	O
path	O
for	O
neonatal	O
infections	O
of	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
following	O
oral	O
ingestion	O
.	O

Clinical	O
benefits	O
of	O
probiotics	O
have	O
been	O
clearly	O
reported	O
in	O
different	O
gastrointestinal	O
disorders	O
,	O
many	O
of	O
them	O
caused	O
by	O
enterobacteria	B-bacteria
.	O

The	O
oral	O
cavity	O
is	O
a	O
port	O
of	O
entry	O
and	O
can	O
be	O
an	O
important	O
reservoir	O
of	O
these	O
microorganisms	O
.	O

This	O
work	O
evaluated	O
whether	O
consumption	O
of	O
probiotics	O
was	O
able	O
to	O
influence	O
the	O
presence	O
of	O
enterobacteria	B-bacteria
in	O
the	O
oral	O
cavity	O
and	O
the	O
specific	O
secretory	O
response	O
against	O
these	O
microorganisms	O
.	O

Saliva	O
samples	O
of	O
healthy	O
individuals	O
were	O
collected	O
and	O
plated	O
in	O
MacConkey	O
agar	O
.	O

Carriers	O
of	O
Gram	O
-	O
negative	O
,	O
rod	O
-	O
shaped	O
microorganisms	O
in	O
the	O
oral	O
cavity	O
were	O
selected	O
and	O
instructed	O
to	O
use	O
the	O
probiotic	O
Yakult	O
LB	B-bacteria
for	O
20	O
days	O
.	O

Saliva	O
was	O
then	O
collected	O
and	O
enterobacteria	B-bacteria
species	I-bacteria
were	O
identified	O
using	O
the	O
API	O
20	O
E	O
system	O
and	O
by	O
ELISA	O
using	O
anti	O
-	O
enterobacteria	O
IgA	O
.	O

The	O
results	O
showed	O
reduction	O
in	O
the	O
prevalence	O
of	O
enterobacteria	B-bacteria
,	O
but	O
no	O
significant	O
changes	O
in	O
enterobacterial	O
counts	O
(	O
log	O
CFU	O
/	O
mL	O
;	O
p	O
=	O
0	O
.	O
3457	O
)	O
.	O

The	O
species	O
most	O
frequently	O
isolated	O
were	O
Enterobacter	B-bacteria
cloacae	I-bacteria
and	O
Klebsiella	B-bacteria
oxytoca	I-bacteria
,	O
both	O
before	O
and	O
after	O
probiotic	O
consumption	O
.	O

No	O
significant	O
changes	O
were	O
observed	O
in	O
anti	O
-	O
enterobacteria	O
IgA	O
levels	O
.	O

In	O
conclusion	O
,	O
probiotic	O
consumption	O
had	O
some	O
influence	O
on	O
enterobacterial	O
presence	O
in	O
the	O
oral	O
cavity	O
,	O
but	O
did	O
not	O
affect	O
enterobacterial	O
counts	O
or	O
the	O
specific	O
immune	O
secretory	O
response	O
against	O
them	O
.	O

Streptococcus	B-bacteria
salivarius	I-bacteria
is	O
a	O
Gram	O
-	O
positive	O
bacterial	O
commensal	O
and	O
pioneer	O
colonizer	O
of	O
the	O
human	O
oral	O
cavity	O
.	O

Many	O
strains	O
produce	O
ribosomally	O
synthesized	O
proteinaceous	O
antibiotics	O
(	O
bacteriocins	O
)	O
,	O
and	O
some	O
strains	O
have	O
been	O
developed	O
for	O
use	O
as	O
oral	O
probiotics	O
.	O

Here	O
,	O
we	O
present	O
the	O
draft	O
genome	O
sequence	O
of	O
the	O
bacteriocin	O
-	O
producing	O
oral	O
probiotic	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
strain	I-bacteria
M18	I-bacteria
.	O

We	O
sought	O
to	O
develop	O
Bifidobacterium	B-bacteria
infantis	I-bacteria
(	O
BI	B-bacteria
)	O
as	O
a	O
vehicle	O
for	O
the	O
expression	O
of	O
heterologous	O
antigens	O
.	O

Two	O
proteins	O
of	O
enterotoxigenic	B-bacteria
Escherichia	I-bacteria
coli	I-bacteria
(	O
ETEC	B-bacteria
)	O
were	O
expressed	O
in	O
BI	B-bacteria
:	O
CfaB	O
,	O
a	O
major	O
fimbrial	O
subunit	O
protein	O
,	O
and	O
LTB	O
,	O
the	O
B	O
subunit	O
of	O
heat	O
-	O
labile	O
enterotoxin	O
.	O

The	O
expression	O
of	O
CfaB	O
and	O
LTB	O
in	O
BI	B-bacteria
was	O
verified	O
by	O
electrophoretic	O
analysis	O
.	O

Sprague	O
-	O
Dawley	O
rats	O
were	O
then	O
subjected	O
to	O
intragastric	O
immunization	O
with	O
BI	O
-	O
CfaB	O
and	O
BI	O
-	O
LTB	O
systems	O
both	O
separately	O
and	O
together	O
.	O

ELISA	O
was	O
used	O
to	O
characterize	O
the	O
serum	O
and	O
mucosal	O
immune	O
responses	O
against	O
ETEC	B-bacteria
antigens	O
.	O

The	O
immunized	O
rats	O
were	O
intraperitoneally	O
challenged	O
with	O
wild	O
-	O
type	O
ETEC	B-bacteria
H10407	I-bacteria
to	O
study	O
the	O
immune	O
response	O
in	O
vivo	O
.	O

The	O
serum	O
titres	O
of	O
IgG	O
and	O
faecal	O
IgA	O
antibodies	O
in	O
the	O
BI	O
-	O
CfaB	O
plus	O
BI	O
-	O
LTB	O
mixed	O
vaccination	O
group	O
were	O
significantly	O
greater	O
than	O
those	O
in	O
the	O
other	O
two	O
groups	O
,	O
which	O
were	O
immunized	O
with	O
a	O
single	O
vaccine	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

However	O
,	O
no	O
significant	O
difference	O
was	O
seen	O
between	O
the	O
two	O
groups	O
that	O
received	O
a	O
single	O
immunization	O
.	O

These	O
results	O
suggest	O
that	O
expressing	O
CfaB	O
and	O
LTB	O
in	O
BI	B-bacteria
provides	O
a	O
probiotic	O
system	O
with	O
immunogenic	O
properties	O
.	O

Furthermore	O
,	O
the	O
expression	O
of	O
LTB	O
in	O
BI	B-bacteria
preserved	O
its	O
mucosal	O
adjuvant	O
effect	O
.	O

So	O
this	O
study	O
confirms	O
that	O
BI	B-bacteria
can	O
be	O
used	O
as	O
a	O
novel	O
oral	O
vaccine	O
expression	O
system	O
for	O
a	O
heterologous	O
antigen	O
and	O
BI	O
-	O
LTB	O
can	O
provide	O
mucosal	O
adjuvant	O
properties	O
.	O

Native	O
bees	O
of	O
the	O
tribe	O
Meliponini	O
produce	O
a	O
distinct	O
kind	O
of	O
propolis	O
called	O
geopropolis	O
.	O

Although	O
many	O
pharmacological	O
activities	O
of	O
propolis	O
have	O
already	O
been	O
demonstrated	O
,	O
little	O
is	O
known	O
about	O
geopropolis	O
,	O
particularly	O
regarding	O
its	O
antimicrobial	O
activity	O
against	O
oral	O
pathogens	O
.	O

The	O
present	O
study	O
aimed	O
at	O
investigating	O
the	O
antimicrobial	O
activity	O
of	O
M	O
.	O
fasciculata	O
geopropolis	O
against	O
oral	O
pathogens	O
,	O
its	O
effects	O
on	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilms	O
,	O
and	O
the	O
chemical	O
contents	O
of	O
the	O
extracts	O
.	O

A	O
gel	O
prepared	O
with	O
a	O
geopropolis	O
extract	O
was	O
also	O
analyzed	O
for	O
its	O
activity	O
on	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
its	O
immunotoxicological	O
potential	O
.	O

Antimicrobial	O
activities	O
of	O
three	O
hydroalcoholic	O
extracts	O
(	O
HAEs	O
)	O
of	O
geopropolis	O
,	O
and	O
hexane	O
and	O
chloroform	O
fractions	O
of	O
one	O
extract	O
,	O
were	O
evaluated	O
using	O
the	O
agar	O
diffusion	O
method	O
and	O
the	O
broth	O
dilution	O
technique	O
.	O

Ethanol	O
(	O
70	O
%	O
,	O
v	O
/	O
v	O
)	O
and	O
chlorhexidine	O
(	O
0	O
.	O
12	O
%	O
,	O
w	O
/	O
w	O
)	O
were	O
used	O
as	O
negative	O
and	O
positive	O
controls	O
,	O
respectively	O
.	O

Total	O
phenol	O
and	O
flavonoid	O
concentrations	O
were	O
assayed	O
by	O
spectrophotometry	O
.	O

Immunotoxicity	O
was	O
evaluated	O
in	O
mice	O
by	O
topical	O
application	O
in	O
the	O
oral	O
cavity	O
followed	O
by	O
quantification	O
of	O
biochemical	O
and	O
immunological	O
parameters	O
,	O
and	O
macro	O
-	O
microscopic	O
analysis	O
of	O
animal	O
organs	O
.	O

Two	O
extracts	O
,	O
HAE	O
-	O
2	O
and	O
HAE	O
-	O
3	O
,	O
showed	O
inhibition	O
zones	O
ranging	O
from	O
9	O
to	O
13	O
mm	O
in	O
diameter	O
for	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
C	O
.	O
albicans	O
,	O
but	O
presented	O
no	O
activity	O
against	O
L	B-bacteria
.	I-bacteria
acidophilus	I-bacteria
.	O

The	O
MBCs	O
for	O
HAE	O
-	O
2	O
and	O
HAE	O
-	O
3	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
were	O
6	O
.	O
25	O
mg	O
/	O
mL	O
and	O
12	O
.	O
5	O
mg	O
/	O
mL	O
,	O
respectively	O
.	O

HAE	O
-	O
2	O
was	O
fractionated	O
,	O
and	O
its	O
chloroform	O
fraction	O
had	O
an	O
MBC	O
of	O
14	O
.	O
57	O
mg	O
/	O
mL	O
.	O

HAE	O
-	O
2	O
also	O
exhibited	O
bactericidal	O
effects	O
on	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilms	O
after	O
3	O
h	O
of	O
treatment	O
.	O

Significant	O
differences	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
in	O
total	O
phenol	O
and	O
flavonoid	O
concentrations	O
were	O
observed	O
among	O
the	O
samples	O
.	O

Signs	O
toxic	O
effects	O
were	O
not	O
observed	O
after	O
application	O
of	O
the	O
geopropolis	O
-	O
based	O
gel	O
,	O
but	O
an	O
increase	O
in	O
the	O
production	O
of	O
IL	O
-	O
4	O
and	O
IL	O
-	O
10	O
,	O
anti	O
-	O
inflammatory	O
cytokines	O
,	O
was	O
detected	O
.	O

In	O
summary	O
,	O
geopropolis	O
produced	O
by	O
M	O
.	O
fasciculata	O
can	O
exert	O
antimicrobial	O
action	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
C	O
.	O
albicans	O
,	O
with	O
significant	O
inhibitory	O
activity	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilms	O
.	O

The	O
extract	O
with	O
the	O
highest	O
flavonoid	O
concentration	O
,	O
HAE	O
-	O
2	O
,	O
presented	O
the	O
highest	O
antimicrobial	O
activity	O
.	O

In	O
addition	O
,	O
a	O
geopropolis	O
-	O
based	O
gel	O
is	O
not	O
toxic	O
in	O
an	O
animal	O
model	O
and	O
displays	O
anti	O
-	O
inflammatory	O
effect	O
.	O

As	O
part	O
of	O
the	O
human	O
gastrointestinal	O
tract	O
,	O
the	O
oral	O
cavity	O
represents	O
a	O
complex	O
biological	O
system	O
and	O
harbors	O
diverse	O
bacterial	O
species	O
.	O

Unlike	O
the	O
gut	O
microbiota	O
,	O
which	O
is	O
often	O
considered	O
a	O
health	O
asset	O
,	O
studies	O
of	O
the	O
oral	O
commensal	O
microbiota	O
have	O
been	O
largely	O
limited	O
to	O
their	O
implication	O
in	O
oral	O
conditions	O
such	O
as	O
dental	O
caries	O
and	O
periodontal	O
disease	O
.	O

Less	O
emphasis	O
has	O
been	O
given	O
to	O
their	O
potential	O
beneficial	O
roles	O
,	O
especially	O
the	O
protective	O
effects	O
against	O
oral	O
colonization	O
by	O
foreign	O
or	O
pathogenic	O
bacteria	O
.	O

In	O
this	O
study	O
,	O
we	O
used	O
salivary	O
microbiota	O
derived	O
from	O
healthy	O
human	O
subjects	O
to	O
investigate	O
protective	O
effects	O
against	O
colonization	O
and	O
integration	O
of	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
`	O
E	O
-	O
bacteria	O
,	O
an	O
opportunistic	O
bacterial	O
pathogen	O
,	O
into	O
developing	O
or	O
pre	O
-	O
formed	O
salivary	O
biofilms	O
.	O

When	O
co	O
-	O
cultivated	O
in	O
saliva	O
medium	O
,	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
persisted	O
in	O
the	O
planktonic	O
phase	O
,	O
but	O
failed	O
to	O
integrate	O
into	O
the	O
salivary	O
microbial	O
community	O
during	O
biofilm	O
formation	O
.	O

Furthermore	O
,	O
in	O
saliva	O
medium	O
supplemented	O
with	O
sucrose	O
,	O
the	O
oral	O
microbiota	O
inhibited	O
the	O
growth	O
of	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
by	O
producing	O
lactic	O
acid	O
.	O

More	O
interestingly	O
,	O
while	O
pre	O
-	O
formed	O
salivary	O
biofilms	O
were	O
able	O
to	O
prevent	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
colonization	O
,	O
the	O
same	O
biofilms	O
recovered	O
from	O
mild	O
chlorhexidine	O
gluconate	O
treatment	O
displayed	O
a	O
shift	O
in	O
microbial	O
composition	O
and	O
showed	O
a	O
drastic	O
reduction	O
in	O
protection	O
.	O

Our	O
study	O
indicates	O
that	O
normal	O
oral	O
communities	O
with	O
balanced	O
microbial	O
compositions	O
could	O
be	O
important	O
in	O
effectively	O
preventing	O
the	O
integration	O
of	O
foreign	O
or	O
pathogenic	O
bacterial	O
species	O
,	O
such	O
as	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
.	O

Probiotics	O
have	O
been	O
proven	O
effective	O
for	O
preventing	O
caries	O
.	O

In	O
contrast	O
,	O
the	O
effect	O
of	O
probiotics	O
on	O
improving	O
oral	O
diseases	O
such	O
as	O
gingivitis	O
,	O
periodontitis	O
and	O
halitosis	O
has	O
been	O
less	O
explored	O
.	O

To	O
perform	O
a	O
screening	O
of	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
,	O
according	O
to	O
international	O
guidelines	O
for	O
the	O
evaluation	O
of	O
probiotics	O
,	O
in	O
order	O
to	O
select	O
candidate	O
probiotic	O
strains	O
for	O
preventing	O
oral	O
disorders	O
.	O

The	O
strains	O
were	O
isolated	O
from	O
healthy	O
children	O
and	O
were	O
subjected	O
to	O
a	O
variety	O
of	O
in	O
vitro	O
tests	O
in	O
order	O
to	O
show	O
their	O
functionality	O
.	O

The	O
safety	O
of	O
the	O
strains	O
was	O
assessed	O
by	O
determining	O
antibiotic	O
susceptibility	O
and	O
production	O
of	O
lactic	O
acid	O
.	O

Forty	O
-	O
six	O
of	O
the	O
100	O
new	O
isolates	O
were	O
assigned	O
to	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
genera	O
after	O
a	O
biochemical	O
characterization	O
.	O

Most	O
of	O
the	O
new	O
isolated	O
strains	O
seem	O
to	O
be	O
resistant	O
to	O
oral	O
conditions	O
,	O
have	O
great	O
ability	O
to	O
form	O
aggregates	O
and	O
have	O
high	O
antagonistic	O
activity	O
against	O
oral	O
pathogens	O
.	O

None	O
of	O
the	O
strains	O
produced	O
unpleasant	O
volatile	O
compounds	O
.	O

The	O
strains	O
showed	O
high	O
ability	O
to	O
adhere	O
to	O
oral	O
tissues	O
and	O
they	O
do	O
not	O
present	O
any	O
antibiotic	O
resistance	O
.	O

Moreover	O
,	O
an	O
increased	O
risk	O
of	O
developing	O
caries	O
due	O
to	O
their	O
ability	O
to	O
produce	O
lactic	O
acid	O
was	O
discarded	O
in	O
seven	O
pre	O
-	O
selected	O
probiotic	O
candidates	O
.	O

These	O
lactic	B-bacteria
acid	I-bacteria
bacteria	I-bacteria
show	O
promising	O
properties	O
to	O
be	O
used	O
as	O
potential	O
probiotics	O
for	O
improving	O
oral	O
health	O
.	O

Cytotoxic	O
chemotherapy	O
induces	O
changes	O
in	O
the	O
oral	O
microflora	O
that	O
may	O
cause	O
oral	O
and	O
systemic	O
infections	O
in	O
myelosuppressed	O
cancer	O
patients	O
.	O

These	O
complications	O
prompted	O
us	O
to	O
assess	O
the	O
antimicrobial	O
activity	O
of	O
a	O
topical	O
Iseganan	O
HCl	O
mouthwash	O
vs	O
.	O
placebo	O
on	O
the	O
aerobic	O
and	O
facultatively	O
anaerobic	O
oral	O
flora	O
in	O
these	O
patients	O
.	O

Two	O
hundred	O
and	O
twenty	O
-	O
five	O
chemotherapy	O
patients	O
were	O
recruited	O
into	O
a	O
randomized	O
,	O
double	O
-	O
blind	O
,	O
placebo	O
-	O
controlled	O
trial	O
,	O
conducted	O
at	O
multiple	O
centers	O
.	O

The	O
study	O
compared	O
the	O
antimicrobial	O
efficacy	O
of	O
Iseganan	O
HCl	O
vs	O
.	O
placebo	O
(	O
95	O
%	O
of	O
the	O
Iseganan	O
and	O
97	O
%	O
of	O
the	O
control	O
group	O
received	O
myeloablative	O
chemotherapy	O
)	O
.	O

Iseganan	O
HCl	O
9	O
mg	O
/	O
3	O
ml	O
was	O
administered	O
as	O
a	O
swish	O
and	O
swallow	O
solution	O
,	O
six	O
times	O
daily	O
for	O
21	O
-	O
28	O
days	O
.	O

Microbial	O
cultures	O
were	O
made	O
before	O
and	O
after	O
the	O
daily	O
Iseganan	O
mouth	O
rinse	O
on	O
the	O
first	O
and	O
final	O
days	O
of	O
chemotherapy	O
.	O

The	O
reduction	O
in	O
total	O
microbial	O
load	O
after	O
the	O
first	O
day	O
of	O
treatment	O
was	O
statistically	O
significant	O
(	O
1	O
.	O
59	O
vs	O
.	O
0	O
.	O
18	O
log10	O
CFU	O
for	O
the	O
Iseganan	O
HCl	O
and	O
placebo	O
groups	O
,	O
respectively	O
,	O
P	O
<	O
0	O
.	O
0001	O
)	O
.	O

Iseganan	O
HCl	O
rinse	O
had	O
a	O
cumulative	O
effect	O
demonstrated	O
by	O
the	O
significant	O
difference	O
between	O
the	O
two	O
groups	O
on	O
the	O
last	O
day	O
of	O
the	O
study	O
(	O
i	O
.	O
e	O
.	O
completion	O
of	O
Iseganan	O
daily	O
treatment	O
)	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
reduction	O
was	O
mainly	O
due	O
to	O
decreased	O
densities	O
of	O
viridans	B-bacteria
streptococci	I-bacteria
,	O
non	B-bacteria
-	I-bacteria
hemolytic	I-bacteria
streptococci	I-bacteria
,	O
and	O
yeasts	O
.	O

The	O
minimal	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
of	O
Iseganan	O
HCl	O
remained	O
the	O
same	O
throughout	O
the	O
course	O
of	O
treatment	O
.	O

Topical	O
Iseganan	O
HCl	O
significantly	O
reduces	O
the	O
total	O
oral	O
aerobic	O
bacterial	O
,	O
streptococcal	B-bacteria
,	O
and	O
yeast	O
load	O
.	O

Its	O
potential	O
as	O
an	O
oral	O
antimicrobial	O
agent	O
in	O
preventing	O
these	O
types	O
of	O
infections	O
is	O
clear	O
.	O

The	O
co	O
-	O
aggregation	O
of	O
oral	O
bacteria	O
leads	O
to	O
their	O
clearance	O
from	O
the	O
oral	O
cavity	O
.	O

Poor	O
oral	O
hygiene	O
and	O
high	O
saliva	O
viscosity	O
are	O
common	O
amongst	O
the	O
elderly	O
;	O
thus	O
,	O
they	O
frequently	O
suffer	O
from	O
pneumonia	O
caused	O
by	O
the	O
aspiration	O
of	O
oral	O
microorganisms	O
.	O

To	O
examine	O
the	O
direct	O
effect	O
of	O
saliva	O
viscosity	O
on	O
the	O
co	O
-	O
aggregation	O
of	O
oral	O
streptococci	B-bacteria
with	O
actinomyces	B-bacteria
.	O

Fifteen	O
oral	O
streptococcal	B-bacteria
and	O
a	O
single	O
actinomyces	B-bacteria
strain	I-bacteria
were	O
used	O
.	O

Co	O
-	O
aggregation	O
was	O
assessed	O
by	O
a	O
visual	O
assay	O
in	O
phosphate	O
buffer	O
and	O
a	O
spectrophotometric	O
assay	O
in	O
the	O
same	O
buffer	O
containing	O
0	O
-	O
60	O
%	O
glycerol	O
or	O
whole	O
saliva	O
.	O

Nine	O
oral	O
streptococci	B-bacteria
co	O
-	O
aggregated	O
with	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
ATCC12104	I-bacteria
in	O
the	O
visual	O
assay	O
and	O
were	O
subsequently	O
used	O
for	O
the	O
spectrophotometric	O
analysis	O
.	O

All	O
tested	O
strains	O
displayed	O
a	O
decrease	O
in	O
co	O
-	O
aggregation	O
with	O
increasing	O
amounts	O
of	O
glycerol	O
in	O
the	O
buffer	O
.	O

The	O
co	O
-	O
aggregation	O
of	O
Streptococcus	B-bacteria
oralis	I-bacteria
with	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
recovered	O
to	O
baseline	O
level	O
following	O
the	O
removal	O
of	O
glycerol	O
.	O

The	O
per	O
cent	O
co	O
-	O
aggregation	O
of	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
with	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
was	O
significantly	O
correlated	O
with	O
the	O
viscosity	O
in	O
unstimulated	O
and	O
stimulated	O
whole	O
saliva	O
samples	O
(	O
correlation	O
coefficients	O
:	O
-	O
0	O
.	O
52	O
and	O
-	O
0	O
.	O
48	O
,	O
respectively	O
)	O
.	O

This	O
study	O
suggests	O
that	O
saliva	O
viscosity	O
affects	O
the	O
co	O
-	O
aggregation	O
of	O
oral	O
streptococci	B-bacteria
with	O
actinomyces	B-bacteria
and	O
that	O
bacterial	O
co	O
-	O
aggregation	O
decreases	O
with	O
increasing	O
saliva	O
viscosity	O
.	O

Ethanol	O
,	O
human	O
papilloma	O
virus	O
(	O
HPV	O
)	O
,	O
and	O
poor	O
oral	O
hygiene	O
are	O
risk	O
factors	O
that	O
have	O
been	O
attributed	O
to	O
oral	O
carcinogenesis	O
.	O

Streptococci	B-bacteria
sp	I-bacteria
and	O
HPV	O
infections	O
are	O
common	O
in	O
the	O
head	O
and	O
neck	O
,	O
often	O
associated	O
with	O
sexual	O
activity	O
.	O

Although	O
HPV	O
is	O
linked	O
to	O
head	O
and	O
neck	O
squamous	O
cell	O
carcinoma	O
,	O
it	O
is	O
unclear	O
whether	O
there	O
is	O
a	O
similar	O
role	O
for	O
Streptococci	B-bacteria
sp	I-bacteria
.	O

This	O
cell	O
study	O
examines	O
whether	O
Streptococci	B-bacteria
sp	I-bacteria
and	O
HPV	O
-	O
16	O
with	O
exposure	O
to	O
ethyl	O
alcohol	O
(	O
ETOH	O
)	O
can	O
act	O
as	O
cofactors	O
in	O
the	O
malignant	O
transformation	O
of	O
oral	O
keratinocytes	O
.	O

ETOH	O
(	O
0	O
.	O
1	O
%	O
-	O
20	O
%	O
vol	O
/	O
vol	O
)	O
was	O
used	O
to	O
investigate	O
Streptococci	B-bacteria
sp	I-bacteria
attachment	O
with	O
immortalized	O
E6	O
-	O
expressing	O
HPV	O
/	O
HOK	O
-	O
16B	O
cells	O
,	O
human	O
oral	O
buccal	O
keratinocytes	O
,	O
and	O
foreskin	O
keratinocytes	O
.	O

Streptococci	B-bacteria
sp	I-bacteria
(	O
Streptococci	B-bacteria
mutans	I-bacteria
[	I-bacteria
LT11	I-bacteria
]	I-bacteria
)	O
and	O
various	O
strains	O
of	O
acetaldehyde	O
(	O
AA	O
)	O
producer	O
and	O
nonproducer	O
Streptococcus	B-bacteria
salivarius	I-bacteria
(	O
110	O
-	O
1	O
,	O
109	O
-	O
2	O
,	O
101	O
-	O
7	O
,	O
and	O
107	O
-	O
1	O
)	O
and	O
a	O
lactic	O
acid	O
producer	O
bacterium	O
,	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
(	O
24	O
-	O
1	O
and	O
25	O
-	O
2	O
)	O
,	O
were	O
examined	O
for	O
interactions	O
with	O
keratinocytes	O
by	O
use	O
of	O
a	O
green	O
dye	O
(	O
percent	O
of	O
cells	O
with	O
colonies	O
after	O
24	O
hours	O
)	O
.	O

Carcinogens	O
,	O
AA	O
,	O
malondialdehyde	O
,	O
DNA	O
damage	O
,	O
and	O
proliferation	O
(	O
5	O
'	O
-	O
bromo	O
-	O
2	O
-	O
deoxyuridine	O
)	O
among	O
keratinocytes	O
were	O
also	O
quantified	O
.	O

AA	O
and	O
malondialdehyde	O
production	O
from	O
permissible	O
Streptococci	B-bacteria
sp	I-bacteria
significantly	O
increased	O
with	O
attachment	O
to	O
keratinocytes	O
,	O
whereas	O
L	B-bacteria
rhamnosus	I-bacteria
did	O
not	O
significantly	O
attach	O
to	O
keratinocytes	O
.	O

This	O
attachment	O
was	O
associated	O
with	O
enhanced	O
levels	O
of	O
AA	O
adduct	O
formation	O
,	O
proliferation	O
(	O
5	O
'	O
-	O
bromo	O
-	O
2	O
-	O
deoxyuridine	O
incorporation	O
)	O
,	O
and	O
enhanced	O
migration	O
through	O
integrin	O
-	O
coated	O
basement	O
membrane	O
by	O
HPV	O
oral	O
keratinocytes	O
,	O
which	O
are	O
characteristics	O
of	O
a	O
malignant	O
phenotype	O
.	O

These	O
cell	O
studies	O
suggest	O
that	O
oral	O
Streptococci	B-bacteria
sp	I-bacteria
and	O
HPV	O
(	O
HPV	O
-	O
16	O
)	O
cooperate	O
to	O
transform	O
oral	O
keratinocytes	O
after	O
low	O
-	O
level	O
ETOH	O
(	O
1	O
%	O
)	O
exposure	O
.	O

These	O
results	O
appear	O
to	O
suggest	O
a	O
significant	O
clinical	O
interaction	O
,	O
but	O
further	O
validation	O
is	O
warranted	O
.	O

To	O
investigate	O
the	O
hypothesis	O
that	O
the	O
rectum	O
may	O
be	O
an	O
important	O
reservoir	O
for	O
vaginal	O
colonisation	O
by	O
Lactobacillus	B-bacteria
species	I-bacteria
.	O

We	O
included	O
60	O
pregnant	O
women	O
aged	O
18	O
-	O
35	O
years	O
and	O
80	O
postmenopausal	O
women	O
aged	O
55	O
-	O
65	O
years	O
in	O
this	O
cross	O
-	O
sectional	O
observational	O

.	O

Participants	O
had	O
to	O
be	O
without	O
clinical	O
signs	O
of	O
vaginal	O
infection	O
and	O
without	O
hormone	O
replacement	O
therapy	O
.	O

Only	O
women	O
with	O
normal	O
vaginal	O
microflora	O
(	O
Nugent	O
scores	O
0	O
-	O
3	O
)	O
were	O
included	O
in	O
the	O
evaluation	O
.	O

The	O
first	O
oral	O
,	O
vaginal	O
,	O
and	O
rectal	O
smears	O
were	O
taken	O
for	O
the	O
enumeration	O
of	O
lactobacilli	B-bacteria
by	O
cultural	O
methods	O
and	O
identification	O
of	O
dominating	O
lactobacilli	B-bacteria
based	O
on	O
multiplex	O
polymerase	O
chain	O
reaction	O
(	O
PCR	O
)	O
.	O

The	O
second	O
oral	O
,	O
vaginal	O
,	O
and	O
rectal	O
smears	O
were	O
taken	O
for	O
molecular	O
lactobacilli	B-bacteria
profiling	O
using	O
PCR	O
denaturing	O
gradient	O
gel	O
electrophoresis	O
(	O
DGGE	O
)	O
.	O

30	O
pregnant	O
and	O
30	O
postmenopausal	O
women	O
were	O
evaluated	O
.	O

On	O
multiplex	O
PCR	O
,	O
99	O
colonies	O
isolated	O
from	O
30	O
pregnant	O
women	O
and	O
37	O
colonies	O
isolated	O
from	O
30	O
postmenopausal	O
women	O
were	O
identified	O
as	O
being	O
members	O
of	O
the	O
genus	O
Lactobacillus	B-bacteria
:	O
50	O
%	O
of	O
pregnant	O
and	O
33	O
%	O
of	O
postmenopausal	O
women	O
had	O
one	O
or	O
more	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
recovered	O
from	O
their	O
oral	O
specimens	O
.	O

Around	O
80	O
%	O
of	O
pregnant	O
and	O
40	O
%	O
of	O
postmenopausal	O
women	O
harboured	O
one	O
or	O
more	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
in	O
the	O
vagina	O
and	O
rectum	O
.	O

On	O
PCR	O
-	O
DGGE	O
,	O
80	O
%	O
of	O
pregnant	O
and	O
40	O
%	O
of	O
postmenopausal	O
women	O
harboured	O
the	O
same	O
lactobacilli	B-bacteria
isolates	I-bacteria
in	O
both	O
the	O
vagina	O
and	O
rectum	O
.	O

This	O
supports	O
the	O
hypothesis	O
that	O
the	O
rectum	O
may	O
play	O
an	O
important	O
role	O
as	O
a	O
reservoir	O
for	O
some	O
strains	O
of	O
lactobacilli	B-bacteria
that	O
colonise	O
the	O
vagina	O
.	O

Molecular	O
method	O
of	O
16S	O
rRNA	O
sequencing	O
is	O
reported	O
to	O
be	O
helpful	O
in	O
the	O
accurate	O
identification	O
of	O
organisms	O
with	O
ambiguous	O
phenotypic	O
profiles	O
.	O

We	O
analyzed	O
the	O
use	O
of	O
16S	O
rRNA	O
sequencing	O
method	O
to	O
identify	O
clinically	O
significant	O
,	O
`	O
`	O
difficult	O
-	O
to	O
-	O
identify	O
'	O
'	O
bacteria	O
recovered	O
from	O
clinical	O
specimens	O
,	O
and	O
evaluated	O
its	O
role	O
in	O
patient	O
management	O
and	O
consequent	O
clinical	O
outcome	O
.	O

Among	O
the	O
172	O
`	O
`	O
difficult	O
-	O
to	O
-	O
identify	O
'	O
'	O
bacteria	O
recovered	O
over	O
a	O
4	O
-	O
year	O
period	O
,	O
140	O
were	O
gram	O
-	O
positive	O
cocci	O
or	O
gram	O
-	O
negative	O
bacilli	O
;	O
identification	O
by	O
16S	O
rRNA	O
did	O
not	O
play	O
a	O
role	O
in	O
the	O
management	O
of	O
patients	O
infected	O
with	O
these	O
bacteria	O
.	O

From	O
32	O
patients	O
,	O
33	O
`	O
`	O
difficult	O
-	O
to	O
-	O
identify	O
'	O
'	O
gram	O
-	O
positive	O
bacilli	O
were	O
identified	O
;	O
the	O
organisms	O
were	O
mycobacteria	B-bacteria
,	O
Nocardia	B-bacteria
,	O
Tsukamurella	B-bacteria
,	O
Rhodococcus	B-bacteria
,	O
and	O
Gordonia	B-bacteria
.	O

In	O
24	O
patients	O
for	O
whom	O
clinical	O
data	O
were	O
available	O
,	O
results	O
from	O
the	O
16S	O
rRNA	O
sequencing	O
method	O
led	O
to	O
treatment	O
change	O
in	O
14	O
immunocompromised	O
patients	O
(	O
including	O
7	O
hematopoietic	O
stem	O
cell	O
recipients	O
and	O
1	O
liver	O
transplant	O
recipient	O
)	O
.	O

Therapy	O
was	O
modified	O
in	O
9	O
patients	O
,	O
initiated	O
in	O
3	O
patients	O
,	O
and	O
discontinued	O
in	O
2	O
patients	O
.	O

Most	O
patients	O
'	O
therapy	O
was	O
switched	O
to	O
oral	O
antibiotics	O
with	O
discontinuation	O
of	O
intravascular	O
catheters	O
,	O
facilitating	O
early	O
hospital	O
discharge	O
.	O

All	O
14	O
patients	O
were	O
alive	O
30	O
days	O
after	O
infection	O
onset	O
.	O

The	O
present	O
study	O
demonstrates	O
the	O
clinical	O
application	O
of	O
16S	O
rRNA	O
sequencing	O
method	O
to	O
identify	O
`	O
`	O
difficult	O
-	O
to	O
-	O
identify	O
'	O
'	O
mycobacteria	B-bacteria
and	O
other	O
gram	O
-	O
positive	O
bacilli	O
in	O
clinical	O
specimens	O
,	O
particularly	O
in	O
immunocompromised	O
hosts	O
.	O

Denture	O
adhesives	O
increase	O
the	O
retention	O
and	O
stability	O
of	O
dentures	O
in	O
edentulous	O
patients	O
,	O
especially	O
in	O
cases	O
where	O
salivary	O
flow	O
is	O
impaired	O
or	O
in	O
the	O
management	O
of	O
traumatised	O
oral	O
mucosa	O
.	O

The	O
effect	O
of	O
a	O
denture	O
adhesive	O
on	O
the	O
oral	O
flora	O
at	O
different	O
time	O
intervals	O
.	O

Thirty	O
denture	O
-	O
wearing	O
patients	O
were	O
involved	O
in	O
this	O
study	O
.	O

While	O
half	O
of	O
the	O
group	O
received	O
a	O
denture	O
adhesive	O
,	O
the	O
other	O
half	O
did	O
not	O
.	O

At	O
baseline	O
,	O
1	O
and	O
2	O
months	O
after	O
delivering	O
the	O
dentures	O
,	O
smear	O
samples	O
were	O
obtained	O
from	O
the	O
saliva	O
,	O
palate	O
and	O
the	O
dentures	O
.	O

Candida	O
albicans	O
,	O
Candida	O
krusei	O
,	O
Candida	O
glabrata	O
,	O
Candida	O
spp	O
.	O
,	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
Moraxella	B-bacteria
catarrhalis	I-bacteria
,	O
alpha	B-bacteria
-	I-bacteria
haemolytic	I-bacteria
streptococci	I-bacteria
,	O
beta	B-bacteria
-	I-bacteria
haemolytic	I-bacteria
streptococci	I-bacteria
,	O
Pneumococcus	B-bacteria
aureus	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
anginosus	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
intermedius	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
constellatus	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
sanguis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
,	O
and	O
yeasts	O
were	O
investigated	O
.	O

The	O
data	O
were	O
statistically	O
analysed	O
using	O
anova	O
and	O
repeated	O
measures	O
.	O

Most	O
types	O
of	O
the	O
micro	O
-	O
organisms	O
were	O
not	O
seen	O
and	O
could	O
not	O
be	O
analysed	O
statistically	O
except	O
alpha	B-bacteria
-	I-bacteria
haemolytic	I-bacteria
streptococci	I-bacteria
and	O
C	O
.	O
albicans	O
.	O

No	O
statistically	O
significant	O
difference	O
was	O
found	O
for	O
alpha	B-bacteria
-	I-bacteria
haemolytic	I-bacteria
streptococci	I-bacteria
and	O
C	O
.	O
albicans	O
in	O
saliva	O
,	O
palate	O
and	O
the	O
denture	O
at	O
all	O
time	O
intervals	O
.	O

Prolonged	O
use	O
of	O
the	O
denture	O
adhesive	O
tested	O
up	O
to	O
2	O
months	O
did	O
not	O
yield	O
to	O
increase	O
in	O
micro	O
-	O
organisms	O
of	O
the	O
oral	O
flora	O
.	O

The	O
antimicrobial	O
activity	O
of	O
four	O
labdane	O
-	O
type	O
diterpenes	O
isolated	O
from	O
the	O
oleoresin	O
of	O
Copaifera	O
langsdorffii	O
as	O
well	O
as	O
of	O
two	O
commercially	O
available	O
diterpenes	O
(	O
sclareol	O
and	O
manool	O
)	O
was	O
investigated	O
against	O
a	O
representative	O
panel	O
of	O
microorganisms	O
responsible	O
for	O
periodontitis	O
.	O

Among	O
all	O
the	O
evaluated	O
compounds	O
,	O
(	O
-	O
)	O
-	O
copalic	O
acid	O
(	O
CA	O
)	O
was	O
the	O
most	O
active	O
,	O
displaying	O
a	O
very	O
promising	O
MIC	O
value	O
(	O
3	O
.	O
1	O
microg	O
mL	O
-	O
1	O
;	O
10	O
.	O
2	O
microM	O
)	O
against	O
the	O
key	O
pathogen	O
(	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
)	O
involved	O
in	O
this	O
infectious	O
disease	O
.	O

Moreover	O
,	O
CA	O
did	O
not	O
exhibit	O
cytotoxicity	O
when	O
tested	O
in	O
human	O
fibroblasts	O
.	O

Time	O
-	O
kill	O
curve	O
assays	O
performed	O
with	O
CA	O
against	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
revealed	O
that	O
this	O
compound	O
only	O
inhibited	O
the	O
growth	O
of	O
the	O
inoculums	O
in	O
the	O
first	O
12	O
h	O
(	O
bacteriostatic	O
effect	O
)	O
.	O

However	O
,	O
its	O
bactericidal	O
effect	O
was	O
clearly	O
noted	O
thereafter	O
(	O
between	O
12	O
and	O
24	O
h	O
)	O
.	O

It	O
was	O
also	O
possible	O
to	O
verify	O
an	O
additive	O
effect	O
when	O
CA	O
and	O
chlorhexidine	O
dihydrochloride	O
(	O
CHD	O
,	O
positive	O
control	O
)	O
were	O
associated	O
at	O
their	O
MBC	O
values	O
.	O

The	O
time	O
curve	O
profile	O
resulting	O
from	O
this	O
combination	O
showed	O
that	O
this	O
association	O
needed	O
only	O
six	O
hours	O
for	O
the	O
bactericidal	O
effect	O
to	O
be	O
noted	O
.	O

In	O
summary	O
,	O
CA	O
has	O
shown	O
to	O
be	O
an	O
important	O
metabolite	O
for	O
the	O
control	O
of	O
periodontal	O
diseases	O
.	O

Moreover	O
,	O
the	O
use	O
of	O
standardized	O
extracts	O
based	O
on	O
copaiba	O
oleoresin	O
with	O
high	O
CA	O
contents	O
can	O
be	O
an	O
important	O
strategy	O
in	O
the	O
development	O
of	O
novel	O
oral	O
care	O
products	O
.	O

The	O
aim	O
of	O
this	O
work	O
was	O
to	O
investigate	O
the	O
antimicrobial	O
activity	O
of	O
thyme	O
essential	O
oil	O
against	O
clinical	O
multidrug	O
resistant	O
strains	O
of	O
Staphylococcus	B-bacteria
,	O
Enterococcus	B-bacteria
,	O
Escherichia	B-bacteria
,	O
and	O
Pseudomonas	B-bacteria
genus	I-bacteria
.	O

The	O
antibacterial	O
activity	O
of	O
oil	O
was	O
tested	O
against	O
standard	O
strains	O
of	O
bacteria	O
and	O
120	O
clinical	O
strains	O
isolated	O
from	O
patients	O
with	O
infections	O
of	O
the	O
oral	O
cavity	O
,	O
abdominal	O
cavity	O
,	O
respiratory	O
and	O
genitourinary	O
tracts	O
,	O
skin	O
,	O
and	O
from	O
the	O
hospital	O
environment	O
.	O

Agar	O
diffusion	O
was	O
used	O
to	O
determine	O
the	O
microbial	O
growth	O
inhibition	O
of	O
bacterial	O
growth	O
at	O
various	O
concentrations	O
of	O
oil	O
from	O
Thymus	O
vulgaris	O
.	O

Susceptibility	O
testing	O
to	O
antibiotics	O
was	O
carried	O
out	O
using	O
disk	O
diffusion	O
.	O

Thyme	O
essential	O
oil	O
strongly	O
inhibited	O
the	O
growth	O
of	O
the	O
clinical	O
strains	O
of	O
bacteria	O
tested	O
.	O

The	O
use	O
of	O
phytopharmaceuticals	O
based	O
on	O
an	O
investigated	O
essential	O
oil	O
from	O
thyme	O
in	O
the	O
prevention	O
and	O
treatment	O
of	O
various	O
human	O
infections	O
may	O
be	O
reasonable	O
.	O

Candida	O
albicans	O
is	O
a	O
commensal	O
colonizer	O
of	O
the	O
gastrointestinal	O
tract	O
of	O
humans	O
,	O
where	O
it	O
coexists	O
with	O
highly	O
diverse	O
bacterial	O
communities	O
.	O

It	O
is	O
not	O
clear	O
whether	O
this	O
interaction	O
limits	O
or	O
promotes	O
the	O
potential	O
of	O
C	O
.	O
albicans	O
to	O
become	O
an	O
opportunistic	O
pathogen	O
.	O

Here	O
we	O
investigate	O
the	O
interaction	O
between	O
C	O
.	O
albicans	O
and	O
three	O
species	O
of	O
streptococci	B-bacteria
from	O
the	O
viridans	O
group	O
,	O
which	O
are	O
ubiquitous	O
and	O
abundant	O
oral	O
commensal	O
bacteria	O
.	O

The	O
ability	O
of	O
C	O
.	O
albicans	O
to	O
form	O
biofilm	O
with	O
Streptococcus	B-bacteria
oralis	I-bacteria
,	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
,	O
or	O
Streptococcus	B-bacteria
gordonii	I-bacteria
was	O
investigated	O
using	O
flow	O
cell	O
devices	O
that	O
allow	O
abiotic	O
biofilm	O
formation	O
under	O
salivary	O
flow	O
.	O

In	O
addition	O
,	O
we	O
designed	O
a	O
novel	O
flow	O
cell	O
system	O
that	O
allows	O
mucosal	O
biofilm	O
formation	O
under	O
conditions	O
that	O
mimic	O
the	O
environment	O
in	O
the	O
oral	O
and	O
esophageal	O
mucosae	O
.	O

It	O
was	O
observed	O
that	O
C	O
.	O
albicans	O
and	O
streptococci	B-bacteria
formed	O
a	O
synergistic	O
partnership	O
where	O
C	O
.	O
albicans	O
promoted	O
the	O
ability	O
of	O
streptococci	B-bacteria
to	O
form	O
biofilm	O
on	O
abiotic	O
surfaces	O
or	O
on	O
the	O
surface	O
of	O
an	O
oral	O
mucosa	O
analogue	O
.	O

The	O
increased	O
ability	O
of	O
streptococci	B-bacteria
to	O
form	O
biofilm	O
in	O
the	O
presence	O
of	O
C	O
.	O
albicans	O
could	O
not	O
be	O
explained	O
by	O
a	O
growth	O
-	O
stimulatory	O
effect	O
since	O
the	O
streptococci	B-bacteria
were	O
unaffected	O
in	O
their	O
growth	O
in	O
planktonic	O
coculture	O
with	O
C	O
.	O
albicans	O
.	O

Conversely	O
,	O
the	O
presence	O
of	O
streptococci	B-bacteria
increased	O
the	O
ability	O
of	O
C	O
.	O
albicans	O
to	O
invade	O
organotypic	O
models	O
of	O
the	O
oral	O
and	O
esophageal	O
mucosae	O
under	O
conditions	O
of	O
salivary	O
flow	O
.	O

Moreover	O
,	O
characterization	O
of	O
mucosal	O
invasion	O
by	O
the	O
biofilm	O
microorganisms	O
suggested	O
that	O
the	O
esophageal	O
mucosa	O
is	O
more	O
permissive	O
to	O
invasion	O
than	O
the	O
oral	O
mucosa	O
.	O

In	O
summary	O
,	O
C	O
.	O
albicans	O
and	O
commensal	O
oral	O
streptococci	B-bacteria
display	O
a	O
synergistic	O
interaction	O
with	O
implications	O
for	O
the	O
pathogenic	O
potential	O
of	O
C	O
.	O
albicans	O
in	O
the	O
upper	O
gastrointestinal	O
tract	O
.	O

Propionibacterium	B-bacteria
acnes	I-bacteria
is	O
a	O
Gram	O
-	O
positive	O
bacterium	O
that	O
forms	O
part	O
of	O
the	O
normal	O
flora	O
of	O
the	O
skin	O
,	O
oral	O
cavity	O
,	O
large	O
intestine	O
,	O
the	O
conjunctiva	O
and	O
the	O
external	O
ear	O
canal	O
.	O

Although	O
primarily	O
recognized	O
for	O
its	O
role	O
in	O
acne	O
,	O
P	B-bacteria
.	I-bacteria
acnes	I-bacteria
is	O
an	O
opportunistic	O
pathogen	O
,	O
causing	O
a	O
range	O
of	O
postoperative	O
and	O
device	O
-	O
related	O
infections	O
.	O

These	O
include	O
infections	O
of	O
the	O
bones	O
and	O
joints	O
,	O
mouth	O
,	O
eye	O
and	O
brain	O
.	O

Device	O
-	O
related	O
infections	O
include	O
those	O
of	O
joint	O
prostheses	O
,	O
shunts	O
and	O
prosthetic	O
heart	O
valves	O
.	O

P	B-bacteria
.	I-bacteria
acnes	I-bacteria
may	O
play	O
a	O
role	O
in	O
other	O
conditions	O
,	O
including	O
inflammation	O
of	O
the	O
prostate	O
leading	O
to	O
cancer	O
,	O
SAPHO	O
(	O
synovitis	O
,	O
acne	O
,	O
pustulosis	O
,	O
hyperostosis	O
,	O
osteitis	O
)	O
syndrome	O
,	O
sarcoidosis	O
and	O
sciatica	O
.	O

If	O
an	O
active	O
role	O
in	O
these	O
conditions	O
is	O
established	O
there	O
are	O
major	O
implications	O
for	O
diagnosis	O
,	O
treatment	O
and	O
protection	O
.	O

Genome	O
sequencing	O
of	O
the	O
organism	O
has	O
provided	O
an	O
insight	O
into	O
the	O
pathogenic	O
potential	O
and	O
virulence	O
of	O
P	B-bacteria
.	I-bacteria
acnes	I-bacteria
.	O

The	O
antibacterial	O
activity	O
of	O
Casbane	O
Diterpene	O
(	O
CD	O
)	O
was	O
evaluated	O
in	O
vitro	O
against	O
Streptococcus	B-bacteria
oralis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
.	O

The	O
viability	O
of	O
planktonic	O
cells	O
was	O
analysed	O
by	O
susceptibility	O
tests	O
(	O
MIC	O
and	O
MBC	O
)	O
and	O
antibiofilm	O
action	O
was	O
assayed	O
.	O

The	O
minimal	O
inhibitory	O
and	O
bactericidal	O
concentrations	O
(	O
MIC	O
and	O
MBC	O
)	O
of	O
oral	O
Streptococcus	B-bacteria
were	O
evaluated	O
through	O
microdilution	O
tests	O
.	O

To	O
assay	O
antibiofilm	O
activity	O
,	O
biofilms	O
were	O
generated	O
on	O
96	O
-	O
wells	O
polystyrene	O
plates	O
under	O
the	O
presence	O
of	O
CD	O
and	O
quantified	O
by	O
a	O
crystal	O
violet	O
technique	O
and	O
colonies	O
forming	O
units	O
counting	O
.	O

The	O
CD	O
isolated	O
from	O
Croton	O
nepetaefolius	O
showed	O
antimicrobial	O
effect	O
on	O
planktonic	O
forms	O
and	O
biofilms	O
of	O
oral	O
pathogens	O
,	O
with	O
MIC	O
values	O
of	O
62	O
.	O
5	O
mug	O
/	O
mL	O
against	O
Streptococcus	B-bacteria
oralis	I-bacteria
and	O
values	O
between	O
125	O
and	O
500	O
mug	O
/	O
mL	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
sobrinus	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
.	O

CD	O
showed	O
an	O
inhibitory	O
effect	O
on	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilm	O
formation	O
at	O
250	O
mug	O
/	O
mL	O
,	O
and	O
a	O
decrease	O
on	O
viable	O
cell	O
of	O
94	O
.	O
28	O
%	O
compared	O
to	O
the	O
normal	O
biofilm	O
growth	O
.	O

The	O
compound	O
CD	O
can	O
be	O
considered	O
as	O
a	O
promising	O
molecule	O
for	O
the	O
treatment	O
against	O
oral	O
pathogens	O
responsible	O
for	O
dental	O
biofilm	O
.	O

The	O
study	O
of	O
initial	O
microbial	O
colonization	O
on	O
dental	O
surfaces	O
is	O
a	O
field	O
of	O
intensive	O
research	O
because	O
of	O
the	O
aetiological	O
role	O
of	O
biofilms	O
in	O
oral	O
diseases	O
.	O

Most	O
previous	O
studies	O
of	O
de	O
novo	O
accumulation	O
and	O
composition	O
of	O
dental	O
biofilms	O
in	O
vivo	O
do	O
not	O
differentiate	O
between	O
biofilms	O
formed	O
during	O
day	O
and	O
night	O
.	O

This	O
study	O
hypothesized	O
that	O
there	O
is	O
a	O
diurnal	O
variation	O
in	O
the	O
rate	O
of	O
accumulation	O
of	O
bacteria	O
on	O
solid	O
surfaces	O
in	O
the	O
oral	O
cavity	O
.	O

In	O
situ	O
biofilm	O
from	O
healthy	O
individuals	O
was	O
collected	O
for	O
12	O
h	O
during	O
day	O
and	O
night	O
,	O
respectively	O
,	O
subjected	O
to	O
fluorescent	O
in	O
situ	O
hybridization	O
and	O
visualized	O
using	O
confocal	O
laser	O
scanning	O
microscopy	O
.	O

Analysis	O
of	O
the	O
biofilms	O
using	O
stereological	O
methods	O
and	O
digital	O
image	O
analysis	O
revealed	O
a	O
consistent	O
statistically	O
significant	O
difference	O
between	O
both	O
the	O
total	O
number	O
of	O
bacteria	O
and	O
the	O
biovolume	O
in	O
the	O
two	O
12	O
-	O
h	O
groups	O
(	O
p	O
=	O
0	O
.	O
012	O
)	O
,	O
with	O
the	O
highest	O
accumulation	O
of	O
bacteria	O
during	O
daytime	O
(	O
a	O
factor	O
of	O
8	O
.	O
8	O
and	O
6	O
.	O
1	O
higher	O
,	O
respectively	O
)	O
.	O

Hybridization	O
with	O
probes	O
specific	O
for	O
streptococci	B-bacteria
and	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
indicated	O
a	O
higher	O
proportion	O
of	O
streptococci	B-bacteria
in	O
biofilms	O
grown	O
during	O
daytime	O
as	O
compared	O
to	O
night	O
-	O
time	O
.	O

No	O
differences	O
could	O
be	O
observed	O
for	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
.	O

The	O
degree	O
of	O
microbial	O
coverage	O
and	O
the	O
bacterial	O
composition	O
varied	O
considerably	O
between	O
different	O
individuals	O
.	O

The	O
data	O
provide	O
firm	O
evidence	O
that	O
initial	O
biofilm	O
formation	O
decreases	O
during	O
the	O
night	O
,	O
which	O
may	O
reflect	O
differences	O
in	O
the	O
availability	O
of	O
salivary	O
nutrients	O
.	O

This	O
finding	O
is	O
of	O
significant	O
importance	O
when	O
studying	O
population	O
dynamics	O
during	O
experimental	O
dental	O
biofilm	O
formation	O
.	O

The	O
oral	O
cavity	O
serves	O
as	O
a	O
reservoir	O
of	O
Staphylococcus	B-bacteria
aureus	I-bacteria
for	O
infection	O
of	O
the	O
lower	O
respiratory	O
tract	O
and	O
cross	O
-	O
infection	O
to	O
other	O
patients	O
.	O

This	O
systematic	O
review	O
was	O
designed	O
to	O
examine	O
the	O
effectiveness	O
of	O
oral	O
health	O
promotion	O
interventions	O
on	O
this	O
pathogen	O
.	O

The	O
PubMed	O
,	O
ISI	O
Web	O
of	O
Science	O
,	O
and	O
Cochrane	O
Library	O
databases	O
were	O
searched	O
for	O
clinical	O
trials	O
assessing	O
the	O
effect	O
of	O
oral	O
health	O
promotion	O
interventions	O
on	O
oral	O
and	O
oropharyngeal	O
carriage	O
of	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
.	O

Oral	O
health	O
promotion	O
interventions	O
on	O
oral	O
reservoirs	O
of	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
in	O
both	O
systemically	O
healthy	O
and	O
medically	O
compromised	O
groups	O
consisted	O
of	O
oral	O
hygiene	O
interventions	O
only	O
.	O

There	O
was	O
a	O
lack	O
of	O
evidence	O
pertaining	O
to	O
the	O
effectiveness	O
of	O
mechanical	O
oral	O
hygiene	O
interventions	O
against	O
this	O
pathogen	O
.	O

Chlorhexidine	O
delivered	O
in	O
oral	O
hygiene	O
products	O
such	O
as	O
mouthrinses	O
,	O
gels	O
,	O
and	O
sprays	O
appeared	O
to	O
have	O
some	O
utility	O
against	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
,	O
although	O
some	O
studies	O
found	O
equivocal	O
effects	O
.	O

There	O
was	O
a	O
dearth	O
of	O
studies	O
investigating	O
the	O
efficacy	O
of	O
other	O
chemical	O
agents	O
.	O

Although	O
many	O
chemical	O
agents	O
contained	O
in	O
oral	O
hygiene	O
products	O
have	O
proven	O
in	O
vitro	O
activity	O
against	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
,	O
their	O
clinical	O
effectiveness	O
and	O
potential	O
role	O
as	O
adjuncts	O
or	O
alternative	O
therapies	O
to	O
conventional	O
treatment	O
remain	O
to	O
be	O
confirmed	O
by	O
further	O
high	O
-	O
quality	O
randomized	O
controlled	O
trials	O
.	O

There	O
is	O
little	O
information	O
about	O
the	O
microbiologic	O
profiles	O
of	O
periodontal	O
lesions	O
in	O
Papillon	O
-	O
Lefevre	O
syndrome	O
(	O
PLS	O
)	O
and	O
the	O
significance	O
of	O
bacteria	O
in	O
the	O
pathogenesis	O
of	O
periodontitis	O
in	O
these	O
patients	O
.	O

This	O
comprehensive	O
analysis	O
of	O
the	O
subgingival	O
microbiota	O
in	O
patients	O
with	O
PLS	O
used	O
16S	O
ribosomal	O
RNA	O
(	O
rRNA	O
)	O
clonal	O
analysis	O
and	O
the	O
16S	O
rRNA	O
-	O
based	O
Human	O
Oral	O
Microbe	O
Identification	O
Microarray	O
(	O
HOMIM	O
)	O
.	O

Thirteen	O
patients	O
with	O
PLS	O
from	O
seven	O
unrelated	O
families	O
volunteered	O
for	O
this	O
microbiologic	O
study	O
.	O

Subgingival	O
plaque	O
was	O
collected	O
with	O
sterile	O
paper	O
points	O
from	O
multiple	O
sites	O
with	O
>	O
/	O
=	O
5	O
mm	O
probing	O
depth	O
,	O
and	O
whole	O
genomic	O
DNA	O
was	O
extracted	O
.	O

The	O
16S	O
rRNA	O
genes	O
were	O
amplified	O
,	O
cloned	O
,	O
and	O
sequenced	O
.	O

The	O
samples	O
were	O
then	O
probed	O
for	O
approximately	O
300	O
predominant	O
oral	O
bacterial	O
species	O
using	O
the	O
HOMIM	O
.	O

The	O
most	O
commonly	O
detected	O
phylotypes	O
in	O
the	O
clonal	O
analysis	O
were	O
Gemella	B-bacteria
morbillorum	I-bacteria
,	O
Gemella	B-bacteria
haemolysans	I-bacteria
,	O
Granulicatella	B-bacteria
adiacens	I-bacteria
,	O
Lachnospiraceae	B-bacteria
OT	I-bacteria
100	I-bacteria
(	O
EI074	B-bacteria
)	O
,	O
Parvimonas	B-bacteria
micra	I-bacteria
,	O
Selenomonas	B-bacteria
noxia	I-bacteria
,	O
and	O
Veillonella	B-bacteria
parvula	I-bacteria
.	O

As	O
a	O
group	O
,	O
streptococci	B-bacteria
were	O
commonly	O
detected	O
in	O
these	O
individuals	O
.	O

In	O
the	O
HOMIM	O
analysis	O
,	O
a	O
total	O
of	O
170	O
bacterial	O
species	O
/	O
phylotypes	O
were	O
detected	O
,	O
with	O
a	O
range	O
of	O
40	O
to	O
80	O
species	O
per	O
patient	O
with	O
PLS	O
.	O

Of	O
these	O
,	O
12	O
bacterial	O
species	O
were	O
detected	O
in	O
medium	O
to	O
high	O
levels	O
in	O
>	O
/	O
=	O
50	O
%	O
of	O
the	O
individuals	O
.	O

The	O
high	O
-	O
frequency	O
strains	O
were	O
clustered	O
into	O
eight	O
groups	O
:	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Campylobacter	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
Capnocytophaga	B-bacteria
granulosa	I-bacteria
,	O
G	B-bacteria
.	I-bacteria
morbillorum	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
micra	I-bacteria
,	O
Porphyromonas	B-bacteria
endodontalis	I-bacteria
,	O
Streptococcus	B-bacteria
spp	I-bacteria
.	I-bacteria
,	O
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
.	O

The	O
subgingival	O
microbiota	O
in	O
PLS	O
is	O
diverse	O
.	O

Periodontal	O
pathogens	O
commonly	O
associated	O
with	O
chronic	O
and	O
aggressive	O
periodontitis	O
and	O
opportunistic	O
pathogens	O
may	O
be	O
associated	O
with	O
the	O
development	O
of	O
severe	O
periodontitis	O
in	O
patients	O
with	O
PLS	O
.	O

In	O
this	O
study	O
,	O
the	O
association	O
of	O
red	O
complex	O
(	O
RC	O
)	O
bacteria	O
that	O
include	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
with	O
acute	O
,	O
exacerbated	O
or	O
chronic	O
apical	O
periodontitis	O
was	O
evaluated	O
.	O

Seventy	O
-	O
one	O
patients	O
with	O
periapical	O
disease	O
were	O
evaluated	O
by	O
clinical	O
examination	O
and	O
microbiological	O
samples	O
obtained	O
from	O
the	O
root	O
canals	O
were	O
analyzed	O
by	O
a	O
polymerase	O
chain	O
reaction	O
assay	O
.	O

Twenty	O
-	O
one	O
(	O
29	O
.	O
6	O
%	O
)	O
samples	O
were	O
positive	O
for	O
RC	O
bacteria	O
,	O
with	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
,	O
T	B-bacteria
.	I-bacteria
forsythia	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
being	O
detected	O
in	O
14	O
(	O
19	O
.	O
7	O
%	O
)	O
,	O
10	O
(	O
14	O
.	O
1	O
%	O
)	O
and	O
6	O
(	O
8	O
.	O
5	O
%	O
)	O
samples	O
,	O
respectively	O
.	O

RC	O
bacteria	O
were	O
mainly	O
associated	O
with	O
acute	O
apical	O
periodontitis	O
(	O
29	O
.	O
2	O
%	O
)	O
and	O
phoenix	O
abscess	O
(	O
63	O
.	O
2	O
%	O
)	O
,	O
while	O
they	O
were	O
only	O
sporadically	O
detected	O
(	O
7	O
.	O
1	O
%	O
)	O
in	O
patients	O
with	O
chronic	O
apical	O
periodontitis	O
.	O

Generally	O
,	O
RC	O
bacteria	O
were	O
associated	O
with	O
pain	O
and	O
a	O
higher	O
frequency	O
of	O
intracanalar	O
/	O
intrasulcular	O
pus	O
drainage	O
.	O

Involvement	O
of	O
RC	O
bacteria	O
in	O
symptomatic	O
periapical	O
disease	O
should	O
be	O
suspected	O
in	O
the	O
presence	O
of	O
particularly	O
severe	O
clinical	O
pain	O
and	O
pus	O
drainage	O
.	O

Enteromorpha	O
linza	O
,	O
a	O
green	O
alga	O
,	O
has	O
been	O
recognized	O
as	O
a	O
potential	O
source	O
of	O
natural	O
antimicrobial	O
and	O
antifungal	O
compounds	O
.	O

We	O
previously	O
reported	O
that	O
an	O
E	O
.	O
linza	O
extract	O
strongly	O
inhibited	O
the	O
growth	O
of	O
Prevotella	B-bacteria
intermedia	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
.	O

The	O
principal	O
objective	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
clinical	O
effect	O
of	O
a	O
mouth	O
rinse	O
containing	O
the	O
E	O
.	O
linza	O
extract	O
on	O
gingivitis	O
disease	O
,	O
as	O
measured	O
by	O
the	O
plaque	O
index	O
(	O
PI	O
)	O
,	O
gingival	O
index	O
(	O
GI	O
)	O
,	O
and	O
bleeding	O
on	O
probing	O
(	O
BOP	O
)	O
,	O
and	O
on	O
two	O
bacterial	O
strains	O
(	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
)	O
,	O
in	O
comparison	O
with	O
Listerine	O
(	O
(	O
R	O
)	O
)	O
(	O
Listerine	O
-	O
Korea	O
,	O
Seoul	O
,	O
Korea	O
)	O
,	O
which	O
was	O
used	O
as	O
a	O
positive	O
control	O
.	O

In	O
total	O
,	O
55	O
subjects	O
were	O
recruited	O
into	O
active	O
participation	O
in	O
this	O
clinical	O
study	O
.	O

The	O
PI	O
,	O
GI	O
,	O
BOP	O
,	O
and	O
bacterial	O
strains	O
were	O
then	O
evaluated	O
over	O
a	O
test	O
period	O
of	O
6	O
weeks	O
.	O

After	O
1	O
,	O
2	O
,	O
4	O
,	O
and	O
6	O
weeks	O
,	O
the	O
same	O
clinical	O
indices	O
were	O
recorded	O
,	O
and	O
the	O
levels	O
of	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
were	O
quantified	O
via	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
.	O

At	O
the	O
end	O
of	O
the	O
study	O
,	O
the	O
group	O
using	O
the	O
mouth	O
rinse	O
containing	O
the	O
E	O
.	O
linza	O
extract	O
evidenced	O
significant	O
reductions	O
in	O
the	O
clinical	O
indices	O
(	O
PI	O
,	O
GI	O
,	O
and	O
BOP	O
)	O
and	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
compared	O
with	O
baseline	O
values	O
.	O

Moreover	O
,	O
E	O
.	O
linza	O
extract	O
containing	O
mouth	O
rinse	O
produced	O
effects	O
similar	O
to	O
those	O
of	O
Listerine	O
.	O

Overall	O
,	O
these	O
results	O
indicate	O
that	O
a	O
mouth	O
rinse	O
containing	O
E	O
.	O
linza	O
extract	O
significantly	O
reduces	O
plaque	O
,	O
improves	O
the	O
condition	O
of	O
gingival	O
tissues	O
,	O
and	O
reduces	O
bleeding	O
.	O

Additionally	O
,	O
E	O
.	O
linza	O
extract	O
mouth	O
rinse	O
significantly	O
inhibits	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
intermedia	I-bacteria
.	O

Thus	O
,	O
this	O
clinical	O
study	O
demonstrated	O
that	O
the	O
twice	O
-	O
daily	O
use	O
of	O
an	O
E	O
.	O
linza	O
extract	O
mouth	O
rinse	O
can	O
inhibit	O
and	O
prevent	O
gingivitis	O
.	O

Modifications	O
of	O
titanium	O
(	O
Ti	O
)	O
implant	O
surfaces	O
have	O
a	O
significant	O
effect	O
on	O
early	O
biofilm	O
formation	O
and	O
the	O
outcome	O
of	O
implant	O
procedures	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
role	O
of	O
plasma	O
proteins	O
and	O
electrostatic	O
forces	O
in	O
the	O
adhesion	O
mechanism	O
of	O
oral	O
bacteria	O
to	O
modified	O
Ti	O
surfaces	O
.	O

Ti	O
discs	O
with	O
three	O
different	O
types	O
of	O
surface	O
modifications	O
,	O
machined	O
,	O
acid	O
-	O
etched	O
,	O
and	O
acid	O
-	O
etched	O
and	O
blasted	O
,	O
were	O
examined	O
for	O
adhesion	O
of	O
oral	O
bacteria	O
:	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
and	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
.	O

Following	O
pretreatment	O
of	O
the	O
Ti	O
with	O
ion	O
rich	O
solutions	O
or	O
coating	O
by	O
human	O
serum	O
albumin	O
or	O
fibronectin	O
,	O
bacterial	O
adhesion	O
was	O
examined	O
by	O
scanning	O
electron	O
microscopy	O
and	O
assessed	O
quantitatively	O
by	O
DNA	O
analysis	O
.	O

Ti	O
coating	O
by	O
proteins	O
as	O
well	O
as	O
bacterial	O
adhesion	O
and	O
their	O
interrelationships	O
were	O
further	O
investigated	O
through	O
confocal	O
scanning	O
laser	O
microscopy	O
.	O

Acid	O
-	O
etched	O
and	O
blasted	O
Ti	O
surfaces	O
exhibited	O
significantly	O
higher	O
amounts	O
of	O
bacteria	O
adhesion	O
than	O
the	O
other	O
two	O
surfaces	O
.	O

Calcium	O
was	O
found	O
to	O
serve	O
as	O
a	O
bridging	O
agent	O
in	O
the	O
adhesion	O
process	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
to	O
Ti	O
surfaces	O
.	O

Although	O
albumin	O
coating	O
of	O
the	O
Ti	O
reduced	O
the	O
adhesion	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
to	O
all	O
surfaces	O
,	O
it	O
had	O
no	O
influence	O
on	O
the	O
adhesion	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
or	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

Coating	O
the	O
Ti	O
with	O
fibronectin	O
enhanced	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
and	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
adhesion	O
.	O

Bacterial	O
adhesion	O
to	O
Ti	O
surfaces	O
is	O
roughness	O
-	O
dependent	O
,	O
and	O
the	O
adhesion	O
mechanism	O
is	O
influenced	O
by	O
ions	O
and	O
proteins	O
of	O
the	O
initial	O
coating	O
derived	O
from	O
the	O
blood	O
.	O

Microbial	O
communities	O
inhabiting	O
human	O
mouth	O
are	O
associated	O
with	O
oral	O
health	O
and	O
disease	O
.	O

Previous	O
studies	O
have	O
indicated	O
the	O
general	O
prevalence	O
of	O
adult	O
gingivitis	O
in	O
China	O
to	O
be	O
high	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
characterize	O
in	O
depth	O
the	O
oral	O
microbiota	O
of	O
Chinese	O
adults	O
with	O
or	O
without	O
gingivitis	O
,	O
by	O
defining	O
the	O
microbial	O
phylogenetic	O
diversity	O
and	O
community	O
-	O
structure	O
using	O
highly	O
paralleled	O
pyrosequencing	O
.	O

Six	O
non	O
-	O
smoking	O
Chinese	O
,	O
three	O
with	O
and	O
three	O
without	O
gingivitis	O
(	O
age	O
range	O
21	O
-	O
39	O
years	O
,	O
4	O
females	O
and	O
2	O
males	O
)	O
were	O
enrolled	O
in	O
the	O
present	O
cross	O
-	O
sectional	O
study	O
.	O

Gingival	O
parameters	O
of	O
inflammation	O
and	O
bleeding	O
on	O
probing	O
were	O
characterized	O
by	O
a	O
clinician	O
using	O
the	O
Mazza	O
Gingival	O
Index	O
(	O
MGI	O
)	O
.	O

Plaque	O
(	O
sampled	O
separately	O
from	O
four	O
different	O
oral	O
sites	O
)	O
and	O
salivary	O
samples	O
were	O
obtained	O
from	O
each	O
subject	O
.	O

Sequences	O
and	O
relative	O
abundance	O
of	O
the	O
bacterial	O
16	O
S	O
rDNA	O
PCR	O
-	O
amplicons	O
were	O
determined	O
via	O
pyrosequencing	O
that	O
produced	O
400	O
bp	O
-	O
long	O
reads	O
.	O

The	O
sequence	O
data	O
were	O
analyzed	O
via	O
a	O
computational	O
pipeline	O
customized	O
for	O
human	O
oral	O
microbiome	O
analyses	O
.	O

Furthermore	O
,	O
the	O
relative	O
abundances	O
of	O
selected	O
microbial	O
groups	O
were	O
validated	O
using	O
quantitative	O
PCR	O
.	O

The	O
oral	O
microbiomes	O
from	O
gingivitis	O
and	O
healthy	O
subjects	O
could	O
be	O
distinguished	O
based	O
on	O
the	O
distinct	O
community	O
structures	O
of	O
plaque	O
microbiomes	O
,	O
but	O
not	O
the	O
salivary	O
microbiomes	O
.	O

Contributions	O
of	O
community	O
members	O
to	O
community	O
structure	O
divergence	O
were	O
statistically	O
accessed	O
at	O
the	O
phylum	O
,	O
genus	O
and	O
species	O
-	O
like	O
levels	O
.	O

Eight	O
predominant	O
taxa	O
were	O
found	O
associated	O
with	O
gingivitis	O
:	O
TM7	B-bacteria
,	O
Leptotrichia	B-bacteria
,	O
Selenomonas	B-bacteria
,	O
Streptococcus	B-bacteria
,	O
Veillonella	B-bacteria
,	O
Prevotella	B-bacteria
,	O
Lautropia	B-bacteria
,	O
and	O
Haemophilus	B-bacteria
.	O

Furthermore	O
,	O
98	O
species	O
-	O
level	O
OTUs	O
were	O
identified	O
to	O
be	O
gingivitis	O
-	O
associated	O
,	O
which	O
provided	O
microbial	O
features	O
of	O
gingivitis	O
at	O
a	O
species	O
resolution	O
.	O

Finally	O
,	O
for	O
the	O
two	O
selected	O
genera	O
Streptococcus	B-bacteria
and	O
Fusobacterium	B-bacteria
,	O
Real	O
-	O
Time	O
PCR	O
based	O
quantification	O
of	O
relative	O
bacterial	O
abundance	O
validated	O
the	O
pyrosequencing	O
-	O
based	O
results	O
.	O

This	O
methods	O
study	O
suggests	O
that	O
oral	O
samples	O
from	O
this	O
patient	O
population	O
of	O
gingivitis	O
can	O
be	O
characterized	O
via	O
plaque	O
microbiome	O
by	O
pyrosequencing	O
the	O
16	O
S	O
rDNA	O
genes	O
.	O

Further	O
studies	O
that	O
characterize	O
serial	O
samples	O
from	O
subjects	O
(	O
longitudinal	O
study	O
design	O
)	O
with	O
a	O
larger	O
population	O
size	O
may	O
provide	O
insight	O
into	O
the	O
temporal	O
and	O
ecological	O
features	O
of	O
oral	O
microbial	O
communities	O
in	O
clinically	O
-	O
defined	O
states	O
of	O
gingivitis	O
.	O

There	O
is	O
growing	O
evidence	O
that	O
the	O
role	O
of	O
lipids	O
in	O
innate	O
immunity	O
is	O
more	O
important	O
than	O
previously	O
realized	O
.	O

How	O
lipids	O
interact	O
with	O
bacteria	O
to	O
achieve	O
a	O
level	O
of	O
protection	O
,	O
however	O
,	O
is	O
still	O
poorly	O
understood	O
.	O

To	O
begin	O
to	O
address	O
the	O
mechanisms	O
of	O
antibacterial	O
activity	O
,	O
we	O
determined	O
MICs	O
and	O
minimum	O
bactericidal	O
concentrations	O
(	O
MBCs	O
)	O
of	O
lipids	O
common	O
to	O
the	O
skin	O
and	O
oral	O
cavity	O
-	O
-	O
the	O
sphingoid	O
bases	O
D	O
-	O
sphingosine	O
,	O
phytosphingosine	O
,	O
and	O
dihydrosphingosine	O
and	O
the	O
fatty	O
acids	O
sapienic	O
acid	O
and	O
lauric	O
acid	O
-	O
-	O
against	O
four	O
Gram	O
-	O
negative	O
bacteria	O
and	O
seven	O
Gram	O
-	O
positive	O
bacteria	O
.	O

Exact	O
Kruskal	O
-	O
Wallis	O
tests	O
of	O
these	O
values	O
showed	O
differences	O
among	O
lipid	O
treatments	O
(	O
P	O
<	O
0	O
.	O
0001	O
)	O
for	O
each	O
bacterial	O
species	O
except	O
Serratia	B-bacteria
marcescens	I-bacteria
and	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
.	O

D	O
-	O
sphingosine	O
(	O
MBC	O
range	O
,	O
0	O
.	O
3	O
to	O
19	O
.	O
6	O
mug	O
/	O
ml	O
)	O
,	O
dihydrosphingosine	O
(	O
MBC	O
range	O
,	O
0	O
.	O
6	O
to	O
39	O
.	O
1	O
mug	O
/	O
ml	O
)	O
,	O
and	O
phytosphingosine	O
(	O
MBC	O
range	O
,	O
3	O
.	O
3	O
to	O
62	O
.	O
5	O
mug	O
/	O
ml	O
)	O
were	O
active	O
against	O
all	O
bacteria	O
except	O
S	B-bacteria
.	I-bacteria
marcescens	I-bacteria
and	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
(	O
MBC	O
>	O
500	O
mug	O
/	O
ml	O
)	O
.	O

Sapienic	O
acid	O
(	O
MBC	O
range	O
,	O
31	O
.	O
3	O
to	O
375	O
.	O
0	O
mug	O
/	O
ml	O
)	O
was	O
active	O
against	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
,	O
Streptococcus	B-bacteria
mitis	I-bacteria
,	O
and	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
but	O
not	O
active	O
against	O
Escherichia	B-bacteria
coli	I-bacteria
,	O
Staphylococcus	B-bacteria
aureus	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
marcescens	I-bacteria
,	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
,	O
Corynebacterium	B-bacteria
bovis	I-bacteria
,	O
Corynebacterium	B-bacteria
striatum	I-bacteria
,	O
and	O
Corynebacterium	B-bacteria
jeikeium	I-bacteria
(	O
MBC	O
>	O
500	O
mug	O
/	O
ml	O
)	O
.	O

Lauric	O
acid	O
(	O
MBC	O
range	O
,	O
6	O
.	O
8	O
to	O
375	O
.	O
0	O
mug	O
/	O
ml	O
)	O
was	O
active	O
against	O
all	O
bacteria	O
except	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
marcescens	I-bacteria
,	O
and	O
P	B-bacteria
.	I-bacteria
aeruginosa	I-bacteria
(	O
MBC	O
>	O
500	O
mug	O
/	O
ml	O
)	O
.	O

Complete	O
killing	O
was	O
achieved	O
as	O
early	O
as	O
0	O
.	O
5	O
h	O
for	O
some	O
lipids	O
but	O
took	O
as	O
long	O
as	O
24	O
h	O
for	O
others	O
.	O

Hence	O
,	O
sphingoid	O
bases	O
and	O
fatty	O
acids	O
have	O
different	O
antibacterial	O
activities	O
and	O
may	O
have	O
potential	O
for	O
prophylactic	O
or	O
therapeutic	O
intervention	O
in	O
infection	O
.	O

Viruses	O
are	O
the	O
most	O
abundant	O
known	O
infectious	O
agents	O
on	O
the	O
planet	O
and	O
are	O
significant	O
drivers	O
of	O
diversity	O
in	O
a	O
variety	O
of	O
ecosystems	O
.	O

Although	O
there	O
have	O
been	O
numerous	O
studies	O
of	O
viral	O
communities	O
,	O
few	O
have	O
focused	O
on	O
viruses	O
within	O
the	O
indigenous	O
human	O
microbiota	O
.	O

We	O
analyzed	O
2	O
267	O
695	O
virome	O
reads	O
from	O
viral	O
particles	O
and	O
compared	O
them	O
with	O
263	O
516	O
bacterial	O
16S	O
rRNA	O
gene	O
sequences	O
from	O
the	O
saliva	O
of	O
five	O
healthy	O
human	O
subjects	O
over	O
a	O
2	O
-	O
to	O
3	O
-	O
month	O
period	O
,	O
in	O
order	O
to	O
improve	O
our	O
understanding	O
of	O
the	O
role	O
viruses	O
have	O
in	O
the	O
complex	O
oral	O
ecosystem	O
.	O

Our	O
data	O
reveal	O
viral	O
communities	O
in	O
human	O
saliva	O
dominated	O
by	O
bacteriophages	O
whose	O
constituents	O
are	O
temporally	O
distinct	O
.	O

The	O
preponderance	O
of	O
shared	O
homologs	O
between	O
the	O
salivary	O
viral	O
communities	O
in	O
two	O
unrelated	O
subjects	O
in	O
the	O
same	O
household	O
suggests	O
that	O
environmental	O
factors	O
are	O
determinants	O
of	O
community	O
membership	O
.	O

When	O
comparing	O
salivary	O
viromes	O
to	O
those	O
from	O
human	O
stool	O
and	O
the	O
respiratory	O
tract	O
,	O
each	O
group	O
was	O
distinct	O
,	O
further	O
indicating	O
that	O
habitat	O
is	O
of	O
substantial	O
importance	O
in	O
shaping	O
human	O
viromes	O
.	O

Compared	O
with	O
coexisting	O
bacteria	O
,	O
there	O
was	O
concordance	O
among	O
certain	O
predicted	O
host	O
-	O
virus	O
pairings	O
such	O
as	O
Veillonella	B-bacteria
and	O
Streptococcus	B-bacteria
,	O
whereas	O
there	O
was	O
discordance	O
among	O
others	O
such	O
as	O
Actinomyces	B-bacteria
.	O

We	O
identified	O
122	O
728	O
virulence	O
factor	O
homologs	O
,	O
suggesting	O
that	O
salivary	O
viruses	O
may	O
serve	O
as	O
reservoirs	O
for	O
pathogenic	O
gene	O
function	O
in	O
the	O
oral	O
environment	O
.	O

That	O
the	O
vast	O
majority	O
of	O
human	O
oral	O
viruses	O
are	O
bacteriophages	O
whose	O
putative	O
gene	O
function	O
signifies	O
some	O
have	O
a	O
prominent	O
role	O
in	O
lysogeny	O
,	O
suggests	O
these	O
viruses	O
may	O
have	O
an	O
important	O
role	O
in	O
helping	O
shape	O
the	O
microbial	O
diversity	O
in	O
the	O
human	O
oral	O
cavity	O
.	O

Implants	O
can	O
be	O
colonized	O
by	O
microorganisms	O
from	O
oral	O
biofilms	O
and	O
may	O
affect	O
peri	O
-	O
implant	O
tissues	O
health	O
.	O

Among	O
these	O
bacteria	O
,	O
pathogens	O
typically	O
associated	O
with	O
periodontitis	O
can	O
be	O
found	O
,	O
such	O
as	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
as	O
well	O
as	O
Gram	O
negative	O
enteric	O
bacilli	O
not	O
typically	O
associated	O
with	O
periodontal	O
diseases	O
.	O

Superinfecting	O
bacteria	O
were	O
characterized	O
from	O
peri	O
-	O
implant	O
lesions	O
in	O
patients	O
with	O
history	O
of	O
periodontitis	O
.	O

Sixty	O
-	O
eight	O
implants	O
were	O
studied	O
in	O
55	O
patients	O
;	O
the	O
average	O
patient	O
age	O
was	O
56	O
years	O
.	O

Forty	O
-	O
nine	O
implants	O
had	O
peri	O
-	O
implant	O
lesions	O
and	O
19	O
were	O
considered	O
stable	O
.	O

Subgingival	O
samples	O
were	O
obtained	O
in	O
affected	O
and	O
stable	O
implants	O
.	O

The	O
samples	O
were	O
streaked	O
on	O
Mac	O
-	O
Conkey	O
agar	O
and	O
incubated	O
at	O
37	O
degrees	O
C	O
for	O
24	O
hours	O
.	O

The	O
colonies	O
were	O
identified	O
with	O
the	O
kit	O
-	O
BD	O
BBL	O
Crystal	O
E	O
/	O
NF	O
(	O
R	O
)	O
.	O

Superinfecting	O
organisms	O
were	O
detected	O
in	O
20	O
patients	O
-	O
-	O
they	O
were	O
seen	O
more	O
frequently	O
at	O
diseased	O
implants	O
(	O
n	O
=	O
15	O
)	O
than	O
at	O
healthy	O
implants	O
(	O
n	O
=	O
5	O
)	O
.	O

The	O
prevalence	O
of	O
superinfecting	O
bacteria	O
on	O
the	O
selected	O
implants	O
was	O
33	O
.	O
8	O
%	O
(	O
n	O
=	O
23	O
/	O
68	O
)	O
.	O

These	O
bacteria	O
were	O
more	O
prevalent	O
among	O
affected	O
implants	O
(	O
n	O
=	O
17	O
or	O
25	O
%	O
)	O
than	O
those	O
with	O
stable	O
implants	O
n	O
=	O
6	O
(	O
8	O
.	O
8	O
%	O
)	O
.	O

Klebsiella	B-bacteria
pneumoniae	I-bacteria
was	O
the	O
most	O
frequent	O
Gram	O
negative	O
rod	O
detected	O
(	O
n	O
=	O
12	O
)	O
.	O

One	O
-	O
third	O
of	O
the	O
implants	O
had	O
superinfecting	O
organisms	O
.	O

Implants	O
with	O
a	O
peri	O
-	O
implant	O
lesion	O
had	O
a	O
higher	O
frequency	O
of	O
superinfecting	O
bacteria	O
.	O

Klebsiella	B-bacteria
pneumoniae	I-bacteria
was	O
the	O
most	O
common	O
superinfecting	O
organism	O
isolated	O
.	O

A	O
multiple	O
infection	O
caused	O
by	O
superinfecting	O
bacteria	O
was	O
present	O
only	O
at	O
diseased	O
implants	O
.	O

These	O
microbial	O
agents	O
potentially	O
affect	O
implant	O
stability	O
.	O

To	O
profile	O
plaque	O
microflora	O
on	O
root	O
-	O
caries	O
lesions	O
,	O
and	O
to	O
examine	O
the	O
protein	O
-	O
denaturing	O
activity	O
as	O
a	O
pilot	O

.	O

Six	O
subjects	O
with	O
root	O
-	O
caries	O
were	O
investigated	O
.	O

Plaque	O
samples	O
on	O
root	O
caries	O
lesions	O
(	O
R	O
)	O
,	O
as	O
well	O
as	O
from	O
healthy	O
supragingival	O
sites	O
(	O
S	O
)	O
and	O
periodontal	O
pockets	O
(	O
>	O
or	O
=	O
5	O
mm	O
)	O
(	O
P	O
)	O
were	O
collected	O
and	O
cultured	O
anaerobically	O
on	O
blood	O
agar	O
plates	O
.	O

The	O
isolated	O
bacteria	O
were	O
identified	O
by	O
16S	O
rRNA	O
sequencing	O
analysis	O
,	O
and	O
examined	O
for	O
the	O
protein	O
-	O
denaturing	O
activity	O
using	O
the	O
skim	O
-	O
milk	O
plates	O
and	O
the	O
SDS	O
-	O
PAGE	O
,	O
and	O
for	O
the	O
acidogenicity	O
using	O
the	O
FAB	O
broth	O
containing	O
1	O
%	O
glucose	O
.	O

Propionibacterium	B-bacteria
,	O
Actinomyces	B-bacteria
,	O
Streptococcus	B-bacteria
,	O
Lactobacillus	B-bacteria
and	O
Bifidobacterium	B-bacteria
were	O
predominant	O
in	O
R	O
,	O
while	O
Actinomyces	B-bacteria
,	O
Streptococcus	B-bacteria
,	O
Veillonella	B-bacteria
and	O
Capnocytophaga	B-bacteria
in	O
S	O
,	O
and	O
Actinomyces	B-bacteria
,	O
Prevotella	B-bacteria
,	O
Actinobaculum	B-bacteria
,	O
Streptococcus	B-bacteria
,	O
Olsenella	B-bacteria
and	O
Eubacterium	B-bacteria
were	O
predominant	O
in	O
P	B-bacteria
.	I-bacteria
Proteolytic	I-bacteria
bacteria	I-bacteria
comprised	O
40	O
%	O
,	O
26	O
%	O
and	O
57	O
%	O
of	O
microflora	O
in	O
R	O
,	O
S	O
and	O
P	O
,	O
respectively	O
.	O

The	O
skim	O
-	O
milk	O
plates	O
distinguished	O
between	O
protein	O
-	O
degrading	O
and	O
protein	O
-	O
coagulating	O
bacteria	O
,	O
which	O
comprised	O
7	O
and	O
33	O
%	O
,	O
0	O
and	O
26	O
%	O
,	O
and	O
17	O
and	O
40	O
%	O
of	O
microflora	O
,	O
in	O
R	O
,	O
S	O
and	O
P	O
,	O
respectively	O
.	O

The	O
SDS	O
-	O
PAGE	O
analysis	O
revealed	O
that	O
protein	O
-	O
degrading	O
isolates	O
were	O
capable	O
of	O
degrading	O
collagen	O
molecules	O
.	O

Furthermore	O
,	O
the	O
final	O
culture	O
pHs	O
of	O
protein	O
-	O
degrading	O
and	O
-	O
coagulating	O
bacteria	O
were	O
5	O
.	O
0	O
-	O
5	O
.	O
4	O
and	O
3	O
.	O
8	O
-	O
3	O
.	O
9	O
,	O
respectively	O
.	O

The	O
latter	O
pH	O
was	O
low	O
enough	O
to	O
denature	O
proteins	O
in	O
skim	O
milk	O
.	O

The	O
microbial	O
composition	O
of	O
R	O
was	O
distinct	O
from	O
those	O
of	O
S	O
and	O
P	O
.	O

Deoxyribonucleic	O
acids	O
(	O
DNA	O
)	O
of	O
periodontal	O
pathogens	O
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
(	O
Pg	B-bacteria
)	O
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
stimulate	O
cytokine	O
production	O
in	O
human	O
monocytic	O
cells	O
(	O
THP	O
-	O
1	O
)	O
through	O
Toll	O
-	O
like	O
receptor	O
9	O
(	O
TLR	O
-	O
9	O
)	O
and	O
nuclear	O
factor	O
-	O
kappaB	O
signaling	O
.	O

Fusobacterium	B-bacteria
nucleatum	I-bacteria
(	O
Fn	B-bacteria
)	O
is	O
one	O
of	O
the	O
most	O
frequently	O
isolated	O
bacteria	O
in	O
periodontally	O
diseased	O
tissues	O
and	O
is	O
reported	O
to	O
synergize	O
with	O
Pg	B-bacteria
,	O
enhancing	O
the	O
pathogenicity	O
.	O

We	O
investigate	O
inflammatory	O
mediator	O
production	O
in	O
THP	O
-	O
1	O
cells	O
challenged	O
with	O
Fn	B-bacteria
and	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
(	O
Ss	B-bacteria
)	O
DNA	O
,	O
a	O
non	O
-	O
pathogenic	O
oral	O
bacteria	O
,	O
and	O
further	O
assess	O
whether	O
cytokines	O
triggered	O
by	O
whole	O
pathogens	O
or	O
Pg	O
lipopolysaccharide	O
(	O
LPS	O
)	O
are	O
affected	O
by	O
TLR	O
-	O
9	O
signaling	O
inhibitors	O
(	O
chloroquine	O
)	O
.	O

THP	O
-	O
1	O
cells	O
were	O
stimulated	O
with	O
Pg	O
-	O
DNA	O
(	O
100	O
ng	O
/	O
muL	O
)	O
,	O
Fn	O
-	O
DNA	O
(	O
100	O
ng	O
/	O
muL	O
)	O
,	O
Ss	O
-	O
DNA	O
(	O
100	O
ng	O
/	O
muL	O
)	O
,	O
Pg	O
-	O
LPS	O
(	O
10	O
ng	O
/	O
muL	O
)	O
,	O
and	O
heat	O
-	O
killed	O
whole	O
bacteria	O
(	O
multiplicity	O
of	O
infection	O
,	O
1	O
:	O
100	O
)	O
for	O
16	O
hours	O
with	O
or	O
without	O
chloroquine	O
pretreatment	O
(	O
10	O
mug	O
/	O
mL	O
)	O
.	O

Interleukin	O
(	O
IL	O
)	O
-	O
1beta	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
and	O
tumor	O
necrosis	O
factor	O
-	O
alpha	O
levels	O
were	O
determined	O
using	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O

Statistical	O
analyses	O
included	O
analysis	O
of	O
variance	O
with	O
multiple	O
comparisons	O
using	O
Dunnett	O
or	O
Tukey	O
methods	O
and	O
paired	O
t	O
test	O
.	O

A	O
value	O
of	O
P	O
<	O
0	O
.	O
05	O
was	O
significant	O
.	O

Inflammatory	O
mediator	O
levels	O
were	O
increased	O
in	O
response	O
to	O
all	O
the	O
stimuli	O
with	O
the	O
exception	O
of	O
Ss	O
-	O
DNA	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Chloroquine	O
pretreatment	O
significantly	O
decreased	O
cytokine	O
production	O
from	O
THP	O
-	O
1	O
cells	O
with	O
the	O
exception	O
of	O
IL	O
-	O
6	O
production	O
triggered	O
by	O
whole	O
Fn	B-bacteria
and	O
Ss	B-bacteria
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Differences	O
exist	O
among	O
oral	O
bacterial	O
DNA	O
in	O
inducing	O
immune	O
responses	O
.	O

By	O
altering	O
the	O
conditions	O
in	O
cytosolic	O
compartments	O
,	O
we	O
can	O
interfere	O
with	O
cellular	O
responses	O
triggered	O
by	O
extracellular	O
receptor	O
activation	O
.	O

Thus	O
,	O
alternative	O
treatment	O
approaches	O
targeted	O
to	O
intracellular	O
receptors	O
might	O
be	O
of	O
benefit	O
in	O
controlling	O
periodontal	O
inflammation	O
.	O

The	O
fimbriae	O
-	O
associated	O
protein	O
1	O
(	O
Fap1	O
)	O
is	O
a	O
major	O
adhesin	O
of	O
Streptococcus	B-bacteria
parasanguinis	I-bacteria
,	O
a	O
primary	O
colonizer	O
of	O
the	O
oral	O
cavity	O
that	O
plays	O
an	O
important	O
role	O
in	O
the	O
formation	O
of	O
dental	O
plaque	O
.	O

Fap1	O
is	O
an	O
extracellular	O
adhesive	O
surface	O
fibre	O
belonging	O
to	O
the	O
serine	O
-	O
rich	O
repeat	O
protein	O
(	O
SRRP	O
)	O
family	O
,	O
which	O
plays	O
a	O
central	O
role	O
in	O
the	O
pathogenesis	O
of	O
streptococci	B-bacteria
and	O
staphylococci	B-bacteria
.	O

The	O
N	O
-	O
terminal	O
adhesive	O
region	O
of	O
Fap1	O
(	O
Fap1	O
-	O
NR	O
)	O
is	O
composed	O
of	O
two	O
domains	O
(	O
Fap1	O
-	O
NR	O
(	O
alpha	O
)	O
and	O
Fap1	O
-	O
NR	O
(	O
beta	O
)	O
)	O
and	O
is	O
projected	O
away	O
from	O
the	O
bacterial	O
surface	O
via	O
the	O
extensive	O
serine	O
-	O
rich	O
repeat	O
region	O
,	O
for	O
adhesion	O
to	O
the	O
salivary	O
pellicle	O
.	O

The	O
adhesive	O
properties	O
of	O
Fap1	O
are	O
modulated	O
through	O
a	O
pH	O
switch	O
in	O
which	O
a	O
reduction	O
in	O
pH	O
results	O
in	O
a	O
rearrangement	O
between	O
the	O
Fap1	O
-	O
NR	O
(	O
alpha	O
)	O
and	O
Fap1	O
-	O
NR	O
(	O
beta	O
)	O
domains	O
,	O
which	O
assists	O
in	O
the	O
survival	O
of	O
S	B-bacteria
.	I-bacteria
parasanguinis	I-bacteria
in	O
acidic	O
environments	O
.	O

We	O
have	O
solved	O
the	O
structure	O
of	O
Fap1	O
-	O
NR	O
(	O
alpha	O
)	O
at	O
pH	O
5	O
.	O
0	O
at	O
3	O
.	O
0A	O
resolution	O
and	O
reveal	O
how	O
subtle	O
rearrangements	O
of	O
the	O
3	O
-	O
helix	O
bundle	O
combined	O
with	O
a	O
change	O
in	O
electrostatic	O
potential	O
mediates	O
'	O
opening	O
'	O
and	O
activation	O
of	O
the	O
adhesive	O
region	O
.	O

Further	O
,	O
we	O
show	O
that	O
pH	O
-	O
dependent	O
changes	O
are	O
critical	O
for	O
biofilm	O
formation	O
and	O
present	O
an	O
atomic	O
model	O
for	O
the	O
inter	O
-	O
Fap1	O
-	O
NR	O
interactions	O
which	O
have	O
been	O
assigned	O
an	O
important	O
role	O
in	O
the	O
biofilm	O
formation	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
identify	O
a	O
group	O
of	O
patients	O
at	O
high	O
risk	O
of	O
methicillin	B-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
(	O
MRSA	B-bacteria
)	O
infection	O
following	O
surgical	O
procedures	O
involving	O
oral	O
cavity	O
,	O
head	O
and	O
neck	O
.	O

A	O
retrospective	O
analysis	O
of	O
demographic	O
,	O
clinical	O
and	O
laboratory	O
data	O
was	O
performed	O
.	O

A	O
manual	O
search	O
of	O
laboratory	O
records	O
for	O
a	O
five	O
years	O
period	O
(	O
2005	O
-	O
2009	O
)	O
was	O
performed	O
for	O
specimens	O
submitted	O
to	O
the	O
diagnostic	O
microbiology	O
laboratory	O
from	O
patients	O
admitted	O
to	O
the	O
Cranio	O
-	O
Maxillofacial	O
and	O
Oncologic	O
Surgery	O
Department	O
.	O

Methicillin	B-bacteria
resistant	I-bacteria
Staphylococcus	I-bacteria
aureus	I-bacteria
was	O
identified	O
in	O
26	O
cases	O
.	O

Most	O
commonly	O
it	O
was	O
isolated	O
from	O
tongue	O
swabs	O
in	O
patients	O
following	O
extensive	O
oncological	O
surgical	O
procedures	O
involving	O
oral	O
cavity	O
.	O

Most	O
common	O
risk	O
factors	O
were	O
:	O
age	O
above	O
65	O
years	O
,	O
neoplasms	O
,	O
multisite	O
trauma	O
with	O
loss	O
of	O
consciousness	O
,	O
cigarette	O
smoking	O
,	O
alcohol	O
abuse	O
,	O
tobacco	O
addiction	O
,	O
antibiotic	O
therapy	O
immediately	O
before	O
hospitalization	O
.	O

More	O
than	O
half	O
of	O
patients	O
with	O
MRSA	B-bacteria
infection	O
required	O
surgical	O
treatment	O
except	O
for	O
pharmacological	O
treatment	O
.	O

Monitoring	O
of	O
postoperative	O
wounds	O
is	O
of	O
great	O
importance	O
with	O
regard	O
to	O
he	O
risk	O
of	O
MRSA	B-bacteria
infection	O
.	O

The	O
intensities	O
and	O
specificities	O
of	O
salivary	O
IgA	O
antibody	O
responses	O
to	O
antigens	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
the	O
main	O
pathogen	O
of	O
dental	O
caries	O
,	O
may	O
influence	O
colonization	O
by	O
these	O
organisms	O
during	O
the	O
first	O
1	O
.	O
5	O
year	O
of	O
life	O
.	O

Thus	O
,	O
the	O
ontogeny	O
of	O
salivary	O
IgA	O
responses	O
to	O
oral	O
colonizers	O
continues	O
to	O
warrant	O
investigation	O
,	O
especially	O
with	O
regard	O
to	O
the	O
influence	O
of	O
birth	O
conditions	O
,	O
e	O
.	O
g	O
.	O
prematurity	O
,	O
on	O
the	O
ability	O
of	O
children	O
to	O
efficiently	O
respond	O
to	O
oral	O
microorganisms	O
.	O

In	O
this	O
study	O
,	O
we	O
characterised	O
the	O
salivary	O
antibody	O
responses	O
to	O
two	O
bacterial	O
species	O
which	O
are	O
prototypes	O
of	O
pioneer	O
and	O
pathogenic	O
microorganisms	O
of	O
the	O
oral	O
cavity	O
(	O
Streptococcus	B-bacteria
mitis	I-bacteria
and	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
respectively	O
)	O
in	O
fullterm	O
(	O
FT	O
)	O
and	O
preterm	O
(	O
PT	O
)	O
newborn	O
children	O
.	O

Salivas	O
from	O
123	O
infants	O
(	O
70	O
FT	O
and	O
53	O
PT	O
)	O
were	O
collected	O
during	O
the	O
first	O
10h	O
after	O
birth	O
and	O
levels	O
of	O
IgA	O
and	O
IgM	O
antibodies	O
and	O
the	O
presence	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
were	O
analysed	O
respectively	O
by	O
ELISA	O
and	O
by	O
chequerboard	O
DNA	O
-	O
DNA	O
hybridization	O
.	O

Two	O
subgroups	O
of	O
24	O
FT	O
and	O
24	O
PT	O
children	O
were	O
compared	O
with	O
respect	O
to	O
patterns	O
of	O
antibody	O
specificities	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
antigens	O
,	O
using	O
Western	O
blot	O
assays	O
.	O

Cross	O
-	O
adsorption	O
of	O
10	O
infant	O
'	O
s	O
saliva	O
was	O
tested	O
to	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
Enterococcus	B-bacteria
faecalis	I-bacteria
antigens	O
.	O

Salivary	O
levels	O
of	O
IgA	O
at	O
birth	O
were	O
2	O
.	O
5	O
-	O
fold	O
higher	O
in	O
FT	O
than	O
in	O
PT	O
children	O
(	O
Mann	O
-	O
Whitney	O
;	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Salivary	O
IgA	O
antibodies	O
reactive	O
with	O
several	O
antigens	O
of	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
were	O
detected	O
at	O
birth	O
in	O
children	O
with	O
undetectable	O
levels	O
of	O
those	O
bacteria	O
.	O

Adsorption	O
of	O
infant	O
saliva	O
with	O
cells	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
produced	O
a	O
reduction	O
of	O
antibodies	O
recognizing	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
antigens	O
in	O
half	O
of	O
the	O
neonates	O
.	O

The	O
diversity	O
and	O
intensity	O
of	O
IgA	O
responses	O
were	O
lower	O
in	O
PT	O
compared	O
to	O
FT	O
children	O
,	O
although	O
those	O
differences	O
were	O
not	O
significant	O
.	O

These	O
data	O
provide	O
evidence	O
that	O
children	O
have	O
salivary	O
IgA	O
antibodies	O
shortly	O
after	O
birth	O
,	O
which	O
might	O
influence	O
the	O
establishment	O
of	O
the	O
oral	O
microbiota	O
,	O
and	O
that	O
the	O
levels	O
of	O
salivary	O
antibody	O
might	O
be	O
related	O
to	O
prematurity	O
.	O

Periodontitis	O
has	O
a	O
polymicrobial	O
etiology	O
within	O
the	O
framework	O
of	O
a	O
complex	O
microbial	O
ecosystem	O
.	O

With	O
advances	O
in	O
sequencing	O
technologies	O
,	O
comprehensive	O
studies	O
to	O
elucidate	O
bacterial	O
community	O
differences	O
have	O
recently	O
become	O
possible	O
.	O

We	O
used	O
454	O
sequencing	O
of	O
16S	O
rRNA	O
genes	O
to	O
compare	O
subgingival	O
bacterial	O
communities	O
from	O
29	O
periodontally	O
healthy	O
controls	O
and	O
29	O
subjects	O
with	O
chronic	O
periodontitis	O
.	O

Amplicons	O
from	O
both	O
the	O
V1	O
-	O
2	O
and	O
V4	O
regions	O
of	O
the	O
16S	O
gene	O
were	O
sequenced	O
,	O
yielding	O
1	O
,	O
393	O
,	O
579	O
sequences	O
.	O

They	O
were	O
identified	O
by	O
BLAST	O
against	O
a	O
curated	O
oral	O
16S	O
database	O
,	O
and	O
mapped	O
to	O
16	O
phyla	O
,	O
106	O
genera	O
,	O
and	O
596	O
species	O
.	O

81	O
%	O
of	O
sequences	O
could	O
be	O
mapped	O
to	O
cultivated	O
species	O
.	O

Differences	O
between	O
health	O
-	O
and	O
periodontitis	O
-	O
associated	O
bacterial	O
communities	O
were	O
observed	O
at	O
all	O
phylogenetic	O
levels	O
,	O
and	O
UniFrac	O
and	O
principal	O
coordinates	O
analysis	O
showed	O
distinct	O
community	O
profiles	O
in	O
health	O
and	O
disease	O
.	O

Community	O
diversity	O
was	O
higher	O
in	O
disease	O
,	O
and	O
123	O
species	O
were	O
identified	O
that	O
were	O
significantly	O
more	O
abundant	O
in	O
disease	O
,	O
and	O
53	O
in	O
health	O
.	O

Spirochaetes	B-bacteria
,	O
Synergistetes	B-bacteria
and	O
Bacteroidetes	B-bacteria
were	O
more	O
abundant	O
in	O
disease	O
,	O
whereas	O
the	O
Proteobacteria	B-bacteria
were	O
found	O
at	O
higher	O
levels	O
in	O
healthy	O
controls	O
.	O

Within	O
the	O
phylum	O
Firmicutes	B-bacteria
,	O
the	O
class	O
Bacilli	B-bacteria
was	O
health	O
-	O
associated	O
,	O
whereas	O
the	O
Clostridia	B-bacteria
,	O
Negativicutes	B-bacteria
and	O
Erysipelotrichia	B-bacteria
were	O
associated	O
with	O
disease	O
.	O

These	O
results	O
implicate	O
a	O
number	O
of	O
taxa	O
that	O
will	O
be	O
targets	O
for	O
future	O
research	O
.	O

Some	O
,	O
such	O
as	O
Filifactor	B-bacteria
alocis	I-bacteria
and	O
many	O
Spirochetes	B-bacteria
were	O
represented	O
by	O
a	O
large	O
fraction	O
of	O
sequences	O
as	O
compared	O
with	O
previously	O
identified	O
targets	O
.	O

Elucidation	O
of	O
these	O
differences	O
in	O
community	O
composition	O
provides	O
a	O
basis	O
for	O
further	O
understanding	O
the	O
pathogenesis	O
of	O
periodontitis	O
.	O

Salivary	O
host	O
-	O
defence	O
peptides	O
include	O
defensins	O
,	O
histatins	O
and	O
cathelicidin	O
.	O

We	O
have	O
investigated	O
the	O
effects	O
of	O
these	O
peptides	O
on	O
the	O
microbial	O
composition	O
of	O
dental	O
plaques	O
.	O

Salivary	O
consortia	O
,	O
established	O
within	O
hydroxyapatite	O
disc	O
models	O
,	O
were	O
exposed	O
during	O
development	O
to	O
physiological	O
levels	O
of	O
human	O
neutrophil	O
proteins	O
(	O
HNP	O
)	O
1	O
and	O
2	O
;	O
human	O
beta	O
defensins	O
(	O
hbetaD	O
)	O
1	O
,	O
2	O
and	O
3	O
;	O
histatins	O
(	O
His	O
)	O
5	O
and	O
8	O
;	O
and	O
cathelicidin	O
(	O
LL37	O
)	O
.	O

Effects	O
on	O
aggregation	O
and	O
microbial	O
composition	O
were	O
determined	O
using	O
fluorescence	O
microscopy	O
;	O
and	O
differential	O
culture	O
with	O
PCR	O
-	O
DGGE	O
,	O
respectively	O
.	O

LIVE	O
/	O
DEAD	O
microscopic	O
analysis	O
indicated	O
that	O
HDPs	O
decreased	O
total	O
bacterial	O
viability	O
,	O
whilst	O
beta	O
defensins	O
,	O
paired	O
HNPs	O
,	O
His	O
5	O
,	O
His	O
8	O
and	O
the	O
HDPs	O
combined	O
inhibited	O
bacterial	O
aggregation	O
.	O

According	O
to	O
differential	O
culture	O
,	O
all	O
test	O
HDPs	O
(	O
except	O
His	O
5	O
)	O
significantly	O
decreased	O
the	O
abundance	O
of	O
Gram	O
-	O
negative	O
anaerobes	O
and	O
lactobacilli	B-bacteria
(	O
except	O
HNP	O
2	O
,	O
hbetaD	O
1	O
,	O
paired	O
HNPs	O
and	O
His	O
5	O
)	O
.	O

Combined	O
HNPs	O
and	O
paired	O
hbetaD	O
1	O
and	O
3	O
inhibited	O
streptococci	B-bacteria
,	O
whereas	O
HNP	O
1	O
,	O
hbetaD	O
1	O
,	O
hbetaD	O
3	O
,	O
His	O
5	O
and	O
LL37	O
increased	O
streptococcal	B-bacteria
numbers	O
.	O

According	O
to	O
cluster	O
analyses	O
of	O
DGGE	O
profiles	O
,	O
HDP	O
-	O
exposed	O
plaques	O
were	O
compositionally	O
distinct	O
from	O
undosed	O
controls	O
.	O

Thus	O
,	O
whilst	O
HDPs	O
reportedly	O
exhibit	O
variable	O
potency	O
against	O
oral	O
bacteria	O
in	O
endpoint	O
susceptibly	O
tests	O
,	O
exposure	O
of	O
nascent	O
plaques	O
can	O
markedly	O
influence	O
bacterial	O
viability	O
,	O
composition	O
and	O
microbial	O
aggregation	O
.	O

To	O
assess	O
the	O
effectiveness	O
of	O
selective	O
digestive	O
decontamination	O
(	O
SDD	O
)	O
for	O
eradicating	O
carbapenem	B-bacteria
-	I-bacteria
resistant	I-bacteria
Klebsiella	I-bacteria
pneumoniae	I-bacteria
(	O
CRKP	B-bacteria	B-bacteria
)	O
oropharyngeal	O
and	O
gastrointestinal	O
carriage	O
.	O

A	O
randomized	O
,	O
double	O
-	O
blind	O
,	O
placebo	O
-	O
controlled	O
trial	O
with	O
7	O
weeks	O
of	O
follow	O
-	O
up	O
per	O
patient	O
.	O

A	O
1	O
,	O
000	O
-	O
bed	O
tertiary	O
-	O
care	O
university	O
hospital	O
.	O

Adults	O
with	O
CRKP	O
-	O
positive	O
rectal	O
swab	O
cultures	O
.	O

Patients	O
were	O
blindly	O
randomized	O
(	O
1	O
:	O
1	O
)	O
over	O
a	O
20	O
-	O
month	O
period	O
.	O

The	O
SDD	O
arm	O
received	O
oral	O
gentamicin	O
and	O
polymyxin	O
E	O
gel	O
(	O
0	O
.	O
5	O
g	O
4	O
times	O
per	O
day	O
)	O
and	O
oral	O
solutions	O
of	O
gentamicin	O
(	O
80	O
mg	O
4	O
times	O
per	O
day	O
)	O
and	O
polymyxin	O
E	O
(	O
1	O
x	O
10	O
(	O
6	O
)	O
units	O
4	O
times	O
per	O
day	O
for	O
7	O
days	O
)	O
.	O

The	O
placebo	O
arm	O
received	O
oral	O
placebo	O
gel	O
4	O
times	O
per	O
day	O
and	O
2	O
placebo	O
oral	O
solutions	O
4	O
times	O
per	O
day	O
for	O
7	O
days	O
.	O

Strict	O
contact	O
precautions	O
were	O
applied	O
.	O

Samples	O
obtained	O
from	O
the	O
throat	O
,	O
groin	O
,	O
and	O
urine	O
were	O
also	O
cultured	O
.	O

Forty	O
patients	O
(	O
mean	O
age	O
+	O
/	O
-	O
standard	O
deviation	O
,	O
71	O
+	O
/	O
-	O
16	O
years	O
;	O
65	O
%	O
male	O
)	O
were	O
included	O
.	O

At	O
screening	O
,	O
greater	O
than	O
or	O
equal	O
to	O
30	O
%	O
of	O
oropharyngeal	O
,	O
greater	O
than	O
or	O
equal	O
to	O
60	O
%	O
of	O
skin	O
,	O
and	O
greater	O
than	O
or	O
equal	O
to	O
35	O
%	O
of	O
urine	O
cultures	O
yielded	O
CRKP	B-bacteria
isolates	I-bacteria
.	O

All	O
throat	O
cultures	O
became	O
negative	O
in	O
the	O
SDD	O
arm	O
after	O
3	O
days	O
(	O
P	O
<	O
.	O
0001	O
)	O
.	O

The	O
percentages	O
of	O
rectal	O
cultures	O
that	O
were	O
positive	O
for	O
CRKP	B-bacteria
were	O
significantly	O
reduced	O
at	O
2	O
weeks	O
.	O

At	O
that	O
time	O
,	O
16	O
.	O
1	O
%	O
of	O
rectal	O
cultures	O
in	O
the	O
placebo	O
arm	O
and	O
61	O
.	O
1	O
%	O
in	O
the	O
SDD	O
arm	O
were	O
negative	O
(	O
odds	O
ratio	O
,	O
0	O
.	O
13	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
0	O
.	O
02	O
-	O
0	O
.	O
74	O
;	O
P	O
<	O
.	O
0016	O
)	O
.	O

A	O
difference	O
between	O
the	O
percentages	O
in	O
the	O
2	O
arms	O
was	O
still	O
maintained	O
at	O
6	O
weeks	O
(	O
33	O
.	O
3	O
%	O
vs	O
58	O
.	O
5	O
%	O
)	O
.	O

Groin	O
colonization	O
prevalence	O
did	O
not	O
change	O
in	O
either	O
arm	O
,	O
and	O
the	O
prevalence	O
of	O
urine	O
colonization	O
increased	O
in	O
the	O
placebo	O
arm	O
.	O

This	O
SDD	O
regimen	O
could	O
be	O
a	O
suitable	O
decolonization	O
therapy	O
for	O
selected	O
patients	O
colonized	O
with	O
CRKP	B-bacteria
,	O
such	O
as	O
transplant	O
recipients	O
or	O
immunocompromised	O
patients	O
pending	O
chemotherapy	O
and	O
patients	O
who	O
require	O
major	O
intestinal	O
or	O
oropharyngeal	O
surgery	O
.	O

Moreover	O
,	O
in	O
outbreaks	O
caused	O
by	O
CRKP	B-bacteria
infections	O
that	O
are	O
uncontrolled	O
by	O
routine	O
infection	O
control	O
measures	O
,	O
SDD	O
could	O
provide	O
additional	O
infection	O
containment	O
.	O

Clinical	O
observations	O
and	O
epidemiologic	O
studies	O
suggest	O
that	O
the	O
incidence	O
of	O
head	O
and	O
neck	O
squamous	O
cell	O
carcinoma	O
(	O
HNSCC	O
)	O
correlates	O
with	O
dental	O
hygiene	O
,	O
implying	O
a	O
role	O
for	O
bacteria	O
-	O
induced	O
inflammation	O
in	O
its	O
pathogenesis	O
.	O

Here	O
we	O
begin	O
to	O
explore	O
the	O
pilot	O
hypothesis	O
that	O
specific	O
microbial	O
populations	O
may	O
contribute	O
to	O
HNSCC	O
pathogenesis	O
via	O
epigenetic	O
modifications	O
in	O
inflammatory	O
-	O
and	O
HNSCC	O
-	O
associated	O
genes	O
.	O

Microbiomic	O
profiling	O
by	O
16S	O
rRNA	O
sequencing	O
of	O
matched	O
tumor	O
and	O
adjacent	O
normal	O
tissue	O
specimens	O
in	O
42	O
individuals	O
with	O
HNSCC	O
demonstrate	O
a	O
significant	O
association	O
of	O
specific	O
bacterial	O
subpopulations	O
with	O
HNSCC	O
over	O
normal	O
tissue	O
(	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

Furthermore	O
,	O
microbial	O
populations	O
can	O
separate	O
tumors	O
by	O
tobacco	O
status	O
(	O
P	O
<	O
0	O
.	O
008	O
)	O
,	O
but	O
not	O
by	O
alcohol	O
status	O
(	O
P	O
=	O
0	O
.	O
41	O
)	O
.	O

If	O
our	O
subhypothesis	O
regarding	O
a	O
mechanistic	O
link	O
from	O
microorganism	O
to	O
carcinogenesis	O
via	O
inflammation	O
and	O
consequent	O
aberrant	O
DNA	O
methylation	O
is	O
correct	O
,	O
then	O
we	O
should	O
see	O
hypermethylation	O
of	O
relevant	O
genes	O
associate	O
with	O
specific	O
microbiomic	O
profiles	O
.	O

Methylation	O
analysis	O
in	O
four	O
genes	O
(	O
MDR1	O
,	O
IL8	O
,	O
RARB	O
,	O
TGFBR2	O
)	O
previously	O
linked	O
to	O
HNSCC	O
or	O
inflammation	O
shows	O
significantly	O
increased	O
methylation	O
in	O
tumor	O
samples	O
compared	O
with	O
normal	O
oral	O
mucosa	O
.	O

Of	O
these	O
,	O
MDR1	O
promoter	O
methylation	O
associates	O
with	O
specific	O
microbiomic	O
profiles	O
in	O
tumor	O
over	O
normal	O
mucosa	O
.	O

Additionally	O
,	O
we	O
report	O
that	O
MDR1	O
methylation	O
correlates	O
with	O
regional	O
nodal	O
metastases	O
in	O
the	O
context	O
of	O
two	O
specific	O
bacterial	O
subpopulations	O
,	O
Enterobacteriaceae	B-bacteria
and	O
Tenericutes	B-bacteria
(	O
P	O
<	O
0	O
.	O
001	O
for	O
each	O
)	O
.	O

These	O
associations	O
may	O
lead	O
to	O
a	O
different	O
,	O
and	O
potentially	O
more	O
comprehensive	O
,	O
perspective	O
on	O
the	O
pathogenesis	O
of	O
HNSCC	O
,	O
and	O
support	O
further	O
exploration	O
of	O
mechanistic	O
linkage	O
and	O
,	O
if	O
so	O
,	O
novel	O
therapeutic	O
strategies	O
such	O
as	O
demethylating	O
agents	O
and	O
probiotic	O
adjuncts	O
,	O
particularly	O
for	O
patients	O
with	O
advanced	O
or	O
refractory	O
disease	O
.	O

The	O
dog	O
has	O
been	O
used	O
extensively	O
for	O
experimental	O
and	O
microbiological	O
studies	O
on	O
periodontitis	O
and	O
peri	O
-	O
implantitis	O
without	O
detailed	O
knowledge	O
about	O
the	O
predominant	O
flora	O
of	O
the	O
subgingival	O
plaque	O
.	O

This	O
study	O
was	O
designed	O
to	O
evaluate	O
the	O
predominant	O
cultivable	O
bacterial	O
species	O
in	O
dogs	O
and	O
compare	O
them	O
phenotypically	O
and	O
genotypically	O
with	O
corresponding	O
human	O
species	O
.	O

Four	O
subgingival	O
samples	O
were	O
taken	O
from	O
two	O
upper	O
premolars	O
in	O
each	O
of	O
six	O
Labrador	O
retrievers	O
.	O

The	O
samples	O
from	O
each	O
dog	O
were	O
processed	O
for	O
anaerobic	O
culture	O
.	O

From	O
the	O
samples	O
of	O
each	O
dog	O
,	O
the	O
five	O
or	O
six	O
predominating	O
bacteria	O
based	O
on	O
colony	O
morphology	O
were	O
selected	O
and	O
pure	O
cultured	O
.	O

Each	O
of	O
the	O
strains	O
was	O
characterized	O
by	O
Gram	O
stain	O
,	O
anaerobic	O
/	O
aerobic	O
growth	O
and	O
API	O
-	O
ZYM	O
test	O
.	O

Eighteen	O
strains	O
showing	O
clear	O
-	O
cut	O
phenotypic	O
differences	O
were	O
further	O
classified	O
based	O
on	O
DNA	O
sequencing	O
technology	O
.	O

Cross	O
-	O
reactions	O
of	O
DNA	O
probes	O
from	O
human	O
and	O
dog	O
strains	O
were	O
also	O
tested	O
against	O
a	O
panel	O
of	O
both	O
human	O
and	O
dog	O
bacterial	O
species	O
.	O

Thirty	O
-	O
one	O
strains	O
in	O
the	O
dogs	O
were	O
isolated	O
and	O
characterized	O
.	O

They	O
represented	O
21	O
different	O
species	O
,	O
of	O
which	O
six	O
belonged	O
to	O
the	O
genus	O
Porphyromonas	B-bacteria
.	O

No	O
species	O
was	O
found	O
consistently	O
in	O
the	O
predominant	O
flora	O
of	O
all	O
six	O
dogs	O
.	O

Porphyromonas	B-bacteria
crevioricanis	I-bacteria
and	O
Fusobacterium	B-bacteria
canifelinum	I-bacteria
were	O
the	O
two	O
most	O
prevalent	O
species	O
in	O
predominant	O
flora	O
in	O
dogs	O
.	O

DNA	O
probes	O
from	O
human	O
and	O
dog	O
species	O
cross	O
-	O
reacted	O
to	O
some	O
extent	O
with	O
related	O
strains	O
from	O
humans	O
and	O
dogs	O
;	O
however	O
,	O
distinct	O
exceptions	O
were	O
found	O
.	O

The	O
predominant	O
cultural	O
subgingival	O
flora	O
in	O
dogs	O
shows	O
great	O
similarities	O
with	O
the	O
subgingival	O
bacteria	O
from	O
humans	O
at	O
the	O
genus	O
level	O
,	O
but	O
distinct	O
differences	O
at	O
the	O
species	O
level	O
;	O
however	O
,	O
a	O
genetic	O
relatedness	O
could	O
be	O
disclosed	O
for	O
most	O
strains	O
investigated	O
.	O

To	O
evaluate	O
the	O
effect	O
of	O
chewing	O
gums	O
containing	O
probiotic	O
bacteria	O
on	O
oral	O
malodour	O
.	O

The	O
null	O
hypothesis	O
was	O
that	O
no	O
difference	O
would	O
be	O
displayed	O
compared	O
with	O
placebo	O
gums	O
.	O

Twenty	O
-	O
five	O
healthy	O
young	O
adults	O
with	O
self	O
-	O
reported	O
malodorous	O
morning	O
breath	O
completed	O
this	O
randomized	O
double	O
-	O
blind	O
placebo	O
-	O
controlled	O
cross	O
-	O
over	O
trial	O
.	O

The	O
design	O
included	O
run	O
-	O
in	O
and	O
wash	O
-	O
out	O
periods	O
interspersed	O
by	O
two	O
intervention	O
periods	O
of	O
14	O
days	O
each	O
.	O

The	O
subjects	O
were	O
instructed	O
to	O
chew	O
one	O
gum	O
in	O
the	O
morning	O
and	O
one	O
in	O
the	O
evening	O
containing	O
either	O
two	O
strains	O
of	O
probiotic	O
lactobacilli	B-bacteria
(	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
DSM	I-bacteria
17938	I-bacteria
and	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
ATCC	I-bacteria
PTA	I-bacteria
5289	I-bacteria
)	O
or	O
placebo	O
.	O

The	O
outcome	O
measures	O
were	O
(	O
i	O
)	O
organoleptic	O
scores	O
(	O
0	O
-	O
5	O
)	O
by	O
a	O
certified	O
test	O
panel	O
,	O
(	O
ii	O
)	O
concentration	O
of	O
volatile	O
sulphur	O
compounds	O
(	O
VSC	O
)	O
measured	O
with	O
a	O
Halimeter	O
and	O
(	O
iii	O
)	O
concentration	O
of	O
VSC	O
after	O
a	O
cysteine	O
rinse	O
.	O

Registrations	O
were	O
made	O
at	O
baseline	O
and	O
after	O
each	O
intervention	O
period	O
.	O

Differences	O
between	O
the	O
groups	O
were	O
assessed	O
by	O
non	O
-	O
parametric	O
paired	O
statistics	O
and	O
chi	O
-	O
square	O
test	O
.	O

The	O
median	O
organoleptic	O
score	O
was	O
similar	O
(	O
score	O
2	O
)	O
in	O
both	O
groups	O
at	O
baseline	O
.	O

After	O
14	O
days	O
of	O
treatment	O
,	O
the	O
organoleptic	O
scores	O
were	O
significantly	O
lower	O
in	O
the	O
probiotic	O
group	O
compared	O
with	O
the	O
placebo	O
group	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Assessments	O
of	O
the	O
VSC	O
levels	O
displayed	O
no	O
significant	O
differences	O
between	O
the	O
groups	O
,	O
either	O
before	O
or	O
after	O
rinsing	O
with	O
L	O
-	O
cysteine	O
.	O

No	O
adverse	O
effects	O
were	O
registered	O
.	O

The	O
results	O
demonstrated	O
that	O
probiotic	O
chewing	O
gums	O
may	O
have	O
some	O
beneficial	O
effect	O
on	O
oral	O
malodour	O
assessed	O
by	O
organoleptic	O
scores	O
.	O

The	O
results	O
indicate	O
that	O
the	O
probiotic	O
gum	O
may	O
affect	O
bacteria	O
that	O
produce	O
malodourous	O
compounds	O
other	O
than	O
VSCs	O
.	O

Oral	O
streptococci	B-bacteria
have	O
been	O
associated	O
with	O
systemic	O
diseases	O
,	O
including	O
infective	O
endocarditis	O
and	O
neutropenic	O
bacteremia	O
.	O

We	O
analyzed	O
58	O
recent	O
oral	O
streptococcal	B-bacteria
bloodstream	I-bacteria
isolates	I-bacteria
,	O
and	O
we	O
obtained	O
clinical	O
and	O
demographic	O
data	O
for	O
source	O
patients	O
.	O

The	O
sodA	O
gene	O
was	O
found	O
to	O
be	O
a	O
better	O
target	O
than	O
the	O
16S	O
-	O
23S	O
rRNA	O
internal	O
transcribed	O
spacer	O
for	O
DNA	O
sequence	O
-	O
based	O
species	O
identification	O
.	O

Together	O
,	O
Streptococcus	B-bacteria
mitis	I-bacteria
and	O
Streptococcus	B-bacteria
oralis	I-bacteria
were	O
significantly	O
more	O
likely	O
than	O
the	O
12	O
combined	O
remaining	O
species	O
to	O
be	O
isolated	O
from	O
neutropenic	O
patients	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
effect	O
of	O
specific	O
parameters	O
of	O
low	O
-	O
level	O
laser	O
therapy	O
(	O
LLLT	O
)	O
on	O
biofilms	O
formed	O
by	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Candida	O
albicans	O
or	O
an	O
association	O
of	O
both	O
species	O
.	O

Single	O
and	O
dual	O
-	O
species	O
biofilms	O
-	O
-	O
SSB	O
and	O
DSB	O
-	O
-	O
were	O
exposed	O
to	O
laser	O
doses	O
of	O
5	O
,	O
10	O
or	O
20	O
J	O
/	O
cm	O
(	O
2	O
)	O
from	O
a	O
near	O
infrared	O
InGaAsP	O
diode	O
laser	O
prototype	O
(	O
LASERTable	O
;	O
780	O
+	O
/	O
-	O
3	O
nm	O
,	O
0	O
.	O
04	O
W	O
)	O
.	O

After	O
irradiation	O
,	O
the	O
analysis	O
of	O
biobilm	O
viability	O
(	O
MTT	O
assay	O
)	O
,	O
biofilm	O
growth	O
(	O
cfu	O
/	O
mL	O
)	O
and	O
cell	O
morphology	O
(	O
SEM	O
)	O
showed	O
that	O
LLLT	O
reduced	O
cell	O
viability	O
as	O
well	O
as	O
the	O
growth	O
of	O
biofilms	O
.	O

The	O
response	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
(	O
SSB	O
)	O
to	O
irradiation	O
was	O
similar	O
for	O
all	O
laser	O
doses	O
and	O
the	O
biofilm	O
growth	O
was	O
dose	O
dependent	O
.	O

However	O
,	O
when	O
associated	O
with	O
C	O
.	O
albicans	O
(	O
DSB	O
)	O
,	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
was	O
resistant	O
to	O
LLLT	O
.	O

For	O
C	O
.	O
albicans	O
,	O
the	O
association	O
with	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
(	O
DSB	O
)	O
caused	O
a	O
significant	O
decrease	O
in	O
biofilm	O
growth	O
in	O
a	O
dose	O
-	O
dependent	O
fashion	O
.	O

The	O
morphology	O
of	O
the	O
microorganisms	O
in	O
the	O
SSB	O
was	O
not	O
altered	O
by	O
LLLT	O
,	O
while	O
the	O
association	O
of	O
microbial	O
species	O
(	O
DSB	O
)	O
promoted	O
a	O
reduction	O
in	O
the	O
formation	O
of	O
C	O
.	O
albicans	O
hyphae	O
.	O

LLLT	O
had	O
an	O
inhibitory	O
effect	O
on	O
the	O
microorganisms	O
,	O
and	O
this	O
capacity	O
can	O
be	O
altered	O
according	O
to	O
the	O
interactions	O
between	O
different	O
microbial	O
species	O
.	O

Oral	O
polymicrobial	O
interactions	O
and	O
biofilm	O
formation	O
are	O
associated	O
with	O
initiation	O
and	O
progression	O
of	O
caries	O
,	O
gingivitis	O
,	O
and	O
periodontitis	O
.	O

Transcriptome	O
studies	O
of	O
such	O
interactions	O
,	O
allowing	O
a	O
first	O
mechanistic	O
insight	O
,	O
are	O
hampered	O
by	O
current	O
single	O
-	O
species	O
array	O
designs	O
.	O

In	O
this	O
study	O
we	O
used	O
385	O
K	O
NimbleGene	O
technology	O
for	O
design	O
and	O
evaluation	O
of	O
an	O
array	O
covering	O
the	O
full	O
genomes	O
of	O
5	O
important	O
physiological	O
-	O
,	O
cariogenic	O
-	O
,	O
and	O
periodontitis	O
-	O
associated	O
microorganisms	O
(	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
)	O
.	O

Array	O
hybridization	O
was	O
done	O
with	O
cDNA	O
from	O
cultures	O
grown	O
for	O
24	O
h	O
anaerobically	O
.	O

Single	O
species	O
experiments	O
identified	O
cross	O
-	O
species	O
hybridizing	O
array	O
probes	O
.	O

These	O
probes	O
could	O
be	O
neglected	O
in	O
a	O
mixed	O
-	O
species	O
experimental	O
setting	O
without	O
the	O
need	O
to	O
exclude	O
the	O
whole	O
genes	O
from	O
the	O
analysis	O
.	O

Between	O
69	O
%	O
and	O
almost	O
99	O
%	O
of	O
the	O
genomes	O
were	O
actively	O
transcribed	O
under	O
the	O
mono	O
-	O
species	O
planktonic	O
,	O
monolayer	O
,	O
and	O
biofilm	O
conditions	O
.	O

The	O
influence	O
of	O
Streptococcus	B-bacteria
mitis	I-bacteria
(	O
not	O
represented	O
on	O
the	O
array	O
)	O
on	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
gene	O
transcription	O
was	O
determined	O
as	O
a	O
test	O
for	O
a	O
dual	O
-	O
species	O
mixed	O
biofilm	O
setup	O
.	O

Phenotypically	O
,	O
under	O
the	O
influence	O
of	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
an	O
increase	O
in	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilm	O
mass	O
and	O
a	O
decrease	O
in	O
media	O
pH	O
-	O
value	O
were	O
noticed	O
,	O
thereby	O
confirming	O
previously	O
published	O
data	O
.	O

Employing	O
a	O
stringent	O
cut	O
-	O
off	O
(	O
2	O
-	O
fold	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
19	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
transcripts	O
were	O
identified	O
with	O
increased	O
abundance	O
,	O
and	O
11	O
with	O
decreased	O
abundance	O
compared	O
to	O
a	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
mono	O
-	O
species	O
biofilm	O
.	O

Several	O
of	O
these	O
genes	O
have	O
previously	O
been	O
found	O
differentially	O
regulated	O
under	O
general	O
and	O
acid	O
stress	O
,	O
thereby	O
confirming	O
the	O
value	O
of	O
this	O
array	O
.	O

This	O
new	O
array	O
allows	O
transcriptome	O
studies	O
on	O
multi	O
-	O
species	O
oral	O
biofilm	O
interactions	O
.	O

It	O
may	O
become	O
an	O
important	O
asset	O
in	O
future	O
oral	O
biofilm	O
and	O
inhibitor	O
/	O
therapy	O
studies	O
.	O

The	O
development	O
of	O
multispecies	O
oral	O
microbial	O
communities	O
involves	O
complex	O
intra	O
-	O
and	O
interspecies	O
interactions	O
at	O
various	O
levels	O
.	O

The	O
ability	O
to	O
adhere	O
to	O
the	O
resident	O
bacteria	O
or	O
the	O
biofilm	O
matrix	O
and	O
overcome	O
community	O
resistance	O
are	O
among	O
the	O
key	O
factors	O
that	O
determine	O
whether	O
a	O
bacterium	O
can	O
integrate	O
into	O
a	O
community	O
.	O

Fusobacterium	B-bacteria
nucleatum	I-bacteria
is	O
a	O
prevalent	O
Gram	O
-	O
negative	O
oral	O
bacterial	O
species	O
that	O
is	O
able	O
to	O
adhere	O
to	O
a	O
variety	O
of	O
oral	O
microbes	O
and	O
has	O
been	O
implicated	O
in	O
playing	O
an	O
important	O
role	O
in	O
the	O
establishment	O
of	O
multispecies	O
oral	O
microbial	O
community	O
.	O

However	O
,	O
the	O
majority	O
of	O
experiments	O
thus	O
far	O
has	O
focused	O
on	O
the	O
physical	O
adherence	O
between	O
two	O
species	O
as	O
measured	O
by	O
in	O
vitro	O
co	O
-	O
aggregation	O
assays	O
,	O
while	O
the	O
community	O
-	O
based	O
effects	O
on	O
the	O
integration	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
into	O
multispecies	O
microbial	O
community	O
remains	O
to	O
be	O
investigated	O
.	O

In	O
this	O
,	O
we	O
focus	O
on	O
community	O
integration	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
.	O

We	O
demonstrated	O
using	O
an	O
established	O
in	O
vitro	O
mice	O
oral	O
microbiota	O
(	O
O	O
-	O
mix	O
)	O
that	O
the	O
viability	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
was	O
significantly	O
reduced	O
upon	O
addition	O
to	O
the	O
O	O
-	O
mix	O
due	O
to	O
cell	O
contact	O
-	O
dependent	O
induction	O
of	O
hydrogen	O
peroxide	O
(	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
)	O
production	O
by	O
oral	O
community	O
.	O

Interestingly	O
,	O
this	O
inhibitory	O
effect	O
was	O
significantly	O
alleviated	O
when	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
was	O
allowed	O
to	O
adhere	O
to	O
its	O
known	O
interacting	O
partner	O
species	O
(	O
such	O
as	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
)	O
prior	O
to	O
addition	O
.	O

Furthermore	O
,	O
this	O
aggregate	O
formation	O
-	O
dependent	O
protection	O
was	O
absent	O
in	O
the	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
mutant	I-bacteria
strain	I-bacteria
DeltaFn1526	I-bacteria
that	O
is	O
unable	O
to	O
bind	O
to	O
a	O
number	O
of	O
Gram	O
-	O
positive	O
species	O
.	O

More	O
importantly	O
,	O
this	O
protective	O
effect	O
was	O
also	O
observed	O
during	O
integration	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
into	O
a	O
human	O
salivary	O
microbial	O
community	O
(	O
S	O
-	O
mix	O
)	O
.	O

These	O
results	O
suggest	O
that	O
by	O
adhering	O
to	O
other	O
oral	O
microbes	O
,	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
is	O
able	O
to	O
mask	O
the	O
surface	O
components	O
that	O
are	O
recognized	O
by	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
producing	O
oral	O
community	O
members	O
.	O

This	O
evasion	O
strategy	O
prevents	O
detection	O
by	O
antagonistic	O
oral	O
bacteria	O
and	O
allows	O
integration	O
into	O
the	O
developing	O
oral	O
microbial	O
community	O
.	O

Salmonella	B-bacteria
enterica	I-bacteria
serovar	I-bacteria
Choleraesuis	I-bacteria
(	O
S	B-bacteria
.	I-bacteria
Choleraesuis	I-bacteria
)	O
is	O
a	O
highly	O
invasive	O
zoonotic	O
pathogen	O
that	O
causes	O
bacteremia	O
in	O
humans	O
and	O
pigs	O
.	O

The	O
prevalence	O
of	O
S	B-bacteria
.	I-bacteria
Choleraesuis	I-bacteria
in	O
man	O
has	O
gradually	O
decreased	O
since	O
the	O
outbreak	O
of	O
foot	O
and	O
mouth	O
disease	O
in	O
pigs	O
in	O
1997	O
in	O
southern	O
Taiwan	O
.	O

The	O
goal	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
change	O
in	O
prevalence	O
of	O
S	B-bacteria
.	I-bacteria
Choleraesuis	I-bacteria
carrying	O
the	O
virulence	O
plasmid	O
(	O
pSCV	O
)	O
in	O
human	O
and	O
swine	O
isolates	O
collected	O
in	O
1995	O
-	O
2005	O
and	O
characterize	O
these	O
.	O

380	O
isolates	O
were	O
collected	O
from	O
human	O
and	O
swine	O
blood	O
samples	O
.	O

Large	O
pSCVs	O
were	O
determined	O
by	O
PCR	O
and	O
Southern	O
blot	O
analysis	O
.	O

Antimicrobial	O
susceptibility	O
and	O
resistance	O
genes	O
,	O
and	O
the	O
phylogenetic	O
association	O
of	O
these	O
large	O
pSCV	O
were	O
analyzed	O
.	O

The	O
number	O
of	O
isolates	O
harboring	O
the	O
large	O
pSCV	O
was	O
significantly	O
reduced	O
,	O
and	O
their	O
prevalence	O
differed	O
between	O
human	O
and	O
swine	O
isolates	O
.	O

These	O
large	O
pSCVs	O
were	O
a	O
recombinant	O
of	O
original	O
50	O
-	O
kb	O
pSCV	O
and	O
R	O
plasmid	O
.	O

In	O
addition	O
,	O
some	O
large	O
pSCVs	O
lacked	O
two	O
pSCV	O
-	O
specific	O
deletion	O
regions	O
from	O
pef	O
to	O
repC	O
and	O
from	O
traT	O
to	O
samA	O
.	O

These	O
large	O
pSCVs	O
carried	O
the	O
resistance	O
genes	O
bla	O
(	O
TEM	O
,	O
)	O
aadA2	O
,	O
and	O
sulI	O
,	O
as	O
well	O
as	O
class	O
I	O
integrons	O
of	O
0	O
.	O
65	O
and	O
/	O
or	O
1	O
.	O
9	O
kb	O
in	O
size	O
,	O
but	O
were	O
inconjugatible	O
.	O

Phylogenetic	O
analysis	O
demonstrated	O
that	O
the	O
large	O
pSCV	O
evolves	O
independently	O
in	O
human	O
and	O
swine	O
isolates	O
.	O

S	B-bacteria
.	I-bacteria
Choleraesuis	I-bacteria
with	O
large	O
pSCV	O
was	O
significantly	O
reduced	O
after	O
the	O
foot	O
and	O
mouth	O
disease	O
outbreak	O
and	O
may	O
evolve	O
in	O
human	O
and	O
swine	O
specific	O
isolates	O
.	O

White	O
Sponge	O
Nevus	O
(	O
WSN	O
)	O
is	O
a	O
rare	O
pathology	O
with	O
a	O
pathogenesis	O
on	O
genetic	O
basis	O
,	O
a	O
benign	O
course	O
and	O
a	O
localization	O
affecting	O
the	O
mucosal	O
keratin	O
.	O

WSN	O
is	O
usually	O
a	O
symptomless	O
pathology	O
:	O
when	O
pain	O
is	O
present	O
,	O
some	O
authors	O
reported	O
reduction	O
of	O
symptoms	O
by	O
taking	O
penicillin	O
or	O
oral	O
tetracycline	O
rinses	O
,	O
suggesting	O
that	O
a	O
bacterial	O
overinfection	O
could	O
be	O
at	O
the	O
base	O
of	O
possible	O
painful	O
symptoms	O
.	O

We	O
describe	O
2	O
patients	O
affected	O
by	O
WSN	O
,	O
father	O
and	O
son	O
:	O
they	O
presented	O
two	O
different	O
oral	O
diseases	O
associated	O
with	O
an	O
infection	O
by	O
Staphylococcus	B-bacteria
aureus	I-bacteria
.	O

So	O
,	O
we	O
have	O
performed	O
a	O
careful	O
oral	O
hygiene	O
to	O
reduce	O
infection	O
in	O
the	O
oral	O
cavity	O
.	O

In	O
the	O
following	O
days	O
we	O
prescribed	O
2	O
rinses	O
a	O
day	O
with	O
a	O
mouthwash	O
containing	O
chlorhexidine	O
digluconate	O
at	O
two	O
different	O
percentages	O
.	O

Early	O
diagnosis	O
of	O
this	O
lesion	O
is	O
important	O
,	O
because	O
it	O
allows	O
us	O
to	O
exclude	O
other	O
more	O
serious	O
diseases	O
.	O

In	O
the	O
most	O
part	O
of	O
cases	O
,	O
WSN	O
requires	O
no	O
treatment	O
because	O
of	O
its	O
benign	O
and	O
asymptomatic	O
behaviour	O
:	O
up	O
to	O
now	O
,	O
no	O
protocol	O
of	O
treatment	O
for	O
this	O
condition	O
was	O
standardized	O
.	O

Even	O
if	O
WSN	O
is	O
a	O
painless	O
condition	O
,	O
sometime	O
a	O
correlated	O
painful	O
symptomatology	O
was	O
reported	O
.	O

In	O
our	O
experience	O
,	O
we	O
have	O
achieved	O
excellent	O
results	O
even	O
with	O
chlorhexidine	O
digluconate	O
rinses	O
,	O
considering	O
that	O
our	O
treated	O
cases	O
were	O
both	O
infected	O
by	O
Staphylococcus	B-bacteria
aureus	I-bacteria
.	O

We	O
hypothesize	O
that	O
the	O
corrugated	O
plaques	O
and	O
the	O
altered	O
texture	O
of	O
the	O
mucosa	O
create	O
the	O
right	O
conditions	O
for	O
the	O
colonization	O
and	O
the	O
development	O
of	O
microbial	O
species	O
such	O
as	O
saprophytic	O
bacteria	O
or	O
fungal	O
species	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
metabolize	O
carbohydrates	O
,	O
such	O
as	O
glucose	O
and	O
sucrose	O
,	O
to	O
produce	O
acid	O
and	O
enhance	O
biofilm	O
formation	O
with	O
the	O
early	O
colonizing	O
bacteria	O
to	O
induce	O
dental	O
caries	O
.	O

Xylitol	O
has	O
been	O
used	O
as	O
a	O
reliable	O
substitute	O
for	O
carbohydrate	O
to	O
inhibit	O
the	O
acid	O
production	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

However	O
,	O
long	O
-	O
term	O
xylitol	O
consumption	O
leads	O
to	O
the	O
emergence	O
of	O
xylitol	O
-	O
resistance	O
in	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
cariogenic	O
trait	O
of	O
Xylitol	O
-	O
resistant	O
(	O
X	O
(	O
R	O
)	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
using	O
biofilm	O
formation	O
and	O
coaggregation	O
of	O
xylitol	O
-	O
sensitive	O
(	O
X	O
(	O
S	O
)	O
)	O
and	O
X	O
(	O
R	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
with	O
salivary	O
bacteria	O
and	O
their	O
glucosyltransferases	O
expression	O
.	O

When	O
X	O
(	O
S	O
)	O
or	O
X	O
(	O
R	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
were	O
incubated	O
in	O
brain	O
heart	O
infusion	O
broth	O
with	O
bacteria	O
from	O
human	O
saliva	O
,	O
X	O
(	O
R	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
exhibited	O
reduction	O
in	O
biofilm	O
formation	O
in	O
comparison	O
to	O
X	O
(	O
S	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

The	O
coaggregation	O
between	O
X	O
(	O
R	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
and	O
S	B-bacteria
,	I-bacteria
gordonii	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
or	O
S	B-bacteria
.	I-bacteria
sanguinis	I-bacteria
was	O
less	O
pronounced	O
than	O
that	O
of	O
X	O
(	O
S	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
the	O
presence	O
of	O
sucrose	O
.	O

However	O
,	O
there	O
was	O
no	O
difference	O
in	O
the	O
coaggregation	O
between	O
X	O
(	O
R	O
)	O
and	O
X	O
(	O
S	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
in	O
the	O
sucrose	O
-	O
free	O
condition	O
.	O

The	O
level	O
of	O
gtfB	O
and	O
gtfC	O
mRNA	O
expression	O
of	O
X	O
(	O
R	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
was	O
lower	O
than	O
that	O
of	O
X	O
(	O
S	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
whilst	O
the	O
level	O
of	O
gtfD	O
mRNA	O
expression	O
did	O
not	O
differ	O
between	O
the	O
two	O
strains	O
.	O

The	O
reduction	O
of	O
biofilm	O
formation	O
in	O
X	O
(	O
S	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
due	O
to	O
decrease	O
in	O
glucosyltransferases	O
expression	O
suggests	O
that	O
X	O
(	O
R	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
may	O
be	O
less	O
cariogenic	O
than	O
X	O
(	O
S	O
)	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

The	O
present	O
investigation	O
aimed	O
to	O
analyse	O
clinical	O
and	O
microbiological	O
effects	O
of	O
systemic	O
administration	O
of	O
metronidazole	O
and	O
amoxicillin	O
combined	O
with	O
the	O
One	O
-	O
Stage	O
-	O
Full	O
-	O
Mouth	O
-	O
Disinfection	O
protocol	O
(	O
OSFMD	O
)	O
in	O
generalized	O
aggressive	O
periodontitis	O
patients	O
(	O
G	O
-	O
AgP	O
)	O
.	O

Thirty	O
-	O
nine	O
systemically	O
healthy	O
patients	O
with	O
G	O
-	O
AgP	O
were	O
consecutively	O
included	O
.	O

The	O
test	O
group	O
(	O
n	O
=	O
19	O
)	O
received	O
amoxicillin	O
-	O
metronidazole	O
combination	O
(	O
500	O
mg	O
of	O
each	O
,	O
three	O
times	O
a	O
day	O
for	O
7	O
days	O
)	O
and	O
the	O
OSFMD	O
,	O
the	O
control	O
group	O
(	O
n	O
=	O
20	O
)	O
received	O
the	O
OSFMD	O
and	O
a	O
placebo	O
.	O

In	O
addition	O
to	O
clinical	O
parameters	O
subgingival	O
plaque	O
samples	O
from	O
moderate	O
(	O
4	O
-	O
5	O
mm	O
)	O
and	O
deep	O
(	O
>	O
/	O
=	O
6	O
mm	O
)	O
pocket	O
sites	O
were	O
analysed	O
for	O
the	O
presence	O
of	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
and	O
Treponema	B-bacteria
denticola	I-bacteria
using	O
polymerase	O
chain	O
reaction	O
.	O

Both	O
therapies	O
led	O
to	O
a	O
statistically	O
significant	O
decrease	O
in	O
clinical	O
and	O
microbiological	O
parameters	O
compared	O
to	O
baseline	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

The	O
most	O
beneficial	O
changes	O
were	O
observed	O
in	O
the	O
test	O
group	O
which	O
showed	O
significantly	O
greater	O
improvements	O
in	O
probing	O
depth	O
and	O
clinical	O
attachment	O
level	O
and	O
a	O
lower	O
prevalence	O
of	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
,	O
Treponema	B-bacteria
denticola	I-bacteria
,	O
and	O
Tannerella	B-bacteria
forsythia	I-bacteria
compared	O
to	O
the	O
control	O
one	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Systemic	O
administration	O
of	O
metronidazole	O
and	O
amoxicillin	O
as	O
an	O
adjunct	O
to	O
OSFMD	O
therapy	O
significantly	O
improved	O
clinical	O
and	O
microbiological	O
outcomes	O
in	O
patients	O
with	O
G	O
-	O
AgP	O
over	O
a	O
6	O
-	O
month	O
period	O
.	O

As	O
the	O
oral	O
cavity	O
is	O
regarded	O
as	O
a	O
relevant	O
site	O
for	O
Staphylococcus	B-bacteria
aureus	I-bacteria
colonization	O
and	O
interhuman	O
transmission	O
,	O
this	O
study	O
aimed	O
to	O
investigate	O
whether	O
different	O
oral	O
conditions	O
influence	O
the	O
rates	O
of	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
oral	O
carriage	O
and	O
genetic	O
characters	O
of	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
isolates	I-bacteria
.	O

Staphylococcus	B-bacteria
aureus	I-bacteria
was	O
searched	O
in	O
samples	O
collected	O
from	O
cheek	O
,	O
gingival	O
margin	O
,	O
and	O
anterior	O
nares	O
of	O
45	O
healthy	O
subjects	O
,	O
27	O
periodontitis	O
affected	O
subjects	O
,	O
and	O
29	O
subjects	O
with	O
fixed	O
prosthetic	O
restorations	O
.	O

Isolates	O
were	O
screened	O
for	O
17	O
genetic	O
determinants	O
,	O
and	O
Partial	O
Least	O
Square	O
Discriminant	O
Analysis	O
was	O
performed	O
to	O
evaluate	O
whether	O
specific	O
characters	O
correlated	O
with	O
oral	O
condition	O
or	O
site	O
of	O
isolation	O
.	O

The	O
three	O
subject	O
groups	O
showed	O
comparable	O
nasal	O
carriage	O
rates	O
but	O
,	O
both	O
the	O
periodontitis	O
and	O
prosthetic	O
restoration	O
groups	O
showed	O
significantly	O
higher	O
oral	O
carriage	O
rates	O
,	O
as	O
compared	O
to	O
healthy	O
subjects	O
(	O
P	O
=	O
0	O
.	O
01	O
and	O
0	O
.	O
02	O
,	O
respectively	O
)	O
.	O

Moreover	O
,	O
periodontitis	O
affected	O
subjects	O
hosted	O
strains	O
possessing	O
a	O
distinct	O
genotypic	O
and	O
phenotypic	O
background	O
,	O
characterized	O
by	O
the	O
presence	O
of	O
a	O
larger	O
number	O
of	O
exotoxins	O
encoding	O
genes	O
.	O

These	O
data	O
confirm	O
that	O
the	O
oral	O
cavity	O
is	O
an	O
important	O
site	O
of	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
colonization	O
and	O
demonstrate	O
that	O
conditions	O
modifying	O
the	O
oral	O
environment	O
,	O
as	O
the	O
presence	O
of	O
periodontitis	O
and	O
of	O
fixed	O
prosthetic	O
restorations	O
,	O
promote	O
S	B-bacteria
.	I-bacteria
aureus	I-bacteria
carriage	O
and	O
may	O
favor	O
the	O
spread	O
of	O
more	O
pathogenic	O
strains	O
.	O

A	O
low	O
pH	O
environment	O
is	O
created	O
by	O
cariogenic	O
bacteria	O
.	O

This	O
study	O
was	O
aimed	O
to	O
measure	O
pH	O
of	O
carious	O
lesions	O
intraorally	O
using	O
a	O
micro	O
-	O
pH	O
sensor	O
,	O
and	O
assess	O
predominant	O
acid	O
-	O
producing	O
cariogens	O
by	O
qPCR	O
to	O
differentiate	O
caries	O
activities	O
.	O

103	O
dentine	O
lesions	O
classified	O
as	O
active	O
or	O
arrested	O
caries	O
based	O
on	O
the	O
clinical	O
and	O
radiological	O
examinations	O
were	O
collected	O
from	O
patients	O
after	O
intraoral	O
measurement	O
of	O
the	O
lesion	O
surface	O
pH	O
using	O
a	O
micro	O
-	O
pH	O
sensor	O
.	O

Quantitative	O
detection	O
of	O
genomic	O
DNA	O
copies	O
of	O
target	O
cariogenic	O
bacteria	O
(	O
mutans	B-bacteria
streptococci	I-bacteria
and	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
)	O
in	O
each	O
lesion	O
was	O
performed	O
using	O
real	O
-	O
time	O
PCR	O
.	O

Correlation	O
between	O
the	O
pH	O
ranges	O
and	O
the	O
number	O
of	O
bacterial	O
species	O
was	O
examined	O
by	O
Spearman	O
test	O
.	O

50	O
samples	O
were	O
diagnosed	O
as	O
active	O
and	O
53	O
as	O
arrested	O
lesions	O
.	O

Statistically	O
significant	O
difference	O
was	O
observed	O
on	O
average	O
surface	O
pH	O
value	O
between	O
active	O
and	O
arrested	O
lesions	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Prevalence	O
of	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
was	O
higher	O
in	O
active	O
lesions	O
than	O
in	O
arrested	O
lesions	O
(	O
76	O
%	O
vs	O
.	O
58	O
%	O
of	O
samples	O
,	O
respectively	O
)	O
.	O

When	O
the	O
carious	O
lesions	O
were	O
categorised	O
into	O
four	O
different	O
pH	O
ranges	O
(	O
up	O
to	O
5	O
.	O
5	O
,	O
from	O
5	O
.	O
6	O
to	O
5	O
.	O
8	O
,	O
from	O
5	O
.	O
9	O
to	O
6	O
.	O
1	O
and	O
6	O
.	O
2	O
or	O
above	O
)	O
,	O
increased	O
prevalence	O
of	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
was	O
observed	O
with	O
decrease	O
of	O
pH	O
levels	O
.	O

A	O
significant	O
negative	O
relationship	O
was	O
found	O
between	O
pH	O
value	O
and	O
number	O
of	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
(	O
r	O
=	O
-	O
0	O
.	O
209	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
but	O
no	O
such	O
correlation	O
was	O
found	O
for	O
mutans	B-bacteria
streptococci	I-bacteria
.	O

Intraoral	O
pH	O
measurement	O
might	O
be	O
clinically	O
useful	O
to	O
determine	O
acidity	O
of	O
the	O
local	O
environment	O
of	O
carious	O
lesions	O
as	O
one	O
aspect	O
of	O
the	O
caries	O
activity	O
assessment	O
.	O

The	O
population	O
of	O
certain	O
bacteria	O
may	O
indicate	O
activity	O
of	O
carious	O
lesions	O
.	O

Intraoral	O
pH	O
measurement	O
of	O
the	O
carious	O
lesions	O
using	O
a	O
micro	O
-	O
pH	O
sensor	O
may	O
be	O
a	O
clinically	O
feasible	O
method	O
for	O
assessment	O
of	O
lesion	O
acidity	O
.	O

One	O
of	O
the	O
major	O
components	O
of	O
dental	O
polymerized	O
resin	O
-	O
based	O
restorative	O
materials	O
is	O
2	O
-	O
hydroxyethyl	O
methacrylate	O
(	O
HEMA	O
)	O
and	O
its	O
release	O
in	O
monomeric	O
form	O
interferes	O
with	O
the	O
oral	O
cavity	O
environment	O
.	O

This	O
study	O
aimed	O
to	O
evaluate	O
HEMA	O
monomeric	O
effects	O
on	O
the	O
co	O
-	O
culture	O
of	O
Streptococcus	B-bacteria
mitis	I-bacteria
and	O
human	O
gingival	O
fibroblasts	O
(	O
HGFs	O
)	O
.	O

Streptococcus	B-bacteria
mitis	I-bacteria
DS12	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
ATCC	I-bacteria
6249	I-bacteria
were	O
co	O
-	O
cultivated	O
with	O
HGF	O
in	O
the	O
presence	O
of	O
HEMA	O
(	O
3	O
mM	O
)	O
,	O
for	O
48	O
and	O
72	O
h	O
;	O
the	O
amount	O
of	O
sessile	O
and	O
planktonic	O
cells	O
,	O
as	O
well	O
as	O
the	O
prokaryotic	O
and	O
eukaryotic	O
cell	O
viability	O
were	O
analyzed	O
in	O
treated	O
and	O
untreated	O
samples	O
.	O

The	O
treatment	O
of	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
/	O
HGFs	O
with	O
HEMA	O
did	O
not	O
produce	O
significant	O
effects	O
on	O
the	O
bacterial	O
adhesion	O
and	O
induced	O
an	O
increase	O
in	O
planktonic	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
ATCC	I-bacteria
6249	I-bacteria
population	O
after	O
48	O
and	O
72	O
h	O
.	O

HEMA	O
increased	O
significantly	O
the	O
planktonic	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
ATCC	I-bacteria
6249	I-bacteria
viability	O
when	O
co	O
-	O
cultured	O
with	O
HGFs	O
,	O
while	O
a	O
cytotoxic	O
effect	O
on	O
HGFs	O
,	O
without	O
bacteria	O
,	O
was	O
recorded	O
.	O

An	O
increase	O
of	O
bacterial	O
aggregation	O
on	O
HGFs	O
was	O
also	O
detected	O
with	O
HEMA	O
.	O

Data	O
obtained	O
in	O
this	O
study	O
suggest	O
that	O
HEMA	O
exhibits	O
a	O
toxic	O
effect	O
mainly	O
on	O
eukaryotic	O
cells	O
and	O
this	O
effect	O
can	O
be	O
modulated	O
by	O
co	O
-	O
cultivation	O
with	O
the	O
S	B-bacteria
.	I-bacteria
mitis	I-bacteria
cells	O
which	O
,	O
in	O
the	O
presence	O
of	O
the	O
monomer	O
,	O
enhance	O
their	O
aggregation	O
rate	O
on	O
HGFs	O
.	O

A	O
well	O
-	O
known	O
indication	O
for	O
the	O
cytologic	O
examination	O
of	O
bronchoalveolar	O
lavage	O
(	O
BAL	O
)	O
fluid	O
is	O
the	O
identification	O
of	O
infectious	O
organisms	O
.	O

However	O
,	O
an	O
important	O
distinction	O
must	O
be	O
made	O
as	O
to	O
whether	O
the	O
organisms	O
seen	O
represent	O
a	O
true	O
opportunistic	O
lower	O
respiratory	O
tract	O
infection	O
or	O
a	O
non	O
-	O
pathologic	O
contamination	O
.	O

We	O
describe	O
herein	O
the	O
case	O
of	O
a	O
13	O
-	O
month	O
-	O
old	O
male	O
infant	O
who	O
presented	O
with	O
persistent	O
chest	O
congestion	O
and	O
tracheobronchitis	O
and	O
who	O
underwent	O
BAL	O
as	O
part	O
of	O
his	O
clinical	O
work	O
-	O
up	O
.	O

On	O
cytological	O
examination	O
of	O
the	O
BAL	O
fluid	O
,	O
the	O
Romanowsky	O
-	O
stained	O
cytospin	O
slides	O
contained	O
numerous	O
squamous	O
epithelial	O
cells	O
with	O
some	O
showing	O
rare	O
striated	O
rod	O
-	O
like	O
structures	O
on	O
their	O
surfaces	O
.	O

The	O
peculiar	O
structures	O
also	O
had	O
rounded	O
ends	O
and	O
were	O
very	O
large	O
when	O
compared	O
to	O
adjacent	O
known	O
bacterial	O
cocci	O
.	O

We	O
have	O
determined	O
that	O
the	O
striated	O
rod	O
-	O
like	O
structures	O
in	O
the	O
infant	O
'	O
s	O
BAL	O
fluid	O
were	O
indeed	O
bacteria	O
,	O
Simonsiella	B-bacteria
sp	I-bacteria
.	O

Simonsiella	B-bacteria
has	O
reportedly	O
been	O
found	O
in	O
up	O
to	O
32	O
%	O
of	O
oral	O
swabs	O
in	O
normal	O
humans	O
and	O
it	O
is	O
considered	O
a	O
commensal	O
and	O
non	O
-	O
pathogenic	O
organism	O
.	O

The	O
characteristically	O
large	O
size	O
,	O
the	O
association	O
with	O
normal	O
oral	O
-	O
derived	O
squamous	O
cells	O
and	O
the	O
striated	O
appearance	O
is	O
diagnostic	O
and	O
will	O
hopefully	O
eliminate	O
any	O
possibility	O
of	O
confusion	O
with	O
a	O
truly	O
pathogenic	O
organism	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
assess	O
gingival	O
fluid	O
(	O
GCF	O
)	O
cytokine	O
messenger	O
RNA	O
(	O
mRNA	O
)	O
levels	O
,	O
subgingival	O
bacteria	O
,	O
and	O
clinical	O
periodontal	O
conditions	O
during	O
a	O
normal	O
pregnancy	O
to	O
postpartum	O
.	O

Subgingival	O
bacterial	O
samples	O
were	O
analyzed	O
with	O
the	O
checkerboard	O
DNA	O
-	O
DNA	O
hybridization	O
method	O
.	O

GCF	O
samples	O
were	O
assessed	O
with	O
real	O
-	O
time	O
PCR	O
including	O
five	O
proinflammatory	O
cytokines	O
and	O
secretory	O
leukocyte	O
protease	O
inhibitor	O
.	O

Nineteen	O
pregnant	O
women	O
with	O
a	O
mean	O
age	O
of	O
32	O
years	O
(	O
S	O
.	O
D	O
.	O
+	O
/	O
-	O
4	O
years	O
,	O
range	O
26	O
-	O
42	O
)	O
participated	O
in	O
the	O
study	O
.	O

Full	O
-	O
mouth	O
bleeding	O
scores	O
(	O
BOP	O
)	O
decreased	O
from	O
an	O
average	O
of	O
41	O
.	O
2	O
%	O
(	O
S	O
.	O
D	O
.	O

+	O
/	O
-	O
18	O
.	O
6	O
%	O
)	O
at	O
the	O
12th	O
week	O
of	O
pregnancy	O
to	O
26	O
.	O
6	O
%	O
(	O
S	O
.	O
D	O
.	O

+	O
/	O
-	O
14	O
.	O
4	O
%	O
)	O
at	O
the	O
4	O
-	O
6	O
weeks	O
postpartum	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Between	O
week	O
12	O
and	O
4	O
-	O
6	O
weeks	O
postpartum	O
,	O
the	O
mean	O
probing	O
pocket	O
depth	O
changed	O
from	O
2	O
.	O
4	O
mm	O
(	O
S	O
.	O
D	O
.	O

+	O
/	O
-	O
0	O
.	O
4	O
)	O
to	O
2	O
.	O
3	O
mm	O
(	O
S	O
.	O
D	O
.	O

+	O
/	O
-	O
0	O
.	O
3	O
)	O
(	O
p	O
=	O
0	O
.	O
34	O
)	O
.	O

Higher	O
counts	O
of	O
Eubacterium	B-bacteria
saburreum	I-bacteria
,	O
Parvimonas	B-bacteria
micra	I-bacteria
,	O
Selenomonas	B-bacteria
noxia	I-bacteria
,	O
and	O
Staphylococcus	B-bacteria
aureus	I-bacteria
were	O
found	O
at	O
week	O
12	O
of	O
pregnancy	O
than	O
at	O
the	O
4	O
-	O
6	O
weeks	O
postpartum	O
examinations	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

During	O
and	O
after	O
pregnancy	O
,	O
statistically	O
significant	O
correlations	O
between	O
BOP	O
scores	O
and	O
bacterial	O
counts	O
were	O
observed	O
.	O

BOP	O
scores	O
and	O
GCF	O
levels	O
of	O
selected	O
cytokines	O
were	O
not	O
related	O
to	O
each	O
other	O
and	O
no	O
differences	O
in	O
GCF	O
levels	O
of	O
the	O
cytokines	O
were	O
observed	O
between	O
samples	O
from	O
the	O
12th	O
week	O
of	O
pregnancy	O
to	O
4	O
-	O
6	O
weeks	O
postpartum	O
.	O

Decreasing	O
postpartum	O
counts	O
of	O
Porphyromonas	B-bacteria
endodontalis	I-bacteria
and	O
Pseudomonas	B-bacteria
aeruginosa	I-bacteria
were	O
associated	O
with	O
decreasing	O
levels	O
of	O
Il	O
-	O
8	O
and	O
Il	O
-	O
1beta	O
.	O

BOP	O
decreased	O
after	O
pregnancy	O
without	O
any	O
active	O
periodontal	O
therapy	O
.	O

Associations	O
between	O
bacterial	O
counts	O
and	O
cytokine	O
levels	O
varied	O
greatly	O
in	O
pregnant	O
women	O
with	O
gingivitis	O
and	O
a	O
normal	O
pregnancy	O
outcome	O
.	O

Postpartum	O
associations	O
between	O
GCF	O
cytokines	O
and	O
bacterial	O
counts	O
were	O
more	O
consistent	O
.	O

Combined	O
assessments	O
of	O
gingival	O
fluid	O
cytokines	O
and	O
subgingival	O
bacteria	O
may	O
provide	O
important	O
information	O
on	O
host	O
response	O
.	O

Oral	O
bacterial	O
biofilms	O
trigger	O
chronic	O
inflammatory	O
responses	O
in	O
the	O
host	O
that	O
can	O
result	O
in	O
the	O
tissue	O
destructive	O
events	O
of	O
periodontitis	O
.	O

However	O
,	O
the	O
characteristics	O
of	O
the	O
capacity	O
of	O
specific	O
host	O
cell	O
types	O
to	O
respond	O
to	O
these	O
biofilms	O
remain	O
ill	O
-	O
defined	O
.	O

This	O
report	O
describes	O
the	O
use	O
of	O
a	O
novel	O
model	O
of	O
bacterial	O
biofilms	O
to	O
stimulate	O
oral	O
epithelial	O
cells	O
and	O
profile	O
select	O
cytokines	O
and	O
chemokines	O
that	O
contribute	O
to	O
the	O
local	O
inflammatory	O
environment	O
in	O
the	O
periodontium	O
.	O

Monoinfection	O
biofilms	O
were	O
developed	O
with	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
,	O
Streptococcus	B-bacteria
oralis	I-bacteria
,	O
Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
,	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
,	O
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
on	O
rigid	O
gas	O
-	O
permeable	O
contact	O
lenses	O
.	O

Biofilms	O
,	O
as	O
well	O
as	O
planktonic	O
cultures	O
of	O
these	O
same	O
bacterial	O
species	O
,	O
were	O
incubated	O
under	O
anaerobic	O
conditions	O
with	O
a	O
human	O
oral	O
epithelial	O
cell	O
line	O
,	O
OKF4	O
,	O
for	O
up	O
to	O
24h	O
.	O

Gro	O
-	O
1alpha	O
,	O
IL1alpha	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
TGFalpha	O
,	O
Fractalkine	O
,	O
MIP	O
-	O
1alpha	O
,	O
and	O
IP	O
-	O
10	O
were	O
shown	O
to	O
be	O
produced	O
in	O
response	O
to	O
a	O
range	O
of	O
the	O
planktonic	O
or	O
biofilm	O
forms	O
of	O
these	O
species	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
biofilms	O
significantly	O
inhibited	O
the	O
production	O
of	O
all	O
of	O
these	O
cytokines	O
and	O
chemokines	O
,	O
except	O
MIP	O
-	O
1alpha	O
.	O

Generally	O
,	O
the	O
biofilms	O
of	O
all	O
species	O
inhibited	O
Gro	O
-	O
1alpha	O
,	O
TGFalpha	O
,	O
and	O
Fractalkine	O
production	O
,	O
while	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
biofilms	O
stimulated	O
significant	O
increases	O
in	O
IL	O
-	O
1alpha	O
,	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
,	O
and	O
IP	O
-	O
10	O
.	O

A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
biofilms	O
induced	O
elevated	O
levels	O
of	O
IL	O
-	O
6	O
,	O
IL	O
-	O
8	O
and	O
IP	O
-	O
10	O
.	O

The	O
oral	O
streptococcal	B-bacteria
species	I-bacteria
in	O
biofilms	O
or	O
planktonic	O
forms	O
were	O
poor	O
stimulants	O
for	O
any	O
of	O
these	O
mediators	O
from	O
the	O
epithelial	O
cells	O
.	O

The	O
results	O
of	O
these	O
studies	O
demonstrate	O
that	O
oral	O
bacteria	O
in	O
biofilms	O
elicit	O
a	O
substantially	O
different	O
profile	O
of	O
responses	O
compared	O
to	O
planktonic	O
bacteria	O
of	O
the	O
same	O
species	O
.	O

Moreover	O
,	O
certain	O
oral	O
species	O
are	O
highly	O
stimulatory	O
when	O
in	O
biofilms	O
and	O
interact	O
with	O
host	O
cell	O
receptors	O
to	O
trigger	O
pathways	O
of	O
responses	O
that	O
appear	O
quite	O
divergent	O
from	O
individual	O
bacteria	O
.	O

Oral	O
candidiasis	O
is	O
often	O
accompanied	O
by	O
severe	O
inflammation	O
,	O
resulting	O
in	O
a	O
decline	O
in	O
the	O
quality	O
of	O
life	O
of	O
immunosuppressed	O
individuals	O
and	O
elderly	O
people	O
.	O

To	O
develop	O
a	O
new	O
oral	O
therapeutic	O
option	O
for	O
candidiasis	O
,	O
a	O
nonpathogenic	O
commensal	O
oral	O
probiotic	O
microorganism	O
,	O
Streptococcus	B-bacteria
salivarius	I-bacteria
K12	I-bacteria
,	O
was	O
evaluated	O
for	O
its	O
ability	O
to	O
modulate	O
Candida	O
albicans	O
growth	O
in	O
vitro	O
,	O
and	O
its	O
therapeutic	O
activity	O
in	O
an	O
experimental	O
oral	O
candidiasis	O
model	O
was	O
tested	O
.	O

In	O
vitro	O
inhibition	O
of	O
mycelial	O
growth	O
of	O
C	O
.	O
albicans	O
was	O
determined	O
by	O
plate	O
assay	O
and	O
fluorescence	O
microscopy	O
.	O

Addition	O
of	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
to	O
modified	O
RPMI	O
1640	O
culture	O
medium	O
inhibited	O
the	O
adherence	O
of	O
C	O
.	O
albicans	O
to	O
the	O
plastic	O
petri	O
dish	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

Preculture	O
of	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
potentiated	O
its	O
inhibitory	O
activity	O
for	O
adherence	O
of	O
C	O
.	O
albicans	O
.	O

Interestingly	O
,	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
was	O
not	O
directly	O
fungicidal	O
but	O
appeared	O
to	O
inhibit	O
Candida	O
adhesion	O
to	O
the	O
substratum	O
by	O
preferentially	O
binding	O
to	O
hyphae	O
rather	O
than	O
yeast	O
.	O

To	O
determine	O
the	O
potentially	O
anti	O
-	O
infective	O
attributes	O
of	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
in	O
oral	O
candidiasis	O
,	O
the	O
probiotic	O
was	O
administered	O
to	O
mice	O
with	O
orally	O
induced	O
candidiasis	O
.	O

Oral	O
treatment	O
with	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
significantly	O
protected	O
the	O
mice	O
from	O
severe	O
candidiasis	O
.	O

These	O
findings	O
suggest	O
that	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
may	O
inhibit	O
the	O
process	O
of	O
invasion	O
of	O
C	O
.	O
albicans	O
into	O
mucous	O
surfaces	O
or	O
its	O
adhesion	O
to	O
denture	O
acrylic	O
resins	O
by	O
mechanisms	O
not	O
associated	O
with	O
the	O
antimicrobial	O
activity	O
of	O
the	O
bacteriocin	O
.	O

S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
K12	I-bacteria
may	O
be	O
useful	O
as	O
a	O
probiotic	O
as	O
a	O
protective	O
tool	O
for	O
oral	O
care	O
,	O
especially	O
with	O
regard	O
to	O
candidiasis	O
.	O

A	O
total	O
of	O
three	O
intensive	O
care	O
units	O
(	O
ICU	O
)	O
at	O
a	O
German	O
university	O
hospital	O
were	O
involved	O
in	O
an	O
outbreak	O
of	O
Burkholderia	B-bacteria
cepacia	I-bacteria
complex	I-bacteria
(	O
Bcc	B-bacteria
)	O
.	O

Patients	O
with	O
microbiological	O
detection	O
of	O
Bcc	B-bacteria
were	O
evaluated	O
.	O

Products	O
used	O
for	O
mouth	O
hygiene	O
were	O
microbiologically	O
tested	O
.	O

The	O
clonal	O
identity	O
of	O
Bcc	B-bacteria
was	O
proven	O
by	O
pulse	O
-	O
field	O
gel	O
electrophoresis	O
(	O
PFGE	O
)	O
.	O

On	O
3	O
ICUs	O
12	O
cases	O
were	O
identified	O
whereby	O
the	O
first	O
detection	O
of	O
Bcc	B-bacteria
was	O
in	O
respiratory	O
specimens	O
of	O
11	O
patients	O
and	O
1	O
in	O
a	O
wound	O
swab	O
from	O
the	O
oral	O
cavity	O
.	O

Of	O
these	O
patients	O
six	O
developed	O
ventilator	O
-	O
associated	O
pneumonia	O
(	O
VAP	O
)	O
.	O

Investigations	O
revealed	O
that	O
five	O
different	O
batches	O
of	O
an	O
alcohol	O
-	O
free	O
mouthwash	O
containing	O
hexetidine	O
were	O
highly	O
contaminated	O
.	O

Isolates	O
of	O
Bcc	B-bacteria
from	O
patients	O
and	O
mouthwashes	O
were	O
genetically	O
indistinguishable	O
.	O

A	O
recall	O
of	O
the	O
product	O
was	O
initiated	O
.	O

After	O
elimination	O
of	O
the	O
product	O
from	O
the	O
ICUs	O
no	O
more	O
cases	O
were	O
identified	O
.	O

The	O
source	O
of	O
the	O
outbreak	O
was	O
an	O
intrinsically	O
contaminated	O
alcohol	O
-	O
free	O
mouthwash	O
.	O

Detection	O
of	O
Bcc	B-bacteria
in	O
specimens	O
from	O
ICU	O
patients	O
should	O
lead	O
to	O
further	O
investigations	O
.	O

Antiseptic	O
oral	O
care	O
products	O
are	O
recommended	O
for	O
reducing	O
the	O
risk	O
of	O
VAP	O
but	O
they	O
may	O
be	O
microbiologically	O
contaminated	O
and	O
,	O
in	O
consequence	O
,	O
increase	O
the	O
risk	O
.	O

The	O
safety	O
of	O
patient	O
care	O
products	O
should	O
be	O
increased	O
by	O
stricter	O
regulations	O
.	O

Dental	O
caries	O
and	O
pulpal	O
diseases	O
are	O
common	O
oral	O
bacterial	O
infectious	O
diseases	O
.	O

Controlling	O
and	O
reducing	O
the	O
causative	O
pathogens	O
,	O
such	O
as	O
Streptococcus	B-bacteria
mutans	I-bacteria
and	O
Enterococcus	B-bacteria
faecalis	I-bacteria
,	O
is	O
a	O
key	O
step	O
toward	O
prevention	O
and	O
treatment	O
of	O
the	O
two	O
diseases	O
.	O

Chrysophsin	O
-	O
1	O
is	O
a	O
cationic	O
antimicrobial	O
peptide	O
having	O
broad	O
-	O
spectrum	O
bactericidal	O
activity	O
against	O
both	O
Gram	O
-	O
positive	O
and	O
Gram	O
-	O
negative	O
bacteria	O
.	O

In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
antibacterial	O
activity	O
of	O
chrysophsin	O
-	O
1	O
against	O
several	O
oral	O
pathogens	O
and	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilms	O
and	O
performed	O
a	O
preliminary	O
study	O
of	O
the	O
antimicrobial	O
mechanism	O
.	O

Cytotoxic	O
activity	O
of	O
chrysophsin	O
-	O
1	O
against	O
human	O
gingival	O
fibroblasts	O
(	O
HGFs	O
)	O
was	O
investigated	O
.	O

Minimal	O
inhibitory	O
concentration	O
(	O
MIC	O
)	O
,	O
minimal	O
bactericidal	O
concentration	O
(	O
MBC	O
)	O
and	O
time	O
-	O
kill	O
assay	O
were	O
used	O
to	O
evaluate	O
the	O
killing	O
effect	O
of	O
chrysophsin	O
-	O
1	O
.	O

Scanning	O
electron	O
microscopy	O
(	O
SEM	O
)	O
was	O
used	O
to	O
analyze	O
morphological	O
and	O
membrane	O
change	O
in	O
oral	O
pathogens	O
.	O

Live	O
/	O
Dead	O
staining	O
,	O
in	O
conjunction	O
with	O
confocal	O
scanning	O
laser	O
microscopy	O
(	O
CSLM	O
)	O
,	O
was	O
used	O
to	O
observe	O
and	O
analyze	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilms	O
.	O

MIC	O
and	O
MBC	O
results	O
demonstrated	O
that	O
chrysophsin	O
-	O
1	O
had	O
different	O
antimicrobial	O
activities	O
against	O
the	O
tested	O
oral	O
microbes	O
.	O

Lysis	O
and	O
pore	O
formation	O
of	O
the	O
cytomembrane	O
were	O
observed	O
following	O
treatment	O
of	O
the	O
bacteria	O
with	O
chrysophsin	O
-	O
1	O
for	O
4h	O
or	O
24h	O
by	O
SEM	O
.	O

Furthermore	O
,	O
CLSM	O
images	O
showed	O
that	O
chrysophsin	O
-	O
1	O
remarkably	O
reduced	O
the	O
viability	O
of	O
cells	O
within	O
biofilms	O
and	O
had	O
a	O
significantly	O
lethal	O
effect	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
biofilms	O
.	O

Toxicity	O
studies	O
showed	O
that	O
chrysophsin	O
-	O
1	O
at	O
concentration	O
between	O
8	O
mug	O
/	O
ml	O
and	O
32	O
mug	O
/	O
ml	O
had	O
little	O
effect	O
on	O
viability	O
of	O
HGFs	O
in	O
5	O
min	O
.	O

Our	O
findings	O
suggest	O
that	O
chrysophsin	O
-	O
1	O
may	O
have	O
potential	O
clinical	O
applications	O
in	O
the	O
prevention	O
and	O
treatment	O
of	O
dental	O
caries	O
and	O
pulpal	O
diseases	O
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
is	O
a	O
Gram	O
-	O
negative	O
anaerobe	O
that	O
resides	O
exclusively	O
in	O
the	O
human	O
oral	O
cavity	O
.	O

Long	O
-	O
term	O
colonization	O
by	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
requires	O
the	O
bacteria	O
to	O
evade	O
host	O
immune	O
responses	O
while	O
adapting	O
to	O
the	O
changing	O
host	O
physiology	O
and	O
alterations	O
in	O
the	O
composition	O
of	O
the	O
oral	O
microflora	O
.	O

The	O
genetic	O
diversity	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
appears	O
to	O
reflect	O
the	O
variability	O
of	O
its	O
habitat	O
;	O
however	O
,	O
little	O
is	O
known	O
about	O
the	O
molecular	O
mechanisms	O
generating	O
this	O
diversity	O
.	O

Previously	O
,	O
our	O
research	O
group	O
established	O
that	O
chromosomal	O
DNA	O
transfer	O
occurs	O
between	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
strains	I-bacteria
.	O

In	O
this	O
study	O
,	O
we	O
examine	O
the	O
role	O
of	O
putative	O
DNA	O
transfer	O
genes	O
in	O
conjugation	O
and	O
transformation	O
and	O
demonstrate	O
that	O
natural	O
competence	O
mediated	O
by	O
comF	O
is	O
the	O
dominant	O
form	O
of	O
chromosomal	O
DNA	O
transfer	O
,	O
with	O
transfer	O
by	O
a	O
conjugation	O
-	O
like	O
mechanism	O
playing	O
a	O
minor	O
role	O
.	O

Our	O
results	O
reveal	O
that	O
natural	O
competence	O
mechanisms	O
are	O
present	O
in	O
multiple	O
strains	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
,	O
and	O
DNA	O
uptake	O
is	O
not	O
sensitive	O
to	O
DNA	O
source	O
or	O
modification	O
status	O
.	O

Furthermore	O
,	O
extracellular	O
DNA	O
was	O
observed	O
for	O
the	O
first	O
time	O
in	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
biofilms	O
and	O
is	O
predicted	O
to	O
be	O
the	O
major	O
DNA	O
source	O
for	O
horizontal	O
transfer	O
and	O
allelic	O
exchange	O
between	O
strains	O
.	O

We	O
propose	O
that	O
exchange	O
of	O
DNA	O
in	O
plaque	O
biofilms	O
by	O
a	O
transformation	O
-	O
like	O
process	O
is	O
of	O
major	O
ecological	O
importance	O
in	O
the	O
survival	O
and	O
persistence	O
of	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
in	O
the	O
challenging	O
oral	O
environment	O
.	O

:	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
colonizes	O
the	O
oral	O
cavities	O
of	O
humans	O
worldwide	O
.	O

The	O
long	O
-	O
term	O
persistence	O
of	O
these	O
bacteria	O
can	O
lead	O
to	O
the	O
development	O
of	O
chronic	O
periodontitis	O
and	O
host	O
morbidity	O
associated	O
with	O
tooth	O
loss	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
is	O
a	O
genetically	O
diverse	O
species	O
,	O
and	O
this	O
variability	O
is	O
believed	O
to	O
contribute	O
to	O
its	O
successful	O
colonization	O
and	O
survival	O
in	O
diverse	O
human	O
hosts	O
,	O
as	O
well	O
as	O
evasion	O
of	O
host	O
immune	O
defenses	O
and	O
immunization	O
strategies	O
.	O

We	O
establish	O
here	O
that	O
natural	O
competence	O
is	O
the	O
major	O
driving	O
force	O
behind	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
DNA	O
exchange	O
and	O
that	O
conjugative	O
DNA	O
transfer	O
plays	O
a	O
minor	O
role	O
.	O

Furthermore	O
,	O
we	O
reveal	O
for	O
the	O
first	O
time	O
the	O
presence	O
of	O
extracellular	O
DNA	O
in	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
biofilms	O
,	O
which	O
is	O
most	O
likely	O
the	O
source	O
of	O
DNA	O
exchanged	O
between	O
strains	O
within	O
dental	O
plaque	O
.	O

These	O
studies	O
expand	O
our	O
understanding	O
of	O
the	O
mechanisms	O
used	O
by	O
this	O
important	O
member	O
of	O
the	O
human	O
oral	O
flora	O
to	O
transition	O
its	O
relationship	O
with	O
the	O
host	O
from	O
a	O
commensal	O
to	O
a	O
pathogenic	O
relationship	O
.	O

The	O
ability	O
to	O
track	O
microbes	O
in	O
real	O
time	O
in	O
vivo	O
is	O
of	O
enormous	O
value	O
for	O
preclinical	O
investigations	O
in	O
infectious	O
disease	O
or	O
gene	O
therapy	O
research	O
.	O

Bacteria	O
present	O
an	O
attractive	O
class	O
of	O
vector	O
for	O
cancer	O
therapy	O
,	O
possessing	O
a	O
natural	O
ability	O
to	O
grow	O
preferentially	O
within	O
tumours	O
following	O
systemic	O
administration	O
.	O

Bioluminescent	O
Imaging	O
(	O
BLI	O
)	O
represents	O
a	O
powerful	O
tool	O
for	O
use	O
with	O
bacteria	O
engineered	O
to	O
express	O
reporter	O
genes	O
such	O
as	O
lux	O
.	O

BLI	O
is	O
traditionally	O
used	O
as	O
a	O
2D	O
modality	O
resulting	O
in	O
images	O
that	O
are	O
limited	O
in	O
their	O
ability	O
to	O
anatomically	O
locate	O
cell	O
populations	O
.	O

Use	O
of	O
3D	O
diffuse	O
optical	O
tomography	O
can	O
localize	O
the	O
signals	O
but	O
still	O
need	O
to	O
be	O
combined	O
with	O
an	O
anatomical	O
imaging	O
modality	O
like	O
micro	O
-	O
Computed	O
Tomography	O
(	O
muCT	O
)	O
for	O
interpretation	O
.	O
In	O
this	O
study	O
,	O
the	O
non	O
-	O
pathogenic	O
commensal	O
bacteria	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
K	I-bacteria
-	I-bacteria
12	I-bacteria
MG1655	I-bacteria
and	O
Bifidobacterium	B-bacteria
breve	I-bacteria
UCC2003	I-bacteria
,	O
or	O
Salmonella	B-bacteria
Typhimurium	I-bacteria
SL7207	I-bacteria
each	O
expressing	O
the	O
luxABCDE	O
operon	O
were	O
intravenously	O
(	O
i	O
.	O
v	O
.	O
)	O
administered	O
to	O
mice	O
bearing	O
subcutaneous	O
(	O
s	O
.	O
c	O
)	O
FLuc	O
-	O
expressing	O
xenograft	O
tumours	O
.	O

Bacterial	O
lux	O
signal	O
was	O
detected	O
specifically	O
in	O
tumours	O
of	O
mice	O
post	O
i	O
.	O
v	O
.	O
-	O
administration	O
and	O
bioluminescence	O
correlated	O
with	O
the	O
numbers	O
of	O
bacteria	O
recovered	O
from	O
tissue	O
.	O

Through	O
whole	O
body	O
imaging	O
for	O
both	O
lux	O
and	O
FLuc	O
,	O
bacteria	O
and	O
tumour	O
cells	O
were	O
co	O
-	O
localised	O
.	O

3D	O
BLI	O
and	O
muCT	O
image	O
analysis	O
revealed	O
a	O
pattern	O
of	O
multiple	O
clusters	O
of	O
bacteria	O
within	O
tumours	O
.	O

Investigation	O
of	O
spatial	O
resolution	O
of	O
3D	O
optical	O
imaging	O
was	O
supported	O
by	O
ex	O
vivo	O
histological	O
analyses	O
.	O

In	O
vivo	O
imaging	O
of	O
orally	O
-	O
administered	O
commensal	O
bacteria	O
in	O
the	O
gastrointestinal	O
tract	O
(	O
GIT	O
)	O
was	O
also	O
achieved	O
using	O
3D	O
BLI	O
.	O

This	O
study	O
demonstrates	O
for	O
the	O
first	O
time	O
the	O
potential	O
to	O
simultaneously	O
image	O
multiple	O
BLI	O
reporter	O
genes	O
three	O
dimensionally	O
in	O
vivo	O
using	O
approaches	O
that	O
provide	O
unique	O
information	O
on	O
spatial	O
locations	O
.	O

Contaminated	O
hands	O
play	O
a	O
major	O
role	O
in	O
fecal	O
-	O
oral	O
transmission	O
of	O
diseases	O
.	O

In	O
1847	O
,	O
Dr	O
Semmelweis	O
Ignac	O
pointed	O
to	O
the	O
link	O
between	O
infection	O
and	O
unclean	O
hands	O
,	O
and	O
demonstrated	O
that	O
washing	O
hands	O
could	O
reduce	O
transmission	O
of	O
puerperal	O
fever	O
(	O
child	O
birth	O
fever	O
)	O
,	O
a	O
dreaded	O
disease	O
with	O
high	O
mortality	O
in	O
those	O
days	O
.	O

A	O
cross	O
-	O
sectional	O
study	O
was	O
conducted	O
to	O
find	O
out	O
the	O
extent	O
of	O
germs	O
present	O
in	O
hand	O
,	O
and	O
also	O
the	O
students	O
'	O
perception	O
on	O
hand	O
washing	O
.	O

This	O
was	O
assessed	O
by	O
questionnaire	O
as	O
well	O
as	O
by	O
collection	O
of	O
swab	O
from	O
hand	O
and	O
performing	O
bacteriological	O
culture	O
in	O
the	O
laboratory	O
.	O

In	O
regard	O
to	O
students	O
'	O
perception	O
about	O
the	O
dirty	O
areas	O
of	O
the	O
hands	O
,	O
it	O
was	O
observed	O
that	O
majority	O
(	O
78	O
%	O
)	O
felt	O
palm	O
was	O
likely	O
to	O
be	O
more	O
dirty	O
while	O
less	O
than	O
70	O
%	O
felt	O
that	O
web	O
spaces	O
could	O
harbor	O
dirt	O
.	O

Almost	O
86	O
%	O
reported	O
that	O
they	O
washed	O
hands	O
before	O
eating	O
lunch	O
,	O
but	O
only	O
21	O
.	O
3	O
%	O
said	O
they	O
always	O
used	O
soap	O
while	O
47	O
.	O
3	O
%	O
never	O
used	O
it	O
.	O

Availability	O
of	O
soap	O
all	O
the	O
time	O
in	O
the	O
school	O
was	O
reported	O
by	O
only	O
18	O
.	O
4	O
%	O
students	O
.	O

The	O
swabs	O
of	O
61	O
%	O
children	O
showed	O
potential	O
pathogens	O
.	O

The	O
commonest	O
of	O
these	O
was	O
Staphylococcus	B-bacteria
aureus	I-bacteria
which	O
was	O
seen	O
in	O
44	O
%	O
samples	O
.	O

The	O
students	O
'	O
hands	O
were	O
contaminated	O
before	O
taking	O
food	O
.	O

Although	O
they	O
washed	O
hands	O
before	O
meals	O
,	O
they	O
hardly	O
used	O
soap	O
due	O
to	O
non	O
-	O
availability	O
of	O
soap	O
.	O

The	O
school	O
authority	O
should	O
be	O
asked	O
to	O
keep	O
soaps	O
in	O
the	O
toilets	O
for	O
hand	O
washing	O
.	O

Previous	O
studies	O
demonstrated	O
that	O
a	O
cranberry	O
high	O
-	O
molecular	O
-	O
mass	O
,	O
nondialyzable	O
material	O
(	O
NDM	O
)	O
can	O
inhibit	O
adhesion	O
of	O
numerous	O
species	O
of	O
bacteria	O
and	O
prevents	O
bacterial	O
coaggregation	O
of	O
bacterial	O
pairs	O
.	O

Bacterial	O
coaggregation	O
leads	O
to	O
plaque	O
formation	O
leading	O
to	O
biofilm	O
development	O
on	O
surfaces	O
of	O
oral	O
cavity	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
evaluated	O
the	O
effect	O
of	O
low	O
concentrations	O
of	O
NDM	O
on	O
Streptococcus	B-bacteria
gordonii	I-bacteria
metabolic	O
activity	O
and	O
biofilm	O
formation	O
on	O
restorative	O
dental	O
surfaces	O
.	O

We	O
found	O
that	O
the	O
NDM	O
selectively	O
inhibited	O
metabolic	O
activity	O
of	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
,	O
without	O
affecting	O
bacterial	O
viability	O
.	O

Inhibiting	O
the	O
metabolic	O
activity	O
of	O
bacteria	O
in	O
biofilm	O
may	O
benefit	O
the	O
health	O
of	O
the	O
oral	O
cavity	O
.	O

To	O
investigate	O
whether	O
a	O
standard	O
dental	O
prophylaxis	O
followed	O
by	O
tooth	O
brushing	O
with	O
an	O
antibacterial	O
dentifrice	O
will	O
affect	O
the	O
oral	O
bacterial	O
community	O
,	O
as	O
determined	O
by	O
denaturing	O
gradient	O
gel	O
electrophoresis	O
(	O
DGGE	O
)	O
combined	O
with	O
16S	O
rRNA	O
gene	O
sequence	O
analysis	O
.	O

Twenty	O
-	O
four	O
healthy	O
adults	O
were	O
instructed	O
to	O
brush	O
their	O
teeth	O
using	O
commercial	O
dentifrice	O
for	O
1	O
week	O
during	O
a	O
washout	O
period	O
.	O

An	O
initial	O
set	O
of	O
pooled	O
supragingival	O
plaque	O
samples	O
was	O
collected	O
from	O
each	O
participant	O
at	O
baseline	O
(	O
0	O
h	O
)	O
before	O
prophylaxis	O
treatment	O
.	O

The	O
subjects	O
were	O
given	O
a	O
clinical	O
examination	O
and	O
dental	O
prophylaxis	O
and	O
asked	O
to	O
brush	O
for	O
1	O
min	O
with	O
a	O
dentifrice	O
containing	O
0	O
.	O
3	O
%	O
triclosan	O
,	O
2	O
.	O
0	O
%	O
PVM	O
/	O
MA	O
copolymer	O
and	O
0	O
.	O
243	O
%	O
sodium	O
fluoride	O
(	O
Colgate	O
Total	O
)	O
.	O

On	O
the	O
following	O
day	O
,	O
a	O
second	O
set	O
of	O
pooled	O
supragingival	O
plaque	O
samples	O
(	O
24	O
h	O
)	O
was	O
collected	O
.	O

Total	O
bacterial	O
genomic	O
DNA	O
was	O
isolated	O
from	O
the	O
samples	O
.	O

Differences	O
in	O
the	O
microbial	O
composition	O
before	O
and	O
after	O
the	O
prophylactic	O
procedure	O
and	O
tooth	O
brushing	O
were	O
assessed	O
by	O
comparing	O
the	O
DGGE	O
profiles	O
and	O
16S	O
rRNA	O
gene	O
segments	O
sequence	O
analysis	O
.	O

Two	O
distinct	O
clusters	O
of	O
DGGE	O
profiles	O
were	O
found	O
,	O
suggesting	O
that	O
a	O
shift	O
in	O
the	O
microbial	O
composition	O
had	O
occurred	O
24	O
h	O
after	O
the	O
prophylaxis	O
and	O
brushing	O
.	O

A	O
detailed	O
sequencing	O
analysis	O
of	O
16S	O
rRNA	O
gene	O
segments	O
further	O
identified	O
6	O
phyla	O
and	O
29	O
genera	O
,	O
including	O
known	O
and	O
unknown	O
bacterial	O
species	O
.	O

Importantly	O
,	O
an	O
increase	O
in	O
bacterial	O
diversity	O
was	O
observed	O
after	O
24	O
h	O
,	O
including	O
members	O
of	O
the	O
Streptococcaceae	B-bacteria
family	I-bacteria
,	O
Prevotella	B-bacteria
,	O
Corynebacterium	B-bacteria
,	O
TM7	B-bacteria
and	O
other	O
commensal	O
bacteria	O
.	O

The	O
results	O
suggest	O
that	O
the	O
use	O
of	O
a	O
standard	O
prophylaxis	O
followed	O
by	O
the	O
use	O
of	O
the	O
dentifrice	O
containing	O
0	O
.	O
3	O
%	O
triclosan	O
,	O
2	O
.	O
0	O
%	O
PVM	O
/	O
MA	O
copolymer	O
and	O
0	O
.	O
243	O
%	O
sodium	O
fluoride	O
may	O
promote	O
a	O
healthier	O
composition	O
within	O
the	O
oral	O
bacterial	O
community	O
.	O

To	O
investigate	O
the	O
effects	O
of	O
chlorhexidine	O
(	O
CHX	O
)	O
,	O
Listerine	O
and	O
Fluoride	O
Listerine	O
on	O
putative	O
root	O
-	O
caries	O
pathogens	O
in	O
the	O
biofilm	O
in	O
the	O
artificial	O
mouth	O
model	O
.	O

A	O
total	O
of	O
24	O
human	O
dentine	O
discs	O
were	O
prepared	O
.	O

A	O
biofilm	O
composed	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
,	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
and	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
was	O
cultured	O
on	O
the	O
surfaces	O
of	O
human	O
dentine	O
discs	O
in	O
an	O
artificial	O
-	O
mouth	O
model	O
.	O

Sucrose	O
was	O
supplied	O
by	O
computer	O
-	O
controlled	O
release	O
on	O
a	O
daily	O
basis	O
to	O
simulate	O
the	O
real	O
-	O
life	O
situation	O
.	O

Three	O
treatment	O
reagents	O
,	O
CHX	O
,	O
Listerine	O
and	O
Fluoride	O
Listerine	O
,	O
were	O
supplied	O
at	O
a	O
flow	O
rate	O
of	O
15	O
ml	O
/	O
h	O
for	O
6	O
min	O
twice	O
a	O
day	O
.	O

The	O
dentine	O
discs	O
with	O
biofilm	O
were	O
removed	O
from	O
the	O
artificial	O
mouth	O
after	O
being	O
cultured	O
for	O
1	O
,	O
2	O
,	O
3	O
,	O
4	O
,	O
5	O
and	O
6	O
days	O
.	O

The	O
bacteria	O
in	O
the	O
biofilm	O
were	O
analysed	O
by	O
plating	O
on	O
BHIS	O
agar	O
and	O
the	O
colony	O
-	O
forming	O
units	O
of	O
each	O
species	O
were	O
counted	O
.	O

The	O
total	O
number	O
of	O
bacteria	O
in	O
the	O
CHX	O
group	O
was	O
significantly	O
lower	O
than	O
in	O
the	O
other	O
three	O
groups	O
(	O
including	O
control	O
)	O
.	O

There	O
was	O
no	O
decline	O
in	O
the	O
number	O
of	O
bacteria	O
in	O
the	O
Listerine	O
group	O
.	O

S	B-bacteria
.	I-bacteria
mutans	I-bacteria
was	O
reduced	O
significantly	O
in	O
the	O
CHX	O
group	O
compared	O
with	O
the	O
control	O
group	O
.	O

The	O
number	O
and	O
proportion	O
of	O
A	B-bacteria
.	I-bacteria
naeslundii	I-bacteria
in	O
the	O
CHX	O
group	O
were	O
significantly	O
lower	O
than	O
in	O
the	O
other	O
three	O
groups	O
.	O

The	O
proportion	O
of	O
L	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
in	O
the	O
CHX	O
group	O
was	O
significantly	O
higher	O
than	O
in	O
the	O
other	O
three	O
groups	O
.	O

CHX	O
has	O
the	O
most	O
significant	O
effect	O
on	O
inhibition	O
of	O
the	O
putative	O
root	O
-	O
caries	O
bacteria	O
,	O
with	O
the	O
exception	O
of	O
L	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
.	O

Both	O
Listerine	O
and	O
a	O
combination	O
of	O
fluoride	O
and	O
Listerine	O
could	O
not	O
effectively	O
reduce	O
the	O
numbers	O
of	O
bacteria	O
in	O
the	O
biofilm	O
.	O

The	O
effects	O
of	O
CHX	O
,	O
Listerine	O
and	O
Fluoride	O
Listerine	O
on	O
root	O
caries	O
prevention	O
need	O
further	O
investigation	O
.	O

A	O
randomized	O
clinical	O
trial	O
studied	O
the	O
effects	O
of	O
early	O
administration	O
of	O
Bifidobacterium	B-bacteria
animalis	I-bacteria
subsp	I-bacteria
.	I-bacteria
lactis	I-bacteria
BB	I-bacteria
-	I-bacteria
12	I-bacteria
(	O
BB	B-bacteria
-	I-bacteria
12	I-bacteria
)	O
on	O
oral	O
colonization	O
of	O
(	O
1	O
)	O
mutans	B-bacteria
streptococci	I-bacteria
(	O
MS	B-bacteria
)	O
,	O
and	O
(	O
2	O
)	O
BB	B-bacteria
-	I-bacteria
12	I-bacteria
.	O

In	O
this	O
double	O
-	O
blind	O
,	O
placebo	O
-	O
controlled	O
study	O
,	O
infants	O
(	O
n	O
=	O
106	O
)	O
received	O
probiotic	O
bacteria	O
(	O
BB	B-bacteria
-	I-bacteria
12	I-bacteria
group	O
)	O
,	O
xylitol	O
(	O
X	O
group	O
)	O
,	O
or	O
sorbitol	O
(	O
S	O
group	O
)	O
.	O

Test	O
tablets	O
were	O
administered	O
twice	O
a	O
day	O
(	O
from	O
the	O
age	O
of	O
1	O
-	O
2	O
months	O
)	O
with	O
a	O
novel	O
slow	O
-	O
release	O
pacifier	O
or	O
a	O
spoon	O
(	O
daily	O
dose	O
of	O
BB	B-bacteria
-	I-bacteria
12	I-bacteria
10	O
(	O
10	O
)	O
CFU	O
,	O
polyol	O
200	O
-	O
600	O
mg	O
)	O
.	O

Samples	O
were	O
collected	O
from	O
mucosa	O
/	O
teeth	O
at	O
the	O
age	O
of	O
8	O
months	O
and	O
2	O
years	O
for	O
BB	O
-	O
12	O
determination	O
(	O
qPCR	O
)	O
and	O
plate	O
culturing	O
of	O
MS	B-bacteria
(	O
MSB	B-bacteria
,	O
TYCSB	B-bacteria
)	O
,	O
lactobacilli	B-bacteria
(	O
Rogosa	B-bacteria
)	O
and	O
yeasts	O
(	O
Sabouraud	O
)	O
.	O

The	O
MS	B-bacteria
levels	O
of	O
the	O
mothers	O
were	O
determined	O
(	O
Dentocult	O
SM	O
Strip	O
Mutans	O
)	O
.	O

The	O
baseline	O
characteristics	O
of	O
the	O
three	O
groups	O
were	O
similar	O
.	O

Mean	O
duration	O
of	O
tablet	O
delivery	O
was	O
14	O
.	O
9	O
+	O
/	O
-	O
6	O
.	O
7	O
months	O
.	O

In	O
all	O
groups	O
,	O
>	O
90	O
%	O
of	O
the	O
mothers	O
showed	O
high	O
MS	B-bacteria
counts	O
(	O
log	O
CFU	O
>	O
/	O
=	O
5	O
)	O
.	O

MS	B-bacteria
colonization	O
percentages	O
of	O
the	O
children	O
at	O
the	O
age	O
of	O
2	O
years	O
were	O
rather	O
low	O
(	O
BB	B-bacteria
-	I-bacteria
12	I-bacteria
group	O
:	O
6	O
%	O
;	O
X	O
group	O
:	O
31	O
%	O
;	O
S	O
group	O
:	O
10	O
%	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
levels	O
of	O
lactobacilli	B-bacteria
and	O
yeasts	O
did	O
not	O
differ	O
between	O
the	O
groups	O
.	O

BB	B-bacteria
-	I-bacteria
12	I-bacteria
cell	O
counts	O
barely	O
exceeding	O
the	O
detection	O
limit	O
were	O
found	O
in	O
three	O
of	O
the	O
oral	O
samples	O
of	O
the	O
8	O
-	O
month	O
-	O
old	O
children	O
;	O
however	O
,	O
the	O
2	O
-	O
year	O
samples	O
did	O
not	O
contain	O
BB	B-bacteria
-	I-bacteria
12	I-bacteria
.	O

The	O
early	O
administration	O
of	O
BB	B-bacteria
-	I-bacteria
12	I-bacteria
did	O
not	O
result	O
in	O
permanent	O
oral	O
colonization	O
of	O
this	O
probiotic	O
or	O
significantly	O
affect	O
MS	B-bacteria
colonization	O
in	O
the	O
children	O
.	O

In	O
this	O
protocol	O
,	O
we	O
describe	O
the	O
application	O
of	O
commercially	O
available	O
three	O
-	O
dimensional	O
organotypic	O
tissues	O
of	O
human	O
oral	O
mucosa	O
to	O
study	O
the	O
interaction	O
between	O
Candida	O
albicans	O
and	O
epithelial	O
cells	O
.	O

Infection	O
experiments	O
show	O
high	O
reproducibility	O
and	O
can	O
be	O
used	O
to	O
analyse	O
directly	O
pathogen	O
/	O
epithelial	O
cell	O
interactions	O
.	O

However	O
,	O
the	O
system	O
is	O
also	O
very	O
flexible	O
.	O

Using	O
histological	O
,	O
biochemical	O
,	O
immunological	O
,	O
and	O
molecular	O
methods	O
,	O
it	O
is	O
possible	O
to	O
analyse	O
several	O
stages	O
of	O
infection	O
by	O
C	O
.	O
albicans	O
wild	O
type	O
or	O
mutant	O
strains	O
and	O
demonstrate	O
the	O
consequence	O
of	O
disrupting	O
genes	O
encoding	O
putative	O
virulence	O
factors	O
required	O
for	O
host	O
cell	O
invasion	O
and	O
immune	O
defence	O
induction	O
.	O

This	O
model	O
provides	O
information	O
about	O
host	O
and	O
pathogen	O
protein	O
and	O
gene	O
expression	O
during	O
direct	O
interactions	O
with	O
each	O
other	O
.	O

It	O
can	O
additionally	O
be	O
supplemented	O
with	O
other	O
host	O
factors	O
,	O
such	O
as	O
immune	O
cells	O
,	O
saliva	O
,	O
and	O
probiotic	O
bacteria	O
,	O
which	O
are	O
relevant	O
for	O
host	O
immune	O
defence	O
in	O
the	O
oral	O
cavity	O
.	O

Granulicatella	B-bacteria
species	I-bacteria
are	O
facultative	O
anaerobic	O
,	O
catalase	O
-	O
negative	O
Gram	O
-	O
positive	O
cocci	O
,	O
oral	O
microbiome	O
researches	O
find	O
out	O
Granulicatella	B-bacteria
species	I-bacteria
are	O
dominant	O
bacteria	O
in	O
oral	O
cavity	O
which	O
may	O
cause	O
opportunistic	O
infection	O
like	O
periodontal	O
disease	O
,	O
endodontic	O
infection	O
.	O

This	O
review	O
summarized	O
research	O
progress	O
of	O
Granulicatella	B-bacteria
species	I-bacteria
.	O

The	O
development	O
of	O
multispecies	O
biofilm	O
models	O
are	O
needed	O
to	O
explain	O
the	O
interactions	O
that	O
take	O
place	O
in	O
root	O
canal	O
biofilms	O
during	O
apical	O
periodontitis	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
ability	O
of	O
4	O
root	O
canal	O
bacteria	O
to	O
establish	O
a	O
multispecies	O
biofilm	O
community	O
and	O
to	O
characterize	O
the	O
main	O
structural	O
,	O
compositional	O
,	O
and	O
physiological	O
features	O
of	O
this	O
community	O
.	O

Four	O
clinical	O
isolates	O
isolated	O
from	O
infected	O
root	O
canals	O
,	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
,	O
Lactobacillus	B-bacteria
salivarius	I-bacteria
,	O
Streptococcus	B-bacteria
gordonii	I-bacteria
,	O
and	O
Enterococcus	B-bacteria
faecalis	I-bacteria
,	O
were	O
grown	O
together	O
in	O
a	O
miniflow	O
cell	O
system	O
.	O

Simultaneous	O
detection	O
of	O
the	O
4	O
species	O
in	O
the	O
biofilm	O
communities	O
was	O
achieved	O
by	O
fluorescence	O
in	O
situ	O
hybridization	O
in	O
combination	O
with	O
confocal	O
microscopy	O
at	O
different	O
time	O
points	O
.	O

The	O
LIVE	O
/	O
DEAD	O
BacLight	O
technique	O
(	O
Molecular	O
Probes	O
,	O
Carlsbad	O
,	O
CA	O
)	O
was	O
used	O
to	O
assess	O
cell	O
viability	O
and	O
to	O
calculate	O
3	O
-	O
dimensional	O
architectural	O
parameters	O
such	O
as	O
biovolume	O
(	O
mum	O
(	O
3	O
)	O
)	O
.	O

Redox	O
fluorescence	O
dye	O
5	O
-	O
cyano	O
-	O
2	O
,	O
3	O
-	O
ditolyl	O
tetrazolium	O
chloride	O
was	O
used	O
to	O
assess	O
the	O
metabolic	O
activity	O
of	O
biofilm	O
bacteria	O
.	O

The	O
4	O
species	O
tested	O
were	O
able	O
to	O
form	O
stable	O
and	O
reproducible	O
biofilm	O
communities	O
.	O

The	O
biofilms	O
formed	O
in	O
rich	O
medium	O
generally	O
showed	O
continuous	O
growth	O
over	O
time	O
,	O
however	O
,	O
in	O
the	O
absence	O
of	O
glucose	O
biofilms	O
showed	O
significantly	O
smaller	O
biovolumes	O
.	O

A	O
high	O
proportion	O
of	O
viable	O
cells	O
(	O
>	O
90	O
%	O
)	O
were	O
generally	O
observed	O
,	O
and	O
biofilm	O
growth	O
was	O
correlated	O
with	O
high	O
metabolic	O
activity	O
of	O
cells	O
.	O

The	O
community	O
structure	O
of	O
biofilms	O
formed	O
in	O
rich	O
medium	O
did	O
not	O
change	O
considerably	O
over	O
the	O
120	O
-	O
hour	O
period	O
,	O
during	O
which	O
E	B-bacteria
.	I-bacteria
faecalis	I-bacteria
,	O
L	B-bacteria
.	I-bacteria
salivarius	I-bacteria
,	O
and	O
S	B-bacteria
.	I-bacteria
gordonii	I-bacteria
were	O
most	O
abundant	O
.	O

The	O
ability	O
of	O
4	O
root	O
canal	O
bacteria	O
to	O
form	O
multispecies	O
biofilm	O
communities	O
shown	O
in	O
this	O
study	O
give	O
insights	O
into	O
assessing	O
the	O
community	O
lifestyle	O
of	O
these	O
microorganisms	O
in	O
vivo	O
.	O

This	O
multispecies	O
model	O
could	O
be	O
useful	O
for	O
further	O
research	O
simulating	O
stresses	O
representative	O
of	O
in	O
vivo	O
conditions	O
.	O

Both	O
hydrogen	O
sulfide	O
(	O
H2S	O
)	O
and	O
methyl	O
mercaptan	O
(	O
CH	O
(	O
3	O
)	O
SH	O
)	O
are	O
frequently	O
detected	O
in	O
large	O
amounts	O
in	O
malodorous	O
mouth	O
air	O
.	O

We	O
investigated	O
the	O
bacterial	O
composition	O
of	O
saliva	O
of	O
30	O
subjects	O
with	O
severe	O
oral	O
malodor	O
exhibiting	O
extreme	O
CH	O
(	O
3	O
)	O
SH	O
/	O
H	O
(	O
2	O
)	O
S	O
ratios	O
(	O
high	O
H	O
(	O
2	O
)	O
S	O
but	O
low	O
CH	O
(	O
3	O
)	O
SH	O
concentrations	O
,	O
n	O
5	O
14	O
;	O
high	O
CH	O
(	O
3	O
)	O
SH	O
but	O
low	O
H2S	O
concentrations	O
,	O
n	O
5	O
16	O
)	O
and	O
13	O
subjects	O
without	O
malodor	O
,	O
using	O
barcoded	O
pyrosequencing	O
analysis	O
of	O
the	O
16S	O
rRNA	O
gene	O
.	O

Phylogenetic	O
community	O
analysis	O
with	O
the	O
UniFrac	O
distance	O
metric	O
revealed	O
a	O
distinct	O
bacterial	O
community	O
structure	O
in	O
each	O
malodor	O
group	O
.	O

The	O
H2S	O
group	O
showed	O
higher	O
proportions	O
of	O
the	O
genera	O
Neisseria	B-bacteria
,	O
Fusobacterium	B-bacteria
,	O
Porphyromonas	B-bacteria
and	O
SR1	B-bacteria
than	O
the	O
other	O
two	O
groups	O
,	O
whereas	O
the	O
CH	O
(	O
3	O
)	O
SH	O
group	O
had	O
higher	O
proportions	O
of	O
the	O
genera	O
Prevotella	B-bacteria
,	O
Veillonella	B-bacteria
,	O
Atopobium	B-bacteria
,	O
Megasphaera	B-bacteria
,	O
and	O
Selenomonas	B-bacteria
.	O

Our	O
results	O
suggested	O
that	O
distinct	O
bacterial	O
populations	O
in	O
the	O
oral	O
microbiota	O
are	O
involved	O
in	O
production	O
of	O
high	O
levels	O
of	O
H2S	O
and	O
CH3SH	O
in	O
the	O
oral	O
cavity	O
.	O

In	O
1986	O
,	O
oral	O
microbiology	O
,	O
and	O
especially	O
the	O
microbiology	O
of	O
periodontal	O
infections	O
,	O
was	O
of	O
central	O
importance	O
.	O

Interest	O
in	O
periodontology	O
was	O
growing	O
rapidly	O
and	O
with	O
it	O
,	O
interest	O
in	O
developments	O
in	O
microbiology	O
and	O
the	O
immunology	O
of	O
infectious	O
diseases	O
of	O
the	O
periodontium	O
.	O

At	O
national	O
and	O
international	O
meetings	O
discussions	O
took	O
place	O
concerning	O
the	O
role	O
of	O
the	O
newly	O
discovered	O
bacterial	O
species	O
Actinobacillus	B-bacteria
actinomycetemcomitans	I-bacteria
and	O
the	O
role	O
of	O
antibiotics	O
in	O
the	O
treatment	O
of	O
severe	O
periodontitis	O
.	O

Since	O
the	O
1980s	O
,	O
much	O
has	O
changed	O
in	O
periodontology	O
,	O
not	O
least	O
of	O
all	O
as	O
a	O
result	O
of	O
a	O
new	O
specialism	O
:	O
oral	O
implantology	O
.	O

With	O
it	O
,	O
a	O
new	O
disease	O
also	O
came	O
into	O
existence	O
:	O
peri	O
-	O
implantitis	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	O
the	O
dependence	O
of	O
the	O
condition	O
of	O
the	O
microflora	O
of	O
the	O
oral	O
cavity	O
on	O
the	O
etiology	O
of	O
xerostomia	O
,	O
patients	O
'	O
sex	O
,	O
age	O
,	O
degree	O
of	O
hyposalivation	O
,	O
and	O
duration	O
of	O
the	O
sense	O
of	O
dryness	O
.	O

A	O
total	O
of	O
64	O
patients	O
with	O
complaints	O
of	O
oral	O
dryness	O
referred	O
to	O
the	O
Clinic	O
of	O
Oral	O
and	O
Dental	O
Diseases	O
,	O
Hospital	O
of	O
Lithuanian	O
University	O
of	O
Health	O
Sciences	O
,	O
for	O
consultation	O
during	O
the	O
period	O
from	O
2003	O
to	O
2005	O
were	O
selected	O
for	O
the	O
study	O
.	O

The	O
etiological	O
factors	O
of	O
xerostomia	O
were	O
as	O
follows	O
:	O
radiotherapy	O
(	O
PRT	O
)	O
to	O
the	O
maxillofacial	O
area	O
,	O
Sjogren	O
'	O
s	O
syndrome	O
(	O
SS	O
)	O
,	O
and	O
xerogenic	O
medications	O
,	O
tricyclic	O
antidepressants	O
(	O
TCAs	O
)	O
.	O

There	O
were	O
50	O
women	O
and	O
14	O
men	O
.	O

Their	O
mean	O
age	O
was	O
60	O
.	O
5	O
+	O
/	O
-	O
1	O
.	O
6	O
years	O
.	O

All	O
the	O
patients	O
in	O
the	O
PRT	O
group	O
had	O
high	O
counts	O
of	O
Candida	O
spp	O
.	O
as	O
compared	O
with	O
percentages	O
of	O
patients	O
in	O
the	O
TCA	O
and	O
SS	O
groups	O
(	O
100	O
%	O
vs	O
.	O
66	O
.	O
7	O
%	O
and	O
56	O
.	O
2	O
%	O
,	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Patients	O
'	O
age	O
and	O
sex	O
in	O
different	O
etiology	O
groups	O
had	O
no	O
significant	O
impact	O
on	O
the	O
condition	O
of	O
their	O
oral	O
microflora	O
.	O

There	O
were	O
equal	O
percentages	O
of	O
patients	O
with	O
deficient	O
and	O
normal	O
salivation	O
in	O
the	O
TCA	O
group	O
(	O
44	O
%	O
in	O
both	O
the	O
groups	O
;	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

All	O
the	O
patients	O
in	O
the	O
PRT	O
group	O
had	O
pronounced	O
hyposalivation	O
(	O
P	O
<	O
0	O
.	O
002	O
)	O
.	O

A	O
significantly	O
greater	O
percentage	O
of	O
patients	O
with	O
severely	O
reduced	O
salivation	O
had	O
high	O
counts	O
of	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
(	O
P	O
<	O
0	O
.	O
01	O
)	O
.	O

Significantly	O
greater	O
percentages	O
of	O
patients	O
with	O
the	O
clinical	O
duration	O
of	O
xerostomia	O
of	O
up	O
to	O
6	O
months	O
had	O
high	O
counts	O
of	O
Lactobacillus	B-bacteria
spp	I-bacteria
.	I-bacteria
and	O
Candida	O
spp	O
.	O
colonies	O
.	O

In	O
patients	O
with	O
xerostomia	O
,	O
the	O
condition	O
of	O
the	O
microflora	O
of	O
the	O
oral	O
cavity	O
and	O
impairment	O
of	O
major	O
salivary	O
gland	O
function	O
varied	O
according	O
to	O
the	O
etiology	O
of	O
the	O
disease	O
.	O

The	O
level	O
of	O
hyposalivation	O
and	O
the	O
duration	O
of	O
xerostomia	O
were	O
found	O
to	O
have	O
a	O
significant	O
impact	O
on	O
the	O
microflora	O
of	O
the	O
oral	O
cavity	O
.	O

Oral	O
dryness	O
can	O
contribute	O
to	O
several	O
diseases	O
in	O
the	O
oral	O
cavity	O
.	O

The	O
objective	O
of	O
the	O
present	O
study	O
was	O
to	O
compare	O
the	O
subjective	O
oral	O
dryness	O
,	O
salivary	O
flow	O
rates	O
,	O
the	O
number	O
of	O
oral	O
microbiota	O
,	O
and	O
the	O
dental	O
status	O
between	O
medicated	O
hypertensive	O
patients	O
and	O
control	O
subjects	O
.	O

Four	O
hundred	O
subjects	O
including	O
200	O
ambulatory	O
hypertensive	O
patients	O
who	O
were	O
taking	O
antihypertensive	O
medications	O
and	O
200	O
control	O
subjects	O
were	O
included	O
.	O

Each	O
subject	O
'	O
s	O
medical	O
history	O
was	O
reviewed	O
.	O

The	O
subject	O
'	O
s	O
oral	O
health	O
status	O
,	O
salivary	O
flow	O
rate	O
,	O
and	O
the	O
number	O
of	O
oral	O
microbiota	O
were	O
also	O
evaluated	O
.	O

The	O
prevalence	O
rate	O
of	O
xerostomia	O
in	O
the	O
medicated	O
hypertensive	O
group	O
was	O
50	O
%	O
whereas	O
only	O
25	O
.	O
5	O
%	O
of	O
the	O
control	O
group	O
had	O
xerostomia	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Using	O
modified	O
Schirmer	O
test	O
(	O
MST	O
)	O
,	O
the	O
mean	O
unstimulated	O
salivary	O
flow	O
rate	O
of	O
the	O
medicated	O
hypertensive	O
group	O
(	O
23	O
.	O
11	O
+	O
/	O
-	O
6	O
.	O
08	O
mm	O
/	O
3	O
min	O
)	O
was	O
significantly	O
lower	O
than	O
that	O
of	O
the	O
control	O
group	O
(	O
31	O
.	O
30	O
+	O
/	O
-	O
3	O
.	O
36	O
mm	O
/	O
3	O
min	O
)	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

In	O
addition	O
,	O
the	O
mean	O
stimulated	O
salivary	O
flow	O
rate	O
of	O
the	O
medicated	O
hypertensive	O
group	O
(	O
0	O
.	O
73	O
+	O
/	O
-	O
0	O
.	O
30	O
ml	O
/	O
min	O
)	O
was	O
also	O
significantly	O
lower	O
than	O
that	O
of	O
the	O
control	O
group	O
(	O
1	O
.	O
31	O
+	O
/	O
-	O
0	O
.	O
34	O
mi	O
/	O
min	O
)	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

The	O
strongest	O
associated	O
factor	O
for	O
dry	O
mouth	O
was	O
the	O
use	O
of	O
antihypertensive	O
medications	O
(	O
OR	O
=	O
6	O
.	O
28	O
)	O
.	O

The	O
mean	O
levels	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
,	O
Lactobacilli	B-bacteria
spp	I-bacteria
.	I-bacteria
and	O
Candida	O
spp	O
.	O
in	O
the	O
medicated	O
hypertensive	O
group	O
were	O
significantly	O
higher	O
than	O
in	O
the	O
control	O
group	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Furthermore	O
,	O
medicated	O
hypertensive	O
patients	O
were	O
more	O
likely	O
to	O
have	O
missing	O
teeth	O
compared	O
to	O
control	O
subjects	O
.	O

Xerostomia	O
,	O
hyposalivation	O
,	O
and	O
increasing	O
number	O
of	O
oral	O
microbiota	O
were	O
more	O
prevalent	O
in	O
hypertensive	O
patients	O
taking	O
antihypertensive	O
medications	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
if	O
three	O
probiotic	O
bacteria	O
present	O
in	O
the	O
milk	O
product	O
Cultura	O
Dofilus	O
(	O
R	O
)	O
naturell	O
could	O
be	O
detected	O
in	O
saliva	O
and	O
on	O
oral	O
mucosal	O
surfaces	O
,	O
and	O
if	O
they	O
colonized	O
dental	O
surfaces	O
in	O
situ	O
in	O
8	O
caries	O
-	O
inactive	O
individuals	O
after	O
8	O
daily	O
exposures	O
to	O
the	O
milk	O
product	O
for	O
up	O
to	O
3	O
days	O
.	O

Bacteria	O
were	O
identified	O
by	O
fluorescence	O
in	O
situ	O
hybridization	O
and	O
confocal	O
laser	O
scanning	O
microscopy	O
.	O

While	O
probiotic	O
bacteria	O
were	O
present	O
sporadically	O
in	O
the	O
oral	O
cavity	O
on	O
mucosal	O
surfaces	O
and	O
in	O
saliva	O
after	O
3	O
days	O
of	O
frequent	O
use	O
of	O
the	O
probiotic	O
milk	O
,	O
they	O
were	O
not	O
detected	O
on	O
dental	O
surfaces	O
.	O

Probiotic	O
bacteria	O
may	O
thus	O
contribute	O
to	O
general	O
oral	O
health	O
,	O
but	O
their	O
potential	O
role	O
in	O
biofilm	O
-	O
induced	O
dental	O
diseases	O
remains	O
unclear	O
.	O

Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
is	O
a	O
gram	O
-	O
negative	O
periodontopathogen	O
found	O
within	O
the	O
subgingival	O
plaque	O
on	O
the	O
tooth	O
surface	O
.	O

It	O
is	O
associated	O
with	O
localized	O
aggressive	O
periodontitis	O
,	O
a	O
severe	O
form	O
of	O
periodontitis	O
in	O
adolescents	O
,	O
and	O
is	O
the	O
cause	O
various	O
extra	O
-	O
oral	O
infections	O
.	O

The	O
ability	O
of	O
this	O
organism	O
to	O
tenaciously	O
adhere	O
to	O
abiotic	O
surfaces	O
has	O
been	O
attributed	O
to	O
bundle	O
-	O
forming	O
type	O
IVb	O
-	O
like	O
fimbriae	O
whose	O
major	O
component	O
is	O
the	O
fimbrial	O
lower	O
molecular	O
weight	O
protein	O
(	O
Flp	O
)	O
.	O

In	O
this	O
study	O
the	O
adhesion	O
of	O
purified	O
Flp	O
fimbriae	O
isolated	O
from	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
to	O
materials	O
with	O
different	O
surface	O
chemistries	O
was	O
measured	O
using	O
atomic	O
force	O
microscopy	O
(	O
AFM	O
)	O
.	O

The	O
adhesion	O
of	O
Flp	O
fimbriae	O
to	O
uncoated	O
and	O
saliva	O
-	O
coated	O
tooth	O
,	O
hydroxylapatite	O
,	O
and	O
glass	O
surfaces	O
was	O
compared	O
.	O

Force	O
data	O
were	O
used	O
to	O
quantify	O
the	O
magnitude	O
of	O
adhesion	O
of	O
the	O
fimbriae	O
and	O
force	O
-	O
distance	O
profiles	O
were	O
used	O
to	O
predict	O
the	O
mechanisms	O
of	O
adhesion	O
.	O

The	O
results	O
of	O
this	O
study	O
confirm	O
that	O
non	O
-	O
specific	O
interactions	O
likely	O
dominate	O
the	O
adhesion	O
of	O
these	O
fimbriae	O
to	O
the	O
surfaces	O
used	O
in	O
this	O
study	O
.	O

However	O
,	O
force	O
data	O
indicate	O
that	O
non	O
-	O
specific	O
electrostatic	O
interactions	O
may	O
be	O
more	O
significant	O
under	O
the	O
conditions	O
used	O
in	O
this	O
study	O
.	O

Salivary	O
coatings	O
did	O
affect	O
both	O
the	O
hydrophobicity	O
and	O
adhesion	O
of	O
these	O
fimbriae	O
to	O
the	O
surfaces	O
used	O
in	O
this	O
study	O
.	O

Additionally	O
,	O
these	O
data	O
demonstrate	O
the	O
affect	O
of	O
salivary	O
proteins	O
on	O
bacterial	O
adhesion	O
in	O
the	O
oral	O
cavity	O
.	O

Many	O
human	O
microbial	O
infectious	O
diseases	O
including	O
dental	O
caries	O
are	O
polymicrobial	O
in	O
nature	O
.	O

How	O
these	O
complex	O
multi	O
-	O
species	O
communities	O
evolve	O
from	O
a	O
healthy	O
to	O
a	O
diseased	O
state	O
is	O
not	O
well	O
understood	O
.	O

Although	O
many	O
health	O
-	O
or	O
disease	O
-	O
associated	O
oral	O
bacteria	O
have	O
been	O
characterized	O
in	O
vitro	O
,	O
their	O
physiology	O
within	O
the	O
complex	O
oral	O
microbiome	O
is	O
difficult	O
to	O
determine	O
with	O
current	O
approaches	O
.	O

In	O
addition	O
,	O
about	O
half	O
of	O
these	O
species	O
remain	O
uncultivated	O
to	O
date	O
with	O
little	O
known	O
besides	O
their	O
16S	O
rRNA	O
sequence	O
.	O

Lacking	O
culture	O
-	O
based	O
physiological	O
analyses	O
,	O
the	O
functional	O
roles	O
of	O
uncultivated	O
species	O
will	O
remain	O
enigmatic	O
despite	O
their	O
apparent	O
disease	O
correlation	O
.	O

To	O
start	O
addressing	O
these	O
knowledge	O
gaps	O
,	O
we	O
applied	O
a	O
combination	O
of	O
Magnetic	O
Resonance	O
Spectroscopy	O
(	O
MRS	O
)	O
with	O
RNA	O
and	O
DNA	O
based	O
Stable	O
Isotope	O
Probing	O
(	O
SIP	O
)	O
to	O
oral	O
plaque	O
communities	O
from	O
healthy	O
children	O
for	O
in	O
vitro	O
temporal	O
monitoring	O
of	O
metabolites	O
and	O
identification	O
of	O
metabolically	O
active	O
and	O
inactive	O
bacterial	O
species	O
.	O

Supragingival	O
plaque	O
samples	O
from	O
caries	O
-	O
free	O
children	O
incubated	O
with	O
(	O
13	O
)	O
C	O
-	O
substrates	O
under	O
imposed	O
healthy	O
(	O
buffered	O
,	O
pH	O
7	O
)	O
and	O
diseased	O
states	O
(	O
pH	O
5	O
.	O
5	O
and	O
pH	O
4	O
.	O
5	O
)	O
produced	O
lactate	O
as	O
the	O
dominant	O
organic	O
acid	O
from	O
glucose	O
metabolism	O
.	O

Rapid	O
lactate	O
utilization	O
upon	O
glucose	O
depletion	O
was	O
observed	O
under	O
pH	O
7	O
conditions	O
.	O

SIP	O
analyses	O
revealed	O
a	O
number	O
of	O
genera	O
containing	O
cultured	O
and	O
uncultivated	O
taxa	O
with	O
metabolic	O
capabilities	O
at	O
pH	O
5	O
.	O
5	O
.	O

The	O
diversity	O
of	O
active	O
species	O
decreased	O
significantly	O
at	O
pH	O
4	O
.	O
5	O
and	O
was	O
dominated	O
by	O
Lactobacillus	B-bacteria
and	O
Propionibacterium	B-bacteria
species	I-bacteria
,	O
both	O
of	O
which	O
have	O
been	O
previously	O
found	O
within	O
carious	O
lesions	O
from	O
children	O
.	O

Our	O
approach	O
allowed	O
for	O
identification	O
of	O
species	O
that	O
metabolize	O
carbohydrates	O
under	O
different	O
pH	O
conditions	O
and	O
supports	O
the	O
importance	O
of	O
Lactobacilli	B-bacteria
and	O
Propionibacterium	B-bacteria
in	O
the	O
development	O
of	O
childhood	O
caries	O
.	O

Identification	O
of	O
species	O
within	O
healthy	O
subjects	O
that	O
are	O
active	O
at	O
low	O
pH	O
can	O
lead	O
to	O
a	O
better	O
understanding	O
of	O
oral	O
caries	O
onset	O
and	O
generate	O
appropriate	O
targets	O
for	O
preventative	O
measures	O
in	O
the	O
early	O
stages	O
.	O

This	O
randomized	O
double	O
-	O
blind	O
clinical	O
study	O
evaluated	O
the	O
antimicrobial	O
efficacy	O
of	O
two	O
mouthwashes	O
containing	O
(	O
1	O
)	O
0	O
.	O
075	O
%	O
cetylpyridinium	O
chloride	O
(	O
CPC	O
)	O
+	O
0	O
.	O
05	O
%	O
sodium	O
fluoride	O
(	O
NaF	O
)	O
in	O
an	O
alcohol	O
-	O
free	O
base	O
and	O
(	O
2	O
)	O
0	O
.	O
075	O
%	O
CPC	O
+	O
0	O
.	O
05	O
%	O
NaF	O
in	O
a	O
6	O
%	O
alcohol	O
base	O
,	O
versus	O
a	O
negative	O
control	O
mouthwash	O
containing	O
0	O
.	O
05	O
%	O
NaF	O
in	O
an	O
alcohol	O
-	O
free	O
base	O
on	O
numbers	O
of	O
bacteria	O
in	O
supragingival	O
plaque	O
12	O
hours	O
after	O
a	O
single	O
use	O
and	O
12	O
hours	O
after	O
14	O
days	O
'	O
use	O
.	O

Enrolled	O
subjects	O
completed	O
a	O
one	O
-	O
week	O
washout	O
phase	O
prior	O
to	O
providing	O
baseline	O
samples	O
of	O
supragingival	O
plaque	O
that	O
were	O
analyzed	O
for	O
numbers	O
of	O
anaerobic	O
microorganisms	O
.	O

Subjects	O
were	O
randomized	O
to	O
a	O
treatment	O
group	O
and	O
instructed	O
to	O
rinse	O
with	O
20	O
mL	O
of	O
the	O
assigned	O
mouthwash	O
for	O
30	O
seconds	O
.	O

Post	O
-	O
treatment	O
microbiological	O
analyses	O
were	O
conducted	O
on	O
plaque	O
samples	O
collected	O
12	O
hours	O
after	O
the	O
first	O
use	O
of	O
each	O
assigned	O
mouthwash	O
and	O
after	O
completing	O
14	O
days	O
of	O
twice	O
-	O
daily	O
use	O
of	O
each	O
assigned	O
mouthwash	O
.	O

Oral	O
examinations	O
were	O
completed	O
by	O
a	O
dentist	O
at	O
each	O
sample	O
collection	O
to	O
assess	O
soft	O
and	O
hard	O
tissue	O
oral	O
health	O
over	O
the	O
course	O
of	O
the	O
study	O
.	O

The	O
study	O
enrolled	O
188	O
adults	O
(	O
mean	O
age	O
45	O
.	O
78	O
years	O
;	O
age	O
range	O
23	O
-	O
69	O
)	O
.	O

Subjects	O
rinsing	O
with	O
the	O
CPC	O
-	O
containing	O
mouthwash	O
realized	O
a	O
statistically	O
significant	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
reduction	O
in	O
numbers	O
of	O
supragingival	O
anaerobic	O
bacteria	O
at	O
the	O
12	O
-	O
hour	O
evaluation	O
after	O
a	O
single	O
use	O
.	O

In	O
comparison	O
to	O
the	O
control	O
mouthwash	O
,	O
use	O
of	O
the	O
CPC	O
mouthwash	O
in	O
an	O
alcohol	O
base	O
resulted	O
in	O
a	O
35	O
.	O
3	O
%	O
reduction	O
in	O
numbers	O
of	O
anaerobic	O
plaque	O
bacteria	O
,	O
while	O
the	O
CPC	O
mouthwash	O
in	O
an	O
alcohol	O
-	O
free	O
base	O
demonstrated	O
a	O
34	O
.	O
5	O
%	O
reduction	O
.	O

Further	O
,	O
the	O
analysis	O
after	O
twice	O
-	O
daily	O
use	O
for	O
14	O
days	O
indicated	O
that	O
the	O
CPC	O
mouthwash	O
in	O
an	O
alcohol	O
base	O
demonstrated	O
a	O
73	O
.	O
8	O
%	O
reduction	O
in	O
anaerobic	O
plaque	O
bacteria	O
,	O
while	O
the	O
CPC	O
mouthwash	O
in	O
an	O
alcohol	O
-	O
free	O
base	O
demonstrated	O
a	O
70	O
.	O
9	O
%	O
reduction	O
in	O
anaerobic	O
plaque	O
bacteria	O
versus	O
the	O
control	O
mouthwash	O
.	O

The	O
CPC	O
mouthwash	O
in	O
an	O
alcohol	O
-	O
free	O
base	O
reduced	O
supragingival	O
plaque	O
bacteria	O
by	O
34	O
.	O
5	O
%	O
and	O
70	O
.	O
9	O
%	O
compared	O
to	O
the	O
control	O
mouthwash	O
12	O
hours	O
after	O
a	O
single	O
use	O
and	O
after	O
14	O
days	O
of	O
use	O
,	O
respectively	O
.	O

In	O
addition	O
,	O
the	O
CPC	O
mouthwash	O
in	O
an	O
alcohol	O
base	O
reduced	O
supragingival	O
bacteria	O
by	O
35	O
.	O
3	O
%	O
and	O
73	O
.	O
8	O
%	O
compared	O
to	O
the	O
control	O
mouthwash	O
12	O
hours	O
after	O
a	O
single	O
use	O
and	O
after	O
14	O
days	O
of	O
use	O
,	O
respectively	O
.	O

There	O
were	O
no	O
statistically	O
significant	O
differences	O
between	O
the	O
CPC	O
-	O
containing	O
mouthwashes	O
at	O
either	O
of	O
the	O
post	O
-	O
treatment	O
time	O
points	O
.	O

This	O
study	O
is	O
a	O
proof	O
of	O
concept	O
to	O
determine	O
the	O
efficacy	O
of	O
a	O
custom	O
-	O
fabricated	O
tray	O
in	O
placing	O
antimicrobial	O
and	O
debriding	O
agents	O
in	O
the	O
periodontal	O
pockets	O
of	O
persons	O
with	O
active	O
gingival	O
infections	O
.	O

Localized	O
subgingival	O
delivery	O
of	O
antimicrobial	O
and	O
antibiotic	O
agents	O
is	O
routinely	O
employed	O
as	O
adjunctive	O
therapy	O
for	O
the	O
treatment	O
and	O
management	O
of	O
periopathogens	O
associated	O
with	O
periodontal	O
disease	O
.	O

Because	O
these	O
delivery	O
techniques	O
often	O
face	O
time	O
constraints	O
and	O
impose	O
temporary	O
restrictions	O
on	O
patient	O
brushing	O
and	O
flossing	O
,	O
a	O
custom	O
-	O
formed	O
prescription	O
dental	O
tray	O
can	O
be	O
used	O
to	O
deliver	O
and	O
maintain	O
medications	O
in	O
periodontal	O
pockets	O
between	O
office	O
visits	O
and	O
without	O
brushing	O
or	O
flossing	O
restrictions	O
.	O

The	O
ability	O
of	O
this	O
tray	O
to	O
maintain	O
sufficient	O
concentrations	O
of	O
medication	O
in	O
the	O
periodontal	O
pockets	O
to	O
have	O
a	O
therapeutic	O
effect	O
is	O
evaluated	O
here	O
with	O
theoretical	O
modeling	O
and	O
practical	O
application	O
.	O

Hydrogen	O
peroxide	O
is	O
an	O
oral	O
debriding	O
agent	O
and	O
oral	O
wound	O
cleanser	O
with	O
antimicrobial	O
properties	O
.	O

The	O
debriding	O
effect	O
of	O
1	O
.	O
7	O
%	O
hydrogen	O
peroxide	O
gel	O
was	O
tested	O
in	O
vitro	O
on	O
Streptococcus	B-bacteria
mutans	I-bacteria
biofilm	O
using	O
glass	O
carriers	O
for	O
collection	O
.	O

Diffusion	O
modeling	O
tested	O
the	O
potential	O
of	O
the	O
customized	O
tray	O
to	O
place	O
hydrogen	O
peroxide	O
gel	O
into	O
the	O
sulcus	O
in	O
the	O
presence	O
of	O
crevicular	O
fluid	O
flow	O
.	O

Changes	O
in	O
periodontal	O
microflora	O
with	O
scanning	O
electron	O
microscopy	O
analysis	O
of	O
in	O
vivo	O
paper	O
point	O
site	O
sampling	O
were	O
analyzed	O
before	O
and	O
after	O
a	O
thin	O
ribbon	O
of	O
1	O
.	O
7	O
%	O
hydrogen	O
peroxide	O
gel	O
(	O
approximately	O
0	O
.	O
7	O
gm	O
)	O
and	O
a	O
subtherapeutic	O
dose	O
(	O
three	O
drops	O
)	O
of	O
Vibramycin	O
(	O
50	O
mg	O
/	O
5	O
ml	O
)	O
were	O
placed	O
via	O
Perio	O
Trays	O
into	O
periodontal	O
pockets	O
,	O
ranging	O
from	O
4	O
-	O
8	O
mm	O
at	O
daily	O
prescribed	O
intervals	O
for	O
two	O
to	O
five	O
weeks	O
.	O

In	O
vitro	O
results	O
indicate	O
that	O
1	O
.	O
7	O
%	O
hydrogen	O
peroxide	O
gel	O
breaks	O
down	O
the	O
exopolysaccharide	O
slime	O
and	O
cell	O
walls	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
and	O
begins	O
to	O
debride	O
the	O
cells	O
from	O
glass	O
carriers	O
within	O
10	O
minutes	O
.	O

Diffusion	O
modeling	O
indicates	O
that	O
hydrogen	O
peroxide	O
can	O
penetrate	O
into	O
the	O
deeper	O
pockets	O
(	O
9	O
mm	O
)	O
,	O
but	O
also	O
its	O
concentration	O
in	O
these	O
deep	O
pockets	O
will	O
increase	O
over	O
wearing	O
time	O
in	O
the	O
absence	O
of	O
degradation	O
by	O
peroxidases	O
and	O
catalase	O
.	O

Site	O
sampling	O
data	O
confirm	O
diffusion	O
modeling	O
results	O
,	O
with	O
evidence	O
that	O
medication	O
delivered	O
with	O
the	O
prescription	O
tray	O
reduced	O
subgingival	O
bacterial	O
loads	O
and	O
enhanced	O
healing	O
of	O
corresponding	O
oral	O
tissues	O
.	O

The	O
prescription	O
Perio	O
Tray	O
effectively	O
placed	O
medication	O
in	O
the	O
gingival	O
sulcus	O
.	O

Mathematical	O
modeling	O
indicated	O
Perio	O
Tray	O
placement	O
of	O
hydrogen	O
peroxide	O
gel	O
in	O
periodontal	O
pockets	O
with	O
depths	O
up	O
to	O
9	O
mm	O
over	O
15	O
minutes	O
treatment	O
time	O
was	O
theoretically	O
possible	O
.	O

Pathology	O
reports	O
reveal	O
reductions	O
in	O
subgingival	O
bacterial	O
loads	O
and	O
improvements	O
in	O
pretreatment	O
pocket	O
depths	O
of	O
up	O
to	O
8	O
mm	O
after	O
1	O
.	O
7	O
%	O
hydrogen	O
peroxide	O
and	O
Vibramycin	O
Syrup	O
were	O
prescribed	O
for	O
use	O
with	O
the	O
Perio	O
Tray	O
.	O

The	O
in	O
vitro	O
analysis	O
indicating	O
that	O
hydrogen	O
peroxide	O
is	O
the	O
active	O
and	O
effective	O
oral	O
debriding	O
agent	O
needs	O
to	O
be	O
confirmed	O
with	O
additional	O
studies	O
.	O

Noma	O
is	O
a	O
gangrenous	O
disease	O
that	O
leads	O
to	O
severe	O
disfigurement	O
of	O
the	O
face	O
with	O
high	O
morbidity	O
and	O
mortality	O
,	O
but	O
its	O
etiology	O
remains	O
unknown	O
.	O

Young	O
children	O
in	O
developing	O
countries	O
are	O
almost	O
exclusively	O
affected	O
.	O

The	O
purpose	O
of	O
the	O
study	O
was	O
to	O
record	O
and	O
compare	O
bacterial	O
diversity	O
in	O
oral	O
samples	O
from	O
children	O
with	O
or	O
without	O
acute	O
noma	O
or	O
acute	O
necrotizing	O
gingivitis	O
from	O
a	O
defined	O
geographical	O
region	O
in	O
Niger	O
by	O
culture	O
-	O
independent	O
molecular	O
methods	O
.	O

Gingival	O
samples	O
from	O
23	O
healthy	O
children	O
,	O
nine	O
children	O
with	O
acute	O
necrotizing	O
gingivitis	O
,	O
and	O
23	O
children	O
with	O
acute	O
noma	O
(	O
both	O
healthy	O
and	O
diseased	O
oral	O
sites	O
)	O
were	O
amplified	O
using	O
`	O
`	O
universal	O
'	O
'	O
PCR	O
primers	O
for	O
the	O
16	O
S	O
rRNA	O
gene	O
and	O
pooled	O
according	O
to	O
category	O
(	O
noma	O
,	O
healthy	O
,	O
or	O
acute	O
necrotizing	O
gingivitis	O
)	O
,	O
gender	O
,	O
and	O
site	O
status	O
(	O
diseased	O
or	O
control	O
site	O
)	O
.	O

Seven	O
libraries	O
were	O
generated	O
.	O

A	O
total	O
of	O
1237	O
partial	O
16	O
S	O
rRNA	O
sequences	O
representing	O
339	O
bacterial	O
species	O
or	O
phylotypes	O
at	O
a	O
98	O
-	O
99	O
%	O
identity	O
level	O
were	O
obtained	O
.	O

Analysis	O
of	O
bacterial	O
composition	O
and	O
frequency	O
showed	O
that	O
diseased	O
(	O
noma	O
or	O
acute	O
necrotizing	O
gingivitis	O
)	O
and	O
healthy	O
site	O
bacterial	O
communities	O
are	O
composed	O
of	O
similar	O
bacteria	O
,	O
but	O
differ	O
in	O
the	O
prevalence	O
of	O
a	O
limited	O
group	O
of	O
phylotypes	O
.	O

Large	O
increases	O
in	O
counts	O
of	O
Prevotella	B-bacteria
intermedia	I-bacteria
and	O
members	O
of	O
the	O
Peptostreptococcus	B-bacteria
genus	I-bacteria
are	O
associated	O
with	O
disease	O
.	O

In	O
contrast	O
,	O
no	O
clear	O
-	O
cut	O
differences	O
were	O
found	O
between	O
noma	O
and	O
non	O
-	O
noma	O
libraries	O
.	O

Similarities	O
between	O
acute	O
necrotizing	O
gingivitis	O
and	O
noma	O
samples	O
support	O
the	O
hypothesis	O
that	O
the	O
disease	O
could	O
evolve	O
from	O
acute	O
necrotizing	O
gingivitis	O
in	O
certain	O
children	O
for	O
reasons	O
still	O
to	O
be	O
elucidated	O
.	O

This	O
study	O
revealed	O
oral	O
microbiological	O
patterns	O
associated	O
with	O
noma	O
and	O
acute	O
necrotizing	O
gingivitis	O
,	O
but	O
no	O
evidence	O
was	O
found	O
for	O
a	O
specific	O
infection	O
-	O
triggering	O
agent	O
.	O

Although	O
oral	O
bacteria	O
-	O
associated	O
systemic	O
diseases	O
have	O
been	O
reported	O
,	O
association	O
between	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
pathogen	O
of	O
dental	O
caries	O
,	O
and	O
ulcerative	O
colitis	O
(	O
UC	O
)	O
has	O
not	O
been	O
reported	O
.	O

We	O
investigated	O
the	O
effect	O
of	O
various	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
strains	I-bacteria
on	O
dextran	O
sodium	O
sulfate	O
(	O
DSS	O
)	O
-	O
induced	O
mouse	O
colitis	O
.	O

Administration	O
of	O
TW295	B-bacteria
,	O
the	O
specific	O
strain	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
caused	O
aggravation	O
of	O
colitis	O
;	O
the	O
standard	O
strain	O
,	O
MT8148	B-bacteria
did	O
not	O
.	O

Localization	O
of	O
TW295	B-bacteria
in	O
hepatocytes	O
in	O
liver	O
was	O
observed	O
.	O

Increased	O
expression	O
of	O
interferon	O
-	O
gamma	O
in	O
liver	O
was	O
also	O
noted	O
,	O
indicating	O
that	O
the	O
liver	O
is	O
target	O
organ	O
for	O
the	O
specific	O
strain	O
of	O
S	O
.	O
mutans	O
-	O
mediated	O
aggravation	O
of	O
colitis	O
.	O

The	O
detection	O
frequency	O
of	O
the	O
specific	O
strains	O
in	O
UC	O
patients	O
was	O
significantly	O
higher	O
than	O
in	O
healthy	O
subjects	O
.	O

Administration	O
of	O
the	O
specific	O
strains	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
isolated	O
from	O
patients	O
caused	O
aggravation	O
of	O
colitis	O
.	O

Infection	O
with	O
highly	O
-	O
virulent	O
specific	O
types	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
might	O
be	O
a	O
potential	O
risk	O
factor	O
in	O
the	O
aggravation	O
of	O
UC	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effectiveness	O
of	O
tablets	O
containing	O
two	O
probiotic	O
Lactobacillus	B-bacteria
reuteri	I-bacteria
strains	I-bacteria
in	O
inhibiting	O
regrowth	O
of	O
salivary	O
mutans	B-bacteria
streptococci	I-bacteria
(	O
MS	B-bacteria
)	O
after	O
full	O
-	O
mouth	O
disinfection	O
(	O
FMD	O
)	O
with	O
chlorhexidine	O
.	O

The	O
null	O
hypothesis	O
was	O
that	O
the	O
levels	O
of	O
MS	B-bacteria
would	O
not	O
differ	O
in	O
comparison	O
with	O
a	O
placebo	O
protocol	O
.	O

The	O
study	O
population	O
was	O
comprised	O
of	O
62	O
young	O
adults	O
(	O
mean	O
age	O
23	O
years	O
)	O
with	O
moderate	O
or	O
high	O
counts	O
of	O
salivary	O
MS	B-bacteria
who	O
volunteered	O
after	O
informed	O
consent	O
.	O

The	O
study	O
was	O
a	O
double	O
-	O
blinded	O
randomized	O
controlled	O
trial	O
with	O
two	O
parallel	O
groups	O
.	O

After	O
a	O
3	O
-	O
day	O
chlorhexidine	O
regimen	O
,	O
the	O
subjects	O
were	O
randomly	O
assigned	O
to	O
a	O
test	O
group	O
(	O
n	O
=	O
32	O
)	O
with	O
probiotic	O
lozenges	O
(	O
2	O
/	O
day	O
)	O
or	O
a	O
placebo	O
group	O
(	O
n	O
=	O
30	O
)	O
.	O

The	O
intervention	O
period	O
was	O
6	O
weeks	O
,	O
and	O
stimulated	O
whole	O
saliva	O
was	O
collected	O
at	O
baseline	O
and	O
after	O
1	O
,	O
6	O
,	O
and	O
12	O
weeks	O
.	O

The	O
samples	O
were	O
processed	O
for	O
MS	B-bacteria
by	O
a	O
chair	O
-	O
side	O
test	O
and	O
DNA	O
-	O
DNA	O
hybridization	O
as	O
an	O
estimate	O
of	O
19	O
bacterial	O
strains	O
associated	O
with	O
oral	O
health	O
and	O
disease	O
.	O

There	O
was	O
no	O
significant	O
difference	O
between	O
the	O
groups	O
at	O
inclusion	O
,	O
and	O
FMD	O
reduced	O
the	O
salivary	O
MS	B-bacteria
levels	O
significantly	O
in	O
both	O
groups	O
.	O

The	O
MS	B-bacteria
suppression	O
lasted	O
less	O
than	O
6	O
weeks	O
and	O
there	O
were	O
no	O
statistical	O
differences	O
in	O
salivary	O
MS	B-bacteria
regrowth	O
between	O
the	O
test	O
and	O
control	O
groups	O
at	O
any	O
of	O
the	O
follow	O
-	O
ups	O
.	O

Likewise	O
,	O
there	O
were	O
no	O
major	O
differences	O
in	O
the	O
regrowth	O
patterns	O
of	O
the	O
checkerboard	O
panel	O
between	O
the	O
two	O
groups	O
.	O

We	O
conclude	O
that	O
daily	O
oral	O
administration	O
of	O
L	B-bacteria
.	I-bacteria
reuteri	I-bacteria
did	O
not	O
seem	O
to	O
affect	O
or	O
delay	O
the	O
regrowth	O
of	O
salivary	O
MS	B-bacteria
after	O
FMD	O
with	O
chlorhexidine	O
.	O

Wingless	O
proteins	O
,	O
termed	O
Wnt	O
,	O
are	O
involved	O
in	O
embryonic	O
development	O
,	O
blood	O
cell	O
differentiation	O
,	O
and	O
tumorigenesis	O
.	O

In	O
mammalian	O
hematopoiesis	O
,	O
Wnt	O
signaling	O
is	O
essential	O
for	O
stem	O
-	O
cell	O
homeostasis	O
and	O
lymphocyte	O
differentiation	O
.	O

Recent	O
studies	O
have	O
suggested	O
that	O
these	O
molecules	O
are	O
associated	O
with	O
cardiovascular	O
diseases	O
,	O
rheumatoid	O
arthritis	O
,	O
and	O
osteoarthritis	O
.	O

Furthermore	O
,	O
Wnt5a	O
signaling	O
is	O
essential	O
for	O
the	O
general	O
inflammatory	O
response	O
of	O
human	O
macrophages	O
.	O

Periodontitis	O
is	O
a	O
chronic	O
inflammatory	O
disease	O
caused	O
by	O
gram	O
-	O
negative	O
periodontopathic	O
bacteria	O
and	O
the	O
resultant	O
host	O
immune	O
response	O
.	O

Periodontitis	O
is	O
characterized	O
by	O
loss	O
of	O
tooth	O
-	O
supporting	O
structures	O
and	O
alveolar	O
bone	O
resorption	O
.	O

There	O
have	O
been	O
no	O
previous	O
reports	O
on	O
Wnt5a	O
expression	O
in	O
periodontitis	O
tissue	O
,	O
and	O
only	O
few	O
study	O
reported	O
the	O
molecular	O
mechanisms	O
of	O
Wnt5a	O
expression	O
in	O
LPS	O
-	O
stimulated	O
monocytic	O
cells	O
.	O

Using	O
RT	O
-	O
PCR	O
,	O
we	O
demonstrated	O
that	O
Wnt5a	O
mRNA	O
expression	O
was	O
up	O
-	O
regulated	O
in	O
chronic	O
periodontitis	O
tissue	O
as	O
compared	O
to	O
healthy	O
control	O
tissue	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
induced	O
Wnt5a	O
mRNA	O
in	O
the	O
human	O
monocytic	O
cell	O
line	O
THP	O
-	O
1	O
with	O
a	O
peak	O
at	O
4	O
hrs	O
after	O
stimulation	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
induced	O
higher	O
up	O
-	O
regulation	O
of	O
Wnt5a	O
mRNA	O
than	O
E	B-bacteria
.	I-bacteria
coli	I-bacteria
LPS	O
.	O

The	O
LPS	O
receptors	O
TLR2	O
and	O
TLR4	O
were	O
equally	O
expressed	O
on	O
the	O
surface	O
of	O
THP	O
-	O
1	O
cells	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
induced	O
IkappaBalpha	O
degradation	O
and	O
was	O
able	O
to	O
increase	O
the	O
NF	O
-	O
kappaB	O
binding	O
activity	O
to	O
DNA	O
.	O

P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
-	O
induced	O
Wnt5a	O
expression	O
was	O
inhibited	O
by	O
NF	O
-	O
kappaB	O
inhibitors	O
,	O
suggesting	O
NF	O
-	O
kappaB	O
involvement	O
.	O

Furthermore	O
,	O
IFN	O
-	O
gamma	O
synergistically	O
enhanced	O
the	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
-	O
induced	O
production	O
of	O
Wnt5a	O
.	O

Pharmacological	O
investigation	O
and	O
siRNA	O
experiments	O
showed	O
that	O
STAT1	O
was	O
important	O
for	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
-	O
induced	O
Wnt5a	O
expression	O
.	O

These	O
results	O
suggest	O
that	O
the	O
modulation	O
of	O
Wnt5a	O
expression	O
by	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
may	O
play	O
an	O
important	O
role	O
in	O
the	O
periodontal	O
inflammatory	O
process	O
and	O
serve	O
a	O
target	O
for	O
the	O
development	O
of	O
new	O
therapies	O
.	O

Virulent	O
biofilms	O
are	O
responsible	O
for	O
a	O
range	O
of	O
infections	O
,	O
including	O
oral	O
diseases	O
.	O

All	O
biofilms	O
harbor	O
a	O
microbial	O
-	O
derived	O
extracellular	O
-	O
matrix	O
.	O

The	O
exopolysaccharides	O
(	O
EPS	O
)	O
formed	O
on	O
tooth	O
-	O
pellicle	O
and	O
bacterial	O
surfaces	O
provide	O
binding	O
sites	O
for	O
microorganisms	O
;	O
eventually	O
the	O
accumulated	O
EPS	O
enmeshes	O
microbial	O
cells	O
.	O

The	O
metabolic	O
activity	O
of	O
the	O
bacteria	O
within	O
this	O
matrix	O
leads	O
to	O
acidification	O
of	O
the	O
milieu	O
.	O

We	O
explored	O
the	O
mechanisms	O
through	O
which	O
the	O
Streptococcus	O
mutans	O
-	O
produced	O
EPS	O
-	O
matrix	O
modulates	O
the	O
three	O
-	O
dimensional	O
(	O
3D	O
)	O
architecture	O
and	O
the	O
population	O
shifts	O
during	O
morphogenesis	O
of	O
biofilms	O
on	O
a	O
saliva	O
-	O
coated	O
-	O
apatitic	O
surface	O
using	O
a	O
mixed	O
-	O
bacterial	O
species	O
system	O
.	O

Concomitantly	O
,	O
we	O
examined	O
whether	O
the	O
matrix	O
influences	O
the	O
development	O
of	O
pH	O
-	O
microenvironments	O
within	O
intact	O
-	O
biofilms	O
using	O
a	O
novel	O
3D	O
in	O
situ	O
pH	O
-	O
mapping	O
technique	O
.	O

Data	O
reveal	O
that	O
the	O
production	O
of	O
the	O
EPS	O
-	O
matrix	O
helps	O
to	O
create	O
spatial	O
heterogeneities	O
by	O
forming	O
an	O
intricate	O
network	O
of	O
exopolysaccharide	O
-	O
enmeshed	O
bacterial	O
-	O
islets	O
(	O
microcolonies	O
)	O
through	O
localized	O
cell	O
-	O
to	O
-	O
matrix	O
interactions	O
.	O

This	O
complex	O
3D	O
architecture	O
creates	O
compartmentalized	O
acidic	O
and	O
EPS	O
-	O
rich	O
microenvironments	O
throughout	O
the	O
biofilm	O
,	O
which	O
triggers	O
the	O
dominance	O
of	O
pathogenic	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
within	O
a	O
mixed	O
-	O
species	O
system	O
.	O

The	O
establishment	O
of	O
a	O
3D	O
-	O
matrix	O
and	O
EPS	O
-	O
enmeshed	O
microcolonies	O
were	O
largely	O
mediated	O
by	O
the	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
gtfB	O
/	O
gtfC	O
genes	O
,	O
expression	O
of	O
which	O
was	O
enhanced	O
in	O
the	O
presence	O
of	O
Actinomyces	B-bacteria
naeslundii	I-bacteria
and	O
Streptococcus	B-bacteria
oralis	I-bacteria
.	O

Acidic	O
pockets	O
were	O
found	O
only	O
in	O
the	O
interiors	O
of	O
bacterial	O
-	O
islets	O
that	O
are	O
protected	O
by	O
EPS	O
,	O
which	O
impedes	O
rapid	O
neutralization	O
by	O
buffer	O
(	O
pH	O
7	O
.	O
0	O
)	O
.	O

As	O
a	O
result	O
,	O
regions	O
of	O
low	O
pH	O
(	O
<	O
5	O
.	O
5	O
)	O
were	O
detected	O
at	O
specific	O
locations	O
along	O
the	O
surface	O
of	O
attachment	O
.	O

Resistance	O
to	O
chlorhexidine	O
was	O
enhanced	O
in	O
cells	O
within	O
EPS	O
-	O
microcolony	O
complexes	O
compared	O
to	O
those	O
outside	O
such	O
structures	O
within	O
the	O
biofilm	O
.	O

Our	O
results	O
illustrate	O
the	O
critical	O
interaction	O
between	O
matrix	O
architecture	O
and	O
pH	O
heterogeneity	O
in	O
the	O
3D	O
environment	O
.	O

The	O
formation	O
of	O
structured	O
acidic	O
-	O
microenvironments	O
in	O
close	O
proximity	O
to	O
the	O
apatite	O
-	O
surface	O
is	O
an	O
essential	O
factor	O
associated	O
with	O
virulence	O
in	O
cariogenic	O
-	O
biofilms	O
.	O

These	O
observations	O
may	O
have	O
relevance	O
beyond	O
the	O
mouth	O
,	O
as	O
matrix	O
is	O
inherent	O
to	O
all	O
biofilms	O
.	O

Determining	O
the	O
bacterial	O
composition	O
of	O
the	O
canine	O
oral	O
microbiome	O
is	O
of	O
interest	O
for	O
two	O
primary	O
reasons	O
.	O

First	O
,	O
while	O
the	O
human	O
oral	O
microbiome	O
has	O
been	O
well	O
studied	O
using	O
molecular	O
techniques	O
,	O
the	O
oral	O
microbiomes	O
of	O
other	O
mammals	O
have	O
not	O
been	O
studied	O
in	O
equal	O
depth	O
using	O
culture	O
independent	O
methods	O
.	O

This	O
study	O
allows	O
a	O
comparison	O
of	O
the	O
number	O
of	O
bacterial	O
taxa	O
,	O
based	O
on	O
16S	O
rRNA	O
-	O
gene	O
sequence	O
comparison	O
,	O
shared	O
between	O
humans	O
and	O
dogs	O
,	O
two	O
divergent	O
mammalian	O
species	O
.	O

Second	O
,	O
canine	O
oral	O
bacteria	O
are	O
of	O
interest	O
to	O
veterinary	O
and	O
human	O
medical	O
communities	O
for	O
understanding	O
their	O
roles	O
in	O
health	O
and	O
infectious	O
diseases	O
.	O

The	O
bacteria	O
involved	O
are	O
mostly	O
unnamed	O
and	O
not	O
linked	O
by	O
16S	O
rRNA	O
-	O
gene	O
sequence	O
identity	O
to	O
a	O
taxonomic	O
scheme	O
.	O

This	O
manuscript	O
describes	O
the	O
analysis	O
of	O
5	O
,	O
958	O
16S	O
rRNA	O
-	O
gene	O
sequences	O
from	O
65	O
clone	O
libraries	O
.	O

Full	O
length	O
16S	O
rRNA	O
reference	O
sequences	O
have	O
been	O
obtained	O
for	O
353	O
canine	O
bacterial	O
taxa	O
,	O
which	O
were	O
placed	O
in	O
14	O
bacterial	O
phyla	O
,	O
23	O
classes	O
,	O
37	O
orders	O
,	O
66	O
families	O
,	O
and	O
148	O
genera	O
.	O

Eighty	O
percent	O
of	O
the	O
taxa	O
are	O
currently	O
unnamed	O
.	O

The	O
bacterial	O
taxa	O
identified	O
in	O
dogs	O
are	O
markedly	O
different	O
from	O
those	O
of	O
humans	O
with	O
only	O
16	O
.	O
4	O
%	O
of	O
oral	O
taxa	O
are	O
shared	O
between	O
dogs	O
and	O
humans	O
based	O
on	O
a	O
98	O
.	O
5	O
%	O
16S	O
rRNA	O
sequence	O
similarity	O
cutoff	O
.	O

This	O
indicates	O
that	O
there	O
is	O
a	O
large	O
divergence	O
in	O
the	O
bacteria	O
comprising	O
the	O
oral	O
microbiomes	O
of	O
divergent	O
mammalian	O
species	O
.	O

The	O
historic	O
practice	O
of	O
identifying	O
animal	O
associated	O
bacteria	O
based	O
on	O
phenotypic	O
similarities	O
to	O
human	O
bacteria	O
is	O
generally	O
invalid	O
.	O

This	O
report	O
describes	O
the	O
diversity	O
of	O
the	O
canine	O
oral	O
microbiome	O
and	O
provides	O
a	O
provisional	O
16S	O
rRNA	O
based	O
taxonomic	O
scheme	O
for	O
naming	O
and	O
identifying	O
unnamed	O
canine	O
bacterial	O
taxa	O
.	O

Objective	O
of	O
this	O
study	O
is	O
to	O
evaluate	O
the	O
changes	O
of	O
the	O
oral	O
microbial	O
flora	O
,	O
concentrating	O
on	O
the	O
oral	O
streptococci	B-bacteria
,	O
after	O
the	O
first	O
3	O
and	O
6	O
months	O
of	O
orthodontic	O
treatment	O
.	O

40	O
patients	O
,	O
aged	O
7	O
-	O
17	O
,	O
that	O
presented	O
for	O
orthodontic	O
treatment	O
between	O
April	O
and	O
September	O
2010	O
in	O
the	O
Department	O
of	O
Orthodontics	O
and	O
Dento	O
-	O
Facial	O
Orthopedics	O
of	O
`	O
`	O
Carol	O
Davila	O
'	O
'	O
University	O
of	O
Medicine	O
and	O
Pharmacy	O
,	O
Bucharest	O
have	O
been	O
selected	O
.	O

According	O
to	O
the	O
protocol	O
,	O
coronary	O
and	O
subgingival	O
plaque	O
was	O
collected	O
from	O
the	O
dental	O
surface	O
before	O
starting	O
any	O
orthodontic	O
treatment	O
(	O
T0	O
)	O
,	O
3	O
months	O
after	O
wearing	O
orthodontic	O
appliances	O
(	O
T1	O
)	O
and	O
6	O
months	O
after	O
wearing	O
orthodontic	O
appliances	O
(	O
T2	O
)	O
.	O

The	O
samples	O
were	O
studied	O
in	O
Cantacuzino	O
National	O
Institute	O
of	O
Research	O
-	O
Development	O
for	O
Microbiology	O
and	O
Immunology	O
[	O
isolation	O
on	O
Columbia	O
agar	O
with	O
5	O
%	O
sheep	O
blood	O
,	O
identification	O
on	O
morphotinctorial	O
,	O
growth	O
and	O
biochemical	O
characteristics	O
using	O
API	O
20	O
STREP	O
(	O
BioMerieux	O
)	O
]	O
.	O

Bacterial	O
concentration	O
(	O
colony	O
-	O
forming	O
units	O
/	O
sample	O
=	O
CFU	O
/	O
sample	O
)	O
for	O
the	O
aerobic	O
and	O
anaerobic	O
flora	O
was	O
calculated	O
by	O
the	O
serial	O
dilution	O
method	O
of	O
counting	O
bacteria	O
.	O

106	O
strains	O
of	O
oral	O
streptococci	B-bacteria
were	O
isolated	O
from	O
dental	O
plaque	O
,	O
belonging	O
to	O
6	O
species	O
(	O
Streptococcus	B-bacteria
mitis	I-bacteria
,	O
Streptococcus	B-bacteria
oralis	I-bacteria
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Streptococcus	B-bacteria
salivarius	I-bacteria
,	O
Streptococcus	B-bacteria
sanguis	I-bacteria
and	O
Streptococcus	B-bacteria
acidominimus	I-bacteria
)	O
,	O
37	O
strains	O
of	O
oral	O
streptococci	B-bacteria
in	O
patients	O
from	O
group	O
I	O
(	O
T0	O
)	O
,	O
40	O
strains	O
from	O
group	O
II	O
(	O
T1	O
)	O
and	O
29	O
strains	O
of	O
oral	O
streptococci	B-bacteria
from	O
group	O
III	O
(	O
T2	O
)	O
.	O

After	O
3	O
months	O
(	O
T1	O
)	O
the	O
aerobic	O
bacteria	O
percentage	O
,	O
detected	O
at	O
a	O
concentration	O
between	O
10	O
(	O
5	O
)	O
and	O
10	O
(	O
6	O
)	O
,	O
increased	O
from	O
30	O
to	O
38	O
.	O
2	O
%	O
.	O

The	O
percentage	O
of	O
patients	O
with	O
a	O
bacterial	O
concentration	O
higher	O
than	O
10	O
(	O
6	O
)	O
CFU	O
/	O
sample	O
increased	O
from	O
5	O
%	O
to	O
8	O
.	O
8	O
%	O
.	O

The	O
samples	O
colected	O
at	O
T2	O
(	O
patients	O
examined	O
after	O
6	O
months	O
of	O
orthodonic	O
treatment	O
)	O
presented	O
a	O
lower	O
bacterial	O
concentration	O
,	O
as	O
compared	O
to	O
group	O
II	O
(	O
T1	O
)	O
.	O

The	O
most	O
common	O
isolated	O
species	O
of	O
streptococci	B-bacteria
were	O
S	B-bacteria
.	I-bacteria
salivarius	I-bacteria
,	O
S	B-bacteria
.	I-bacteria
oralis	I-bacteria
and	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
(	O
37	O
.	O
5	O
%	O
,	O
22	O
.	O
5	O
%	O
and	O
10	O
%	O
)	O
,	O
whose	O
frequency	O
increased	O
after	O
3	O
months	O
of	O
treatment	O
to	O
41	O
.	O
14	O
%	O
,	O
32	O
.	O
3	O
%	O
and	O
respectively	O
14	O
.	O
4	O
%	O
,	O
returning	O
after	O
6	O
months	O
of	O
treatment	O
at	O
values	O
similar	O
to	O
those	O
recorded	O
before	O
beginning	O
the	O
orthodontic	O
treatment	O
.	O

Presence	O
of	O
orthodontic	O
appliances	O
may	O
produce	O
a	O
transitory	O
increase	O
of	O
bacterial	O
concentration	O
(	O
CFU	O
/	O
sample	O
)	O
and	O
isolation	O
rate	O
of	O
oral	O
streptococci	B-bacteria
,	O
returning	O
to	O
the	O
level	O
prior	O
to	O
the	O
application	O
of	O
these	O
devices	O
after	O
a	O
time	O
interval	O
of	O
several	O
months	O
.	O

In	O
this	O
study	O
hypothesing	O
the	O
translocation	O
of	O
oral	O
bacteria	O
from	O
oropharynx	O
into	O
the	O
middle	O
ear	O
cavity	O
may	O
be	O
involved	O
in	O
the	O
pathogenesis	O
of	O
otitis	O
media	O
with	O
effusion	O
(	O
OME	O
)	O
,	O
we	O
aimed	O
to	O
investigate	O
the	O
presence	O
and	O
similarity	O
of	O
Fusobacterium	B-bacteria
nucleatum	I-bacteria
and	O
Treponema	B-bacteria
denticola	I-bacteria
in	O
saliva	O
,	O
nasopharyngeal	O
secretion	O
and	O
the	O
middle	O
ear	O
effusion	O
samples	O
from	O
the	O
children	O
with	O
OME	O
.	O

Totally	O
20	O
children	O
with	O
OME	O
undergoing	O
myringotomy	O
and	O
ventilation	O
tube	O
placement	O
were	O
attended	O
.	O

Stimulated	O
saliva	O
samples	O
were	O
collected	O
after	O
otorhinolaryngological	O
and	O
oral	O
examinations	O
were	O
done	O
.	O

The	O
middle	O
ear	O
effusion	O
and	O
nasopharyngeal	O
secretions	O
were	O
collected	O
during	O
the	O
operations	O
.	O

The	O
presence	O
of	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
and	O
T	B-bacteria
.	I-bacteria
denticola	I-bacteria
were	O
detected	O
using	O
16SrRNA	O
-	O
based	O
PCR	O
.	O

The	O
clonal	O
similarities	O
of	O
the	O
bacteria	O
were	O
detected	O
in	O
the	O
samples	O
which	O
the	O
same	O
bacteria	O
had	O
been	O
detected	O
in	O
each	O
samples	O
of	O
the	O
same	O
child	O
.	O

After	O
DNA	O
sequencing	O
,	O
clonal	O
similarity	O
was	O
determined	O
by	O
16SrRNA	O
gene	O
clone	O
library	O
analysis	O
.	O

The	O
sequences	O
from	O
each	O
clone	O
were	O
compared	O
with	O
similar	O
sequences	O
of	O
reference	O
organisms	O
by	O
FASTA	O
search	O
.	O

T	B-bacteria
.	I-bacteria
denticola	I-bacteria
was	O
detected	O
only	O
in	O
four	O
(	O
20	O
%	O
)	O
saliva	O
and	O
in	O
one	O
(	O
5	O
%	O
)	O
nasopharyngeal	O
sample	O
.	O

F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
was	O
detected	O
in	O
11	O
(	O
55	O
%	O
)	O
saliva	O
,	O
eight	O
(	O
40	O
%	O
)	O
nasopharyngeal	O
and	O
six	O
(	O
30	O
%	O
)	O
middle	O
ear	O
effusion	O
samples	O
.	O

Sequences	O
from	O
F	B-bacteria
.	I-bacteria
nucleatum	I-bacteria
clones	O
derived	O
from	O
three	O
different	O
anatomic	O
sites	O
within	O
patients	O
were	O
similar	O
in	O
33	O
%	O
of	O
OME	O
patients	O
,	O
indicating	O
their	O
genetic	O
relatedness	O
.	O

Bacteria	O
involved	O
in	O
this	O
process	O
most	O
likely	O
originate	O
from	O
the	O
oropharynx	O
since	O
they	O
show	O
a	O
close	O
genetic	O
relatedness	O
with	O
their	O
oropharyngeal	O
counterparts	O
.	O

Candida	O
albicans	O
frequently	O
causes	O
superficial	O
infections	O
by	O
invading	O
and	O
damaging	O
epithelial	O
cells	O
,	O
but	O
may	O
also	O
cause	O
systemic	O
infections	O
by	O
penetrating	O
through	O
epithelial	O
barriers	O
.	O

C	O
.	O
albicans	O
is	O
a	O
remarkable	O
pathogen	O
because	O
it	O
can	O
invade	O
epithelial	O
cells	O
via	O
two	O
distinct	O
mechanisms	O
:	O
induced	O
endocytosis	O
,	O
analogous	O
to	O
facultative	O
intracellular	O
enteropathogenic	O
bacteria	O
,	O
and	O
active	O
penetration	O
,	O
similar	O
to	O
plant	O
pathogenic	O
fungi	O
.	O

Here	O
we	O
investigated	O
the	O
contributions	O
of	O
the	O
two	O
invasion	O
routes	O
of	O
C	O
.	O
albicans	O
to	O
epithelial	O
invasion	O
.	O

Using	O
selective	O
cellular	O
inhibition	O
approaches	O
and	O
differential	O
fluorescence	O
microscopy	O
,	O
we	O
demonstrate	O
that	O
induced	O
endocytosis	O
contributes	O
considerably	O
to	O
the	O
early	O
time	O
points	O
of	O
invasion	O
,	O
while	O
active	O
penetration	O
represents	O
the	O
dominant	O
epithelial	O
invasion	O
route	O
.	O

Although	O
induced	O
endocytosis	O
depends	O
mainly	O
on	O
Als3	O
-	O
E	O
-	O
cadherin	O
interactions	O
,	O
we	O
observed	O
E	O
-	O
cadherin	O
independent	O
induced	O
endocytosis	O
.	O

Finally	O
,	O
we	O
provide	O
evidence	O
of	O
a	O
protective	O
role	O
for	O
serum	O
factors	O
in	O
oral	O
infection	O
:	O
human	O
serum	O
strongly	O
inhibited	O
C	O
.	O
albicans	O
adhesion	O
to	O
,	O
invasion	O
and	O
damage	O
of	O
oral	O
epithelial	O
cells	O
.	O

Probiotics	O
are	O
living	O
microorganisms	O
(	O
e	O
.	O
g	O
.	O
,	O
bacteria	O
)	O
that	O
are	O
either	O
the	O
same	O
as	O
or	O
similar	O
to	O
organisms	O
found	O
naturally	O
in	O
the	O
human	O
body	O
and	O
may	O
be	O
beneficial	O
to	O
health	O
.	O

Current	O
researches	O
have	O
shown	O
that	O
the	O
balance	O
between	O
beneficial	O
and	O
pathogenic	O
bacteria	O
is	O
essential	O
in	O
order	O
to	O
maintain	O
the	O
oral	O
health	O
.	O

Therefore	O
,	O
oral	O
cavity	O
has	O
recently	O
been	O
suggested	O
as	O
a	O
relevant	O
target	O
for	O
probiotic	O
applications	O
.	O

Dental	O
caries	O
can	O
be	O
seen	O
as	O
a	O
microbial	O
imbalance	O
where	O
the	O
oral	O
microbiota	O
shift	O
towards	O
community	O
dominance	O
which	O
produces	O
acidogenic	O
and	O
acid	O
-	O
tolerant	O
gram	O
positive	O
bacteria	O
.	O

Similarly	O
,	O
the	O
accumulation	O
of	O
bacteria	O
within	O
the	O
biofilm	O
,	O
facilitated	O
by	O
poor	O
oral	O
hygiene	O
,	O
predisposes	O
to	O
allogenic	O
shifts	O
in	O
the	O
microbial	O
community	O
,	O
leading	O
to	O
the	O
onset	O
of	O
periodontal	O
inflammation	O
.	O

probiotic	O
bacteria	O
belonging	O
to	O
the	O
genus	O
of	O
Lactobacillus	B-bacteria
,	O
Bifidobacterium	B-bacteria
and	O
Streptococcus	B-bacteria
have	O
been	O
proven	O
effective	O
for	O
preventing	O
caries	O
by	O
reducing	O
the	O
number	O
of	O
cariogenic	O
bacteria	O
in	O
saliva	O
after	O
a	O
short	O
period	O
of	O
consuming	O
the	O
probiotic	O
.	O

In	O
contrast	O
,	O
the	O
effect	O
of	O
probiotics	O
on	O
improving	O
gingivitis	O
and	O
periodontitis	O
has	O
been	O
less	O
investigated	O
.	O

The	O
currently	O
available	O
studies	O
on	O
the	O
effect	O
of	O
probiotics	O
on	O
periodontal	O
pathogens	O
and	O
clinical	O
periodontal	O
parameters	O
showed	O
differing	O
results	O
depending	O
on	O
the	O
strains	O
used	O
and	O
the	O
endpoints	O
analyzed	O
.	O

Many	O
of	O
the	O
clinical	O
studies	O
are	O
pilot	O
in	O
nature	O
and	O
with	O
low	O
quality	O
,	O
therefore	O
,	O
properly	O
conducted	O
clinical	O
trials	O
,	O
using	O
probiotic	O
strains	O
with	O
in	O
vitro	O
proven	O
periodontal	O
probiotic	O
effects	O
,	O
are	O
needed	O
.	O

The	O
putative	O
beneficial	O
effects	O
of	O
probiotics	O
on	O
oral	O
malodour	O
have	O
also	O
been	O
evaluated	O
,	O
but	O
further	O
evidence	O
is	O
needed	O
to	O
fully	O
explore	O
the	O
potential	O
of	O
probiotics	O
for	O
preventing	O
malodour	O
.	O

Campylobacter	B-bacteria
concisus	I-bacteria
,	O
a	O
bacterium	O
colonizing	O
the	O
human	O
oral	O
cavity	O
,	O
has	O
been	O
shown	O
to	O
be	O
associated	O
with	O
inflammatory	O
bowel	O
disease	O
(	O
IBD	O
)	O
.	O

This	O
study	O
investigated	O
if	O
patients	O
with	O
IBD	O
are	O
colonized	O
with	O
specific	O
oral	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
strains	I-bacteria
that	O
have	O
potential	O
to	O
cause	O
enteric	O
diseases	O
.	O

:	O
Seventy	O
oral	O
and	O
enteric	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
isolates	I-bacteria
obtained	O
from	O
eight	O
patients	O
with	O
IBD	O
and	O
six	O
controls	O
were	O
examined	O
for	O
housekeeping	O
genes	O
by	O
multilocus	O
sequence	O
typing	O
(	O
MLST	O
)	O
,	O
Caco2	O
cell	O
invasion	O
by	O
gentamicin	O
-	O
protection	O
-	O
assay	O
,	O
protein	O
analysis	O
by	O
mass	O
spectrometry	O
and	O
SDS	O
-	O
PAGE	O
,	O
and	O
morphology	O
by	O
scanning	O
electron	O
microscopy	O
.	O

The	O
whole	O
genome	O
sequenced	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
strain	I-bacteria
13826	I-bacteria
which	O
was	O
isolated	O
from	O
an	O
individual	O
with	O
bloody	O
diarrhea	O
was	O
included	O
in	O
MLST	O
analysis	O
.	O

:	O
MLST	O
analysis	O
showed	O
that	O
87	O
.	O
5	O
%	O
of	O
individuals	O
whose	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
belonged	O
to	O
Cluster	O
I	O
had	O
inflammatory	O
enteric	O
diseases	O
(	O
six	O
IBD	O
and	O
one	O
with	O
bloody	O
diarrhea	O
)	O
,	O
which	O
was	O
significantly	O
higher	O
than	O
that	O
in	O
the	O
remaining	O
individuals	O
(	O
28	O
.	O
6	O
%	O
)	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Enteric	B-bacteria
invasive	I-bacteria
C	I-bacteria
.	I-bacteria
concisus	I-bacteria
(	O
EICC	B-bacteria
)	O
oral	O
strain	O
was	O
detected	O
in	O
50	O
%	O
of	O
patients	O
with	O
IBD	O
and	O
none	O
of	O
the	O
controls	O
.	O

All	O
EICC	B-bacteria
strains	I-bacteria
were	O
in	O
Cluster	O
1	O
.	O

The	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
strain	I-bacteria
colonizing	O
intestinal	O
tissues	O
of	O
patient	O
No	O
.	O
1	O
was	O
closely	O
related	O
to	O
the	O
oral	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
strain	I-bacteria
from	O
patient	O
No	O
.	O
6	O
and	O
had	O
gene	O
recombination	O
with	O
the	O
patient	O
'	O
s	O
own	O
oral	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
.	O

The	O
oral	O
and	O
intestinal	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
strains	I-bacteria
of	O
patient	O
No	O
.	O
3	O
were	O
the	O
same	O
strain	O
.	O

Some	O
individuals	O
were	O
colonized	O
with	O
multiple	O
oral	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
strains	I-bacteria
that	O
have	O
undergone	O
natural	O
recombination	O
.	O

This	O
study	O
provides	O
the	O
first	O
evidence	O
that	O
patients	O
with	O
IBD	O
are	O
colonized	O
with	O
specific	O
oral	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
strains	I-bacteria
,	O
with	O
some	O
being	O
EICC	B-bacteria
strains	I-bacteria
.	O

C	B-bacteria
.	I-bacteria
concisus	I-bacteria
colonizing	O
intestinal	O
tissues	O
of	O
patients	O
with	O
IBD	O
at	O
least	O
in	O
some	O
instances	O
results	O
from	O
an	O
endogenous	O
colonization	O
of	O
the	O
patient	O
'	O
s	O
oral	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
and	O
that	O
C	B-bacteria
.	I-bacteria
concisus	I-bacteria
strains	I-bacteria
undergo	O
natural	O
recombination	O
.	O

Highantagonistic	O
strains	O
of	O
lactobacillus	B-bacteria
isolated	O
from	O
the	O
oral	O
cavity	O
of	O
healthy	O
people	O
,	O
genetically	O
identified	O
as	O
L	B-bacteria
.	I-bacteria
fermentum	I-bacteria
39	I-bacteria
,	O
L	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
50	I-bacteria
,	O
L	B-bacteria
.	I-bacteria
rhamnosus	I-bacteria
24	I-bacteria
,	O
showed	O
high	O
degree	O
of	O
autoaggregation	O
,	O
surface	O
hydrophobicity	O
,	O
coaggregation	O
,	O
adhesion	O
,	O
and	O
the	O
ability	O
to	O
form	O
biofilms	O
.	O

These	O
strains	O
can	O
be	O
used	O
to	O
create	O
new	O
probiotic	O
drugs	O
for	O
the	O
prevention	O
and	O
correction	O
the	O
dysbiosis	O
of	O
the	O
oral	O
cavity	O
.	O

The	O
phylogenetic	O
significance	O
of	O
the	O
diversity	O
of	O
key	O
enzymes	O
of	O
methylotrophic	O
and	O
autotrophic	O
metabolism	O
is	O
discussed	O
.	O

Primers	O
for	O
these	O
key	O
enzymes	O
were	O
designed	O
using	O
gene	O
sequences	O
encoding	O
methanol	O
dehydrogenase	O
(	O
mxaF	O
;	O
using	O
subsets	O
from	O
database	O
sequences	O
for	O
22	O
Bacteria	O
)	O
,	O
hydroxypyruvate	O
reductase	O
(	O
hpr	O
;	O
36	O
sequences	O
)	O
,	O
methylamine	O
dehydrogenase	O
(	O
mauA	O
;	O
12	O
sequences	O
)	O
,	O
methanesulfonate	O
monooxygenase	O
(	O
msmA	O
;	O
four	O
sequences	O
)	O
,	O
and	O
the	O
ccbL	O
and	O
cbbM	O
genes	O
of	O
ribulose	O
bisphosphate	O
carboxylase	O
(	O
26	O
and	O
23	O
sequences	O
)	O
.	O

These	O
were	O
effective	O
in	O
amplifying	O
the	O
correct	O
gene	O
products	O
for	O
the	O
target	O
genes	O
in	O
reference	O
organisms	O
and	O
in	O
test	O
organisms	O
not	O
previously	O
shown	O
to	O
contain	O
the	O
genes	O
,	O
as	O
well	O
as	O
in	O
some	O
methylotrophic	B-bacteria
Proteobacteria	I-bacteria
isolated	O
from	O
the	O
human	O
mouth	O
.	O

The	O
availability	O
of	O
the	O
new	O
primers	O
increases	O
the	O
probability	O
of	O
detecting	O
diverse	O
examples	O
of	O
the	O
genes	O
encoding	O
these	O
key	O
enzymes	O
both	O
in	O
natural	O
populations	O
and	O
in	O
isolated	O
bacterial	O
strains	O
.	O

The	O
objectives	O
of	O
this	O
study	O
were	O
to	O
identify	O
the	O
bacteria	O
involved	O
in	O
delayed	O
-	O
onset	O
infections	O
after	O
lower	O
third	O
molar	O
removal	O
and	O
to	O
determine	O
the	O
most	O
suitable	O
antibiotic	O
for	O
such	O
complication	O
.	O

Bacterial	O
samples	O
were	O
collected	O
from	O
13	O
patients	O
who	O
developed	O
delayed	O
-	O
onset	O
infections	O
after	O
lower	O
third	O
molar	O
extraction	O
.	O

After	O
the	O
identification	O
of	O
the	O
bacterial	O
isolates	O
,	O
the	O
in	O
vitro	O
antimicrobial	O
susceptibility	O
of	O
the	O
isolated	O
strains	O
was	O
determined	O
.	O

A	O
total	O
of	O
11	O
patients	O
(	O
12	O
samples	O
)	O
were	O
finally	O
included	O
in	O
the	O
study	O
.	O

Up	O
to	O
7	O
bacteria	O
genera	O
were	O
identified	O
.	O

Fusobacterium	B-bacteria
sp	I-bacteria
.	I-bacteria
was	O
present	O
in	O
11	O
patients	O
,	O
Prevotella	B-bacteria
sp	I-bacteria
.	I-bacteria
in	O
8	O
cases	O
,	O
and	O
Peptostreptococcus	B-bacteria
sp	I-bacteria
.	I-bacteria
in	O
7	O
.	O

Some	O
strains	O
of	O
these	O
bacteria	O
were	O
not	O
susceptible	O
to	O
amoxicillin	O
,	O
amoxicillin	O
/	O
clavulanate	O
,	O
and	O
metronidazol	O
,	O
whereas	O
no	O
resistances	O
were	O
found	O
to	O
clindamycin	O
.	O

Fusobacterium	B-bacteria
sp	I-bacteria
.	I-bacteria
,	O
Prevotella	B-bacteria
sp	I-bacteria
.	I-bacteria
,	O
and	O
Peptostreptococcus	B-bacteria
sp	I-bacteria
.	I-bacteria
are	O
frequently	O
present	O
in	O
delayed	O
-	O
onset	O
infections	O
after	O
lower	O
third	O
molar	O
removal	O
.	O

Based	O
on	O
the	O
results	O
of	O
the	O
microbial	O
susceptibility	O
tests	O
,	O
clindamycin	O
seems	O
to	O
be	O
the	O
most	O
adequate	O
antibiotic	O
for	O
the	O
treatment	O
of	O
this	O
complication	O
.	O

Bacteria	O
communicate	O
by	O
producing	O
quorum	O
sensing	O
molecules	O
called	O
autoinducers	O
,	O
which	O
include	O
autoinducer	O
-	O
1	O
,	O
an	O
N	O
-	O
hexanoyl	O
homoserine	O
lactone	O
(	O
AHL	O
)	O
,	O
and	O
autoinducer	O
-	O
2	O
.	O

Bacteria	O
present	O
in	O
the	O
human	O
oral	O
cavity	O
have	O
been	O
shown	O
to	O
produce	O
autoinducer	O
-	O
2	O
,	O
but	O
not	O
AHL	O
.	O

Here	O
,	O
we	O
report	O
the	O
isolation	O
of	O
two	O
AHL	O
-	O
producing	O
Klebsiella	B-bacteria
pneumoniae	I-bacteria
strains	I-bacteria
from	O
the	O
posterior	O
dorsal	O
surface	O
of	O
the	O
tongue	O
of	O
a	O
healthy	O
individual	O
.	O

Spent	O
culture	O
supernatant	O
extracts	O
from	O
K	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
activated	O
the	O
biosensors	O
Agrobacterium	B-bacteria
tumefaciens	I-bacteria
NTL4	I-bacteria
(	O
pZLR4	B-bacteria
)	O
and	O
Escherichia	B-bacteria
coli	I-bacteria
[	O
O	O
pSB401	B-bacteria
]	O
O	O
,	O
suggesting	O
the	O
presence	O
of	O
both	O
long	O
and	O
short	O
chain	O
AHLs	O
.	O

High	O
resolution	O
mass	O
spectrometry	O
analyses	O
of	O
these	O
extracts	O
confirmed	O
that	O
both	O
K	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
isolates	O
produced	O
N	O
-	O
octanoylhomoserine	O
lactone	O
and	O
N	O
-	O
3	O
-	O
dodecanoyl	O
-	O
L	O
-	O
homoserine	O
lactone	O
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
report	O
of	O
the	O
isolation	O
of	O
K	B-bacteria
.	I-bacteria
pneumoniae	I-bacteria
from	O
the	O
posterior	O
dorsal	O
surface	O
of	O
the	O
human	O
tongue	O
and	O
the	O
production	O
of	O
these	O
AHLs	O
by	O
this	O
bacterium	O
.	O

To	O
determine	O
whether	O
variation	O
in	O
glucan	O
synthesis	O
by	O
Streptococcus	B-bacteria
mutans	I-bacteria
isolates	I-bacteria
is	O
associated	O
with	O
caries	O
development	O
in	O
children	O
receiving	O
a	O
fluoride	O
mouth	O
rinse	O
(	O
FMR	O
)	O
.	O

Of	O
122	O
children	O
(	O
aged	O
9	O
to	O
10	O
years	O
)	O
,	O
64	O
had	O
received	O
FMR	O
(	O
FMR	O
(	O
+	O
)	O
group	O
)	O
and	O
the	O
remaining	O
58	O
children	O
had	O
not	O
(	O
FMR	O
(	O
-	O
)	O
group	O
)	O
.	O

The	O
number	O
of	O
decayed	O
and	O
filled	O
teeth	O
(	O
DFT	O
)	O
and	O
increases	O
in	O
the	O
number	O
of	O
DFT	O
in	O
1	O
year	O
(	O
dDFT	O
)	O
were	O
recorded	O
.	O

Saliva	O
samples	O
were	O
collected	O
to	O
isolate	O
the	O
clinical	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
strains	I-bacteria
.	O

The	O
isolates	O
were	O
incubated	O
in	O
heart	O
infusion	O
broth	O
supplemented	O
with	O
1	O
%	O
sucrose	O
,	O
then	O
the	O
amount	O
of	O
water	O
-	O
insoluble	O
glucan	O
(	O
WIG	O
)	O
formed	O
on	O
a	O
glass	O
tube	O
surface	O
was	O
evaluated	O
.	O

In	O
the	O
FMR	O
(	O
-	O
)	O
group	O
,	O
children	O
carrying	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
had	O
a	O
higher	O
DFT	O
(	O
P	O
=	O
0	O
.	O
039	O
)	O
and	O
tended	O
to	O
have	O
a	O
higher	O
dDFT	O
(	O
P	O
=	O
0	O
.	O
080	O
)	O
than	O
the	O
others	O
.	O

In	O
the	O
FMR	O
(	O
+	O
)	O
group	O
,	O
although	O
the	O
differences	O
between	O
children	O
with	O
and	O
without	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
were	O
not	O
significant	O
,	O
children	O
carrying	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
that	O
produced	O
a	O
high	O
amount	O
of	O
WIG	O
had	O
higher	O
dDFT	O
than	O
the	O
other	O
S	O
.	O
mutans	O
-	O
positive	O
children	O
(	O
P	O
=	O
0	O
.	O
034	O
)	O
.	O

This	O
study	O
revealed	O
that	O
the	O
variation	O
in	O
glucan	O
synthesis	O
by	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
is	O
associated	O
with	O
caries	O
development	O
in	O
children	O
receiving	O
a	O
FMR	O
.	O

Nickel	O
chromium	O
brackets	O
are	O
the	O
most	O
common	O
type	O
of	O
fixed	O
orthodontic	O
appliance	O
used	O
in	O
our	O
environment	O
and	O
may	O
alter	O
the	O
oral	O
microflora	O
.	O

This	O
study	O
aimed	O
to	O
determine	O
the	O
effect	O
of	O
nickel	O
chromium	O
brackets	O
in	O
orthodontic	O
treatment	O
on	O
the	O
oral	O
microflora	O
and	O
to	O
compare	O
with	O
a	O
control	O
group	O
of	O
dental	O
students	O
.	O

Thirty	O
-	O
eight	O
randomly	O
selected	O
participants	O
were	O
divided	O
into	O
two	O
groups	O
.	O

Group	O
1	O
was	O
19	O
orthodontic	O
patients	O
(	O
OS	O
)	O
with	O
anterior	O
segment	O
crowding	O
.	O

Group	O
2	O
were	O
19	O
normal	O
dental	O
students	O
(	O
DS	O
)	O
who	O
served	O
as	O
a	O
control	O
group	O
.	O

Two	O
samples	O
of	O
stimulated	O
saliva	O
were	O
collected	O
.	O

The	O
initial	O
sample	O
was	O
collected	O
before	O
the	O
placement	O
of	O
nickel	O
chromium	O
brackets	O
(	O
OS1	O
)	O
and	O
the	O
other	O
6	O
months	O
after	O
wearing	O
the	O
appliance	O
in	O
both	O
arches	O
(	O
OS2	O
)	O
for	O
group	O
1	O
.	O

Group	O
2	O
also	O
had	O
the	O
initial	O
(	O
DS1	O
)	O
and	O
second	O
samples	O
(	O
DS2	O
)	O
collected	O
after	O
a	O
6	O
month	O
interval	O
.	O

The	O
saliva	O
was	O
analysed	O
after	O
being	O
inoculated	O
onto	O
blood	O
,	O
chocolate	O
and	O
MacConkey	O
agar	O
plates	O
which	O
were	O
incubated	O
for	O
24	O
hours	O
at	O
37	O
degrees	O
C	O
aerobically	O
except	O
chocolate	O
agar	O
,	O
which	O
was	O
incubated	O
in	O
a	O
candle	O
extinction	O
jar	O
.	O

The	O
results	O
showed	O
that	O
Streptococcus	B-bacteria
viridans	I-bacteria
was	O
the	O
most	O
prevalent	O
microorganism	O
and	O
was	O
isolated	O
in	O
15	O
(	O
79	O
%	O
)	O
,	O
and	O
11	O
(	O
57	O
.	O
9	O
%	O
)	O
,	O
of	O
groups	O
OS1	O
and	O
DS1	O
respectively	O
.	O

There	O
was	O
no	O
statistical	O
difference	O
between	O
both	O
control	O
groups	O
OS1	O
and	O
DS1	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
,	O
and	O
treatment	O
groups	O
OS2	O
and	O
DS2	O
for	O
Streptococcus	B-bacteria
viridans	I-bacteria
.	O

There	O
was	O
a	O
significant	O
difference	O
between	O
DS1	O
with	O
7	O
(	O
36	O
.	O
8	O
%	O
)	O
and	O
OS1	O
with	O
2	O
(	O
10	O
.	O
5	O
%	O
)	O
for	O
Staphylococcus	B-bacteria
aureus	I-bacteria
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O

Klebsiella	B-bacteria
pneumoniae	I-bacteria
was	O
cultured	O
in	O
all	O
groups	O
except	O
OS2	O
.	O

There	O
was	O
also	O
no	O
statistically	O
significant	O
difference	O
between	O
groups	O
OS1	O
and	O
OS2	O
and	O
the	O
control	O
groups	O
DS1	O
and	O
DS2	O
for	O
all	O
the	O
organisms	O
cultured	O
.	O

There	O
was	O
no	O
change	O
in	O
composition	O
of	O
bacteria	O
between	O
groups	O
OS1	O
,	O
OS2	O
and	O
DS1	O
.	O

There	O
is	O
no	O
difference	O
in	O
the	O
oral	O
microflora	O
between	O
orthodontic	O
patients	O
and	O
normal	O
subjects	O
and	O
wearing	O
nickel	O
chromium	O
brackets	O
does	O
not	O
significantly	O
alter	O
the	O
composition	O
of	O
the	O
oral	O
microflora	O
.	O

A	O
comparative	O
study	O
was	O
carried	O
out	O
between	O
cinnamon	O
oil	O
and	O
clove	O
oil	O
on	O
the	O
oral	O
micro	O
-	O
biota	O
causing	O
dental	O
caries	O
.	O

Cinnamon	O
oil	O
was	O
found	O
to	O
be	O
more	O
effective	O
than	O
clove	O
oil	O
exhibiting	O
broad	O
spectrum	O
of	O
antibacterial	O
activity	O
inhibiting	O
all	O
the	O
ten	O
test	O
bacterial	O
species	O
involved	O
in	O
dental	O
caries	O
.	O

Cinnamon	O
oil	O
produced	O
maximum	O
inhibition	O
zone	O
of	O
diameter	O
(	O
IZD	O
)	O
of	O
24	O
.	O
0	O
mm	O
against	O
Streptococcus	B-bacteria
mutans	I-bacteria
(	O
major	O
causative	O
bacteria	O
of	O
dental	O
plaque	O
)	O
as	O
compared	O
to	O
clove	O
oil	O
(	O
IZD	O
=	O
13	O
.	O
0mm	O
)	O
.	O

This	O
is	O
contrary	O
to	O
the	O
popular	O
belief	O
that	O
clove	O
oil	O
is	O
effective	O
in	O
tooth	O
decay	O
and	O
dental	O
plaque	O
.	O

This	O
study	O
shows	O
the	O
potential	O
of	O
cinnamon	O
oil	O
over	O
clove	O
oil	O
in	O
the	O
treatment	O
of	O
dental	O
caries	O
.	O

Empirically	O
prescribed	O
antibiotics	O
are	O
widely	O
employed	O
in	O
the	O
management	O
of	O
odontogenic	O
infections	O
.	O

To	O
characterise	O
the	O
infections	O
associated	O
with	O
extracted	O
teeth	O
and	O
assess	O
effectiveness	O
of	O
the	O
antibiotics	O
prescribed	O
empirically	O
following	O
tooth	O
extraction	O
.	O

The	O
study	O
was	O
cross	O
-	O
sectional	O
and	O
consisted	O
of	O
41	O
consecutively	O
recruited	O
subjects	O
who	O
required	O
extraction	O
for	O
infections	O
associated	O
with	O
the	O
tooth	O
.	O

Appropriate	O
clinical	O
specimens	O
were	O
collected	O
aseptically	O
from	O
each	O
patient	O
and	O
transported	O
in	O
Stuart	O
'	O
s	O
transport	O
medium	O
for	O
processing	O
in	O
the	O
laboratory	O
.	O

Isolation	O
,	O
identification	O
,	O
and	O
susceptibility	O
pattern	O
of	O
anaerobic	O
and	O
facultative	O
organisms	O
were	O
done	O
employing	O
standard	O
bacteriologic	O
techniques	O
.	O

Antimicrobial	O
susceptibility	O
testing	O
was	O
performed	O
by	O
the	O
disc	O
diffusion	O
technique	O
.	O

There	O
were	O
positive	O
cultures	O
for	O
37	O
patients	O
.	O

Twenty	O
-	O
eight	O
aerobic	O
(	O
45	O
.	O
9	O
%	O
)	O
bacteria	O
and	O
32	O
anaerobic	O
(	O
54	O
.	O
1	O
%	O
)	O
bacteria	O
were	O
isolated	O
,	O
an	O
approximation	O
of	O
two	O
microorganisms	O
per	O
patient	O
.	O

Staphylococcus	B-bacteria
was	O
the	O
most	O
predominant	O
aerobe	O
(	O
25	O
.	O
0	O
%	O
)	O
whereas	O
Bacteroides	B-bacteria
fragilis	I-bacteria
was	O
the	O
most	O
predominant	O
anaerobe	O
(	O
34	O
.	O
2	O
%	O
)	O
.	O

All	O
the	O
bacteria	O
isolated	O
showed	O
in	O
vitro	O
resistance	O
to	O
cephalexin	O
,	O
cloxacillin	O
and	O
metronidazole	O
.	O

Eighteen	O
(	O
64	O
.	O
3	O
%	O
)	O
different	O
aerobic	O
bacteria	O
and	O
13	O
(	O
40	O
.	O
6	O
%	O
)	O
different	O
anaerobic	O
bacteria	O
were	O
sensitive	O
to	O
ciprofloxacillin	O
and	O
these	O
included	O
staphylococcus	B-bacteria
and	O
Bacteroides	B-bacteria
fragilis	I-bacteria
.	O

Sensitivity	O
pattern	O
for	O
amoxycillin	O
was	O
very	O
poor	O
with	O
3	O
.	O
6	O
%	O
and	O
6	O
.	O
3	O
%	O
for	O
aerobes	O
and	O
anaerobes	O
respectively	O
.	O

Odontogenic	O
infections	O
from	O
our	O
centre	O
are	O
polymicrobial	O
in	O
nature	O
with	O
anaerobes	O
predominating	O
.	O

High	O
resistance	O
to	O
most	O
of	O
the	O
antibiotics	O
routinely	O
prescribed	O
in	O
our	O
centre	O
is	O
common	O
.	O

Ciprofloxacillin	O
demonstrated	O
the	O
highest	O
sensitivity	O
pattern	O
.	O

The	O
efficacy	O
of	O
early	O
maternal	O
caries	O
prevention	O
was	O
evaluated	O
.	O

Furthermore	O
,	O
the	O
difference	O
between	O
children	O
colonised	O
with	O
mutans	B-bacteria
streptococci	I-bacteria
(	O
MS	B-bacteria
)	O
at	O
an	O
early	O
or	O
late	O
stage	O
with	O
regard	O
to	O
the	O
prevalence	O
of	O
carious	O
lesions	O
was	O
determined	O
.	O

The	O
children	O
of	O
first	O
-	O
time	O
mothers	O
selected	O
on	O
the	O
basis	O
of	O
high	O
salivary	O
levels	O
of	O
MS	B-bacteria
for	O
participation	O
in	O
a	O
caries	O
prevention	O
programme	O
were	O
recalled	O
at	O
the	O
age	O
of	O
19	O
years	O
.	O

They	O
were	O
examined	O
for	O
salivary	O
MS	B-bacteria
,	O
lesion	O
prevalence	O
(	O
decayed	O
and	O
filled	O
surfaces	O
,	O
DFS	O
)	O
and	O
MS	B-bacteria
in	O
plaque	O
from	O
12	O
selected	O
proximal	O
surfaces	O
.	O

The	O
recall	O
rate	O
was	O
70	O
%	O
for	O
the	O
children	O
of	O
both	O
the	O
high	O
-	O
control	O
and	O
interventional	O
groups	O
.	O

All	O
high	O
-	O
control	O
children	O
and	O
67	O
%	O
of	O
the	O
interventional	O
children	O
were	O
colonised	O
by	O
MS	B-bacteria
.	O

All	O
the	O
children	O
with	O
non	O
-	O
detectable	O
MS	B-bacteria
in	O
saliva	O
were	O
also	O
negative	O
in	O
all	O
plaque	O
samples	O
.	O

No	O
statistically	O
significant	O
difference	O
was	O
found	O
between	O
the	O
groups	O
in	O
terms	O
of	O
DFS	O
,	O
although	O
more	O
interventional	O
children	O
were	O
caries	O
free	O
than	O
in	O
the	O
control	O
group	O
.	O

Early	O
-	O
colonised	O
children	O
,	O
irrespective	O
of	O
group	O
identity	O
,	O
had	O
higher	O
salivary	O
MS	B-bacteria
levels	O
and	O
DFS	O
than	O
later	O
MS	O
-	O
colonised	O
children	O
.	O

The	O
results	O
indicate	O
that	O
it	O
is	O
possible	O
to	O
remain	O
negative	O
for	O
MS	B-bacteria
into	O
adulthood	O
if	O
non	O
-	O
colonised	O
at	O
an	O
early	O
age	O
and	O
this	O
affects	O
the	O
development	O
of	O
carious	O
lesions	O
.	O

Strategies	O
for	O
the	O
prevention	O
of	O
dental	O
caries	O
in	O
early	O
childhood	O
should	O
,	O
therefore	O
,	O
include	O
measures	O
to	O
prevent	O
or	O
delay	O
early	O
colonisation	O
by	O
cariogenic	O
bacteria	O
.	O

Oral	O
streptococci	B-bacteria
are	O
able	O
to	O
produce	O
growth	O
-	O
inhibiting	O
amounts	O
of	O
hydrogen	O
peroxide	O
(	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
)	O
as	O
byproduct	O
of	O
aerobic	O
metabolism	O
.	O

Several	O
recent	O
studies	O
showed	O
that	O
the	O
produced	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
is	O
not	O
a	O
simple	O
byproduct	O
of	O
metabolism	O
but	O
functions	O
in	O
several	O
aspects	O
of	O
oral	O
bacterial	O
biofilm	O
ecology	O
.	O

First	O
,	O
the	O
release	O
of	O
DNA	O
from	O
cells	O
is	O
closely	O
associated	O
to	O
the	O
production	O
of	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
in	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
and	O
Streptococcus	B-bacteria
gordonii	I-bacteria
.	O

Extracellular	O
DNA	O
is	O
crucial	O
for	O
biofilm	O
development	O
and	O
stabilization	O
and	O
can	O
also	O
serve	O
as	O
source	O
for	O
horizontal	O
gene	O
transfer	O
between	O
oral	O
streptococci	B-bacteria
.	O

Second	O
,	O
due	O
to	O
the	O
growth	O
inhibiting	O
nature	O
of	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
,	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
compatible	O
species	O
associate	O
with	O
the	O
producers	O
.	O

H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
production	O
therefore	O
might	O
help	O
in	O
structuring	O
the	O
initial	O
biofilm	O
development	O
.	O

On	O
the	O
other	O
hand	O
,	O
the	O
oral	O
environment	O
harbors	O
salivary	O
peroxidases	O
that	O
are	O
potent	O
in	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
scavenging	O
.	O

Therefore	O
,	O
the	O
effects	O
of	O
biofilm	O
intrinsic	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
production	O
might	O
be	O
locally	O
confined	O
.	O

However	O
,	O
taking	O
into	O
account	O
that	O
80	O
%	O
of	O
initial	O
oral	O
biofilm	O
constituents	O
are	O
streptococci	B-bacteria
,	O
the	O
influence	O
of	O
H	O
(	O
2	O
)	O
O	O
(	O
2	O
)	O
on	O
biofilm	O
development	O
and	O
environmental	O
adaptation	O
might	O
be	O
under	O
appreciated	O
in	O
current	O
research	O
.	O

Currently	O
there	O
are	O
no	O
evidence	O
-	O
based	O
ecological	O
measures	O
for	O
prevention	O
of	O
overgrowth	O
and	O
subsequent	O
infection	O
by	O
fungi	O
in	O
the	O
oral	O
cavity	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
increase	O
our	O
knowledge	O
on	O
fungal	O
-	O
bacterial	O
ecological	O
interactions	O
.	O

Salivary	O
Candida	O
abundance	O
of	O
82	O
Dutch	O
adults	O
aged	O
58	O
-	O
80	O
years	O
was	O
established	O
relative	O
to	O
the	O
bacterial	O
load	O
by	O
quantitative	O
PCR	O
analysis	O
of	O
the	O
Internal	O
Transcribed	O
(	O
ITS	O
)	O
region	O
(	O
Candida	O
)	O
and	O
16S	O
rDNA	O
gene	O
(	O
bacteria	O
)	O
.	O

The	O
salivary	O
microbiome	O
was	O
assessed	O
using	O
barcoded	O
pyrosequencing	O
of	O
the	O
bacterial	O
hypervariable	O
regions	O
V5	O
-	O
V7	O
of	O
16S	O
rDNA	O
.	O

Sequencing	O
data	O
was	O
preprocessed	O
by	O
denoising	O
and	O
chimera	O
removal	O
,	O
clustered	O
in	O
Operational	O
Taxonomic	O
Units	O
(	O
OTUs	O
)	O
and	O
assigned	O
to	O
taxonomy	O
.	O

Both	O
OTU	O
-	O
based	O
(	O
PCA	O
,	O
diversity	O
statistics	O
)	O
and	O
phylogeny	O
-	O
based	O
analyses	O
(	O
UniFrac	O
,	O
PCoA	O
)	O
were	O
performed	O
.	O

Saliva	O
of	O
Dutch	O
older	O
adults	O
contained	O
0	O
-	O
4	O
x	O
10	O
(	O
8	O
)	O
CFU	O
/	O
mL	O
Candida	O
with	O
a	O
median	O
Candida	O
load	O
of	O
0	O
.	O
06	O
%	O
.	O

With	O
increased	O
Candida	O
load	O
the	O
diversity	O
of	O
the	O
salivary	O
microbiome	O
decreased	O
significantly	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

Increase	O
in	O
the	O
Candida	O
load	O
correlated	O
positively	O
with	O
class	O
Bacilli	B-bacteria
,	O
and	O
negatively	O
with	O
class	O
Fusobacteria	B-bacteria
,	O
Flavobacteria	B-bacteria
,	O
and	O
Bacteroidia	B-bacteria
.	O

Microbiomes	O
with	O
high	O
Candida	O
load	O
were	O
less	O
diverse	O
and	O
had	O
a	O
distinct	O
microbial	O
composition	O
towards	O
dominance	O
by	O
saccharolytic	O
and	O
acidogenic	O
bacteria	O
-	O
-	O
streptococci	B-bacteria
.	O

The	O
control	O
of	O
the	O
acidification	O
of	O
the	O
oral	O
environment	O
may	O
be	O
a	O
potential	O
preventive	O
measure	O
for	O
Candida	O
outgrowth	O
that	O
should	O
be	O
evaluated	O
in	O
longitudinal	O
clinical	O
intervention	O
trials	O
.	O

The	O
purpose	O
of	O
the	O
present	O
study	O
was	O
to	O
evaluate	O
the	O
relationship	O
between	O
infection	O
with	O
cariogenic	O
bacteria	O
or	O
periodontal	O
pathogens	O
and	O
the	O
oral	O
condition	O
of	O
children	O
in	O
the	O
primary	O
and	O
mixed	O
dentition	O
stages	O
.	O

Children	O
aged	O
3	O
to	O
11	O
years	O
were	O
selected	O
Detection	O
of	O
cariogenic	O
and	O
periodontopathic	O
bacteria	O
and	O
single	O
nucleotide	O
polymorphism	O
(	O
SNP	O
)	O
analyses	O
were	O
performed	O
,	O
and	O
the	O
prevalence	O
of	O
infection	O
with	O
cariogenic	O
bacteria	O
or	O
periodontal	O
pathogens	O
based	O
on	O
caries	O
experience	O
and	O
dental	O
stage	O
was	O
compared	O
.	O

The	O
prevalence	O
of	O
Streptococcus	B-bacteria
mutans	I-bacteria
in	O
both	O
stages	O
was	O
significantly	O
higher	O
in	O
the	O
caries	O
group	O
than	O
in	O
the	O
caries	O
-	O
free	O
group	O
.	O

The	O
prevalence	O
of	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
was	O
significantly	O
higher	O
in	O
the	O
caries	O
group	O
only	O
in	O
the	O
mixed	O
dentition	O
stage	O
.	O

The	O
prevalence	O
ofperiodontal	O
pathogens	O
was	O
significantly	O
higher	O
in	O
the	O
mixed	O
dentition	O
stage	O
than	O
in	O
the	O
primary	O
dentition	O
stage	O
,	O
regardless	O
of	O
caries	O
experience	O
.	O

However	O
,	O
there	O
were	O
no	O
significant	O
differences	O
in	O
the	O
prevalence	O
of	O
the	O
periodontal	O
pathogens	O
between	O
the	O
primary	O
dentition	O
and	O
mixed	O
dentition	O
stages	O
,	O
based	O
on	O
caries	O
experience	O
.	O

Our	O
data	O
suggested	O
that	O
cariogenic	O
and	O
periodontopathic	O
bacteria	O
have	O
different	O
infection	O
patterns	O
,	O
and	O
that	O
the	O
period	O
of	O
infection	O
with	O
these	O
bacteria	O
also	O
differs	O
.	O

Congenital	O
heart	O
disease	O
(	O
CHD	O
)	O
,	O
abnormalities	O
in	O
the	O
structural	O
development	O
of	O
the	O
heart	O
,	O
occurs	O
in	O
approximately	O
8	O
:	O
1000	O
live	O
births	O
.	O

The	O
causative	O
microorganism	O
for	O
infective	O
endocarditis	O
in	O
more	O
than	O
60	O
%	O
of	O
the	O
patients	O
with	O
positive	O
hemoculture	O
of	O
viridans	B-bacteria
streptococci	I-bacteria
(	O
s	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
s	B-bacteria
.	I-bacteria
mitior	I-bacteria
)	O
thus	O
making	O
it	O
mandatory	O
for	O
these	O
children	O
to	O
maintain	O
their	O
oral	O
health	O
.	O

The	O
present	O
study	O
assessed	O
the	O
oral	O
health	O
of	O
children	O
with	O
congenital	O
heart	O
disease	O
following	O
preventive	O
treatment	O
.	O

A	O
total	O
of	O
74	O
children	O
with	O
congenital	O
heart	O
disease	O
were	O
selected	O
for	O
the	O
study	O
with	O
30	O
healthy	O
controls	O
between	O
the	O
ages	O
5	O
-	O
16	O
.	O

The	O
oral	O
health	O
was	O
assessed	O
by	O
measuring	O
the	O
microbial	O
counts	O
,	O
the	O
OHI	O
-	O
S	O
and	O
the	O
gingival	O
indices	O
.	O

The	O
data	O
thus	O
obtained	O
were	O
subjected	O
to	O
paired	O
and	O
unpaired	O
t	O
-	O
test	O
.	O

Poor	O
oral	O
health	O
was	O
prevalent	O
among	O
these	O
children	O
of	O
the	O
study	O
group	O
as	O
compared	O
to	O
the	O
controls	O
indicating	O
a	O
lack	O
of	O
sound	O
knowledge	O
of	O
the	O
maintenance	O
of	O
oral	O
hygiene	O
.	O

Following	O
preventive	O
treatment	O
the	O
oral	O
health	O
improved	O
considerably	O
.	O

Interaction	O
of	O
oral	O
streptococci	B-bacteria
biofilm	O
is	O
the	O
main	O
etiological	O
factor	O
for	O
dental	O
caries	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
compare	O
oral	B-bacteria
streptococci	I-bacteria
(	O
OS	B-bacteria
)	O
distribution	O
in	O
the	O
biofilm	O
of	O
primary	O
dentition	O
from	O
caries	O
-	O
free	O
and	O
caries	O
-	O
affected	O
preschool	O
Mexican	O
children	O
.	O

This	O
cross	O
-	O
sectional	O
study	O
involved	O
40	O
caries	O
-	O
free	O
and	O
40	O
caries	O
-	O
affected	O
children	O
with	O
primary	O
dentition	O
.	O

Each	O
child	O
was	O
examined	O
using	O
the	O
dmfs	O
index	O
,	O
DNA	O
was	O
extracted	O
from	O
saliva	O
and	O
presence	O
of	O
OS	B-bacteria
was	O
determined	O
by	O
PCR	O
.	O

Data	O
obtained	O
showed	O
no	O
statistical	O
difference	O
regarding	O
age	O
and	O
gender	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
.	O

Streptococcus	B-bacteria
mutans	I-bacteria
(	O
Smut	B-bacteria
)	O
,	O
Streptococcus	B-bacteria
sobrinus	I-bacteria
(	O
Ssob	B-bacteria
)	O
and	O
their	O
combination	O
showed	O
significant	O
statistical	O
differences	O
between	O
groups	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

Smut	B-bacteria
,	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
and	O
Streptococcus	B-bacteria
gordonii	I-bacteria
had	O
an	O
inverse	O
relation	O
with	O
dmfs	O
index	O
and	O
Ssob	B-bacteria
had	O
a	O
direct	O
relation	O
similar	O
to	O
combined	O
with	O
Smut	B-bacteria
.	O

Smut	B-bacteria
-	O
Ssob	B-bacteria
combined	O
with	O
other	O
OS	B-bacteria
showed	O
statistical	O
differences	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
.	O

In	O
free	O
-	O
caries	O
group	O
Streptococcus	B-bacteria
gordonii	I-bacteria
was	O
more	O
frequently	O
identified	O
than	O
Smut	B-bacteria
.	O

The	O
ratio	O
Smut	B-bacteria
/	O
Streptococcus	B-bacteria
sanguinis	I-bacteria
could	O
represent	O
a	O
high	O
risk	O
of	O
dental	O
caries	O
development	O
;	O
this	O
ratio	O
was	O
higher	O
in	O
the	O
caries	O
-	O
affected	O
(	O
1	O
.	O
18	O
)	O
than	O
in	O
the	O
caries	O
-	O
free	O
group	O
(	O
0	O
.	O
32	O
)	O
.	O

In	O
conclusion	O
,	O
OS	B-bacteria
play	O
an	O
important	O
role	O
in	O
dental	O
caries	O
predisposition	O
and	O
severity	O
,	O
not	O
only	O
the	O
presence	O
of	O
Smut	B-bacteria
and	O
Srob	B-bacteria
,	O
but	O
also	O
the	O
complexity	O
and	O
distribution	O
of	O
OS	B-bacteria
in	O
the	O
biofilm	O
.	O

Mouthwashes	O
decrease	O
the	O
risk	O
of	O
VAP	O
by	O
reducing	O
the	O
number	O
of	O
microorganisms	O
and	O
their	O
transmission	O
and	O
colonization	O
in	O
the	O
lung	O
.	O

Among	O
the	O
oral	O
rinses	O
,	O
chlorhexidine	O
is	O
considered	O
as	O
the	O
gold	O
standard	O
but	O
it	O
has	O
a	O
variety	O
of	O
complications	O
.	O

The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	O
and	O
compare	O
anti	O
-	O
bacterial	O
effects	O
of	O
the	O
chlorhexidine	O
gluconate	O
and	O
herbal	O
mouthwashes	O
in	O
intensive	O
care	O
unit	O
patients	O
.	O

In	O
this	O
double	O
blind	O
randomized	O
clinical	O
trial	O
,	O
60	O
patients	O
who	O
were	O
admitted	O
in	O
ICU	O
were	O
divided	O
into	O
two	O
equal	O
30	O
persons	O
groups	O
.	O

In	O
the	O
first	O
group	O
Chlorhexidine	O
gluconate	O
2	O
%	O
mouthwash	O
and	O
in	O
the	O
second	O
group	O
herbal	O
mouth	O
wash	O
was	O
used	O
.	O

Just	O
before	O
and	O
again	O
after	O
6	O
min	O
of	O
oral	O
rinsing	O
,	O
salivary	O
samples	O
were	O
obtained	O
without	O
any	O
stimulation	O
in	O
order	O
to	O
culture	O
Staphylococcus	B-bacteria
aureus	I-bacteria
and	O
Streptococcus	B-bacteria
pneumoniae	I-bacteria
.	O

The	O
data	O
were	O
processed	O
in	O
SPSS16	O
software	O
and	O
were	O
analyzed	O
by	O
appropriate	O
statistical	O
tests	O
.	O

Matrica	O
(	O
R	O
)	O
and	O
chlorhexidine	O
mouthwashes	O
have	O
significant	O
antibacterial	O
effects	O
against	O
Streptococcus	B-bacteria
pneumoniae	I-bacteria
and	O
Staphylococcus	B-bacteria
aureus	I-bacteria
.	O

Decreasing	O
of	O
the	O
number	O
of	O
bacteria	O
in	O
samples	O
after	O
oral	O
rinsing	O
was	O
significant	O
in	O
both	O
groups	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
but	O
chlorhexidine	O
was	O
significantly	O
more	O
effective	O
than	O
herbal	O
mouth	O
wash	O
in	O
reducing	O
the	O
number	O
of	O
colonies	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O

The	O
herbal	O
mouth	O
wash	O
has	O
significant	O
antibacterial	O
effects	O
against	O
Staphylococcus	B-bacteria
aureus	I-bacteria
and	O
Streptococcus	B-bacteria
pneumoniae	I-bacteria
,	O
but	O
its	O
efficacy	O
is	O
less	O
than	O
chlorhexidine	O
,	O
so	O
after	O
further	O
investigation	O
,	O
it	O
would	O
be	O
considered	O
as	O
an	O
alternative	O
to	O
chlorhexidine	O
in	O
ICUs	O
(	O
Tab	O
.	O
3	O
,	O
Ref	O
.	O
33	O
)	O
.	O

Outbreaks	O
of	O
antibiotic	O
-	O
resistant	O
bacterial	O
infections	O
emphasize	O
the	O
importance	O
of	O
surveillance	O
of	O
potentially	O
pathogenic	O
bacteria	O
.	O

Genomic	O
sequencing	O
of	O
clinical	O
microbiological	O
specimens	O
expands	O
our	O
capacity	O
to	O
cultivable	O
,	O
fastidious	O
and	O
uncultivable	O
members	O
of	O
the	O
bacterial	O
community	O
.	O

Herein	O
,	O
we	O
compared	O
the	O
primary	O
data	O
collected	O
by	O
the	O
NIH	O
'	O
s	O
Human	O
Microbiome	O
Project	O
(	O
HMP	O
)	O
with	O
published	O
epidemiological	O
surveillance	O
data	O
of	O
Staphylococcus	B-bacteria
aureus	I-bacteria
.	O

The	O
HMP	O
'	O
s	O
initial	O
dataset	O
contained	O
microbial	O
survey	O
data	O
from	O
five	O
body	O
regions	O
(	O
skin	O
,	O
nares	O
,	O
oral	O
cavity	O
,	O
gut	O
and	O
vagina	O
)	O
of	O
242	O
healthy	O
volunteers	O
.	O

A	O
significant	O
component	O
of	O
the	O
HMP	O
dataset	O
was	O
deep	O
sequencing	O
of	O
the	O
16S	O
ribosomal	O
RNA	O
gene	O
,	O
which	O
contains	O
variable	O
regions	O
enabling	O
taxonomic	O
classification	O
.	O

Since	O
species	O
-	O
level	O
identification	O
is	O
essential	O
in	O
clinical	O
microbiology	O
,	O
we	O
built	O
a	O
reference	O
database	O
and	O
used	O
phylogenetic	O
placement	O
followed	O
by	O
most	O
recent	O
common	O
ancestor	O
classification	O
to	O
look	O
at	O
the	O
species	O
distribution	O
for	O
Staphylococcus	B-bacteria
,	O
Klebsiella	B-bacteria
and	O
Enterococcus	B-bacteria
.	O

We	O
show	O
that	O
selecting	O
the	O
accurate	O
region	O
of	O
the	O
16S	O
rRNA	O
gene	O
to	O
sequence	O
is	O
analogous	O
to	O
carefully	O
selecting	O
culture	O
conditions	O
to	O
distinguish	O
closely	O
related	O
bacterial	O
species	O
.	O

Analysis	O
of	O
the	O
HMP	O
data	O
showed	O
that	O
Staphylococcus	B-bacteria
aureus	I-bacteria
was	O
present	O
in	O
the	O
nares	O
of	O
36	O
%	O
of	O
healthy	O
volunteers	O
,	O
consistent	O
with	O
culture	O
-	O
based	O
epidemiological	O
data	O
.	O

Klebsiella	B-bacteria
pneumoniae	I-bacteria
and	O
Enterococcus	B-bacteria
faecalis	I-bacteria
were	O
found	O
less	O
frequently	O
,	O
but	O
across	O
many	O
habitats	O
.	O

This	O
work	O
demonstrates	O
that	O
large	O
16S	O
rRNA	O
survey	O
studies	O
can	O
be	O
used	O
to	O
support	O
epidemiological	O
goals	O
in	O
the	O
context	O
of	O
an	O
increasing	O
awareness	O
that	O
microbes	O
flourish	O
and	O
compete	O
within	O
a	O
larger	O
bacterial	O
community	O
.	O

This	O
demonstrates	O
how	O
genomic	O
techniques	O
and	O
information	O
could	O
be	O
critically	O
important	O
to	O
trace	O
microbial	O
evolution	O
and	O
implement	O
hospital	O
infection	O
control	O
.	O

The	O
mouth	O
is	O
a	O
complex	O
biological	O
structure	O
inhabited	O
by	O
diverse	O
bacterial	O
communities	O
.	O

The	O
purpose	O
of	O
this	O
study	O
is	O
to	O
describe	O
the	O
effects	O
of	O
allogeneic	O
stem	O
cell	O
transplantation	O
on	O
the	O
oral	O
microbiota	O
and	O
to	O
examine	O
differences	O
among	O
those	O
patients	O
who	O
acquired	O
respiratory	O
complications	O
after	O
transplantation	O
.	O

All	O
patients	O
were	O
consented	O
at	O
the	O
National	O
Institutes	O
of	O
Health	O
,	O
Clinical	O
Center	O
.	O

Bacterial	O
DNA	O
was	O
analyzed	O
from	O
patients	O
'	O
oral	O
specimens	O
using	O
the	O
Human	O
Oral	O
Microbe	O
Identification	O
Microarray	O
.	O

The	O
specimens	O
were	O
collected	O
from	O
four	O
oral	O
sites	O
in	O
45	O
allogeneic	O
transplantation	O
patients	O
.	O

Specimens	O
were	O
collected	O
at	O
baseline	O
prior	O
to	O
transplantation	O
,	O
after	O
transplantation	O
at	O
the	O
nadir	O
of	O
the	O
neutrophil	O
count	O
and	O
after	O
myeloid	O
engraftment	O
.	O

If	O
respiratory	O
signs	O
and	O
symptoms	O
developed	O
,	O
additional	O
specimens	O
were	O
obtained	O
.	O

Patients	O
were	O
followed	O
for	O
100	O
days	O
post	O
transplantation	O
.	O

Eleven	O
patients	O
'	O
specimens	O
were	O
subjected	O
to	O
further	O
statistical	O
analysis	O
.	O

Many	O
common	O
bacterial	O
genera	O
,	O
such	O
as	O
Streptococcus	B-bacteria
,	O
Veillonella	B-bacteria
,	O
Gemella	B-bacteria
,	O
Granulicatella	B-bacteria
and	O
Camplyobacter	B-bacteria
were	O
identified	O
as	O
being	O
present	O
before	O
and	O
after	O
transplantation	O
.	O

Five	O
of	O
11	O
patients	O
developed	O
respiratory	O
complications	O
following	O
transplantation	O
and	O
there	O
was	O
preliminary	O
evidence	O
that	O
the	O
oral	O
microbiome	O
changed	O
in	O
their	O
oral	O
specimens	O
.	O

Cluster	O
analysis	O
and	O
principal	O
component	O
analysis	O
revealed	O
this	O
change	O
in	O
the	O
oral	O
microbiota	O
.	O

After	O
allogeneic	O
transplantation	O
,	O
the	O
oral	O
bacterial	O
community	O
'	O
s	O
response	O
to	O
a	O
new	O
immune	O
system	O
was	O
not	O
apparent	O
and	O
many	O
of	O
the	O
most	O
common	O
core	O
oral	O
taxa	O
remained	O
unaffected	O
.	O

However	O
,	O
the	O
oral	O
microbiome	O
was	O
affected	O
in	O
patients	O
who	O
developed	O
respiratory	O
signs	O
and	O
symptoms	O
after	O
transplantation	O
.	O

The	O
association	O
related	O
to	O
the	O
change	O
in	O
the	O
oral	O
microbiota	O
and	O
respiratory	O
complications	O
after	O
transplantation	O
will	O
be	O
validated	O
by	O
future	O
studies	O
using	O
high	O
throughput	O
molecular	O
methods	O
.	O

Antimicrobial	O
resistance	O
is	O
on	O
the	O
increase	O
in	O
'	O
medical	O
and	O
dental	O
fields	O
.	O

Beta	O
-	O
lactam	O
antibiotics	O
are	O
the	O
most	O
widely	O
used	O
antimicrobials	O
in	O
dental	O
patients	O
.	O

This	O
study	O
investigated	O
the	O
prevalence	O
of	O
beta	O
-	O
lactamase	O
-	O
producing	O
anaerobic	O
oral	O
bacteria	O
in	O
patients	O
with	O
chronic	O
periodontitis	O
.	O

Pooled	O
subgingival	O
samples	O
from	O
two	O
sites	O
in	O
42	O
patients	O
with	O
chronic	O
periodontitis	O
were	O
cultured	O
anaerobically	O
on	O
blood	O
agar	O
plates	O
containing	O
amoxycillin	O
or	O
/	O
and	O
Augmentin	O
.	O

Colonies	O
that	O
grew	O
on	O
amoxycillin	O
but	O
not	O
Augmentin	O
were	O
identified	O
and	O
tested	O
for	O
beta	O
-	O
lactamase	O
production	O
.	O

Sixty	O
-	O
nine	O
percent	O
of	O
patients	O
carried	O
beta	O
-	O
lactamase	O
-	O
producing	O
anaerobes	O
,	O
with	O
a	O
mean	O
of	O
one	O
to	O
two	O
strains	O
per	O
patient	O
.	O

Seventy	O
isolates	O
of	O
the	O
beta	O
-	O
lactamase	O
-	O
producing	O
strains	O
formed	O
4	O
%	O
of	O
the	O
total	O
cultivable	O
anaerobic	O
flora	O
.	O

Prevotella	B-bacteria
was	O
the	O
most	O
prevalent	O
beta	O
-	O
lactamase	O
-	O
producing	O
species	O
,	O
followed	O
by	O
Capnocytophaga	B-bacteria
,	O
Veillonella	B-bacteria
and	O
Bacteroides	B-bacteria
.	O

A	O
high	O
prevalence	O
of	O
beta	O
-	O
lactamase	O
-	O
producing	O
oral	O
anaerobes	O
was	O
detected	O
in	O
this	O
preliminary	O
study	O
.	O

However	O
,	O
the	O
percentage	O
of	O
beta	O
-	O
lactamase	O
producers	O
in	O
the	O
total	O
number	O
of	O
bacteria	O
per	O
patient	O
was	O
low	O
.	O

Therefore	O
,	O
beta	O
-	O
lactam	O
antibiotics	O
still	O
remain	O
the	O
drug	O
of	O
choice	O
in	O
infections	O
with	O
odontogenic	O
origin	O
.	O

The	O
objective	O
of	O
the	O
present	O
study	O
was	O
to	O
evaluate	O
the	O
bacterial	O
diversity	O
in	O
the	O
saliva	O
of	O
patients	O
with	O
different	O
oral	O
hygiene	O
indexes	O
using	O
of	O
two	O
16S	O
rRNA	O
gene	O
libraries	O
.	O

Each	O
library	O
was	O
composed	O
of	O
samples	O
from	O
patients	O
with	O
different	O
averages	O
of	O
the	O
differentiated	O
Silness	O
-	O
Loe	O
biofilm	O
index	O
:	O
the	O
first	O
library	O
(	O
A	O
)	O
with	O
an	O
index	O
between	O
1	O
.	O
0	O
and	O
3	O
.	O
0	O
(	O
considered	O
a	O
high	O
index	O
)	O
and	O
the	O
second	O
library	O
(	O
B	O
)	O
between	O
0	O
and	O
0	O
.	O
5	O
(	O
considered	O
a	O
low	O
index	O
)	O
.	O

Saliva	O
DNA	O
was	O
extracted	O
and	O
the	O
16S	O
rRNA	O
gene	O
was	O
amplified	O
and	O
cloned	O
.	O

The	O
obtained	O
sequences	O
were	O
compared	O
with	O
those	O
stored	O
at	O
NCBI	O
and	O
RDP	O
GenBank	O
.	O

The	O
saliva	O
of	O
patients	O
with	O
high	O
index	O
presented	O
five	O
known	O
genera	O
-	O
Streptococcus	B-bacteria
,	O
Granulicatella	B-bacteria
,	O
Gemella	B-bacteria
,	O
Veillonella	B-bacteria
and	O
Peptostreptococcus	B-bacteria
-	O
and	O
33	O
.	O
3	O
%	O
of	O
nonculturable	O
bacteria	O
grouped	O
into	O
23	O
operational	O
taxonomic	O
units	O
(	O
OTUs	O
)	O
.	O

The	O
saliva	O
of	O
patients	O
with	O
low	O
index	O
differed	O
significantly	O
from	O
the	O
first	O
library	O
(	O
p	O
=	O
0	O
.	O
000	O
)	O
and	O
was	O
composed	O
of	O
42	O
OTUs	O
distributed	O
into	O
11	O
known	O
genera	O
-	O
Streptococcus	B-bacteria
,	O
Granulicatella	B-bacteria
,	O
Gemella	B-bacteria
,	O
Veillonella	B-bacteria
,	O
Oribacterium	B-bacteria
,	O
Haemophilus	B-bacteria
,	O
Escherichia	B-bacteria
,	O
Neisseria	B-bacteria
,	O
Prevotella	B-bacteria
,	O
Capnocytophaga	B-bacteria
,	O
Actinomyces	B-bacteria
-	O
including	O
24	O
.	O
87	O
%	O
of	O
nonculturable	O
bacteria	O
.	O

It	O
was	O
possible	O
to	O
conclude	O
that	O
there	O
is	O
greater	O
bacterial	O
diversity	O
in	O
the	O
saliva	O
of	O
patients	O
with	O
low	O
dental	O
plaque	O
in	O
relation	O
to	O
patients	O
with	O
high	O
dental	O
plaque	O
.	O

The	O
objective	O
of	O
this	O
study	O
was	O
to	O
assess	O
the	O
possible	O
modifications	O
due	O
to	O
amoxicillin	O
-	O
clavulanic	O
acid	O
(	O
AMC	O
)	O
treatment	O
on	O
total	O
bacteria	O
and	O
on	O
Bifidobacterium	B-bacteria
species	I-bacteria
balance	O
in	O
human	O
colonic	O
microbiota	O
.	O

Eighteen	O
healthy	O
volunteers	O
(	O
19	O
to	O
36	O
years	O
old	O
)	O
were	O
given	O
a	O
875	O
/	O
125	O
mg	O
dose	O
of	O
AMC	O
twice	O
a	O
day	O
for	O
5	O
days	O
.	O

Fecal	O
samples	O
were	O
obtained	O
before	O
and	O
after	O
antibiotic	O
exposure	O
.	O

After	O
total	O
DNA	O
extraction	O
,	O
total	O
bacteria	O
and	O
bifidobacteria	B-bacteria
were	O
specifically	O
quantified	O
using	O
real	O
-	O
time	O
PCR	O
.	O

Dominant	O
species	O
were	O
monitored	O
over	O
time	O
using	O
bacterial	O
and	O
bifidobacterial	O
Temporal	O
Temperature	O
Gradient	O
gel	O
Electrophoresis	O
(	O
TTGE	O
)	O
.	O

At	O
the	O
end	O
of	O
AMC	O
exposure	O
,	O
total	O
bacterial	O
concentrations	O
as	O
well	O
as	O
bifidobacteria	B-bacteria
concentrations	O
were	O
significantly	O
reduced	O
compared	O
to	O
before	O
AMC	O
exposure	O
:	O
10	O
.	O
7	O
+	O
/	O
-	O
0	O
.	O
1	O
log	O
(	O
10	O
)	O
16S	O
rRNA	O
gene	O
copies	O
/	O
g	O
vs	O
11	O
.	O
1	O
+	O
/	O
-	O
0	O
.	O
1	O
log	O
(	O
10	O
)	O
(	O
p	O
=	O
0	O
.	O
003	O
)	O
and	O
8	O
.	O
1	O
+	O
/	O
-	O
0	O
.	O
5	O
log	O
(	O
10	O
)	O
16S	O
rRNA	O
gene	O
copies	O
/	O
g	O
vs	O
9	O
.	O
4	O
+	O
/	O
-	O
0	O
.	O
3	O
log	O
(	O
10	O
)	O
(	O
p	O
=	O
0	O
.	O
003	O
)	O
,	O
respectively	O
.	O

At	O
the	O
same	O
time	O
,	O
the	O
mean	O
similarity	O
percentages	O
of	O
TTGE	O
bacteria	O
and	O
TTGE	O
bifidobacteria	B-bacteria
profiles	O
were	O
significantly	O
reduced	O
compared	O
to	O
before	O
AMC	O
exposure	O
:	O
51	O
.	O
6	O
%	O
+	O
/	O
-	O
3	O
.	O
5	O
%	O
vs	O
81	O
.	O
4	O
%	O
+	O
/	O
-	O
2	O
.	O
1	O
%	O
and	O
55	O
.	O
8	O
%	O
+	O
/	O
-	O
7	O
.	O
6	O
%	O
vs	O
84	O
.	O
5	O
%	O
+	O
/	O
-	O
4	O
.	O
1	O
%	O
,	O
respectively	O
.	O

Occurrence	O
of	O
B	B-bacteria
.	I-bacteria
adolescentis	I-bacteria
,	O
B	B-bacteria
.	I-bacteria
bifidum	I-bacteria
and	O
B	B-bacteria
.	I-bacteria
pseudocatenulatum	I-bacteria
/	O
B	B-bacteria
.	I-bacteria
catenulatum	I-bacteria
species	I-bacteria
significantly	O
decreased	O
.	O

Occurrence	O
of	O
B	B-bacteria
.	I-bacteria
longum	I-bacteria
remained	O
stable	O
.	O

Moreover	O
,	O
the	O
number	O
of	O
distinct	O
Bifidobacterium	B-bacteria
species	I-bacteria
per	O
sample	O
significantly	O
decreased	O
(	O
1	O
.	O
5	O
+	O
/	O
-	O
0	O
.	O
3	O
vs	O
2	O
.	O
3	O
+	O
/	O
-	O
0	O
.	O
3	O
;	O
p	O
=	O
0	O
.	O
01	O
)	O
.	O

Two	O
months	O
after	O
AMC	O
exposure	O
,	O
the	O
mean	O
similarity	O
percentage	O
of	O
TTGE	O
profiles	O
was	O
55	O
.	O
6	O
%	O
for	O
bacteria	O
and	O
62	O
.	O
3	O
%	O
for	O
bifidobacteria	B-bacteria
.	O

These	O
results	O
clearly	O
demonstrated	O
that	O
a	O
common	O
antibiotic	O
treatment	O
may	O
qualitatively	O
alter	O
the	O
colonic	O
microbiota	O
.	O

Such	O
modifications	O
may	O
have	O
potential	O
long	O
-	O
term	O
physiological	O
consequences	O
.	O

Periodontal	O
(	O
gum	O
)	O
disease	O
is	O
one	O
of	O
the	O
main	O
global	O
oral	O
health	O
burdens	O
and	O
severe	O
periodontal	O
disease	O
(	O
periodontitis	O
)	O
is	O
a	O
leading	O
cause	O
of	O
tooth	O
loss	O
in	O
adults	O
globally	O
.	O

It	O
also	O
increases	O
the	O
risk	O
of	O
cardiovascular	O
disease	O
and	O
diabetes	O
mellitus	O
.	O

Porphyromonas	B-bacteria
gingivalis	I-bacteria
lipopolysaccharide	O
(	O
LPS	O
)	O
is	O
a	O
key	O
virulent	O
attribute	O
that	O
significantly	O
contributes	O
to	O
periodontal	O
pathogenesis	O
.	O

Baicalin	O
is	O
a	O
flavonoid	O
from	O
Scutellaria	O
radix	O
,	O
an	O
herb	O
commonly	O
used	O
in	O
traditional	O
Chinese	O
medicine	O
for	O
treating	O
inflammatory	O
diseases	O
.	O

The	O
present	O
study	O
examined	O
the	O
modulatory	O
effect	O
of	O
baicalin	O
on	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
-	O
induced	O
expression	O
of	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
in	O
human	O
oral	O
keratinocytes	O
(	O
HOKs	O
)	O
.	O

Cells	O
were	O
pre	O
-	O
treated	O
with	O
baicalin	O
(	O
0	O
-	O
80	O
microM	O
)	O
for	O
24	O
h	O
,	O
and	O
subsequently	O
treated	O
with	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
at	O
10	O
microg	O
/	O
ml	O
with	O
or	O
without	O
baicalin	O
for	O
3	O
h	O
.	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
transcripts	O
and	O
proteins	O
were	O
detected	O
by	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
and	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
,	O
respectively	O
.	O

The	O
expression	O
of	O
nuclear	O
factor	O
-	O
kappaB	O
(	O
NF	O
-	O
kappaB	O
)	O
,	O
p38	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
(	O
MAPK	O
)	O
and	O
c	O
-	O
Jun	O
N	O
-	O
terminal	O
kinase	O
(	O
JNK	O
)	O
proteins	O
was	O
analyzed	O
by	O
western	O
blot	O
.	O

A	O
panel	O
of	O
genes	O
related	O
to	O
toll	O
-	O
like	O
receptor	O
(	O
TLR	O
)	O
signaling	O
was	O
examined	O
by	O
PCR	O
array	O
.	O

We	O
found	O
that	O
baicalin	O
significantly	O
downregulated	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
-	O
stimulated	O
expression	O
of	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
,	O
and	O
inhibited	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
-	O
activated	O
NF	O
-	O
kappaB	O
,	O
p38	O
MAPK	O
and	O
JNK	O
.	O

Furthermore	O
,	O
baicalin	O
markedly	O
downregulated	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
-	O
induced	O
expression	O
of	O
genes	O
associated	O
with	O
TLR	O
signaling	O
.	O

In	O
conclusion	O
,	O
the	O
present	O
study	O
shows	O
that	O
baicalin	O
may	O
significantly	O
downregulate	O
P	B-bacteria
.	I-bacteria
gingivalis	I-bacteria
LPS	O
-	O
upregulated	O
expression	O
of	O
IL	O
-	O
6	O
and	O
IL	O
-	O
8	O
in	O
HOKs	O
via	O
negative	O
regulation	O
of	O
TLR	O
signaling	O
.	O

In	O
the	O
aging	O
population	O
,	O
the	O
prevalence	O
of	O
root	O
caries	O
has	O
been	O
observed	O
,	O
which	O
is	O
a	O
characteristic	O
feature	O
of	O
the	O
elderly	O
people	O
.	O

The	O
most	O
important	O
element	O
used	O
in	O
caries	O
prevention	O
is	O
fluoride	O
,	O
which	O
is	O
derived	O
from	O
the	O
air	O
,	O
diet	O
or	O
fluoride	O
-	O
containing	O
preparations	O
and	O
materials	O
,	O
e	O
.	O
g	O
.	O
glass	O
-	O
ionomer	O
restorations	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
evaluate	O
the	O
effect	O
of	O
Ketac	O
Molar	O
Aplicap	O
glass	O
-	O
ionomer	O
on	O
the	O
growth	O
of	O
Lactobacillus	B-bacteria
sp	I-bacteria
.	I-bacteria
bacteria	I-bacteria
,	O
one	O
of	O
the	O
species	O
most	O
frequently	O
found	O
in	O
the	O
carietic	O
focus	O
of	O
the	O
tooth	O
root	O
.	O

The	O
study	O
was	O
carried	O
out	O
in	O
15	O
patients	O
with	O
good	O
oral	O
hygiene	O
,	O
in	O
whom	O
35	O
fillings	O
from	O
Ketac	O
Molar	O
Aplicap	O
conventional	O
glass	O
-	O
ionomer	O
material	O
were	O
performed	O
.	O

After	O
6	O
months	O
,	O
three	O
-	O
day	O
dental	O
plaque	O
from	O
these	O
fillings	O
and	O
from	O
the	O
tooth	O
enamel	O
of	O
the	O
control	O
group	O
was	O
examined	O
.	O

No	O
statistically	O
significant	O
differences	O
(	O
p	O
=	O
0	O
.	O
554	O
)	O
in	O
the	O
amounts	O
of	O
Lactobacillus	B-bacteria
sp	I-bacteria
.	I-bacteria
between	O
the	O
study	O
and	O
control	O
group	O
were	O
revealed	O
.	O

Lack	O
of	O
inhibiting	O
effect	O
of	O
glass	O
-	O
ionomer	O
material	O
on	O
the	O
growth	O
of	O
the	O
dental	O
plaque	O
with	O
Lactobacillus	B-bacteria
sp	I-bacteria
.	I-bacteria
after	O
the	O
time	O
of	O
observation	O
is	O
implied	O
.	O

Imbalance	O
in	O
the	O
resident	O
microbiota	O
may	O
promote	O
the	O
growth	O
of	O
opportunistic	O
microorganisms	O
,	O
such	O
as	O
yeasts	O
of	O
Candida	O
genus	O
and	O
the	O
development	O
of	O
diseases	O
,	O
especially	O
in	O
aged	O
people	O
.	O

This	O
study	O
evaluated	O
whether	O
the	O
consumption	O
of	O
the	O
probiotic	O
Yakult	O
LBz	O
(	O
(	O
R	O
)	O
)	O
(	O
Lactobacillus	B-bacteria
casei	I-bacteria
and	O
Bifidobacterium	B-bacteria
breve	I-bacteria
)	O
was	O
able	O
to	O
influence	O
on	O
the	O
specific	O
immunological	O
response	O
against	O
Candida	O
and	O
on	O
the	O
presence	O
of	O
these	O
yeasts	O
in	O
the	O
oral	O
cavity	O
of	O
42	O
healthy	O
aged	O
individuals	O
.	O

Saliva	O
samples	O
were	O
collected	O
before	O
and	O
after	O
the	O
probiotic	O
use	O
for	O
30	O
days	O
,	O
3	O
times	O
a	O
week	O
.	O

The	O
samples	O
were	O
plated	O
in	O
Dextrose	O
Saboraud	O
Agar	O
with	O
chloramphenicol	O
,	O
the	O
colony	O
-	O
forming	O
units	O
(	O
CFU	O
/	O
mL	O
)	O
were	O
counted	O
and	O
the	O
Candida	O
species	O
were	O
identified	O
.	O

Anti	O
-	O
Candida	O
IgA	O
analysis	O
was	O
conducted	O
using	O
the	O
ELISA	O
technique	O
.	O

ANOVA	O
and	O
Student	O
'	O
s	O
t	O
-	O
test	O
were	O
used	O
for	O
normally	O
distributed	O
data	O
and	O
the	O
Wilcoxon	O
test	O
was	O
used	O
for	O
data	O
with	O
non	O
-	O
normal	O
distribution	O
(	O
alpha	O
=	O
0	O
.	O
05	O
)	O
.	O

The	O
results	O
showed	O
a	O
statistically	O
significant	O
reduction	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
in	O
Candida	O
prevalence	O
(	O
from	O
92	O
.	O
9	O
%	O
to	O
85	O
.	O
7	O
%	O
)	O
,	O
in	O
CFU	O
/	O
mL	O
counts	O
of	O
Candida	O
and	O
in	O
the	O
number	O
of	O
non	O
-	O
albicans	O
species	O
after	O
consumption	O
of	O
the	O
probiotic	O
.	O

Immunological	O
analysis	O
demonstrated	O
a	O
significant	O
increase	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
in	O
anti	O
-	O
Candida	O
IgA	O
levels	O
.	O

In	O
conclusion	O
,	O
probiotic	O
bacteria	O
reduced	O
Candida	O
numbers	O
in	O
the	O
oral	O
cavity	O
of	O
the	O
elderly	O
and	O
increased	O
specific	O
secretory	O
immune	O
response	O
against	O
these	O
yeasts	O
,	O
suggesting	O
its	O
possible	O
use	O
in	O
controlling	O
oral	O
candidosis	O
.	O

Recent	O
insights	O
in	O
medical	O
science	O
indicate	O
that	O
human	O
biofilms	O
play	O
an	O
important	O
role	O
in	O
health	O
and	O
well	O
-	O
being	O
,	O
and	O
have	O
put	O
microbiota	O
modulation	O
through	O
bacteriotherapy	O
into	O
focus	O
.	O

In	O
dentistry	O
,	O
bacterial	O
interference	O
with	O
probiotic	O
bacteria	O
to	O
support	O
the	O
stability	O
and	O
diversity	O
of	O
oral	O
biofilms	O
has	O
gained	O
similar	O
interest	O
.	O

Investigations	O
in	O
vitro	O
into	O
metabolic	O
activity	O
,	O
co	O
-	O
aggregation	O
,	O
growth	O
inhibition	O
,	O
bacteriocin	O
production	O
,	O
and	O
adhesion	O
have	O
collectively	O
suggested	O
a	O
potential	O
role	O
for	O
probiotic	O
lactobacilli	B-bacteria
and	O
bifidobacteria	B-bacteria
to	O
modulate	O
the	O
oral	O
microbial	O
ecology	O
.	O

Likewise	O
,	O
short	O
-	O
term	O
clinical	O
studies	O
with	O
intermediate	O
microbial	O
endpoints	O
indicate	O
that	O
interference	O
with	O
caries	O
-	O
associated	O
bacteria	O
seems	O
possible	O
through	O
probiotic	O
dairy	O
products	O
,	O
tablets	O
,	O
lozenges	O
and	O
chewing	O
gum	O
in	O
various	O
dose	O
regimens	O
.	O

Few	O
randomized	O
controlled	O
clinical	O
trials	O
with	O
caries	O
outcomes	O
are	O
available	O
,	O
but	O
three	O
studies	O
with	O
preschool	O
children	O
and	O
the	O
elderly	O
have	O
demonstrated	O
preventive	O
fractions	O
between	O
21	O
%	O
and	O
75	O
%	O
,	O
following	O
regular	O
intake	O
of	O
milk	O
supplemented	O
with	O
probiotic	O
lactobacilli	B-bacteria
.	O

However	O
,	O
further	O
large	O
-	O
scale	O
trials	O
with	O
orally	O
derived	O
anti	O
-	O
caries	O
candidates	O
are	O
needed	O
before	O
we	O
can	O
say	O
that	O
we	O
are	O
ready	O
for	O
bacteriotherapy	O
as	O
an	O
adjunct	O
to	O
complement	O
the	O
existing	O
evidence	O
-	O
based	O
methods	O
for	O
preventing	O
and	O
controlling	O
caries	O
in	O
daily	O
practice	O
.	O

Dental	O
caries	O
is	O
the	O
destruction	O
of	O
enamel	O
,	O
dentin	O
,	O
or	O
cementum	O
of	O
teeth	O
due	O
to	O
bacterial	O
activities	O
,	O
which	O
if	O
left	O
untreated	O
can	O
cause	O
considerable	O
pain	O
,	O
discomfort	O
,	O

treatment	O
costs	O
are	O
very	O
high	O
.	O

Of	O
the	O
oral	O
bacteria	O
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
is	O
considered	O
to	O
be	O
causative	O
agent	O
of	O
dental	O
caries	O
in	O
humans	O
.	O

This	O

aims	O
at	O
screening	O
the	O
antibacterial	O
potential	O
of	O
available	O
oral	O
hygiene	O
products	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
,	O
the	O
primary	O
etiological	O
agent	O
.	O

selective	O
number	O
of	O
toothpaste	O
mouth	O
rinse	O
available	O
in	O
the	O
nearby	O
local	O
market	O
was	O
subjected	O
to	O
the	O
.	O

The	O
experiments	O
were	O
designed	O
in	O
a	O
way	O
to	O
determine	O
which	O
one	O
of	O
these	O
products	O
had	O
the	O
greatest	O
anti	O
-	O
S	O
.	O
mutans	O
activity	O
.	O

Antibiotic	O
sensitivity	O
tests	O
against	O
the	O
pathogenic	O
strains	O
were	O
also	O
conducted	O
.	O

Pathogenic	O
strains	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
were	O
isolated	O
from	O
clinical	O
dental	O
specimen	O

identified	O
using	O
MTCC	O
standard	O
strain	O
No	B-bacteria
.	I-bacteria
890	I-bacteria
.	O

Of	O
the	O
86	O
.	O
66	O
%	O
samples	O
which	O
showed	O
positive	O
for	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
growth	O
,	O
almost	O
96	O
%	O
conferred	O
sensitivity	O
to	O
0	O
.	O
08	O
mg	O
/	O
ml	O
of	O
penicillin	O
.	O

Among	O
the	O
toothpastes	O
used	O
,	O
A	O
showed	O
the	O
maximum	O
inhibitory	O
activity	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
inhibiting	O
its	O
growth	O
even	O
at	O
a	O
very	O
low	O
concentration	O
of	O
0	O
.	O
0156	O
g	O
/	O
ml	O
.	O

Similar	O
results	O
were	O
seen	O
in	O
the	O
case	O
of	O
the	O
mouth	O
rinses	O
used	O
for	O
the	O

,	O
which	O
showed	O
that	O
N	O
had	O
the	O
most	O
effective	O
activity	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
even	O
at	O
1	O
:	O
8	O
dilution	O
.	O

The	O
oral	O
hygiene	O
products	O
containing	O
triclosan	O
proved	O
to	O
be	O
the	O
most	O
effective	O
followed	O
by	O
those	O
containing	O
fluoride	O
.	O

Herbal	O
products	O
showed	O
comparatively	O
lesser	O
activity	O
in	O
inhibiting	O
the	O
growth	O
of	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
.	O

Even	O
though	O
there	O
are	O
so	O
many	O
products	O
available	O
to	O
curb	O
the	O
progression	O
of	O
dental	O
caries	O
in	O
the	O
population	O
targeted	O
,	O
there	O
is	O
still	O
an	O
undoubted	O
prevalence	O

incidence	O
of	O
caries	O
among	O
the	O
general	O
public	O
.	O

The	O
need	O
for	O
a	O
better	O
alternative	O
to	O
help	O
control	O
dental	O
caries	O
is	O
on	O
the	O
rise	O
even	O
today	O
.	O

We	O
have	O
isolated	O
4	O
antibacterial	O
substances	O
that	O
were	O
active	O
against	O
the	O
oral	O
bacteria	O
that	O
cause	O
dental	O
caries	O
and	O
periodontitis	O
,	O
such	O
as	O
Streptococcus	B-bacteria
mutans	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
and	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
from	O
lemon	O
peel	O
,	O
a	O
waste	O
product	O
in	O
the	O
citrus	O
industry	O
.	O

The	O
isolated	O
substances	O
were	O
identified	O
as	O
8	O
-	O
geranyloxypsolaren	O
,	O
5	O
-	O
geranyloxypsolaren	O
,	O
5	O
-	O
geranyloxy	O
-	O
7	O
-	O
methoxycoumarin	O
,	O
and	O
phloroglucinol	O
1	O
-	O
beta	O
-	O
D	O
-	O
glucopyranoside	O
(	O
phlorin	O
)	O
upon	O
structural	O
analyses	O
.	O

Among	O
these	O
,	O
8	O
-	O
Geranyloxypsolaren	O
,	O
5	O
-	O
geranyloxypsolaren	O
,	O
and	O
5	O
-	O
geranyloxy	O
-	O
7	O
-	O
methoxycoumarin	O
exhibited	O
high	O
antibacterial	O
activity	O
.	O

These	O
3	O
compounds	O
were	O
effectively	O
extracted	O
using	O
ethanol	O
and	O
n	O
-	O
hexane	O
,	O
whereas	O
phlorin	O
was	O
extracted	O
with	O
water	O
.	O

Further	O
,	O
the	O
above	O
3	O
compounds	O
were	O
present	O
in	O
lemon	O
essential	O
oil	O
and	O
abundantly	O
present	O
in	O
the	O
residue	O
produced	O
upon	O
the	O
cooling	O
treatment	O
of	O
concentrated	O
lemon	O
essential	O
oil	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
find	O
the	O
oral	O
isolate	O
of	O
lactobacilli	B-bacteria
,	O
which	O
has	O
the	O
potential	O
to	O
inhibit	O
either	O
periodontal	O
,	O
cariogenic	O
,	O
or	O
fungal	O
pathogens	O
in	O
vitro	O
,	O
and	O
to	O
examine	O
the	O
effects	O
of	O
bovine	O
milk	O
fermented	O
with	O
the	O
isolate	O
on	O
the	O
oral	O
carriage	O
of	O
cariogenic	O
and	O
periodontal	O
pathogens	O
.	O

The	O
inhibitory	O
effects	O
of	O
the	O
supernatant	O
of	O
Man	O
-	O
Rogosa	O
-	O
Sharpe	O
broth	O
,	O
in	O
which	O
each	O
of	O
42	O
oral	O
isolates	O
of	O
lactobacilli	B-bacteria
grown	O
,	O
was	O
examined	O
.	O

One	O
isolate	O
,	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
L8020	I-bacteria
,	O
that	O
showed	O
the	O
potential	O
to	O
inhibit	O
either	O
periodontal	O
,	O
cariogenic	O
,	O
or	O
fungal	O
pathogens	O
in	O
vitro	O
,	O
was	O
used	O
to	O
examine	O
the	O
effects	O
of	O
fermented	O
milk	O
on	O
the	O
oral	O
carriage	O
of	O
cariogenic	O
and	O
periodontal	O
pathogens	O
,	O
which	O
was	O
examined	O
by	O
a	O
placebo	O
-	O
controlled	O
and	O
cohort	O
trial	O
using	O
50	O
participants	O
.	O

Edible	O
yogurt	O
containing	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
L8020	I-bacteria
significantly	O
reduced	O
the	O
oral	O
carriage	O
of	O
mutans	B-bacteria
streptococci	I-bacteria
(	O
P	O
<	O
0	O
.	O
01	O
)	O
and	O
four	O
periodontal	O
pathogens	O
examined	O
:	O
Porphyromonas	B-bacteria
gingivalis	I-bacteria
,	O
Prevotella	B-bacteria
intermedia	I-bacteria
,	O
Tannerella	B-bacteria
forsythia	I-bacteria
,	O
and	O
Fusobacterium	B-bacteria
spp	I-bacteria
.	I-bacteria
(	O
P	O
<	O
0	O
.	O
01	O
)	O
,	O
but	O
the	O
phenomenon	O
were	O
not	O
observed	O
with	O
the	O
placebo	O
yogurt	O
(	O
P	O
>	O
0	O
.	O
05	O
)	O
.	O

These	O
results	O
suggest	O
that	O
yogurt	O
with	O
Lactobacillus	B-bacteria
rhamnosus	I-bacteria
L8020	I-bacteria
could	O
reduce	O
the	O
risk	O
of	O
dental	O
caries	O
and	O
periodontal	O
disease	O
.	O

The	O
polysaccharide	O
gel	O
(	O
PG	O
)	O
extract	O
from	O
durian	O
fruit	O
rinds	O
(	O
Durio	O
zibethinus	O
Murr	O
.	O
`	O
`	O
Monthong	O
'	O
'	O
)	O
is	O
a	O
pectic	O
polysaccharide	O
with	O
antibacterial	O
activity	O
.	O

This	O
study	O
aimed	O
to	O
investigate	O
the	O
in	O
vitro	O
antibacterial	O
activity	O
of	O
PG	O
against	O
oral	O
pathogens	O
,	O
Streptococcus	B-bacteria
mutans	I-bacteria
(	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
)	O
and	O
Aggregatibacter	B-bacteria
actinomycetemcomitans	I-bacteria
(	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
)	O
.	O

The	O
inhibitory	O
activity	O
of	O
PG	O
at	O
50	O
,	O
100	O
,	O
and	O
150	O
mg	O
/	O
mL	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
(	O
American	O
Tissue	O
Culture	O
Collection	O
25175	O
)	O
and	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
(	O
American	O
Tissue	O
Culture	O
Collection	O
43718	O
)	O
was	O
determined	O
after	O
1	O
-	O
and	O
5	O
-	O
min	O
exposure	O
by	O
broth	O
macrodilution	O
susceptibility	O
test	O
and	O
scanning	O
electron	O
microscopy	O
.	O

Normal	O
saline	O
or	O
culture	O
broth	O
medium	O
and	O
0	O
.	O
1	O
%	O
chlorhexidine	O
were	O
used	O
as	O
negative	O
and	O
positive	O
controls	O
,	O
respectively	O
.	O

For	O
1	O
-	O
min	O
exposure	O
,	O
150	O
mg	O
/	O
mL	O
PG	O
or	O
0	O
.	O
1	O
%	O
chlorhexidine	O
significantly	O
possessed	O
bactericidal	O
activity	O
against	O
both	O
tested	O
bacteria	O
(	O
P	O
=	O
0	O
.	O
037	O
)	O
,	O
while	O
PG	O
at	O
100	O
mg	O
/	O
mL	O
possessed	O
significant	O
bactericidal	O
activity	O
against	O
S	B-bacteria
.	I-bacteria
mutans	I-bacteria
(	O
P	O
=	O
0	O
.	O
037	O
)	O
and	O
inhibitory	O
activity	O
against	O
A	B-bacteria
.	I-bacteria
actinomycetemcomitans	I-bacteria
(	O
P	O
=	O
0	O
.	O
05	O
)	O
.	O

Blebs	O
,	O
irregular	O
-	O
shaped	O
cells	O
,	O
and	O
disrupted	O
cells	O
were	O
found	O
in	O
bacteria	O
treated	O
with	O
either	O
0	O
.	O
1	O
%	O
chlorhexidine	O
or	O
50	O
-	O
150mg	O
/	O
mL	O
PG	O
under	O
scanning	O
electron	O
microscopy	O
.	O

The	O
bactericidal	O
activity	O
of	O
PG	O
at	O
150	O
mg	O
/	O
mL	O
against	O
oral	O
bacteria	O
at	O
1	O
-	O
min	O
exposure	O
suggests	O
its	O
possibility	O
to	O
be	O
used	O
as	O
a	O
natural	O
antibacterial	O
ingredient	O
in	O
oral	O
hygiene	O
products	O
.	O

